$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4-fluoro-5-methylbenzoate
C9H10FNO2
1037206-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 N 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 F 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-6-methyl-4(3H)-quinazolinone
C9H7FN2O
1037206-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3338 0.0 0
M  V30 2 C 5.3900 0.0000 0.0 0
M  V30 3 F 6.9300 2.6674 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1037206-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037206-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-890411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step D - Synthesis of Compound 5E The solution of compound 5D (500 mg,
2.73 mmol) in formamide (6.0 mL) was heated to 150 °C in an oil bath and
stirred for 18 hours. After cooled to room temperature, ethyl acetate
(100 mL) and water (100 mL) were added and the layers were separated. The
organic solution was washed with water (2 x 60 mL), dried over MgSO4 and
concentrated in vacuo to provide the crude product 5E (0.50 g, quant.)
which, was used without further purification. Compound 5E, yield (0.50 g,
quant.). MS found for C9H7FN2O: 179.0 (M+H)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM other reaction condition gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tricyclic indole derivatives as HCV NS5B polymerase inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of HCV
infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Venkatraman, Srikanth; Anilkumar, Gopinadhan N.; Chen, Kevin X.;
Velazquez, Francisco; Zeng, Qingbei; Liu, Duan; Jiang, Yueheng;
Kozlowski, Joseph A.; Njoroge, F. George; Rosenblum, Stuart B.; Gavalas,
Stephen J.; Pinto, Patrick A.; Selyutin, Oleg B.; Vibulbhan, Bancha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009152200 A1 2009-12-17

$RFMT $RIREG SCHEME1 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4-fluoro-5-methylbenzoate
C9H10FNO2
1037206-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 N 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 F 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-6-methyl-4(3H)-quinazolinone
C9H7FN2O
1037206-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3338 0.0 0
M  V30 2 C 5.3900 0.0000 0.0 0
M  V30 3 F 6.9300 2.6674 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1037206-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037206-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9285441
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The solution of compound 28D (500 mg, 2.73 mmol) in formamide (6.0 mL)
was heated to 150 °C in an oil bath and stirred for 18 hours. After
cooled to room temperature, ethyl acetate (100 mL) and water (100 mL)
were added and the layers were separated. The organic solution was washed
with water (2 x 60 mL), dried over MgSO4 and concentrated in vacuo to
provide the crude product 28E (0.50 g, quant.) which was used without
further purification. Compound 28E, yield (0.50 g, quant.)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted indole derivatives for use in treatment or
prevention of hepatitis C viral infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anilkumar, Gopinadhan N.; Bennett, Frank; Chan, Tin-Yau; Chen, Kevin X.;
Sannigrahi, Mousumi; Velazquez, Francisco; Venkatraman, Srikanth; Zeng,
Qingbei; Duca, Jose S.; Lesburg, Charles A.; Kozlowski, Joseph A.;
Njoroge, F. George; Rosenblum, Stuart B.; Shih, Neng-Yang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009032124 A1 2009-03-12

$RFMT $RIREG SCHEME1 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4-fluoro-5-methylbenzoate
C9H10FNO2
1037206-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 N 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 F 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-6-methyl-4(3H)-quinazolinone
C9H7FN2O
1037206-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3338 0.0 0
M  V30 2 C 5.3900 0.0000 0.0 0
M  V30 3 F 6.9300 2.6674 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1037206-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037206-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4251425
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step D-Synthesis of Compound 9E. The solution of compound 9D (500 mg,
2.73 mmol) in formamide (6.0 mL) was heated to 150°C in an oil bath and
stirred for 18 hours. After cooled to room temperature, ethyl acetate
(100 mL) and water (100 mL) were added and the layers were separated. The
organic solution was washed with water (2 × 60 mL), dried over MgSO4 and
concentrated in vacuo to provide the crude product 9E (0.50 g, quant.)
which, was used without further purification. MS found for C9H7FN2O:
179.0 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2,3-substituted azaindole derivatives for treating viral
infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anilkumar, Gopinadhan N.; Rosenblum, Stuart B.; Venkatraman, Srikanth;
Njoroge, F. George; Kozlowski, Joseph A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009032125 A1 2009-03-12

$RFMT $RIREG SCHEME1 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4-fluoro-5-methylbenzoate
C9H10FNO2
1037206-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 N 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 F 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-6-methyl-4(3H)-quinazolinone
C9H7FN2O
1037206-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3338 0.0 0
M  V30 2 C 5.3900 0.0000 0.0 0
M  V30 3 F 6.9300 2.6674 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1037206-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037206-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12974378
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The solution of compound 28D (500 mg, 2.73 mmol) in formamide (6.0 mL)
was heated to 150 °C in an oil bath and stirred for 18 hours. After
cooled to room temperature, ethyl acetate (100 mL) and water (100 mL)
were added and the layers were separated. The organic solution was washed
with water (2 x 60 mL), dried over MgSO4 and concentrated in vacuo to
provide the crude product 28E (0.50 g, quant.) which, was used without
further purification. compound 28E, yield (0.50 g, quant.). MS found for
C9H7FN2O: 179.0 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetracyclic indole derivatives as HCV NS5B polymerase inhibitors and
their preparation, pharmaceutical compositions and use in the treatment
of viral infection and viral related disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bennett, Frank; Zeng, Qingbei; Venkatraman, Srikanth; Sannigrahi,
Mousumi; Chen, Kevin X.; Anilkumar, Gopinadhan N.; Rosenblum, Stuart B.;
Kozlowski, Joseph A.; Njoroge, F. George
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009032123 A2 2009-03-12

$RFMT $RIREG SCHEME1 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4-fluoro-5-methylbenzoate
C9H10FNO2
1037206-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 N 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 F 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-6-methyl-4(3H)-quinazolinone
C9H7FN2O
1037206-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3338 0.0 0
M  V30 2 C 5.3900 0.0000 0.0 0
M  V30 3 F 6.9300 2.6674 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1037206-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037206-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2829926
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step D-Synthesis of Compound AA5 The solution of compound AA4 (500 mg,
2.73 mmol) in formamide (6.0 mL) was heated to 150° C. in an oil bath and
stirred for 18 h. After cooled to room temperature, ethyl acetate (100
mL) and water (100 mL) were added and the layers were separated. The
organic solution was washed with water (2×60 mL), dried over MgSO4 and
concentrated in vacuo. The crude product AA5 (0.50 g, quant.) which, was
used without further purification. MS found for C9H7FN2O: 179.0 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted indole derivatives for use as antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bennett, Frank; Venkatraman, Srikanth; Njoroge, F. George; Chen, Kevin
X.; Shih, Neng-Yang; Rosenblum, Stuart B.; Kozlowski, Joseph A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008136815 A2 2008-11-13

$RFMT $RIREG SCHEME1 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4-fluoro-5-methylbenzoate
C9H10FNO2
1037206-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 N 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 F 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-6-methyl-4(3H)-quinazolinone
C9H7FN2O
1037206-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3338 0.0 0
M  V30 2 C 5.3900 0.0000 0.0 0
M  V30 3 F 6.9300 2.6674 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1037206-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037206-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3912001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step D - Synthesis of Compound AA5. The solution of compound AA4 (500 mg,
2.73 mmol) in formamide (6.0 mL) was heated to 150°C in an oil bath and
stirred for 18 hours. After cooled to room temperature, ethyl acetate
(100 mL) and water (100 mL) were added and the layers were separated. The
organic solution was washed with water (2 × 60 mL), dried over MgSO4 and
concentrated in vacuo to provide the crude product AA5 (0.50 g, quant.)
which, was used without further purification. MS found for C9H7FN2O:
179.0 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indole derivatives for treating or preventing of HCV and
related viral infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Kevin X.; Venkatraman, Srikanth; Njoroge, F. George; Rosenblum,
Stuart B.; Lesburg, Charles A.; Duca, Jose S.; Shih, Neng-Yang;
Velazquez, Francisco; Anilkumar, Gopinadhan N.; Zeng, Qingbei; Kozlowski,
Joseph A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008082484 A1 2008-07-10

$RFMT $RIREG SCHEME1 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4-fluoro-5-methylbenzoate
C9H10FNO2
1037206-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 N 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 F 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-6-methyl-4(3H)-quinazolinone
C9H7FN2O
1037206-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3338 0.0 0
M  V30 2 C 5.3900 0.0000 0.0 0
M  V30 3 F 6.9300 2.6674 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1037206-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037206-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12360206
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step D-Synthesis of Compound AA5. The solution of compound AA4 (500 mg,
2.73 mmol) in formamide (6.0 mL) was heated to 150°C in an oil bath and
stirred for 18 h. After cooled to room temperature, ethyl acetate (100
mL) and water (100 mL) were added and the layers were separated. The
organic solution was washed with water (2 × 60 mL), dried over MgSO4 and
concentrated in vacuo to provide the crude product AAS (0.50 g, quant.)
which, was used without further purification. MS found for C9H7FN2O:
179.0 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indole derivatives for treating or preventing of HCV and
related viral infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anilkumar, Gopinadhan N.; Jiang, Yueheng; Rosenblum, Stuart B.;
Venkatraman, Srikanth; Velazquez, Francisco; Shih, Neng-Yang; Njoroge, F.
George; Kozlowski, Joseph A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008082488 A1 2008-07-10

$RFMT $RIREG SCHEME2 STEP1
$RXN



  4  1
$MOL
Methyl 2,3-dihydro-6-nitro-2-oxo-1H-benzimidazole-5-carboxylate
C9H7N3O5
205259-23-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 O 1.5400 5.3347 0.0 0
M  V30 3 O 1.5400 2.6674 0.0 0
M  V30 4 C 0.0000 5.3347 0.0 0
M  V30 5 O 9.9312 6.6229 0.0 0
M  V30 6 N 3.8500 1.3338 0.0 0 VAL=5
M  V30 7 O 2.3100 1.3338 0.0 0
M  V30 8 O 4.6200 0.0000 0.0 0
M  V30 9 C 6.1600 5.3347 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 N 7.1906 6.4792 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0
M  V30 14 N 8.4364 4.3212 0.0 0
M  V30 15 C 3.8500 4.0011 0.0 0
M  V30 16 C 8.5974 5.8529 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 5 16
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 17
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Iodopropane
C3H7I
107-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 I 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Piperazine
C4H10N2
110-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 C 0.7700 0.0000 0.0 0
M  V30 3 N 0.7700 2.6673 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dihydro-8-(1-piperazinyl)-1,3-dipropyl-2H-imidazo[4,5-g]quinazolin-2-one
C19H26N6O
205259-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9581 2.6091 0.0 0
M  V30 2 C 6.4341 1.1444 0.0 0
M  V30 3 C 5.4036 0.0000 0.0 0
M  V30 4 C 10.6530 5.3195 0.0 0
M  V30 5 C 11.6834 4.1751 0.0 0
M  V30 6 C 13.1898 4.4953 0.0 0
M  V30 7 O 9.2902 2.2587 0.0 0
M  V30 8 C 6.6685 5.2597 0.0 0
M  V30 9 C 8.0021 6.0297 0.0 0
M  V30 10 N 6.9887 3.7534 0.0 0
M  V30 11 C 5.3347 6.0297 0.0 0
M  V30 12 N 9.1465 4.9993 0.0 0
M  V30 13 C 8.0021 7.5697 0.0 0
M  V30 14 C 8.5202 3.5925 0.0 0
M  V30 15 C 5.3347 7.5697 0.0 0
M  V30 16 C 6.6685 8.3397 0.0 0
M  V30 17 C 4.0011 8.3397 0.0 0
M  V30 18 N 6.6685 9.8797 0.0 0
M  V30 19 N 4.0011 9.8797 0.0 0
M  V30 20 C 5.3347 10.6497 0.0 0
M  V30 21 N 2.6674 7.5697 0.0 0
M  V30 22 C 2.6674 6.0297 0.0 0
M  V30 23 C 1.3338 8.3397 0.0 0
M  V30 24 C 1.3338 5.2597 0.0 0
M  V30 25 C 0.0000 7.5697 0.0 0
M  V30 26 N 0.0000 6.0297 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 14
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 16
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 205259-23-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107-08-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 110-85-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 205259-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-5841347
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(6):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To an ice-cooled solution of
1,3-dihydro-6-nitro-2-oxo-2H-benzimidazole-5-carboxylic acid methyl ester
(7.78 g, 32.8 mmol) in DMF (100 mL) was added 60% sodium hydride (3.94 g,
98.5 mmol). The mixture was stirred for 15 min at the same temperature,
and iodomethane (6.13 mL, 98.5 mmol) was added. Then the reaction mixture
was stirred for 1.5 h at room temperature and poured into water. The
resulting precipitate was collected, washed with water, and dried to
provide
1,3-dihydro-1,3-dimethyl-6-nitro-2-oxo-2H-benzimidazole-5-carboxylic acid
methyl ester (8.58 g, 32.5 mmol) in 99% yield. (3) A suspension of
1,3-dihydro-1,3-dimethyl-6-nitro-2-oxo-2H-benzimidazole-5-carboxylic acid
methyl ester (8.58 g, 32.4 mmol) and 10% Pd/C (1.60 g, containing 50%
water) in ethanol (100 mL) was hydrogenated for 5.5 h under hydrogen
stream at room temperature. After removal of catalyst by filtration
through Celite, the filtrate was evaporated to provide
6-amino-1,3-dihydro-1,3-dimethyl-2-oxo-2H-benzimidazole-5-carboxylic acid
methyl ester. This compound was used for the next reaction without
further purification. (4) A solution of
6-amino-1,3-dihydro-1,3-dimethyl-2-oxo-2H-benzimidazole-5-carboxylic acid
methyl ester in forma- mide (100 mL) was heated for 2 h at 190°C. The
reaction mixture was cooled to room temperature and poured into water,
and then NaCl was added. The resulting precipitate was collected, washed
with water, and dried to provide
1,3-dihydro-1,3-dimethyl-2H,7H-imidazo[4,5-g]quinazoline-2,8-di-one (4.73
g, 20.7 mmol) in 64% yield in two steps. Commercially available
4-hydroxyquinazoline (1.00 g, 6.85 mmol) was chlorinated with phosphorus
oxychloride (20 mL) by a known procedure. A mixture of
4-chloroquinazoline and anhydrous piperazine (5.89 g, 68.4 mmol) in
2-propanol (20 mL) was refluxed for 4 h. The reaction mixture was
evaporated, and the resulting residue was dissolved in brine, extracted
with chloroform, washed with brine, dried over anhydrous sodium sulfate,
and evaporated.
1,3-dihydro-1,3-dipropyl-2-oxo-8-(1-piperazinyl)-2H-imidazo[4,5-g]quinazoline.
quantitative yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent and Selective Inhibitors of Platelet-Derived Growth Factor
Receptor Phosphorylation. 3. Replacement of Quinazoline Moiety and
Improvement of Metabolic Polymorphism of 4-[4-(N-Substituted
(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matsuno, Kenji; Ushiki, Junko; Seishi, Takashi; Ichimura, Michio; Giese,
Neill A.; Yu, Jin-Chen; Takahashi, Shusuke; Oda, Shoji; Nomoto, Yuji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(23), 4910-4925

$RFMT $RIREG SCHEME3 STEP1
$RXN



  4  1
$MOL
Methyl 2,3-dihydro-6-nitro-2-oxo-1H-benzimidazole-5-carboxylate
C9H7N3O5
205259-23-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 O 1.5400 5.3347 0.0 0
M  V30 3 O 1.5400 2.6674 0.0 0
M  V30 4 C 0.0000 5.3347 0.0 0
M  V30 5 O 9.9312 6.6229 0.0 0
M  V30 6 N 3.8500 1.3338 0.0 0 VAL=5
M  V30 7 O 2.3100 1.3338 0.0 0
M  V30 8 O 4.6200 0.0000 0.0 0
M  V30 9 C 6.1600 5.3347 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 N 7.1906 6.4792 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0
M  V30 14 N 8.4364 4.3212 0.0 0
M  V30 15 C 3.8500 4.0011 0.0 0
M  V30 16 C 8.5974 5.8529 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 5 16
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 17
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butyl iodide
C4H9I
542-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 C 4.0010 0.0000 0.0 0
M  V30 4 C 0.0000 0.7700 0.0 0
M  V30 5 I 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Piperazine
C4H10N2
110-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 C 0.7700 0.0000 0.0 0
M  V30 3 N 0.7700 2.6673 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dibutyl-1,3-dihydro-8-(1-piperazinyl)-2H-imidazo[4,5-g]quinazolin-2-one
C21H30N6O
205259-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6402 3.5673 0.0 0
M  V30 2 C 8.7848 2.5368 0.0 0
M  V30 3 C 8.4646 1.0304 0.0 0
M  V30 4 C 9.6090 0.0000 0.0 0
M  V30 5 C 10.3508 8.2621 0.0 0
M  V30 6 C 11.8155 7.7861 0.0 0
M  V30 7 C 12.9599 8.8167 0.0 0
M  V30 8 C 14.4246 8.3408 0.0 0
M  V30 9 O 10.7010 4.9300 0.0 0
M  V30 10 C 6.9300 6.2181 0.0 0
M  V30 11 C 7.7000 7.5517 0.0 0
M  V30 12 N 7.9606 5.0737 0.0 0
M  V30 13 C 5.3900 6.2181 0.0 0
M  V30 14 N 9.2064 7.2315 0.0 0
M  V30 15 C 6.9300 8.8855 0.0 0
M  V30 16 C 9.3674 5.7000 0.0 0
M  V30 17 C 4.6200 7.5517 0.0 0
M  V30 18 C 5.3900 8.8855 0.0 0
M  V30 19 C 3.0800 7.5517 0.0 0
M  V30 20 N 4.6200 10.2191 0.0 0
M  V30 21 N 2.3100 8.8855 0.0 0
M  V30 22 C 3.0800 10.2191 0.0 0
M  V30 23 N 2.3100 6.2181 0.0 0
M  V30 24 C 3.0800 4.8844 0.0 0
M  V30 25 C 0.7700 6.2181 0.0 0
M  V30 26 C 2.3100 3.5508 0.0 0
M  V30 27 C 0.0000 4.8844 0.0 0
M  V30 28 N 0.7700 3.5508 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 9 16
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 18
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 205259-23-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 542-69-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 110-85-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 205259-30-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-7968618
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(6):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To an ice-cooled solution of
1,3-dihydro-6-nitro-2-oxo-2H-benzimidazole-5-carboxylic acid methyl ester
(7.78 g, 32.8 mmol) in DMF (100 mL) was added 60% sodium hydride (3.94 g,
98.5 mmol). The mixture was stirred for 15 min at the same temperature,
and iodomethane (6.13 mL, 98.5 mmol) was added. Then the reaction mixture
was stirred for 1.5 h at room temperature and poured into water. The
resulting precipitate was collected, washed with water, and dried to
provide
1,3-dihydro-1,3-dimethyl-6-nitro-2-oxo-2H-benzimidazole-5-carboxylic acid
methyl ester (8.58 g, 32.5 mmol) in 99% yield. (3) A suspension of
1,3-dihydro-1,3-dimethyl-6-nitro-2-oxo-2H-benzimidazole-5-carboxylic acid
methyl ester (8.58 g, 32.4 mmol) and 10% Pd/C (1.60 g, containing 50%
water) in ethanol (100 mL) was hydrogenated for 5.5 h under hydrogen
stream at room temperature. After removal of catalyst by filtration
through Celite, the filtrate was evaporated to provide
6-amino-1,3-dihydro-1,3-dimethyl-2-oxo-2H-benzimidazole-5-carboxylic acid
methyl ester. This compound was used for the next reaction without
further purification. (4) A solution of
6-amino-1,3-dihydro-1,3-dimethyl-2-oxo-2H-benzimidazole-5-carboxylic acid
methyl ester in forma- mide (100 mL) was heated for 2 h at 190°C. The
reaction mixture was cooled to room temperature and poured into water,
and then NaCl was added. The resulting precipitate was collected, washed
with water, and dried to provide
1,3-dihydro-1,3-dimethyl-2H,7H-imidazo[4,5-g]quinazoline-2,8-di-one (4.73
g, 20.7 mmol) in 64% yield in two steps. Commercially available
4-hydroxyquinazoline (1.00 g, 6.85 mmol) was chlorinated with phosphorus
oxychloride (20 mL) by a known procedure. A mixture of
4-chloroquinazoline and anhydrous piperazine (5.89 g, 68.4 mmol) in
2-propanol (20 mL) was refluxed for 4 h. The reaction mixture was
evaporated, and the resulting residue was dissolved in brine, extracted
with chloroform, washed with brine, dried over anhydrous sodium sulfate,
and evaporated.
1,3-dibutyl-1,3-dihydro-2-oxo-8-(1-piperazinyl)-2H-imidazo[4,5-g]quinazoline.
quantitative yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent and Selective Inhibitors of Platelet-Derived Growth Factor
Receptor Phosphorylation. 3. Replacement of Quinazoline Moiety and
Improvement of Metabolic Polymorphism of 4-[4-(N-Substituted
(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matsuno, Kenji; Ushiki, Junko; Seishi, Takashi; Ichimura, Michio; Giese,
Neill A.; Yu, Jin-Chen; Takahashi, Shusuke; Oda, Shoji; Nomoto, Yuji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(23), 4910-4925

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-4-fluoro-, ethyl ester
C9H10FNO2
117324-05-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 C 9.3358 2.3100 0.0 0
M  V30 6 N 2.6674 0.0000 0.0 0
M  V30 7 F 0.0000 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 9
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoroquinazolin-4(3H)-one
C8H5FN2O
16499-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 F 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 N 2.3101 0.0000 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117324-05-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16499-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6984633
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step B: To the formamide (6mL) solution of ethy2-amino-4-fluorobenzoate
(811mg, 4.43mmol) added ammonium formate (0.450g, 7.14mmol) and the
reaction mixture was heated at 140°C overnight. After cooling added water
and ethyl acetate. The layers were separated, the EtOAc layer was dried,
filtered and evaporated to give desired quinazolinone (quantitative).
Yield 1g. MS (ES) 165 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-[4-(phenylcarbamoyl)piperazino]quinazolines as PDGF
receptor phosphorylation inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pandey, Anjali; Scarborough, Robert M.; Matsuno, Kenji; Ichimura, Michio;
Nomoto, Yuji; Fujiwara, Shigeki; Ide, Shinichi; Tsukuda, Eiji; Irie,
Junko; Oda, Shoji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002016362 A2 2002-02-28

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxybenzophenone
C13H10O2
13020-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 O 9.3358 1.5400 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 C 6.6684 1.5400 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 6.6684 4.6200 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 1.3336 1.5400 0.0 0
M  V30 13 C 1.3336 4.6200 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 7
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Hydroxyphenyl)phenylmethyl]formamide
C14H13NO2
1416069-95-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0
M  V30 2 N 4.0011 2.3100 0.0 0
M  V30 3 C 2.6674 1.5400 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 O 9.3358 3.8500 0.0 0
M  V30 6 C 5.3347 4.6200 0.0 0
M  V30 7 C 6.6684 3.8500 0.0 0
M  V30 8 C 5.3347 6.1600 0.0 0
M  V30 9 C 8.0021 4.6200 0.0 0
M  V30 10 C 6.6684 6.9300 0.0 0
M  V30 11 C 8.0021 6.1600 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 2.6674 6.1600 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 16 C 1.3336 6.9300 0.0 0
M  V30 17 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 2 3 4
M  V30 6 1 5 9
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13020-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1416069-95-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11574079
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of compounds having muscarinic receptor antagonist and β2
adrenergic receptor agonist activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rancati, Fabio; Linney, Ian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014086924 A1 2014-06-12

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxybenzophenone
C13H10O2
13020-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 O 9.3358 1.5400 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 C 6.6684 1.5400 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 6.6684 4.6200 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 1.3336 1.5400 0.0 0
M  V30 13 C 1.3336 4.6200 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 7
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Hydroxyphenyl)phenylmethyl]formamide
C14H13NO2
1416069-95-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0
M  V30 2 N 4.0011 2.3100 0.0 0
M  V30 3 C 2.6674 1.5400 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 O 9.3358 3.8500 0.0 0
M  V30 6 C 5.3347 4.6200 0.0 0
M  V30 7 C 6.6684 3.8500 0.0 0
M  V30 8 C 5.3347 6.1600 0.0 0
M  V30 9 C 8.0021 4.6200 0.0 0
M  V30 10 C 6.6684 6.9300 0.0 0
M  V30 11 C 8.0021 6.1600 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 2.6674 6.1600 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 16 C 1.3336 6.9300 0.0 0
M  V30 17 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 2 3 4
M  V30 6 1 5 9
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13020-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1416069-95-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-759431
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of compounds having muscarinic receptor antagonist and beta2
adrenergic receptor agonist activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rancati, Fabio; Linney, Ian; Knight, Chris; Schmidt, Wolfgang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014086927 A1 2014-06-12

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxybenzophenone
C13H10O2
13020-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 O 9.3358 1.5400 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 C 6.6684 1.5400 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 6.6684 4.6200 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 1.3336 1.5400 0.0 0
M  V30 13 C 1.3336 4.6200 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 7
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Hydroxyphenyl)phenylmethyl]formamide
C14H13NO2
1416069-95-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0
M  V30 2 N 4.0011 2.3100 0.0 0
M  V30 3 C 2.6674 1.5400 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 O 9.3358 3.8500 0.0 0
M  V30 6 C 5.3347 4.6200 0.0 0
M  V30 7 C 6.6684 3.8500 0.0 0
M  V30 8 C 5.3347 6.1600 0.0 0
M  V30 9 C 8.0021 4.6200 0.0 0
M  V30 10 C 6.6684 6.9300 0.0 0
M  V30 11 C 8.0021 6.1600 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 2.6674 6.1600 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 16 C 1.3336 6.9300 0.0 0
M  V30 17 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 2 3 4
M  V30 6 1 5 9
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13020-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1416069-95-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2583305
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1; Step 1; N-((3-hydroxyphenyl)(phenyl)methyl)formamide.
3-Hydroxybenzophenone (25 g, 126.1 mmol) in formamide (130 mL, 3.3 mmol)
was heated to 180°C for 18 hours. The reaction was allowed to cool
slightly then poured into ice-cooled water and stirred for 30 minutes,
filtered, and washed with water. The solid was stirred in water (60 mL)
and ethanol (60 mL) and heated to 50°C for 1 hour, then allowed to cool.
The solid was filtered and washed with water. Yield: (33.94 g, 118%). 1H
NMR (400 MHz, CD3OD): δ 7.39-7.28 (m, 5H); 7.21-7.13 (m, 1H); 6.79 (d, J
= 7.78 Hz, 1H); 6.73-6.68 (m, 2H); 5.45 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic-based compounds having muscarinic receptor
antagonist and beta2 adrenergic receptor agonist activity for treatment
of respiratory and inflammatory diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rancati, Fabio; Rizzi, Andrea; Amari, Gabriele; Biagetti, Matteo; Linney,
Ian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012168359 A1 2012-12-13

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3,5-Bis(trifluoromethyl)phenyl]-2-bromoethanone
C10H5BrF6O
131805-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 F 2.1037 7.4937 0.0 0
M  V30 3 F 0.0000 6.9301 0.0 0
M  V30 4 F 0.5636 4.8264 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 F 2.4611 1.5400 0.0 0
M  V30 7 F 4.0011 0.0000 0.0 0
M  V30 8 F 5.5411 1.5400 0.0 0
M  V30 9 C 6.6684 6.1601 0.0 0
M  V30 10 C 8.0022 5.3901 0.0 0
M  V30 11 O 6.6684 7.7001 0.0 0
M  V30 12 Br 9.3359 6.1601 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 15 C 4.0011 6.1601 0.0 0
M  V30 16 C 4.0011 3.0800 0.0 0
M  V30 17 C 5.3348 5.3901 0.0 0
M  V30 18 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 16
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 1 10 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[3,5-Bis(trifluoromethyl)phenyl]-1H-imidazole
C11H6F6N2
497948-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 6.1600 0.0 0
M  V30 2 F 2.1037 7.4937 0.0 0
M  V30 3 F 0.0000 6.9300 0.0 0
M  V30 4 F 0.5636 4.8264 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 F 2.4611 1.5400 0.0 0
M  V30 7 F 4.0011 0.0000 0.0 0
M  V30 8 F 5.5411 1.5400 0.0 0
M  V30 9 C 5.3348 5.3900 0.0 0
M  V30 10 C 4.0011 6.1600 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6673 5.3900 0.0 0
M  V30 13 C 4.0011 3.0800 0.0 0
M  V30 14 C 2.6673 3.8500 0.0 0
M  V30 15 C 6.6684 6.1600 0.0 0
M  V30 16 C 6.8295 7.6916 0.0 0
M  V30 17 N 8.0754 5.5336 0.0 0
M  V30 18 N 8.3358 8.0118 0.0 0
M  V30 19 C 9.1058 6.6781 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 131805-94-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 497948-24-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28648191
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of α-ketoamide derivatives as cathepsin K inhibitors useful
against bone disorders such as osteoporosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barrett, David Gene; Deaton, David Norman; McFadyen, Robert Blount;
Miller, Aaron Bayne; Ray, John Albert; Tavares, Francis Xavier; Zhou,
Huiqiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003013518 A1 2003-02-20

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N-phenylmethacrylamide
C11H13NO
15796-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 4.0011 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 1.3336 1.5400 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-1,3-dimethyl-2-oxo-1H-indole-3-acetamide
C12H14N2O2
935447-83-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1266 3.6644 0.0 0
M  V30 2 C 6.8966 4.9980 0.0 0
M  V30 3 N 8.4366 4.9980 0.0 0
M  V30 4 O 6.1266 6.3317 0.0 0
M  V30 5 C 4.7475 5.1959 0.0 0
M  V30 6 O 6.0811 1.3628 0.0 0
M  V30 7 C 3.0203 0.0000 0.0 0
M  V30 8 C 3.0801 3.9845 0.0 0
M  V30 9 C 4.5865 3.6644 0.0 0
M  V30 10 C 2.3101 2.6509 0.0 0
M  V30 11 C 2.3101 5.3182 0.0 0
M  V30 12 C 4.7475 2.1328 0.0 0
M  V30 13 N 3.3406 1.5063 0.0 0
M  V30 14 C 0.7700 2.6509 0.0 0
M  V30 15 C 0.7700 5.3182 0.0 0
M  V30 16 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 9
M  V30 6 2 6 12
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15796-89-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 935447-83-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29942139
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7782-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):NOTES
$DATUM continuous flow mode, Fenton reaction, irradiated with 450W Hg lamp,
optimization study (optimized on light source, stoichiometry of catalyst,
reagent and temperature)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nontraditional Application of the Photo-Fenton Process: A Novel Strategy
for Molecular Construction Using Formamide and Flow Chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sanabria, Marialy N.; Hornink, Milene M.; Correia, Valquiria G.; Andrade,
Leandro H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2020), 24(10), 2288-2297

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N-phenylmethacrylamide
C11H13NO
15796-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 4.0011 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 1.3336 1.5400 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-1,3-dimethyl-2-oxo-1H-indole-3-acetamide
C12H14N2O2
935447-83-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1266 3.6644 0.0 0
M  V30 2 C 6.8966 4.9980 0.0 0
M  V30 3 N 8.4366 4.9980 0.0 0
M  V30 4 O 6.1266 6.3317 0.0 0
M  V30 5 C 4.7475 5.1959 0.0 0
M  V30 6 O 6.0811 1.3628 0.0 0
M  V30 7 C 3.0203 0.0000 0.0 0
M  V30 8 C 3.0801 3.9845 0.0 0
M  V30 9 C 4.5865 3.6644 0.0 0
M  V30 10 C 2.3101 2.6509 0.0 0
M  V30 11 C 2.3101 5.3182 0.0 0
M  V30 12 C 4.7475 2.1328 0.0 0
M  V30 13 N 3.3406 1.5063 0.0 0
M  V30 14 C 0.7700 2.6509 0.0 0
M  V30 15 C 0.7700 5.3182 0.0 0
M  V30 16 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 9
M  V30 6 2 6 12
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15796-89-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 935447-83-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25489267
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7720-78-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study (amt. of cat.)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Iron-Catalyzed Synthesis of Oxindoles: Application to the Preparation of
Pyrroloindolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Correia, Valquirio G.; Abreu, Juliana C.; Barata, Caio A. E.; Andrade,
Leandro H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(5), 1060-1063

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyanopyrazole
C4H4N4
16617-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.7104 0.0 0
M  V30 2 N 5.4498 2.7104 0.0 0
M  V30 3 N 1.9406 0.0000 0.0 0
M  V30 4 C 2.3698 2.7104 0.0 0
M  V30 5 C 1.4645 1.4645 0.0 0
M  V30 6 C 1.4645 3.9563 0.0 0
M  V30 7 N 0.0000 1.9404 0.0 0
M  V30 8 N 0.0000 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazolo[3,4-d]pyrimidin-4-amine
C5H5N5
2380-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 C 2.1579 4.5864 0.0 0
M  V30 6 N 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 N 3.8119 0.7700 0.0 0
M  V30 9 N 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16617-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2380-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-12051477
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Targeted polypharmacology: discovery of dual inhibitors of tyrosine and
phosphoinositide kinases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Apsel, Beth; Blair, Jimmy A.; Gonzalez, Beatriz; Nazif, Tamim M.;
Feldman, Morri E.; Aizenstein, Brian; Hoffman, Randy; Williams, Roger L.;
Shokat, Kevan M.; Knight, Zachary A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Chemical Biology (2008), 4(11), 691-699

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyanopyrazole
C4H4N4
16617-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.7104 0.0 0
M  V30 2 N 5.4498 2.7104 0.0 0
M  V30 3 N 1.9406 0.0000 0.0 0
M  V30 4 C 2.3698 2.7104 0.0 0
M  V30 5 C 1.4645 1.4645 0.0 0
M  V30 6 C 1.4645 3.9563 0.0 0
M  V30 7 N 0.0000 1.9404 0.0 0
M  V30 8 N 0.0000 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazolo[3,4-d]pyrimidin-4-amine
C5H5N5
2380-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 C 2.1579 4.5864 0.0 0
M  V30 6 N 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 N 3.8119 0.7700 0.0 0
M  V30 9 N 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16617-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2380-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-8863445
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 28. Preparation of Intermediate C. Commercially available
5-amino-1H-pyrazole-4-carbonitrile (2.0 g, 18.5 mmol) was mixed with
formamide (10 mL) and heated to 180°C. overnight under nitrogen. The
solution was cooled to rt, 60 mL of water was added, and the resulting
precipitate was collected by vacuum filtration. Yield: (2.367 g, 95%). 1H
NMR (DMSO-d6, 300 MHz) δ 8.13 (s, 1H), 8.06 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and methods for treating toxoplasmosis, cryptosporidiosis,
and other apicomplexan protozoan related diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van Voorhis, Wesley C.; Hol, Wilhelmus G. J.; Larson, Eric T.; Maly,
Dustin James; Merritt, Ethan; Ojo, Kayode K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20130018040 A1 2013-01-17

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyanopyrazole
C4H4N4
16617-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.7104 0.0 0
M  V30 2 N 5.4498 2.7104 0.0 0
M  V30 3 N 1.9406 0.0000 0.0 0
M  V30 4 C 2.3698 2.7104 0.0 0
M  V30 5 C 1.4645 1.4645 0.0 0
M  V30 6 C 1.4645 3.9563 0.0 0
M  V30 7 N 0.0000 1.9404 0.0 0
M  V30 8 N 0.0000 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazolo[3,4-d]pyrimidin-4-amine
C5H5N5
2380-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 C 2.1579 4.5864 0.0 0
M  V30 6 N 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 N 3.8119 0.7700 0.0 0
M  V30 9 N 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16617-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2380-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-2441523
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 28. Preparation of Intermediate C. Commercially available
5-amino-1H-pyrazole-4-carbonitrile (2.0 g, 18.5 mmol) was mixed with
formamide (10 mL) and heated to 180°C overnight under nitrogen. The
solution was cooled to rt, 60 mL of water was added, and the resulting
precipitate was collected by vacuum filtration. Intermediate C (2.367 g,
95%). 1H NMR (DMSO-d6, 300 MHz) δ 8.13 (s, 1H), 8.06 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and methods for treating toxoplasmosis. cryptosporidiosis
and other apicomplexan protozoan related diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van Voorhis, Wesley C.; Hol, Wilhelmus G. J.; Larson, Eric T.; Maly,
Dustin James; Merritt, Ethan; Ojo, Kayode K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011094628 A1 2011-08-04

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyanopyrazole
C4H4N4
16617-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.7104 0.0 0
M  V30 2 N 5.4498 2.7104 0.0 0
M  V30 3 N 1.9406 0.0000 0.0 0
M  V30 4 C 2.3698 2.7104 0.0 0
M  V30 5 C 1.4645 1.4645 0.0 0
M  V30 6 C 1.4645 3.9563 0.0 0
M  V30 7 N 0.0000 1.9404 0.0 0
M  V30 8 N 0.0000 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazolo[3,4-d]pyrimidin-4-amine
C5H5N5
2380-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 C 2.1579 4.5864 0.0 0
M  V30 6 N 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 N 3.8119 0.7700 0.0 0
M  V30 9 N 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16617-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2380-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-5783609
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM C: Commercially available 5-amino-1H-pyrazole-4-carbonitrile (2.0 g, 18.5
mmol) was mixed with formamide (10 ml) and heated to 180°C overnight
under nitrogen. The solution was cooled to rt, 60 ml of water was added,
and the resulting precipitate was collected by vacuum filtration to yield
C (2.367 g, 95%). 1H NMR (DMSO-d6, 300 MHz) δ 8.13 (s, 1H), 8.06 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and
T. gondii
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murphy, Ryan C.; Ojo, Kayode K.; Larson, Eric T.; Castellanos-Gonzalez,
Alejandro; Perera, B. Gayani K.; Keyloun, Katelyn R.; Kim, Jessica E.;
Bhandari, Janhavi G.; Muller, Natascha R.; Verlinde, Christophe L. M. J.;
White, A. Clinton Jr.; Merritt, Ethan A.; Van Voorhis, Wesley C.; Maly,
Dustin J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2010), 1(7), 331-335

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyanopyrazole
C4H4N4
16617-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.7104 0.0 0
M  V30 2 N 5.4498 2.7104 0.0 0
M  V30 3 N 1.9406 0.0000 0.0 0
M  V30 4 C 2.3698 2.7104 0.0 0
M  V30 5 C 1.4645 1.4645 0.0 0
M  V30 6 C 1.4645 3.9563 0.0 0
M  V30 7 N 0.0000 1.9404 0.0 0
M  V30 8 N 0.0000 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazolo[3,4-d]pyrimidin-4-amine
C5H5N5
2380-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 C 2.1579 4.5864 0.0 0
M  V30 6 N 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 N 3.8119 0.7700 0.0 0
M  V30 9 N 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16617-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2380-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-16484532
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):NOTES
$DATUM microwave irradiation, microwave vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM eCF309: a potent, selective and cell-permeable mTOR inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fraser, Craig; Carragher, Neil O.; Unciti-Broceta, Asier
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM MedChemComm (2016), 7(3), 471-477

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyanopyrazole
C4H4N4
16617-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.7104 0.0 0
M  V30 2 N 5.4498 2.7104 0.0 0
M  V30 3 N 1.9406 0.0000 0.0 0
M  V30 4 C 2.3698 2.7104 0.0 0
M  V30 5 C 1.4645 1.4645 0.0 0
M  V30 6 C 1.4645 3.9563 0.0 0
M  V30 7 N 0.0000 1.9404 0.0 0
M  V30 8 N 0.0000 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazolo[3,4-d]pyrimidin-4-amine
C5H5N5
2380-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 C 2.1579 4.5864 0.0 0
M  V30 6 N 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 N 3.8119 0.7700 0.0 0
M  V30 9 N 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16617-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2380-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-3390607
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 3:
N-(6-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)benzo[d]thiazol-2-yl)acetamide.
Scheme 5: Synthesis of N-(6-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]
pyrimidin-3-yl)benzo[d]thiazol-2-yl)acetamide. A solution of 200 mL of
formamide and 3-amino-4-pyrazolecarbonitrile (101) (55 g, 0.509 mol) was
stirred at reflux for 1 h. The reaction mixture was cooled to room
temperature and 800 mL of water was added. The resulting solid was
collected by filtration, rinsed with water and dried in vacuo to yield
the desired product, 1H- pyrazolo[3,4-d]pyrimidin-4-amine (102) (64 g,
93% yield) as an off-white solid. ESI-MS (M+H)+ m/z :135.95.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzothiazoles as protein and lipid kinase inhibitors.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Pingda; Liu, Yi; Li, Liansheng; Chan, Katrina; Wilson, Troy Edward
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009114874 A2 2009-09-17

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyanopyrazole
C4H4N4
16617-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.7104 0.0 0
M  V30 2 N 5.4498 2.7104 0.0 0
M  V30 3 N 1.9406 0.0000 0.0 0
M  V30 4 C 2.3698 2.7104 0.0 0
M  V30 5 C 1.4645 1.4645 0.0 0
M  V30 6 C 1.4645 3.9563 0.0 0
M  V30 7 N 0.0000 1.9404 0.0 0
M  V30 8 N 0.0000 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazolo[3,4-d]pyrimidin-4-amine
C5H5N5
2380-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 C 2.1579 4.5864 0.0 0
M  V30 6 N 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 N 3.8119 0.7700 0.0 0
M  V30 9 N 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16617-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2380-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-20559558
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):NOTES
$DATUM microwave irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidines as selective Src kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Unciti-Broceta, Asier; Fraser, Craig; Carragher, Neil O.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016185160 A1 2016-11-24

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyanopyrazole
C4H4N4
16617-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.7104 0.0 0
M  V30 2 N 5.4498 2.7104 0.0 0
M  V30 3 N 1.9406 0.0000 0.0 0
M  V30 4 C 2.3698 2.7104 0.0 0
M  V30 5 C 1.4645 1.4645 0.0 0
M  V30 6 C 1.4645 3.9563 0.0 0
M  V30 7 N 0.0000 1.9404 0.0 0
M  V30 8 N 0.0000 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazolo[3,4-d]pyrimidin-4-amine
C5H5N5
2380-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 C 2.1579 4.5864 0.0 0
M  V30 6 N 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 N 3.8119 0.7700 0.0 0
M  V30 9 N 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16617-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2380-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-10662626
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Process A, also described above under Preparation of the Compounds, was
used to prepare the following compound: Step A: A mixture of commercially
available S-amino-1H-pyrazole-4-carbonitrile (16.22 g, 0.15 mol) and
formamide (84.6 ml) was heated at 180°C for 4 hr under a nitrogen
atmosphere. The solution was cooled to ambient temperature and the
crystals were separated, washed with water and dried to afford the
product (18.6 g, 91 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aminopyrazolopyrimidines and related compounds useful for inhibition of
alpha-synuclein toxicity and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lindquist, Susan L.; Outeiro, Tiago; Labaudiniere, Richard; Fleming,
James; Bulawa, Christine Ellen; Weigel, Charlotte; Liang, Feng; Gupta,
Sandeep; Ripka, Amy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007126841 A2 2007-11-08

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-3-(4-bromophenyl)-1-(2,2,2-trifluoroethyl)-1H-pyrazole-4-carbonitrile
C12H8BrF3N4
2089246-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3513 1.0304 0.0 0
M  V30 2 N 3.2067 0.0000 0.0 0
M  V30 3 N 7.6284 0.3339 0.0 0
M  V30 4 C 9.3036 3.2354 0.0 0
M  V30 5 C 9.9299 4.6423 0.0 0
M  V30 6 F 11.3369 4.0159 0.0 0
M  V30 7 F 10.5564 6.0491 0.0 0
M  V30 8 F 8.5231 5.2686 0.0 0
M  V30 9 Br 0.0000 6.6725 0.0 0
M  V30 10 C 5.3347 3.5925 0.0 0
M  V30 11 C 5.4956 2.0610 0.0 0
M  V30 12 N 6.7417 4.2188 0.0 0
M  V30 13 C 7.0021 1.7408 0.0 0
M  V30 14 N 7.7721 3.0745 0.0 0
M  V30 15 C 4.0011 4.3625 0.0 0
M  V30 16 C 4.0011 5.9025 0.0 0
M  V30 17 C 2.6674 3.5925 0.0 0
M  V30 18 C 2.6674 6.6725 0.0 0
M  V30 19 C 1.3336 4.3625 0.0 0
M  V30 20 C 1.3336 5.9025 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 11
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 20
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 15
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Bromophenyl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C13H9BrF3N5
2089246-37-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.9590 2.1050 0.0 0
M  V30 2 C 9.3037 4.1037 0.0 0
M  V30 3 C 9.9300 5.5106 0.0 0
M  V30 4 F 8.5232 6.1369 0.0 0
M  V30 5 F 10.5565 6.9174 0.0 0
M  V30 6 F 11.3370 4.8841 0.0 0
M  V30 7 Br 0.0000 7.5408 0.0 0
M  V30 8 C 5.3348 4.4608 0.0 0
M  V30 9 C 5.4957 2.9293 0.0 0
M  V30 10 N 6.7417 5.0873 0.0 0
M  V30 11 C 7.0021 2.6091 0.0 0
M  V30 12 C 4.4653 1.7849 0.0 0
M  V30 13 N 7.7721 3.9427 0.0 0
M  V30 14 N 7.4780 1.1444 0.0 0
M  V30 15 N 4.9411 0.3202 0.0 0
M  V30 16 C 6.4476 0.0000 0.0 0
M  V30 17 C 4.0011 5.2308 0.0 0
M  V30 18 C 4.0011 6.7708 0.0 0
M  V30 19 C 2.6675 4.4608 0.0 0
M  V30 20 C 2.6675 7.5408 0.0 0
M  V30 21 C 1.3337 5.2308 0.0 0
M  V30 22 C 1.3337 6.7708 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 22
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2089246-34-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2089246-37-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21207530
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of
cancer and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guisot, Nicolas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017046604 A1 2017-03-23

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-6-bromobenzo[b]thiophene-3-carboxylate
C11H10BrNO2S
221061-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.3321 0.0 0
M  V30 2 O 8.7355 2.8561 0.0 0
M  V30 3 O 6.9506 4.8384 0.0 0
M  V30 4 C 9.8799 3.8867 0.0 0
M  V30 5 C 11.3446 3.4106 0.0 0
M  V30 6 N 7.6210 0.0000 0.0 0
M  V30 7 Br 0.0000 2.6217 0.0 0
M  V30 8 C 4.6200 2.6217 0.0 0
M  V30 9 C 6.1264 2.3015 0.0 0
M  V30 10 C 3.8500 1.2881 0.0 0
M  V30 11 C 3.8500 3.9555 0.0 0
M  V30 12 C 6.2874 0.7700 0.0 0
M  V30 13 S 4.8806 0.1437 0.0 0
M  V30 14 C 2.3100 1.2881 0.0 0
M  V30 15 C 2.3100 3.9555 0.0 0
M  V30 16 C 1.5400 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H5BrN2OS
884873-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 8.8070 4.8667 0.0 0
M  V30 3 C 4.5865 2.9876 0.0 0
M  V30 4 C 3.0800 2.6673 0.0 0
M  V30 5 C 4.7474 4.5192 0.0 0
M  V30 6 C 5.8323 2.0824 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 S 3.3404 5.1455 0.0 0
M  V30 10 C 6.1542 5.1455 0.0 0
M  V30 11 C 7.2391 2.7087 0.0 0
M  V30 12 N 0.7700 4.0011 0.0 0
M  V30 13 N 0.7700 1.3336 0.0 0
M  V30 14 C 7.4000 4.2403 0.0 0
M  V30 15 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221061-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 884873-96-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9605072
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5. Preparation of 7-bromornbenzothieno[2,3-d]pyrimidin-4(3H)-one
Ethyl 2-amino-6-bromo-1-benzothiophene-3-carboxylate (9.0 g, 27 mmol),
formamide (85 mL) and ammonium formate (2.7 g, 43 mmol) were heated in an
oil bath at 135 °C overnight. The next morning the reaction mixture was a
pastel blue slurry. The reaction mixture was allowed to cool to room
temperature and was then filtered. The solid was washed with water, dried
by filtration, and finally dried in a vacuum oven overnight at 45 °C to
yield a light blue solid (7.8 g, quantitative).
7-bromornbenzothieno[2,3-d]pyrimidin-4(3H)-one, yield (7.8 g,
quantitative). 1H NMR (DMSO-d6) δ 12.9 (br, 1H), 8.37 (s, 1H), 8.35 (d,
1H), 8.31 (s, 1H), 7.69 (d, 1H); LCMS RT = 3.08 min, [M+H]+ = 281.1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzothieno[2,3-d]pyrimidine derivatives as inhibitors of
tyrosine kinase for treatment of hyperproliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Chengzhi; Smith, Roger; Duquette, Jason; Zhao, Qian; Dumas,
Jacques; Bondar, Georgiy; Li, Yingfu; Fan, Dongping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006044524 A1 2006-04-27

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorophthalic anhydride
C8H3FO3
319-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7104 0.0000 0.0 0
M  V30 2 O 0.0000 4.6948 0.0 0
M  V30 3 F 7.2706 3.9844 0.0 0
M  V30 4 C 3.4206 2.6508 0.0 0
M  V30 5 C 2.6506 3.9844 0.0 0
M  V30 6 C 2.3902 1.5064 0.0 0
M  V30 7 C 4.9606 2.6508 0.0 0
M  V30 8 C 1.1444 3.6643 0.0 0
M  V30 9 C 3.4206 5.3182 0.0 0
M  V30 10 O 0.9834 2.1327 0.0 0
M  V30 11 C 5.7306 3.9844 0.0 0
M  V30 12 C 4.9606 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorophthalimide
C8H4FNO2
94514-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7104 0.0000 0.0 0
M  V30 2 O 0.0000 4.6948 0.0 0
M  V30 3 F 7.2706 3.9844 0.0 0
M  V30 4 C 3.4206 2.6508 0.0 0
M  V30 5 C 2.6506 3.9844 0.0 0
M  V30 6 C 2.3902 1.5064 0.0 0
M  V30 7 C 4.9606 2.6508 0.0 0
M  V30 8 C 1.1444 3.6643 0.0 0
M  V30 9 C 3.4206 5.3182 0.0 0
M  V30 10 N 0.9834 2.1327 0.0 0
M  V30 11 C 5.7306 3.9844 0.0 0
M  V30 12 C 4.9606 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 319-03-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 94514-21-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-10881862
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (a) 5-Fluoro-isoindole-1,3-dione A mixture of 144 mmol 4-fluorophthalic
anhydride and 1.16 mol formamide was heated at 200°C for 2 h. The
reaction mixture was poured onto ice-water and the resulting crystals
collected by filtration and dried in vacuo to afford the title compound
as a yellow solid (100% yield). 5-Fluoro-isoindole-1,3-dione (100%
yield). MS (m/e): 164.4 ([M-H]+, 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic substituted phenyl methanones as inhibitors
of the glycine transporter 1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jolidon, Synese; Narquizian, Robert; Norcross, Roger, David; Pinard,
Emmanuel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006082001 A1 2006-08-10

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cycloocta[b]thiophene-3-carboxylic acid, 2-amino-4,5,6,7,8,9-hexahydro-, ethy...
C13H19NO2S
40106-16-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5341 3.3322 0.0 0
M  V30 2 O 7.8677 2.5622 0.0 0
M  V30 3 O 6.5341 4.8722 0.0 0
M  V30 4 C 9.2014 3.3322 0.0 0
M  V30 5 C 10.5351 2.5622 0.0 0
M  V30 6 N 6.1839 0.0000 0.0 0
M  V30 7 C 3.7934 3.1885 0.0 0
M  V30 8 C 5.2002 2.5622 0.0 0
M  V30 9 C 2.7630 2.0441 0.0 0
M  V30 10 C 3.7129 4.7264 0.0 0
M  V30 11 C 5.0393 1.0306 0.0 0
M  V30 12 S 3.5330 0.7103 0.0 0
M  V30 13 C 1.2249 1.9634 0.0 0
M  V30 14 C 2.5683 5.7570 0.0 0
M  V30 15 C 0.0805 2.9940 0.0 0
M  V30 16 C 1.0304 5.6763 0.0 0
M  V30 17 C 0.0000 4.5319 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8,9,10-Hexahydrocycloocta[4,5]thieno[2,3-d]pyrimidin-4(1H)-one
C12H14N2OS
40106-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3649 0.0000 0.0 0
M  V30 2 C 3.8586 2.9877 0.0 0
M  V30 3 C 5.3649 2.6673 0.0 0
M  V30 4 C 3.6976 4.5192 0.0 0
M  V30 5 C 2.8894 1.7908 0.0 0
M  V30 6 C 6.1349 4.0012 0.0 0
M  V30 7 C 6.1349 1.3337 0.0 0
M  V30 8 S 5.1044 5.1456 0.0 0
M  V30 9 C 2.5007 5.4884 0.0 0
M  V30 10 C 1.3577 1.6298 0.0 0
M  V30 11 N 7.6749 4.0012 0.0 0
M  V30 12 N 7.6749 1.3337 0.0 0
M  V30 13 C 0.9691 5.3274 0.0 0
M  V30 14 C 0.1609 2.5990 0.0 0
M  V30 15 C 8.4449 2.6673 0.0 0
M  V30 16 C 0.0000 4.1305 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40106-16-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 40106-32-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11893093
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fine tuning Exo2, a small molecule inhibitor of secretion and retrograde
trafficking pathways in mammalian cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guetzoyan, Lucie J.; Spooner, Robert A.; Boal, Frederic; Stephens, David
J.; Lord, J. Michael; Roberts, Lynne M.; Clarkson, Guy J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular BioSystems (2010), 6(10), 2030-2038

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Morpholinamine
C4H10N2O
4319-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 N 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 O 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-4-Morpholinylformamide
C5H10N2O2
210582-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 N 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4319-49-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 210582-47-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-13559480
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7782-61-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Transamidation Reaction.
Amide (5.1 mmol) and amine (3.0 mmol) were dissolved or suspended in
toluene (3.0 mL), Fe(NO3)3·9H2O (61 mg, 0.15 mmol) was added, and the
mixture was refluxed until complete conversion (by TLC) of the amine. The
hot reaction mixture was filtered through a pad of Celite, concentrated,
and purified by flash chromatography as indicated below.
N-Benzylacetamide (7). The crude mixture was purified by flash
chromatography with DCM. Morpholine-4-carbaldehyde (13h). The crude
mixture was purified by flash chromatography with DCM/AcOEt (1:1). The
product was obtained as a yellow oil. Yield: 345 mg, quantitative. 1H NMR
(300 MHz, CDCl3): δ (ppm) 8.07 (s, 1H), 3.64-3.72 (m, 4H), 3.58 (t, J = 9
Hz, 2H), 3.40 (t, J = 9 Hz, 2H). 13C{1H} NMR (75 MHz, CDCl3): δ (ppm)
160.8, 67.2, 66.4, 45.8, 40.6. IR (ν, cm-1, KBr): 2979, 2924, 2863, 1655,
1442,1399, 1363, 1301, 1272, 1232, 1188, 1111, 1069, 1006, 855, 811. MS
(EI): 115 (99), 100 (74), 86 (46), 72 (33), 56 (92), 42 (100).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transamidation of Carboxamides Catalyzed by Fe(III) and Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Becerra-Figueroa, Liliana; Ojeda-Porras, Andrea; Gamba-Sanchez, Diego
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(10), 4544-4552

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
C11H15NO2S
4506-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3321 0.0 0
M  V30 2 O 7.1954 2.8561 0.0 0
M  V30 3 O 5.4106 4.8383 0.0 0
M  V30 4 C 8.3398 3.8866 0.0 0
M  V30 5 C 9.8045 3.4108 0.0 0
M  V30 6 N 6.0810 0.0000 0.0 0
M  V30 7 C 3.0800 2.6217 0.0 0
M  V30 8 C 4.5864 2.3015 0.0 0
M  V30 9 C 2.3100 1.2880 0.0 0
M  V30 10 C 2.3100 3.9555 0.0 0
M  V30 11 C 4.7473 0.7700 0.0 0
M  V30 12 S 3.3405 0.1437 0.0 0
M  V30 13 C 0.7700 1.2880 0.0 0
M  V30 14 C 0.7700 3.9555 0.0 0
M  V30 15 C 0.0000 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H10N2OS
14346-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.8322 2.0824 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3404 5.1455 0.0 0
M  V30 9 C 6.1542 5.1455 0.0 0
M  V30 10 C 7.2391 2.7087 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 7.4001 4.2403 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4506-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5582931
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-one (9)
Ethyl-2-amino-4,5,6,7-tetrahydrobenzothiophene-3-carboxylate (10.32 g,
45.86 mmol) was taken in formamide (44 mL) and heated to 170 °C Mass
temperature under a nitrogen atmosphere. The heating was continued until
the reaction was complete, and the progress of the reaction was monitored
by TLC. After 8 h, the reaction Mass was cooled to 10 °C, and solids were
thrown out. The solids were filtered, and the cake was washed with 50mL
of hexane. The product was sucked dry and finally dried in an oven at 50
°C. The yield being quantitative. % purity (HPLC)=98.85. The material was
utilized in the next step without any further purification. IR spectra
(cm-1): 3156, 3007, 2939, 2923, 1659, 1590, 1372, 990, 913, 580; mass
(m/z): 207.1 (M+H)+. Purified: IR (cm-1): 2939, 2857, 1659, 1590, 1372,
1170, 990, 913, 580; mass (m/z): 207.0 (M+H)+; 1H NMR (ppm): 1.86-1.88
(4H, m), 2.91-2.93 (4H, m), 8.75 (1H, s).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convenient and efficient synthesis of some novel fused thieno pyrimidines
using Gewald's reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nirogi, Ramakrishna V. S.; Kambhampati, Rama Sastri; Kothmirkar,
Prabhakar; Arepalli, Sobhanadri; Pamuleti, Narasimha Reddy G.; Shinde,
Anil K.; Dubey, P. K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2011), 41(19), 2835-2851

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
C11H15NO2S
4506-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3321 0.0 0
M  V30 2 O 7.1954 2.8561 0.0 0
M  V30 3 O 5.4106 4.8383 0.0 0
M  V30 4 C 8.3398 3.8866 0.0 0
M  V30 5 C 9.8045 3.4108 0.0 0
M  V30 6 N 6.0810 0.0000 0.0 0
M  V30 7 C 3.0800 2.6217 0.0 0
M  V30 8 C 4.5864 2.3015 0.0 0
M  V30 9 C 2.3100 1.2880 0.0 0
M  V30 10 C 2.3100 3.9555 0.0 0
M  V30 11 C 4.7473 0.7700 0.0 0
M  V30 12 S 3.3405 0.1437 0.0 0
M  V30 13 C 0.7700 1.2880 0.0 0
M  V30 14 C 0.7700 3.9555 0.0 0
M  V30 15 C 0.0000 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H10N2OS
14346-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.8322 2.0824 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3404 5.1455 0.0 0
M  V30 9 C 6.1542 5.1455 0.0 0
M  V30 10 C 7.2391 2.7087 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 7.4001 4.2403 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4506-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6294103
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities
of tetrahydrobenzothienopyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aponte, Jose C.; Vaisberg, Abraham J.; Castillo, Denis; Gonzalez, German;
Estevez, Yannick; Arevalo, Jorge; Quiliano, Miguel; Zimic, Mirko;
Verastegui, Manuela; Malaga, Edith; Gilman, Robert H.; Bustamante, Juan
M.; Tarleton, Rick L.; Wang, Yuehong; Franzblau, Scott G.; Pauli, Guido
F.; Sauvain, Michel; Hammond, Gerald B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2010), 18(8), 2880-2886

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
C11H15NO2S
4506-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3321 0.0 0
M  V30 2 O 7.1954 2.8561 0.0 0
M  V30 3 O 5.4106 4.8383 0.0 0
M  V30 4 C 8.3398 3.8866 0.0 0
M  V30 5 C 9.8045 3.4108 0.0 0
M  V30 6 N 6.0810 0.0000 0.0 0
M  V30 7 C 3.0800 2.6217 0.0 0
M  V30 8 C 4.5864 2.3015 0.0 0
M  V30 9 C 2.3100 1.2880 0.0 0
M  V30 10 C 2.3100 3.9555 0.0 0
M  V30 11 C 4.7473 0.7700 0.0 0
M  V30 12 S 3.3405 0.1437 0.0 0
M  V30 13 C 0.7700 1.2880 0.0 0
M  V30 14 C 0.7700 3.9555 0.0 0
M  V30 15 C 0.0000 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H10N2OS
14346-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.8322 2.0824 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3404 5.1455 0.0 0
M  V30 9 C 6.1542 5.1455 0.0 0
M  V30 10 C 7.2391 2.7087 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 7.4001 4.2403 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4506-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-789505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction condition shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5,6,7,8-tetrahydrobenzo[1]thieno[2,3-d]pyrimidine and
chalcone derivatives for treatment of cancers or infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hammond, Gerald B.; Aponte, Jose C.; Gilman, Robert H.; Sauvain, Michel
Henri-Auguste; Vaisberg, Abraham
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010019861 A1 2010-02-18

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
C11H15NO2S
4506-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3321 0.0 0
M  V30 2 O 7.1954 2.8561 0.0 0
M  V30 3 O 5.4106 4.8383 0.0 0
M  V30 4 C 8.3398 3.8866 0.0 0
M  V30 5 C 9.8045 3.4108 0.0 0
M  V30 6 N 6.0810 0.0000 0.0 0
M  V30 7 C 3.0800 2.6217 0.0 0
M  V30 8 C 4.5864 2.3015 0.0 0
M  V30 9 C 2.3100 1.2880 0.0 0
M  V30 10 C 2.3100 3.9555 0.0 0
M  V30 11 C 4.7473 0.7700 0.0 0
M  V30 12 S 3.3405 0.1437 0.0 0
M  V30 13 C 0.7700 1.2880 0.0 0
M  V30 14 C 0.7700 3.9555 0.0 0
M  V30 15 C 0.0000 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H10N2OS
14346-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.8322 2.0824 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3404 5.1455 0.0 0
M  V30 9 C 6.1542 5.1455 0.0 0
M  V30 10 C 7.2391 2.7087 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 7.4001 4.2403 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4506-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16148454
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Computer-aided identification, synthesis and evaluation of substituted
thienopyrimidines as novel inhibitors of HCV replication
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bassetto, Marcella; Leyssen, Pieter; Neyts, Johan; Yerukhimovich, Mark
M.; Frick, David N.; Brancale, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 12331-47

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
C11H15NO2S
4506-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3321 0.0 0
M  V30 2 O 7.1954 2.8561 0.0 0
M  V30 3 O 5.4106 4.8383 0.0 0
M  V30 4 C 8.3398 3.8866 0.0 0
M  V30 5 C 9.8045 3.4108 0.0 0
M  V30 6 N 6.0810 0.0000 0.0 0
M  V30 7 C 3.0800 2.6217 0.0 0
M  V30 8 C 4.5864 2.3015 0.0 0
M  V30 9 C 2.3100 1.2880 0.0 0
M  V30 10 C 2.3100 3.9555 0.0 0
M  V30 11 C 4.7473 0.7700 0.0 0
M  V30 12 S 3.3405 0.1437 0.0 0
M  V30 13 C 0.7700 1.2880 0.0 0
M  V30 14 C 0.7700 3.9555 0.0 0
M  V30 15 C 0.0000 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H10N2OS
14346-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.8322 2.0824 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3404 5.1455 0.0 0
M  V30 9 C 6.1542 5.1455 0.0 0
M  V30 10 C 7.2391 2.7087 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 7.4001 4.2403 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4506-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7866032
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and biological studies of some novel
thieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Al-Taisan, Khulud M.; Al-Hazimi, Hassan M. A.; Al-Shihry, Shar S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2010), 153932-3957

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
C11H15NO2S
4506-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3321 0.0 0
M  V30 2 O 7.1954 2.8561 0.0 0
M  V30 3 O 5.4106 4.8383 0.0 0
M  V30 4 C 8.3398 3.8866 0.0 0
M  V30 5 C 9.8045 3.4108 0.0 0
M  V30 6 N 6.0810 0.0000 0.0 0
M  V30 7 C 3.0800 2.6217 0.0 0
M  V30 8 C 4.5864 2.3015 0.0 0
M  V30 9 C 2.3100 1.2880 0.0 0
M  V30 10 C 2.3100 3.9555 0.0 0
M  V30 11 C 4.7473 0.7700 0.0 0
M  V30 12 S 3.3405 0.1437 0.0 0
M  V30 13 C 0.7700 1.2880 0.0 0
M  V30 14 C 0.7700 3.9555 0.0 0
M  V30 15 C 0.0000 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H10N2OS
14346-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.8322 2.0824 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3404 5.1455 0.0 0
M  V30 9 C 6.1542 5.1455 0.0 0
M  V30 10 C 7.2391 2.7087 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 7.4001 4.2403 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4506-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5532733
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of some thienopyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM El-Baih, Fatma E. M.; Al-Blowy, Hanan A. S.; Al-Hazimi, Hassan M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2006), 11(7), 498-513

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-5-phenylthiophene-3-carboxylate
C13H13NO2S
4815-34-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9700 2.9016 0.0 0
M  V30 2 O 8.5965 4.3086 0.0 0
M  V30 3 O 8.8752 1.6557 0.0 0
M  V30 4 C 10.1280 4.4695 0.0 0
M  V30 5 C 10.7544 5.8763 0.0 0
M  V30 6 N 6.2949 0.0000 0.0 0
M  V30 7 C 4.0010 3.2587 0.0 0
M  V30 8 C 5.4080 3.8850 0.0 0
M  V30 9 S 4.1621 1.7271 0.0 0
M  V30 10 C 6.4384 2.7406 0.0 0
M  V30 11 C 5.6684 1.4070 0.0 0
M  V30 12 C 2.6673 4.0287 0.0 0
M  V30 13 C 2.6673 5.5688 0.0 0
M  V30 14 C 1.3337 3.2587 0.0 0
M  V30 15 C 1.3337 6.3388 0.0 0
M  V30 16 C 0.0000 4.0287 0.0 0
M  V30 17 C 0.0000 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Phenylthieno[2,3-d]pyrimidin-4(1H)-one
C12H8N2OS
35970-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 C 5.0371 3.0801 0.0 0
M  V30 3 C 4.1321 1.8342 0.0 0
M  V30 4 S 4.1321 4.3260 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 2.6673 3.8501 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 N 1.3337 4.6201 0.0 0
M  V30 9 N 0.0000 2.3101 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 11 C 6.5772 3.0801 0.0 0
M  V30 12 C 7.3472 1.7464 0.0 0
M  V30 13 C 7.3472 4.4137 0.0 0
M  V30 14 C 8.8872 1.7464 0.0 0
M  V30 15 C 8.8872 4.4137 0.0 0
M  V30 16 C 9.6572 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-34-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35970-78-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2172860
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6-Phenyl-3H-thieno[2,3-d]pyrimidin-4-one (8). Compound 7 (117 mmol) was
added to 170 °C hot formamide (225 ml) and the flask was equipped with a
distil. The mixture was heated at 190 °C for 2.5 h. The cooled mixture
was poured on water (200 ml). The precipitate was filtered off, washed
with water (200 ml) and dried. Yield: 27.0 g (100%). Grey solid,
6-Phenyl-3H-thieno[2,3-d]pyrimidin-4-one (8), yield 27.0 g (100%) mp
252-254 °C (EtOH), (lit. 263- 265 °C (CHCl3/MeOH), Arya et al. Indian J.
Chem. 1971, 9, 1209-1212).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-Metalated Condensed Pyrimidines: Their Preparation and Reaction with
Aldehydes under Barbier-Type Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Therkelsen, Frans D.; Rottlaender, Mario; Thorup, Niels; Pedersen, Erik
Bjerregaard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2004), 6(12), 1991-1994

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Aminosalicylic acid
C7H7NO3
570-23-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 O 2.6674 4.6200 0.0 0
M  V30 5 N 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Formylamino)-2-hydroxybenzoic acid
C8H7NO4
17968-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 4.0012 4.6201 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 570-23-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17968-71-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-7653786
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Hydroxy-3-formylaminobenzoic acid (49): Aniline 48 (0.51 g, 3.31 mmol)
was suspended in formamide (3.0 mL under N2) and the mixture stirred at
150° for 0.5 h. The resulting solution was allowed to cool, dissolved in
6% NaHCO3 (50 mL), acidified with 1 M KHSO4, and extracted with EtOAc (3
x 50 mL). The combined extract was washed with 5 M NaCl (10 mL), dried,
evaporated, and the residue coevaporated with toluene (10 mL) to furnish
90% of phenol 49 as a greenish gray solid. mp 168-169°; tlc Rf 0.20
(95:5:1 DCM- MeOH-HOAc); 1H NMR (d6-DMSO) δ 9.82 (1H, s), 8.38 (1H, d, J
= 9.3 Hz), 7.55 (1H, d, J = 7.7 Hz), 6.92 (1H, t, J = 7.7 Hz); 13C NMR
(d6-DMSO) δ 172.3, 160.3, 151.2, 126.5, 125.7, 124.5, 118.6, 112.6.
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of cyclodepsipeptide compounds, especially respirantin,
having antineoplastic and/or antimicrobial activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pettit, George R.; Smith, Thomas H.; Feng, Song
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008151306 A1 2008-12-11

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Aminosalicylic acid
C7H7NO3
570-23-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 O 2.6674 4.6200 0.0 0
M  V30 5 N 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Formylamino)-2-hydroxybenzoic acid
C8H7NO4
17968-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 4.0012 4.6201 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 570-23-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17968-71-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27880525
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7646-93-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Functionalization of Antimycin A Through an N-Transacylation
Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chevalier, Arnaud; Zhang, Yanmin; Khdour, Omar M.; Hecht, Sidney M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2016), 18(10), 2395-2398

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-5-methoxy-4-(phenylmethoxy)benzoate
C16H17NO4
61032-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 7.7000 0.0000 0.0 0
M  V30 5 N 10.0100 6.6685 0.0 0
M  V30 6 C 11.5500 4.0011 0.0 0
M  V30 7 O 12.3200 2.6674 0.0 0
M  V30 8 O 12.3200 5.3347 0.0 0
M  V30 9 C 13.8600 2.6674 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 7.7000 2.6674 0.0 0
M  V30 12 C 7.7000 5.3347 0.0 0
M  V30 13 C 9.2400 2.6674 0.0 0
M  V30 14 C 9.2400 5.3347 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 16 C 3.0800 5.3347 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 2.3100 6.6685 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 0.7700 6.6685 0.0 0
M  V30 21 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 15
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Benzyloxy-6-methoxy-3,4-dihydroquinazolin-4-one
C16H14N2O3
179688-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 C 3.0800 5.3347 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 4.6200 5.3347 0.0 0
M  V30 9 N 2.3100 6.6685 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 0.7700 6.6685 0.0 0
M  V30 14 C 4.6200 2.6674 0.0 0
M  V30 15 N 0.0000 5.3347 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.0100 6.6685 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61032-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 179688-01-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35041744
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of SOS1 Inhibitor-Based Degraders to Target KRAS-Mutant
Colorectal Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bian, Yujia; Alem, Diego; Beato, Francisca; Hogenson, Tara L.; Yang,
Xinrui; Jiang, Kun; Cai, Jianfeng; Ma, Wen Wee; Fernandez-Zapico, Martin;
Tan, Aik Choon; Lawrence, Nicholas J.; Fleming, Jason B.; Yuan, Yu; Xie,
Hao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(24), 16432-16450

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-5-methoxy-4-(phenylmethoxy)benzoate
C16H17NO4
61032-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 7.7000 0.0000 0.0 0
M  V30 5 N 10.0100 6.6685 0.0 0
M  V30 6 C 11.5500 4.0011 0.0 0
M  V30 7 O 12.3200 2.6674 0.0 0
M  V30 8 O 12.3200 5.3347 0.0 0
M  V30 9 C 13.8600 2.6674 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 7.7000 2.6674 0.0 0
M  V30 12 C 7.7000 5.3347 0.0 0
M  V30 13 C 9.2400 2.6674 0.0 0
M  V30 14 C 9.2400 5.3347 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 16 C 3.0800 5.3347 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 2.3100 6.6685 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 0.7700 6.6685 0.0 0
M  V30 21 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 15
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Benzyloxy-6-methoxy-3,4-dihydroquinazolin-4-one
C16H14N2O3
179688-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 C 3.0800 5.3347 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 4.6200 5.3347 0.0 0
M  V30 9 N 2.3100 6.6685 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 0.7700 6.6685 0.0 0
M  V30 14 C 4.6200 2.6674 0.0 0
M  V30 15 N 0.0000 5.3347 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.0100 6.6685 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61032-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 179688-01-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14725933
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2d. 7-(Benzyloxy)-6-methoxyquinazolin-4(3H)-one (Compound 205). A
mixture of compound 204 (7.5 g, 25 mmol), ammonium formate (1.1 g, 22.4
mmol) and formamide (60 mL) was stirred and heated at 180~190 °C (oil
bath temperature) for 2 hours. Then the mixture was cooled to room
temperature and the resulting precipitate was isolated, washed with water
and dried to give the title compound 205 as a brown solid (6.5 g, 95%).
LCMS: 283 [M+1]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazoline derivatives as VEGFR inhibitors, their preparation,
pharmaceutical compositions, and use in the treatment of cell
proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Changgeng; Cai, Xiong; Zhai, Haixiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009036055 A1 2009-03-19

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-5-methoxy-4-(phenylmethoxy)benzoate
C16H17NO4
61032-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 7.7000 0.0000 0.0 0
M  V30 5 N 10.0100 6.6685 0.0 0
M  V30 6 C 11.5500 4.0011 0.0 0
M  V30 7 O 12.3200 2.6674 0.0 0
M  V30 8 O 12.3200 5.3347 0.0 0
M  V30 9 C 13.8600 2.6674 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 7.7000 2.6674 0.0 0
M  V30 12 C 7.7000 5.3347 0.0 0
M  V30 13 C 9.2400 2.6674 0.0 0
M  V30 14 C 9.2400 5.3347 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 16 C 3.0800 5.3347 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 2.3100 6.6685 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 0.7700 6.6685 0.0 0
M  V30 21 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 15
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Benzyloxy-6-methoxy-3,4-dihydroquinazolin-4-one
C16H14N2O3
179688-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 C 3.0800 5.3347 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 4.6200 5.3347 0.0 0
M  V30 9 N 2.3100 6.6685 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 0.7700 6.6685 0.0 0
M  V30 14 C 4.6200 2.6674 0.0 0
M  V30 15 N 0.0000 5.3347 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.0100 6.6685 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61032-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 179688-01-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1478208
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2d. 7-(Benzyloxy)-6-methoxyquinazolin-4(3H)-one (Compound 205). A
mixture of compound 204 (7.5 g, 25 mmol), ammonium formate (1.1 g, 22.4
mmol) and formamide (60 mL) was stirred and heated at 180∼190 °C (oil
bath temperature) for 2 hours. Then the mixture was cooled to room
temperature and the resulting precipitate was isolated, washed with water
and dried to give the title compound 205 as a brown solid (6.5 g, 95%).
LCMS: 283 [M+1]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multi-functional small molecules as anti-proliferative agents and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Qian, Changgeng; Gould, Stephen; Zhai, Haixiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008033747 A2 2008-03-20

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine methyl ester
C3H7NO2
616-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 N 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine, N-formyl-, methyl ester
C4H7NO3
3154-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 O 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6687 2.3101 0.0 0
M  V30 8 O 8.0023 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 616-34-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3154-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-413408
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7782-61-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Transamidation Reaction.
Amide (5.1 mmol) and amine (3.0 mmol) were dissolved or suspended in
toluene (3.0 mL), Fe(NO3)3·9H2O (61 mg, 0.15 mmol) was added, and the
mixture was refluxed until complete conversion (by TLC) of the amine. The
hot reaction mixture was filtered through a pad of Celite, concentrated,
and purified by flash chromatography as indicated below.
N-Benzylacetamide (7). The crude mixture was purified by flash
chromatography with DCM. Methyl Formylglycinate (13m). The crude mixture
was purified by flash chromatography with DCM/MeOH (9:1). The product was
obtained as a colorless oil. Yield: 351 mg, quantitative. 1H NMR (300
MHz, CDCl3): δ (ppm) 7.28 (s, 1H), 4.11 (d, J = 5.3 Hz, 2H), 3.79 (s,
3H). 13C{1H} NMR (75 MHz, CDCl3): δ (ppm) 170.0, 161.1, 52.5, 39.8. IR
(ν, cm-1, KBr): 3424, 2917, 2849, 1741, 1688, 1452, 1442, 1391, 1312,
1226, 1051. MS (EI) [M - CO]: 89 (22), 58 (65), 30 (100).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transamidation of Carboxamides Catalyzed by Fe(III) and Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Becerra-Figueroa, Liliana; Ojeda-Porras, Andrea; Gamba-Sanchez, Diego
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(10), 4544-4552

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine methyl ester
C3H7NO2
616-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 N 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine, N-formyl-, methyl ester
C4H7NO3
3154-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 O 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6687 2.3101 0.0 0
M  V30 8 O 8.0023 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 616-34-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3154-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27605445
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1809269-30-4
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on temperature, optimized on stoichiometry
of catalyst, optimized on stoichiometry of reactant, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide Synthesis through Borinic Acid-Catalysed Transamidation under
Mild Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohy El Dine, Tharwat; Evans, David; Rouden, Jacques; Blanchet, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2016), 22(17), 5894-5898

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 2-amino-4-methoxy-5-(phenylmethoxy)benzoate
C22H21NO4
634197-80-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.5500 4.0011 0.0 0
M  V30 2 C 12.3200 5.3347 0.0 0
M  V30 3 O 10.0100 1.3336 0.0 0
M  V30 4 C 9.2400 0.0000 0.0 0
M  V30 5 C 6.9300 6.6684 0.0 0
M  V30 6 O 5.3900 6.6684 0.0 0
M  V30 7 O 7.7000 8.0021 0.0 0
M  V30 8 C 4.6200 8.0021 0.0 0
M  V30 9 N 5.3900 4.0011 0.0 0
M  V30 10 C 10.0100 4.0011 0.0 0
M  V30 11 C 9.2400 2.6674 0.0 0
M  V30 12 C 9.2400 5.3347 0.0 0
M  V30 13 C 7.7000 2.6674 0.0 0
M  V30 14 C 7.7000 5.3347 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 13.8600 5.3347 0.0 0
M  V30 17 C 14.6300 6.6684 0.0 0
M  V30 18 C 14.6300 4.0011 0.0 0
M  V30 19 C 16.1700 6.6684 0.0 0
M  V30 20 C 16.1700 4.0011 0.0 0
M  V30 21 C 16.9400 5.3347 0.0 0
M  V30 22 C 3.0800 8.0021 0.0 0
M  V30 23 C 2.3100 9.3358 0.0 0
M  V30 24 C 2.3100 6.6684 0.0 0
M  V30 25 C 0.7700 9.3358 0.0 0
M  V30 26 C 0.7700 6.6684 0.0 0
M  V30 27 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 14
M  V30 9 1 6 8
M  V30 10 1 8 22
M  V30 11 1 9 15
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-6-(phenylmethoxy)-4(3H)-quinazolinone
C16H14N2O3
286371-64-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 8.0021 0.0 0
M  V30 2 O 5.3900 1.3336 0.0 0
M  V30 3 C 4.6200 0.0000 0.0 0
M  V30 4 O 6.9300 4.0011 0.0 0
M  V30 5 C 7.7000 5.3347 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 3.0800 5.3347 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 N 0.7700 4.0011 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 C 2.3100 6.6685 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 0.0000 5.3347 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 N 0.7700 6.6685 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.0100 6.6685 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 634197-80-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 286371-64-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-910230
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A solution of 4 (20.2 g, 55.6 mmol) in
formamide (120 mL)was heated at 190°C for 5 h. The reaction mixture was
cooled to room temperature and poured into water. Then NaCl was added.
The resulting precipitate was collected, washed with water, and dried.
6-benzyloxy-7-methoxy-4(3H)-quinazolone (6) (19.4 g, 68.8 mmol) in
quantitative yield (5).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent and Selective Inhibitors of Platelet-Derived Growth Factor
Receptor Phosphorylation. 3. Replacement of Quinazoline Moiety and
Improvement of Metabolic Polymorphism of 4-[4-(N-Substituted
(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matsuno, Kenji; Ushiki, Junko; Seishi, Takashi; Ichimura, Michio; Giese,
Neill A.; Yu, Jin-Chen; Takahashi, Shusuke; Oda, Shoji; Nomoto, Yuji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(23), 4910-4925

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propanedioic acid, 2-fluoro-, 1,3-diethyl ester
C7H11FO4
685-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 F 5.3348 0.0000 0.0 0
M  V30 5 O 2.6673 1.5400 0.0 0
M  V30 6 O 4.0012 3.8501 0.0 0
M  V30 7 O 8.0023 1.5400 0.0 0
M  V30 8 O 6.6685 3.8501 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 10.6697 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-6-hydroxy-4(3H)-pyrimidinone
C4H3FN2O2
106615-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 1.5400 0.0 0
M  V30 3 O 5.3349 1.5400 0.0 0
M  V30 4 C 2.6674 1.5400 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 N 1.3338 3.8500 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 1 3 6
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 685-88-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 106615-61-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10713702
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a three neck 5 L round bottom flask equipped with magnetic stirrer,
nitrogen flow and reflux condenser, was charged the following: sodium
methoxide (25% NaOMe in Methanol) (1.425 L, 6.230 mol) and formamide
(0.535 L, 13.5 mol) under nitrogen and heated to 64°C. To the reaction
mixture diethyl 2-fluoromalonate (CAS# 685-88-1, 0.266 L, 1.684 mol) was
added slowly using an addition funnel (reaction exothermic). The reaction
was heated at 64°C for 72 h. The reaction was cooled down to room
temperature and solvent was removed under reduced pressure. The residue
was cooled to 0°C by ice bath. The mixture was stirred and acidified
slowly with 10 N HCl to pH 1-2. The product precipitated out and was
filtered. The product was washed with ice cold 1N HCl. The off-white
solid was suspended in ACN, filtered and dried (vacuum oven) at 30°C for
16 h to give 5-fluoropyrimidine-4,6-diol. Light brown-pinkish solid,
yield 349.4 g, 2.686 mol, 160%. 1H NMR (400 MHz, DMSO-d6) δ ppm 7.9 (s,
1H), 12.3 (brs, 2H).
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, exothermic (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxadiazolyl containing compounds as modulators of the
GPR119 receptor for use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jones, Robert M.; Lehmann, Juerg; Chen, Weichao; Edwards, Jeffrey;
Marquez, Glen; Morgan, Michael E.; Sadeque, Abu J.M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012040279 A1 2012-03-29

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Acetaldehyde
C2H4O
75-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Hydroxyethyl)formamide
C3H7NO2
693-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 0.7700 0.0 0
M  V30 2 N 4.0012 0.0000 0.0 0
M  V30 3 C 1.3338 0.0000 0.0 0
M  V30 4 C 5.3348 0.7700 0.0 0
M  V30 5 O 0.0000 0.7700 0.0 0
M  V30 6 O 6.6687 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-07-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 693-06-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30356487
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):NOTES
$DATUM continuous flow mode,optimization study (optimized on
time,catalyst,stoichiometry of reactant and solvent)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of n-vinyl carboxylic acid amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dumoleijn, Kim; Moonen, Kristof; Henricot, Alexis; Han, Cai Xing Simon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018041615 A1 2018-03-08

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Acetaldehyde
C2H4O
75-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Hydroxyethyl)formamide
C3H7NO2
693-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 0.7700 0.0 0
M  V30 2 N 4.0012 0.0000 0.0 0
M  V30 3 C 1.3338 0.0000 0.0 0
M  V30 4 C 5.3348 0.7700 0.0 0
M  V30 5 O 0.0000 0.7700 0.0 0
M  V30 6 O 6.6687 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-07-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 693-06-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26350752
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):NOTES
$DATUM flow system, optimization study, optimized on reactant ratio, time,
temperature, catalyst and its amount, and in the presence of solvent, no
solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of n-vinyl carboxylic acid amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dumoleijn, Kim; Moonen, Kristof; Henricot, Alexis; Han, Cai Xing Simon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20180057445 A1 2018-03-01

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[1-[[4-(3-Chlorophenyl)-1,2-dihydro-1-methyl-2-oxo-6-quinolinyl]hydroxymet...
C28H21ClN4O2
852510-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 9.3359 0.0 0
M  V30 2 C 8.4701 8.0021 0.0 0
M  V30 3 O 9.2401 6.6684 0.0 0
M  V30 4 O 0.0000 6.6684 0.0 0
M  V30 5 Cl 3.8501 0.0000 0.0 0
M  V30 6 C 11.8023 8.3523 0.0 0
M  V30 7 C 17.8276 9.6331 0.0 0
M  V30 8 N 19.3341 9.9533 0.0 0
M  V30 9 C 4.6201 6.6684 0.0 0
M  V30 10 C 3.8501 5.3348 0.0 0
M  V30 11 C 3.8501 8.0021 0.0 0
M  V30 12 C 6.1601 6.6684 0.0 0
M  V30 13 C 2.3100 5.3348 0.0 0
M  V30 14 C 4.6201 9.3359 0.0 0
M  V30 15 N 2.3100 8.0021 0.0 0
M  V30 16 C 6.9301 8.0021 0.0 0
M  V30 17 C 1.5400 6.6684 0.0 0
M  V30 18 C 6.1601 9.3359 0.0 0
M  V30 19 C 4.6201 4.0011 0.0 0
M  V30 20 C 3.8501 2.6673 0.0 0
M  V30 21 C 6.1601 4.0010 0.0 0
M  V30 22 C 4.6201 1.3337 0.0 0
M  V30 23 C 6.9301 2.6673 0.0 0
M  V30 24 C 6.1601 1.3337 0.0 0
M  V30 25 N 9.2401 9.3358 0.0 0
M  V30 26 C 10.7717 9.4969 0.0 0
M  V30 27 C 8.6138 10.7427 0.0 0
M  V30 28 C 11.0919 11.0031 0.0 0
M  V30 29 N 9.7582 11.7732 0.0 0
M  V30 30 C 13.3086 8.6725 0.0 0
M  V30 31 C 14.3390 7.5281 0.0 0
M  V30 32 C 13.7844 10.1372 0.0 0
M  V30 33 C 15.8454 7.8483 0.0 0
M  V30 34 C 15.2909 10.4574 0.0 0
M  V30 35 C 16.3213 9.3130 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 2 25
M  V30 5 2 4 17
M  V30 6 1 5 22
M  V30 7 1 6 26
M  V30 8 1 6 30
M  V30 9 3 7 8
M  V30 10 1 7 35
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 2 10 13
M  V30 15 1 10 19
M  V30 16 2 11 14
M  V30 17 1 11 15
M  V30 18 1 12 16
M  V30 19 1 13 17
M  V30 20 1 14 18
M  V30 21 1 15 17
M  V30 22 2 16 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[4-(3-Chlorophenyl)-1,2-dihydro-1-methyl-2-oxo-6-quinolinyl][5-[(4-cyanoph...
C29H22ClN5O2
852510-42-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 9.3360 0.0 0
M  V30 2 C 8.4702 8.0022 0.0 0
M  V30 3 N 9.2402 6.6685 0.0 0
M  V30 4 C 10.7802 6.6685 0.0 0
M  V30 5 O 11.5503 5.3348 0.0 0
M  V30 6 O 0.0000 6.6685 0.0 0
M  V30 7 Cl 3.8501 0.0000 0.0 0
M  V30 8 C 11.8024 8.3524 0.0 0
M  V30 9 C 17.8277 9.6332 0.0 0
M  V30 10 N 19.3342 9.9534 0.0 0
M  V30 11 C 4.6201 6.6685 0.0 0
M  V30 12 C 3.8501 5.3348 0.0 0
M  V30 13 C 3.8501 8.0022 0.0 0
M  V30 14 C 6.1601 6.6685 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 4.6201 9.3360 0.0 0
M  V30 17 N 2.3101 8.0022 0.0 0
M  V30 18 C 6.9302 8.0022 0.0 0
M  V30 19 C 1.5400 6.6685 0.0 0
M  V30 20 C 6.1601 9.3360 0.0 0
M  V30 21 C 4.6201 4.0010 0.0 0
M  V30 22 C 3.8501 2.6673 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 C 4.6201 1.3337 0.0 0
M  V30 25 C 6.9302 2.6673 0.0 0
M  V30 26 C 6.1601 1.3337 0.0 0
M  V30 27 N 9.2402 9.3360 0.0 0
M  V30 28 C 10.7718 9.4969 0.0 0
M  V30 29 C 8.6139 10.7428 0.0 0
M  V30 30 C 11.0919 11.0032 0.0 0
M  V30 31 N 9.7583 11.7732 0.0 0
M  V30 32 C 13.3087 8.6725 0.0 0
M  V30 33 C 13.7845 10.1373 0.0 0
M  V30 34 C 14.3391 7.5281 0.0 0
M  V30 35 C 15.2910 10.4574 0.0 0
M  V30 36 C 15.8456 7.8483 0.0 0
M  V30 37 C 16.3214 9.3130 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 2 27
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 2 6 19
M  V30 8 1 7 24
M  V30 9 1 8 28
M  V30 10 1 8 32
M  V30 11 3 9 10
M  V30 12 1 9 37
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 12 21
M  V30 18 2 13 16
M  V30 19 1 13 17
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 17 19
M  V30 24 2 18 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 852510-39-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 852510-42-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-8903029
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and activity of achiral analogs of 2-quinolones and
indoles as non-thiol farnesyltransferase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Qun; Woods, Keith W.; Wang, Weibo; Lin, Nan-Horng; Claiborne, Akiyo;
Gu, Wen-zhen; Cohen, Jerry; Stoll, Vincent S.; Hutchins, Charles; Frost,
David; Rosenberg, Saul H.; Sham, Hing L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(8), 2033-2039

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-4-methoxy-5-(phenylmethoxy)-, methyl ester
C16H17NO4
855793-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3347 0.0 0
M  V30 3 O 5.3900 1.3336 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 C 2.3100 6.6685 0.0 0
M  V30 6 O 0.7700 6.6685 0.0 0
M  V30 7 O 3.0800 8.0021 0.0 0
M  V30 8 C 0.0000 8.0021 0.0 0
M  V30 9 N 0.7700 4.0011 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.0100 6.6685 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 14
M  V30 9 1 6 8
M  V30 10 1 9 15
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-6-(phenylmethoxy)-4(3H)-quinazolinone
C16H14N2O3
286371-64-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 8.0021 0.0 0
M  V30 2 O 5.3900 1.3336 0.0 0
M  V30 3 C 4.6200 0.0000 0.0 0
M  V30 4 O 6.9300 4.0011 0.0 0
M  V30 5 C 7.7000 5.3347 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 3.0800 5.3347 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 N 0.7700 4.0011 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 C 2.3100 6.6685 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 0.0000 5.3347 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 N 0.7700 6.6685 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.0100 6.6685 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 855793-63-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 286371-64-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8243250
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 107A Step 4: A mixture of methyl
2-amino-5-(benzyloxy)-4-methoxybenzoate (7.36 g, 0.025 mol), formamide
(25 mL) and acetic acid (6.25 mL) was heated at 130°C for 24 hr. After
letting cooling down to room temperature, water was added and the
resulting solid was filtered and washed with plenty of cold water. The
solid was dried under vacuum at 120°C for 3 hr to yield
6-(benzyloxy)-7-methoxyquinazolin-4(3H)-one. Yield: 7.45 g (100%).
6-(benzyloxy)-7-methoxyquinazolin-4(3H)-one. Yield: 7.45 g 100%. 1H NMR
(DMSO-d6): δ 12.15 (1H, s), 8.05 (1H, s), 7.66 (1H, s), 7.44 (5H, m),
7.23 (1H, s), 5.28 (2H, s), 3.92 (3H, s). LC-MS (ESI) m/z 207 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline derivatives as RAF kinase modulators for
treating cancers, inflammations and immune diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abraham, Sunny; Bhagwat, Shripad; Campbell, Brian T.; Chao, Qi; Faraoni,
Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.;
Setti, Eduardo; Sprankle, Kelly G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009117080 A1 2009-09-24

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methylquinoline
C10H9N
91-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 2.6673 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 N 4.6201 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-4-quinolinecarboxamide
C11H10N2O
15821-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 N 2.3101 6.6687 0.0 0
M  V30 3 O 0.0000 5.3348 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 3.8501 4.0012 0.0 0
M  V30 6 C 4.6201 2.6675 0.0 0
M  V30 7 C 2.3101 4.0012 0.0 0
M  V30 8 C 4.6201 5.3348 0.0 0
M  V30 9 N 3.8501 1.3338 0.0 0
M  V30 10 C 6.1601 2.6675 0.0 0
M  V30 11 C 1.5400 2.6675 0.0 0
M  V30 12 C 6.1601 5.3348 0.0 0
M  V30 13 C 2.3101 1.3338 0.0 0
M  V30 14 C 6.9302 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-63-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15821-13-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-095-CAS-15089984
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical, alternative reaction conditions gave lower yield, sunlight
used, yield depends on catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sunlight induced functionalization of some heterocyclic bases in the
presence of polycrystalline TiO2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Caronna, T.; Gambarotti, C.; Palmisano, L.; Punta, C.; Recupero, F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2003), (18),
2350-2351

$RFMT $RIREG SCHEME25 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Toluenesulfinic acid
C7H8O2S
536-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.7700 1.3337 0.0 0 VAL=4
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[(4-Methylphenyl)sulfonyl]phenylmethyl]formamide
C15H15NO3S
37643-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 3 N 2.3100 5.3347 0.0 0
M  V30 4 O 4.6200 2.4611 0.0 0
M  V30 5 O 4.6200 5.5411 0.0 0
M  V30 6 C 0.7700 5.3347 0.0 0
M  V30 7 O 0.0000 6.6685 0.0 0
M  V30 8 C 10.7800 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 3.0800 1.3338 0.0 0
M  V30 12 C 0.0000 1.3338 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 6.1600 4.0011 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0
M  V30 17 C 6.9300 2.6674 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 8.4700 2.6674 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 15
M  V30 7 1 3 6
M  V30 8 2 6 7
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 37643-54-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19732227
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic Enantio- and Diastereoselective Mannich Addition of TosMIC to
Ketimines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Franchino, Allegra; Chapman, Jack; Funes-Ardoiz, Ignacio; Paton, Robert
S.; Dixon, Darren J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2018), 24(67), 17660-17664

$RFMT $RIREG SCHEME25 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Toluenesulfinic acid
C7H8O2S
536-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.7700 1.3337 0.0 0 VAL=4
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[(4-Methylphenyl)sulfonyl]phenylmethyl]formamide
C15H15NO3S
37643-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 3 N 2.3100 5.3347 0.0 0
M  V30 4 O 4.6200 2.4611 0.0 0
M  V30 5 O 4.6200 5.5411 0.0 0
M  V30 6 C 0.7700 5.3347 0.0 0
M  V30 7 O 0.0000 6.6685 0.0 0
M  V30 8 C 10.7800 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 3.0800 1.3338 0.0 0
M  V30 12 C 0.0000 1.3338 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 6.1600 4.0011 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0
M  V30 17 C 6.9300 2.6674 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 8.4700 2.6674 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 15
M  V30 7 1 3 6
M  V30 8 2 6 7
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 37643-54-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11790857
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalytic Asymmetric Synthesis of β-Aryl-β-isocyano Esters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morana, Fabio; Basso, Andrea; Bella, Marco; Riva, Renata; Banfi, Luca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2012), 354(11-12), 2199-2210,
S2199/1-S2199/39

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Alanine methyl ester
C4H9NO2
10065-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0 CFG=1
M  V30 3 O 4.0011 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 N 1.3338 0.0000 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Alanine, N-formyl-, methyl ester
C5H9NO3
32221-83-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 N 5.3348 2.3100 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 1.3337 1.5400 0.0 0
M  V30 6 O 2.6675 3.8500 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 O 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10065-72-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32221-83-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29217818
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1809269-30-4
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, ee = 94%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide Synthesis through Borinic Acid-Catalysed Transamidation under
Mild Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohy El Dine, Tharwat; Evans, David; Rouden, Jacques; Blanchet, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2016), 22(17), 5894-5898

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-3-[(7-ethoxy-7-oxoheptyl)oxy]-4-methoxybenzoate
C19H29NO6
1012057-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 4.6201 0.0 0
M  V30 2 C 10.6697 3.8501 0.0 0
M  V30 3 C 12.0033 4.6201 0.0 0
M  V30 4 C 13.3370 3.8501 0.0 0
M  V30 5 C 14.6708 4.6201 0.0 0
M  V30 6 C 16.0045 3.8501 0.0 0
M  V30 7 C 17.3382 4.6201 0.0 0
M  V30 8 C 18.6718 3.8501 0.0 0
M  V30 9 O 20.0057 4.6201 0.0 0
M  V30 10 O 18.6718 2.3101 0.0 0
M  V30 11 C 21.3393 3.8501 0.0 0
M  V30 12 C 22.6730 4.6201 0.0 0
M  V30 13 O 9.3360 1.5400 0.0 0
M  V30 14 C 9.3360 0.0000 0.0 0
M  V30 15 N 6.6685 6.1601 0.0 0
M  V30 16 C 4.0012 4.6201 0.0 0
M  V30 17 O 2.6673 3.8501 0.0 0
M  V30 18 O 4.0012 6.1601 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 0.0000 3.8501 0.0 0
M  V30 21 C 8.0022 3.8501 0.0 0
M  V30 22 C 8.0022 2.3101 0.0 0
M  V30 23 C 6.6685 4.6201 0.0 0
M  V30 24 C 6.6685 1.5400 0.0 0
M  V30 25 C 5.3348 3.8501 0.0 0
M  V30 26 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 22
M  V30 15 1 15 23
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 25
M  V30 19 1 17 19
M  V30 20 1 19 20
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-[(3,4-dihydro-7-methoxy-4-oxo-6-quinazolinyl)oxy]heptanoate
C18H24N2O5
1012057-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 O 2.6675 6.9301 0.0 0
M  V30 3 C 1.3337 7.7001 0.0 0
M  V30 4 O 5.3348 5.3901 0.0 0
M  V30 5 C 6.6684 4.6201 0.0 0
M  V30 6 C 8.0022 5.3901 0.0 0
M  V30 7 C 9.3359 4.6201 0.0 0
M  V30 8 C 10.6695 5.3901 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0
M  V30 10 C 13.3370 5.3901 0.0 0
M  V30 11 C 14.6707 4.6201 0.0 0
M  V30 12 O 16.0043 5.3901 0.0 0
M  V30 13 O 14.6707 3.0800 0.0 0
M  V30 14 C 17.3381 4.6201 0.0 0
M  V30 15 C 18.6718 5.3901 0.0 0
M  V30 16 C 1.3337 3.0800 0.0 0
M  V30 17 C 2.6675 2.3100 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 N 0.0000 2.3100 0.0 0
M  V30 20 C 4.0011 3.0800 0.0 0
M  V30 21 C 2.6675 0.7700 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 0.0000 0.7700 0.0 0
M  V30 24 C 4.0011 4.6201 0.0 0
M  V30 25 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 2 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1012057-24-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012057-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3560408
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 8e'. Ethyl
7-(7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yloxy)heptanoate (Compound
0406-12). A mixture of compound 0405-12 (8.71 g, 23.7 mmol), ammonium
formate (1.48 g, 23.7 mmol) and formamide (40 mL) was stirred at 180°C
for 3 hours. After reaction the mixture was cooled to room temperature.
The formamide was removed under reduce pressure, and the residue was
dissolved in dichloromethane and washed with brine. The organic phase was
dried over sodium sulfate, filtered and concentrated to give the title
product 0406-12 as a pale white solid (8.18g, 99%). LCMS: 349 [M+1]+, 1H
NMR (DMSO-d6): δ 1.17 (t, J = 6.9 Hz, 3H), 1.38 (m, 4H), 1.55 (m, 2H),
1.75 (m, 2H), 2.29 (t, J = 7.2 Hz, 2H), 3.90 (s, 3H), 4.05 (m, 4H), 7.13
(s, 1H), 7.42 (s, 1H), 7.97 (d, J = 3.6 Hz, 1H), 12.07 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multi-functional small molecules as anti-proliferative agents and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Qian, Changgeng; Gould, Stephen; Zhai, Haixiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008033747 A2 2008-03-20

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-5-[(7-ethoxy-7-oxoheptyl)oxy]-4-methoxy-, ethyl ester
C19H29NO6
1012067-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 4.0011 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 C 10.7800 5.3347 0.0 0
M  V30 4 C 11.5500 6.6684 0.0 0
M  V30 5 C 13.0900 6.6684 0.0 0
M  V30 6 C 13.8600 8.0021 0.0 0
M  V30 7 C 15.4000 8.0021 0.0 0
M  V30 8 C 16.1700 9.3358 0.0 0
M  V30 9 O 17.7100 9.3358 0.0 0
M  V30 10 O 15.4000 10.6694 0.0 0
M  V30 11 C 18.4800 10.6694 0.0 0
M  V30 12 C 20.0200 10.6694 0.0 0
M  V30 13 O 6.9300 1.3336 0.0 0
M  V30 14 C 6.1600 0.0000 0.0 0
M  V30 15 C 3.8500 6.6684 0.0 0
M  V30 16 O 2.3100 6.6684 0.0 0
M  V30 17 O 4.6200 8.0021 0.0 0
M  V30 18 C 1.5400 8.0021 0.0 0
M  V30 19 C 0.0000 8.0021 0.0 0
M  V30 20 N 2.3100 4.0011 0.0 0
M  V30 21 C 6.9300 4.0011 0.0 0
M  V30 22 C 6.1600 2.6673 0.0 0
M  V30 23 C 6.1600 5.3347 0.0 0
M  V30 24 C 4.6200 2.6673 0.0 0
M  V30 25 C 4.6200 5.3347 0.0 0
M  V30 26 C 3.8500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 22
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 25
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 20 26
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-[(3,4-dihydro-7-methoxy-4-oxo-6-quinazolinyl)oxy]heptanoate
C18H24N2O5
1012057-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 O 2.6675 6.9301 0.0 0
M  V30 3 C 1.3337 7.7001 0.0 0
M  V30 4 O 5.3348 5.3901 0.0 0
M  V30 5 C 6.6684 4.6201 0.0 0
M  V30 6 C 8.0022 5.3901 0.0 0
M  V30 7 C 9.3359 4.6201 0.0 0
M  V30 8 C 10.6695 5.3901 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0
M  V30 10 C 13.3370 5.3901 0.0 0
M  V30 11 C 14.6707 4.6201 0.0 0
M  V30 12 O 16.0043 5.3901 0.0 0
M  V30 13 O 14.6707 3.0800 0.0 0
M  V30 14 C 17.3381 4.6201 0.0 0
M  V30 15 C 18.6718 5.3901 0.0 0
M  V30 16 C 1.3337 3.0800 0.0 0
M  V30 17 C 2.6675 2.3100 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 N 0.0000 2.3100 0.0 0
M  V30 20 C 4.0011 3.0800 0.0 0
M  V30 21 C 2.6675 0.7700 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 0.0000 0.7700 0.0 0
M  V30 24 C 4.0011 4.6201 0.0 0
M  V30 25 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 2 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1012067-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012057-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13911556
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Ethyl 7-(7-methoxy-4-oxo-3, 4-dihydroquinazolin-6-yloxy)heptanoate (61).
A mixture of 59 (8.71 g, 23.7 mmol), ammonium formate (1.48 g, 23.7 mmol)
and formamide (40 mL) was stirred at 180 °C for 3 h. The mixture was
cooled to room temperature and the excess formamide was removed in vacuo.
The residue was dissolved in dichloromethane, and washed with water and
brine. The organic layer was dried over sodium sulfate, filtered, and
concentrated to give 61 as a pale white solid (8.18g, 99%). Ethyl
7-(7-methoxy-4-oxo-3, 4-dihydroquinazolin-6-yloxy)heptanoate (61), yield
8.18g, 99% 1H NMR (DMSO-d6): δ 1.17 (t, J = 6.9 Hz, 3H), 1.38 (m, 4H),
1.55 (m, 2H), 1.75 (m, 2H), 2.29 (t, J = 7.2 Hz, 2H), 3.90 (s, 3H), 4.05
(m, 4H), 7.13 (s, 1H), 7.42 (s, 1H), 7.97 (d, J = 3.6 Hz, 1H), 12.07 (s,
1H). LCMS (ESI): m/z 349 [M + H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide
(CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for
the Treatment of Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Zhai, Hai-Xiao; Wang, Jing; Forrester, Jeffrey; Qu, Hui; Yin,
Ling; Lai, Cheng-Jung; Bao, Rudi; Qian, Changgeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(5), 2000-2009

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-5-[(7-ethoxy-7-oxoheptyl)oxy]-4-methoxy-, ethyl ester
C19H29NO6
1012067-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 4.0011 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 C 10.7800 5.3347 0.0 0
M  V30 4 C 11.5500 6.6684 0.0 0
M  V30 5 C 13.0900 6.6684 0.0 0
M  V30 6 C 13.8600 8.0021 0.0 0
M  V30 7 C 15.4000 8.0021 0.0 0
M  V30 8 C 16.1700 9.3358 0.0 0
M  V30 9 O 17.7100 9.3358 0.0 0
M  V30 10 O 15.4000 10.6694 0.0 0
M  V30 11 C 18.4800 10.6694 0.0 0
M  V30 12 C 20.0200 10.6694 0.0 0
M  V30 13 O 6.9300 1.3336 0.0 0
M  V30 14 C 6.1600 0.0000 0.0 0
M  V30 15 C 3.8500 6.6684 0.0 0
M  V30 16 O 2.3100 6.6684 0.0 0
M  V30 17 O 4.6200 8.0021 0.0 0
M  V30 18 C 1.5400 8.0021 0.0 0
M  V30 19 C 0.0000 8.0021 0.0 0
M  V30 20 N 2.3100 4.0011 0.0 0
M  V30 21 C 6.9300 4.0011 0.0 0
M  V30 22 C 6.1600 2.6673 0.0 0
M  V30 23 C 6.1600 5.3347 0.0 0
M  V30 24 C 4.6200 2.6673 0.0 0
M  V30 25 C 4.6200 5.3347 0.0 0
M  V30 26 C 3.8500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 22
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 25
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 20 26
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-[(3,4-dihydro-7-methoxy-4-oxo-6-quinazolinyl)oxy]heptanoate
C18H24N2O5
1012057-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 O 2.6675 6.9301 0.0 0
M  V30 3 C 1.3337 7.7001 0.0 0
M  V30 4 O 5.3348 5.3901 0.0 0
M  V30 5 C 6.6684 4.6201 0.0 0
M  V30 6 C 8.0022 5.3901 0.0 0
M  V30 7 C 9.3359 4.6201 0.0 0
M  V30 8 C 10.6695 5.3901 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0
M  V30 10 C 13.3370 5.3901 0.0 0
M  V30 11 C 14.6707 4.6201 0.0 0
M  V30 12 O 16.0043 5.3901 0.0 0
M  V30 13 O 14.6707 3.0800 0.0 0
M  V30 14 C 17.3381 4.6201 0.0 0
M  V30 15 C 18.6718 5.3901 0.0 0
M  V30 16 C 1.3337 3.0800 0.0 0
M  V30 17 C 2.6675 2.3100 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 N 0.0000 2.3100 0.0 0
M  V30 20 C 4.0011 3.0800 0.0 0
M  V30 21 C 2.6675 0.7700 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 0.0000 0.7700 0.0 0
M  V30 24 C 4.0011 4.6201 0.0 0
M  V30 25 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 2 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1012067-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012057-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12331763
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 8e′. Ethyl 7-(7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yloxy)
heptanoate (Compound 0406-12) A mixture of compound 0405-12 (8.71 g, 23.7
mmol), ammonium formate (1.48 g, 23.7 mmol) and formamide (40 mL) was
stirred at 180° C. for 3 hours. After reaction the mixture was cooled to
room temperature. The formamide was removed under reduce pressure, and
the residue was dissolved in dichloromethane and washed with brine. The
organic phase was dried over sodium sulfate, filtered and concentrated to
give the title product 0406-12 as a pale white solid (8.18 g, 99%): LCMS:
349 [M+1], 1H NMR (DMSO-d6): δ1.17 (t, J=6.9 Hz, 3H), 1.38 (m, 4H), 1.55
(m, 2H), 1.75 (m, 2H), 2.29 (t, J=7.2 Hz, 2H), 3.90 (s, 3H), 4.05 (m,
4H), 7.13 (s, 1H), 7.42 (s, 1H), 7.97 (d, J=3.6 Hz, 1H), 12.07 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-phenylaminoquinazoline derivatives as epidermal growth
factor receptor tyrosine kinase (EGFR-TK) inhibitors containing a zinc
binding moiety and formulation containing them
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Qian, Changgeng; Zhai, Haixiao; Bao, Rudi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090111772 A1 2009-04-30

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-5-[(7-ethoxy-7-oxoheptyl)oxy]-4-methoxy-, ethyl ester
C19H29NO6
1012067-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 4.0011 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 C 10.7800 5.3347 0.0 0
M  V30 4 C 11.5500 6.6684 0.0 0
M  V30 5 C 13.0900 6.6684 0.0 0
M  V30 6 C 13.8600 8.0021 0.0 0
M  V30 7 C 15.4000 8.0021 0.0 0
M  V30 8 C 16.1700 9.3358 0.0 0
M  V30 9 O 17.7100 9.3358 0.0 0
M  V30 10 O 15.4000 10.6694 0.0 0
M  V30 11 C 18.4800 10.6694 0.0 0
M  V30 12 C 20.0200 10.6694 0.0 0
M  V30 13 O 6.9300 1.3336 0.0 0
M  V30 14 C 6.1600 0.0000 0.0 0
M  V30 15 C 3.8500 6.6684 0.0 0
M  V30 16 O 2.3100 6.6684 0.0 0
M  V30 17 O 4.6200 8.0021 0.0 0
M  V30 18 C 1.5400 8.0021 0.0 0
M  V30 19 C 0.0000 8.0021 0.0 0
M  V30 20 N 2.3100 4.0011 0.0 0
M  V30 21 C 6.9300 4.0011 0.0 0
M  V30 22 C 6.1600 2.6673 0.0 0
M  V30 23 C 6.1600 5.3347 0.0 0
M  V30 24 C 4.6200 2.6673 0.0 0
M  V30 25 C 4.6200 5.3347 0.0 0
M  V30 26 C 3.8500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 22
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 25
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 20 26
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-[(3,4-dihydro-7-methoxy-4-oxo-6-quinazolinyl)oxy]heptanoate
C18H24N2O5
1012057-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 O 2.6675 6.9301 0.0 0
M  V30 3 C 1.3337 7.7001 0.0 0
M  V30 4 O 5.3348 5.3901 0.0 0
M  V30 5 C 6.6684 4.6201 0.0 0
M  V30 6 C 8.0022 5.3901 0.0 0
M  V30 7 C 9.3359 4.6201 0.0 0
M  V30 8 C 10.6695 5.3901 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0
M  V30 10 C 13.3370 5.3901 0.0 0
M  V30 11 C 14.6707 4.6201 0.0 0
M  V30 12 O 16.0043 5.3901 0.0 0
M  V30 13 O 14.6707 3.0800 0.0 0
M  V30 14 C 17.3381 4.6201 0.0 0
M  V30 15 C 18.6718 5.3901 0.0 0
M  V30 16 C 1.3337 3.0800 0.0 0
M  V30 17 C 2.6675 2.3100 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 N 0.0000 2.3100 0.0 0
M  V30 20 C 4.0011 3.0800 0.0 0
M  V30 21 C 2.6675 0.7700 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 0.0000 0.7700 0.0 0
M  V30 24 C 4.0011 4.6201 0.0 0
M  V30 25 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 2 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1012067-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012057-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8214171
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tartaric acid salts or complexes of quinazoline compounds
containing a zinc binding moiety as EGFR tyrosine kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Qian, Changgeng; Zhai, Haixiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009035718 A1 2009-03-19

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-5-[(7-ethoxy-7-oxoheptyl)oxy]-4-methoxy-, ethyl ester
C19H29NO6
1012067-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 4.0011 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 C 10.7800 5.3347 0.0 0
M  V30 4 C 11.5500 6.6684 0.0 0
M  V30 5 C 13.0900 6.6684 0.0 0
M  V30 6 C 13.8600 8.0021 0.0 0
M  V30 7 C 15.4000 8.0021 0.0 0
M  V30 8 C 16.1700 9.3358 0.0 0
M  V30 9 O 17.7100 9.3358 0.0 0
M  V30 10 O 15.4000 10.6694 0.0 0
M  V30 11 C 18.4800 10.6694 0.0 0
M  V30 12 C 20.0200 10.6694 0.0 0
M  V30 13 O 6.9300 1.3336 0.0 0
M  V30 14 C 6.1600 0.0000 0.0 0
M  V30 15 C 3.8500 6.6684 0.0 0
M  V30 16 O 2.3100 6.6684 0.0 0
M  V30 17 O 4.6200 8.0021 0.0 0
M  V30 18 C 1.5400 8.0021 0.0 0
M  V30 19 C 0.0000 8.0021 0.0 0
M  V30 20 N 2.3100 4.0011 0.0 0
M  V30 21 C 6.9300 4.0011 0.0 0
M  V30 22 C 6.1600 2.6673 0.0 0
M  V30 23 C 6.1600 5.3347 0.0 0
M  V30 24 C 4.6200 2.6673 0.0 0
M  V30 25 C 4.6200 5.3347 0.0 0
M  V30 26 C 3.8500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 22
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 25
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 20 26
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-[(3,4-dihydro-7-methoxy-4-oxo-6-quinazolinyl)oxy]heptanoate
C18H24N2O5
1012057-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 O 2.6675 6.9301 0.0 0
M  V30 3 C 1.3337 7.7001 0.0 0
M  V30 4 O 5.3348 5.3901 0.0 0
M  V30 5 C 6.6684 4.6201 0.0 0
M  V30 6 C 8.0022 5.3901 0.0 0
M  V30 7 C 9.3359 4.6201 0.0 0
M  V30 8 C 10.6695 5.3901 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0
M  V30 10 C 13.3370 5.3901 0.0 0
M  V30 11 C 14.6707 4.6201 0.0 0
M  V30 12 O 16.0043 5.3901 0.0 0
M  V30 13 O 14.6707 3.0800 0.0 0
M  V30 14 C 17.3381 4.6201 0.0 0
M  V30 15 C 18.6718 5.3901 0.0 0
M  V30 16 C 1.3337 3.0800 0.0 0
M  V30 17 C 2.6675 2.3100 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 N 0.0000 2.3100 0.0 0
M  V30 20 C 4.0011 3.0800 0.0 0
M  V30 21 C 2.6675 0.7700 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 0.0000 0.7700 0.0 0
M  V30 24 C 4.0011 4.6201 0.0 0
M  V30 25 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 2 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1012067-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012057-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8342079
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 8e'. Ethyl 7-(7-methoxy-4-oxo-3, 4-dihydroquinazolin-6-yloxy)
heptanoate (Compound 0406-12) A mixture of compound 0405-12 (8.71 g, 23.7
mmol), ammonium formate (1.48 g, 23.7 mmol) and formamide (40 mL) was
stirred at 180 °C for 3 hours. After reaction the mixture was cooled to
room temperature. The formamide was removed under reduce pressure, and
the residue was dissolved in dichloromethane and washed with brine. The
organic phase was dried over sodium sulfate, filtered and concentrated to
give the title product 0406-12 as a pale white solid (8.18g, 99%) Ethyl
7-(7-methoxy-4-oxo-3, 4-dihydroquinazolin-6-yloxy) heptanoate (Compound
0406-12), yield (8.18g, 99%): LCMS: 349 [M+1] + , 1H NMR (DMSO-d6): δ(t,
J= 6.9 Hz, 3H), 1.38 (m, 4H), 1.55 (m, 2H), 1.75 (m, 2H), 2.29 (t, J= 7.2
Hz, 2H), 3.90 (s, 3H), 4.05 (m, 4H), 7.13 (s, 1H), 7.42 (s, 1H), 7.97 (d,
J= 3.6 Hz, 1H), 12.07 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline based EGFR inhibitors containing a zinc
binding moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Changgeng; Cai, Xiong; Gould, Stephen; Zhai, Haixiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008033749 A2 2008-03-20

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-5-[(7-ethoxy-7-oxoheptyl)oxy]-4-methoxy-, ethyl ester
C19H29NO6
1012067-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 4.0011 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 C 10.7800 5.3347 0.0 0
M  V30 4 C 11.5500 6.6684 0.0 0
M  V30 5 C 13.0900 6.6684 0.0 0
M  V30 6 C 13.8600 8.0021 0.0 0
M  V30 7 C 15.4000 8.0021 0.0 0
M  V30 8 C 16.1700 9.3358 0.0 0
M  V30 9 O 17.7100 9.3358 0.0 0
M  V30 10 O 15.4000 10.6694 0.0 0
M  V30 11 C 18.4800 10.6694 0.0 0
M  V30 12 C 20.0200 10.6694 0.0 0
M  V30 13 O 6.9300 1.3336 0.0 0
M  V30 14 C 6.1600 0.0000 0.0 0
M  V30 15 C 3.8500 6.6684 0.0 0
M  V30 16 O 2.3100 6.6684 0.0 0
M  V30 17 O 4.6200 8.0021 0.0 0
M  V30 18 C 1.5400 8.0021 0.0 0
M  V30 19 C 0.0000 8.0021 0.0 0
M  V30 20 N 2.3100 4.0011 0.0 0
M  V30 21 C 6.9300 4.0011 0.0 0
M  V30 22 C 6.1600 2.6673 0.0 0
M  V30 23 C 6.1600 5.3347 0.0 0
M  V30 24 C 4.6200 2.6673 0.0 0
M  V30 25 C 4.6200 5.3347 0.0 0
M  V30 26 C 3.8500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 22
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 25
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 20 26
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-[(3,4-dihydro-7-methoxy-4-oxo-6-quinazolinyl)oxy]heptanoate
C18H24N2O5
1012057-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 O 2.6675 6.9301 0.0 0
M  V30 3 C 1.3337 7.7001 0.0 0
M  V30 4 O 5.3348 5.3901 0.0 0
M  V30 5 C 6.6684 4.6201 0.0 0
M  V30 6 C 8.0022 5.3901 0.0 0
M  V30 7 C 9.3359 4.6201 0.0 0
M  V30 8 C 10.6695 5.3901 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0
M  V30 10 C 13.3370 5.3901 0.0 0
M  V30 11 C 14.6707 4.6201 0.0 0
M  V30 12 O 16.0043 5.3901 0.0 0
M  V30 13 O 14.6707 3.0800 0.0 0
M  V30 14 C 17.3381 4.6201 0.0 0
M  V30 15 C 18.6718 5.3901 0.0 0
M  V30 16 C 1.3337 3.0800 0.0 0
M  V30 17 C 2.6675 2.3100 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 N 0.0000 2.3100 0.0 0
M  V30 20 C 4.0011 3.0800 0.0 0
M  V30 21 C 2.6675 0.7700 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 0.0000 0.7700 0.0 0
M  V30 24 C 4.0011 4.6201 0.0 0
M  V30 25 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 2 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1012067-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012057-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3480157
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 8e'. Ethyl 7-(7-methoxy-4-oxo-3, 4-dihydroquinazolin-6-yloxy)
heptanoate(Compound 0406-12). A mixture of compound 0405-12 (8.71 g, 23.7
mmol), ammonium formate (1.48 g, 23.7 mmol) and formamide (40 mL) was
stirred at 180°C for 3 hours. After reaction the mixture was cooled to
room temperature. The formamide was removed under reduce pressure, and
the residue was dissolved in dichloromethane and washed with brine. The
organic phase was dried over sodium sulfate, filtered and concentrated to
give the title product 0406-12 as a pale white solid (8.18g, 99%):. LCMS:
349[M+1]+, 1H NMR (DMSO-d6): δ1.17 (t, J = 6.9 Hz, 3H), 1.38 (m, 4H),
1.55 (m, 2H), 1.75 (m, 2H), 2.29 (t, J = 7.2 Hz, 2H), 3.90 (s, 3H), 4.05
(m, 4H), 7.13 (s, 1H), 7.42 (s, 1H), 7.97 (d, J = 3.6 Hz, 1H), 12.07 (s,
1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline based EGFR inhibitors containing a zinc
binding moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Changgeng; Cai, Xiong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008033748 A2 2008-03-20

$RFMT $RIREG SCHEME29 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Toluenesulfonic acid
C7H8O3S
104-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)[(4-methylphenyl)sulfonyl]methyl]formamide
C16H17NO4S
185243-93-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.8501 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 N 6.6685 2.3101 0.0 0
M  V30 4 O 4.5648 3.2864 0.0 0
M  V30 5 O 6.1048 5.9538 0.0 0
M  V30 6 C 8.0022 1.5400 0.0 0
M  V30 7 O 8.0022 0.0000 0.0 0
M  V30 8 O 12.0033 6.9302 0.0 0
M  V30 9 C 13.3370 6.1601 0.0 0
M  V30 10 C 0.0000 7.7002 0.0 0
M  V30 11 C 8.0022 4.6201 0.0 0
M  V30 12 C 8.0022 6.1601 0.0 0
M  V30 13 C 9.3360 3.8501 0.0 0
M  V30 14 C 9.3360 6.9302 0.0 0
M  V30 15 C 10.6697 4.6201 0.0 0
M  V30 16 C 10.6697 6.1601 0.0 0
M  V30 17 C 4.0010 5.3901 0.0 0
M  V30 18 C 4.0010 6.9302 0.0 0
M  V30 19 C 2.6673 4.6201 0.0 0
M  V30 20 C 2.6673 7.7002 0.0 0
M  V30 21 C 1.3337 5.3901 0.0 0
M  V30 22 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 17
M  V30 7 1 3 6
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 16
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 185243-93-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14064313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Shape-selective fluorescent sensing ensemble using a tweezer-type
metalloreceptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Plante, Jeffrey P.; Glass, Timothy E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2006), 8(10), 2163-2166

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyanobenzaldehyde
C8H5NO
105-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 N 8.4701 1.3337 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Cyanophenyl)methyl]formamide
C9H8N2O
1467452-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6673 0.0 0
M  V30 2 N 2.3100 1.3337 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 O 0.0000 0.0000 0.0 0
M  V30 5 C 9.2401 2.6673 0.0 0
M  V30 6 N 10.7801 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 5.3901 1.3337 0.0 0
M  V30 9 C 5.3901 4.0010 0.0 0
M  V30 10 C 6.9301 1.3337 0.0 0
M  V30 11 C 6.9301 4.0010 0.0 0
M  V30 12 C 7.7001 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-07-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1467452-70-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31537523
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-48-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, sealed pressure tube used, catalyst prepared and used,
recyclable catalyst, catalyst on nitrogen-doped carbon support
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM ZIF-67 Derived Co/NC Nanoparticles Enable Catalytic Leuckart-type
Reductive Amination of Bio-based Carbonyls to N-Formyl Compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Chuanhui; Meng, Ye; Yang, Song; Li, Hu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2021), 13(24), 5166-5177

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminophenol
C6H7NO
123-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Hydroxyphenyl)formamide
C7H7NO2
1693-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-30-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25069248
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent,reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst-Free Transamidation of Aromatic Amines with Formamide
Derivatives and Tertiary Amides with Aliphatic Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yin, Jiawen; Zhang, Jingyu; Cai, Changqun; Deng, Guo-Jun; Gong, Hang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(2), 387-392

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Butyl-3-chloro-2-pyrazinamine
C8H12ClN3
1250679-34-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 C 9.3359 1.5400 0.0 0
M  V30 6 Cl 1.3337 0.0000 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 N 2.6675 3.8500 0.0 0
M  V30 10 N 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 8
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Butyl-1H-imidazo[4,5-b]pyrazine
C9H12N4
1365094-35-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1884 0.0 0
M  V30 2 C 7.1954 2.7125 0.0 0
M  V30 3 C 8.3398 3.7429 0.0 0
M  V30 4 C 9.8045 3.2671 0.0 0
M  V30 5 C 3.0800 2.4782 0.0 0
M  V30 6 N 4.5864 2.1580 0.0 0
M  V30 7 C 2.3100 1.1444 0.0 0
M  V30 8 N 2.3100 3.8118 0.0 0
M  V30 9 C 4.7473 0.6263 0.0 0
M  V30 10 N 3.3405 0.0000 0.0 0
M  V30 11 N 0.7700 1.1444 0.0 0
M  V30 12 C 0.7700 3.8118 0.0 0
M  V30 13 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 10
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1250679-34-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365094-35-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3416232
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 29154-12-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1160861-53-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1-(4-Methoxybenzyl)-1H-imidazo[4,5-b]pyridine
(3a) To an oven-dried 25 mL Schlenk-tube equipped with a stirbar was
added Pd2(dba)3 · CHCl3 (20.8 mg, 0.02 mmol),
2-Di-t-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-tri-i-propylbiphenyl
(L1) (48 mg, 0.1 mmol), K3PO4 (639 mg, 3.01 mmol) and
2-Chloro-N-(4-methoxybenzyl)pyridin-3-amine (2a) (500 mg, 2.01 mmol) (if
solid). The tube was evacuated and refilled with Ar(g). Formamide (0.12
mL, 3.01 mmol) was added via syringe as a single portion, followed by the
chloropyridine (if liquid) in 4 mL of tert-butanol. The reaction mixture
was degassed with 3 x vacuum / Ar(g) purge cycles. The reaction vessel
was then equipped with a cold-finger under a positive pressure of argon
gas and immersed in a 110°C pre-heated oil-bath for 4h at which time TLC
showed consumption of the chloro-pyridine. The reaction was cooled to
room temperature, diluted with MeOH (4 mL) filtered through a Celite plug
and concentrated to give a dark brown oil. The crude product was purified
on a silica gel column (4.5 cm x 12 cm), eluting with 4% MeOH in CH2Cl2.
1-Butyl-1H-imidazo[4,5-b]pyrazine (12) Following the general
experimental; N-butyl-3-chloropyrazin-2-amine (6) (74 mg, 0.4 mmol),
Pd2(dba)3·CHCl3 (4.14 mg, 0.004 mmol), t-BuBrettphos (9.7 mg, 0.02 mmol),
K3PO4 (128 mg, 0.6 mmol), formamide (0.022 mL, 0.6 mmol) were combined
with 2.0 mL tert-butanol in a 25 mL Schlenk flask. After 2 h the reaction
was complete, the reaction cooled to RT, filtered through Celite,
concentrated and purified on a silica gel column (2.5 cm x 12 cm),
eluting with 4% MeOH / CH2Cl2. 12 as 70 mg of a yellow solid (99%). 1H
NMR (300 MHz, CDCl3) δ = 8.50 (d, J = 2.7 Hz, 1H), 8.32-8.30 (m, 2H),
4.29 (t, J = 7.2 Hz, 2H), 1.90 (pent, J = 7.5 Hz, 2H), 1.35 (hex, J = 7.5
Hz, 2H), 0.93 (t, J = 7.5 Hz, 3H); 13C NMR (75.4 MHz, CDCl3) δ = 146.1,
147.0, 140.1, 140.0, 138.6, 44.2, 31.9, 20.0, 13.6; FT-IR (NaCl, thin
film) ν = 3412, 3096, 2057, 2960, 2874, 1655, 1570, 1486, 1464, 1402,
1351, 1196, 850, 757, 638 cm-1. HRMS (ESI) Calc (C9H12N4)H+: 177.1135,
Found: 177.1142; MP: 84-86°C; Rf (4% MeOH / CH2Cl2): 0.23.
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Imidazo[4,5-b]pyridines and Imidazo[4,5-b]pyrazines by
Palladium Catalyzed Amidation of 2-Chloro-3-amino-heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Zhao, Jinbo; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(7), 1764-1767

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-5-[(7-ethoxy-7-oxoheptyl)oxy]-4-(methoxy-d3)benzoate
C19H26D3NO6
1313875-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 5.3347 0.0 0
M  V30 2 C 9.2400 6.6684 0.0 0
M  V30 3 C 10.7800 6.6684 0.0 0
M  V30 4 C 11.5500 8.0020 0.0 0
M  V30 5 C 13.0900 8.0020 0.0 0
M  V30 6 C 13.8600 9.3358 0.0 0
M  V30 7 C 15.4000 9.3358 0.0 0
M  V30 8 C 16.1700 10.6694 0.0 0
M  V30 9 O 17.7100 10.6694 0.0 0
M  V30 10 O 15.4000 12.0031 0.0 0
M  V30 11 C 18.4800 12.0031 0.0 0
M  V30 12 C 20.0200 12.0031 0.0 0
M  V30 13 O 6.9300 2.6673 0.0 0
M  V30 14 C 6.1600 1.3336 0.0 0
M  V30 15 C 3.8500 8.0020 0.0 0
M  V30 16 O 2.3100 8.0020 0.0 0
M  V30 17 O 4.6200 9.3358 0.0 0
M  V30 18 C 1.5400 9.3358 0.0 0
M  V30 19 C 0.0000 9.3358 0.0 0
M  V30 20 N 2.3100 5.3347 0.0 0
M  V30 21 C 6.9300 5.3347 0.0 0
M  V30 22 C 6.1600 4.0011 0.0 0
M  V30 23 C 6.1600 6.6684 0.0 0
M  V30 24 C 4.6200 4.0011 0.0 0
M  V30 25 C 4.6200 6.6684 0.0 0
M  V30 26 C 3.8500 5.3347 0.0 0
M  V30 27 H 4.6200 1.3336 0.0 0 MASS=2
M  V30 28 H 5.3900 0.0000 0.0 0 MASS=2
M  V30 29 H 6.9300 0.0000 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 22
M  V30 15 1 14 27
M  V30 16 1 14 28
M  V30 17 1 14 29
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 1 15 25
M  V30 21 1 16 18
M  V30 22 1 18 19
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-[[3,4-dihydro-7-(methoxy-d3)-4-oxo-6-quinazolinyl]oxy]heptanoate
C18H21D3N2O5
1313875-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 9.2402 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 3.8501 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 C 8.0023 3.8501 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 C 10.6697 3.8501 0.0 0
M  V30 9 C 12.0035 4.6201 0.0 0
M  V30 10 C 13.3372 3.8501 0.0 0
M  V30 11 C 14.6708 4.6201 0.0 0
M  V30 12 O 16.0045 3.8501 0.0 0
M  V30 13 O 14.6708 6.1601 0.0 0
M  V30 14 C 17.3383 4.6201 0.0 0
M  V30 15 C 18.6720 3.8501 0.0 0
M  V30 16 C 1.3337 6.1601 0.0 0
M  V30 17 C 2.6675 6.9302 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 N 0.0000 6.9302 0.0 0
M  V30 20 C 4.0012 6.1601 0.0 0
M  V30 21 C 2.6675 8.4702 0.0 0
M  V30 22 C 2.6675 3.8501 0.0 0
M  V30 23 C 0.0000 8.4702 0.0 0
M  V30 24 C 4.0012 4.6201 0.0 0
M  V30 25 N 1.3337 9.2402 0.0 0
M  V30 26 H 0.0000 2.3101 0.0 0 MASS=2
M  V30 27 H 0.0000 0.7700 0.0 0 MASS=2
M  V30 28 H 1.3337 0.0000 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 3 26
M  V30 5 1 3 27
M  V30 6 1 3 28
M  V30 7 1 4 5
M  V30 8 1 4 24
M  V30 9 1 5 6
M  V30 10 1 6 7
M  V30 11 1 7 8
M  V30 12 1 8 9
M  V30 13 1 9 10
M  V30 14 1 10 11
M  V30 15 1 11 12
M  V30 16 2 11 13
M  V30 17 1 12 14
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 16 19
M  V30 22 2 17 20
M  V30 23 1 17 21
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 2 22 24
M  V30 29 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1313875-19-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1313875-21-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7469165
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Ethyl 7-(7-(D3-methoxy)-4-oxo-3,4-dihydroquinazolin-6-yloxy) heptanoate
(6). A mixture of 5 (0.3 g, 0.81 mmol), ammonium formate 1.0 equivalent
and formamide (2 mL) was stirred at 180 °C for 3 h. The mixture was
cooled to room temperature and the excess formamide was removed in vacuo.
The residue was dissolved in dichloromethane, and washed with water and
brine. The organic layer was dried over sodium sulfate, filtered, and
concentrated to give 6. Yield 0.28 g, 99%, pale yellow solid. HPLC-MS
(ESI): m/z 352 [M + H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline derivatives as anticancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Qiang; Zhu, Hongwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011084796 A2 2011-07-14

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-2-thiophenecarboxamide
C5H6N2OS
147123-47-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 N 5.1049 2.3100 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 N 0.7104 0.1773 0.0 0
M  V30 5 C 2.4374 2.3100 0.0 0
M  V30 6 C 1.0306 1.6836 0.0 0
M  V30 7 S 2.2765 3.8416 0.0 0
M  V30 8 C 0.0000 2.8281 0.0 0
M  V30 9 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[3,2-d]pyrimidin-4(3H)-one
C6H4N2OS
16234-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 S 2.1579 4.5864 0.0 0
M  V30 6 N 1.1444 0.7700 0.0 0
M  V30 7 C 0.0000 3.3405 0.0 0
M  V30 8 N 3.8119 0.7700 0.0 0
M  V30 9 C 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 147123-47-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16234-10-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-7317391
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Procedure for the Preparation of 7-Bromo-4-chlorothieno[ 3,2-d]pyrimidine
(4). 3-Aminothiophene-2-carboxamide (1) (1.42 g, 10.0 mmol) was dissolved
in formamide (5 mL). The resulting solution was heated at 180 °C for 5 h,
and then it was allowed to stand at room temperature for 2 h. The
precipitate that formed was collected by vacuum filtration to give
3H-thieno[3, 2-d]pyrimidin-4-one (2) (1.52 g, 99% yield) as a white
solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of a 7-Arylthieno[3,2-d]pyrimidin-4-Amine Library
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peng, Jinsong; Lin, Wenqing; Jiang, Dahong; Yuan, Shixue; Chen, Yuanwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2007), 9(3), 431-436

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,2S)-(-)-2-Amino-1,2-diphenylethanol
C14H15NO
23190-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0 CFG=2
M  V30 2 C 5.3901 1.3337 0.0 0 CFG=1
M  V30 3 N 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 5
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S,2R)-2-Hydroxy-1,2-diphenylethyl]formamide
C15H15NO2
39664-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 3 N 5.3900 2.6674 0.0 0
M  V30 4 O 4.6200 6.6685 0.0 0
M  V30 5 C 4.6200 1.3338 0.0 0
M  V30 6 O 5.3900 0.0000 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 13
M  V30 6 1 3 5
M  V30 7 2 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 23190-16-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 39664-88-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27516543
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 463-77-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoinversion of Unactivated Alcohols by Tethered Sulfonamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marcyk, Paul T.; Jefferies, Latisha R.; Abu Salim, Deyaa I.; Pink, Maren;
Baik, Mu-Hyun; Cook, Silas P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2019), 58(6), 1727-1731

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,2S)-(-)-2-Amino-1,2-diphenylethanol
C14H15NO
23190-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0 CFG=2
M  V30 2 C 5.3901 1.3337 0.0 0 CFG=1
M  V30 3 N 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 5
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S,2R)-2-Hydroxy-1,2-diphenylethyl]formamide
C15H15NO2
39664-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 3 N 5.3900 2.6674 0.0 0
M  V30 4 O 4.6200 6.6685 0.0 0
M  V30 5 C 4.6200 1.3338 0.0 0
M  V30 6 O 5.3900 0.0000 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 13
M  V30 6 1 3 5
M  V30 7 2 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 23190-16-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 39664-88-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-11553346
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):NOTES
$DATUM 47.5 g scale, formamide also used as solvent, no ammonium formate gave a
lower yield, formamide containing a formate impurity gave a 98% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pseudoephenamine: A Practical Chiral Auxiliary for Asymmetric Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales, Marvin R.; Mellem, Kevin T.; Myers, Andrew G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2012), 51(19), 4568-4571,
S4568/1-S4568/112

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,5-Trimethoxyaniline
C9H13NO3
24313-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 6.1601 0.0 0
M  V30 2 C 2.6675 6.9302 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 C 8.0023 3.8501 0.0 0
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 N 4.0012 0.0000 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4,5-Trimethoxyphenyl)formamide
C10H13NO4
38951-44-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 2.3101 0.0 0
M  V30 2 C 0.0000 3.0801 0.0 0
M  V30 3 O 4.0012 0.7700 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 1.3337 6.9302 0.0 0
M  V30 7 N 6.6685 5.3901 0.0 0
M  V30 8 C 8.0023 4.6201 0.0 0
M  V30 9 O 9.3360 5.3901 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 4.0012 5.3901 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24313-88-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 38951-44-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25612538
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent,reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst-Free Transamidation of Aromatic Amines with Formamide
Derivatives and Tertiary Amides with Aliphatic Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yin, Jiawen; Zhang, Jingyu; Cai, Changqun; Deng, Guo-Jun; Gong, Hang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(2), 387-392

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1-(4-hydroxyphenyl)ethanone
C8H7BrO2
2491-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 Br 0.0000 2.6673 0.0 0
M  V30 5 O 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1H-Imidazol-5-yl)phenol
C9H8N2O
68535-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.5298 1.3336 0.0 0
M  V30 2 C 3.9098 1.3336 0.0 0
M  V30 3 C 4.6798 2.6673 0.0 0
M  V30 4 C 4.6798 0.0000 0.0 0
M  V30 5 C 6.2198 2.6673 0.0 0
M  V30 6 C 6.2198 0.0000 0.0 0
M  V30 7 C 6.9898 1.3336 0.0 0
M  V30 8 C 2.3698 1.3336 0.0 0
M  V30 9 C 1.4645 2.5795 0.0 0
M  V30 10 N 1.4645 0.0878 0.0 0
M  V30 11 N 0.0000 2.1037 0.0 0
M  V30 12 C 0.0000 0.5636 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2491-38-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68535-65-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27435393
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-Based Approach to Targeting Inosine-5'-monophosphate
Dehydrogenase (IMPDH) from Mycobacterium tuberculosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trapero, Ana; Pacitto, Angela; Singh, Vinayak; Sabbah, Mohamad; Coyne,
Anthony G.; Mizrahi, Valerie; Blundell, Tom L.; Ascher, David B.; Abell,
Chris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2018), 61(7), 2806-2822

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-L-Proline methyl ester
C6H11NO2
2577-48-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 5.1049 2.3100 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4385 1.5400 0.0 0
M  V30 5 C 2.4374 2.3100 0.0 0 CFG=1
M  V30 6 C 1.0306 1.6836 0.0 0
M  V30 7 N 2.2765 3.8416 0.0 0
M  V30 8 C 0.0000 2.8281 0.0 0
M  V30 9 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 5 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Formyl-L-proline methyl ester
C7H11NO3
3154-58-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5251 2.6218 0.0 0
M  V30 2 O 5.8589 1.8518 0.0 0
M  V30 3 O 4.5251 4.1617 0.0 0
M  V30 4 C 7.1925 2.6218 0.0 0
M  V30 5 C 1.4646 3.9845 0.0 0
M  V30 6 O 0.0000 4.4603 0.0 0
M  V30 7 C 3.1915 1.8518 0.0 0 CFG=2
M  V30 8 N 1.7848 2.4781 0.0 0
M  V30 9 C 3.0306 0.3202 0.0 0
M  V30 10 C 0.7543 1.3337 0.0 0
M  V30 11 C 1.5242 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 8
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2577-48-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3154-58-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25747206
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1809269-30-4
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide Synthesis through Borinic Acid-Catalysed Transamidation under
Mild Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohy El Dine, Tharwat; Evans, David; Rouden, Jacques; Blanchet, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2016), 22(17), 5894-5898

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-4,6-dimethylfuro[2,3-b]pyridine-2-carboximidate
C12H15N3O2
2868313-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.9416 0.3694 0.0 0
M  V30 2 C 2.6674 0.0000 0.0 0
M  V30 3 C 7.9110 3.0800 0.0 0
M  V30 4 O 8.6810 4.4136 0.0 0
M  V30 5 N 8.6810 1.7462 0.0 0
M  V30 6 C 10.2210 4.4136 0.0 0
M  V30 7 C 10.9910 5.7473 0.0 0
M  V30 8 C 0.0000 4.6200 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 O 5.4658 4.3259 0.0 0
M  V30 12 N 2.6674 4.6200 0.0 0
M  V30 13 C 5.4658 1.8341 0.0 0
M  V30 14 C 2.6674 1.5400 0.0 0
M  V30 15 C 6.3710 3.0800 0.0 0
M  V30 16 C 1.3338 3.8500 0.0 0
M  V30 17 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 1 14 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7,9-Dimethylpyrido[3′,2′:4,5]furo[3,2-d]pyrimidin-4(3H)-one
C11H9N3O2
59615-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3200 6.6772 0.0 0
M  V30 2 O 1.0849 0.0000 0.0 0
M  V30 3 C 8.9401 4.0097 0.0 0
M  V30 4 C 4.3200 4.0097 0.0 0
M  V30 5 C 2.8138 3.6896 0.0 0
M  V30 6 C 5.0901 2.6761 0.0 0
M  V30 7 C 5.0901 5.3434 0.0 0
M  V30 8 C 2.6527 2.1580 0.0 0
M  V30 9 N 1.5679 4.5948 0.0 0
M  V30 10 O 4.0596 1.5317 0.0 0
M  V30 11 N 6.6301 2.6761 0.0 0
M  V30 12 C 6.6301 5.3434 0.0 0
M  V30 13 C 1.2459 1.5315 0.0 0
M  V30 14 C 0.1609 3.9685 0.0 0
M  V30 15 C 7.4001 4.0097 0.0 0
M  V30 16 N 0.0000 2.4368 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 13
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 8 10
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2868313-17-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59615-79-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32657174
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3473-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of formamidine acetate after 3 hours
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of structurally distinct tricyclic M4 positive allosteric
modulator (PAM) chemotypes - Part 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Long, Madeline F.; Capstick, Rory A.; Spearing, Paul K.; Engers, Julie
L.; Gregro, Alison R.; Bollinger, Sean R.; Chang, Sichen; Luscombe,
Vincent B.; Rodriguez, Alice L.; Cho, Hyekyung P.; Niswender, Colleen M.;
Bridges, Thomas M.; Conn, P. Jeffrey; Lindsley, Craig W.; Engers, Darren
W.; Temple, Kayla J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 53128416

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N6-[(1,1-Dimethylethoxy)carbonyl]-L-lysine methyl ester
C12H24N2O4
3017-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 N 5.3348 1.5400 0.0 0
M  V30 3 O 2.6675 1.5400 0.0 0
M  V30 4 O 4.0012 3.8501 0.0 0
M  V30 5 C 6.6687 2.3101 0.0 0
M  V30 6 C 1.3338 2.3101 0.0 0
M  V30 7 C 8.0023 1.5400 0.0 0
M  V30 8 C 0.5638 0.9764 0.0 0
M  V30 9 C 0.0000 3.0801 0.0 0
M  V30 10 C 2.1038 3.6437 0.0 0
M  V30 11 C 9.3360 2.3101 0.0 0
M  V30 12 C 10.6698 1.5400 0.0 0
M  V30 13 C 12.0035 2.3101 0.0 0 CFG=2
M  V30 14 C 13.3372 1.5400 0.0 0
M  V30 15 N 12.0035 3.8501 0.0 0
M  V30 16 O 14.6708 2.3101 0.0 0
M  V30 17 O 13.3372 0.0000 0.0 0
M  V30 18 C 16.0046 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 13 15 CFG=3
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 16 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N6-[(1,1-Dimethylethoxy)carbonyl]-N2-formyl-L-lysine methyl ester
C13H24N2O5
1313611-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.8501 0.0 0 CFG=2
M  V30 2 C 4.0010 4.6201 0.0 0
M  V30 3 C 1.3337 4.6201 0.0 0
M  V30 4 N 2.6673 2.3101 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 O 0.0000 3.8501 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 C 0.0000 6.9302 0.0 0
M  V30 11 O 1.3337 0.0000 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 N 9.3358 4.6201 0.0 0
M  V30 14 C 10.6697 3.8501 0.0 0
M  V30 15 O 12.0033 4.6201 0.0 0
M  V30 16 O 10.6697 2.3101 0.0 0
M  V30 17 C 13.3370 3.8501 0.0 0
M  V30 18 C 14.1070 5.1838 0.0 0
M  V30 19 C 14.6707 3.0801 0.0 0
M  V30 20 C 12.5670 2.5164 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3017-32-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1313611-06-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28973691
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1809269-30-4
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide Synthesis through Borinic Acid-Catalysed Transamidation under
Mild Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohy El Dine, Tharwat; Evans, David; Rouden, Jacques; Blanchet, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2016), 22(17), 5894-5898

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-5-fluorobenzoate
C8H8FNO2
319-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 O 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 N 3.0800 0.0000 0.0 0
M  V30 6 F 0.0000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Fluoro-4(3H)-quinazolinone
C8H5FN2O
16499-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 F 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 319-24-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16499-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10554472
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination
Activity of USP10 and USP13
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Junli; Xia, Hongguang; Kim, Minsu; Xu, Lihua; Li, Ying; Zhang,
Lihong; Cai, Yu; Norberg, Helin Vakifahmetoglu; Zhang, Tao; Furuya,
Tsuyoshi; Jin, Minzhi; Zhu, Zhimin; Wang, Huanchen; Yu, Jia; Li, Yanxia;
Hao, Yan; Choi, Augustine; Ke, Hengming; Ma, Dawei; Yuan, Junying
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Cell (Cambridge, MA, United States) (2011), 147(1), 223-234

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hydroxyanthranilic acid
C7H7NO3
394-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 O 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Hydroxy-4(3H)-quinazolinone
C8H6N2O2
16064-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 394-31-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-10-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7456373
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 9a. 6-Hydroxyquinazolin-4(3H)-one (compound 0202) To a solution of
2-amino-5-hydroxybenzoic acid 0201 (30.6 g, 0.2 mol) in formamide was
stirred and heated to 190° C. for 0.5 h. The mixture was allowed to cool
to room temperature. The precipitate was isolated, washed with ether and
dried to obtain title compound 0202 (32 g, brown solid, yield: 99%):
LC-MS m/z 163 [M+1]; 1H NMR (DMSO-d6): δ7.25 (dd, 1H), 7.40 (d, 1H), 7.46
(d, 1H), 7.88 (s, 1H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-phenylaminoquinazoline derivatives as epidermal growth
factor receptor tyrosine kinase (EGFR-TK) inhibitors containing a zinc
binding moiety and formulation containing them
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Qian, Changgeng; Zhai, Haixiao; Bao, Rudi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090111772 A1 2009-04-30

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hydroxyanthranilic acid
C7H7NO3
394-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 O 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Hydroxy-4(3H)-quinazolinone
C8H6N2O2
16064-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 394-31-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-10-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12461915
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tartaric acid salts or complexes of quinazoline compounds
containing a zinc binding moiety as EGFR tyrosine kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Qian, Changgeng; Zhai, Haixiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009035718 A1 2009-03-19

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hydroxyanthranilic acid
C7H7NO3
394-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 O 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Hydroxy-4(3H)-quinazolinone
C8H6N2O2
16064-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 394-31-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-10-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21310194
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 9: Preparation of
2-(4-(3-chloro-4-fluorophenylamino)quinazolin-6-yloxy)-N-hydroxyacetamide
(Compound 13). Step 9a. 6-hydroxyquinazolin-4(3H)-one (compound 0202). To
a solution of 2-amino-5-hydroxybenzoic acid 0201 (30.6 g, 0.2 mol) in
formamide was stirred and heated to 190°C for 0.5 h. The mixture was
allowed to cool to room temperature. The precipitate was isolated, washed
with ether and dried to obtain title compound 0202 (32g, brown solid,
yield: 99%). LC-MS m/z 163 [M+1]; 1H NMR (DMSO) δ 7.25 (dd, 1H), 7.40 (d,
1H), 7.46 (d, 1H), 7.88 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multi-functional small molecules as anti-proliferative agents and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Qian, Changgeng; Gould, Stephen; Zhai, Haixiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008033747 A2 2008-03-20

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hydroxyanthranilic acid
C7H7NO3
394-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 O 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Hydroxy-4(3H)-quinazolinone
C8H6N2O2
16064-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 394-31-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-10-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6487774
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 9a. 6-Hydroxyquinazolin-4(3H)-one (compound 0202) To a solution of
2-amino-5-hydroxybenzoic acid 0201 (30.6 g, 0.2 mol) in formamide was
stirred and heated to 190 °C for 0.5 h. The mixture was allowed to cool
to room temperature. The precipitate was isolated, washed with ether and
dried to obtain title compound 0202 (32g, brown solid, yield: 99%):
6-Hydroxyquinazolin-4(3H)-one (compound 0202), yield (32g, yield: 99%):
LC-MS m/z 163 [M+1]; 1H NMR (DMSO) δ),7.88(s,1H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline based EGFR inhibitors containing a zinc
binding moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Changgeng; Cai, Xiong; Gould, Stephen; Zhai, Haixiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008033749 A2 2008-03-20

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hydroxyanthranilic acid
C7H7NO3
394-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 O 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Hydroxy-4(3H)-quinazolinone
C8H6N2O2
16064-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 394-31-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-10-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21316620
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 9: Preparation of Ethyl
2-(4-(3-chloro-4-fluorophenylamino)quinazolin-6-yloxy)acetate (Compound
0210-13). Step 9a. 6-Hydroxyquinazolin-4(3H)-one (compound 0202). To a
solution of 2-amino-5-hydroxybenzoic acid 0201 (30.6 g, 0.2 mol) in
formamide was stirred and heated to 190°C for 0.5 h. The mixture was
allowed to cool to room temperature. The precipitate was isolated, washed
with ether and dried to obtain title compound 0202 (32g, brown solid,
yield: 99%):. LC-MS m/z 163[M+1]; 1H NMR (DMSO) δ7.25 (dd,1H) ,7.40
(d,1H) ,7.46 (d,1H) ,7.88 (s,1H) .
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline based EGFR inhibitors containing a zinc
binding moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Changgeng; Cai, Xiong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008033748 A2 2008-03-20

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hydroxyanthranilic acid
C7H7NO3
394-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 O 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Hydroxy-4(3H)-quinazolinone
C8H6N2O2
16064-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 394-31-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-10-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33119281
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New quinazolinone derivatives useful in treatment of cancer and
preparation method
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dolente, Cosimo; Hewings, David Stephen; Hunziker, Daniel; Krummenacher,
Daniela; Pettazzoni, Piergiorgio Francesco Tommaso; Ricklin, Fabienne;
Riemer, Claus; Wichmann, Juergen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022129259 A1 2022-06-23

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-(formylamino)-4-methyl-2-thiophenecarboxylate
C8H9NO3S
443762-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 3.7709 0.0 0
M  V30 2 O 0.7700 3.7709 0.0 0
M  V30 3 O 3.0800 5.1047 0.0 0
M  V30 4 C 0.0000 5.1047 0.0 0
M  V30 5 N 5.6420 3.4208 0.0 0
M  V30 6 C 7.1483 3.1006 0.0 0
M  V30 7 O 8.1788 4.2451 0.0 0
M  V30 8 C 6.3386 0.1437 0.0 0
M  V30 9 C 3.0800 2.4373 0.0 0
M  V30 10 C 4.6116 2.2764 0.0 0
M  V30 11 S 2.4536 1.0306 0.0 0
M  V30 12 C 4.9318 0.7700 0.0 0
M  V30 13 C 3.5980 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 6 7
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methylthieno[3,2-d]pyrimidin-4(3H)-one
C7H6N2OS
175137-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0801 0.0 0
M  V30 2 C 6.6520 3.0203 0.0 0
M  V30 3 C 2.6675 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 S 2.9877 4.5864 0.0 0
M  V30 7 C 5.1456 3.3405 0.0 0
M  V30 8 N 4.0012 0.7700 0.0 0
M  V30 9 N 1.3337 0.7700 0.0 0
M  V30 10 C 4.5192 4.7473 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 7
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 443762-03-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 175137-13-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28377266
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic compounds as protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fernandez, Joaquin Pastor; Alvarez Escobar, Rosa Maria; Riesco Fagundo,
Rosario Concepcion; Garcia Garcia, Ana Belen; Rodriguez Hergueta,
Antonio; Martin Hernando, Jose Ignacio; Blanco Aparicio, Carmen; Cebrian
Munoz, David Alvaro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20140256717 A1 2014-09-11

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Hydroxymethyl)formamide
C2H5NO2
13052-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 C 4.0010 0.0000 0.0 0
M  V30 4 O 0.0000 0.7700 0.0 0
M  V30 5 O 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13052-19-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-314-CAS-6429495
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Adducts 2a,c,d,f,h-j; General Procedure An aqueous solution of
formaldehyde (37% w/w, 1 equiv) was added to a mixture of the appropriate
amide (1 equiv) and either solid K2CO3 (0.1 equiv; 2a,c,j) or aq 1 N NaOH
(0.01 equiv, 2d,f,h,i). The mixture was stirred at r.t. for 2 h. The H2O
formed was removed in vacuo. The residue was diluted with CHCl3, EtOAc,
or MeOH (1 mL/mmol), dried (MgSO4), and filtered. After removal of the
solvent, the adduct was obtained and used for the next step without
further purification. N-Hydroxymethylformamide (2a)3 From formamide 1a
(3.6 g, 80 mmol); yield: 5.96 g (99%); colorless oil. IR (ATR): 3290,
2962, 1657, 1532, 1386, 1233, 1016, 875, 697, 648, 605 cm-1. 1H NMR (400
MHz, CDCl3): δ = 3.27 (br s, 1 H), 4.67 (s, 1 H), 4.79 (m, 2 H), 8.18 (s,
1 H). 13C NMR (100 MHz, CDCl3): δ = 63.8, 164.2. HRMS (EI): m/z [M]+
calcd for C2H5NO2: 75.0320; found: 75.0316.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A simple and efficient preparation of novel formaldehyde derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hartung, Rainer; Golz, Gregor; Schlaf, Susanne; Silvennoinen, Gudrun;
Polborn, Kurt; Mayer, Peter; Pfaendler, Hans Rudolf
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2009), (3), 495-501

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Nitrophenyl)-1-butanone
C10H11NO3
50766-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0
M  V30 2 C 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 4.6201 0.0 0
M  V30 4 C 9.3359 3.0800 0.0 0
M  V30 5 C 10.6695 2.3100 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 4.0011 0.0000 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-(3-Nitrophenyl)butyl]formamide
C11H14N2O3
698379-58-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.8500 0.0 0
M  V30 2 C 8.0021 4.6200 0.0 0
M  V30 3 N 6.6684 2.3100 0.0 0
M  V30 4 C 9.3358 3.8500 0.0 0
M  V30 5 C 8.0021 1.5400 0.0 0
M  V30 6 C 10.6694 4.6200 0.0 0
M  V30 7 O 8.0021 0.0000 0.0 0
M  V30 8 N 1.3336 3.8500 0.0 0 VAL=5
M  V30 9 O 1.3336 2.3100 0.0 0
M  V30 10 O 0.0000 4.6200 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0
M  V30 12 C 4.0011 3.8500 0.0 0
M  V30 13 C 5.3347 6.1600 0.0 0
M  V30 14 C 2.6673 4.6200 0.0 0
M  V30 15 C 4.0011 6.9300 0.0 0
M  V30 16 C 2.6673 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 14
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 50766-86-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 698379-58-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5920307
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of enantiopure 1-aryl-1-butylamines and 1-aryl-3-butenylamines
by diastereoselective addition of allylzinc bromide to imines derived
from (R)-phenylglycine amide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dalmolen, Jan; Van der Sluis, Marcel; Nieuwenhuijzen, Jose W.; Meetsma,
Auke; De Lange, Ben; Kaptein, Bernard; Kellogg, Richard M.; Broxterman,
Quirinus B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2004), (7), 1544-1557

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[2,3-b]pyridine-2-carboxylic acid, 3-amino-4,6-dimethyl-, ethyl ester
C12H14N2O2S
52505-56-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.9416 0.3694 0.0 0
M  V30 2 C 2.6674 0.0000 0.0 0
M  V30 3 C 7.9110 3.0800 0.0 0
M  V30 4 O 8.6810 4.4136 0.0 0
M  V30 5 O 8.6810 1.7462 0.0 0
M  V30 6 C 10.2210 4.4136 0.0 0
M  V30 7 C 10.9910 5.7473 0.0 0
M  V30 8 C 0.0000 4.6200 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 S 5.4658 4.3259 0.0 0
M  V30 12 N 2.6674 4.6200 0.0 0
M  V30 13 C 5.4658 1.8341 0.0 0
M  V30 14 C 2.6674 1.5400 0.0 0
M  V30 15 C 6.3710 3.0800 0.0 0
M  V30 16 C 1.3338 3.8500 0.0 0
M  V30 17 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 1 14 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7,9-Dimethylpyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4(3H)-one
C11H9N3OS
55023-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3200 6.6772 0.0 0
M  V30 2 O 1.0849 0.0000 0.0 0
M  V30 3 C 8.9401 4.0097 0.0 0
M  V30 4 C 4.3200 4.0097 0.0 0
M  V30 5 C 2.8138 3.6896 0.0 0
M  V30 6 C 5.0901 2.6761 0.0 0
M  V30 7 C 5.0901 5.3434 0.0 0
M  V30 8 C 2.6527 2.1580 0.0 0
M  V30 9 N 1.5679 4.5948 0.0 0
M  V30 10 S 4.0596 1.5317 0.0 0
M  V30 11 N 6.6301 2.6761 0.0 0
M  V30 12 C 6.6301 5.3434 0.0 0
M  V30 13 C 1.2459 1.5315 0.0 0
M  V30 14 C 0.1609 3.9685 0.0 0
M  V30 15 C 7.4001 4.0097 0.0 0
M  V30 16 N 0.0000 2.4368 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 13
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 8 10
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52505-56-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 55023-35-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32657171
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3473-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of formamidine acetate after 3 hours
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of structurally distinct tricyclic M4 positive allosteric
modulator (PAM) chemotypes - Part 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Long, Madeline F.; Capstick, Rory A.; Spearing, Paul K.; Engers, Julie
L.; Gregro, Alison R.; Bollinger, Sean R.; Chang, Sichen; Luscombe,
Vincent B.; Rodriguez, Alice L.; Cho, Hyekyung P.; Niswender, Colleen M.;
Bridges, Thomas M.; Conn, P. Jeffrey; Lindsley, Craig W.; Engers, Darren
W.; Temple, Kayla J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 53128416

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl bromoacetate
C6H11BrO2
5292-43-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 2.3101 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 0.5638 2.8737 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 2.1038 0.2064 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 O 4.0012 0.0000 0.0 0
M  V30 9 Br 6.6687 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Diformylglycine 1,1-dimethylethyl ester
C8H13NO4
126385-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 5.3349 0.0 0
M  V30 2 C 1.5400 5.3349 0.0 0
M  V30 3 C 3.8500 4.0011 0.0 0
M  V30 4 C 1.5400 3.7949 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 1.5400 6.8749 0.0 0
M  V30 7 C 5.3900 4.0011 0.0 0
M  V30 8 O 3.0800 2.6674 0.0 0
M  V30 9 N 6.1600 2.6674 0.0 0
M  V30 10 C 5.3900 1.3338 0.0 0
M  V30 11 C 7.7000 2.6674 0.0 0
M  V30 12 O 6.1600 0.0000 0.0 0
M  V30 13 O 8.4700 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5292-43-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 126385-84-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-4180741
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM literature prepn., in-situ generated reactant
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclopropylamines from N,N-Dialkylcarboxamides and Grignard Reagents in
the Presence of Titanium Tetraisopropoxide or Methyltitanium
Triisopropoxide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de Meijere, Armin; Chaplinski, Vladimir; Winsel, Harald; Kordes, Markus;
Stecker, Bjoern; Gazizova, Vesta; Savchenko, Andrei I.; Boese, Roland;
Schill, Farina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2010), 16(46), 13862-13875,
S13862/1-S13862/59

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloroquinoline
C9H6ClN
612-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.9302 2.6673 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 N 0.7700 2.6673 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-6-Quinolinylformamide
C10H8N2O
83407-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 C 2.6675 2.3101 0.0 0
M  V30 5 C 2.6675 0.7700 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 N 1.3337 0.0000 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 612-57-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83407-37-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-20400527
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2923-18-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1798782-15-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 96-47-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Buchwald-Hartwig coupling, screw cap vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Amidation and Amination of (Hetero)aryl Chlorides
under Homogeneous Conditions Enabled by a Soluble DBU/NaTFA Dual-Base
System
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beutner, Gregory L.; Coombs, John R.; Green, Rebecca A.; Inankur, Bahar;
Lin, Dong; Qiu, Jun; Roberts, Frederick; Simmons, Eric M.; Wisniewski,
Steven R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2019), 23(8), 1529-1537

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-[5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]i...
C22H21N5O2
705263-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 6.7720 0.0 0
M  V30 2 C 12.1641 4.6665 0.0 0
M  V30 3 O 13.6958 4.8275 0.0 0
M  V30 4 O 11.5377 3.2596 0.0 0
M  V30 5 C 14.6010 3.5816 0.0 0
M  V30 6 C 16.1325 3.7425 0.0 0
M  V30 7 C 6.1516 3.9437 0.0 0
M  V30 8 C 4.6200 4.1046 0.0 0
M  V30 9 C 6.4719 2.4374 0.0 0
M  V30 10 N 3.9937 2.6978 0.0 0
M  V30 11 N 5.1381 1.6674 0.0 0
M  V30 12 C 7.6163 1.4068 0.0 0
M  V30 13 C 5.4583 0.1609 0.0 0
M  V30 14 C 6.9899 0.0000 0.0 0
M  V30 15 C 7.1821 5.0880 0.0 0
M  V30 16 C 8.6884 4.7679 0.0 0
M  V30 17 C 6.7063 6.5527 0.0 0
M  V30 18 N 9.7190 5.9124 0.0 0
M  V30 19 C 7.7367 7.6971 0.0 0
M  V30 20 C 9.2430 7.3769 0.0 0
M  V30 21 C 11.2590 5.9124 0.0 0
M  V30 22 N 10.4890 8.2822 0.0 0
M  V30 23 C 11.7349 7.3769 0.0 0
M  V30 24 C 3.8500 5.4384 0.0 0
M  V30 25 N 2.3100 5.4384 0.0 0
M  V30 26 C 4.6200 6.7720 0.0 0
M  V30 27 C 1.5400 6.7720 0.0 0
M  V30 28 C 3.8500 8.1057 0.0 0
M  V30 29 C 2.3100 8.1057 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 27
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 21
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 8 10
M  V30 11 1 8 24
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 11
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 18 21
M  V30 24 1 19 20
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]imidazo...
C20H18N6O
705263-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.6956 6.7720 0.0 0
M  V30 2 C 1.5315 4.6665 0.0 0
M  V30 3 N 0.0000 4.8275 0.0 0
M  V30 4 O 2.1579 3.2596 0.0 0
M  V30 5 C 7.5440 3.9437 0.0 0
M  V30 6 C 9.0756 4.1046 0.0 0
M  V30 7 C 7.2239 2.4374 0.0 0
M  V30 8 N 9.7021 2.6978 0.0 0
M  V30 9 N 8.5575 1.6674 0.0 0
M  V30 10 C 6.0793 1.4068 0.0 0
M  V30 11 C 8.2373 0.1609 0.0 0
M  V30 12 C 6.7058 0.0000 0.0 0
M  V30 13 C 6.5136 5.0880 0.0 0
M  V30 14 C 5.0072 4.7679 0.0 0
M  V30 15 C 6.9895 6.5527 0.0 0
M  V30 16 N 3.9768 5.9124 0.0 0
M  V30 17 C 5.9591 7.6971 0.0 0
M  V30 18 C 4.4526 7.3769 0.0 0
M  V30 19 C 2.4368 5.9124 0.0 0
M  V30 20 N 3.2068 8.2822 0.0 0
M  V30 21 C 1.9609 7.3769 0.0 0
M  V30 22 C 9.8456 5.4384 0.0 0
M  V30 23 N 11.3856 5.4384 0.0 0
M  V30 24 C 9.0756 6.7720 0.0 0
M  V30 25 C 12.1556 6.7720 0.0 0
M  V30 26 C 9.8456 8.1057 0.0 0
M  V30 27 C 11.3856 8.1057 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 25
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 19
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 6 8
M  V30 9 1 6 22
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 8 9
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 1 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 1 17 18
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 26 1 22 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 705263-26-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 705263-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-200358
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel fused pyrazoles, in particular pyrrolopyrazoles, as
transforming growth factor-β (TGF-β) signal transduction inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beight, Douglas Wade; Burkholder, Timothy Paul; Decollo, Todd Vincent;
Godfrey, Alexander Glenn; Heap, Charles Raymond; King, Chi-Hsin Richard;
Li, Hong-Yu; McMillen, William Thomas; Sawyer, Jason Scott; Wang, Yan;
Diefenbacher, Clive Gideon; Engler, Thomas Albert; Malhotra, Sushant;
Mundla, Sreenivasa Reedy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004050659 A1 2004-06-17

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Diethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3,6-dicarboxylate
C14H19NO4S
835632-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3510 3.3320 0.0 0
M  V30 2 O 11.8158 2.8561 0.0 0
M  V30 3 O 10.0309 4.8385 0.0 0
M  V30 4 C 12.9602 3.8866 0.0 0
M  V30 5 C 14.4249 3.4107 0.0 0
M  V30 6 N 10.7012 0.0000 0.0 0
M  V30 7 C 3.0801 2.6218 0.0 0
M  V30 8 O 2.3101 3.9554 0.0 0
M  V30 9 O 2.3101 1.2881 0.0 0
M  V30 10 C 0.7700 3.9554 0.0 0
M  V30 11 C 0.0000 5.2891 0.0 0
M  V30 12 C 7.7002 2.6218 0.0 0
M  V30 13 C 6.9302 1.2881 0.0 0
M  V30 14 C 9.2066 2.3016 0.0 0
M  V30 15 C 6.9302 3.9554 0.0 0
M  V30 16 C 5.3901 1.2881 0.0 0
M  V30 17 S 7.9607 0.1435 0.0 0
M  V30 18 C 9.3676 0.7700 0.0 0
M  V30 19 C 5.3901 3.9554 0.0 0
M  V30 20 C 4.6201 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 18
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,4,5,6,7,8-hexahydro-4-oxo[1]benzothieno[2,3-d]pyrimidine-7-carboxylate
C13H14N2O3S
835632-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.3420 0.0000 0.0 0
M  V30 2 C 8.5289 5.4387 0.0 0
M  V30 3 O 9.8625 4.6687 0.0 0
M  V30 4 O 8.5289 6.9787 0.0 0
M  V30 5 C 11.1962 5.4387 0.0 0
M  V30 6 C 12.5298 4.6687 0.0 0
M  V30 7 C 4.5278 3.1287 0.0 0
M  V30 8 C 3.0631 2.6528 0.0 0
M  V30 9 C 4.5278 4.6687 0.0 0
M  V30 10 C 5.8614 2.3587 0.0 0
M  V30 11 C 2.1579 3.8987 0.0 0
M  V30 12 C 2.4368 1.2459 0.0 0
M  V30 13 S 3.0631 5.1446 0.0 0
M  V30 14 C 5.8614 5.4387 0.0 0
M  V30 15 C 7.1951 3.1287 0.0 0
M  V30 16 N 0.6263 3.7378 0.0 0
M  V30 17 N 0.9052 1.0849 0.0 0
M  V30 18 C 7.1951 4.6687 0.0 0
M  V30 19 C 0.0000 2.3308 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 11 13
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 835632-29-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 835632-30-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5193254
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2. Preparation of Example 14: Ethyl
4-oxo-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxylate
In a 100 mL round-bottom flask was placed 3.5 g (11.75 mmol, 1 equiv) of
2-amino-4,5,6,7-tetrahydro-benzo[b]thiophene-3,6-dicarboxylic acid
diethyl ester in 10 mL of formamide. The flask was equipped with a reflux
condenser and heated at 140 °C for 16 h. The mixture was then allowed to
cool to rt and a brown solid precipitated from solution. The resulting
precipitate was filtered and rinsed with EtOAc (200 mL) and dried in a
hi-vac oven for 2 h. After drying 3.25 g (99%) of the desired product as
a brown solid was obtained and used without further purification in the
next step. LCMS RT = 2.80 min; [M+H]+ = 279.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted tetrahydrobenzothienopyrimidinamines for
treating hyper-proliferative disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Chengzhi; Ladouceur, Gaetan H.; Brennan, Catherine; Chandler,
Brent; Dixon, Julie A.; Miranda, Karl; Fan, Dongping; Zhu, Qingming;
Verma, Sharad K.; Dumas, Jacques
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005010008 A1 2005-02-03

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Anthraquinone
C14H8O2
84-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 O 4.0011 6.1600 0.0 0
M  V30 3 C 2.6674 2.3100 0.0 0
M  V30 4 C 2.6674 3.8500 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 C 1.3336 1.5400 0.0 0
M  V30 7 C 4.0011 4.6200 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 C 6.6685 1.5400 0.0 0
M  V30 14 C 6.6685 4.6200 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 9 13
M  V30 14 2 10 12
M  V30 15 2 11 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-9,10-Anthracenediylbis[formamide]
C16H12N2O2
10303-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 4.0011 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 O 0.0000 5.3347 0.0 0
M  V30 4 N 8.4700 4.0011 0.0 0
M  V30 5 C 9.2400 2.6674 0.0 0
M  V30 6 O 10.7800 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3336 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 6.9300 1.3336 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 C 6.1600 5.3347 0.0 0
M  V30 16 C 6.1600 0.0000 0.0 0
M  V30 17 C 3.8500 6.6685 0.0 0
M  V30 18 C 6.9300 6.6685 0.0 0
M  V30 19 C 4.6200 8.0021 0.0 0
M  V30 20 C 6.1600 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 84-65-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10303-96-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-478-CAS-15902583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 9,10-Bis(formamido)anthracene (7) 2 A mixture of anthraquinone (10.0 g,
0.048 mol) and formamide (90 ml, 2.33 mol) was refluxed for 12 h. During
that time, the solid initially present dissolved, then a second material
began to separate, yielding eventually a thick slurry. When the reaction
was complete, it was cooled and filtered. The straw-yellow solid was
washed with water, and then repeatedly with methanol and dried. The
obtained brown-yellow solid was vigorously washed with aniline, and then
filtered. To remove aniline, the precipitate was washed with chloroform.
Obtained 9,10-bis(formamido)anthracene was straw-yellow solid (12.7 g).
Yield ≥99%. FT-IR (KBr) : 3207, 1651, 1539, 1515, 1398 cm-1. Any other
peak was not observed in carbonyl region (1600-1900 cm-1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Twisted N,N-Dialkylamines as a Design Strategy to Tune Simple
Aromatic Hydrocarbons as Steric Environment-Sensitive Fluorophores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasaki, Shunsuke; Suzuki, Satoshi; Sameera, W. M. C.; Igawa, Kazunobu;
Morokuma, Keiji; Konishi, Gen-ichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2016), 138(26), 8194-8206

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-5-(methylthio)-1H-pyrazole-4-carboxamide
C5H8N4OS
90914-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7104 0.7700 0.0 0
M  V30 2 N 4.0442 0.0000 0.0 0
M  V30 3 O 1.3768 0.0000 0.0 0
M  V30 4 S 5.4210 2.7392 0.0 0
M  V30 5 C 6.5654 3.7698 0.0 0
M  V30 6 N 0.0000 2.7392 0.0 0
M  V30 7 C 2.7104 2.3100 0.0 0
M  V30 8 C 3.9563 3.2152 0.0 0
M  V30 9 C 1.4645 3.2152 0.0 0
M  V30 10 N 3.4804 4.6798 0.0 0
M  V30 11 N 1.9404 4.6798 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dihydro-3-(methylthio)-4H-pyrazolo[3,4-d]pyrimidin-4-one
C6H6N4OS
90914-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.7308 1.9570 0.0 0
M  V30 2 C 7.1955 2.4329 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 C 3.0800 2.6673 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 4.5864 2.9876 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 N 3.3406 5.1454 0.0 0
M  V30 9 N 0.7700 4.0011 0.0 0
M  V30 10 N 4.7474 4.5191 0.0 0
M  V30 11 N 0.7700 1.3336 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90914-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90914-36-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30988890
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel heteroaryl and heterocycle compounds as PI3K
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Su, Wei-Guo; Dai, Guangxiu; Xiao, Kun; Jia, Hong; Venable, Jennifer
Diane; Bembenek, Scott Damian; Chai, Wenying
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150291593 A1 2015-10-15

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-5-(methylthio)-1H-pyrazole-4-carboxamide
C5H8N4OS
90914-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7104 0.7700 0.0 0
M  V30 2 N 4.0442 0.0000 0.0 0
M  V30 3 O 1.3768 0.0000 0.0 0
M  V30 4 S 5.4210 2.7392 0.0 0
M  V30 5 C 6.5654 3.7698 0.0 0
M  V30 6 N 0.0000 2.7392 0.0 0
M  V30 7 C 2.7104 2.3100 0.0 0
M  V30 8 C 3.9563 3.2152 0.0 0
M  V30 9 C 1.4645 3.2152 0.0 0
M  V30 10 N 3.4804 4.6798 0.0 0
M  V30 11 N 1.9404 4.6798 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dihydro-3-(methylthio)-4H-pyrazolo[3,4-d]pyrimidin-4-one
C6H6N4OS
90914-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.7308 1.9570 0.0 0
M  V30 2 C 7.1955 2.4329 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 C 3.0800 2.6673 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 4.5864 2.9876 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 N 3.3406 5.1454 0.0 0
M  V30 9 N 0.7700 4.0011 0.0 0
M  V30 10 N 4.7474 4.5191 0.0 0
M  V30 11 N 0.7700 1.3336 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90914-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90914-36-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29563357
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel heteroaryl and heterocycle compounds as PI3K inhibitors,
composition and their preparation and use in the treatment of
immune-based diseases and cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Su, Wei-Guo; Dai, Guangxiu; Xiao, Kun; Jia, Hong; Zhang, Zhulin; Venable,
Jennifer Diane; Bembenek, Scott Damian; Chai, Wenying
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014015830 A1 2014-01-30

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-5-(methylthio)-1H-pyrazole-4-carboxamide
C5H8N4OS
90914-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7104 0.7700 0.0 0
M  V30 2 N 4.0442 0.0000 0.0 0
M  V30 3 O 1.3768 0.0000 0.0 0
M  V30 4 S 5.4210 2.7392 0.0 0
M  V30 5 C 6.5654 3.7698 0.0 0
M  V30 6 N 0.0000 2.7392 0.0 0
M  V30 7 C 2.7104 2.3100 0.0 0
M  V30 8 C 3.9563 3.2152 0.0 0
M  V30 9 C 1.4645 3.2152 0.0 0
M  V30 10 N 3.4804 4.6798 0.0 0
M  V30 11 N 1.9404 4.6798 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dihydro-3-(methylthio)-4H-pyrazolo[3,4-d]pyrimidin-4-one
C6H6N4OS
90914-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.7308 1.9570 0.0 0
M  V30 2 C 7.1955 2.4329 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 C 3.0800 2.6673 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 4.5864 2.9876 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 N 3.3406 5.1454 0.0 0
M  V30 9 N 0.7700 4.0011 0.0 0
M  V30 10 N 4.7474 4.5191 0.0 0
M  V30 11 N 0.7700 1.3336 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90914-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90914-36-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25162933
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryl and heterocycle compounds as inhibitors of PI3K
for treating inflammatory and autoimmune disorders and cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Su, Wei-Guo; Dai, Guangxiu; Xiao, Kun; Jia, Hong; Venable, Jennifer
Diane; Bembenek, Scott Damian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014015675 A1 2014-01-30

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobiphenyl
C12H11N
92-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 1.3337 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 C 5.3901 2.6673 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 6.9302 0.0000 0.0 0
M  V30 7 C 7.7002 1.3337 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1,1′-Biphenyl]-4-ylformamide
C13H11NO
5472-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 1.3337 0.0 0
M  V30 2 C 10.0102 2.6673 0.0 0
M  V30 3 O 11.5503 2.6673 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 5.3901 2.6673 0.0 0
M  V30 6 C 5.3901 0.0000 0.0 0
M  V30 7 C 6.9302 2.6673 0.0 0
M  V30 8 C 6.9302 0.0000 0.0 0
M  V30 9 C 7.7002 1.3337 0.0 0
M  V30 10 C 3.0801 1.3337 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 0.7700 2.6673 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 92-67-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5472-79-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28240334
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent,reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst-Free Transamidation of Aromatic Amines with Formamide
Derivatives and Tertiary Amides with Aliphatic Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yin, Jiawen; Zhang, Jingyu; Cai, Changqun; Deng, Guo-Jun; Gong, Hang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(2), 387-392

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-5-[(7-ethoxy-7-oxoheptyl)oxy]-4-(2-methoxyethoxy)-, eth...
C21H33NO7
1012057-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4702 8.0022 0.0 0
M  V30 2 C 9.2402 9.3358 0.0 0
M  V30 3 C 10.7802 9.3358 0.0 0
M  V30 4 C 11.5503 10.6697 0.0 0
M  V30 5 C 13.0903 10.6697 0.0 0
M  V30 6 C 13.8603 12.0033 0.0 0
M  V30 7 C 15.4003 12.0033 0.0 0
M  V30 8 C 16.1704 13.3370 0.0 0
M  V30 9 O 17.7104 13.3370 0.0 0
M  V30 10 O 15.4003 14.6707 0.0 0
M  V30 11 C 18.4804 14.6707 0.0 0
M  V30 12 C 20.0204 14.6707 0.0 0
M  V30 13 O 6.9302 5.3348 0.0 0
M  V30 14 C 6.1601 4.0010 0.0 0
M  V30 15 C 6.9302 2.6673 0.0 0
M  V30 16 O 6.1601 1.3337 0.0 0
M  V30 17 C 6.9302 0.0000 0.0 0
M  V30 18 C 3.8501 10.6697 0.0 0
M  V30 19 O 2.3101 10.6697 0.0 0
M  V30 20 O 4.6201 12.0033 0.0 0
M  V30 21 C 1.5400 12.0033 0.0 0
M  V30 22 C 0.0000 12.0033 0.0 0
M  V30 23 N 2.3101 8.0022 0.0 0
M  V30 24 C 6.9302 8.0022 0.0 0
M  V30 25 C 6.1601 6.6685 0.0 0
M  V30 26 C 6.1601 9.3358 0.0 0
M  V30 27 C 4.6201 6.6685 0.0 0
M  V30 28 C 4.6201 9.3358 0.0 0
M  V30 29 C 3.8501 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 25
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 28
M  V30 21 1 19 21
M  V30 22 1 21 22
M  V30 23 1 23 29
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-[[3,4-dihydro-7-(2-methoxyethoxy)-4-oxo-6-quinazolinyl]oxy]heptanoate
C20H28N2O6
1012057-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2400 12.0031 0.0 0
M  V30 2 O 4.6200 6.6684 0.0 0
M  V30 3 C 3.0800 6.6684 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 O 0.7700 5.3347 0.0 0
M  V30 6 C 0.0000 4.0009 0.0 0
M  V30 7 O 7.7000 6.6684 0.0 0
M  V30 8 C 9.2400 6.6684 0.0 0
M  V30 9 C 10.0100 5.3347 0.0 0
M  V30 10 C 11.5500 5.3347 0.0 0
M  V30 11 C 12.3200 4.0009 0.0 0
M  V30 12 C 13.8600 4.0009 0.0 0
M  V30 13 C 14.6300 2.6673 0.0 0
M  V30 14 C 16.1700 2.6673 0.0 0
M  V30 15 O 16.9400 1.3336 0.0 0
M  V30 16 O 16.9400 4.0009 0.0 0
M  V30 17 C 18.4800 1.3336 0.0 0
M  V30 18 C 19.2500 0.0000 0.0 0
M  V30 19 C 5.3900 10.6694 0.0 0
M  V30 20 C 6.9300 10.6694 0.0 0
M  V30 21 C 4.6200 9.3358 0.0 0
M  V30 22 N 4.6200 12.0031 0.0 0
M  V30 23 C 7.7000 9.3358 0.0 0
M  V30 24 C 7.7000 12.0031 0.0 0
M  V30 25 C 5.3900 8.0020 0.0 0
M  V30 26 C 5.3900 13.3367 0.0 0
M  V30 27 C 6.9300 8.0020 0.0 0
M  V30 28 N 6.9300 13.3367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 24
M  V30 2 1 2 3
M  V30 3 1 2 25
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 1 19 22
M  V30 22 2 20 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 1 24 28
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1012057-42-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012057-43-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7295815
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 20e. Ethyl
7-(7-(2-methoxyethoxy)-4-oxo-3,4-dihydroquinazolin-6-yloxy)heptanoate
(Compound 0406-30) A mixture of compound 0405-30 (315.0 mg, 0.76 mmol),
ammonium formate (48.0 mg, 0.76 mmol) and formamide (2.46 mL) was stirred
at 190° C. for 3 hours. The reaction mixture was cooled to room
temperature. The formamide was removed under reduce pressure, and the
residue was dissolved in ethyl acetate (30 mL). The organic layer was
washed with brine (10 mL×5) and dried over sodium sulfate, filtered and
evaporated to give the title product 0406-30 as a white solid (235 mg,
98%): LCMS: 393 [M+1]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-phenylaminoquinazoline derivatives as epidermal growth
factor receptor tyrosine kinase (EGFR-TK) inhibitors containing a zinc
binding moiety and formulation containing them
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Qian, Changgeng; Zhai, Haixiao; Bao, Rudi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090111772 A1 2009-04-30

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-5-[(7-ethoxy-7-oxoheptyl)oxy]-4-(2-methoxyethoxy)-, eth...
C21H33NO7
1012057-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4702 8.0022 0.0 0
M  V30 2 C 9.2402 9.3358 0.0 0
M  V30 3 C 10.7802 9.3358 0.0 0
M  V30 4 C 11.5503 10.6697 0.0 0
M  V30 5 C 13.0903 10.6697 0.0 0
M  V30 6 C 13.8603 12.0033 0.0 0
M  V30 7 C 15.4003 12.0033 0.0 0
M  V30 8 C 16.1704 13.3370 0.0 0
M  V30 9 O 17.7104 13.3370 0.0 0
M  V30 10 O 15.4003 14.6707 0.0 0
M  V30 11 C 18.4804 14.6707 0.0 0
M  V30 12 C 20.0204 14.6707 0.0 0
M  V30 13 O 6.9302 5.3348 0.0 0
M  V30 14 C 6.1601 4.0010 0.0 0
M  V30 15 C 6.9302 2.6673 0.0 0
M  V30 16 O 6.1601 1.3337 0.0 0
M  V30 17 C 6.9302 0.0000 0.0 0
M  V30 18 C 3.8501 10.6697 0.0 0
M  V30 19 O 2.3101 10.6697 0.0 0
M  V30 20 O 4.6201 12.0033 0.0 0
M  V30 21 C 1.5400 12.0033 0.0 0
M  V30 22 C 0.0000 12.0033 0.0 0
M  V30 23 N 2.3101 8.0022 0.0 0
M  V30 24 C 6.9302 8.0022 0.0 0
M  V30 25 C 6.1601 6.6685 0.0 0
M  V30 26 C 6.1601 9.3358 0.0 0
M  V30 27 C 4.6201 6.6685 0.0 0
M  V30 28 C 4.6201 9.3358 0.0 0
M  V30 29 C 3.8501 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 25
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 28
M  V30 21 1 19 21
M  V30 22 1 21 22
M  V30 23 1 23 29
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-[[3,4-dihydro-7-(2-methoxyethoxy)-4-oxo-6-quinazolinyl]oxy]heptanoate
C20H28N2O6
1012057-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2400 12.0031 0.0 0
M  V30 2 O 4.6200 6.6684 0.0 0
M  V30 3 C 3.0800 6.6684 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 O 0.7700 5.3347 0.0 0
M  V30 6 C 0.0000 4.0009 0.0 0
M  V30 7 O 7.7000 6.6684 0.0 0
M  V30 8 C 9.2400 6.6684 0.0 0
M  V30 9 C 10.0100 5.3347 0.0 0
M  V30 10 C 11.5500 5.3347 0.0 0
M  V30 11 C 12.3200 4.0009 0.0 0
M  V30 12 C 13.8600 4.0009 0.0 0
M  V30 13 C 14.6300 2.6673 0.0 0
M  V30 14 C 16.1700 2.6673 0.0 0
M  V30 15 O 16.9400 1.3336 0.0 0
M  V30 16 O 16.9400 4.0009 0.0 0
M  V30 17 C 18.4800 1.3336 0.0 0
M  V30 18 C 19.2500 0.0000 0.0 0
M  V30 19 C 5.3900 10.6694 0.0 0
M  V30 20 C 6.9300 10.6694 0.0 0
M  V30 21 C 4.6200 9.3358 0.0 0
M  V30 22 N 4.6200 12.0031 0.0 0
M  V30 23 C 7.7000 9.3358 0.0 0
M  V30 24 C 7.7000 12.0031 0.0 0
M  V30 25 C 5.3900 8.0020 0.0 0
M  V30 26 C 5.3900 13.3367 0.0 0
M  V30 27 C 6.9300 8.0020 0.0 0
M  V30 28 N 6.9300 13.3367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 24
M  V30 2 1 2 3
M  V30 3 1 2 25
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 1 19 22
M  V30 22 2 20 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 1 24 28
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1012057-42-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012057-43-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7545695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tartaric acid salts or complexes of quinazoline compounds
containing a zinc binding moiety as EGFR tyrosine kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Qian, Changgeng; Zhai, Haixiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009035718 A1 2009-03-19

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-5-[(7-ethoxy-7-oxoheptyl)oxy]-4-(2-methoxyethoxy)-, eth...
C21H33NO7
1012057-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4702 8.0022 0.0 0
M  V30 2 C 9.2402 9.3358 0.0 0
M  V30 3 C 10.7802 9.3358 0.0 0
M  V30 4 C 11.5503 10.6697 0.0 0
M  V30 5 C 13.0903 10.6697 0.0 0
M  V30 6 C 13.8603 12.0033 0.0 0
M  V30 7 C 15.4003 12.0033 0.0 0
M  V30 8 C 16.1704 13.3370 0.0 0
M  V30 9 O 17.7104 13.3370 0.0 0
M  V30 10 O 15.4003 14.6707 0.0 0
M  V30 11 C 18.4804 14.6707 0.0 0
M  V30 12 C 20.0204 14.6707 0.0 0
M  V30 13 O 6.9302 5.3348 0.0 0
M  V30 14 C 6.1601 4.0010 0.0 0
M  V30 15 C 6.9302 2.6673 0.0 0
M  V30 16 O 6.1601 1.3337 0.0 0
M  V30 17 C 6.9302 0.0000 0.0 0
M  V30 18 C 3.8501 10.6697 0.0 0
M  V30 19 O 2.3101 10.6697 0.0 0
M  V30 20 O 4.6201 12.0033 0.0 0
M  V30 21 C 1.5400 12.0033 0.0 0
M  V30 22 C 0.0000 12.0033 0.0 0
M  V30 23 N 2.3101 8.0022 0.0 0
M  V30 24 C 6.9302 8.0022 0.0 0
M  V30 25 C 6.1601 6.6685 0.0 0
M  V30 26 C 6.1601 9.3358 0.0 0
M  V30 27 C 4.6201 6.6685 0.0 0
M  V30 28 C 4.6201 9.3358 0.0 0
M  V30 29 C 3.8501 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 25
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 28
M  V30 21 1 19 21
M  V30 22 1 21 22
M  V30 23 1 23 29
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-[[3,4-dihydro-7-(2-methoxyethoxy)-4-oxo-6-quinazolinyl]oxy]heptanoate
C20H28N2O6
1012057-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2400 12.0031 0.0 0
M  V30 2 O 4.6200 6.6684 0.0 0
M  V30 3 C 3.0800 6.6684 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 O 0.7700 5.3347 0.0 0
M  V30 6 C 0.0000 4.0009 0.0 0
M  V30 7 O 7.7000 6.6684 0.0 0
M  V30 8 C 9.2400 6.6684 0.0 0
M  V30 9 C 10.0100 5.3347 0.0 0
M  V30 10 C 11.5500 5.3347 0.0 0
M  V30 11 C 12.3200 4.0009 0.0 0
M  V30 12 C 13.8600 4.0009 0.0 0
M  V30 13 C 14.6300 2.6673 0.0 0
M  V30 14 C 16.1700 2.6673 0.0 0
M  V30 15 O 16.9400 1.3336 0.0 0
M  V30 16 O 16.9400 4.0009 0.0 0
M  V30 17 C 18.4800 1.3336 0.0 0
M  V30 18 C 19.2500 0.0000 0.0 0
M  V30 19 C 5.3900 10.6694 0.0 0
M  V30 20 C 6.9300 10.6694 0.0 0
M  V30 21 C 4.6200 9.3358 0.0 0
M  V30 22 N 4.6200 12.0031 0.0 0
M  V30 23 C 7.7000 9.3358 0.0 0
M  V30 24 C 7.7000 12.0031 0.0 0
M  V30 25 C 5.3900 8.0020 0.0 0
M  V30 26 C 5.3900 13.3367 0.0 0
M  V30 27 C 6.9300 8.0020 0.0 0
M  V30 28 N 6.9300 13.3367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 24
M  V30 2 1 2 3
M  V30 3 1 2 25
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 1 19 22
M  V30 22 2 20 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 1 24 28
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1012057-42-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012057-43-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14751699
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 20e. Ethyl
7-(7-(2-methoxyethoxy)-4-oxo-3,4-dihydroquinazolin-6-yloxy)heptanoate
(Compound 0406-30). A mixture of compound 0405-30 (315.0 mg, 0.76 mmol),
ammonium formate (48.0 mg, 0.76 mmol) and formamide (2.46 mL) was stirred
at 190°C for 3 hours. The reaction mixture was cooled to room
temperature. The formamide was removed under reduce pressure, and the
residue was dissolved in ethyl acetate (30 mL). The organic layer was
washed with brine (10 mL×5) and dried over sodium sulfate, filtered and
evaporated to give the title product 0406-30 as a white solid (235 mg,
98%). LCMS: 393 [M+1]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multi-functional small molecules as anti-proliferative agents and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Qian, Changgeng; Gould, Stephen; Zhai, Haixiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008033747 A2 2008-03-20

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-5-[(7-ethoxy-7-oxoheptyl)oxy]-4-(2-methoxyethoxy)-, eth...
C21H33NO7
1012057-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4702 8.0022 0.0 0
M  V30 2 C 9.2402 9.3358 0.0 0
M  V30 3 C 10.7802 9.3358 0.0 0
M  V30 4 C 11.5503 10.6697 0.0 0
M  V30 5 C 13.0903 10.6697 0.0 0
M  V30 6 C 13.8603 12.0033 0.0 0
M  V30 7 C 15.4003 12.0033 0.0 0
M  V30 8 C 16.1704 13.3370 0.0 0
M  V30 9 O 17.7104 13.3370 0.0 0
M  V30 10 O 15.4003 14.6707 0.0 0
M  V30 11 C 18.4804 14.6707 0.0 0
M  V30 12 C 20.0204 14.6707 0.0 0
M  V30 13 O 6.9302 5.3348 0.0 0
M  V30 14 C 6.1601 4.0010 0.0 0
M  V30 15 C 6.9302 2.6673 0.0 0
M  V30 16 O 6.1601 1.3337 0.0 0
M  V30 17 C 6.9302 0.0000 0.0 0
M  V30 18 C 3.8501 10.6697 0.0 0
M  V30 19 O 2.3101 10.6697 0.0 0
M  V30 20 O 4.6201 12.0033 0.0 0
M  V30 21 C 1.5400 12.0033 0.0 0
M  V30 22 C 0.0000 12.0033 0.0 0
M  V30 23 N 2.3101 8.0022 0.0 0
M  V30 24 C 6.9302 8.0022 0.0 0
M  V30 25 C 6.1601 6.6685 0.0 0
M  V30 26 C 6.1601 9.3358 0.0 0
M  V30 27 C 4.6201 6.6685 0.0 0
M  V30 28 C 4.6201 9.3358 0.0 0
M  V30 29 C 3.8501 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 25
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 28
M  V30 21 1 19 21
M  V30 22 1 21 22
M  V30 23 1 23 29
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-[[3,4-dihydro-7-(2-methoxyethoxy)-4-oxo-6-quinazolinyl]oxy]heptanoate
C20H28N2O6
1012057-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2400 12.0031 0.0 0
M  V30 2 O 4.6200 6.6684 0.0 0
M  V30 3 C 3.0800 6.6684 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 O 0.7700 5.3347 0.0 0
M  V30 6 C 0.0000 4.0009 0.0 0
M  V30 7 O 7.7000 6.6684 0.0 0
M  V30 8 C 9.2400 6.6684 0.0 0
M  V30 9 C 10.0100 5.3347 0.0 0
M  V30 10 C 11.5500 5.3347 0.0 0
M  V30 11 C 12.3200 4.0009 0.0 0
M  V30 12 C 13.8600 4.0009 0.0 0
M  V30 13 C 14.6300 2.6673 0.0 0
M  V30 14 C 16.1700 2.6673 0.0 0
M  V30 15 O 16.9400 1.3336 0.0 0
M  V30 16 O 16.9400 4.0009 0.0 0
M  V30 17 C 18.4800 1.3336 0.0 0
M  V30 18 C 19.2500 0.0000 0.0 0
M  V30 19 C 5.3900 10.6694 0.0 0
M  V30 20 C 6.9300 10.6694 0.0 0
M  V30 21 C 4.6200 9.3358 0.0 0
M  V30 22 N 4.6200 12.0031 0.0 0
M  V30 23 C 7.7000 9.3358 0.0 0
M  V30 24 C 7.7000 12.0031 0.0 0
M  V30 25 C 5.3900 8.0020 0.0 0
M  V30 26 C 5.3900 13.3367 0.0 0
M  V30 27 C 6.9300 8.0020 0.0 0
M  V30 28 N 6.9300 13.3367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 24
M  V30 2 1 2 3
M  V30 3 1 2 25
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 1 19 22
M  V30 22 2 20 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 1 24 28
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1012057-42-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012057-43-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1575341
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 20e. Ethyl 7-(7-(2-methoxyethoxy)-4-oxo-3,
4-dihydroquinazolin-6-yloxy) heptanoate (Compound 0406-30) A mixture of
compound 0405-30 (315.0 mg, 0.76 mmol), ammonium formate (48.0 mg, 0.76
mmol) and formamide (2.46 mL) was stirred at 190 °C for 3 hours. The
reaction mixture was cooled to room temperature. The formamide was
removed under reduce pressure, and the residue was dissolved in ethyl
acetate (30 mL). The organic layer was washed with brine (10 mLx5) and
dried over sodium sulfate, filtered and evaporated to give the title
product 0406-30 as a white solid (235 mg, 98%): Ethyl
7-(7-(2-methoxyethoxy)-4-oxo-3, 4-dihydroquinazolin-6-yloxy) heptanoate
(Compound 0406-30), yield (235 mg, 98%): LCMS: 393 [M+1] + .
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline based EGFR inhibitors containing a zinc
binding moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Changgeng; Cai, Xiong; Gould, Stephen; Zhai, Haixiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008033749 A2 2008-03-20

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dimethoxyaniline
C8H11NO2
10272-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 C 8.0023 3.8501 0.0 0
M  V30 5 N 4.0012 0.0000 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 C 4.0012 4.6201 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,5-Dimethoxyphenyl)formamide
C9H11NO3
1353562-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 O 8.4700 5.3347 0.0 0
M  V30 4 O 1.5400 1.3338 0.0 0
M  V30 5 C 2.3100 0.0000 0.0 0
M  V30 6 O 1.5400 6.6685 0.0 0
M  V30 7 C 0.0000 6.6685 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10272-07-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1353562-24-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28259966
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent,reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst-Free Transamidation of Aromatic Amines with Formamide
Derivatives and Tertiary Amides with Aliphatic Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yin, Jiawen; Zhang, Jingyu; Cai, Changqun; Deng, Guo-Jun; Gong, Hang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(2), 387-392

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30908786
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent,reaction in a sealed tube,optimization study (optimized on
formyl reactant),alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst-Free Transamidation of Aromatic Amines with Formamide
Derivatives and Tertiary Amides with Aliphatic Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yin, Jiawen; Zhang, Jingyu; Cai, Changqun; Deng, Guo-Jun; Gong, Hang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(2), 387-392

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24429488
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, thermal, reaction in a sealed tube, reaction carried out
under air, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM HCl-mediated transamidation of unactivated formamides using aromatic
amines in aqueous media
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dhawan, Sanjeev; Girase, Pankaj Sanjay; Kumar, Vishal; Karpoormath,
Rajshekhar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2021), 51(24), 3729-3739

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-18274646
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1313-13-9
$DTYPE RXN:VAR(1):NOTES
$DATUM scalable, no solvent, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM MnO2 catalyzed formylation of amines and transamidation of amides under
solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yedage, Subhash L.; D'Silva, Denvert S.; Bhanage, Bhalchandra M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2015), 5(98), 80441-80449

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-11107546
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 11120-01-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM sulfated
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, no solvent, catalyst prepared
and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfated tungstate: a highly efficient catalyst for transamidation of
carboxamides with amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pathare, Sagar P.; Jain, Ashish Kumar H.; Akamanchi, Krishnacharya G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2013), 3(21), 7697-7703

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27561787
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, recyclable and reusable catalyst used,
alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solvent-free, Efficient Transamidation of Carboxamides with Amines
Catalyzed by Recyclable Sulfated Polyborate Catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mali, Anil S.; Indalkar, Krishna; Chaturbhuj, Ganesh U.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Preparations and Procedures International (2021), 53(4), 369-378

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27375132
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 77-92-9
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, iron oxide support used,
catalyst prepared and used, recyclable catalyst used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Citric acid stabilized on the surface of magnetic nanoparticles as an
efficient and recyclable catalyst for transamidation of carboxamides,
phthalimide, urea and thiourea with amines under neat conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arefi, Marzban; Kazemi Miraki, Maryam; Mostafalu, Ramin; Satari,
Mohammad; Heydari, Akbar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2019), 16(2), 393-400

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methylbenzaldehyde-formyl-d
C8H7DO
13277-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 C 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 H 0.0000 2.6673 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C9H10DNO
3061907-91-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 N 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 9.3359 2.3100 0.0 0
M  V30 5 C 0.0000 4.6201 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6675 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3337 2.3100 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 3.8500 0.0 0
M  V30 12 H 5.3348 0.0000 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 2 3 4
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13277-99-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3061907-91-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42417661
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Deuterated reagents in multicomponent reactions to afford
deuterium-labeled products
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schofield, Kevin; Maddern, Shayna; Zhang, Yueteng; Mastin, Grace E.;
Knight, Rachel; Wang, Wei; Galligan, James; Hulme, Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Beilstein Journal of Organic Chemistry (2024), 202270-2279

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Amino-3-cyano-4-phenyl-1H-pyrrol-1-yl)benzoic acid
C18H13N3O2
2279111-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7383 1.4070 0.0 0
M  V30 2 N 4.1120 0.0000 0.0 0
M  V30 3 N 8.0157 2.1035 0.0 0
M  V30 4 C 12.3670 7.7457 0.0 0
M  V30 5 O 12.3670 9.2857 0.0 0
M  V30 6 O 13.7007 6.9757 0.0 0
M  V30 7 C 4.5948 4.1476 0.0 0
M  V30 8 C 5.3648 2.8138 0.0 0
M  V30 9 C 5.6252 5.2920 0.0 0
M  V30 10 C 6.8711 3.1339 0.0 0
M  V30 11 N 7.0322 4.6657 0.0 0
M  V30 12 C 3.0633 4.3085 0.0 0
M  V30 13 C 2.4368 5.7153 0.0 0
M  V30 14 C 2.1580 3.0626 0.0 0
M  V30 15 C 0.9052 5.8764 0.0 0
M  V30 16 C 0.6265 3.2236 0.0 0
M  V30 17 C 0.0000 4.6304 0.0 0
M  V30 18 C 8.3659 5.4357 0.0 0
M  V30 19 C 9.6995 4.6657 0.0 0
M  V30 20 C 8.3659 6.9757 0.0 0
M  V30 21 C 11.0332 5.4357 0.0 0
M  V30 22 C 9.6995 7.7457 0.0 0
M  V30 23 C 11.0332 6.9757 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 23
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 1 11 18
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Amino-5-phenyl-7H-pyrrolo[2,3-d]pyrimidin-7-yl)benzoic acid
C19H14N4O2
2279111-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.3825 8.2566 0.0 0
M  V30 2 C 12.3669 1.5400 0.0 0
M  V30 3 O 12.3669 0.0000 0.0 0
M  V30 4 O 13.7006 2.3100 0.0 0
M  V30 5 C 5.3648 6.4718 0.0 0
M  V30 6 C 4.5948 5.1381 0.0 0
M  V30 7 C 6.8711 6.1516 0.0 0
M  V30 8 C 4.8889 7.9365 0.0 0
M  V30 9 C 5.6252 3.9936 0.0 0
M  V30 10 N 7.0322 4.6200 0.0 0
M  V30 11 N 7.9017 7.2960 0.0 0
M  V30 12 N 5.9194 9.0809 0.0 0
M  V30 13 C 7.4256 8.7607 0.0 0
M  V30 14 C 3.0632 4.9772 0.0 0
M  V30 15 C 2.4368 3.5702 0.0 0
M  V30 16 C 2.1580 6.2230 0.0 0
M  V30 17 C 0.9052 3.4093 0.0 0
M  V30 18 C 0.6265 6.0621 0.0 0
M  V30 19 C 0.0000 4.6552 0.0 0
M  V30 20 C 8.3658 3.8500 0.0 0
M  V30 21 C 9.6995 4.6200 0.0 0
M  V30 22 C 8.3658 2.3100 0.0 0
M  V30 23 C 11.0331 3.8500 0.0 0
M  V30 24 C 9.6995 1.5400 0.0 0
M  V30 25 C 11.0331 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 25
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 14
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 10
M  V30 14 1 10 20
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2279111-95-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2279111-96-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-22113777
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of some heterocyclic compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohamed, Menna-Allah; Mohamed, Yassin; Eid, Nahed M.; Barsoum, Flora F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Applied Pharmaceutical Research (2018), 6(2), 01-15

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2R)-2-Amino-1,2-diphenylethanol
C14H15NO
23364-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0 CFG=1
M  V30 2 C 5.3901 1.3337 0.0 0 CFG=2
M  V30 3 N 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 5
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1R,2S)-2-Hydroxy-1,2-diphenylethyl]formamide
C15H15NO2
131350-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 2 C 5.3900 5.3347 0.0 0 CFG=2
M  V30 3 N 5.3900 2.6674 0.0 0
M  V30 4 O 4.6200 6.6685 0.0 0
M  V30 5 C 4.6200 1.3338 0.0 0
M  V30 6 O 5.3900 0.0000 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 7
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 13
M  V30 6 1 3 5
M  V30 7 2 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 23364-44-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 131350-15-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-8206812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):NOTES
$DATUM 33.4 g scale, formamide also used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pseudoephenamine: A Practical Chiral Auxiliary for Asymmetric Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales, Marvin R.; Mellem, Kevin T.; Myers, Andrew G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2012), 51(19), 4568-4571,
S4568/1-S4568/112

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2R)-2-Amino-1,2-diphenylethanol
C14H15NO
23364-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0 CFG=1
M  V30 2 C 5.3901 1.3337 0.0 0 CFG=2
M  V30 3 N 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 5
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1R,2S)-2-Hydroxy-1,2-diphenylethyl]formamide
C15H15NO2
131350-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 2 C 5.3900 5.3347 0.0 0 CFG=2
M  V30 3 N 5.3900 2.6674 0.0 0
M  V30 4 O 4.6200 6.6685 0.0 0
M  V30 5 C 4.6200 1.3338 0.0 0
M  V30 6 O 5.3900 0.0000 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 7
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 13
M  V30 6 1 3 5
M  V30 7 2 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 23364-44-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 131350-15-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29783719
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Large-scale preparation of key building blocks for the manufacture of
fully synthetic macrolide antibiotics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hogan, Philip C.; Chen, Chi-Li; Mulvihill, Kristen M.; Lawrence, Jonathan
F.; Moorhead, Eric; Rickmeier, Jens; Myers, Andrew G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Antibiotics (2018), 71(2), 318-325

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(4-bromophenyl)methylamino]-2-methylene-4-oxobutanoate
C13H14BrNO3
2529933-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 O 6.6685 3.8501 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 9.3360 3.8501 0.0 0
M  V30 9 O 12.0033 2.3101 0.0 0
M  V30 10 O 10.6697 0.0000 0.0 0
M  V30 11 C 13.3370 1.5400 0.0 0
M  V30 12 Br 0.0000 4.6201 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 C 4.0010 3.8501 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6′-Bromo-1′-methylspiro[pyrrolidine-3,4′(1′H)-quinoline]-2,2′,5(3′H)-trione
C13H11BrN2O3
2529933-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.7173 0.7102 0.0 0
M  V30 2 O 0.0000 3.7710 0.0 0
M  V30 3 O 7.1086 0.1437 0.0 0
M  V30 4 C 1.5400 6.4384 0.0 0
M  V30 5 Br 8.4700 5.1048 0.0 0
M  V30 6 C 3.8500 2.4374 0.0 0
M  V30 7 C 4.6200 3.7710 0.0 0
M  V30 8 C 2.3100 2.4374 0.0 0
M  V30 9 C 5.3815 2.2764 0.0 0
M  V30 10 C 3.2237 1.0306 0.0 0
M  V30 11 C 3.8500 5.1048 0.0 0
M  V30 12 C 6.1600 3.7710 0.0 0
M  V30 13 C 1.5400 3.7710 0.0 0
M  V30 14 C 5.7017 0.7700 0.0 0
M  V30 15 N 4.3681 0.0000 0.0 0
M  V30 16 N 2.3100 5.1048 0.0 0
M  V30 17 C 4.6200 6.4384 0.0 0
M  V30 18 C 6.9300 5.1048 0.0 0
M  V30 19 C 6.1600 6.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 13
M  V30 3 2 3 14
M  V30 4 1 4 16
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 1 12 18
M  V30 18 1 13 16
M  V30 19 1 14 15
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2529933-60-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2529933-76-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22928584
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7720-78-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical (Hg lamp (450W) used (stage 1)), Fenton reaction (stage 1),
continuous flow mode (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biobased Spiroimides from Itaconic Acid and Formamides: Molecular Targets
for a Novel Synthetic Application of Renewable Chemicals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hornink, Milene Macedo; Lopes, Alice Uva; Andrade, Leandro Helgueira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2021), 53(2), 296-308

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, methyl ester
C10H13NO2
2577-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=2
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 5.3347 3.8500 0.0 0
M  V30 5 O 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 0.0000 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-formyl-, methyl ester
C11H13NO3
2311-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 N 6.9300 4.0011 0.0 0
M  V30 5 O 5.3900 1.3338 0.0 0
M  V30 6 O 3.0800 2.6674 0.0 0
M  V30 7 C 7.7000 5.3347 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 O 9.2400 5.3347 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 0.7700 4.0011 0.0 0
M  V30 14 C 0.7700 6.6685 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 10
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2577-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2311-21-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30837241
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1809269-30-4
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, ee = 92%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide Synthesis through Borinic Acid-Catalysed Transamidation under
Mild Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohy El Dine, Tharwat; Evans, David; Rouden, Jacques; Blanchet, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2016), 22(17), 5894-5898

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, methyl ester
C10H13NO2
2577-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=2
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 5.3347 3.8500 0.0 0
M  V30 5 O 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 0.0000 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-formyl-, methyl ester
C11H13NO3
2311-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 N 6.9300 4.0011 0.0 0
M  V30 5 O 5.3900 1.3338 0.0 0
M  V30 6 O 3.0800 2.6674 0.0 0
M  V30 7 C 7.7000 5.3347 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 O 9.2400 5.3347 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 0.7700 4.0011 0.0 0
M  V30 14 C 0.7700 6.6685 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 10
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2577-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2311-21-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-6550624
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7782-61-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Transamidation Reaction.
Amide (5.1 mmol) and amine (3.0 mmol) were dissolved or suspended in
toluene (3.0 mL), Fe(NO3)3·9H2O (61 mg, 0.15 mmol) was added, and the
mixture was refluxed until complete conversion (by TLC) of the amine. The
hot reaction mixture was filtered through a pad of Celite, concentrated,
and purified by flash chromatography as indicated below.
N-Benzylacetamide (7). The crude mixture was purified by flash
chromatography with DCM. N-Formyl-(S)-phenylalanine Methyl Ester (13l).
The crude mixture was purified by flash chromatography with DCM/MeOH
(9:1). The product was obtained as a viscous oil. Yield: 590 mg, 95%. 1H
NMR (300 MHz, CDCl3): δ (ppm) 8.17 (s, 1H), 7.09- 7.33(m, 5H), 6.11 (s,
1H), 4.94-5.01 (m, 1H), 3.75 (s, 3H), 3.16 (t, J = 5.9 Hz, 2H). 13C NMR
(75 MHz, CDCl3): δ (ppm) 172.0, 161.3, 136.0, 129.8, 129.2, 127.8, 53.0,
52.3, 38.3. IR (ν, cm-1, KBr): 3301, 3030, 2953, 2960, 2870, 1744, 1668,
1543. MS (EI) [M - NHCOH]: 162 (17), 91 (20), 44 (18). [α]D 18 = 89.14 (c
= 1.1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transamidation of Carboxamides Catalyzed by Fe(III) and Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Becerra-Figueroa, Liliana; Ojeda-Porras, Andrea; Gamba-Sanchez, Diego
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(10), 4544-4552

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridinemethanamine
C6H8N2
3731-52-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 N 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Pyridinylmethyl)formamide
C7H8N2O
56625-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 N 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 N 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3731-52-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56625-04-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-455681
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 65-85-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 106-42-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzoic Acid-Catalyzed Transamidation Reactions of Carboxamides,
Phthalimide, Ureas and Thioamide with Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Ji-Wei; Wu, Ya-Dong; Dai, Jian-Jun; Xu, Hua-Jian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(11-12), 2429-2436

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridinemethanamine
C6H8N2
3731-52-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 N 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Pyridinylmethyl)formamide
C7H8N2O
56625-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 N 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 N 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3731-52-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56625-04-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-64374
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, thermal, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formylation of amines through catalyst- and solvent-free transamidation
reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lebleu, Thomas; Kotsuki, Hiyoshizo; Maddaluno, Jacques; Legros, Julien
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2014), 55(2), 362-364

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,4′-Dimethylbenzophenone
C15H14O
611-97-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 5.3347 0.0000 0.0 0
M  V30 3 C 10.6694 4.6200 0.0 0
M  V30 4 C 0.0000 4.6200 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0
M  V30 6 C 6.6684 3.8500 0.0 0
M  V30 7 C 8.0021 1.5400 0.0 0
M  V30 8 C 8.0021 4.6200 0.0 0
M  V30 9 C 9.3358 2.3100 0.0 0
M  V30 10 C 9.3358 3.8500 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 4.0011 3.8500 0.0 0
M  V30 13 C 2.6673 1.5400 0.0 0
M  V30 14 C 2.6673 4.6200 0.0 0
M  V30 15 C 1.3336 2.3100 0.0 0
M  V30 16 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 10
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[Bis(4-methylphenyl)methyl]formamide
C16H17NO
127568-35-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.8500 0.0 0
M  V30 2 N 5.3347 2.3100 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 10.6694 6.9300 0.0 0
M  V30 6 C 0.0000 6.9300 0.0 0
M  V30 7 C 6.6684 4.6200 0.0 0
M  V30 8 C 6.6684 6.1600 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 8.0021 6.9300 0.0 0
M  V30 11 C 9.3358 4.6200 0.0 0
M  V30 12 C 9.3358 6.1600 0.0 0
M  V30 13 C 4.0011 4.6200 0.0 0
M  V30 14 C 4.0011 6.1600 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 2.6673 6.9300 0.0 0
M  V30 17 C 1.3336 4.6200 0.0 0
M  V30 18 C 1.3336 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 2 3
M  V30 5 2 3 4
M  V30 6 1 5 12
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-97-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 127568-35-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11165404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A cation-directed two-component cascade approach to enantioenriched
pyrroloindolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wolstenhulme, Jamie R.; Cavell, Alex; Gredicak, Matija; Driver, Russell
W.; Smith, Martin D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2014), 50(88),
13585-13588

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl E-crotonate
C5H8O2
623-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 O 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-amino-3-methyl-4-oxobutanoate
C6H11NO3
1161438-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 1.3336 1.5400 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 O 6.6685 1.5400 0.0 0
M  V30 7 O 5.3347 3.8500 0.0 0
M  V30 8 N 0.0000 2.3100 0.0 0
M  V30 9 O 1.3336 0.0000 0.0 0
M  V30 10 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 6 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 623-43-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1161438-21-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40722461
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68109-03-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Incorporation of renewable carbons via formamide reactivity for the
production of novel biobased polymers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rocha, Bianca C.; Dourado, Isabela L. A.; Sanabria, Marialy N.; Kimura,
Noemi S. P.; Cordeiro, Priscila H.; Catalani, Luiz H.; Andrade, Leandro
H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2024), 26(12), 7019-7030

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
1,3-Dimethyladamantane
C12H20
702-79-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5320 4.4960 0.0 0
M  V30 2 C 3.4741 0.0000 0.0 0
M  V30 3 C 4.1956 3.7245 0.0 0
M  V30 4 C 4.2780 2.1867 0.0 0
M  V30 5 C 2.9050 4.5648 0.0 0
M  V30 6 C 2.4986 3.7137 0.0 0
M  V30 7 C 3.0698 1.4892 0.0 0
M  V30 8 C 1.6968 3.8672 0.0 0
M  V30 9 C 1.2906 3.0161 0.0 0
M  V30 10 C 1.3730 1.4782 0.0 0
M  V30 11 C 1.7794 2.3295 0.0 0
M  V30 12 C 0.0000 3.8561 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 10
M  V30 14 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,5-Dimethyltricyclo[3.3.1.13,7]dec-1-yl)formamide
C13H21NO
351329-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5314 4.4956 0.0 0
M  V30 2 C 6.8677 3.7242 0.0 0
M  V30 3 O 8.2038 4.4956 0.0 0
M  V30 4 C 1.2925 5.3559 0.0 0
M  V30 5 C 3.4738 0.0000 0.0 0
M  V30 6 C 4.1952 3.7242 0.0 0
M  V30 7 C 2.9048 4.5643 0.0 0
M  V30 8 C 4.2776 2.1866 0.0 0
M  V30 9 C 2.4984 3.7132 0.0 0
M  V30 10 C 1.6967 3.8669 0.0 0
M  V30 11 C 3.0696 1.4890 0.0 0
M  V30 12 C 1.2903 3.0159 0.0 0
M  V30 13 C 1.7792 2.3293 0.0 0
M  V30 14 C 0.0000 3.8558 0.0 0
M  V30 15 C 1.3729 1.4781 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 702-79-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 351329-88-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26827765
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7697-37-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simple Two-step Procedure for the Synthesis of Memantine Hydrochloride
from 1,3-Dimethyl-adamantane
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, Binh Duong; Ho Ba, Ngoc Minh; Pham, Van Hien; Phan, Dinh Chau
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2020), 5(26), 16085-16088

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
1,3-Dimethyladamantane
C12H20
702-79-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5320 4.4960 0.0 0
M  V30 2 C 3.4741 0.0000 0.0 0
M  V30 3 C 4.1956 3.7245 0.0 0
M  V30 4 C 4.2780 2.1867 0.0 0
M  V30 5 C 2.9050 4.5648 0.0 0
M  V30 6 C 2.4986 3.7137 0.0 0
M  V30 7 C 3.0698 1.4892 0.0 0
M  V30 8 C 1.6968 3.8672 0.0 0
M  V30 9 C 1.2906 3.0161 0.0 0
M  V30 10 C 1.3730 1.4782 0.0 0
M  V30 11 C 1.7794 2.3295 0.0 0
M  V30 12 C 0.0000 3.8561 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 10
M  V30 14 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,5-Dimethyltricyclo[3.3.1.13,7]dec-1-yl)formamide
C13H21NO
351329-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5314 4.4956 0.0 0
M  V30 2 C 6.8677 3.7242 0.0 0
M  V30 3 O 8.2038 4.4956 0.0 0
M  V30 4 C 1.2925 5.3559 0.0 0
M  V30 5 C 3.4738 0.0000 0.0 0
M  V30 6 C 4.1952 3.7242 0.0 0
M  V30 7 C 2.9048 4.5643 0.0 0
M  V30 8 C 4.2776 2.1866 0.0 0
M  V30 9 C 2.4984 3.7132 0.0 0
M  V30 10 C 1.6967 3.8669 0.0 0
M  V30 11 C 3.0696 1.4890 0.0 0
M  V30 12 C 1.2903 3.0159 0.0 0
M  V30 13 C 1.7792 2.3293 0.0 0
M  V30 14 C 0.0000 3.8558 0.0 0
M  V30 15 C 1.3729 1.4781 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 702-79-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 351329-88-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-212-CAS-3536264
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7697-37-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1: 300 g (1.83 mol) of 1,3-dimethyladamantane (1,3-DMA) and 900
ml of sulfuric acid 96% (16.2 mol) are mixed and cooled to 0°C to 5°C.
This solution is concurrently added together with 180 ml of formam ide
(4.53 mol) into a vessel precharged with sulfuric acid 96% (150 ml)
preheated to 55-60°C, over the time period of two hours, keeping the
internal temperature at T = 55°C-60°C. After completion of the
formylation, the mixture is cooled to 5°C and quenched into a cold
solution (0°C), containing water (720 ml), aqueous ammonia 30% (480 ml)
and dichloromethane (900 ml), while keeping the temperature below 25°C.
The aqueous acidic layer is re-extracted with 450 ml of dichloromethane.
The combined organic layers are washed three times with 600 ml water.
With the last washing the pH is corrected to 8 to 9 using aqueous
ammonia. N-Formyl-1-amino-3,5-dimethyladamantane is obtained as a
solution in dichloromethane, which can be used in the subsequent step.
Solvent removal gives 360 g of N-Formyl-1-amino-3,5-dimethyladamantane
(NFORM) (yield 95%). The purity as measured by GC is 98%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the manufacture of memantine and intermediate product
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huber, Florian Anton Martin; Gallo, Giorgio; De Faveri, Carla
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009115334 A2 2009-09-24

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-3,5-dimethyladamantane
C12H19Cl
707-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.2412 0.0 0
M  V30 2 C 2.8647 0.0000 0.0 0
M  V30 3 Cl 5.7294 4.0301 0.0 0
M  V30 4 C 1.4918 3.6356 0.0 0
M  V30 5 C 1.4918 2.2406 0.0 0
M  V30 6 C 2.8647 4.3330 0.0 0
M  V30 7 C 0.6530 5.1107 0.0 0
M  V30 8 C 2.8647 1.5430 0.0 0
M  V30 9 C 4.2376 3.6356 0.0 0
M  V30 10 C 2.0256 4.4131 0.0 0
M  V30 11 C 4.2376 2.2406 0.0 0
M  V30 12 C 2.0256 3.0181 0.0 0
M  V30 13 C 3.3987 5.1107 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 8
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,5-Dimethyltricyclo[3.3.1.13,7]dec-1-yl)formamide
C13H21NO
351329-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5314 4.4956 0.0 0
M  V30 2 C 6.8677 3.7242 0.0 0
M  V30 3 O 8.2038 4.4956 0.0 0
M  V30 4 C 1.2925 5.3559 0.0 0
M  V30 5 C 3.4738 0.0000 0.0 0
M  V30 6 C 4.1952 3.7242 0.0 0
M  V30 7 C 2.9048 4.5643 0.0 0
M  V30 8 C 4.2776 2.1866 0.0 0
M  V30 9 C 2.4984 3.7132 0.0 0
M  V30 10 C 1.6967 3.8669 0.0 0
M  V30 11 C 3.0696 1.4890 0.0 0
M  V30 12 C 1.2903 3.0159 0.0 0
M  V30 13 C 1.7792 2.3293 0.0 0
M  V30 14 C 0.0000 3.8558 0.0 0
M  V30 15 C 1.3729 1.4781 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 707-36-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 351329-88-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-3872107
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-(3,5-Dimethyl-adamantan-1-yl)formamide (8). A mixture of
1-chloro-3,5-dimethyl-adamantane (7, 100.0 g, 0.50 mol) and formamide
(500.0 mL) was heated to 150 °C for 8 h, to which was added ice-cold
water; the reaction mass was extracted with methylene chloride (70.0 mL),
the separated organic layer was concentrated, and a white solid was
isolated and dried under vacuum: yield 101 g (98%), GC purity 99.85%. 1H
NMR: δ 8.2 (d, 1H), 7.8 (s, 1H), 2.15 (m, 1H), 1.68 (m, 2H), 1.45 (s,
4H), 1.2-1.3 (m, 6H), 0.80 (s, 6H); IR: 3347 cm-1 (NH), 1690 cm-1 (C=O);
MS: 208 (M + 1); Anal. calcd for C13H21NO: C 75.32, H 10.21, N 6.76.
Found: C 75.16, H 10.16, N 6.86.
$DTYPE RXN:VAR(1):NOTES
$DATUM key step
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Improved Synthesis of Memantine Hydrochloride: Anti-Alzheimer's Drug
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reddy, Jambula Mukunda; Prasad, Ganji; Raju, Veeramalla; Ravikumar,
Mylavarapu; Himabindu, Vurumidi; Reddy, Ghanta Mahesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2007), 11(2), 268-269

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-phenyl-3-pyridinamine
C11H9ClN2
793675-14-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 Cl 1.3336 0.0000 0.0 0
M  V30 3 C 2.6674 2.3100 0.0 0
M  V30 4 C 1.3336 1.5400 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 N 0.0000 2.3100 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 C 0.0000 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 1 2 4
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Phenyl-1H-imidazo[4,5-b]pyridine
C12H9N3
1365094-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.4196 1.8517 0.0 0
M  V30 2 C 3.0127 2.4782 0.0 0
M  V30 3 C 4.2587 0.3202 0.0 0
M  V30 4 C 1.9823 1.3336 0.0 0
M  V30 5 C 2.5368 3.9427 0.0 0
M  V30 6 N 2.7523 0.0000 0.0 0
M  V30 7 N 0.4760 1.6538 0.0 0
M  V30 8 C 1.0306 4.2629 0.0 0
M  V30 9 C 0.0000 3.1185 0.0 0
M  V30 10 C 5.7533 2.6217 0.0 0
M  V30 11 C 7.0869 1.8517 0.0 0
M  V30 12 C 5.7533 4.1617 0.0 0
M  V30 13 C 8.4207 2.6217 0.0 0
M  V30 14 C 7.0869 4.9317 0.0 0
M  V30 15 C 8.4207 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 793675-14-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365094-51-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9703632
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 29154-12-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 857356-94-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1-(4-Methoxybenzyl)-1H-imidazo[4,5-b]pyridine
(3a) To an oven-dried 25 mL Schlenk-tube equipped with a stirbar was
added Pd2(dba)3 · CHCl3 (20.8 mg, 0.02 mmol),
2-Di-t-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-tri-i-propylbiphenyl
(L1) (48 mg, 0.1 mmol), K3PO4 (639 mg, 3.01 mmol) and
2-Chloro-N-(4-methoxybenzyl)pyridin-3-amine (2a) (500 mg, 2.01 mmol) (if
solid). The tube was evacuated and refilled with Ar(g). Formamide (0.12
mL, 3.01 mmol) was added via syringe as a single portion, followed by the
chloropyridine (if liquid) in 4 mL of tert-butanol. The reaction mixture
was degassed with 3 x vacuum / Ar(g) purge cycles. The reaction vessel
was then equipped with a cold-finger under a positive pressure of argon
gas and immersed in a 110°C pre-heated oil-bath for 4h at which time TLC
showed consumption of the chloro-pyridine. The reaction was cooled to
room temperature, diluted with MeOH (4 mL) filtered through a Celite plug
and concentrated to give a dark brown oil. The crude product was purified
on a silica gel column (4.5 cm x 12 cm), eluting with 4% MeOH in CH2Cl2.
1-Phenyl-1H-imidazo[4,5-b]pyridine (3o) Following the general
experimental; 2-chloro-N-(phenyl)pyridin-3-amine (2o) (82 mg, 0.36 mmol),
Pd2(dba)3·CHCl3 (4.14 mg, 0.004 mmol), L1 (9.6 mg, 0.02 mmol), K3PO4 (128
mg, 0.6 mmol), formamide (0.022 mL, 0.6 mmol) were combined with 2 mL
tert-butanol in a 25 mL Schlenk flask. After 4 h the reaction was
complete, the reaction cooled to RT, filtered through Celite,
concentrated and purified on a silica gel column (2.5 cm x 12 cm),
eluting with 4% MeOH / CH2Cl2. 3o as 76.5 mg of a white solid (98%). 1H
NMR (300 MHz, CDCl3) δ = 8.65 (d, J = 4.5 Hz, 1H), 8.37 (s, 1H), 7.89
(dd, J = 8.1 Hz, 1.2 Hz, 1H), 7.65-7.57 (m, 2H), 7.55-7.47 (m, 3H), 7.30
(dd, J = 8.4 Hz, 4.8 Hz, 1H); 13C NMR (75.4 MHz, CDCl3) δ = 145.6, 145.6,
144.5, 135.8, 130.5, 128.8, 126.3, 124.0, 119.1, 119.0; FT-IR (NaCl, thin
film) ν = 3124, 1597, 1502, 1477, 1412, 1301, 1194, 785 cm-1. HRMS (ESI)
Calc (C12H9N3): 195.0796, Found: 195.0794; MP: 120-124°C; Rf (4% MeOH /
CH2Cl2): 0.24.
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Imidazo[4,5-b]pyridines and Imidazo[4,5-b]pyrazines by
Palladium Catalyzed Amidation of 2-Chloro-3-amino-heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Zhao, Jinbo; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(7), 1764-1767

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-phenyl-3-pyridinamine
C11H9ClN2
793675-14-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 Cl 1.3336 0.0000 0.0 0
M  V30 3 C 2.6674 2.3100 0.0 0
M  V30 4 C 1.3336 1.5400 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 N 0.0000 2.3100 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 C 0.0000 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 1 2 4
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Phenyl-1H-imidazo[4,5-b]pyridine
C12H9N3
1365094-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.4196 1.8517 0.0 0
M  V30 2 C 3.0127 2.4782 0.0 0
M  V30 3 C 4.2587 0.3202 0.0 0
M  V30 4 C 1.9823 1.3336 0.0 0
M  V30 5 C 2.5368 3.9427 0.0 0
M  V30 6 N 2.7523 0.0000 0.0 0
M  V30 7 N 0.4760 1.6538 0.0 0
M  V30 8 C 1.0306 4.2629 0.0 0
M  V30 9 C 0.0000 3.1185 0.0 0
M  V30 10 C 5.7533 2.6217 0.0 0
M  V30 11 C 7.0869 1.8517 0.0 0
M  V30 12 C 5.7533 4.1617 0.0 0
M  V30 13 C 8.4207 2.6217 0.0 0
M  V30 14 C 7.0869 4.9317 0.0 0
M  V30 15 C 8.4207 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 793675-14-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365094-51-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7738977
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved synthesis of imidazo[4,5-b]pyridines and
imidazo[4,5-b]pyrazines by palladium catalyzed amidation using xantphos
in a 1,4-Dioxane:tert-amyl alcohol aolvent aystem
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Ahmed, Ijaz; Wilson, Robert J.; Williams, Theresa M.;
Kaminsky, Lauren; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(16), 3465-3470

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dimethyl 2,6-naphthalenedicarboxylate
C14H12O4
840-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0
M  V30 2 O 1.3337 3.8501 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 C 10.6697 1.5400 0.0 0
M  V30 6 O 12.0033 2.3101 0.0 0
M  V30 7 O 10.6697 0.0000 0.0 0
M  V30 8 C 13.3370 1.5400 0.0 0
M  V30 9 C 6.6685 3.8501 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 8.0022 4.6201 0.0 0
M  V30 13 C 8.0022 1.5400 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 C 4.0010 3.8501 0.0 0
M  V30 16 C 9.3360 3.8501 0.0 0
M  V30 17 C 9.3360 2.3101 0.0 0
M  V30 18 C 4.0010 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 18
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Naphthalenedicarboxamide
C12H10N2O2
46711-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 1.5400 0.0 0
M  V30 2 N 9.3358 0.0000 0.0 0
M  V30 3 O 10.6694 2.3100 0.0 0
M  V30 4 C 1.3336 4.6200 0.0 0
M  V30 5 N 1.3336 6.1600 0.0 0
M  V30 6 O 0.0000 3.8500 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 6.6684 4.6200 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 2.6673 2.3100 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 840-65-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 46711-49-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13261851
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2,6-Naphthalenedicarboxamide (CAS #46711-49-3) was prepared as follows.
To a two liter three neck round-bottom flask fitted with a mechanical
stirrer, addition funnel and condenser/ Dean Stark apparatus, with a
nitrogen inlet was charged 85.4 grams (0.35 mol) dimethyl
2,6-naphthalenedicarboxylate, 105.3 grams (2.34 mol) formamide, and 200
mls of anhydrous N,N-dimethylformamide. The flask contents were heated to
100 degrees C. under a nitrogen atmosphere and held for one hour. One
hundred ml of a 25 wt. % solution of sodium methoxide in methanol was
added through the addition funnel in four approximately equal portions.
The flask contents were then heated for four hours at 100 degrees C.
during which time methanol was being condensed and removed. The flask was
cooled to room temperature and one liter of isopropyl alcohol was added
in two 500 ml increments. After the resulting mixture was stirred for 15
minutes it was allowed to settle for one hour. Crystallized solid
material was collected by filtration and air dried in the filter for 2
hours. The recovered off-white colored product weighed 112.7 grams. The
solid was washed three times in deionized water and twice in methanol.
71.4 grams of greater than 98% pure product. Melting point: 347-349
degrees C.; 1H NMR: This compound is insoluble in all common NMR solvents
and only sparingly soluble in DMSO-d6. (DMSO-d6) δ 8.53 ppm (broad s),
8.21 ppm (broad s), 8.07 ppm (complex multi. from 8.09−8.00 ppm), 7.55
ppm (broad s), also 3.38 ppm (water), and 2.51 (DMSO); MS m/z 214 [M].
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark apparatus used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polyesters with low molecular weight additives for improved gas barrier
properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peters, Richard Dalton; Cliffton, Michael Duane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20120199515 A1 2012-08-09

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4,5-bis(4-chlorophenyl)-3-furancarbonitrile
C17H10Cl2N2O
866181-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4647 6.5892 0.0 0
M  V30 2 N 0.0000 6.1133 0.0 0
M  V30 3 N 2.5000 9.7756 0.0 0
M  V30 4 Cl 4.1751 0.0000 0.0 0
M  V30 5 Cl 11.2796 5.1616 0.0 0
M  V30 6 C 4.1751 6.1600 0.0 0
M  V30 7 C 5.4211 7.0652 0.0 0
M  V30 8 C 2.9292 7.0652 0.0 0
M  V30 9 O 4.9451 8.5298 0.0 0
M  V30 10 C 3.4051 8.5298 0.0 0
M  V30 11 C 4.1751 4.6200 0.0 0
M  V30 12 C 2.8415 3.8500 0.0 0
M  V30 13 C 5.5089 3.8500 0.0 0
M  V30 14 C 2.8415 2.3100 0.0 0
M  V30 15 C 5.5089 2.3100 0.0 0
M  V30 16 C 4.1751 1.5400 0.0 0
M  V30 17 C 6.8856 6.5892 0.0 0
M  V30 18 C 7.2058 5.0829 0.0 0
M  V30 19 C 8.0302 7.6198 0.0 0
M  V30 20 C 8.6705 4.6071 0.0 0
M  V30 21 C 9.4947 7.1439 0.0 0
M  V30 22 C 9.8149 5.6375 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 1 4 16
M  V30 5 1 5 22
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 7 17
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Bis(4-chlorophenyl)furo[2,3-d]pyrimidin-4-amine
C18H11Cl2N3O
866181-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.0244 0.0 0
M  V30 2 Cl 6.0355 0.0000 0.0 0
M  V30 3 Cl 11.1973 7.1045 0.0 0
M  V30 4 C 4.1321 5.8586 0.0 0
M  V30 5 C 5.0371 7.1045 0.0 0
M  V30 6 C 2.6673 6.3345 0.0 0
M  V30 7 O 4.1321 8.3504 0.0 0
M  V30 8 C 2.6673 7.8745 0.0 0
M  V30 9 C 1.3337 5.5644 0.0 0
M  V30 10 N 1.3337 8.6445 0.0 0
M  V30 11 N 0.0000 6.3345 0.0 0
M  V30 12 C 0.0000 7.8745 0.0 0
M  V30 13 C 4.6079 4.3939 0.0 0
M  V30 14 C 6.1142 4.0737 0.0 0
M  V30 15 C 3.5773 3.2495 0.0 0
M  V30 16 C 6.5901 2.6091 0.0 0
M  V30 17 C 4.0534 1.7847 0.0 0
M  V30 18 C 5.5597 1.4646 0.0 0
M  V30 19 C 6.5772 7.1045 0.0 0
M  V30 20 C 7.3472 8.4382 0.0 0
M  V30 21 C 7.3472 5.7708 0.0 0
M  V30 22 C 8.8872 8.4382 0.0 0
M  V30 23 C 8.8872 5.7708 0.0 0
M  V30 24 C 9.6572 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 18
M  V30 3 1 3 24
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 1 5 19
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 8
M  V30 12 2 8 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 866181-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 866181-76-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21289261
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 6: Preparation of 4-amino
furopyrimidine-based compound
4-amino-6-(4-chlorophenyl)furo[2,3,d]Pyrimidine(Vla) 20ml of formamide
was applied dropwisely to the 4.37 g (20 mmol) of 2-
amino-3-cyano-5-(4-chlorophenyl)furan (IVa) obtained in Example 5, which
was heated and refluxed for 12 hours and then cooled at a room
temperature. 100 ml of water was added thereto, and a generated solid was
filtered, which was washed with water and n-hexane sufficiently, and
then, dried. Thereafter, the resultant material was re-crystallized with
acetone and ethylalcohol to obtain a brown-colored solid product of
4-amino-6-(4-chlorophenyl)furo[2,3,d]pyrimidine (VIa). Compounds Vlb to
VIy of table 4 were also obtained, respectively, according to the same
method. [Table 4] VIv, yield 98% Table 4 shows analysis results of the
obtained 4-amino furopyrimidine based compound VIa to VIy 1H NMR (400 MHz
DMSO-d6) δ (ppm) : 8.27 (s, 1H), 7.62 (d, J= 8.4 Hz, 2H), 7.51 (d, J= 8.4
Hz, 2H), 7.46 (d, J= 8.4 Hz, 2H), 7.39 (d. J= 8.4 Hz, 2H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of furo[2,3-d]pyrimidines as inhibitors of DDR2 (discoidin
domain receptor 2) tyrosine kinase.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Beom-Seok; Yang, Kyung-Mi; Kim, Hae-Jong; Park, In-Sung; Park,
Sung-Dae; Lee, Jang-Hyuk; Kwon, Hyuk-Man; Woo, Byoung-Young
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005092896 A1 2005-10-06

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline
C14H14ClN3
99010-64-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6518 5.3303 0.0 0
M  V30 2 C 7.6824 6.4748 0.0 0
M  V30 3 C 7.2065 7.9394 0.0 0
M  V30 4 C 9.1887 6.1545 0.0 0
M  V30 5 Cl 0.0000 5.3901 0.0 0
M  V30 6 C 4.0011 4.6201 0.0 0
M  V30 7 C 4.0011 3.0800 0.0 0
M  V30 8 C 2.6673 5.3901 0.0 0
M  V30 9 N 5.1455 5.6505 0.0 0
M  V30 10 C 2.6673 2.3100 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 N 2.9875 6.8964 0.0 0
M  V30 14 C 4.5192 7.0574 0.0 0
M  V30 15 N 1.3337 3.0800 0.0 0
M  V30 16 C 2.6673 0.7700 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 2 10 16
M  V30 16 1 11 17
M  V30 17 2 12 15
M  V30 18 2 13 14
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imiquimod
C14H16N4
99011-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6518 5.3303 0.0 0
M  V30 2 C 7.6824 6.4748 0.0 0
M  V30 3 C 7.2065 7.9394 0.0 0
M  V30 4 C 9.1887 6.1545 0.0 0
M  V30 5 N 0.0000 5.3901 0.0 0
M  V30 6 C 4.0011 4.6201 0.0 0
M  V30 7 C 4.0011 3.0800 0.0 0
M  V30 8 C 2.6673 5.3901 0.0 0
M  V30 9 N 5.1455 5.6505 0.0 0
M  V30 10 C 2.6673 2.3100 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 N 2.9875 6.8964 0.0 0
M  V30 14 C 4.5192 7.0574 0.0 0
M  V30 15 N 1.3337 3.0800 0.0 0
M  V30 16 C 2.6673 0.7700 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 2 10 16
M  V30 16 1 11 17
M  V30 17 2 12 15
M  V30 18 2 13 14
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99010-64-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99011-02-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14876434
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 2: 1-isobutyl-1H-imidazo [4,5-c] quinolin-4-amine Potassium
tert-butoxide (2.16 g, 0.019 mole), 4.5 mL of dimethylsulfoxide and 0.76
mL (0.019 mole) of formamide were added in a 50-mL round-bottomed flask,
under inert atmosphere followed by stirring for 30 minutes. After
addition of 4-chloro-1H-imidazo [4,5-c] quinoline (1g, 3.8 mmoles), the
mixture was heated at 105°C, followed by stirring for 2 hours and then
cooled to room temperature.Then 10 mL of water and 6N HCl were
sequentially added until pH 8. The reaction mixture was filtered followed
by washing with abundant water and dried to give 0.91 g of
1-isobutyl-1H-imidazo [4, 5-c] quinolin-4-amine. Yield 98%.
$DTYPE RXN:VAR(1):NOTES
$DATUM yield and product distribution depends on solvent, temperature
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Base-hydrolysis method for making
1-substituted-1H-imidazo[4,5-c]quinolin-4-amines from their corresponding
4-aminoformyl derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sallares, Juan; Petschen, Ines; Camps, Francesc-Xavier
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006100226 A1 2006-09-28

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzyl bromide
C7H7Br
100-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 Br 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formyl-N-(phenylmethyl)formamide
C9H9NO2
55756-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 5.3900 2.6674 0.0 0
M  V30 3 C 4.6200 1.3338 0.0 0
M  V30 4 C 6.9300 2.6674 0.0 0
M  V30 5 O 5.3900 0.0000 0.0 0
M  V30 6 O 7.7000 4.0011 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3349 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-39-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 55756-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-13347421
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM literature prepn., in-situ generated reactant
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclopropylamines from N,N-Dialkylcarboxamides and Grignard Reagents in
the Presence of Titanium Tetraisopropoxide or Methyltitanium
Triisopropoxide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de Meijere, Armin; Chaplinski, Vladimir; Winsel, Harald; Kordes, Markus;
Stecker, Bjoern; Gazizova, Vesta; Savchenko, Andrei I.; Boese, Roland;
Schill, Farina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2010), 16(46), 13862-13875,
S13862/1-S13862/59

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30896987
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, recyclable and reusable catalyst used,
alternative preparation shown, optimization study, optimized on
stoichiometry of catalyst, time and temperature
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solvent-free, Efficient Transamidation of Carboxamides with Amines
Catalyzed by Recyclable Sulfated Polyborate Catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mali, Anil S.; Indalkar, Krishna; Chaturbhuj, Ganesh U.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Preparations and Procedures International (2021), 53(4), 369-378

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-13238653
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 11120-01-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM sulfated
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, no solvent, catalyst prepared
and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfated tungstate: a highly efficient catalyst for transamidation of
carboxamides with amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pathare, Sagar P.; Jain, Ashish Kumar H.; Akamanchi, Krishnacharya G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2013), 3(21), 7697-7703

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26719110
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, sealed vial used, recyclable catalyst,
nanosized beta Zeolite catalyst used, yield depends on catalyst used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transamidation of carboxamides with amines over nanosized zeolite beta
under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Durgaiah, Chevella; Naresh, Mameda; Swamy, Peraka; Srujana, Kodumuri;
Rammurthy, Banothu; Narender, Nama
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Catalysis Communications (2016), 8129-32

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-9400165
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10043-35-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure. A mixture of amide (10
mmol), amine (10 mmol), water (180-360 mg, 10-20 mmol) and boric acid (62
mg, 1 mmol) was stirred in a pressure equalization tubes at indicated
temperature for indicated reaction time (See Tables 1-4). After being
cooled to room temperature, the crude reaction mixture was purified by
recrystallization or silica gel column chromatography (dissolved in
dichloromethane, eluted with dichloromethane and ethyl acetate or
methanol). N-(4-Chlorophenyl)formamide15 (4g). Purification of the crude
mixture by recrystallization (CH2Cl2/heptanes 1/1) afforded the product
as grey powder, yield 92%.The presence of two rotamers (ratio 5:1) was
observed in the NMR spectra. 1H NMR (500 MHz, DMSO-d6) δ 10.37 (M) (broad
s, 1H), 8.79 (m) (s, 1H), 8.29 (M) (s, 1H), 8.60 (m) (d, J=11.2 Hz, 1H),
7.62 (M) (d, J=8.4 Hz, 2H), 7.36 (d, J=8.4 Hz, 2H), 7.22 (m) (d, J=8.3
Hz, 2H). 13C NMR (125 MHz, DMSO-d6) δ 163.0 (m), 160.2 (M), 137.9 (m),
137.7 (M), 129.7 (m), 129.2 (M), 127.9 (m), 120.2 (m), 127.6 (M), 121.2
(M), 119.4 (m).
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, pressure tube used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Boric Acid: A Highly Efficient Catalyst for Transamidation of
Carboxamides with Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nguyen, Thanh Binh; Sorres, Jonathan; Tran, Minh Quan; Ermolenko,
Ludmila; Al-Mourabit, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(12), 3202-3205

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30158585
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM surface sulfonic acid-functionalized
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM Fe3O4-bound
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst (magnetic nanoparticles
supported sulfonic acid used as catalyst), no solvent, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nano-Magnetic Sulfonic Acid Catalyzed Facile Synthesis of Diverse Amide
Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kothandapani, Jagatheeswaran; Ganesan, Asaithampi; Ganesan,
Subramaniapillai Selva
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2017), 49(3), 685-692

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Undecenal
C11H20O
112-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.0000 0.0 0
M  V30 2 C 8.0022 0.7700 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 9.3358 0.0000 0.0 0
M  V30 5 C 4.0010 0.0000 0.0 0
M  V30 6 C 10.6697 0.7700 0.0 0
M  V30 7 C 2.6673 0.7700 0.0 0
M  V30 8 C 12.0033 0.0000 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 13.3370 0.7700 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 12 O 14.6707 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-10-Undecen-1-ylformamide
C12H23NO
463930-55-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 0.0000 0.0 0
M  V30 2 C 8.0023 0.7700 0.0 0
M  V30 3 C 10.6697 0.7700 0.0 0
M  V30 4 C 6.6687 0.0000 0.0 0
M  V30 5 C 12.0035 0.0000 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 13.3372 0.7700 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 14.6708 0.0000 0.0 0
M  V30 10 N 2.6675 0.7700 0.0 0
M  V30 11 C 16.0045 0.7700 0.0 0
M  V30 12 C 1.3338 0.0000 0.0 0
M  V30 13 C 17.3383 0.0000 0.0 0
M  V30 14 O 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 112-45-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 463930-55-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10378803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):NOTES
$DATUM Leuckart-Wallach reaction, formamide/formic acid also used as solvent,
microwave heating required less time but gave a lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient Isocyanide-less Isocyanide-Based Multicomponent Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neochoritis, Constantinos G.; Stotani, Silvia; Mishra, Bhupendra;
Doemling, Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(8), 2002-2005

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Undecenal
C11H20O
112-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.0000 0.0 0
M  V30 2 C 8.0022 0.7700 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 9.3358 0.0000 0.0 0
M  V30 5 C 4.0010 0.0000 0.0 0
M  V30 6 C 10.6697 0.7700 0.0 0
M  V30 7 C 2.6673 0.7700 0.0 0
M  V30 8 C 12.0033 0.0000 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 13.3370 0.7700 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 12 O 14.6707 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-10-Undecen-1-ylformamide
C12H23NO
463930-55-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 0.0000 0.0 0
M  V30 2 C 8.0023 0.7700 0.0 0
M  V30 3 C 10.6697 0.7700 0.0 0
M  V30 4 C 6.6687 0.0000 0.0 0
M  V30 5 C 12.0035 0.0000 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 13.3372 0.7700 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 14.6708 0.0000 0.0 0
M  V30 10 N 2.6675 0.7700 0.0 0
M  V30 11 C 16.0045 0.7700 0.0 0
M  V30 12 C 1.3338 0.0000 0.0 0
M  V30 13 C 17.3383 0.0000 0.0 0
M  V30 14 O 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 112-45-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 463930-55-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17943715
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Artificial Macrocycles as Potent p53-MDM2 Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Estrada-Ortiz, Natalia; Neochoritis, Constantinos G.; Twarda-Clapa,
Aleksandra; Musielak, Bogdan; Holak, Tad A.; Doemling, Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2017), 8(10), 1025-1030

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridinamine, 2-chloro-N-methyl-6-phenyl-
C12H11ClN2
1365094-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 7.7002 0.0000 0.0 0
M  V30 2 N 9.2402 2.6673 0.0 0
M  V30 3 C 10.0102 4.0010 0.0 0
M  V30 4 C 4.6201 2.6673 0.0 0
M  V30 5 N 5.3901 1.3337 0.0 0
M  V30 6 C 5.3901 4.0010 0.0 0
M  V30 7 C 6.9302 1.3337 0.0 0
M  V30 8 C 6.9302 4.0010 0.0 0
M  V30 9 C 7.7002 2.6673 0.0 0
M  V30 10 C 3.0801 2.6673 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 0.7700 4.0010 0.0 0
M  V30 14 C 0.7700 1.3337 0.0 0
M  V30 15 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-5-phenyl-1H-imidazo[4,5-b]pyridine
C13H11N3
1365094-34-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.1884 0.0 0
M  V30 2 C 2.6506 2.4782 0.0 0
M  V30 3 C 3.4206 1.1444 0.0 0
M  V30 4 C 3.4206 3.8118 0.0 0
M  V30 5 N 1.1444 2.1580 0.0 0
M  V30 6 N 4.9606 1.1444 0.0 0
M  V30 7 N 2.3902 0.0000 0.0 0
M  V30 8 C 4.9606 3.8118 0.0 0
M  V30 9 C 0.9834 0.6263 0.0 0
M  V30 10 C 5.7306 2.4782 0.0 0
M  V30 11 C 7.2706 2.4782 0.0 0
M  V30 12 C 8.0406 3.8118 0.0 0
M  V30 13 C 8.0406 1.1444 0.0 0
M  V30 14 C 9.5806 3.8118 0.0 0
M  V30 15 C 9.5806 1.1444 0.0 0
M  V30 16 C 10.3506 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 10 11
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1365094-30-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365094-34-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14676118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 29154-12-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 857356-94-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1-(4-Methoxybenzyl)-1H-imidazo[4,5-b]pyridine
(3a) To an oven-dried 25 mL Schlenk-tube equipped with a stirbar was
added Pd2(dba)3 · CHCl3 (20.8 mg, 0.02 mmol),
2-Di-t-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-tri-i-propylbiphenyl
(L1) (48 mg, 0.1 mmol), K3PO4 (639 mg, 3.01 mmol) and
2-Chloro-N-(4-methoxybenzyl)pyridin-3-amine (2a) (500 mg, 2.01 mmol) (if
solid). The tube was evacuated and refilled with Ar(g). Formamide (0.12
mL, 3.01 mmol) was added via syringe as a single portion, followed by the
chloropyridine (if liquid) in 4 mL of tert-butanol. The reaction mixture
was degassed with 3 x vacuum / Ar(g) purge cycles. The reaction vessel
was then equipped with a cold-finger under a positive pressure of argon
gas and immersed in a 110°C pre-heated oil-bath for 4h at which time TLC
showed consumption of the chloro-pyridine. The reaction was cooled to
room temperature, diluted with MeOH (4 mL) filtered through a Celite plug
and concentrated to give a dark brown oil. The crude product was purified
on a silica gel column (4.5 cm x 12 cm), eluting with 4% MeOH in CH2Cl2.
1-Methyl-5-phenyl-1H-imidazo[4,5-b]pyridine (11) Following the general
experimental; 2-chloro-N-methyl-6-phenylpyridin-3-amine (5) (87.5 mg, 0.4
mmol), Pd2(dba)3·CHCl3 (4.14 mg, 0.004 mmol), L1 (9.6 mg, 0.02 mmol),
K3PO4 (128 mg, 0.6 mmol), formamide (0.022 mL, 0.6 mmol) were combined
with 2.0 mL tert-butanol in a 25 mL Schlenk flask. After 3 h the reaction
was complete, the reaction cooled to RT, filtered through Celite,
concentrated and purified on a silica gel column (2.5 cm x 12 cm),
eluting with 4% MeOH / CH2Cl2. 11 as 81 mg of a pale brown solid (89%).
1H NMR (300 MHz, CDCl3) δ = 8.13-8.08 (m, 2H), 7.99 (s, 1H), 7.67 (1/2 AB
d, J = 8.4 Hz, 1H), 7.64 (1/2 AB d, J = 8.4 Hz, 1H), 7.49-7.41 (m, 2H),
7.40-7.33 (m, 1H), 3.78 (s, 3H); 13C NMR (75.4 MHz, CDCl3) δ = 156.4,
152.9, 146.1, 139.8, 128.7, 128.5, 127.2, 125.8, 118.2, 115.6, 31.5;
FT-IR (NaCl, thin film) ν = 2920, 2852, 1613, 1574, 1495, 1461, 1436,
1407, 1345, 1293, 1199, 1051, 762 cm-1. Anal. Calc C13H11N3: C, 74.62; H,
5.30; N, 20.08; found C, 74.95; H, 5.49; N, 20.37; Rf (4% MeOH / CH2Cl2):
0.23; MP: 157-160°C.
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Imidazo[4,5-b]pyridines and Imidazo[4,5-b]pyrazines by
Palladium Catalyzed Amidation of 2-Chloro-3-amino-heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Zhao, Jinbo; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(7), 1764-1767

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-3-(4-methoxyphenyl)-1-phenyl-1H-pyrazole-4-carboxaldehyde
C17H15N3O2
1400634-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8391 1.1445 0.0 0
M  V30 2 O 4.8087 0.0000 0.0 0
M  V30 3 N 2.6528 2.1799 0.0 0
M  V30 4 O 12.4284 3.8551 0.0 0
M  V30 5 C 13.1984 5.1887 0.0 0
M  V30 6 C 6.2684 3.8551 0.0 0
M  V30 7 C 5.3632 2.6091 0.0 0
M  V30 8 N 5.3632 5.1010 0.0 0
M  V30 9 C 3.8987 3.0851 0.0 0
M  V30 10 N 3.8987 4.6251 0.0 0
M  V30 11 C 7.8084 3.8551 0.0 0
M  V30 12 C 8.5784 2.5213 0.0 0
M  V30 13 C 8.5784 5.1887 0.0 0
M  V30 14 C 10.1184 2.5213 0.0 0
M  V30 15 C 10.1184 5.1887 0.0 0
M  V30 16 C 10.8884 3.8551 0.0 0
M  V30 17 C 2.6528 5.5302 0.0 0
M  V30 18 C 1.2459 4.9038 0.0 0
M  V30 19 C 2.8137 7.0618 0.0 0
M  V30 20 C 0.0000 5.8090 0.0 0
M  V30 21 C 1.5679 7.9671 0.0 0
M  V30 22 C 0.1609 7.3406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 10 17
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methoxyphenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C18H14N4O
1400634-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.4285 3.7827 0.0 0
M  V30 2 C 13.1985 5.1164 0.0 0
M  V30 3 C 6.2684 3.7827 0.0 0
M  V30 4 C 5.3632 2.5369 0.0 0
M  V30 5 N 5.3632 5.0286 0.0 0
M  V30 6 C 3.8987 3.0127 0.0 0
M  V30 7 C 5.6834 1.0304 0.0 0
M  V30 8 N 3.8987 4.5527 0.0 0
M  V30 9 N 2.7542 1.9823 0.0 0
M  V30 10 N 4.5390 0.0000 0.0 0
M  V30 11 C 3.0743 0.4759 0.0 0
M  V30 12 C 7.8085 3.7827 0.0 0
M  V30 13 C 8.5785 2.4491 0.0 0
M  V30 14 C 8.5785 5.1164 0.0 0
M  V30 15 C 10.1185 2.4491 0.0 0
M  V30 16 C 10.1185 5.1164 0.0 0
M  V30 17 C 10.8885 3.7827 0.0 0
M  V30 18 C 2.6528 5.4579 0.0 0
M  V30 19 C 2.8137 6.9895 0.0 0
M  V30 20 C 1.2459 4.8316 0.0 0
M  V30 21 C 1.5679 7.8947 0.0 0
M  V30 22 C 0.0000 5.7367 0.0 0
M  V30 23 C 0.1609 7.2684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 8 18
M  V30 13 1 9 11
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1400634-72-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-70-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31005884
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
Pyrazolo[3,4-d]-pyrimidines (17-32, 65, 66, and 73-76). The reliable
procedure involved the treatment of 5-aminopyrazoles (1-16; 1.0 equiv),
5- amino-4-formylpyrazoles (37-41; 1.0 equiv), 5-aminoquinoline (61; 1.0
equiv), 8-aminoquinoline (62; 1.0 equiv), 5-aminopyrimidine (68; 1.0
equiv), or 2-aminopyrazines (69-71; 1.0 equiv) with PBr3 (~ 3 equiv) in
formamide solution (2 mL) at 50-60 °C over 0.5-1 h. When the reaction was
complete, the reaction mixture was added to saturated sodium bicarbonate
(15 mL) and extracted with dichloromethane (15 mL). The organic extracts
were dried over MgSO4, filtered, and concentrated under reduced pressure.
The residue solution was purified by column chromatography on silica gel
to give the corresponding aromatic or heterocyclic fused pyrimidine
products (17-32, 65, 66, and 73-76) in 82-96% yields.
3-(4-Methoxylphenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine (32), yield
97%. Mp 175-176 °C (hexane-EtOAc). 1H NMR (CDCl3, 500 MHz): δ 3.87 (3H,
s), 7.08-7.84 (2H, m), 7.32-7.36 (1H, m), 7.50-7.56 (2H, m), 7.95- 8.01
(2H, m), 8.28-8.32 (2H, m), 9.10 (1H, s), 9.45 (1H, s). 13C NMR (125 MHz,
CDCl3): δ 55.4 (CH3), 114.2, 114.6 (2 × C), 121.3 (2 × C), 124.1, 126.7,
128.7 (2 × C), 129.2 (2 × C), 138.6, 144.8, 152.8, 153.2, 155.5, 160.8.
IR (KBr): 3047, 2924, 1612, 1582, 1503, 1431, 1356, 1254, 1219, 1092
cm-1. EIMS m/z (rel int): 302 (100, M+). Anal. Calcd for C18H14N4O: C,
71.51; H, 4.67; N, 18.53. Found: C, 71.48; H, 4.68; N, 18.50.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME76 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Sodium p-toluenesulfinate
C7H8O2S.Na
824-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.7700 2.8737 0.0 0 VAL=4
M  V30 2 O 0.0000 1.5400 0.0 0
M  V30 3 O 0.0000 4.2073 0.0 0
M  V30 4 C 6.9302 2.8737 0.0 0
M  V30 5 C 2.3101 2.8737 0.0 0
M  V30 6 C 3.0801 4.2073 0.0 0
M  V30 7 C 3.0801 1.5400 0.0 0
M  V30 8 C 4.6201 4.2073 0.0 0
M  V30 9 C 4.6201 1.5400 0.0 0
M  V30 10 C 5.3901 2.8737 0.0 0
M  V30 11 Na 3.4651 0.0000 0.0 0 VAL=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Difluorobenzaldehyde
C7H4F2O
1550-35-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 F 2.3101 0.0000 0.0 0
M  V30 4 F 6.9302 2.6673 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2,4-Difluorophenyl)[(4-methylphenyl)sulfonyl]methyl]formamide
C15H13F2NO3S
668990-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8501 0.0 0
M  V30 2 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 3 N 5.3348 2.3101 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 O 5.8985 5.9538 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 O 6.6685 0.0000 0.0 0
M  V30 8 F 2.6673 2.3101 0.0 0
M  V30 9 F 0.0000 6.9302 0.0 0
M  V30 10 C 12.0033 7.7002 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 4.0012 6.1601 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 2.6673 6.9302 0.0 0
M  V30 16 C 1.3337 6.1601 0.0 0
M  V30 17 C 8.0022 5.3901 0.0 0
M  V30 18 C 9.3360 4.6201 0.0 0
M  V30 19 C 8.0022 6.9302 0.0 0
M  V30 20 C 10.6697 5.3901 0.0 0
M  V30 21 C 9.3360 7.7002 0.0 0
M  V30 22 C 10.6697 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 17
M  V30 7 1 3 6
M  V30 8 2 6 7
M  V30 9 1 8 12
M  V30 10 1 9 16
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 824-79-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1550-35-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 668990-82-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41355997
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Scalable Synthesis of the Key Fexuprazan Intermediate and Investigation
of Reaction Mechanism
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Ting; Hua, Yueting; Deng, Fangbo; Wen, Rui; Zhang, Haoyu; Li,
Chunshi; Liu, Yang; Cheng, Maosheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2024), 9(36), 37942-37952

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-(6-cyano-4-methyl-2-phenylthieno[2,3-d]pyrimidin-5-yl)methanimidate
C17H14N4OS
1603990-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.3509 4.1020 0.0 0
M  V30 2 C 11.8156 3.6262 0.0 0
M  V30 3 O 12.9600 4.6566 0.0 0
M  V30 4 C 14.4247 4.1807 0.0 0
M  V30 5 C 15.5691 5.2112 0.0 0
M  V30 6 C 7.7002 6.0591 0.0 0
M  V30 7 C 10.7012 0.7700 0.0 0
M  V30 8 N 12.0349 0.0000 0.0 0
M  V30 9 C 7.7002 3.3918 0.0 0
M  V30 10 C 6.9302 2.0581 0.0 0
M  V30 11 C 9.2065 3.0716 0.0 0
M  V30 12 C 6.9302 4.7254 0.0 0
M  V30 13 N 5.3901 2.0581 0.0 0
M  V30 14 S 7.9606 0.9135 0.0 0
M  V30 15 C 9.3674 1.5400 0.0 0
M  V30 16 N 5.3901 4.7254 0.0 0
M  V30 17 C 4.6201 3.3918 0.0 0
M  V30 18 C 3.0801 3.3918 0.0 0
M  V30 19 C 2.3101 4.7254 0.0 0
M  V30 20 C 2.3101 2.0581 0.0 0
M  V30 21 C 0.7700 4.7254 0.0 0
M  V30 22 C 0.7700 2.0581 0.0 0
M  V30 23 C 0.0000 3.3918 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 3 7 8
M  V30 8 1 7 15
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 17 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H11N5OS
1603990-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7001 6.6773 0.0 0
M  V30 2 N 10.9353 0.0000 0.0 0
M  V30 3 C 13.4272 1.8105 0.0 0
M  V30 4 O 14.6731 2.7157 0.0 0
M  V30 5 C 7.7001 4.0098 0.0 0
M  V30 6 C 9.2064 3.6896 0.0 0
M  V30 7 C 6.9301 2.6761 0.0 0
M  V30 8 C 6.9301 5.3434 0.0 0
M  V30 9 C 9.3675 2.1580 0.0 0
M  V30 10 N 10.4525 4.5948 0.0 0
M  V30 11 S 7.9606 1.5317 0.0 0
M  V30 12 N 5.3901 2.6761 0.0 0
M  V30 13 N 5.3901 5.3434 0.0 0
M  V30 14 C 10.7743 1.5317 0.0 0
M  V30 15 C 11.8593 3.9685 0.0 0
M  V30 16 C 4.6201 4.0098 0.0 0
M  V30 17 N 12.0202 2.4368 0.0 0
M  V30 18 C 3.0801 4.0098 0.0 0
M  V30 19 C 2.3100 5.3434 0.0 0
M  V30 20 C 2.3100 2.6761 0.0 0
M  V30 21 C 0.7700 5.3434 0.0 0
M  V30 22 C 0.7700 2.6761 0.0 0
M  V30 23 C 0.0000 4.0098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 14
M  V30 3 2 3 4
M  V30 4 1 3 17
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 11
M  V30 14 1 9 14
M  V30 15 2 10 15
M  V30 16 1 12 16
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1603990-50-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1603990-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29585562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thioxopyrimidine in Heterocyclic Synthesis II: Novel Synthesis of Some
Triazoles and Triazepine Derivatives with a
Pyrimido[3,2:4,5]thieno[2,3-d]pyrimidine Skeleton
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ho, Yuh Wen; Chou, Se Long
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemistry (2013), 696579, 12 pp.

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-(2-pyridinyl)-1H-pyrazol-5-amine
C9H10N4
19541-96-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.0492 0.0000 0.0 0
M  V30 2 C 8.2356 4.3856 0.0 0
M  V30 3 N 4.6200 2.7104 0.0 0
M  V30 4 N 5.5252 3.9564 0.0 0
M  V30 5 C 5.5252 1.4645 0.0 0
M  V30 6 C 6.9898 3.4804 0.0 0
M  V30 7 C 6.9898 1.9404 0.0 0
M  V30 8 C 3.0800 2.7104 0.0 0
M  V30 9 C 2.3100 1.3768 0.0 0
M  V30 10 N 2.3100 4.0442 0.0 0
M  V30 11 C 0.7700 1.3768 0.0 0
M  V30 12 C 0.7700 4.0442 0.0 0
M  V30 13 C 0.0000 2.7104 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-(2-pyridinyl)-1H-pyrazolo[3,4-d]pyrimidine
C11H9N5
1410783-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1260 0.0000 0.0 0
M  V30 2 N 4.4196 3.2586 0.0 0
M  V30 3 C 3.0127 3.8850 0.0 0
M  V30 4 N 4.2587 1.7271 0.0 0
M  V30 5 C 1.9823 2.7406 0.0 0
M  V30 6 N 2.5368 5.3497 0.0 0
M  V30 7 C 2.7523 1.4069 0.0 0
M  V30 8 C 0.4760 3.0608 0.0 0
M  V30 9 C 1.0306 5.6698 0.0 0
M  V30 10 N 0.0000 4.5254 0.0 0
M  V30 11 C 5.7533 4.0286 0.0 0
M  V30 12 C 5.7533 5.5686 0.0 0
M  V30 13 N 7.0869 3.2586 0.0 0
M  V30 14 C 7.0869 6.3386 0.0 0
M  V30 15 C 8.4207 4.0286 0.0 0
M  V30 16 C 8.4207 5.5686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19541-96-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1410783-57-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28991616
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-bromobenzoic acid
C7H6BrNO2
20776-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-4(3H)-quinazolinone
C8H5BrN2O
194851-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 Br 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 N 2.3101 0.0000 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20776-50-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 194851-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31670821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and evaluation of novel
(E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides
as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dung, Do T. M.; Park, Eun J.; Anh, Duong T.; Hai, Pham-The; Huy, Le D.;
Jun, Hye W.; Kwon, Joo-Hee; Young Ji, A.; Kang, Jong S.; Tung, Truong T.;
Dung, Phan T. P.; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2022), 355(1), 2100216

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-bromobenzoic acid
C7H6BrNO2
20776-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-4(3H)-quinazolinone
C8H5BrN2O
194851-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 Br 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 N 2.3101 0.0000 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20776-50-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 194851-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21364254
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of Specific, Irreversible Inhibitors for a Receptor Tyrosine
Kinase EphB3
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kung, Alvin; Chen, Ying-Chu; Schimpl, Marianne; Ni, Feng; Zhu, Jianfa;
Turner, Maurice; Molina, Henrik; Overman, Ross; Zhang, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2016), 138(33), 10554-10560

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methylene-N-phenyl-N-(phenylmethyl)-4-pentenamide
C19H19NO
2416583-00-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 4.6200 5.3347 0.0 0
M  V30 4 C 7.7000 5.3347 0.0 0
M  V30 5 O 7.7000 2.6674 0.0 0
M  V30 6 C 9.2400 5.3347 0.0 0
M  V30 7 C 6.9300 6.6685 0.0 0
M  V30 8 C 10.0100 6.6685 0.0 0
M  V30 9 C 11.5500 6.6685 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 5.3900 1.3338 0.0 0
M  V30 12 C 3.0800 2.6674 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 14 C 2.3100 1.3338 0.0 0
M  V30 15 C 3.0800 0.0000 0.0 0
M  V30 16 C 3.0800 5.3347 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 16
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 6 8
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-2-oxo-1-(phenylmethyl)-3-(2-propen-1-yl)-1H-indole-3-acetamide
C20H20N2O2
2416582-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6528 4.6274 0.0 0
M  V30 2 C 1.4069 3.7222 0.0 0
M  V30 3 N 1.5679 2.1907 0.0 0
M  V30 4 O 0.0000 4.3487 0.0 0
M  V30 5 C 3.2896 2.6674 0.0 0
M  V30 6 C 4.0596 1.3336 0.0 0
M  V30 7 C 3.2896 0.0000 0.0 0
M  V30 8 O 5.3056 1.5559 0.0 0
M  V30 9 C 8.0160 3.5252 0.0 0
M  V30 10 C 4.0596 4.0011 0.0 0
M  V30 11 C 4.5356 5.4656 0.0 0
M  V30 12 C 5.3056 3.0959 0.0 0
M  V30 13 C 6.0756 5.4656 0.0 0
M  V30 14 C 3.7656 6.7994 0.0 0
M  V30 15 N 6.5515 4.0011 0.0 0
M  V30 16 C 6.8456 6.7994 0.0 0
M  V30 17 C 4.5356 8.1331 0.0 0
M  V30 18 C 6.0756 8.1331 0.0 0
M  V30 19 C 9.1606 4.5556 0.0 0
M  V30 20 C 8.8404 6.0619 0.0 0
M  V30 21 C 10.6251 4.0798 0.0 0
M  V30 22 C 9.9848 7.0925 0.0 0
M  V30 23 C 11.7696 5.1102 0.0 0
M  V30 24 C 11.4495 6.6166 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 6 7
M  V30 8 2 8 12
M  V30 9 1 9 15
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2416583-00-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2416582-97-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27491881
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7782-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):NOTES
$DATUM continuous flow mode, Fenton reaction, irradiated with 450W Hg lamp
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nontraditional Application of the Photo-Fenton Process: A Novel Strategy
for Molecular Construction Using Formamide and Flow Chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sanabria, Marialy N.; Hornink, Milene M.; Correia, Valquiria G.; Andrade,
Leandro H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2020), 24(10), 2288-2297

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propargylamine
C3H5N
2450-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.7700 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 N 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 3 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-2-Propyn-1-ylformamide
C4H5NO
14502-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 N 4.0012 0.7700 0.0 0
M  V30 3 C 1.3338 0.7700 0.0 0
M  V30 4 C 5.3348 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 6.6687 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 3 3 5
M  V30 5 2 4 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2450-71-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14502-66-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-4154801
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 9012-76-4
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, sealed tube used, no solvent, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chitosan: an efficient recyclable catalyst for transamidation of
carboxamides with amines under neat conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nageswara Rao, Sadu; Chandra Mohan, Darapaneni; Adimurthy, Subbarayappa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2014), 16(9), 4122-4126

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1-(2-hydroxyphenyl)ethanone
C8H7BrO2
2491-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 Br 6.9302 4.0010 0.0 0
M  V30 5 O 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1H-Imidazol-5-yl)phenol
C9H8N2O
19170-74-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 0.0000 0.0 0
M  V30 2 C 2.3698 2.6673 0.0 0
M  V30 3 C 1.4646 1.4215 0.0 0
M  V30 4 N 1.4646 3.9132 0.0 0
M  V30 5 N 0.0000 1.8973 0.0 0
M  V30 6 C 0.0000 3.4374 0.0 0
M  V30 7 C 3.9098 2.6673 0.0 0
M  V30 8 C 4.6799 1.3337 0.0 0
M  V30 9 C 4.6799 4.0010 0.0 0
M  V30 10 C 6.2199 1.3337 0.0 0
M  V30 11 C 6.2199 4.0010 0.0 0
M  V30 12 C 6.9899 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 7
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2491-36-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19170-74-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36040175
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted imidazolecarboxamides as acid ceramidase
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Jennifer Y.; Dergado, William F.; Jo, Hyunil; Beresis, Richard;
Adler, Marc
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023023156 A1 2023-02-23

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(+)-L-Leucine methyl ester
C7H15NO2
2666-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0 CFG=1
M  V30 2 C 5.3347 1.5400 0.0 0
M  V30 3 C 2.6674 1.5400 0.0 0
M  V30 4 N 4.0011 3.8500 0.0 0
M  V30 5 O 6.6685 2.3100 0.0 0
M  V30 6 O 5.3347 0.0000 0.0 0
M  V30 7 C 1.3336 2.3100 0.0 0
M  V30 8 C 8.0021 1.5400 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Formyl-L-leucine methyl ester
C8H15NO3
54259-27-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=1
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 N 2.3100 2.6674 0.0 0
M  V30 5 O 0.7700 5.3347 0.0 0
M  V30 6 O 3.0800 6.6685 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 0.0000 6.6685 0.0 0
M  V30 10 C 4.6200 6.6685 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 O 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2666-93-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54259-27-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26588339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1809269-30-4
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide Synthesis through Borinic Acid-Catalysed Transamidation under
Mild Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohy El Dine, Tharwat; Evans, David; Rouden, Jacques; Blanchet, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2016), 22(17), 5894-5898

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-4,5-dimethoxy-, methyl ester
C10H13NO4
26759-46-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 O 8.0023 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 N 4.0012 6.9302 0.0 0
M  V30 6 O 4.0012 0.7700 0.0 0
M  V30 7 C 5.3348 0.0000 0.0 0
M  V30 8 O 1.3337 2.3101 0.0 0
M  V30 9 C 0.0000 3.0801 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dimethoxy-4(3H)-quinazolinone
C10H10N2O3
13794-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6201 0.0 0
M  V30 2 O 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 4.0011 0.7700 0.0 0
M  V30 5 C 2.6675 0.0000 0.0 0
M  V30 6 C 4.0011 5.3901 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 N 4.0011 6.9301 0.0 0
M  V30 10 C 2.6675 3.0800 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 2.6675 7.7001 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 N 1.3337 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 26759-46-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13794-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1070433
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6,7-Dimethoxy-4-quinazolone (9). To a solution of 8 (200 g) in DMF (1.6
L) and methanol (400 mL), formamide (180 g) and sodium methoxide (146 g)
were added. The reaction mixture was stirred for 10 h under reflux
conditions. After quench by cold water, the mixture was neutralized by 1
N hydrochloride solution. Precipitated solid was collected by filtration
and washed with water, ethyl acetate, and hexane to give 9 (190 g, yield
97%). 6,7-Dimethoxy-4-quinazolone (9), Yield (190 g, 97%)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of Potent and Selective Inhibitors of PDGF Receptor
Autophosphorylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Furuta, Takayuki; Sakai, Teruyuki; Senga, Terufumi; Osawa, Tatsushi;
Kubo, Kazuo; Shimizu, Toshiyuki; Suzuki, Rika; Yoshino, Tetsuya; Endo,
Megumi; Miwa, Atsushi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2006), 49(7), 2186-2192

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-4,5-dimethoxy-, methyl ester
C10H13NO4
26759-46-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 O 8.0023 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 N 4.0012 6.9302 0.0 0
M  V30 6 O 4.0012 0.7700 0.0 0
M  V30 7 C 5.3348 0.0000 0.0 0
M  V30 8 O 1.3337 2.3101 0.0 0
M  V30 9 C 0.0000 3.0801 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dimethoxy-4(3H)-quinazolinone
C10H10N2O3
13794-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6201 0.0 0
M  V30 2 O 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 4.0011 0.7700 0.0 0
M  V30 5 C 2.6675 0.0000 0.0 0
M  V30 6 C 4.0011 5.3901 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 N 4.0011 6.9301 0.0 0
M  V30 10 C 2.6675 3.0800 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 2.6675 7.7001 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 N 1.3337 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 26759-46-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13794-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2061363
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of novel quinazolinyl-diaryl
urea derivatives as potential anticancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Jia-Nian; Wang, Xian-Fu; Li, Ting; Wu, De-Wen; Fu, Xiao-Bo; Zhang,
Guang-Ji; Shen, Xing-Can; Wang, Heng-Shan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 10712-25

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoroaniline
C6H6FN
371-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-Bis(4-fluorophenyl)methanimidamide
C13H10F2N2
18464-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 N 8.0022 3.0801 0.0 0
M  V30 4 F 0.0000 0.0000 0.0 0
M  V30 5 F 13.3370 0.0000 0.0 0
M  V30 6 C 4.0010 2.3101 0.0 0
M  V30 7 C 4.0010 0.7700 0.0 0
M  V30 8 C 2.6673 3.0801 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 1.3337 0.7700 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 C 10.6697 3.0801 0.0 0
M  V30 14 C 9.3360 0.7700 0.0 0
M  V30 15 C 12.0033 2.3101 0.0 0
M  V30 16 C 10.6697 0.0000 0.0 0
M  V30 17 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 12
M  V30 5 1 4 11
M  V30 6 1 5 17
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18464-36-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27067216
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
N,N′-Diarylformamidines (50-56 and 73). The reliable procedure involved
the treatment of arylamines (43-49; 1.0 equiv) or 3-aminopyridine (68;
1.0 equiv) with PBr3 (~3.0 equiv) in formamide solution (2 mL) at 50-60
°C over 0.5-1.0 h. When the reaction was complete, the crude solid was
triturated in cold n-pentane and filtered through a glass frit with
suction. Then the solid was washed with n-pentane and dried in vacuo to
give the crude formamidines (50-56 and 73). The crude products were
recrystallized from the mixture of acetone and diisopropyl ether to give
the corresponding N,N′-diarylformamidine products (50-56 and 73) in
88-97% yields as white to light yellow solids.
N,N'-Bis(4-fluorophenyl)formamidine (56).35 The standard procedure
involved the treatment of 4-fluoroaniline (49; 49 mg, 0.51 mmol, 1.0
equiv) with PBr3 (0.14 mL, 1.5 mmol, 3.0 equiv) in formamide solution (2
mL) at 50-60 °C over 0.5-1.0 h. The reaction mixture was then worked up,
and the residue was purified by chromatography on silica gel to give pure
56: 97% yield (115 mg), yellow solid. Mp 142-144 °C (CH2Cl2-methanol). 1H
NMR (CDCl3, 200 MHz): δ 7.09-6.96 (8H, m), 8.02 (1H, s), 9.61 (1H, s).
13C NMR (50 MHz, CDCl3): δ 161.8, 1573.0, 150.2, 141.2, 120.5, 120.4,
116.2, 115.8. IR (KBr): 3428, 2928, 2862, 1671, 1603, 1502, 1380, 1313,
1202 cm-1. EIMS m/z (rel int): 236 (100, M+). Anal. Calcd for C13H10F2N2:
C, 67.24; H, 4.32; N, 12.06. Found: C, 67.23; H, 4.34; N, 12.07.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoroaniline
C6H6FN
371-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluorophenyl)formamide
C7H6FNO
459-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 F 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 459-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-8471055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 9012-76-4
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, sealed tube used, no solvent, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chitosan: an efficient recyclable catalyst for transamidation of
carboxamides with amines under neat conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nageswara Rao, Sadu; Chandra Mohan, Darapaneni; Adimurthy, Subbarayappa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2014), 16(9), 4122-4126

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Valine methyl ester
C6H13NO2
4070-48-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0 CFG=1
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 O 5.3347 1.5400 0.0 0
M  V30 6 O 4.0011 3.8500 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 C 1.3338 3.8500 0.0 0
M  V30 9 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 5 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Formyl-L-valine methyl ester
C7H13NO3
3154-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0 CFG=2
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 N 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 O 5.3900 4.0011 0.0 0
M  V30 6 O 5.3900 1.3338 0.0 0
M  V30 7 C 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 O 0.0000 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 7 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4070-48-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3154-46-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25895618
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1809269-30-4
$DTYPE RXN:VAR(1):NOTES
$DATUM ee = 99%, scalable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide Synthesis through Borinic Acid-Catalysed Transamidation under
Mild Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohy El Dine, Tharwat; Evans, David; Rouden, Jacques; Blanchet, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2016), 22(17), 5894-5898

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Valine methyl ester
C6H13NO2
4070-48-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0 CFG=1
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 O 5.3347 1.5400 0.0 0
M  V30 6 O 4.0011 3.8500 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 C 1.3338 3.8500 0.0 0
M  V30 9 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 5 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Formyl-L-valine methyl ester
C7H13NO3
3154-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0 CFG=2
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 N 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 O 5.3900 4.0011 0.0 0
M  V30 6 O 5.3900 1.3338 0.0 0
M  V30 7 C 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 O 0.0000 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 7 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4070-48-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3154-46-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-10777612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 11120-01-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM sulfated
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, no solvent, catalyst prepared
and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfated tungstate: a highly efficient catalyst for transamidation of
carboxamides with amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pathare, Sagar P.; Jain, Ashish Kumar H.; Akamanchi, Krishnacharya G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2013), 3(21), 7697-7703

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-methoxybenzoic acid
C8H9NO3
4294-95-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-4(3H)-quinazolinone
C9H8N2O2
16064-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 O 6.6686 4.6201 0.0 0
M  V30 3 C 8.0022 3.8500 0.0 0
M  V30 4 C 2.6675 3.8500 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 4.6201 0.0 0
M  V30 7 N 1.3337 4.6201 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4294-95-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-24-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31670818
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and evaluation of novel
(E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides
as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dung, Do T. M.; Park, Eun J.; Anh, Duong T.; Hai, Pham-The; Huy, Le D.;
Jun, Hye W.; Kwon, Joo-Hee; Young Ji, A.; Kang, Jong S.; Tung, Truong T.;
Dung, Phan T. P.; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2022), 355(1), 2100216

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-fluorobenzoic acid
C7H6FNO2
446-08-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 F 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Fluoro-4(3H)-quinazolinone
C8H5FN2O
16499-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 F 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-08-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16499-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31670816
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and evaluation of novel
(E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides
as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dung, Do T. M.; Park, Eun J.; Anh, Duong T.; Hai, Pham-The; Huy, Le D.;
Jun, Hye W.; Kwon, Joo-Hee; Young Ji, A.; Kang, Jong S.; Tung, Truong T.;
Dung, Phan T. P.; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2022), 355(1), 2100216

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-fluorobenzoic acid
C7H6FNO2
446-08-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 F 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Fluoro-4(3H)-quinazolinone
C8H5FN2O
16499-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 F 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-08-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16499-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21290403
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design,
synthesis and evaluation of antitumor cytotoxicity and caspase activation
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huan, Le Cong; Tran, Phuong-Thao; Phuong, Cao Viet; Duc, Phan Huy; Anh,
Duong Tien; Hai, Pham The; Huong, Le Thi Thu; Nguyen, Thi Thuan; Lee, Hye
Jin; Park, Eun Jae; Kang, Jong Soon; Nguyen, Phuong Linh; Hieu, Tran
Trung; Oanh, Dao Thi Kim; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2019), 92103202

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-fluorobenzoic acid
C7H6FNO2
446-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoroquinazolin-4(3H)-one
C8H5FN2O
16499-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 F 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 N 2.3101 0.0000 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-32-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16499-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31670823
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and evaluation of novel
(E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides
as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dung, Do T. M.; Park, Eun J.; Anh, Duong T.; Hai, Pham-The; Huy, Le D.;
Jun, Hye W.; Kwon, Joo-Hee; Young Ji, A.; Kang, Jong S.; Tung, Truong T.;
Dung, Phan T. P.; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2022), 355(1), 2100216

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-fluorobenzoic acid
C7H6FNO2
446-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoroquinazolin-4(3H)-one
C8H5FN2O
16499-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 F 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 N 2.3101 0.0000 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-32-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16499-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21290052
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design,
synthesis and evaluation of antitumor cytotoxicity and caspase activation
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huan, Le Cong; Tran, Phuong-Thao; Phuong, Cao Viet; Duc, Phan Huy; Anh,
Duong Tien; Hai, Pham The; Huong, Le Thi Thu; Nguyen, Thi Thuan; Lee, Hye
Jin; Park, Eun Jae; Kang, Jong Soon; Nguyen, Phuong Linh; Hieu, Tran
Trung; Oanh, Dao Thi Kim; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2019), 92103202

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5-dimethylthiophene-3-carboxylate
C9H13NO2S
4815-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 3.3320 0.0 0
M  V30 2 O 6.6363 2.5620 0.0 0
M  V30 3 O 5.3026 4.8721 0.0 0
M  V30 4 C 7.9700 3.3320 0.0 0
M  V30 5 C 9.3037 2.5620 0.0 0
M  V30 6 C 2.2418 4.6948 0.0 0
M  V30 7 N 4.9524 0.0000 0.0 0
M  V30 8 C 0.0000 2.2049 0.0 0
M  V30 9 C 3.9688 2.5620 0.0 0
M  V30 10 C 2.5620 3.1885 0.0 0
M  V30 11 C 3.8079 1.0304 0.0 0
M  V30 12 C 1.5316 2.0439 0.0 0
M  V30 13 S 2.3016 0.7103 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 11
M  V30 8 1 8 12
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-5,6-dimethylthieno[2,3-d]pyrimidine
C8H8N2OS
18593-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.3694 0.0 0
M  V30 2 O 1.3336 0.0000 0.0 0
M  V30 3 C 6.5770 3.0800 0.0 0
M  V30 4 C 2.6673 3.8500 0.0 0
M  V30 5 C 2.6673 2.3100 0.0 0
M  V30 6 S 4.1320 4.3259 0.0 0
M  V30 7 N 1.3336 4.6200 0.0 0
M  V30 8 C 4.1320 1.8341 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 5.0370 3.0800 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 9
M  V30 3 1 3 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18593-44-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18346826
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Search for Bactericides Among Derivatives of Deoxyvasicinone,
Mackinazolinone, and Thienopyrimidinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ortikov, I. S.; Turdibaev, Zh. E.; Islamova, Zh. I.; Elmuradov, B. Zh.;
Abdurazakov, A. Sh.; Bektemirov, A. M.; Osipova, S. O.; Khushbaktova, Z.
A.; Syrov, V. N.; Shakhidoyatov, Kh. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2017), 51(6), 456-464

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5-dimethylthiophene-3-carboxylate
C9H13NO2S
4815-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 3.3320 0.0 0
M  V30 2 O 6.6363 2.5620 0.0 0
M  V30 3 O 5.3026 4.8721 0.0 0
M  V30 4 C 7.9700 3.3320 0.0 0
M  V30 5 C 9.3037 2.5620 0.0 0
M  V30 6 C 2.2418 4.6948 0.0 0
M  V30 7 N 4.9524 0.0000 0.0 0
M  V30 8 C 0.0000 2.2049 0.0 0
M  V30 9 C 3.9688 2.5620 0.0 0
M  V30 10 C 2.5620 3.1885 0.0 0
M  V30 11 C 3.8079 1.0304 0.0 0
M  V30 12 C 1.5316 2.0439 0.0 0
M  V30 13 S 2.3016 0.7103 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 11
M  V30 8 1 8 12
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-5,6-dimethylthieno[2,3-d]pyrimidine
C8H8N2OS
18593-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.3694 0.0 0
M  V30 2 O 1.3336 0.0000 0.0 0
M  V30 3 C 6.5770 3.0800 0.0 0
M  V30 4 C 2.6673 3.8500 0.0 0
M  V30 5 C 2.6673 2.3100 0.0 0
M  V30 6 S 4.1320 4.3259 0.0 0
M  V30 7 N 1.3336 4.6200 0.0 0
M  V30 8 C 4.1320 1.8341 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 5.0370 3.0800 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 9
M  V30 3 1 3 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18593-44-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5712068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thieno[2,3-d]pyrimidin-4-ones. part 3. electrophilic ipso-substitution
reactions of methyl and methoxycarbonyl groups
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Elmuradov, B. Zh.; Bozorov, Kh. A.; Kurbanbayeva, A. Zh.; Ortikov, I. S.;
Bobakulov, Kh. M.; Abdullayev, N. D.; Yili, A.; Aisa, H. A.;
Shakhidoyatov, Kh. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM American Chemical Science Journal (2013), 3(4), 364-377

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5-dimethylthiophene-3-carboxylate
C9H13NO2S
4815-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 3.3320 0.0 0
M  V30 2 O 6.6363 2.5620 0.0 0
M  V30 3 O 5.3026 4.8721 0.0 0
M  V30 4 C 7.9700 3.3320 0.0 0
M  V30 5 C 9.3037 2.5620 0.0 0
M  V30 6 C 2.2418 4.6948 0.0 0
M  V30 7 N 4.9524 0.0000 0.0 0
M  V30 8 C 0.0000 2.2049 0.0 0
M  V30 9 C 3.9688 2.5620 0.0 0
M  V30 10 C 2.5620 3.1885 0.0 0
M  V30 11 C 3.8079 1.0304 0.0 0
M  V30 12 C 1.5316 2.0439 0.0 0
M  V30 13 S 2.3016 0.7103 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 11
M  V30 8 1 8 12
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-5,6-dimethylthieno[2,3-d]pyrimidine
C8H8N2OS
18593-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.3694 0.0 0
M  V30 2 O 1.3336 0.0000 0.0 0
M  V30 3 C 6.5770 3.0800 0.0 0
M  V30 4 C 2.6673 3.8500 0.0 0
M  V30 5 C 2.6673 2.3100 0.0 0
M  V30 6 S 4.1320 4.3259 0.0 0
M  V30 7 N 1.3336 4.6200 0.0 0
M  V30 8 C 4.1320 1.8341 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 5.0370 3.0800 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 9
M  V30 3 1 3 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18593-44-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12115740
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and biological studies of some novel
thieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Al-Taisan, Khulud M.; Al-Hazimi, Hassan M. A.; Al-Shihry, Shar S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2010), 153932-3957

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-5-chlorobenzoate
C8H8ClNO2
5202-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 O 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 N 3.0800 0.0000 0.0 0
M  V30 6 Cl 0.0000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-4(3H)-quinazolinone
C8H5ClN2O
16064-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Cl 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5202-89-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16826705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3473-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM preparation of quinazoline and quinoline derivatives as interleukin-1
receptor-associated kinases (IRAK) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Romero, Donna L.; Robinson, Shaughnessy; Greenwood, Jeremy Robert;
Shelley, Mee; Masse, Craig E.; Harriman, Geraldine C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015164374 A1 2015-10-29

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromonicotinic acid
C6H5BrN2O2
52833-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromopyrido[2,3-d]pyrimidin-4(3H)-one
C7H4BrN3O
155690-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 N 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52833-94-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 155690-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36816381
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of menin-mll interaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abagyan, Ruben; Parchinsky, Vladislav Zenonovich; Khvat, Alexander;
Ivachtchenko, Alexandre Vasilievich; Savchuk, Nikolay
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023107687 A1 2023-06-15

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromonicotinic acid
C6H5BrN2O2
52833-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromopyrido[2,3-d]pyrimidin-4(3H)-one
C7H4BrN3O
155690-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 N 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52833-94-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 155690-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37544635
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazoline derivatives as inhibitors of menin and MLL interaction and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abagyan, Ruben; Parchinsky, Vladislav Zenonovich; Savchuk, Nikolay;
Ivachtchenko, Alexandre Vasilievich; Khvat, Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023107696 A2 2023-06-15

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-iodobenzoic acid
C7H6INO2
5326-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 I 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Iodo-4(3H)-quinazolinone
C8H5IN2O
16064-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 I 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5326-47-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-08-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31670814
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and evaluation of novel
(E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides
as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dung, Do T. M.; Park, Eun J.; Anh, Duong T.; Hai, Pham-The; Huy, Le D.;
Jun, Hye W.; Kwon, Joo-Hee; Young Ji, A.; Kang, Jong S.; Tung, Truong T.;
Dung, Phan T. P.; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2022), 355(1), 2100216

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-iodobenzoic acid
C7H6INO2
5326-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 I 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Iodo-4(3H)-quinazolinone
C8H5IN2O
16064-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 I 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5326-47-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-08-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11257574
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (1) 6-Iodo-quinazolin-4-ol. A solution of 2-amino-5-iodo-benzoic acid
(5.0 g, 19.0 mmol) in formamide (21.6 g, 479 mmol) was heated at 160
degree for 3 hours. Water (50 mL) was added to form the black fine solid.
The mixture was stirred for 16 hour, then filtered to collect the solid.
The dark brown solid was then dried in vacuum oven for overnight at 60
degree to give the intermediate title compound. Yield: (4.83 g, 94%). m/z
273.0 [M+1].
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles containing a 4-substituted pyrimidine subunit
for pharmaceutical use as mGluR1 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ambler, Samantha Jayne; Baker, Stephen Richard; Clark, Barry Peter;
Coleman, Darrell Stephen; Foglesong, Robert James; Goldsworthy, John;
Jagdmann, Gunnar Erik, Jr.; Johnson, Kirk Willis; Kingston, Ann
Elizabeth; Owton, William Martin; Schoepp, Darryle Darwin; Hong, Jian
Eric; Schkeryantz, Jeffrey Michael; Vannieuwenhze, Michael Scott;
Zia-Ebrahimi, Mohammad Sadegh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001032632 A2 2001-05-10

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-iodobenzoic acid
C7H6INO2
5326-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 I 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Iodo-4(3H)-quinazolinone
C8H5IN2O
16064-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 I 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5326-47-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-08-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7109208
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and structure-activity relationships of a novel class of
quinazoline glucokinase activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iino, Tomoharu; Sasaki, Yasuhiro; Bamba, Makoto; Mitsuya, Morihiro; Ohno,
Akio; Kamata, Kenji; Hosaka, Hideka; Maruki, Hiroko; Futamura, Mayumi;
Yoshimoto, Riki; Ohyama, Sumika; Sasaki, Kaori; Chiba, Masato; Ohtake,
Norikazu; Nagata, Yasufumi; Eiki, Jun-ichi; Nishimura, Teruyuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(19), 5531-5538

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4,5-dimethoxybenzoic acid
C9H11NO4
5653-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 1.3337 6.9301 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 N 4.0011 6.9301 0.0 0
M  V30 5 O 4.0011 0.7700 0.0 0
M  V30 6 C 2.6675 0.0000 0.0 0
M  V30 7 O 6.6686 2.3100 0.0 0
M  V30 8 C 8.0022 3.0800 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 4.0011 5.3901 0.0 0
M  V30 11 C 2.6675 3.0800 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 5.3348 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dimethoxy-4(3H)-quinazolinone
C10H10N2O3
13794-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6201 0.0 0
M  V30 2 O 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 4.0011 0.7700 0.0 0
M  V30 5 C 2.6675 0.0000 0.0 0
M  V30 6 C 4.0011 5.3901 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 N 4.0011 6.9301 0.0 0
M  V30 10 C 2.6675 3.0800 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 2.6675 7.7001 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 N 1.3337 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5653-40-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13794-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31670819
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and evaluation of novel
(E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides
as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dung, Do T. M.; Park, Eun J.; Anh, Duong T.; Hai, Pham-The; Huy, Le D.;
Jun, Hye W.; Kwon, Joo-Hee; Young Ji, A.; Kang, Jong S.; Tung, Truong T.;
Dung, Phan T. P.; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2022), 355(1), 2100216

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4,5-dimethoxybenzoic acid
C9H11NO4
5653-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 1.3337 6.9301 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 N 4.0011 6.9301 0.0 0
M  V30 5 O 4.0011 0.7700 0.0 0
M  V30 6 C 2.6675 0.0000 0.0 0
M  V30 7 O 6.6686 2.3100 0.0 0
M  V30 8 C 8.0022 3.0800 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 4.0011 5.3901 0.0 0
M  V30 11 C 2.6675 3.0800 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 5.3348 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dimethoxy-4(3H)-quinazolinone
C10H10N2O3
13794-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6201 0.0 0
M  V30 2 O 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 4.0011 0.7700 0.0 0
M  V30 5 C 2.6675 0.0000 0.0 0
M  V30 6 C 4.0011 5.3901 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 N 4.0011 6.9301 0.0 0
M  V30 10 C 2.6675 3.0800 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 2.6675 7.7001 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 N 1.3337 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5653-40-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13794-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21289610
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design,
synthesis and evaluation of antitumor cytotoxicity and caspase activation
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huan, Le Cong; Tran, Phuong-Thao; Phuong, Cao Viet; Duc, Phan Huy; Anh,
Duong Tien; Hai, Pham The; Huong, Le Thi Thu; Nguyen, Thi Thuan; Lee, Hye
Jin; Park, Eun Jae; Kang, Jong Soon; Nguyen, Phuong Linh; Hieu, Tran
Trung; Oanh, Dao Thi Kim; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2019), 92103202

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4,5-dimethoxybenzoic acid
C9H11NO4
5653-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 1.3337 6.9301 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 N 4.0011 6.9301 0.0 0
M  V30 5 O 4.0011 0.7700 0.0 0
M  V30 6 C 2.6675 0.0000 0.0 0
M  V30 7 O 6.6686 2.3100 0.0 0
M  V30 8 C 8.0022 3.0800 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 4.0011 5.3901 0.0 0
M  V30 11 C 2.6675 3.0800 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 5.3348 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dimethoxy-4(3H)-quinazolinone
C10H10N2O3
13794-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6201 0.0 0
M  V30 2 O 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 4.0011 0.7700 0.0 0
M  V30 5 C 2.6675 0.0000 0.0 0
M  V30 6 C 4.0011 5.3901 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 N 4.0011 6.9301 0.0 0
M  V30 10 C 2.6675 3.0800 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 2.6675 7.7001 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 N 1.3337 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5653-40-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13794-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21172458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal (thermal condition (stage 2)), key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Potency of Pyruvate Dehydrogenase Complex E1
Inhibitors against Cyanobacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yuan; Feng, Jiangtao; He, Hongwu; Hou, Leifeng; Jiang, Wen; Xie,
Dan; Feng, Lingling; Cai, Meng; Peng, Hao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biochemistry (2017), 56(49), 6491-6502

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromobenzoic acid
C7H6BrNO2
5794-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4(3H)-quinazolinone
C8H5BrN2O
32084-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5794-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32084-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31670812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and evaluation of novel
(E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides
as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dung, Do T. M.; Park, Eun J.; Anh, Duong T.; Hai, Pham-The; Huy, Le D.;
Jun, Hye W.; Kwon, Joo-Hee; Young Ji, A.; Kang, Jong S.; Tung, Truong T.;
Dung, Phan T. P.; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2022), 355(1), 2100216

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromobenzoic acid
C7H6BrNO2
5794-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4(3H)-quinazolinone
C8H5BrN2O
32084-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5794-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32084-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21288093
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design,
synthesis and evaluation of antitumor cytotoxicity and caspase activation
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huan, Le Cong; Tran, Phuong-Thao; Phuong, Cao Viet; Duc, Phan Huy; Anh,
Duong Tien; Hai, Pham The; Huong, Le Thi Thu; Nguyen, Thi Thuan; Lee, Hye
Jin; Park, Eun Jae; Kang, Jong Soon; Nguyen, Phuong Linh; Hieu, Tran
Trung; Oanh, Dao Thi Kim; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2019), 92103202

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromobenzoic acid
C7H6BrNO2
5794-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4(3H)-quinazolinone
C8H5BrN2O
32084-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5794-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32084-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26205271
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, biological evaluation of
6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as
novel anticancer agents with Aurora kinase inhibition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fan, Chengcheng; Zhong, Ting; Yang, Huarong; Yang, Ying; Wang, Daoping;
Yang, Xiaosheng; Xu, Yongnan; Fan, Yanhua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 190112108pp.

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromobenzoic acid
C7H6BrNO2
5794-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4(3H)-quinazolinone
C8H5BrN2O
32084-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5794-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32084-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21173307
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal (thermal condition (stage 2)), key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Potency of Pyruvate Dehydrogenase Complex E1
Inhibitors against Cyanobacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yuan; Feng, Jiangtao; He, Hongwu; Hou, Leifeng; Jiang, Wen; Xie,
Dan; Feng, Lingling; Cai, Meng; Peng, Hao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biochemistry (2017), 56(49), 6491-6502

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromobenzoic acid
C7H6BrNO2
5794-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4(3H)-quinazolinone
C8H5BrN2O
32084-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5794-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32084-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12397874
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM synthesis of 6-bromo-4-hydroxy-quinazoline. A suspension of
2-amino-5-bromobenzoic acid (5.4 g, 25 mmol) in formamide (40ml) was
heated at 165°C for 6 hours. After cooling to room temperature, water
(100ml) was added to the reaction mixture. The precipitate was collected
by filtration, washed with water and dried over P2O5, yielding the title
compound as a white solid (5.3 g, yield: 95%) which was characterized by
its mass spectrum as follows:. MS (m/z): 225 ([M+H]+, 100)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4,6-Di- AND 2,4,6-trisubstituted quinazoline derivatives useful for
treating viral infection and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Ling-Jie; Herdewijn, Piet Andre Maurits Maria; De Jonghe, Steven
Cesar Alfons; Watkins, William John; Chong, Lee Shun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008009077 A2 2008-01-24

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromobenzoic acid
C7H6BrNO2
5794-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4(3H)-quinazolinone
C8H5BrN2O
32084-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5794-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32084-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21091784
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 2 -synthesis of 6-bromo-4-hydroxy-guinazoline A suspension of
2-amino-5-bromobenzoic acid (5.4 g, 25 mmol) in formamide (40 ml) was
heated at 165 C for 6 hours. After cooling to room temperature, water
(100 ml) was added to the reaction mixture. The precipitate was collected
by filtration, washed with water and dried over P2O5, yielding the title
compound as a white solid (5.3 g, yield: 95 %) which was characterized by
its mass spectrum as follows: MS (m/z): 225 ([M+H]+, 100).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4,6-Di- AND 2,4,6-trisubstituted quinazoline derivatives useful for
treating viral infection and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Ling-Jie; Herdewijn, Piet Andre Maurits Maria; De Jonghe, Steven
Cesar Alfons; Watkins, William John; Chong, Lee Shun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008009078 A2 2008-01-24

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromobenzoic acid
C7H6BrNO2
5794-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4(3H)-quinazolinone
C8H5BrN2O
32084-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5794-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32084-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38331759
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Visible-light-promoted photoredox-catalyzed N-aminoalkylation of
quinazolinones with simple alkylamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gu, Yi-Jie; Cui, Wenwen; Jiang, De-Lu; Yuan, Hua; Liang, Xiao-Wei; Wang,
Shou-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2023), 132154801

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-nitrobenzoic acid
C7H6N2O4
616-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Nitro-4(3H)-quinazolinone
C8H5N3O3
6943-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3336 0.0000 0.0 0
M  V30 2 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 N 1.3336 4.6200 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 N 0.0000 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 616-79-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6943-17-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31670813
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and evaluation of novel
(E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides
as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dung, Do T. M.; Park, Eun J.; Anh, Duong T.; Hai, Pham-The; Huy, Le D.;
Jun, Hye W.; Kwon, Joo-Hee; Young Ji, A.; Kang, Jong S.; Tung, Truong T.;
Dung, Phan T. P.; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2022), 355(1), 2100216

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-nitrobenzoic acid
C7H6N2O4
616-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Nitro-4(3H)-quinazolinone
C8H5N3O3
6943-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3336 0.0000 0.0 0
M  V30 2 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 N 1.3336 4.6200 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 N 0.0000 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 616-79-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6943-17-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21288366
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design,
synthesis and evaluation of antitumor cytotoxicity and caspase activation
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huan, Le Cong; Tran, Phuong-Thao; Phuong, Cao Viet; Duc, Phan Huy; Anh,
Duong Tien; Hai, Pham The; Huong, Le Thi Thu; Nguyen, Thi Thuan; Lee, Hye
Jin; Park, Eun Jae; Kang, Jong Soon; Nguyen, Phuong Linh; Hieu, Tran
Trung; Oanh, Dao Thi Kim; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2019), 92103202

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-nitrobenzoic acid
C7H6N2O4
619-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Nitro-4(3H)-quinazolinone
C8H5N3O3
20872-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.8500 0.0 0
M  V30 2 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 N 4.0011 6.1600 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 2.6674 6.9300 0.0 0
M  V30 13 N 1.3336 6.1600 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20872-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31670825
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and evaluation of novel
(E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides
as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dung, Do T. M.; Park, Eun J.; Anh, Duong T.; Hai, Pham-The; Huy, Le D.;
Jun, Hye W.; Kwon, Joo-Hee; Young Ji, A.; Kang, Jong S.; Tung, Truong T.;
Dung, Phan T. P.; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2022), 355(1), 2100216

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-nitrobenzoic acid
C7H6N2O4
619-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Nitro-4(3H)-quinazolinone
C8H5N3O3
20872-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.8500 0.0 0
M  V30 2 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 N 4.0011 6.1600 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 2.6674 6.9300 0.0 0
M  V30 13 N 1.3336 6.1600 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20872-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21196428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design,
synthesis and evaluation of antitumor cytotoxicity and caspase activation
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huan, Le Cong; Tran, Phuong-Thao; Phuong, Cao Viet; Duc, Phan Huy; Anh,
Duong Tien; Hai, Pham The; Huong, Le Thi Thu; Nguyen, Thi Thuan; Lee, Hye
Jin; Park, Eun Jae; Kang, Jong Soon; Nguyen, Phuong Linh; Hieu, Tran
Trung; Oanh, Dao Thi Kim; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2019), 92103202

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-nitrobenzoic acid
C7H6N2O4
619-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Nitro-4(3H)-quinazolinone
C8H5N3O3
20872-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.8500 0.0 0
M  V30 2 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 N 4.0011 6.1600 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 2.6674 6.9300 0.0 0
M  V30 13 N 1.3336 6.1600 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20872-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21129178
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal (thermal condition (stage 2)), key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Potency of Pyruvate Dehydrogenase Complex E1
Inhibitors against Cyanobacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yuan; Feng, Jiangtao; He, Hongwu; Hou, Leifeng; Jiang, Wen; Xie,
Dan; Feng, Lingling; Cai, Meng; Peng, Hao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biochemistry (2017), 56(49), 6491-6502

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-nitrobenzoic acid
C7H6N2O4
619-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Nitro-4(3H)-quinazolinone
C8H5N3O3
20872-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.8500 0.0 0
M  V30 2 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 N 4.0011 6.1600 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 2.6674 6.9300 0.0 0
M  V30 13 N 1.3336 6.1600 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20872-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21221764
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 6-[2-(1-pyridazinyl-4-piperidinyl)ethoxy]benzoxazoles and
analogs as antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keith, Watson; Krippner, Guy; Stanislawski, Pauline; McConnell, Darryl
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002050045 A1 2002-06-27

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-nitrobenzoic acid
C7H6N2O4
619-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Nitro-4(3H)-quinazolinone
C8H5N3O3
20872-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.8500 0.0 0
M  V30 2 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 N 4.0011 6.1600 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 2.6674 6.9300 0.0 0
M  V30 13 N 1.3336 6.1600 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20872-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9626059
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 46A 7-nitroquniazolin-4(3H)-one A mixture of 4-nitroanthranilic acid
(2.07 g, 11.4 mmol) and formamide (2 mL, 50 mmol) was heated to 200 °C
(oil bath temperature) with stirring for 1.5 h. Water (4 mL) was added to
the cooled reaction mixture. The resulting slurry was filtered and washed
with ethanol (3X) to afford 46A. Brown crystals, yield 2.048 g, 94%.
LC-MS: 192.2 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenylglycine sulfonamide derivatives useful as serine
protease inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Glunz, Peter W.; Bisacchi, Gregory S.; Morton, George C.; Holubec,
Alexandra A.; Priestley, E. Scott; Zhang, Xiaojun; Treuner, Uwe D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004072101 A2 2004-08-26

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-nitrobenzoic acid
C7H6N2O4
619-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Nitro-4(3H)-quinazolinone
C8H5N3O3
20872-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.8500 0.0 0
M  V30 2 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 N 4.0011 6.1600 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 2.6674 6.9300 0.0 0
M  V30 13 N 1.3336 6.1600 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20872-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21035809
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):NOTES
$DATUM click reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline compounds and methods for inhibiting vacuolar
ATPase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Chao; Chen, Ying-Chu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20170174638 A1 2017-06-22

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-nitrobenzoic acid
C7H6N2O4
619-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Nitro-4(3H)-quinazolinone
C8H5N3O3
20872-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.8500 0.0 0
M  V30 2 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 N 4.0011 6.1600 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 2.6674 6.9300 0.0 0
M  V30 13 N 1.3336 6.1600 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20872-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21110874
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of Specific, Irreversible Inhibitors for a Receptor Tyrosine
Kinase EphB3
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kung, Alvin; Chen, Ying-Chu; Schimpl, Marianne; Ni, Feng; Zhu, Jianfa;
Turner, Maurice; Molina, Henrik; Overman, Ross; Zhang, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2016), 138(33), 10554-10560

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxyaniline
C8H11NO2
6315-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3349 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 N 6.9300 4.0011 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 3.0800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethoxyphenyl)formamide
C9H11NO3
33904-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 N 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 O 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6315-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 33904-02-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-18262396
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1313-13-9
$DTYPE RXN:VAR(1):NOTES
$DATUM scalable, no solvent, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM MnO2 catalyzed formylation of amines and transamidation of amides under
solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yedage, Subhash L.; D'Silva, Denvert S.; Bhanage, Bhalchandra M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2015), 5(98), 80441-80449

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chlorobenzoic acid
C7H6ClNO2
635-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Cl 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-4(3H)-quinazolinone
C8H5ClN2O
16064-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Cl 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 635-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31670817
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and evaluation of novel
(E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides
as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dung, Do T. M.; Park, Eun J.; Anh, Duong T.; Hai, Pham-The; Huy, Le D.;
Jun, Hye W.; Kwon, Joo-Hee; Young Ji, A.; Kang, Jong S.; Tung, Truong T.;
Dung, Phan T. P.; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2022), 355(1), 2100216

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chlorobenzoic acid
C7H6ClNO2
635-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Cl 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-4(3H)-quinazolinone
C8H5ClN2O
16064-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Cl 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 635-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38113252
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum
sensing transcriptional regulator PqsR
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grossman, Scott; Soukarieh, Fadi; Richardson, William; Liu, Ruiling;
Mashabi, Alaa; Emsley, Jonas; Williams, Paul; Camara, Miguel; Stocks,
Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 208112778

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chlorobenzoic acid
C7H6ClNO2
635-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Cl 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-4(3H)-quinazolinone
C8H5ClN2O
16064-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Cl 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 635-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21287691
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design,
synthesis and evaluation of antitumor cytotoxicity and caspase activation
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huan, Le Cong; Tran, Phuong-Thao; Phuong, Cao Viet; Duc, Phan Huy; Anh,
Duong Tien; Hai, Pham The; Huong, Le Thi Thu; Nguyen, Thi Thuan; Lee, Hye
Jin; Park, Eun Jae; Kang, Jong Soon; Nguyen, Phuong Linh; Hieu, Tran
Trung; Oanh, Dao Thi Kim; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2019), 92103202

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chlorobenzoic acid
C7H6ClNO2
635-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Cl 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-4(3H)-quinazolinone
C8H5ClN2O
16064-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Cl 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 635-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38331760
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Visible-light-promoted photoredox-catalyzed N-aminoalkylation of
quinazolinones with simple alkylamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gu, Yi-Jie; Cui, Wenwen; Jiang, De-Lu; Yuan, Hua; Liang, Xiao-Wei; Wang,
Shou-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2023), 132154801

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chlorobenzoic acid
C7H6ClNO2
635-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Cl 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-4(3H)-quinazolinone
C8H5ClN2O
16064-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Cl 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 635-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21129926
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal (thermal condition (stage 2)), key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Potency of Pyruvate Dehydrogenase Complex E1
Inhibitors against Cyanobacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yuan; Feng, Jiangtao; He, Hongwu; Hou, Leifeng; Jiang, Wen; Xie,
Dan; Feng, Lingling; Cai, Meng; Peng, Hao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biochemistry (2017), 56(49), 6491-6502

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromoadamantane
C10H15Br
768-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 5.5321 3.0179 0.0 0
M  V30 2 C 4.1957 2.2463 0.0 0
M  V30 3 C 2.9051 3.0867 0.0 0
M  V30 4 C 4.2781 0.7086 0.0 0
M  V30 5 C 2.4986 2.2355 0.0 0
M  V30 6 C 1.6969 2.3891 0.0 0
M  V30 7 C 3.0699 0.0111 0.0 0
M  V30 8 C 1.2906 1.5379 0.0 0
M  V30 9 C 0.0000 2.3780 0.0 0
M  V30 10 C 1.7794 0.8513 0.0 0
M  V30 11 C 1.3730 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 9
M  V30 13 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-1-Adamantylformamide
C11H17NO
3405-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5317 3.0177 0.0 0
M  V30 2 C 6.8681 2.2463 0.0 0
M  V30 3 O 8.2043 3.0177 0.0 0
M  V30 4 C 4.1955 2.2463 0.0 0
M  V30 5 C 2.9049 3.0866 0.0 0
M  V30 6 C 4.2779 0.7085 0.0 0
M  V30 7 C 2.4985 2.2355 0.0 0
M  V30 8 C 1.6968 2.3890 0.0 0
M  V30 9 C 3.0697 0.0111 0.0 0
M  V30 10 C 1.2904 1.5379 0.0 0
M  V30 11 C 0.0000 2.3779 0.0 0
M  V30 12 C 1.7794 0.8513 0.0 0
M  V30 13 C 1.3729 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 768-90-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3405-48-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-7405159
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10170-69-1
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent, hermetically closed stainless-steel high-pressure
microreactor or sealed glass ampoule used, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-(adamantan-1-yl)amides by reaction of carboxylic acid
amides with 1-bromo(chloro)adamantane catalyzed by manganese compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khusnutdinov, R. I.; Shchadneva, N. A.; Khisamova, L. F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2015), 51(4), 476-479

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromoadamantane
C10H15Br
768-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 5.5321 3.0179 0.0 0
M  V30 2 C 4.1957 2.2463 0.0 0
M  V30 3 C 2.9051 3.0867 0.0 0
M  V30 4 C 4.2781 0.7086 0.0 0
M  V30 5 C 2.4986 2.2355 0.0 0
M  V30 6 C 1.6969 2.3891 0.0 0
M  V30 7 C 3.0699 0.0111 0.0 0
M  V30 8 C 1.2906 1.5379 0.0 0
M  V30 9 C 0.0000 2.3780 0.0 0
M  V30 10 C 1.7794 0.8513 0.0 0
M  V30 11 C 1.3730 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 9
M  V30 13 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-1-Adamantylformamide
C11H17NO
3405-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5317 3.0177 0.0 0
M  V30 2 C 6.8681 2.2463 0.0 0
M  V30 3 O 8.2043 3.0177 0.0 0
M  V30 4 C 4.1955 2.2463 0.0 0
M  V30 5 C 2.9049 3.0866 0.0 0
M  V30 6 C 4.2779 0.7085 0.0 0
M  V30 7 C 2.4985 2.2355 0.0 0
M  V30 8 C 1.6968 2.3890 0.0 0
M  V30 9 C 3.0697 0.0111 0.0 0
M  V30 10 C 1.2904 1.5379 0.0 0
M  V30 11 C 0.0000 2.3779 0.0 0
M  V30 12 C 1.7794 0.8513 0.0 0
M  V30 13 C 1.3729 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 768-90-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3405-48-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-22291079
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Simple Process for the Synthesis of 1-Aminoadamantane Hydrochloride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pham, Van Hien; Tran, Thi Hang; Vu, Binh Duong; Le, Huy Binh; Nguyen, Huu
Tung; Phan, Dinh Chau
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Preparations and Procedures International (2020), 52(1), 77-80

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzylamine
C7H9N
100-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzylformamide
C8H9NO
6343-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 N 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-46-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6343-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26076380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1034343-98-0
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM oxide
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, photochemical, sealed tube used, no solvent,
concentrated solar radiation used, graphene oxide catalyst prepared and
used, alternate conventional heating method may be used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green transamidation catalysed by graphene oxide under concentrated solar
irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patel, Khushbu P.; Kamble, Sujit S.; Boraste, Deepak R.; Shankarling,
Ganapati S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Environmental Chemistry Letters (2020), 18(5), 1731-1735

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzylamine
C7H9N
100-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzylformamide
C8H9NO
6343-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 N 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-46-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6343-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29599669
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1034343-98-0
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM oxide
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, catalyst prepared and used, sealed tube used, no
solvent, recyclable catalyst used, reusable catalyst used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Graphene Oxide: A Metal-Free Carbocatalyst for the Synthesis of Diverse
Amides under Solvent-Free Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patel, Khushbu P.; Gayakwad, Eknath M.; Patil, Vilas V.; Shankarling,
Ganapati S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2019), 361(9), 2107-2116

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzylamine
C7H9N
100-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzylformamide
C8H9NO
6343-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 N 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-46-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6343-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27315104
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, recyclable and reusable catalyst used,
alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solvent-free, Efficient Transamidation of Carboxamides with Amines
Catalyzed by Recyclable Sulfated Polyborate Catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mali, Anil S.; Indalkar, Krishna; Chaturbhuj, Ganesh U.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Preparations and Procedures International (2021), 53(4), 369-378

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[(2,4-difluorophenyl)amino]-6,7-dimethoxy-3-cinnolinecarboxylate
C19H17F2N3O4
1041853-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 6.1601 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 O 10.6697 3.8501 0.0 0
M  V30 4 O 9.3360 6.1601 0.0 0
M  V30 5 C 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 C 0.0000 3.8501 0.0 0
M  V30 9 O 1.3337 1.5400 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 F 6.6685 9.2402 0.0 0
M  V30 12 F 1.3337 9.2402 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 4.0010 4.6201 0.0 0
M  V30 17 C 8.0022 3.8501 0.0 0
M  V30 18 C 4.0010 1.5400 0.0 0
M  V30 19 N 6.6685 1.5400 0.0 0
M  V30 20 C 2.6673 3.8501 0.0 0
M  V30 21 N 8.0022 2.3101 0.0 0
M  V30 22 C 2.6673 2.3101 0.0 0
M  V30 23 C 5.3348 6.9302 0.0 0
M  V30 24 C 5.3348 8.4702 0.0 0
M  V30 25 C 4.0010 6.1601 0.0 0
M  V30 26 C 4.0010 9.2402 0.0 0
M  V30 27 C 2.6673 6.9302 0.0 0
M  V30 28 C 2.6673 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 1 11 24
M  V30 13 1 12 28
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2,4-Difluorophenyl)amino]-6,7-dimethoxy-3-cinnolinecarboxamide
C17H14F2N4O3
1041852-34-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 8.0021 0.0 0
M  V30 2 C 9.2400 8.0021 0.0 0
M  V30 3 N 8.4700 9.3358 0.0 0
M  V30 4 O 10.7800 8.0021 0.0 0
M  V30 5 O 2.3100 4.0011 0.0 0
M  V30 6 C 1.5400 2.6673 0.0 0
M  V30 7 O 3.8500 1.3336 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 F 4.6200 10.6694 0.0 0
M  V30 10 F 0.0000 8.0021 0.0 0
M  V30 11 C 6.1600 5.3347 0.0 0
M  V30 12 C 6.9300 6.6684 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 8.4700 6.6684 0.0 0
M  V30 16 C 6.1600 2.6673 0.0 0
M  V30 17 N 8.4700 4.0011 0.0 0
M  V30 18 C 3.8500 4.0011 0.0 0
M  V30 19 N 9.2400 5.3347 0.0 0
M  V30 20 C 4.6200 2.6673 0.0 0
M  V30 21 C 4.6200 8.0021 0.0 0
M  V30 22 C 3.8500 9.3358 0.0 0
M  V30 23 C 3.8500 6.6684 0.0 0
M  V30 24 C 2.3100 9.3358 0.0 0
M  V30 25 C 2.3100 6.6684 0.0 0
M  V30 26 C 1.5400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 1 9 22
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1041853-30-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1041852-34-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7781016
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Amido-4-anilinocinnolines as a novel class of CSF-1R inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Scott, David A.; Dakin, Les A.; Del Valle, David J.; Bruce Diebold, R.;
Drew, Lisa; Gero, Thomas W.; Ogoe, Claude A.; Omer, Charles A.; Repik,
Galina; Thakur, Kumar; Ye, Qing; Zheng, Xiaolan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(5), 1382-1384

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[(2-fluoro-4-methylphenyl)amino]-6,7-dimethoxy-3-cinnolinecarboxylate
C20H20FN3O4
1041853-32-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 6.1601 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 O 10.6697 3.8501 0.0 0
M  V30 4 O 9.3360 6.1601 0.0 0
M  V30 5 C 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 C 0.0000 3.8501 0.0 0
M  V30 9 O 1.3337 1.5400 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 F 6.6685 9.2402 0.0 0
M  V30 12 C 1.3337 9.2402 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 4.0010 4.6201 0.0 0
M  V30 17 C 8.0022 3.8501 0.0 0
M  V30 18 C 4.0010 1.5400 0.0 0
M  V30 19 N 6.6685 1.5400 0.0 0
M  V30 20 C 2.6673 3.8501 0.0 0
M  V30 21 N 8.0022 2.3101 0.0 0
M  V30 22 C 2.6673 2.3101 0.0 0
M  V30 23 C 5.3348 6.9302 0.0 0
M  V30 24 C 5.3348 8.4702 0.0 0
M  V30 25 C 4.0010 6.1601 0.0 0
M  V30 26 C 4.0010 9.2402 0.0 0
M  V30 27 C 2.6673 6.9302 0.0 0
M  V30 28 C 2.6673 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 1 11 24
M  V30 13 1 12 28
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2-Fluoro-4-methylphenyl)amino]-6,7-dimethoxy-3-cinnolinecarboxamide
C18H17FN4O3
1041852-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 8.0021 0.0 0
M  V30 2 C 9.2400 8.0021 0.0 0
M  V30 3 N 10.7800 8.0021 0.0 0
M  V30 4 O 8.4700 9.3358 0.0 0
M  V30 5 O 2.3100 4.0011 0.0 0
M  V30 6 C 1.5400 2.6673 0.0 0
M  V30 7 O 3.8500 1.3336 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 F 4.6200 10.6694 0.0 0
M  V30 10 C 0.0000 8.0021 0.0 0
M  V30 11 C 6.1600 5.3347 0.0 0
M  V30 12 C 6.9300 6.6684 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 8.4700 6.6684 0.0 0
M  V30 16 C 6.1600 2.6673 0.0 0
M  V30 17 N 8.4700 4.0011 0.0 0
M  V30 18 C 3.8500 4.0011 0.0 0
M  V30 19 N 9.2400 5.3347 0.0 0
M  V30 20 C 4.6200 2.6673 0.0 0
M  V30 21 C 4.6200 8.0021 0.0 0
M  V30 22 C 3.8500 9.3358 0.0 0
M  V30 23 C 3.8500 6.6684 0.0 0
M  V30 24 C 2.3100 9.3358 0.0 0
M  V30 25 C 2.3100 6.6684 0.0 0
M  V30 26 C 1.5400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 1 9 22
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1041853-32-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1041852-36-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9916378
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Amido-4-anilinocinnolines as a novel class of CSF-1R inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Scott, David A.; Dakin, Les A.; Del Valle, David J.; Bruce Diebold, R.;
Drew, Lisa; Gero, Thomas W.; Ogoe, Claude A.; Omer, Charles A.; Repik,
Galina; Thakur, Kumar; Ye, Qing; Zheng, Xiaolan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(5), 1382-1384

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[(3-chloro-2-fluorophenyl)amino]-6,7-dimethoxy-3-cinnolinecarboxylate
C19H17ClFN3O4
1041853-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 9.3360 6.1601 0.0 0
M  V30 3 O 10.6697 6.9302 0.0 0
M  V30 4 O 9.3360 4.6201 0.0 0
M  V30 5 C 12.0033 6.1601 0.0 0
M  V30 6 C 13.3370 6.9302 0.0 0
M  V30 7 O 1.3337 6.1601 0.0 0
M  V30 8 C 0.0000 6.9302 0.0 0
M  V30 9 F 6.6685 1.5400 0.0 0
M  V30 10 O 1.3337 9.2402 0.0 0
M  V30 11 C 1.3337 10.7802 0.0 0
M  V30 12 Cl 4.0010 0.0000 0.0 0
M  V30 13 C 6.6685 6.1601 0.0 0
M  V30 14 C 5.3348 6.9302 0.0 0
M  V30 15 C 8.0022 6.9302 0.0 0
M  V30 16 C 5.3348 8.4702 0.0 0
M  V30 17 C 4.0010 6.1601 0.0 0
M  V30 18 N 8.0022 8.4702 0.0 0
M  V30 19 C 4.0010 9.2402 0.0 0
M  V30 20 N 6.6685 9.2402 0.0 0
M  V30 21 C 2.6673 6.9302 0.0 0
M  V30 22 C 2.6673 8.4702 0.0 0
M  V30 23 C 5.3348 3.8501 0.0 0
M  V30 24 C 5.3348 2.3101 0.0 0
M  V30 25 C 4.0010 4.6201 0.0 0
M  V30 26 C 4.0010 1.5400 0.0 0
M  V30 27 C 2.6673 3.8501 0.0 0
M  V30 28 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 9 24
M  V30 11 1 10 11
M  V30 12 1 10 22
M  V30 13 1 12 26
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 2 18 20
M  V30 23 2 19 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(3-Chloro-2-fluorophenyl)amino]-6,7-dimethoxy-3-cinnolinecarboxamide
C17H14ClFN4O3
1041852-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 4.6200 1.3336 0.0 0
M  V30 3 N 3.8500 0.0000 0.0 0
M  V30 4 O 6.1600 1.3336 0.0 0
M  V30 5 O 4.6200 9.3358 0.0 0
M  V30 6 C 3.8500 10.6694 0.0 0
M  V30 7 F 9.2400 4.0011 0.0 0
M  V30 8 O 1.5400 9.3358 0.0 0
M  V30 9 C 0.0000 9.3358 0.0 0
M  V30 10 Cl 10.7800 6.6684 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 3.8500 2.6673 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 4.6200 6.6684 0.0 0
M  V30 16 N 2.3100 2.6673 0.0 0
M  V30 17 C 1.5400 6.6684 0.0 0
M  V30 18 N 1.5400 4.0011 0.0 0
M  V30 19 C 3.8500 8.0021 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 6.9300 5.3347 0.0 0
M  V30 22 C 8.4700 5.3347 0.0 0
M  V30 23 C 6.1600 6.6684 0.0 0
M  V30 24 C 9.2400 6.6684 0.0 0
M  V30 25 C 6.9300 8.0021 0.0 0
M  V30 26 C 8.4700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 7 22
M  V30 9 1 8 9
M  V30 10 1 8 20
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 2 16 18
M  V30 21 2 17 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1041853-33-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1041852-38-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14177577
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Amido-4-anilinocinnolines as a novel class of CSF-1R inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Scott, David A.; Dakin, Les A.; Del Valle, David J.; Bruce Diebold, R.;
Drew, Lisa; Gero, Thomas W.; Ogoe, Claude A.; Omer, Charles A.; Repik,
Galina; Thakur, Kumar; Ye, Qing; Zheng, Xiaolan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(5), 1382-1384

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[(2-fluoro-5-methylphenyl)amino]-6,7-dimethoxy-3-cinnolinecarboxylate
C20H20FN3O4
1041853-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 6.1601 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 O 10.6697 3.8501 0.0 0
M  V30 4 O 9.3360 6.1601 0.0 0
M  V30 5 C 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 C 0.0000 3.8501 0.0 0
M  V30 9 F 6.6685 9.2402 0.0 0
M  V30 10 O 1.3337 1.5400 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 1.3337 6.1601 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 N 8.0022 2.3101 0.0 0
M  V30 19 C 4.0010 1.5400 0.0 0
M  V30 20 N 6.6685 1.5400 0.0 0
M  V30 21 C 2.6673 3.8501 0.0 0
M  V30 22 C 2.6673 2.3101 0.0 0
M  V30 23 C 5.3348 6.9302 0.0 0
M  V30 24 C 5.3348 8.4702 0.0 0
M  V30 25 C 4.0010 6.1601 0.0 0
M  V30 26 C 4.0010 9.2402 0.0 0
M  V30 27 C 2.6673 6.9302 0.0 0
M  V30 28 C 2.6673 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 9 24
M  V30 11 1 10 11
M  V30 12 1 10 22
M  V30 13 1 12 27
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 2 18 20
M  V30 23 2 19 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2-Fluoro-5-methylphenyl)amino]-6,7-dimethoxy-3-cinnolinecarboxamide
C18H17FN4O3
1041852-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 4.6200 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 N 2.6673 0.0000 0.0 0
M  V30 4 O 1.3336 2.3100 0.0 0
M  V30 5 O 6.6684 8.4700 0.0 0
M  V30 6 C 8.0021 9.2400 0.0 0
M  V30 7 F 0.0000 6.1600 0.0 0
M  V30 8 O 9.3358 6.9300 0.0 0
M  V30 9 C 10.6694 6.1600 0.0 0
M  V30 10 C 5.3347 9.2400 0.0 0
M  V30 11 C 4.0011 3.8500 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 6.6684 3.8500 0.0 0
M  V30 15 C 5.3347 6.1600 0.0 0
M  V30 16 N 5.3347 1.5400 0.0 0
M  V30 17 C 8.0021 4.6200 0.0 0
M  V30 18 N 6.6684 2.3100 0.0 0
M  V30 19 C 6.6684 6.9300 0.0 0
M  V30 20 C 8.0021 6.1600 0.0 0
M  V30 21 C 2.6673 6.1600 0.0 0
M  V30 22 C 1.3336 6.9300 0.0 0
M  V30 23 C 4.0011 6.9300 0.0 0
M  V30 24 C 1.3336 8.4700 0.0 0
M  V30 25 C 4.0011 8.4700 0.0 0
M  V30 26 C 2.6673 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 7 22
M  V30 9 1 8 9
M  V30 10 1 8 20
M  V30 11 1 10 25
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 2 16 18
M  V30 21 2 17 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1041853-34-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1041852-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12048811
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Amido-4-anilinocinnolines as a novel class of CSF-1R inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Scott, David A.; Dakin, Les A.; Del Valle, David J.; Bruce Diebold, R.;
Drew, Lisa; Gero, Thomas W.; Ogoe, Claude A.; Omer, Charles A.; Repik,
Galina; Thakur, Kumar; Ye, Qing; Zheng, Xiaolan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(5), 1382-1384

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[(2,3-dichlorophenyl)amino]-6,7-dimethoxy-3-cinnolinecarboxylate
C19H17Cl2N3O4
1041853-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 9.3360 6.1601 0.0 0
M  V30 3 O 10.6697 6.9302 0.0 0
M  V30 4 O 9.3360 4.6201 0.0 0
M  V30 5 C 12.0033 6.1601 0.0 0
M  V30 6 C 13.3370 6.9302 0.0 0
M  V30 7 O 1.3337 6.1601 0.0 0
M  V30 8 C 0.0000 6.9302 0.0 0
M  V30 9 Cl 6.6685 1.5400 0.0 0
M  V30 10 O 1.3337 9.2402 0.0 0
M  V30 11 C 1.3337 10.7802 0.0 0
M  V30 12 Cl 4.0010 0.0000 0.0 0
M  V30 13 C 6.6685 6.1601 0.0 0
M  V30 14 C 5.3348 6.9302 0.0 0
M  V30 15 C 8.0022 6.9302 0.0 0
M  V30 16 C 5.3348 8.4702 0.0 0
M  V30 17 C 4.0010 6.1601 0.0 0
M  V30 18 N 8.0022 8.4702 0.0 0
M  V30 19 C 4.0010 9.2402 0.0 0
M  V30 20 N 6.6685 9.2402 0.0 0
M  V30 21 C 2.6673 6.9302 0.0 0
M  V30 22 C 2.6673 8.4702 0.0 0
M  V30 23 C 5.3348 3.8501 0.0 0
M  V30 24 C 5.3348 2.3101 0.0 0
M  V30 25 C 4.0010 4.6201 0.0 0
M  V30 26 C 4.0010 1.5400 0.0 0
M  V30 27 C 2.6673 3.8501 0.0 0
M  V30 28 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 9 24
M  V30 11 1 10 11
M  V30 12 1 10 22
M  V30 13 1 12 26
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 2 18 20
M  V30 23 2 19 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2,3-Dichlorophenyl)amino]-6,7-dimethoxy-3-cinnolinecarboxamide
C17H14Cl2N4O3
1041852-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 4.6200 1.3336 0.0 0
M  V30 3 N 3.8500 0.0000 0.0 0
M  V30 4 O 6.1600 1.3336 0.0 0
M  V30 5 O 4.6200 9.3358 0.0 0
M  V30 6 C 3.8500 10.6694 0.0 0
M  V30 7 Cl 9.2400 4.0011 0.0 0
M  V30 8 O 1.5400 9.3358 0.0 0
M  V30 9 C 0.0000 9.3358 0.0 0
M  V30 10 Cl 10.7800 6.6684 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 3.8500 2.6673 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 4.6200 6.6684 0.0 0
M  V30 16 N 2.3100 2.6673 0.0 0
M  V30 17 C 1.5400 6.6684 0.0 0
M  V30 18 N 1.5400 4.0011 0.0 0
M  V30 19 C 3.8500 8.0021 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 6.9300 5.3347 0.0 0
M  V30 22 C 8.4700 5.3347 0.0 0
M  V30 23 C 6.1600 6.6684 0.0 0
M  V30 24 C 9.2400 6.6684 0.0 0
M  V30 25 C 6.9300 8.0021 0.0 0
M  V30 26 C 8.4700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 7 22
M  V30 9 1 8 9
M  V30 10 1 8 20
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 2 16 18
M  V30 21 2 17 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1041853-35-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1041852-42-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-785145
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Amido-4-anilinocinnolines as a novel class of CSF-1R inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Scott, David A.; Dakin, Les A.; Del Valle, David J.; Bruce Diebold, R.;
Drew, Lisa; Gero, Thomas W.; Ogoe, Claude A.; Omer, Charles A.; Repik,
Galina; Thakur, Kumar; Ye, Qing; Zheng, Xiaolan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(5), 1382-1384

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzylamine
C7H8ClN
104-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Chlorophenyl)methyl]formamide
C8H8ClNO
86386-67-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 O 9.3360 2.3101 0.0 0
M  V30 5 Cl 0.0000 0.0000 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6675 0.0000 0.0 0
M  V30 11 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-86-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 86386-67-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-18265735
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 65-85-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 106-42-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzoic Acid-Catalyzed Transamidation Reactions of Carboxamides,
Phthalimide, Ureas and Thioamide with Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Ji-Wei; Wu, Ya-Dong; Dai, Jian-Jun; Xu, Hua-Jian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(11-12), 2429-2436

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromotoluene
C7H7Br
106-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methylphenyl)formamide
C8H9NO
3085-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 C 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-38-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3085-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-15024970
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-99-8
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligand free open air copper(II) mediated aryl formamidation and amination
of aryl halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Komati, Rajesh; Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2014), 55(9), 1523-1527

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromotoluene
C7H7Br
106-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methylphenyl)formamide
C8H9NO
3085-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 C 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-38-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3085-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-7753195
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12168-54-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, green chemistry-solvent, Buchwald-Hartwig type
amination, nickel ferrite nanoparticles used as catalyst, catalyst
prepared and used, recyclable and reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM C-N Bond Formation Using Highly Effective and Reusable Nickel Ferrite
Nanoparticles in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moghaddam, Firouz Matloubi; Tavakoli, Ghazal; Moafi, Atiyeh; Saberi,
Vahid; Rezvani, Hamid Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2014), 6(12), 3474-3481

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ciprofloxacin methyl ester
C18H20FN3O3
107884-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.0102 6.8749 0.0 0
M  V30 2 C 11.5503 4.2075 0.0 0
M  V30 3 O 12.3203 2.8739 0.0 0
M  V30 4 O 12.3203 5.5412 0.0 0
M  V30 5 C 13.8603 2.8739 0.0 0
M  V30 6 F 4.6201 8.2087 0.0 0
M  V30 7 C 6.9302 4.2075 0.0 0
M  V30 8 N 7.7002 2.8739 0.0 0
M  V30 9 C 7.7002 5.5412 0.0 0
M  V30 10 C 5.3901 4.2075 0.0 0
M  V30 11 C 9.2402 2.8739 0.0 0
M  V30 12 C 9.2402 5.5412 0.0 0
M  V30 13 C 6.9302 6.8749 0.0 0
M  V30 14 C 4.6201 5.5412 0.0 0
M  V30 15 C 10.0102 4.2075 0.0 0
M  V30 16 C 5.3901 6.8749 0.0 0
M  V30 17 C 6.9302 1.5400 0.0 0
M  V30 18 C 6.9302 0.0000 0.0 0
M  V30 19 C 5.5965 0.7700 0.0 0
M  V30 20 N 3.0801 5.5412 0.0 0
M  V30 21 C 2.3101 4.2075 0.0 0
M  V30 22 C 2.3101 6.8749 0.0 0
M  V30 23 C 0.7700 4.2075 0.0 0
M  V30 24 C 0.7700 6.8749 0.0 0
M  V30 25 N 0.0000 5.5412 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 6 16
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 17
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 19 1 14 20
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-cyclopropyl-6-fluoro-7-(4-formyl-1-piperazinyl)-1,4-dihydro-4-oxo-3-...
C19H20FN3O4
1879963-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8501 6.8749 0.0 0
M  V30 2 C 2.3101 4.2075 0.0 0
M  V30 3 O 1.5400 2.8739 0.0 0
M  V30 4 O 1.5400 5.5412 0.0 0
M  V30 5 C 0.0000 2.8739 0.0 0
M  V30 6 F 9.2402 8.2087 0.0 0
M  V30 7 C 15.4003 5.5412 0.0 0
M  V30 8 O 16.1704 6.8749 0.0 0
M  V30 9 C 6.9302 4.2075 0.0 0
M  V30 10 N 6.1601 2.8739 0.0 0
M  V30 11 C 6.1601 5.5412 0.0 0
M  V30 12 C 8.4702 4.2075 0.0 0
M  V30 13 C 4.6201 2.8739 0.0 0
M  V30 14 C 4.6201 5.5412 0.0 0
M  V30 15 C 6.9302 6.8749 0.0 0
M  V30 16 C 9.2402 5.5412 0.0 0
M  V30 17 C 3.8501 4.2075 0.0 0
M  V30 18 C 8.4702 6.8749 0.0 0
M  V30 19 C 6.9302 1.5400 0.0 0
M  V30 20 C 8.2638 0.7700 0.0 0
M  V30 21 C 6.9302 0.0000 0.0 0
M  V30 22 N 10.7802 5.5412 0.0 0
M  V30 23 C 11.5503 6.8749 0.0 0
M  V30 24 C 11.5503 4.2075 0.0 0
M  V30 25 C 13.0903 6.8749 0.0 0
M  V30 26 C 13.0903 4.2075 0.0 0
M  V30 27 N 13.8603 5.5412 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 6 18
M  V30 7 2 7 8
M  V30 8 1 7 27
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 19
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 2 16 18
M  V30 21 1 16 22
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107884-23-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1879963-34-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31002360
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of membrane active benzimidazole quinolones-based topoisomerase
inhibitors as potential DNA-binding antimicrobial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Ling; Addla, Dinesh; Ponmani, Jeyakkumar; Wang, Ao; Xie, Dan;
Wang, Ya-Nan; Zhang, Shao-Lin; Geng, Rong-Xia; Cai, Gui-Xin; Li, Shuo;
Zhou, Cheng-He
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 111160-182

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylenecyclohexane
C7H12
1192-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Methylcyclohexyl)formamide
C8H15NO
101253-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.2597 2.3235 0.0 0
M  V30 2 C 5.7066 1.7968 0.0 0
M  V30 3 O 6.8864 2.7867 0.0 0
M  V30 4 C 4.2597 0.3437 0.0 0
M  V30 5 C 3.0799 1.3336 0.0 0
M  V30 6 C 2.3099 2.6674 0.0 0
M  V30 7 C 2.3099 0.0000 0.0 0
M  V30 8 C 0.7700 2.6674 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1192-37-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 101253-12-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-13481633
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7758-02-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Ritter reaction, other products also detected
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of N-substituted amides from alkenes and amides by a
Bronsted acid mediated electrophilic addition reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mihara, Karin; Okada, Iku; Chiba, Kazuhiro; Kitano, Yoshikazu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2014), 46(11), 1455-1462, 8 pp.

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[(1R)-1-phenylethyl]-3-pyridinamine
C13H13ClN2
1365094-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 3 C 4.6200 5.3349 0.0 0
M  V30 4 Cl 3.0800 0.0000 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 0.7700 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 C 7.7000 5.3349 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 C 9.2400 5.3349 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 11
M  V30 5 1 4 6
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[(1R)-1-Phenylethyl]-1H-imidazo[4,5-b]pyridine
C14H13N3
1365094-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 3.7710 0.0 0 CFG=2
M  V30 2 C 4.4608 5.1048 0.0 0
M  V30 3 C 2.9292 2.2764 0.0 0
M  V30 4 N 4.4608 2.4374 0.0 0
M  V30 5 C 2.6091 0.7700 0.0 0
M  V30 6 C 1.7849 3.3068 0.0 0
M  V30 7 C 5.0872 1.0306 0.0 0
M  V30 8 N 3.9427 0.0000 0.0 0
M  V30 9 N 1.1444 0.2941 0.0 0
M  V30 10 C 0.3202 2.8310 0.0 0
M  V30 11 C 0.0000 1.3247 0.0 0
M  V30 12 C 6.7708 3.7710 0.0 0
M  V30 13 C 7.5408 2.4374 0.0 0
M  V30 14 C 7.5408 5.1048 0.0 0
M  V30 15 C 9.0808 2.4374 0.0 0
M  V30 16 C 9.0808 5.1048 0.0 0
M  V30 17 C 9.8508 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 4
M  V30 3 1 1 12
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1365094-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365094-48-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3787542
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved synthesis of imidazo[4,5-b]pyridines and
imidazo[4,5-b]pyrazines by palladium catalyzed amidation using xantphos
in a 1,4-Dioxane:tert-amyl alcohol aolvent aystem
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Ahmed, Ijaz; Wilson, Robert J.; Williams, Theresa M.;
Kaminsky, Lauren; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(16), 3465-3470

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyanophenacyl bromide
C9H6BrNO
20099-89-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3337 0.0 0
M  V30 2 C 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 Br 0.0000 2.6673 0.0 0
M  V30 5 C 8.4701 1.3337 0.0 0
M  V30 6 N 10.0101 1.3337 0.0 0
M  V30 7 C 3.8500 1.3337 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 4.6201 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.1601 2.6673 0.0 0
M  V30 12 C 6.9301 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1H-Imidazol-5-yl)benzonitrile
C10H7N3
34443-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.5298 1.3336 0.0 0
M  V30 2 N 10.0698 1.3336 0.0 0
M  V30 3 C 3.9098 1.3336 0.0 0
M  V30 4 C 4.6798 2.6673 0.0 0
M  V30 5 C 4.6798 0.0000 0.0 0
M  V30 6 C 6.2198 2.6673 0.0 0
M  V30 7 C 6.2198 0.0000 0.0 0
M  V30 8 C 6.9898 1.3336 0.0 0
M  V30 9 C 2.3698 1.3336 0.0 0
M  V30 10 C 1.4645 0.0878 0.0 0
M  V30 11 N 1.4645 2.5795 0.0 0
M  V30 12 N 0.0000 0.5636 0.0 0
M  V30 13 C 0.0000 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20099-89-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 34443-07-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30790742
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted imidazole carboxamides and their use in the treatment of
medical disorders and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Skerlj, Renato T.; Bourque, Elyse Marie Josee; Ray, Soumya; Lansbury,
Peter T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021055612 A1 2021-03-25

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Hepten-2-one
C7H12O
21889-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 C 6.6687 1.5400 0.0 0
M  V30 8 C 8.0023 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Methyl-5-hexen-1-yl)formamide
C8H15NO
1691205-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 N 2.6673 2.3101 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21889-88-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1691205-36-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12500777
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):NOTES
$DATUM Leuckart-Wallach reaction, formamide/formic acid also used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient Isocyanide-less Isocyanide-Based Multicomponent Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neochoritis, Constantinos G.; Stotani, Silvia; Mishra, Bhupendra;
Doemling, Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(8), 2002-2005

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Diamantane
C14H20
2292-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1706 3.4130 0.0 0
M  V30 2 C 2.4010 2.0801 0.0 0
M  V30 3 C 4.7017 3.4178 0.0 0
M  V30 4 C 2.1285 4.5835 0.0 0
M  V30 5 C 0.7705 1.1850 0.0 0
M  V30 6 C 3.1626 0.7519 0.0 0
M  V30 7 C 3.0799 2.5174 0.0 0
M  V30 8 C 5.4722 2.0843 0.0 0
M  V30 9 C 0.7696 3.8514 0.0 0
M  V30 10 C 2.3104 1.1845 0.0 0
M  V30 11 C 0.0000 2.5183 0.0 0
M  V30 12 C 4.7026 0.7514 0.0 0
M  V30 13 C 2.3096 3.8507 0.0 0
M  V30 14 C 3.3565 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 6 12
M  V30 12 1 7 10
M  V30 13 1 7 13
M  V30 14 1 8 12
M  V30 15 1 9 11
M  V30 16 1 9 13
M  V30 17 1 10 14
M  V30 18 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C15H21NO
2599852-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.8546 3.0794 0.0 0
M  V30 2 C 7.1876 2.3098 0.0 0
M  V30 3 O 8.5206 3.0794 0.0 0
M  V30 4 C 4.5216 2.3098 0.0 0
M  V30 5 C 2.6618 2.3498 0.0 0
M  V30 6 C 3.1882 3.0802 0.0 0
M  V30 7 C 4.5221 0.7696 0.0 0
M  V30 8 C 1.3288 1.5802 0.0 0
M  V30 9 C 2.6664 3.8810 0.0 0
M  V30 10 C 1.8551 2.3105 0.0 0
M  V30 11 C 2.8744 4.6291 0.0 0
M  V30 12 C 3.1890 0.0000 0.0 0
M  V30 13 C 0.0005 2.3418 0.0 0
M  V30 14 C 1.6461 0.0454 0.0 0
M  V30 15 C 1.3330 4.6516 0.0 0
M  V30 16 C 1.8555 0.7705 0.0 0
M  V30 17 C 0.0000 3.8819 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 13
M  V30 16 1 10 16
M  V30 17 1 11 15
M  V30 18 1 12 14
M  V30 19 1 12 16
M  V30 20 1 13 17
M  V30 21 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2292-79-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2599852-68-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27704068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7697-37-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Diamantane Derivatives in Nitric Acid Media
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Klimochkin, Yu. N.; Ivleva, E. A.; Zaborskaya, M. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2021), 57(2), 186-194

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 2-amino-5-bromo-3-[(tetrahydro-2H-pyran-4-yl)oxy]-, methyl ester
C13H16BrNO4
2562363-18-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 4.6201 0.0 0
M  V30 2 N 6.6685 6.1601 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 O 10.6697 3.8501 0.0 0
M  V30 5 O 9.3360 6.1601 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 Br 6.6685 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 8.0022 3.8501 0.0 0
M  V30 12 C 6.6685 1.5400 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 1.3337 1.5400 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 19 O 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 9
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 4 6
M  V30 8 1 7 12
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-8-[(tetrahydro-2H-pyran-4-yl)oxy]-4(3H)-quinazolinone
C13H13BrN2O3
2562363-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 4.6200 0.0 0
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 Br 4.0011 0.0000 0.0 0
M  V30 4 C 4.0011 4.6200 0.0 0
M  V30 5 C 5.3347 3.8500 0.0 0
M  V30 6 C 2.6673 3.8500 0.0 0
M  V30 7 N 4.0011 6.1600 0.0 0
M  V30 8 C 5.3347 2.3100 0.0 0
M  V30 9 C 2.6673 2.3100 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 2.6673 6.9300 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 N 1.3336 6.1600 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 16 C 9.3358 4.6200 0.0 0
M  V30 17 C 9.3358 1.5400 0.0 0
M  V30 18 C 10.6694 3.8500 0.0 0
M  V30 19 O 10.6694 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 14
M  V30 3 2 2 10
M  V30 4 1 3 12
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2562363-18-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2562363-19-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23307088
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminoquinazoline derivatives as P2X3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bruno, Paolo; Biagetti, Matteo; Fiorelli, Claudio; Pizzirani, Daniela;
Pala, Daniele; Ronchi, Paolo; Baker-Glenn, Charles; Van de Poel, Herve;
Hirst, Kim; Guariento, Sara
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020239952 A1 2020-12-03

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-chlorophenyl)-7-methoxy-4H-1-benzopyran-3-carbonitrile
C17H13ClN2O2
326918-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 6.6684 0.0 0
M  V30 2 N 0.0000 6.6684 0.0 0
M  V30 3 N 3.0800 9.3358 0.0 0
M  V30 4 O 10.0100 5.3347 0.0 0
M  V30 5 C 10.7800 4.0011 0.0 0
M  V30 6 Cl 0.7700 0.0000 0.0 0
M  V30 7 C 3.8500 5.3347 0.0 0
M  V30 8 C 5.3900 5.3347 0.0 0
M  V30 9 C 3.0800 6.6684 0.0 0
M  V30 10 C 6.1600 6.6684 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 3.8500 8.0021 0.0 0
M  V30 13 O 5.3900 8.0021 0.0 0
M  V30 14 C 7.7000 6.6684 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 3.0800 4.0011 0.0 0
M  V30 18 C 1.5400 4.0011 0.0 0
M  V30 19 C 3.8500 2.6674 0.0 0
M  V30 20 C 0.7700 2.6674 0.0 0
M  V30 21 C 3.0800 1.3336 0.0 0
M  V30 22 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 6 22
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Chlorophenyl)-8-methoxy-5H-[1]benzopyrano[2,3-d]pyrimidin-4-amine
C18H14ClN3O2
1403826-27-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 O 9.3358 9.2400 0.0 0
M  V30 3 C 10.6694 8.4700 0.0 0
M  V30 4 Cl 4.0011 0.0000 0.0 0
M  V30 5 C 4.0011 6.1600 0.0 0
M  V30 6 C 2.6673 6.9300 0.0 0
M  V30 7 C 5.3347 6.9300 0.0 0
M  V30 8 C 2.6673 8.4700 0.0 0
M  V30 9 C 1.3336 6.1600 0.0 0
M  V30 10 C 5.3347 8.4700 0.0 0
M  V30 11 C 6.6684 6.1600 0.0 0
M  V30 12 O 4.0011 9.2400 0.0 0
M  V30 13 N 1.3336 9.2400 0.0 0
M  V30 14 N 0.0000 6.9300 0.0 0
M  V30 15 C 6.6684 9.2400 0.0 0
M  V30 16 C 8.0021 6.9300 0.0 0
M  V30 17 C 0.0000 8.4700 0.0 0
M  V30 18 C 8.0021 8.4700 0.0 0
M  V30 19 C 4.0011 4.6200 0.0 0
M  V30 20 C 5.3347 3.8500 0.0 0
M  V30 21 C 2.6673 3.8500 0.0 0
M  V30 22 C 5.3347 2.3100 0.0 0
M  V30 23 C 2.6673 2.3100 0.0 0
M  V30 24 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 24
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 12
M  V30 16 2 10 15
M  V30 17 1 11 16
M  V30 18 1 13 17
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 2 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 326918-74-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1403826-27-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-18240689
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel chromenes as cytotoxic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kandeel, Manal M.; Kamal, Aliaa M.; Abdelall, Eman K. A.; Elshemy, Heba
A. H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2013), 37(2), 110-114

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-chlorophenyl)-7-methoxy-4H-1-benzopyran-3-carbonitrile
C17H13ClN2O2
326918-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 6.6684 0.0 0
M  V30 2 N 0.0000 6.6684 0.0 0
M  V30 3 N 3.0800 9.3358 0.0 0
M  V30 4 O 10.0100 5.3347 0.0 0
M  V30 5 C 10.7800 4.0011 0.0 0
M  V30 6 Cl 0.7700 0.0000 0.0 0
M  V30 7 C 3.8500 5.3347 0.0 0
M  V30 8 C 5.3900 5.3347 0.0 0
M  V30 9 C 3.0800 6.6684 0.0 0
M  V30 10 C 6.1600 6.6684 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 3.8500 8.0021 0.0 0
M  V30 13 O 5.3900 8.0021 0.0 0
M  V30 14 C 7.7000 6.6684 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 3.0800 4.0011 0.0 0
M  V30 18 C 1.5400 4.0011 0.0 0
M  V30 19 C 3.8500 2.6674 0.0 0
M  V30 20 C 0.7700 2.6674 0.0 0
M  V30 21 C 3.0800 1.3336 0.0 0
M  V30 22 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 6 22
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Chlorophenyl)-8-methoxy-5H-[1]benzopyrano[2,3-d]pyrimidin-4-amine
C18H14ClN3O2
1403826-27-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 O 9.3358 9.2400 0.0 0
M  V30 3 C 10.6694 8.4700 0.0 0
M  V30 4 Cl 4.0011 0.0000 0.0 0
M  V30 5 C 4.0011 6.1600 0.0 0
M  V30 6 C 2.6673 6.9300 0.0 0
M  V30 7 C 5.3347 6.9300 0.0 0
M  V30 8 C 2.6673 8.4700 0.0 0
M  V30 9 C 1.3336 6.1600 0.0 0
M  V30 10 C 5.3347 8.4700 0.0 0
M  V30 11 C 6.6684 6.1600 0.0 0
M  V30 12 O 4.0011 9.2400 0.0 0
M  V30 13 N 1.3336 9.2400 0.0 0
M  V30 14 N 0.0000 6.9300 0.0 0
M  V30 15 C 6.6684 9.2400 0.0 0
M  V30 16 C 8.0021 6.9300 0.0 0
M  V30 17 C 0.0000 8.4700 0.0 0
M  V30 18 C 8.0021 8.4700 0.0 0
M  V30 19 C 4.0011 4.6200 0.0 0
M  V30 20 C 5.3347 3.8500 0.0 0
M  V30 21 C 2.6673 3.8500 0.0 0
M  V30 22 C 5.3347 2.3100 0.0 0
M  V30 23 C 2.6673 2.3100 0.0 0
M  V30 24 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 24
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 12
M  V30 16 2 10 15
M  V30 17 1 11 16
M  V30 18 1 13 17
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 2 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 326918-74-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1403826-27-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-18053594
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of some novel chromene derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kandeel, M. M.; Kamal, Aliaa M.; Abdelall, Eman K. A.; Elshemy, Heba A.
H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry: An Indian Journal (2012), 8(9), 342-348

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-chlorophenyl)-7-methoxy-4H-1-benzopyran-3-carbonitrile
C17H13ClN2O2
326918-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 6.6684 0.0 0
M  V30 2 N 0.0000 6.6684 0.0 0
M  V30 3 N 3.0800 9.3358 0.0 0
M  V30 4 O 10.0100 5.3347 0.0 0
M  V30 5 C 10.7800 4.0011 0.0 0
M  V30 6 Cl 0.7700 0.0000 0.0 0
M  V30 7 C 3.8500 5.3347 0.0 0
M  V30 8 C 5.3900 5.3347 0.0 0
M  V30 9 C 3.0800 6.6684 0.0 0
M  V30 10 C 6.1600 6.6684 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 3.8500 8.0021 0.0 0
M  V30 13 O 5.3900 8.0021 0.0 0
M  V30 14 C 7.7000 6.6684 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 3.0800 4.0011 0.0 0
M  V30 18 C 1.5400 4.0011 0.0 0
M  V30 19 C 3.8500 2.6674 0.0 0
M  V30 20 C 0.7700 2.6674 0.0 0
M  V30 21 C 3.0800 1.3336 0.0 0
M  V30 22 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 6 22
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Chlorophenyl)-8-methoxy-5H-[1]benzopyrano[2,3-d]pyrimidin-4-amine
C18H14ClN3O2
1403826-27-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 O 9.3358 9.2400 0.0 0
M  V30 3 C 10.6694 8.4700 0.0 0
M  V30 4 Cl 4.0011 0.0000 0.0 0
M  V30 5 C 4.0011 6.1600 0.0 0
M  V30 6 C 2.6673 6.9300 0.0 0
M  V30 7 C 5.3347 6.9300 0.0 0
M  V30 8 C 2.6673 8.4700 0.0 0
M  V30 9 C 1.3336 6.1600 0.0 0
M  V30 10 C 5.3347 8.4700 0.0 0
M  V30 11 C 6.6684 6.1600 0.0 0
M  V30 12 O 4.0011 9.2400 0.0 0
M  V30 13 N 1.3336 9.2400 0.0 0
M  V30 14 N 0.0000 6.9300 0.0 0
M  V30 15 C 6.6684 9.2400 0.0 0
M  V30 16 C 8.0021 6.9300 0.0 0
M  V30 17 C 0.0000 8.4700 0.0 0
M  V30 18 C 8.0021 8.4700 0.0 0
M  V30 19 C 4.0011 4.6200 0.0 0
M  V30 20 C 5.3347 3.8500 0.0 0
M  V30 21 C 2.6673 3.8500 0.0 0
M  V30 22 C 5.3347 2.3100 0.0 0
M  V30 23 C 2.6673 2.3100 0.0 0
M  V30 24 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 24
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 12
M  V30 16 2 10 15
M  V30 17 1 11 16
M  V30 18 1 13 17
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 2 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 326918-74-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1403826-27-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-18149232
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel chromenes as cytotoxic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kandeel, Manal M.; Kamal, Aliaa M.; Abdelall, Eman K. A.; Elshemy, Heba
A. H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharma Chemica (2012), 4(4), 1653-1661

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-5-methylthiophene-3-carboxylate
C8H11NO2S
4815-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 2.7106 0.0 0
M  V30 2 O 5.9256 4.0442 0.0 0
M  V30 3 O 5.9256 1.3769 0.0 0
M  V30 4 C 7.4656 4.0442 0.0 0
M  V30 5 C 8.2357 5.3780 0.0 0
M  V30 6 N 3.1864 0.0000 0.0 0
M  V30 7 C 0.0000 4.3858 0.0 0
M  V30 8 C 3.6156 2.7106 0.0 0
M  V30 9 C 2.7104 1.4647 0.0 0
M  V30 10 C 2.7104 3.9564 0.0 0
M  V30 11 S 1.2459 1.9406 0.0 0
M  V30 12 C 1.2459 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methylthieno[2,3-d]pyrimidin-4(1H)-one
C7H6N2OS
108831-66-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 C 6.5771 3.0800 0.0 0
M  V30 3 C 2.6673 3.8500 0.0 0
M  V30 4 C 2.6673 2.3100 0.0 0
M  V30 5 S 4.1320 4.3259 0.0 0
M  V30 6 N 1.3337 4.6201 0.0 0
M  V30 7 C 4.1320 1.8342 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 5.0371 3.0800 0.0 0
M  V30 10 C 0.0000 3.8500 0.0 0
M  V30 11 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-32-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 108831-66-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2595198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To the material from step 1 (5.0 gm, 27 mmol) was added formamide (16 mL,
405 mmol) at rt under argon followed by ammonium formate (3.41 gm, 54
mmol). The resulting solution was warmed to 150-155°C and stirred over
night. After cooling to rt, the mostly solidified reaction mixture was
transferred to a cold brine solution and swirled vigorously for 15
minutes. The off-white solid was filtered, air dried for an hour, and
then stored under high vacuum over night to afford the desired product.
Yield 96%. ES-MS: (M+H)+ 167.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazine and homopiperazine compounds useful in the
treatment of thrombosis and to inhibit ADP-mediated platelet aggregation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Levy, Daniel E.; Smyth, Mark S.; Scarborough, Robert M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003022214 A2 2003-03-20

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-1-(2-hydroxyethyl)-1H-pyrazole-4-carbonitrile
C6H8N4O
5346-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8342 1.3628 0.0 0
M  V30 2 C 8.1680 2.1328 0.0 0
M  V30 3 O 9.5017 1.3628 0.0 0
M  V30 4 N 3.7735 0.0000 0.0 0
M  V30 5 C 1.5316 2.4899 0.0 0
M  V30 6 N 0.0000 2.3290 0.0 0
M  V30 7 N 5.5005 2.1328 0.0 0
M  V30 8 C 4.0937 1.5065 0.0 0
M  V30 9 N 5.3396 3.6644 0.0 0
M  V30 10 C 3.0631 2.6509 0.0 0
M  V30 11 C 3.8331 3.9847 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 3 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-1H-pyrazolo[3,4-d]pyrimidine-1-ethanol
C7H9N5O
100524-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 C 7.6825 4.1647 0.0 0
M  V30 3 O 9.1888 3.8445 0.0 0
M  V30 4 N 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 N 5.1456 3.3405 0.0 0
M  V30 8 N 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.9875 4.5864 0.0 0
M  V30 11 N 4.5192 4.7473 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 N 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5346-53-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 100524-24-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26735498
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A suspension of 5-amino-1-( β-hydroxyethyl)-4-pyrazolecarbonitrile26 10
(1.52 g, 10 mmol) in 3 mL of formamide was vigorously boiled under
stirring for 2 h. The cooled solution was then diluted with ice-water,
and the solid separated was filtrated, washed with water, and
recrystallized. Yield 96%. m.p = 217-219 °C (Lett. mp 223-224 °C).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel, Highly Potent Adenosine Deaminase Inhibitors Containing the
Pyrazolo[3,4-d]pyrimidine Ring System. Synthesis, Structure-Activity
Relationships, and Molecular Modeling Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Da Settimo, Federico; Primofiore, Giampaolo; La Motta, Concettina;
Taliani, Sabrina; Simorini, Francesca; Marini, Anna Maria; Mugnaini,
Laura; Lavecchia, Antonio; Novellino, Ettore; Tuscano, Daniela; Martini,
Claudia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2005), 48(16), 5162-5174

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-1-(2-hydroxyethyl)-1H-pyrazole-4-carbonitrile
C6H8N4O
5346-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8342 1.3628 0.0 0
M  V30 2 C 8.1680 2.1328 0.0 0
M  V30 3 O 9.5017 1.3628 0.0 0
M  V30 4 N 3.7735 0.0000 0.0 0
M  V30 5 C 1.5316 2.4899 0.0 0
M  V30 6 N 0.0000 2.3290 0.0 0
M  V30 7 N 5.5005 2.1328 0.0 0
M  V30 8 C 4.0937 1.5065 0.0 0
M  V30 9 N 5.3396 3.6644 0.0 0
M  V30 10 C 3.0631 2.6509 0.0 0
M  V30 11 C 3.8331 3.9847 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 3 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-1H-pyrazolo[3,4-d]pyrimidine-1-ethanol
C7H9N5O
100524-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 C 7.6825 4.1647 0.0 0
M  V30 3 O 9.1888 3.8445 0.0 0
M  V30 4 N 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 N 5.1456 3.3405 0.0 0
M  V30 8 N 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.9875 4.5864 0.0 0
M  V30 11 N 4.5192 4.7473 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 N 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5346-53-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 100524-24-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28458125
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A suspension of 5-amino-1-(
β-hydroxyethyl)-4-pyrazolecarbonitrile26 10 (1.52 g, 10 mmol) in 3 mL of
formamide was vigorously boiled under stirring for 2 h. The cooled
solution was then diluted with ice-water, and the solid separated was
filtrated, washed with water, and recrystallized. Yield 96%.
4-Amino-1-(β-hydroxyethyl)pyrazolo[3,4-d]pyrimidine. m.p = 217-219 °C
(Lett. mp 223-224 °C).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel, Highly Potent Adenosine Deaminase Inhibitors Containing the
Pyrazolo[3,4-d]pyrimidine Ring System. Synthesis, Structure-Activity
Relationships, and Molecular Modeling Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Da Settimo, Federico; Primofiore, Giampaolo; La Motta, Concettina;
Taliani, Sabrina; Simorini, Francesca; Marini, Anna Maria; Mugnaini,
Laura; Lavecchia, Antonio; Novellino, Ettore; Tuscano, Daniela; Martini,
Claudia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2005), 48(16), 5162-5174

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylcyclohexene
C7H12
591-49-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Methylcyclohexyl)formamide
C8H15NO
101253-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.2597 2.3235 0.0 0
M  V30 2 C 5.7066 1.7968 0.0 0
M  V30 3 O 6.8864 2.7867 0.0 0
M  V30 4 C 4.2597 0.3437 0.0 0
M  V30 5 C 3.0799 1.3336 0.0 0
M  V30 6 C 2.3099 2.6674 0.0 0
M  V30 7 C 2.3099 0.0000 0.0 0
M  V30 8 C 0.7700 2.6674 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-49-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 101253-12-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-13750450
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7758-02-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Ritter reaction, other products also detected
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of N-substituted amides from alkenes and amides by a
Bronsted acid mediated electrophilic addition reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mihara, Karin; Okada, Iku; Chiba, Kazuhiro; Kitano, Yoshikazu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2014), 46(11), 1455-1462, 8 pp.

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Chlorophenyl)-3-phenyl-1H-pyrazol-5-amine
C15H12ClN3
618098-26-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0176 7.1820 0.0 0
M  V30 2 Cl 1.3338 0.0000 0.0 0
M  V30 3 N 4.0011 4.6200 0.0 0
M  V30 4 N 5.4080 3.9935 0.0 0
M  V30 5 C 4.1620 6.1516 0.0 0
M  V30 6 C 6.4385 5.1381 0.0 0
M  V30 7 C 5.6685 6.4717 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 1.3338 4.6200 0.0 0
M  V30 11 C 1.3338 1.5400 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 7.9700 4.9772 0.0 0
M  V30 15 C 8.5965 3.5702 0.0 0
M  V30 16 C 8.8752 6.2230 0.0 0
M  V30 17 C 10.1280 3.4093 0.0 0
M  V30 18 C 10.4068 6.0619 0.0 0
M  V30 19 C 11.0332 4.6551 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Chlorophenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C17H11ClN4
1400634-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.3338 0.0000 0.0 0
M  V30 2 N 4.0011 4.6200 0.0 0
M  V30 3 C 4.1620 6.1515 0.0 0
M  V30 4 N 5.4080 3.9935 0.0 0
M  V30 5 C 5.6684 6.4717 0.0 0
M  V30 6 N 3.1316 7.2959 0.0 0
M  V30 7 C 6.4384 5.1381 0.0 0
M  V30 8 C 6.1443 7.9364 0.0 0
M  V30 9 C 3.6075 8.7606 0.0 0
M  V30 10 N 5.1139 9.0808 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 1.3338 4.6200 0.0 0
M  V30 14 C 1.3338 1.5400 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 7.9700 4.9771 0.0 0
M  V30 18 C 8.8752 6.2230 0.0 0
M  V30 19 C 8.5964 3.5702 0.0 0
M  V30 20 C 10.4067 6.0621 0.0 0
M  V30 21 C 10.1280 3.4093 0.0 0
M  V30 22 C 11.0332 4.6551 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 618098-26-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-61-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-8323755
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Chlorophenyl)-3-phenyl-1H-pyrazol-5-amine
C15H12ClN3
618098-26-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0176 7.1820 0.0 0
M  V30 2 Cl 1.3338 0.0000 0.0 0
M  V30 3 N 4.0011 4.6200 0.0 0
M  V30 4 N 5.4080 3.9935 0.0 0
M  V30 5 C 4.1620 6.1516 0.0 0
M  V30 6 C 6.4385 5.1381 0.0 0
M  V30 7 C 5.6685 6.4717 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 1.3338 4.6200 0.0 0
M  V30 11 C 1.3338 1.5400 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 7.9700 4.9772 0.0 0
M  V30 15 C 8.5965 3.5702 0.0 0
M  V30 16 C 8.8752 6.2230 0.0 0
M  V30 17 C 10.1280 3.4093 0.0 0
M  V30 18 C 10.4068 6.0619 0.0 0
M  V30 19 C 11.0332 4.6551 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Chlorophenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C17H11ClN4
1400634-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.3338 0.0000 0.0 0
M  V30 2 N 4.0011 4.6200 0.0 0
M  V30 3 C 4.1620 6.1515 0.0 0
M  V30 4 N 5.4080 3.9935 0.0 0
M  V30 5 C 5.6684 6.4717 0.0 0
M  V30 6 N 3.1316 7.2959 0.0 0
M  V30 7 C 6.4384 5.1381 0.0 0
M  V30 8 C 6.1443 7.9364 0.0 0
M  V30 9 C 3.6075 8.7606 0.0 0
M  V30 10 N 5.1139 9.0808 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 1.3338 4.6200 0.0 0
M  V30 14 C 1.3338 1.5400 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 7.9700 4.9771 0.0 0
M  V30 18 C 8.8752 6.2230 0.0 0
M  V30 19 C 8.5964 3.5702 0.0 0
M  V30 20 C 10.4067 6.0621 0.0 0
M  V30 21 C 10.1280 3.4093 0.0 0
M  V30 22 C 11.0332 4.6551 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 618098-26-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-61-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27105840
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
Pyrazolo[3,4-d]-pyrimidines (17-32, 65, 66, and 73-76). The reliable
procedure involved the treatment of 5-aminopyrazoles (1-16; 1.0 equiv),
5- amino-4-formylpyrazoles (37-41; 1.0 equiv), 5-aminoquinoline (61; 1.0
equiv), 8-aminoquinoline (62; 1.0 equiv), 5-aminopyrimidine (68; 1.0
equiv), or 2-aminopyrazines (69-71; 1.0 equiv) with PBr3 (~ 3 equiv) in
formamide solution (2 mL) at 50-60 °C over 0.5-1 h. When the reaction was
complete, the reaction mixture was added to saturated sodium bicarbonate
(15 mL) and extracted with dichloromethane (15 mL). The organic extracts
were dried over MgSO4, filtered, and concentrated under reduced pressure.
The residue solution was purified by column chromatography on silica gel
to give the corresponding aromatic or heterocyclic fused pyrimidine
products (17-32, 65, 66, and 73-76) in 82-96% yields.
1-(3-Chlorophenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine (21). The
standard procedure involved the treatment of
5-amino-1-(3-chlorophenyl)-3-phenyl-1H-pyrazole (5; 101 mg, 0.33 mmol,
1.0 equiv) with PBr3 (0.09 mL, 0.99 mmol, 3 equiv) in formamide solution
(2 mL) at 50-60 °C over 0.5-1 h. The reaction mixture was then worked up,
and the residue was purified by chromatography on silica gel to give pure
21: 96% yield (97 mg), yellow solid. Mp 188- 189 °C (hexane-EtOAc). 1H
NMR (CDCl3, 500 MHz): δ 7.27-7.33 (1H, m), 7.43-7.48 (1H, m), 7.48-7.52
(1H, m), 7.53-7.59 (2H, m), 8.01-8.07 (2H, m), 8.32-8.36 (1H, m),
8.42-8.44 (1H, m), 9.14 (1H, s), 9.50 (1H, s). 13C NMR (125 MHz, CDCl3):
δ 114.5, 118.9, 121.1, 126.6, 127.4 (2 × C), 129.3 (2 × C), 129.9, 130.2,
131.2, 135.0, 139.6, 145.4, 152.9, 153.6, 155.8. IR (KBr): 3099, 3062,
2922, 2851, 1585, 1491, 1406, 1215 cm-1. EIMS m/z (rel int): 306 (100,
M+). Anal. Calcd for C17H11ClN4: C, 66.56; H, 3.61; N, 18.26. Found: C,
66.58; H, 3.62; N, 18.29.
$DTYPE RXN:VAR(1):NOTES
$DATUM sequential three-component heterocyclization, one-pot multi-component
process
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-2-bromo-3-chlorobenzoic acid
C7H5BrClNO2
65971-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Br 4.0011 0.0000 0.0 0
M  V30 5 N 1.3338 4.6201 0.0 0
M  V30 6 Cl 6.6686 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-6-chloro-4(3H)-quinazolinone
C8H4BrClN2O
65971-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 5.3900 1.3338 0.0 0
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 Cl 6.9300 4.0011 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 3.0800 5.3349 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 N 0.7700 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 9
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65971-76-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65971-77-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28235712
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfonylamino quinazolin-4-one derivatives as BRAF inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of the
treatment of CNS tumors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barbour, Patrick Michael; Brown, Katie Keaton; Cook, Adam Wade; Hicken,
Erik James; Kahn, Dean Russell; Laird, Ellen Ruth; Metcalf, Andrew
Terrance; Moreno, David Austin; Newhouse, Bradley Jon; Pajk, Spencer
Phillip; Prigaro, Brett Joseph; Ren, Li; Tarlton, Eugene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020261156 A1 2020-12-30

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-4-methylnaphthalene
C11H9Br
6627-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 1.5400 4.0011 0.0 0
M  V30 6 C 1.5400 1.3338 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 2.3100 5.3349 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 7
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methyl-1-naphthalenyl)formamide
C12H11NO
1569103-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 O 8.4700 5.3349 0.0 0
M  V30 4 C 0.0000 4.0011 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6627-78-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1569103-01-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-5903864
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-99-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligand free open air copper(II) mediated aryl formamidation and amination
of aryl halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Komati, Rajesh; Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2014), 55(9), 1523-1527

$RFMT $RIREG SCHEME124 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,5-Trimethylpyridine
C8H11N
695-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 C 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 N 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5,6-Trimethyl-2-pyridinecarboxamide
C9H12N2O
1903749-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6675 0.0 0
M  V30 2 N 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 5.3901 5.3349 0.0 0
M  V30 6 C 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 N 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 695-98-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1903749-65-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-095-CAS-21321200
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-53-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7727-21-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7761-88-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, Schlenk flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acid-Free Silver-Catalyzed Cross-Dehydrogenative Carbamoylation of
Pyridines with Formamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Wei; Jin, Fengli; Zhao, Qian; Du, Hongyan; Yao, Lifang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(12), 1854-1859

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2R,4R)-7,7-Dimethyl-1-[(methylthio)methyl]bicyclo[2.2.1]heptan-2-amine
C11H21NS
745801-35-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0414 2.6723 0.0 0
M  V30 2 S 4.8114 4.0059 0.0 0
M  V30 3 C 6.3514 4.0059 0.0 0
M  V30 4 C 2.3969 0.0000 0.0 0
M  V30 5 C 4.6255 1.3468 0.0 0
M  V30 6 N 4.6126 4.5890 0.0 0
M  V30 7 C 2.5013 2.6723 0.0 0 CFG=2
M  V30 8 C 3.0858 1.3774 0.0 0
M  V30 9 C 3.1495 4.1085 0.0 0 CFG=2
M  V30 10 C 1.1632 2.6658 0.0 0
M  V30 11 C 1.4675 3.4484 0.0 0 CFG=2
M  V30 12 C 2.1188 4.6879 0.0 0
M  V30 13 C 0.0000 3.2245 0.0 0
M  V30 14 H 0.5737 4.7026 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 8
M  V30 6 1 9 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S,2R,4R)-7,7-Dimethyl-1-[(methylthio)methyl]bicyclo[2.2.1]hept-2-yl]form...
C12H21NOS
835883-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7132 2.6673 0.0 0
M  V30 2 S 2.9432 1.3337 0.0 0
M  V30 3 C 3.7132 0.0000 0.0 0
M  V30 4 N 5.9197 3.7123 0.0 0
M  V30 5 C 6.9888 4.8208 0.0 0
M  V30 6 O 8.4834 4.4490 0.0 0
M  V30 7 C 2.3469 7.5224 0.0 0
M  V30 8 C 0.0000 6.3945 0.0 0
M  V30 9 C 2.9432 4.0010 0.0 0 CFG=1
M  V30 10 C 4.4253 4.0840 0.0 0 CFG=2
M  V30 11 C 1.5299 6.2171 0.0 0
M  V30 12 C 2.1764 2.8295 0.0 0
M  V30 13 C 3.3206 4.7512 0.0 0
M  V30 14 C 1.9880 4.8724 0.0 0 CFG=2
M  V30 15 C 1.2057 3.5047 0.0 0
M  V30 16 H 0.4549 5.0193 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 10 4 CFG=1
M  V30 6 2 5 6
M  V30 7 1 7 11
M  V30 8 1 8 11
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 14 16 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 10 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 745801-35-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 835883-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-15050396
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of new camphor based N,S chiral ligands and their application
in transfer hydrogenation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gayet, Arnaud; Bolea, Christelle; Andersson, Pher G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2004), 2(13), 1887-1893

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarbox...
C17H20FN3O3
75001-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 1.3336 0.0 0
M  V30 2 C 7.7000 0.0000 0.0 0
M  V30 3 O 10.0100 6.6685 0.0 0
M  V30 4 C 11.5500 4.0011 0.0 0
M  V30 5 O 12.3200 2.6674 0.0 0
M  V30 6 O 12.3200 5.3347 0.0 0
M  V30 7 C 13.8600 2.6674 0.0 0
M  V30 8 F 4.6200 8.0021 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 C 7.7000 5.3347 0.0 0
M  V30 11 N 7.7000 2.6674 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 6.9300 6.6685 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 5.3900 6.6685 0.0 0
M  V30 19 N 3.0800 5.3347 0.0 0
M  V30 20 C 2.3100 4.0011 0.0 0
M  V30 21 C 2.3100 6.6685 0.0 0
M  V30 22 C 0.7700 4.0011 0.0 0
M  V30 23 C 0.7700 6.6685 0.0 0
M  V30 24 N 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 3 13
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 17
M  V30 7 1 5 7
M  V30 8 1 8 18
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 16 19
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-ethyl-6-fluoro-7-(4-formyl-1-piperazinyl)-1,4-dihydro-4-oxo-3-quinol...
C18H20FN3O4
1879963-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 1.3336 0.0 0
M  V30 2 C 6.1600 0.0000 0.0 0
M  V30 3 O 3.8500 6.6685 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 O 1.5400 2.6674 0.0 0
M  V30 6 O 1.5400 5.3347 0.0 0
M  V30 7 C 0.0000 2.6674 0.0 0
M  V30 8 F 9.2400 8.0021 0.0 0
M  V30 9 C 15.4000 5.3347 0.0 0
M  V30 10 O 16.1700 6.6685 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 6.1600 5.3347 0.0 0
M  V30 13 N 6.1600 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 6.9300 6.6685 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 19 C 3.8500 4.0011 0.0 0
M  V30 20 C 8.4700 6.6685 0.0 0
M  V30 21 N 10.7800 5.3347 0.0 0
M  V30 22 C 11.5500 4.0011 0.0 0
M  V30 23 C 11.5500 6.6685 0.0 0
M  V30 24 C 13.0900 4.0011 0.0 0
M  V30 25 C 13.0900 6.6685 0.0 0
M  V30 26 N 13.8600 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 3 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 19
M  V30 7 1 5 7
M  V30 8 1 8 20
M  V30 9 2 9 10
M  V30 10 1 9 26
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 18 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75001-83-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1879963-33-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30899062
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of membrane active benzimidazole quinolones-based topoisomerase
inhibitors as potential DNA-binding antimicrobial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Ling; Addla, Dinesh; Ponmani, Jeyakkumar; Wang, Ao; Xie, Dan;
Wang, Ya-Nan; Zhang, Shao-Lin; Geng, Rong-Xia; Cai, Gui-Xin; Li, Shuo;
Zhou, Cheng-He
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 111160-182

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-methyl-5-(4-phenoxyphenyl)-3-furancarbonitrile
C18H14N2O2
866181-48-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.0630 5.3915 0.0 0
M  V30 2 C 13.3048 2.9016 0.0 0
M  V30 3 N 14.8364 3.0625 0.0 0
M  V30 4 N 11.6296 0.0000 0.0 0
M  V30 5 O 4.0010 6.3388 0.0 0
M  V30 6 C 9.3358 3.2587 0.0 0
M  V30 7 C 10.7428 3.8850 0.0 0
M  V30 8 O 9.4969 1.7271 0.0 0
M  V30 9 C 11.7732 2.7406 0.0 0
M  V30 10 C 11.0032 1.4070 0.0 0
M  V30 11 C 8.0022 4.0287 0.0 0
M  V30 12 C 6.6685 3.2587 0.0 0
M  V30 13 C 8.0022 5.5688 0.0 0
M  V30 14 C 5.3348 4.0287 0.0 0
M  V30 15 C 6.6685 6.3388 0.0 0
M  V30 16 C 5.3348 5.5688 0.0 0
M  V30 17 C 2.6673 5.5688 0.0 0
M  V30 18 C 1.3337 6.3388 0.0 0
M  V30 19 C 2.6673 4.0287 0.0 0
M  V30 20 C 0.0000 5.5688 0.0 0
M  V30 21 C 1.3337 3.2587 0.0 0
M  V30 22 C 0.0000 4.0287 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 3 2 3
M  V30 3 1 2 9
M  V30 4 1 4 10
M  V30 5 1 5 16
M  V30 6 1 5 17
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 11
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methyl-6-(4-phenoxyphenyl)furo[2,3-d]pyrimidin-4-amine
C19H15N3O2
866181-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 6.7115 0.0 0
M  V30 2 N 1.3336 7.0809 0.0 0
M  V30 3 O 11.1970 4.0009 0.0 0
M  V30 4 C 5.0370 4.0009 0.0 0
M  V30 5 C 4.1320 5.2469 0.0 0
M  V30 6 O 4.1320 2.7551 0.0 0
M  V30 7 C 2.6673 4.7709 0.0 0
M  V30 8 C 2.6673 3.2309 0.0 0
M  V30 9 C 1.3336 5.5409 0.0 0
M  V30 10 N 1.3336 2.4609 0.0 0
M  V30 11 N 0.0000 4.7709 0.0 0
M  V30 12 C 0.0000 3.2309 0.0 0
M  V30 13 C 6.5770 4.0009 0.0 0
M  V30 14 C 7.3470 5.3347 0.0 0
M  V30 15 C 7.3470 2.6673 0.0 0
M  V30 16 C 8.8870 5.3347 0.0 0
M  V30 17 C 8.8870 2.6673 0.0 0
M  V30 18 C 9.6570 4.0009 0.0 0
M  V30 19 C 11.9670 2.6673 0.0 0
M  V30 20 C 13.5070 2.6673 0.0 0
M  V30 21 C 11.1970 1.3336 0.0 0
M  V30 22 C 14.2770 1.3336 0.0 0
M  V30 23 C 11.9670 0.0000 0.0 0
M  V30 24 C 13.5070 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 9
M  V30 3 1 3 18
M  V30 4 1 3 19
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 4 13
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 2 8 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 866181-48-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 866181-67-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21323470
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 6: Preparation of 4-amino
furopyrimidine-based compound
4-amino-6-(4-chlorophenyl)furo[2,3,d]Pyrimidine(Vla) 20ml of formamide
was applied dropwisely to the 4.37 g (20 mmol) of 2-
amino-3-cyano-5-(4-chlorophenyl)furan (IVa) obtained in Example 5, which
was heated and refluxed for 12 hours and then cooled at a room
temperature. 100 ml of water was added thereto, and a generated solid was
filtered, which was washed with water and n-hexane sufficiently, and
then, dried. Thereafter, the resultant material was re-crystallized with
acetone and ethylalcohol to obtain a brown-colored solid product of
4-amino-6-(4-chlorophenyl)furo[2,3,d]pyrimidine (VIa). Compounds Vlb to
VIy of table 4 were also obtained, respectively, according to the same
method. [Table 4] VIj, yield 96% Table 4 shows analysis results of the
obtained 4-amino furopyrimidine based compound VIa to VIy 1H NMR (400 MHz
DMSO-d6) δ (ppm) : 8.15 (s, 1H), 7.72 (d, J= 8.8 Hz, 2H), 7.60 (d, J= 8.8
Hz, 1H), 7.48-7.40 (m, 1H), 7.26-7.02 (m, 7H), 2.51 (s, 3H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of furo[2,3-d]pyrimidines as inhibitors of DDR2 (discoidin
domain receptor 2) tyrosine kinase.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Beom-Seok; Yang, Kyung-Mi; Kim, Hae-Jong; Park, In-Sung; Park,
Sung-Dae; Lee, Jang-Hyuk; Kwon, Hyuk-Man; Woo, Byoung-Young
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005092896 A1 2005-10-06

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-(4-chlorophenyl)-4-phenyl-3-furancarbonitrile
C17H11ClN2O
866181-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.2459 3.9646 0.0 0
M  V30 2 N 0.0000 3.0594 0.0 0
M  V30 3 N 1.2459 7.3150 0.0 0
M  V30 4 Cl 11.0215 5.6398 0.0 0
M  V30 5 C 3.9564 4.3940 0.0 0
M  V30 6 C 4.8615 5.6398 0.0 0
M  V30 7 C 2.4917 4.8698 0.0 0
M  V30 8 O 3.9564 6.8857 0.0 0
M  V30 9 C 2.4917 6.4098 0.0 0
M  V30 10 C 4.4323 2.9292 0.0 0
M  V30 11 C 3.4017 1.7849 0.0 0
M  V30 12 C 5.9386 2.6091 0.0 0
M  V30 13 C 3.8777 0.3202 0.0 0
M  V30 14 C 6.4144 1.1445 0.0 0
M  V30 15 C 5.3840 0.0000 0.0 0
M  V30 16 C 6.4015 5.6398 0.0 0
M  V30 17 C 7.1715 4.3062 0.0 0
M  V30 18 C 7.1715 6.9735 0.0 0
M  V30 19 C 8.7115 4.3062 0.0 0
M  V30 20 C 8.7115 6.9735 0.0 0
M  V30 21 C 9.4815 5.6398 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 21
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 6 16
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Chlorophenyl)-5-phenylfuro[2,3-d]pyrimidin-4-amine
C18H12ClN3O
866181-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 2.5598 0.0 0
M  V30 2 Cl 11.1972 5.6398 0.0 0
M  V30 3 C 4.1320 4.3940 0.0 0
M  V30 4 C 5.0371 5.6398 0.0 0
M  V30 5 C 2.6673 4.8698 0.0 0
M  V30 6 O 4.1320 6.8857 0.0 0
M  V30 7 C 2.6673 6.4099 0.0 0
M  V30 8 C 1.3337 4.0998 0.0 0
M  V30 9 N 1.3337 7.1799 0.0 0
M  V30 10 N 0.0000 4.8698 0.0 0
M  V30 11 C 0.0000 6.4099 0.0 0
M  V30 12 C 4.6079 2.9293 0.0 0
M  V30 13 C 6.1142 2.6091 0.0 0
M  V30 14 C 3.5773 1.7849 0.0 0
M  V30 15 C 6.5900 1.1445 0.0 0
M  V30 16 C 4.0533 0.3202 0.0 0
M  V30 17 C 5.5596 0.0000 0.0 0
M  V30 18 C 6.5771 5.6398 0.0 0
M  V30 19 C 7.3471 6.9735 0.0 0
M  V30 20 C 7.3471 4.3062 0.0 0
M  V30 21 C 8.8871 6.9735 0.0 0
M  V30 22 C 8.8871 4.3062 0.0 0
M  V30 23 C 9.6571 5.6398 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 23
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 1 4 18
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 7
M  V30 11 2 7 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 866181-58-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 866181-75-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21288802
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 6: Preparation of 4-amino
furopyrimidine-based compound
4-amino-6-(4-chlorophenyl)furo[2,3,d]Pyrimidine(Vla) 20ml of formamide
was applied dropwisely to the 4.37 g (20 mmol) of 2-
amino-3-cyano-5-(4-chlorophenyl)furan (IVa) obtained in Example 5, which
was heated and refluxed for 12 hours and then cooled at a room
temperature. 100 ml of water was added thereto, and a generated solid was
filtered, which was washed with water and n-hexane sufficiently, and
then, dried. Thereafter, the resultant material was re-crystallized with
acetone and ethylalcohol to obtain a brown-colored solid product of
4-amino-6-(4-chlorophenyl)furo[2,3,d]pyrimidine (VIa). Compounds Vlb to
VIy of table 4 were also obtained, respectively, according to the same
method. [Table 4] VIu, yield 96% Table 4 shows analysis results of the
obtained 4-amino furopyrimidine based compound VIa to VIy 1H NMR (400 MHz
DMSO-d6) δ (ppm) : 8.29 (s, 1H), 7.68-7.18 (m, 9H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of furo[2,3-d]pyrimidines as inhibitors of DDR2 (discoidin
domain receptor 2) tyrosine kinase.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Beom-Seok; Yang, Kyung-Mi; Kim, Hae-Jong; Park, In-Sung; Park,
Sung-Dae; Lee, Jang-Hyuk; Kwon, Hyuk-Man; Woo, Byoung-Young
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005092896 A1 2005-10-06

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[(4-fluorophenyl)methyl]-3-pyridinamine
C12H10ClFN2
906371-80-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 Cl 3.0800 0.0000 0.0 0
M  V30 4 F 11.5500 4.0011 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 0.7700 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 C 7.7000 5.3349 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 C 9.2400 5.3349 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 1 3 6
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Fluorophenyl)methyl]-1H-imidazo[4,5-b]pyridine
C13H10FN3
142872-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 3.7710 0.0 0
M  V30 2 F 11.3908 3.7710 0.0 0
M  V30 3 C 2.9292 2.2764 0.0 0
M  V30 4 N 4.4608 2.4374 0.0 0
M  V30 5 C 2.6091 0.7700 0.0 0
M  V30 6 C 1.7849 3.3068 0.0 0
M  V30 7 C 5.0872 1.0306 0.0 0
M  V30 8 N 3.9427 0.0000 0.0 0
M  V30 9 N 1.1444 0.2941 0.0 0
M  V30 10 C 0.3202 2.8310 0.0 0
M  V30 11 C 0.0000 1.3247 0.0 0
M  V30 12 C 6.7708 3.7710 0.0 0
M  V30 13 C 7.5408 2.4374 0.0 0
M  V30 14 C 7.5408 5.1048 0.0 0
M  V30 15 C 9.0808 2.4374 0.0 0
M  V30 16 C 9.0808 5.1048 0.0 0
M  V30 17 C 9.8508 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 12
M  V30 3 1 2 17
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 906371-80-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 142872-80-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2706921
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved synthesis of imidazo[4,5-b]pyridines and
imidazo[4,5-b]pyrazines by palladium catalyzed amidation using xantphos
in a 1,4-Dioxane:tert-amyl alcohol aolvent aystem
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Ahmed, Ijaz; Wilson, Robert J.; Williams, Theresa M.;
Kaminsky, Lauren; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(16), 3465-3470

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[(4-fluorophenyl)methyl]-3-pyridinamine
C12H10ClFN2
906371-80-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 Cl 3.0800 0.0000 0.0 0
M  V30 4 F 11.5500 4.0011 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 0.7700 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 C 7.7000 5.3349 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 C 9.2400 5.3349 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 1 3 6
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Fluorophenyl)methyl]-1H-imidazo[4,5-b]pyridine
C13H10FN3
142872-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 3.7710 0.0 0
M  V30 2 F 11.3908 3.7710 0.0 0
M  V30 3 C 2.9292 2.2764 0.0 0
M  V30 4 N 4.4608 2.4374 0.0 0
M  V30 5 C 2.6091 0.7700 0.0 0
M  V30 6 C 1.7849 3.3068 0.0 0
M  V30 7 C 5.0872 1.0306 0.0 0
M  V30 8 N 3.9427 0.0000 0.0 0
M  V30 9 N 1.1444 0.2941 0.0 0
M  V30 10 C 0.3202 2.8310 0.0 0
M  V30 11 C 0.0000 1.3247 0.0 0
M  V30 12 C 6.7708 3.7710 0.0 0
M  V30 13 C 7.5408 2.4374 0.0 0
M  V30 14 C 7.5408 5.1048 0.0 0
M  V30 15 C 9.0808 2.4374 0.0 0
M  V30 16 C 9.0808 5.1048 0.0 0
M  V30 17 C 9.8508 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 12
M  V30 3 1 2 17
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 906371-80-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 142872-80-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4988381
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1359986-22-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2-amino-imidazo[4,5-b]pyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Williams, Theresa M.; Jordan, Abraham J.; Clark,
Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2013), 11(18), 3064-3072

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-phenylbenzamide
C13H10BrNO
10282-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 O 5.3900 1.3338 0.0 0
M  V30 4 Br 3.0800 0.0000 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 0.7700 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 C 7.7000 5.3349 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 C 9.2400 5.3349 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 11
M  V30 5 1 4 6
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Phenyl-4(3H)-quinazolinone
C14H10N2O
16347-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 0.0000 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 4.6201 1.3337 0.0 0
M  V30 4 C 4.6201 4.0010 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 N 3.0801 4.0010 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 2.3101 0.0000 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 13 C 7.7002 4.0010 0.0 0
M  V30 14 C 7.7002 1.3337 0.0 0
M  V30 15 C 9.2402 4.0010 0.0 0
M  V30 16 C 9.2402 1.3337 0.0 0
M  V30 17 C 10.0102 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 7
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10282-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16347-60-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16799235
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51-35-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM trans-4-Hydroxy-L-proline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kamal, Ahmed; Sultana, Farheen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM e-EROS Encyclopedia of Reagents for Organic Synthesis (2013), 1-4

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
2-Bromo-N-phenylbenzamide
C13H10BrNO
10282-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 O 5.3900 1.3338 0.0 0
M  V30 4 Br 3.0800 0.0000 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 0.7700 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 C 7.7000 5.3349 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 C 9.2400 5.3349 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 11
M  V30 5 1 4 6
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Phenyl-4(3H)-quinazolinone
C14H10N2O
16347-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 0.0000 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 4.6201 1.3337 0.0 0
M  V30 4 C 4.6201 4.0010 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 N 3.0801 4.0010 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 2.3101 0.0000 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 13 C 7.7002 4.0010 0.0 0
M  V30 14 C 7.7002 1.3337 0.0 0
M  V30 15 C 9.2402 4.0010 0.0 0
M  V30 16 C 9.2402 1.3337 0.0 0
M  V30 17 C 10.0102 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 7
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 10282-57-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16347-60-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3439555
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51-35-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General procedure for CuI-catalyzed formation of
3-substituted-4-quinazolines and 2,3-disubstituted-4(3H )-quinazolines
from 2-bromo-N-phenylbenzamide. For 3-substituted-4-quinazoline
(11a-11r). A Schlenk tube was charged with N-substituted 2-bromobenzamide
(0.25 mmol), CuI (5 mg, 0.025 mmol), trans-4-hydroxy-L-proline (3 mg,
0.025 mmol), and Cs2CO3 (163 mg, 0.5 mmol). The tube was evacuated and
backfilled with argon before formamide (20 µL, 0.5 mmol) and 1 mL DMF was
added. The reaction mixture was stirred at 80 o C (or 90 o C for
substrate 7l) for 24 h. After the reaction mixture was cooled to room
temperature, 5 mL of saturated NH4Cl solution was added. The mixture was
extracted with EtOAc and the organic layer was washed with water, brine
and dried over Na2SO4. After concentration in vacuo, the residue was
purified by column chromatography on silica gel. The desired
3-substituted 4-quinazoline. 3-Phenylquinazolin-4(3H)-one (11a). 1 53 mg,
95% yield. 1H NMR (400 MHz, CDCl3) δ 8.38 (d, J = 8.0 Hz, 1H), 8.14 (s,
1H), 7.83-7.76 (m, 2H), 7.57-7.42 (m, 6H); 13C NMR (100 MHz, CDCl3) δ
160.85, 147.97, 146.19, 137.59, 134.68, 129.74 (2C), 129.21, 127.75,
127.69, 127.27, 127.11 (2C), 122.48; HRMS-ESI: m/z calcd for C14H11N2O [M
+ H]+: 223.0871, found 223.0860.
$DTYPE RXN:VAR(1):NOTES
$DATUM optimized on base, solvent, ligand; catalyst formed in-situ; Schlenk tube
used, optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Substituted and 2,3-Disubstituted Quinazolinones via
Cu-Catalyzed Aryl Amidation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Lanting; Jiang, Yongwen; Ma, Dawei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(4), 1150-1153

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-5-(1-piperidinyl)-1H-pyrazole-4-carbonitrile
C9H13N5
103184-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0492 1.4647 0.0 0
M  V30 2 N 4.5733 0.0000 0.0 0
M  V30 3 N 8.2356 2.5000 0.0 0
M  V30 4 C 4.6200 4.1752 0.0 0
M  V30 5 C 5.5252 2.9292 0.0 0
M  V30 6 N 5.5252 5.4211 0.0 0
M  V30 7 C 6.9898 3.4052 0.0 0
M  V30 8 N 6.9898 4.9452 0.0 0
M  V30 9 N 3.0800 4.1752 0.0 0
M  V30 10 C 2.3100 5.5089 0.0 0
M  V30 11 C 2.3100 2.8415 0.0 0
M  V30 12 C 0.7700 5.5089 0.0 0
M  V30 13 C 0.7700 2.8415 0.0 0
M  V30 14 C 0.0000 4.1752 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1-Piperidinyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C10H14N6
1408088-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5674 5.0873 0.0 0
M  V30 2 C 4.4197 1.8517 0.0 0
M  V30 3 C 3.0127 2.4782 0.0 0
M  V30 4 N 4.2588 0.3202 0.0 0
M  V30 5 C 1.9823 1.3337 0.0 0
M  V30 6 C 2.5369 3.9428 0.0 0
M  V30 7 N 2.7523 0.0000 0.0 0
M  V30 8 N 0.4760 1.6540 0.0 0
M  V30 9 N 1.0306 4.2631 0.0 0
M  V30 10 C 0.0000 3.1185 0.0 0
M  V30 11 N 5.7533 2.6217 0.0 0
M  V30 12 C 5.7533 4.1617 0.0 0
M  V30 13 C 7.0870 1.8517 0.0 0
M  V30 14 C 7.0870 4.9318 0.0 0
M  V30 15 C 8.4208 2.6217 0.0 0
M  V30 16 C 8.4208 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103184-17-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1408088-51-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-6699357
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Intermediate 70:
3-morpholino-1H-pyrazolo[3,4-d]pyrimidin-4-amine: To intermediate 69
(0.450 g, 2.32 mmol), formamide (4 ml) was added and heated to 130°C for
12h. The reaction mass was quenched with water, extracted with ethyl
acetate, dried over sodium sulphate and concentrated The crude product
was purified by column chromatography with methanol: ethyl acetate to
afford the title compound. Intermediate 76:
3-(piperidin-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine: The title
compound was obtained as a brown solid (0.600 g, 95%) by using a
procedure that is similar to the one described for intermediate 70 from
intermediate 75 (0.550 g, 2.87 mmol) and formamide (5 ml). 1H-NMR (δ ppm,
DMSO-d6, 400 MHz): 12.44 (s, 1H), 8.07 (s, 1H), 6.69 (s, 2H), 3.05 (t, J=
5.1 Hz, 4H), 1.69 (m, 4H), 1.54 (m, 2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of chromenone derivatives for use as PI3K protein kinase
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nagarathnam, Dhanapalan; Vakkalanka, Swaroop Kumar V. S.;
Muthuppalaniappan, Meyyappan; Viswanadha, Srikant; Babu, Govindarajulu;
Bhavar, Prashant Kashinath
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012151525 A1 2012-11-08

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
C10H13NO2S
108354-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 1.5063 0.0 0
M  V30 2 O 7.1953 1.9823 0.0 0
M  V30 3 O 5.4105 0.0000 0.0 0
M  V30 4 C 8.3397 0.9517 0.0 0
M  V30 5 N 6.0810 4.8384 0.0 0
M  V30 6 C 3.0800 2.2167 0.0 0
M  V30 7 C 4.5863 2.5368 0.0 0
M  V30 8 C 2.3100 3.5503 0.0 0
M  V30 9 C 2.3100 0.8829 0.0 0
M  V30 10 C 4.7472 4.0684 0.0 0
M  V30 11 S 3.3404 4.6947 0.0 0
M  V30 12 C 0.7700 3.5503 0.0 0
M  V30 13 C 0.7700 0.8829 0.0 0
M  V30 14 C 0.0000 2.2167 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H10N2OS
14346-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.8322 2.0824 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3404 5.1455 0.0 0
M  V30 9 C 6.1542 5.1455 0.0 0
M  V30 10 C 7.2391 2.7087 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 7.4001 4.2403 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108354-78-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13514635
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis And Bioevaluation Of Thieno[2,3-d]Pyrimidinone Derivatives As
Potential Tumor Cell Growth Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Huangyong; Chen, Changshui; Xu, Shengzhen; Cao, Xiufang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemistry (2013), 692074, 7 pp.

$RFMT $RIREG SCHEME133 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bromobenzene
C6H5Br
108-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formanilide
C7H7NO
103-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-86-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 103-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-5614604
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-99-8
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligand free open air copper(II) mediated aryl formamidation and amination
of aryl halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Komati, Rajesh; Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2014), 55(9), 1523-1527

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-amino-5-(4-iodophenyl)-2-thiophenecarboxylate
C12H10INO2S
1094321-88-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3038 2.9016 0.0 0
M  V30 2 O 9.9303 4.3085 0.0 0
M  V30 3 O 10.2090 1.6557 0.0 0
M  V30 4 C 11.4618 4.4695 0.0 0
M  V30 5 N 7.6285 0.0000 0.0 0
M  V30 6 I 0.0000 6.3388 0.0 0
M  V30 7 C 5.3348 3.2587 0.0 0
M  V30 8 S 6.7418 3.8850 0.0 0
M  V30 9 C 5.4959 1.7271 0.0 0
M  V30 10 C 7.7722 2.7406 0.0 0
M  V30 11 C 7.0022 1.4070 0.0 0
M  V30 12 C 4.0011 4.0287 0.0 0
M  V30 13 C 2.6675 3.2587 0.0 0
M  V30 14 C 4.0011 5.5687 0.0 0
M  V30 15 C 1.3337 4.0287 0.0 0
M  V30 16 C 2.6675 6.3388 0.0 0
M  V30 17 C 1.3337 5.5687 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Iodophenyl)thieno[3,2-d]pyrimidin-4(3H)-one
C12H7IN2OS
1094322-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 I 11.1973 3.0801 0.0 0
M  V30 3 C 5.0371 3.0801 0.0 0
M  V30 4 S 4.1321 1.8342 0.0 0
M  V30 5 C 4.1321 4.3260 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 2.6673 3.8501 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 N 1.3337 4.6201 0.0 0
M  V30 10 N 0.0000 2.3101 0.0 0
M  V30 11 C 0.0000 3.8501 0.0 0
M  V30 12 C 6.5772 3.0801 0.0 0
M  V30 13 C 7.3472 1.7464 0.0 0
M  V30 14 C 7.3472 4.4137 0.0 0
M  V30 15 C 8.8872 1.7464 0.0 0
M  V30 16 C 8.8872 4.4137 0.0 0
M  V30 17 C 9.6572 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1094321-88-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1094322-04-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19726103
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of 6-Substituted
Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor
Receptor Kinase and Microtubule Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Romagnoli, Romeo; Prencipe, Filippo; Oliva, Paola; Baraldi, Stefania;
Baraldi, Pier Giovanni; Schiaffino Ortega, Santiago; Chayah, Mariem;
Kimatrai Salvador, Maria; Lopez-Cara, Luisa Carlota; Brancale, Andrea;
Ferla, Salvatore; Hamel, Ernest; Ronca, Roberto; Bortolozzi, Roberta;
Mariotto, Elena; Mattiuzzo, Elena; Viola, Giampietro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(3), 1274-1290

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-5-[(6-ethoxy-6-oxohexyl)oxy]-4-(phenylmethoxy)benzoate
C24H31NO6
1133461-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7002 9.3358 0.0 0
M  V30 2 C 9.2402 9.3358 0.0 0
M  V30 3 C 10.0102 10.6697 0.0 0
M  V30 4 C 11.5503 10.6697 0.0 0
M  V30 5 C 12.3203 12.0033 0.0 0
M  V30 6 C 13.8603 12.0033 0.0 0
M  V30 7 C 14.6303 13.3370 0.0 0
M  V30 8 O 16.1704 13.3370 0.0 0
M  V30 9 O 13.8603 14.6707 0.0 0
M  V30 10 C 16.9404 14.6707 0.0 0
M  V30 11 C 18.4804 14.6707 0.0 0
M  V30 12 O 4.6201 9.3358 0.0 0
M  V30 13 C 3.0801 9.3358 0.0 0
M  V30 14 C 7.7002 4.0010 0.0 0
M  V30 15 O 6.9302 2.6673 0.0 0
M  V30 16 O 9.2402 4.0010 0.0 0
M  V30 17 C 7.7002 1.3337 0.0 0
M  V30 18 C 6.9302 0.0000 0.0 0
M  V30 19 N 4.6201 4.0010 0.0 0
M  V30 20 C 6.9302 8.0022 0.0 0
M  V30 21 C 5.3901 8.0022 0.0 0
M  V30 22 C 7.7002 6.6685 0.0 0
M  V30 23 C 4.6201 6.6685 0.0 0
M  V30 24 C 6.9302 5.3348 0.0 0
M  V30 25 C 5.3901 5.3348 0.0 0
M  V30 26 C 2.3101 10.6697 0.0 0
M  V30 27 C 0.7700 10.6697 0.0 0
M  V30 28 C 3.0801 12.0033 0.0 0
M  V30 29 C 0.0000 12.0033 0.0 0
M  V30 30 C 2.3101 13.3370 0.0 0
M  V30 31 C 0.7700 13.3370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 21
M  V30 14 1 13 26
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 24
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 19 25
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-[[3,4-dihydro-4-oxo-7-(phenylmethoxy)-6-quinazolinyl]oxy]hexanoate
C23H26N2O5
1133461-70-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2400 1.3336 0.0 0
M  V30 2 O 7.7000 6.6684 0.0 0
M  V30 3 C 9.2400 6.6684 0.0 0
M  V30 4 C 10.0100 8.0020 0.0 0
M  V30 5 C 11.5500 8.0020 0.0 0
M  V30 6 C 12.3200 9.3358 0.0 0
M  V30 7 C 13.8600 9.3358 0.0 0
M  V30 8 C 14.6300 10.6694 0.0 0
M  V30 9 O 16.1700 10.6694 0.0 0
M  V30 10 O 13.8600 12.0031 0.0 0
M  V30 11 C 16.9400 12.0031 0.0 0
M  V30 12 C 18.4800 12.0031 0.0 0
M  V30 13 O 4.6200 6.6684 0.0 0
M  V30 14 C 3.0800 6.6684 0.0 0
M  V30 15 C 6.9300 2.6673 0.0 0
M  V30 16 C 5.3900 2.6673 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 7.7000 1.3336 0.0 0
M  V30 19 C 4.6200 4.0011 0.0 0
M  V30 20 N 4.6200 1.3336 0.0 0
M  V30 21 C 6.9300 5.3347 0.0 0
M  V30 22 N 6.9300 0.0000 0.0 0
M  V30 23 C 5.3900 5.3347 0.0 0
M  V30 24 C 5.3900 0.0000 0.0 0
M  V30 25 C 2.3100 8.0020 0.0 0
M  V30 26 C 0.7700 8.0020 0.0 0
M  V30 27 C 3.0800 9.3358 0.0 0
M  V30 28 C 0.0000 9.3358 0.0 0
M  V30 29 C 2.3100 10.6694 0.0 0
M  V30 30 C 0.7700 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 3
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 23
M  V30 15 1 14 25
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 2 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1133461-69-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1133461-70-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3547482
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 9e: Ethyl
6-(7-(benzyloxy)-4-oxo-3,4-dihydroquinazolin-6-yloxy)hexanoate (Compound
506-16). A mixture of Compound 505-16 (5.7 g, 13.3 mmol),
aminooxyformaldehyde (0.81 g, 13.3 mmol) in formamide (80 mL) was heated
to 190°C for 2h. The mixture was cooled to room temperature and the
formamide was removed under reduced pressure. The residue was poured into
ice-water. The resulting solid was collected by filtration, washed with
water (3X), dried. title compound 506-16 as a brown solid (5.7 g, 95%).
LCMS: 411 [M+1]+; 1H NMR (DMSO-d 6): δ 12.13 (brs, 1 H), 7.94 (s, 1 H),
7.47-7.32 (m, 6 H), 7.19 (s, 1 H), 5.26 (s, 2 H), 4.08- 3.97 (m, 4 H),
2.28 (t, J = 7.5 Hz, 2 H), 1.79-1.70 (m, 2 H), 1.63- 1.56 (m, 2 H), 1.51-
1.38 (m, 2 H), 1.14 ( t, J = 6.6 Hz, 2 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazoline derivatives as VEGFR inhibitors, their preparation,
pharmaceutical compositions, and use in the treatment of cell
proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Changgeng; Cai, Xiong; Zhai, Haixiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009036055 A1 2009-03-19

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[[4-(trifluoromethyl)phenyl]methyl]-3-pyridinamine
C13H10ClF3N2
1154721-46-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0009 0.0 0
M  V30 2 N 4.6200 2.6673 0.0 0
M  V30 3 C 11.5500 4.0009 0.0 0
M  V30 4 F 11.5500 2.4609 0.0 0
M  V30 5 F 13.0900 4.0009 0.0 0
M  V30 6 F 11.5500 5.5409 0.0 0
M  V30 7 Cl 3.0800 0.0000 0.0 0
M  V30 8 C 6.9300 4.0009 0.0 0
M  V30 9 C 7.7000 2.6673 0.0 0
M  V30 10 C 7.7000 5.3347 0.0 0
M  V30 11 C 9.2400 2.6673 0.0 0
M  V30 12 C 9.2400 5.3347 0.0 0
M  V30 13 C 10.0100 4.0009 0.0 0
M  V30 14 C 3.0800 2.6673 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 2.3100 4.0009 0.0 0
M  V30 17 N 0.7700 1.3336 0.0 0
M  V30 18 C 0.7700 4.0009 0.0 0
M  V30 19 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 13
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[4-(Trifluoromethyl)phenyl]methyl]-1H-imidazo[4,5-b]pyridine
C14H10F3N3
1670258-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 3.7712 0.0 0
M  V30 2 C 11.3908 3.7712 0.0 0
M  V30 3 F 11.3908 5.3112 0.0 0
M  V30 4 F 12.9308 3.7712 0.0 0
M  V30 5 F 11.3908 2.2312 0.0 0
M  V30 6 C 2.9292 2.2764 0.0 0
M  V30 7 N 4.4608 2.4374 0.0 0
M  V30 8 C 2.6091 0.7700 0.0 0
M  V30 9 C 1.7849 3.3068 0.0 0
M  V30 10 C 5.0872 1.0306 0.0 0
M  V30 11 N 3.9427 0.0000 0.0 0
M  V30 12 N 1.1444 0.2941 0.0 0
M  V30 13 C 0.3202 2.8310 0.0 0
M  V30 14 C 0.0000 1.3247 0.0 0
M  V30 15 C 6.7708 3.7712 0.0 0
M  V30 16 C 7.5408 2.4374 0.0 0
M  V30 17 C 7.5408 5.1048 0.0 0
M  V30 18 C 9.0808 2.4374 0.0 0
M  V30 19 C 9.0808 5.1048 0.0 0
M  V30 20 C 9.8508 3.7712 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1154721-46-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1670258-72-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12584471
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved synthesis of imidazo[4,5-b]pyridines and
imidazo[4,5-b]pyrazines by palladium catalyzed amidation using xantphos
in a 1,4-Dioxane:tert-amyl alcohol aolvent aystem
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Ahmed, Ijaz; Wilson, Robert J.; Williams, Theresa M.;
Kaminsky, Lauren; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(16), 3465-3470

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Chloro-3-pyridinyl)-2-pyridinemethanamine
C11H10ClN3
1154723-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 Cl 3.0800 0.0000 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 N 0.7700 1.3338 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 C 0.0000 2.6674 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 7.7000 2.6674 0.0 0
M  V30 12 N 7.7000 5.3349 0.0 0
M  V30 13 C 9.2400 2.6674 0.0 0
M  V30 14 C 9.2400 5.3349 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 10
M  V30 4 1 3 5
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Pyridinylmethyl)-1H-imidazo[4,5-b]pyridine
C12H10N4
273757-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 1.3338 0.0 0
M  V30 2 C 2.9292 2.8284 0.0 0
M  V30 3 N 4.4608 2.6674 0.0 0
M  V30 4 C 2.6091 4.3348 0.0 0
M  V30 5 C 1.7849 1.7980 0.0 0
M  V30 6 C 5.0872 4.0742 0.0 0
M  V30 7 N 3.9427 5.1048 0.0 0
M  V30 8 N 1.1444 4.8107 0.0 0
M  V30 9 C 0.3202 2.2738 0.0 0
M  V30 10 C 0.0000 3.7801 0.0 0
M  V30 11 C 6.7708 1.3338 0.0 0
M  V30 12 C 7.5408 0.0000 0.0 0
M  V30 13 N 7.5408 2.6674 0.0 0
M  V30 14 C 9.0808 0.0000 0.0 0
M  V30 15 C 9.0808 2.6674 0.0 0
M  V30 16 C 9.8508 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 2 6 7
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1154723-18-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 273757-19-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3395010
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 29154-12-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 857356-94-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1-(4-Methoxybenzyl)-1H-imidazo[4,5-b]pyridine
(3a) To an oven-dried 25 mL Schlenk-tube equipped with a stirbar was
added Pd2(dba)3 · CHCl3 (20.8 mg, 0.02 mmol),
2-Di-t-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-tri-i-propylbiphenyl
(L1) (48 mg, 0.1 mmol), K3PO4 (639 mg, 3.01 mmol) and
2-Chloro-N-(4-methoxybenzyl)pyridin-3-amine (2a) (500 mg, 2.01 mmol) (if
solid). The tube was evacuated and refilled with Ar(g). Formamide (0.12
mL, 3.01 mmol) was added via syringe as a single portion, followed by the
chloropyridine (if liquid) in 4 mL of tert-butanol. The reaction mixture
was degassed with 3 x vacuum / Ar(g) purge cycles. The reaction vessel
was then equipped with a cold-finger under a positive pressure of argon
gas and immersed in a 110°C pre-heated oil-bath for 4h at which time TLC
showed consumption of the chloro-pyridine. The reaction was cooled to
room temperature, diluted with MeOH (4 mL) filtered through a Celite plug
and concentrated to give a dark brown oil. The crude product was purified
on a silica gel column (4.5 cm x 12 cm), eluting with 4% MeOH in CH2Cl2.
1-(Pyridin-2-ylmethyl)-1H-imidazo[4,5-b]pyridine (3f) Following the
general experimental; 2-chloro-N-(pyridin-2-ylmethyl)pyridin-3-amine (2f)
(93 mg, 0.4 mmol), Pd2(dba)3·CHCl3 (4.14 mg, 0.004 mmol), L1 (9.6 mg,
0.02 mmol), K3PO4 (128 mg, 0.6 mmol), formamide (0.022 mL, 0.6 mmol) were
combined with 2.0 mL tert-butanol in a 25 mL Schlenk flask. After 4 h the
reaction was complete, the reaction cooled to RT, filtered through
Celite, concentrated and purified on a silica gel column (2.5 cm x 12
cm), eluting with 4% MeOH / CH2Cl2. 3f as 81 mg of a brown solid (95%).
1H NMR (300 MHz, CDCl3) δ = 8.60 (ddd, J = 4.8 Hz, 1.5 Hz, 0.9 Hz, 1H),
8.57 (dd, J = 4.8 Hz, 1.5 Hz, 1H), 8.31 (s, 1H), 7.70 (dd, J = 8.1 Hz,
1.5 Hz, 1H), 7.65 (td, J = 7.8 Hz, 1.8 Hz, 1H), 7.28-7.22 (m, 1H), 7.20
(dd, J = 8.1 Hz, 4.8 Hz, 1H), 7.01 (d, J = 8.1 Hz, 1H), 5.50 (s, 2H); 13C
NMR (75.4 MHz, CDCl3) δ = 156.4, 154.8, 150.1, 145.7, 145.3, 145.2,
137.6, 123.5, 121.5, 118.7, 118.5, 51.3; FT-IR (NaCl, thin film) ν =
3391, 1647, 1614, 1495, 1419, 1439, 1379, 1363, 1292, 783 cm-1. HRMS
(ESI) Calc (C12H10N4): 210.0905, Found: 210.0905; MP: 165-169°C; Rf (4%
MeOH / CH2Cl2): 0.20.
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Imidazo[4,5-b]pyridines and Imidazo[4,5-b]pyrazines by
Palladium Catalyzed Amidation of 2-Chloro-3-amino-heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Zhao, Jinbo; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(7), 1764-1767

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzophenone
C13H10O
119-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Diphenylmethyl)formamide
C14H13NO
6744-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 N 5.3348 5.3901 0.0 0
M  V30 3 C 6.6687 4.6201 0.0 0
M  V30 4 O 8.0023 5.3901 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 5.3901 0.0 0
M  V30 12 C 2.6675 6.9302 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 1.3337 7.7002 0.0 0
M  V30 15 C 0.0000 5.3901 0.0 0
M  V30 16 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 2 3
M  V30 5 2 3 4
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119-61-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6744-65-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-261873
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 3. Reductive amination of
1-(2,4-dichlorophenyl)-4,4-dimethyl-1-propen-3-one (V). One g (3.9 mmol)
of V, 2 ml of formic acid, and 20 ml of formamide were placed in a round
bottom flask equipped with thermometer, reflux condenser, and a heating
mantle. The reaction mixture was heated to 188-190°C and maintained at
this temperature for 10 minutes. The reaction mixture was left to cool to
room temperature overnight. The precipitated crystals were separated by
filtration, rinsed with water, and dried with vacuum, producing 70% of
N-[1-(2,4-dichlorophenyl)-4,4- dimethyl-1-propen-3-yl]-formamide (VI).
Example 4. Reductive amination of benzophenone (VII). The reaction
procedure for V was repeated with 5 g of benzophenone and the reaction
time of 15 minutes. The reaction produced 95% of benzhydrylformamide
(VIII)(isolated yield).
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved method for the synthesis of substituted formylamines and
substituted amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bobylev, Mikhail
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009018353 A1 2009-02-05

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-1,5-diphenyl-1H-pyrrole-3-carbonitrile
C17H13N3
122238-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.7282 7.2317 0.0 0
M  V30 2 C 7.9701 4.7419 0.0 0
M  V30 3 N 9.5017 4.9029 0.0 0
M  V30 4 N 4.0012 5.0991 0.0 0
M  V30 5 C 4.1621 3.5673 0.0 0
M  V30 6 C 5.4080 5.7254 0.0 0
M  V30 7 C 5.6686 3.2472 0.0 0
M  V30 8 C 6.4386 4.5810 0.0 0
M  V30 9 C 2.6675 5.8691 0.0 0
M  V30 10 C 2.6675 7.4091 0.0 0
M  V30 11 C 1.3337 5.0991 0.0 0
M  V30 12 C 1.3337 8.1791 0.0 0
M  V30 13 C 0.0000 5.8691 0.0 0
M  V30 14 C 0.0000 7.4091 0.0 0
M  V30 15 C 3.0177 2.5369 0.0 0
M  V30 16 C 1.5530 3.0128 0.0 0
M  V30 17 C 3.3379 1.0306 0.0 0
M  V30 18 C 0.4086 1.9823 0.0 0
M  V30 19 C 2.1933 0.0000 0.0 0
M  V30 20 C 0.7287 0.4760 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 3 2 3
M  V30 3 1 2 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 2 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
C18H14N4
1257392-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.6646 5.6686 0.0 0
M  V30 2 N 4.5191 5.4080 0.0 0
M  V30 3 C 5.1454 4.0012 0.0 0
M  V30 4 C 5.6636 6.4386 0.0 0
M  V30 5 C 6.6771 4.1621 0.0 0
M  V30 6 C 6.9973 5.6686 0.0 0
M  V30 7 N 5.6636 7.9786 0.0 0
M  V30 8 C 8.3310 6.4386 0.0 0
M  V30 9 C 6.9973 8.7486 0.0 0
M  V30 10 N 8.3310 7.9786 0.0 0
M  V30 11 C 3.0128 5.7283 0.0 0
M  V30 12 C 2.5367 7.1929 0.0 0
M  V30 13 C 1.9822 4.5838 0.0 0
M  V30 14 C 1.0304 7.5131 0.0 0
M  V30 15 C 0.4759 4.9039 0.0 0
M  V30 16 C 0.0000 6.3687 0.0 0
M  V30 17 C 4.3754 2.6675 0.0 0
M  V30 18 C 2.8354 2.6675 0.0 0
M  V30 19 C 5.1454 1.3337 0.0 0
M  V30 20 C 2.0653 1.3337 0.0 0
M  V30 21 C 4.3754 0.0000 0.0 0
M  V30 22 C 2.8354 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 2 3 5
M  V30 6 1 3 17
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 6
M  V30 10 2 6 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122238-00-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1257392-10-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21263860
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial
and antifungal agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hassan Hilmy, Khalid Mohammed; Khalifa, Maha M. A.; Allah Hawata,
Mohammed Abd; AboAlzeen Keshk, Reda Mohammed; El-Torgman, Abd Almeneam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2010), 45(11), 5243-5250

$RFMT $RIREG SCHEME140 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Pyrrolidinylmethyl)formamide
C6H12N2O
28919-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 N 5.1048 1.8517 0.0 0
M  V30 3 C 6.4386 2.6218 0.0 0
M  V30 4 O 7.7722 1.8517 0.0 0
M  V30 5 N 2.4374 1.8517 0.0 0
M  V30 6 C 1.0304 2.4782 0.0 0
M  V30 7 C 2.2765 0.3202 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 28919-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-14935512
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):NOTES
$DATUM solid state, microwave, alumina support
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solvent-free preparation of monoacylaminals assisted by microwave
irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharifi, Ali; Mohsenzadeh, Farshid; Naimi-Jamal, M. Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research, Synopses (2000), (8), 394-396

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodoacetophenone
C8H7IO
13329-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 I 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Acetylbenzonitrile
C9H7NO
1443-80-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13329-40-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1443-80-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34483936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-89-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-Catalyzed Cyanation of Aryl Iodides with Formamide as the Cyano
Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peng, Sha; Yang, Luo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Asian Journal of Organic Chemistry (2022), 11(11), e202200437

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
2-Bromo-N-cyclohexylbenzamide
C13H16BrNO
159029-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 O 5.3900 1.3338 0.0 0
M  V30 4 Br 3.0800 0.0000 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 0.7700 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 C 7.7000 5.3349 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 C 9.2400 5.3349 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 11
M  V30 5 1 4 6
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyclohexyl-4(3H)-quinazolinone
C14H16N2O
14663-51-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 0.0000 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 4.6201 1.3337 0.0 0
M  V30 4 C 4.6201 4.0010 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 N 3.0801 4.0010 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 2.3101 0.0000 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 13 C 7.7002 4.0010 0.0 0
M  V30 14 C 7.7002 1.3337 0.0 0
M  V30 15 C 9.2402 4.0010 0.0 0
M  V30 16 C 9.2402 1.3337 0.0 0
M  V30 17 C 10.0102 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 7
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 159029-70-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14663-51-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4988444
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51-35-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for CuI-catalyzed formation
of 3-substituted-4-quinazolines and 2,3-disubstituted-4(3H )-quinazolines
from 2-bromo-N-phenylbenzamide. For 3-substituted-4-quinazoline
(11a-11r). A Schlenk tube was charged with N-substituted 2-bromobenzamide
(0.25 mmol), CuI (5 mg, 0.025 mmol), trans-4-hydroxy-L-proline (3 mg,
0.025 mmol), and Cs2CO3 (163 mg, 0.5 mmol). The tube was evacuated and
backfilled with argon before formamide (20 µL, 0.5 mmol) and 1 mL DMF was
added. The reaction mixture was stirred at 80 o C (or 90 o C for
substrate 7l) for 24 h. After the reaction mixture was cooled to room
temperature, 5 mL of saturated NH4Cl solution was added. The mixture was
extracted with EtOAc and the organic layer was washed with water, brine
and dried over Na2SO4. After concentration in vacuo, the residue was
purified by column chromatography on silica gel. The desired
3-substituted 4-quinazoline. 3-Cyclohexylquinazolin-4(3H)-one (11m).5 54
mg, 95% yield. 1H NMR (400 MHz, CDCl3) δ 8.30 (d, J = 8.0 Hz, 1H), 8.10
(s, 1H), 7.73-7.66 (m, 2H), 7.48 (t, J = 7.6 Hz, 1H), 4.82-4.76 (m, 1H),
1.99-1.90 (m, 4H), 1.78 (d, J = 13.2 Hz, 1H), 1.67-1.58 (m, 2H),
1.54-1.45 (m, 2H), 1.28-1.19 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 160.77,
147.61, 143.99, 134.17, 127.34, 127.16, 127.03, 122.03, 53.45, 32.68
(2C), 25.99 (2C), 25.37; HRMS-ESI: m/z calcd for C14H17N2O [M + H]+:
229.1341, found 229.1333.
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst formed in-situ; Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Substituted and 2,3-Disubstituted Quinazolinones via
Cu-Catalyzed Aryl Amidation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Lanting; Jiang, Yongwen; Ma, Dawei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(4), 1150-1153

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-amino[2,2′-bithiophene]-5-carboxylate
C10H9NO2S2
169759-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5257 2.7104 0.0 0
M  V30 2 O 8.2957 4.0442 0.0 0
M  V30 3 O 8.2957 1.3768 0.0 0
M  V30 4 C 9.8357 4.0442 0.0 0
M  V30 5 N 5.5563 0.0000 0.0 0
M  V30 6 C 3.6158 3.4804 0.0 0
M  V30 7 S 5.0805 3.9564 0.0 0
M  V30 8 C 3.6158 1.9404 0.0 0
M  V30 9 C 5.9857 2.7104 0.0 0
M  V30 10 C 5.0805 1.4645 0.0 0
M  V30 11 C 2.3699 4.3856 0.0 0
M  V30 12 C 2.3699 5.9256 0.0 0
M  V30 13 S 0.9052 3.9098 0.0 0
M  V30 14 C 0.9052 6.4015 0.0 0
M  V30 15 C 0.0000 5.1556 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(2-Thienyl)thieno[3,2-d]pyrimidin-4(3H)-one
C10H6N2OS2
1094398-62-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3338 0.0000 0.0 0
M  V30 2 C 5.0372 3.0800 0.0 0
M  V30 3 S 4.1320 1.8341 0.0 0
M  V30 4 C 4.1320 4.3259 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 1.3338 1.5400 0.0 0
M  V30 8 N 1.3338 4.6200 0.0 0
M  V30 9 N 0.0000 2.3100 0.0 0
M  V30 10 C 0.0000 3.8500 0.0 0
M  V30 11 C 6.5772 3.0800 0.0 0
M  V30 12 C 7.4824 1.8341 0.0 0
M  V30 13 S 7.4824 4.3259 0.0 0
M  V30 14 C 8.9471 2.3100 0.0 0
M  V30 15 C 8.9471 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 169759-79-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1094398-62-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19726100
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of 6-Substituted
Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor
Receptor Kinase and Microtubule Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Romagnoli, Romeo; Prencipe, Filippo; Oliva, Paola; Baraldi, Stefania;
Baraldi, Pier Giovanni; Schiaffino Ortega, Santiago; Chayah, Mariem;
Kimatrai Salvador, Maria; Lopez-Cara, Luisa Carlota; Brancale, Andrea;
Ferla, Salvatore; Hamel, Ernest; Ronca, Roberto; Bortolozzi, Roberta;
Mariotto, Elena; Mattiuzzo, Elena; Viola, Giampietro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(3), 1274-1290

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-4,5-dimethoxy-, ethyl ester
C11H15NO4
20323-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 5.3901 0.0 0
M  V30 2 O 8.0022 4.6201 0.0 0
M  V30 3 O 6.6684 6.9301 0.0 0
M  V30 4 C 9.3359 5.3901 0.0 0
M  V30 5 C 10.6695 4.6201 0.0 0
M  V30 6 N 4.0011 6.9301 0.0 0
M  V30 7 O 4.0011 0.7700 0.0 0
M  V30 8 C 5.3348 0.0000 0.0 0
M  V30 9 O 1.3337 2.3100 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 4.0011 5.3901 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 2.6673 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dimethoxy-4(3H)-quinazolinone
C10H10N2O3
13794-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6201 0.0 0
M  V30 2 O 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 4.0011 0.7700 0.0 0
M  V30 5 C 2.6675 0.0000 0.0 0
M  V30 6 C 4.0011 5.3901 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 N 4.0011 6.9301 0.0 0
M  V30 10 C 2.6675 3.0800 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 2.6675 7.7001 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 N 1.3337 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20323-74-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13794-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17933806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of novel perfluorocarbon-modulated 4-anilinoquinazoline
analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shi, Huiping; Lai, Bonan; Chen, Shizhen; Zhou, Xin; Nie, Jing; Ma, Jun-An
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Journal of Chemistry (2017), 35(11), 1693-1700

$RFMT $RIREG SCHEME145 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-chlorobenzoic acid
C7H6ClNO2
2148-56-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6675 0.0 0
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0012 0.0 0
M  V30 4 Cl 2.3101 5.3350 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6675 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 3.0801 1.3338 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-4(3H)-quinazolinone
C8H5ClN2O
60233-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3338 0.0 0
M  V30 2 Cl 2.3100 0.0000 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 0.7700 2.6674 0.0 0
M  V30 6 C 3.0800 1.3338 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 N 2.3100 5.3349 0.0 0
M  V30 9 N 0.0000 4.0011 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 6
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2148-56-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60233-66-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21130151
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal (thermal condition (stage 2)), key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Potency of Pyruvate Dehydrogenase Complex E1
Inhibitors against Cyanobacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yuan; Feng, Jiangtao; He, Hongwu; Hou, Leifeng; Jiang, Wen; Xie,
Dan; Feng, Lingling; Cai, Meng; Peng, Hao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biochemistry (2017), 56(49), 6491-6502

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Amino-4,6-dimethylthieno[2,3-b]pyridin-2-yl)(tetrahydro-2H-pyran-4-yl)meth...
C15H18N2O2S
2226211-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.0494 0.3694 0.0 0
M  V30 2 C 8.3236 0.0000 0.0 0
M  V30 3 C 3.0800 3.0800 0.0 0
M  V30 4 O 2.3100 1.7462 0.0 0
M  V30 5 C 10.9910 4.6200 0.0 0
M  V30 6 C 6.9899 2.3100 0.0 0
M  V30 7 C 6.9899 3.8500 0.0 0
M  V30 8 C 5.5252 1.8340 0.0 0
M  V30 9 C 8.3236 1.5400 0.0 0
M  V30 10 S 5.5252 4.3259 0.0 0
M  V30 11 N 8.3236 4.6200 0.0 0
M  V30 12 C 4.6200 3.0800 0.0 0
M  V30 13 C 9.6572 2.3100 0.0 0
M  V30 14 C 9.6572 3.8500 0.0 0
M  V30 15 C 2.3100 4.4137 0.0 0
M  V30 16 C 3.0800 5.7473 0.0 0
M  V30 17 C 0.7700 4.4137 0.0 0
M  V30 18 C 2.3100 7.0809 0.0 0
M  V30 19 C 0.0000 5.7473 0.0 0
M  V30 20 O 0.7700 7.0809 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 2 3 4
M  V30 4 1 3 12
M  V30 5 1 3 15
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7,9-Dimethyl-4-(tetrahydro-2H-pyran-4-yl)pyrido[3′,2′:4,5]thieno[3,2-d]pyrimi...
C16H17N3OS
2226211-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9813 7.4513 0.0 0
M  V30 2 C 11.1172 3.1353 0.0 0
M  V30 3 C 6.8966 5.0145 0.0 0
M  V30 4 C 5.3901 5.3348 0.0 0
M  V30 5 C 7.0575 3.4829 0.0 0
M  V30 6 C 8.1424 5.9197 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 N 4.6201 6.6685 0.0 0
M  V30 9 S 5.6505 2.8566 0.0 0
M  V30 10 N 8.4643 2.8566 0.0 0
M  V30 11 C 9.5493 5.2934 0.0 0
M  V30 12 C 3.0801 4.0010 0.0 0
M  V30 13 C 3.0801 6.6685 0.0 0
M  V30 14 C 9.7102 3.7618 0.0 0
M  V30 15 N 2.3100 5.3348 0.0 0
M  V30 16 C 2.3100 2.6673 0.0 0
M  V30 17 C 0.7700 2.6673 0.0 0
M  V30 18 C 3.0801 1.3337 0.0 0
M  V30 19 C 0.0000 1.3337 0.0 0
M  V30 20 C 2.3100 0.0000 0.0 0
M  V30 21 O 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 2 13 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2226211-74-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2226211-44-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32657292
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3473-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of structurally distinct tricyclic M4 positive allosteric
modulator (PAM) chemotypes - Part 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Long, Madeline F.; Capstick, Rory A.; Spearing, Paul K.; Engers, Julie
L.; Gregro, Alison R.; Bollinger, Sean R.; Chang, Sichen; Luscombe,
Vincent B.; Rodriguez, Alice L.; Cho, Hyekyung P.; Niswender, Colleen M.;
Bridges, Thomas M.; Conn, P. Jeffrey; Lindsley, Craig W.; Engers, Darren
W.; Temple, Kayla J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 53128416

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl isonicotinate
C7H7NO2
2459-09-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 N 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-(aminocarbonyl)-4-pyridinecarboxylate
C8H8N2O3
1379342-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 N 1.3337 4.6201 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 N 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2459-09-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1379342-46-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-095-CAS-21157759
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-53-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7727-21-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7761-88-8
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, Schlenk flask used, optimization study,
optimized on catalyst, oxidant and base, scale up
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acid-Free Silver-Catalyzed Cross-Dehydrogenative Carbamoylation of
Pyridines with Formamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Wei; Jin, Fengli; Zhao, Qian; Du, Hongyan; Yao, Lifang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(12), 1854-1859

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Amino-4,6-dimethylthieno[2,3-b]pyridin-2-yl)cyclohexylmethanone
C16H20N2OS
2868313-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.0494 0.3694 0.0 0
M  V30 2 C 8.3236 0.0000 0.0 0
M  V30 3 C 3.0800 3.0800 0.0 0
M  V30 4 O 2.3100 1.7462 0.0 0
M  V30 5 C 10.9910 4.6200 0.0 0
M  V30 6 C 6.9899 2.3100 0.0 0
M  V30 7 C 6.9899 3.8500 0.0 0
M  V30 8 C 5.5252 1.8340 0.0 0
M  V30 9 C 8.3236 1.5400 0.0 0
M  V30 10 S 5.5252 4.3259 0.0 0
M  V30 11 N 8.3236 4.6200 0.0 0
M  V30 12 C 4.6200 3.0800 0.0 0
M  V30 13 C 9.6572 2.3100 0.0 0
M  V30 14 C 9.6572 3.8500 0.0 0
M  V30 15 C 2.3100 4.4137 0.0 0
M  V30 16 C 3.0800 5.7473 0.0 0
M  V30 17 C 0.7700 4.4137 0.0 0
M  V30 18 C 2.3100 7.0809 0.0 0
M  V30 19 C 0.0000 5.7473 0.0 0
M  V30 20 C 0.7700 7.0809 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 2 3 4
M  V30 4 1 3 12
M  V30 5 1 3 15
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyclohexyl-7,9-dimethylpyrido[3′,2′:4,5]thieno[3,2-d]pyrimidine
C17H19N3S
2226211-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9813 7.4513 0.0 0
M  V30 2 C 11.1172 3.1353 0.0 0
M  V30 3 C 6.8966 5.0145 0.0 0
M  V30 4 C 5.3901 5.3348 0.0 0
M  V30 5 C 7.0575 3.4829 0.0 0
M  V30 6 C 8.1424 5.9197 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 N 4.6201 6.6685 0.0 0
M  V30 9 S 5.6505 2.8566 0.0 0
M  V30 10 N 8.4643 2.8566 0.0 0
M  V30 11 C 9.5493 5.2934 0.0 0
M  V30 12 C 3.0801 4.0010 0.0 0
M  V30 13 C 3.0801 6.6685 0.0 0
M  V30 14 C 9.7102 3.7618 0.0 0
M  V30 15 N 2.3100 5.3348 0.0 0
M  V30 16 C 2.3100 2.6673 0.0 0
M  V30 17 C 0.7700 2.6673 0.0 0
M  V30 18 C 3.0801 1.3337 0.0 0
M  V30 19 C 0.0000 1.3337 0.0 0
M  V30 20 C 2.3100 0.0000 0.0 0
M  V30 21 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 2 13 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2868313-36-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2226211-54-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32657288
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3473-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of structurally distinct tricyclic M4 positive allosteric
modulator (PAM) chemotypes - Part 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Long, Madeline F.; Capstick, Rory A.; Spearing, Paul K.; Engers, Julie
L.; Gregro, Alison R.; Bollinger, Sean R.; Chang, Sichen; Luscombe,
Vincent B.; Rodriguez, Alice L.; Cho, Hyekyung P.; Niswender, Colleen M.;
Bridges, Thomas M.; Conn, P. Jeffrey; Lindsley, Craig W.; Engers, Darren
W.; Temple, Kayla J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 53128416

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Amino-4,6-dimethylthieno[2,3-b]pyridin-2-yl)cyclopropylmethanone
C13H14N2OS
2868313-37-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0730 0.3694 0.0 0
M  V30 2 C 7.3472 0.0000 0.0 0
M  V30 3 C 2.1038 3.0800 0.0 0
M  V30 4 O 1.3338 1.7464 0.0 0
M  V30 5 C 10.0146 4.6200 0.0 0
M  V30 6 C 6.0135 2.3100 0.0 0
M  V30 7 C 6.0135 3.8500 0.0 0
M  V30 8 C 4.5489 1.8341 0.0 0
M  V30 9 C 7.3472 1.5400 0.0 0
M  V30 10 S 4.5489 4.3259 0.0 0
M  V30 11 N 7.3472 4.6200 0.0 0
M  V30 12 C 3.6438 3.0800 0.0 0
M  V30 13 C 8.6808 2.3100 0.0 0
M  V30 14 C 8.6808 3.8500 0.0 0
M  V30 15 C 1.3338 4.4136 0.0 0
M  V30 16 C 1.3338 5.9536 0.0 0
M  V30 17 C 0.0000 5.1836 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 2 3 4
M  V30 4 1 3 12
M  V30 5 1 3 15
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyclopropyl-7,9-dimethylpyrido[3′,2′:4,5]thieno[3,2-d]pyrimidine
C14H13N3S
2226211-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0052 6.3240 0.0 0
M  V30 2 C 10.1408 2.0081 0.0 0
M  V30 3 C 3.6437 2.8737 0.0 0
M  V30 4 C 4.4137 4.2074 0.0 0
M  V30 5 C 2.1037 2.8737 0.0 0
M  V30 6 S 4.6743 1.7293 0.0 0
M  V30 7 C 5.9202 3.8872 0.0 0
M  V30 8 N 3.6437 5.5412 0.0 0
M  V30 9 N 1.3337 4.2074 0.0 0
M  V30 10 C 6.0811 2.3556 0.0 0
M  V30 11 C 7.1661 4.7924 0.0 0
M  V30 12 C 2.1037 5.5412 0.0 0
M  V30 13 N 7.4880 1.7293 0.0 0
M  V30 14 C 8.5729 4.1661 0.0 0
M  V30 15 C 8.7340 2.6344 0.0 0
M  V30 16 C 1.3337 1.5400 0.0 0
M  V30 17 C 1.3337 0.0000 0.0 0
M  V30 18 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 5 16
M  V30 10 1 6 10
M  V30 11 1 7 10
M  V30 12 2 7 11
M  V30 13 1 8 12
M  V30 14 2 9 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2868313-37-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2226211-50-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32657297
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3473-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of structurally distinct tricyclic M4 positive allosteric
modulator (PAM) chemotypes - Part 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Long, Madeline F.; Capstick, Rory A.; Spearing, Paul K.; Engers, Julie
L.; Gregro, Alison R.; Bollinger, Sean R.; Chang, Sichen; Luscombe,
Vincent B.; Rodriguez, Alice L.; Cho, Hyekyung P.; Niswender, Colleen M.;
Bridges, Thomas M.; Conn, P. Jeffrey; Lindsley, Craig W.; Engers, Darren
W.; Temple, Kayla J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 53128416

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Amino-4,6-dimethylthieno[2,3-b]pyridin-2-yl)-4-piperidinylmethanone
C15H19N3OS
2868313-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.0494 0.3694 0.0 0
M  V30 2 C 8.3236 0.0000 0.0 0
M  V30 3 C 3.0800 3.0800 0.0 0
M  V30 4 O 2.3100 1.7462 0.0 0
M  V30 5 C 10.9910 4.6200 0.0 0
M  V30 6 C 6.9899 2.3100 0.0 0
M  V30 7 C 6.9899 3.8500 0.0 0
M  V30 8 C 5.5252 1.8340 0.0 0
M  V30 9 C 8.3236 1.5400 0.0 0
M  V30 10 S 5.5252 4.3259 0.0 0
M  V30 11 N 8.3236 4.6200 0.0 0
M  V30 12 C 4.6200 3.0800 0.0 0
M  V30 13 C 9.6572 2.3100 0.0 0
M  V30 14 C 9.6572 3.8500 0.0 0
M  V30 15 C 2.3100 4.4137 0.0 0
M  V30 16 C 3.0800 5.7473 0.0 0
M  V30 17 C 0.7700 4.4137 0.0 0
M  V30 18 C 2.3100 7.0809 0.0 0
M  V30 19 C 0.0000 5.7473 0.0 0
M  V30 20 N 0.7700 7.0809 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 2 3 4
M  V30 4 1 3 12
M  V30 5 1 3 15
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7,9-Dimethyl-4-(4-piperidinyl)pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidine
C16H18N4S
722455-52-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9813 7.4513 0.0 0
M  V30 2 C 11.1172 3.1353 0.0 0
M  V30 3 C 6.8966 5.0145 0.0 0
M  V30 4 C 5.3901 5.3348 0.0 0
M  V30 5 C 7.0575 3.4829 0.0 0
M  V30 6 C 8.1424 5.9197 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 N 4.6201 6.6685 0.0 0
M  V30 9 S 5.6505 2.8566 0.0 0
M  V30 10 N 8.4643 2.8566 0.0 0
M  V30 11 C 9.5493 5.2934 0.0 0
M  V30 12 C 3.0801 4.0010 0.0 0
M  V30 13 C 3.0801 6.6685 0.0 0
M  V30 14 C 9.7102 3.7618 0.0 0
M  V30 15 N 2.3100 5.3348 0.0 0
M  V30 16 C 2.3100 2.6673 0.0 0
M  V30 17 C 0.7700 2.6673 0.0 0
M  V30 18 C 3.0801 1.3337 0.0 0
M  V30 19 C 0.0000 1.3337 0.0 0
M  V30 20 C 2.3100 0.0000 0.0 0
M  V30 21 N 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 2 13 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2868313-38-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 722455-52-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32657299
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3473-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of structurally distinct tricyclic M4 positive allosteric
modulator (PAM) chemotypes - Part 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Long, Madeline F.; Capstick, Rory A.; Spearing, Paul K.; Engers, Julie
L.; Gregro, Alison R.; Bollinger, Sean R.; Chang, Sichen; Luscombe,
Vincent B.; Rodriguez, Alice L.; Cho, Hyekyung P.; Niswender, Colleen M.;
Bridges, Thomas M.; Conn, P. Jeffrey; Lindsley, Craig W.; Engers, Darren
W.; Temple, Kayla J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 53128416

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Amino-4-methoxy-9H-xanthen-9-one
C14H11NO3
29949-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7001 5.3348 0.0 0
M  V30 2 C 9.2401 5.3348 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 N 4.6201 0.0000 0.0 0
M  V30 5 C 5.3901 4.0011 0.0 0
M  V30 6 C 4.6201 2.6675 0.0 0
M  V30 7 C 6.9301 4.0011 0.0 0
M  V30 8 O 4.6201 5.3348 0.0 0
M  V30 9 C 3.0800 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 7.7001 2.6675 0.0 0
M  V30 12 C 3.0800 5.3348 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 6.9301 1.3338 0.0 0
M  V30 15 C 2.3100 6.6686 0.0 0
M  V30 16 C 0.7700 4.0011 0.0 0
M  V30 17 C 0.7700 6.6686 0.0 0
M  V30 18 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 1 12 13
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy[1]benzopyrano[4,3,2-de]quinazoline
C15H10N2O2
957767-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 5.3347 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 5.3900 4.0011 0.0 0
M  V30 6 C 5.3900 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 2.3100 1.3338 0.0 0
M  V30 9 O 4.6200 5.3347 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 6.9300 1.3338 0.0 0
M  V30 12 N 4.6200 0.0000 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 3.0800 0.0000 0.0 0
M  V30 16 C 7.7000 2.6674 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 0.0000 5.3347 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 2 8 15
M  V30 15 1 9 13
M  V30 16 1 10 16
M  V30 17 2 11 16
M  V30 18 1 12 15
M  V30 19 2 13 17
M  V30 20 1 14 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29949-62-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 957767-48-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25339110
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of new chromeno[4,3,2-de]quinazolin-2-ones, -quinazolines and
-pyrrolo[2,1-b]quinazolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Martinez-Viturro, Carlos M.; Dominguez, Domingo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2007), 44(5), 1035-1043

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-amino-5-(3-methoxyphenyl)-2-thiophenecarboxylate
C13H13NO3S
354811-97-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1580 2.9016 0.0 0
M  V30 2 O 1.5316 4.3086 0.0 0
M  V30 3 O 1.2528 1.6557 0.0 0
M  V30 4 C 0.0000 4.4695 0.0 0
M  V30 5 N 3.8333 0.0000 0.0 0
M  V30 6 O 11.4619 3.2587 0.0 0
M  V30 7 C 12.7955 4.0287 0.0 0
M  V30 8 C 6.1270 3.2587 0.0 0
M  V30 9 S 4.7200 3.8850 0.0 0
M  V30 10 C 5.9659 1.7271 0.0 0
M  V30 11 C 3.6896 2.7406 0.0 0
M  V30 12 C 4.4596 1.4070 0.0 0
M  V30 13 C 7.4607 4.0287 0.0 0
M  V30 14 C 8.7944 3.2587 0.0 0
M  V30 15 C 7.4607 5.5688 0.0 0
M  V30 16 C 10.1280 4.0287 0.0 0
M  V30 17 C 8.7944 6.3388 0.0 0
M  V30 18 C 10.1280 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(3-Methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one
C13H10N2O2S
874818-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.2645 0.0 0
M  V30 2 O 10.0823 3.0801 0.0 0
M  V30 3 C 11.4160 2.3101 0.0 0
M  V30 4 C 2.3101 3.5981 0.0 0
M  V30 5 C 3.0801 4.9318 0.0 0
M  V30 6 S 3.3405 2.4536 0.0 0
M  V30 7 C 0.7700 3.5981 0.0 0
M  V30 8 C 4.5864 4.6116 0.0 0
M  V30 9 N 2.3101 6.2655 0.0 0
M  V30 10 C 4.7475 3.0801 0.0 0
M  V30 11 N 0.0000 4.9318 0.0 0
M  V30 12 C 0.7700 6.2655 0.0 0
M  V30 13 C 6.0811 2.3101 0.0 0
M  V30 14 C 7.4148 3.0801 0.0 0
M  V30 15 C 6.0811 0.7700 0.0 0
M  V30 16 C 8.7486 2.3101 0.0 0
M  V30 17 C 7.4148 0.0000 0.0 0
M  V30 18 C 8.7486 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 354811-97-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 874818-79-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19726106
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of 6-Substituted
Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor
Receptor Kinase and Microtubule Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Romagnoli, Romeo; Prencipe, Filippo; Oliva, Paola; Baraldi, Stefania;
Baraldi, Pier Giovanni; Schiaffino Ortega, Santiago; Chayah, Mariem;
Kimatrai Salvador, Maria; Lopez-Cara, Luisa Carlota; Brancale, Andrea;
Ferla, Salvatore; Hamel, Ernest; Ronca, Roberto; Bortolozzi, Roberta;
Mariotto, Elena; Mattiuzzo, Elena; Viola, Giampietro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(3), 1274-1290

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenecarboxylic acid, 3-amino-5-(4-methoxyphenyl)-, methyl ester
C13H13NO3S
37572-23-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1580 2.9016 0.0 0
M  V30 2 O 1.5316 4.3086 0.0 0
M  V30 3 O 1.2528 1.6557 0.0 0
M  V30 4 C 0.0000 4.4695 0.0 0
M  V30 5 N 3.8333 0.0000 0.0 0
M  V30 6 O 11.4619 6.3388 0.0 0
M  V30 7 C 12.7955 5.5688 0.0 0
M  V30 8 C 6.1270 3.2587 0.0 0
M  V30 9 S 4.7200 3.8850 0.0 0
M  V30 10 C 5.9659 1.7271 0.0 0
M  V30 11 C 3.6896 2.7406 0.0 0
M  V30 12 C 4.4596 1.4070 0.0 0
M  V30 13 C 7.4607 4.0287 0.0 0
M  V30 14 C 8.7944 3.2587 0.0 0
M  V30 15 C 7.4607 5.5688 0.0 0
M  V30 16 C 10.1280 4.0287 0.0 0
M  V30 17 C 8.7944 6.3388 0.0 0
M  V30 18 C 10.1280 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one
C13H10N2O2S
225385-22-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 O 11.1973 3.0801 0.0 0
M  V30 3 C 11.9673 4.4137 0.0 0
M  V30 4 C 5.0371 3.0801 0.0 0
M  V30 5 S 4.1321 1.8342 0.0 0
M  V30 6 C 4.1321 4.3260 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 N 1.3337 4.6201 0.0 0
M  V30 11 N 0.0000 2.3101 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 C 6.5772 3.0801 0.0 0
M  V30 14 C 7.3472 1.7464 0.0 0
M  V30 15 C 7.3472 4.4137 0.0 0
M  V30 16 C 8.8872 1.7464 0.0 0
M  V30 17 C 8.8872 4.4137 0.0 0
M  V30 18 C 9.6572 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 37572-23-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 225385-22-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19726105
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of 6-Substituted
Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor
Receptor Kinase and Microtubule Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Romagnoli, Romeo; Prencipe, Filippo; Oliva, Paola; Baraldi, Stefania;
Baraldi, Pier Giovanni; Schiaffino Ortega, Santiago; Chayah, Mariem;
Kimatrai Salvador, Maria; Lopez-Cara, Luisa Carlota; Brancale, Andrea;
Ferla, Salvatore; Hamel, Ernest; Ronca, Roberto; Bortolozzi, Roberta;
Mariotto, Elena; Mattiuzzo, Elena; Viola, Giampietro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(3), 1274-1290

$RFMT $RIREG SCHEME154 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[(4-Chlorophenyl)methyl]amino]ethanol
C9H12ClNO
40172-04-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 C 9.2401 4.0010 0.0 0
M  V30 5 O 10.7801 4.0010 0.0 0
M  V30 6 Cl 0.0000 1.3337 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 3.8500 2.6673 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 2.3100 2.6673 0.0 0
M  V30 12 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Chlorophenyl)methyl]-N-(2-hydroxyethyl)formamide
C10H12ClNO2
1031880-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 2.6674 0.0 0
M  V30 3 C 8.4700 2.6674 0.0 0
M  V30 4 C 6.1600 1.3338 0.0 0
M  V30 5 C 9.2400 4.0011 0.0 0
M  V30 6 O 6.9300 0.0000 0.0 0
M  V30 7 O 10.7800 4.0011 0.0 0
M  V30 8 Cl 0.0000 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40172-04-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1031880-17-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-6216492
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM R-XVIII. a. 2-(4-Cl-Benzylamino)-N-formyl-ethanol (55). A total of 1.85 g
of 2-(4-chloro-benzylamino)-ethanol (78, 10 mmol) was heated to 80 °C in
5 mL formamide for 1 h. When the reaction was completed (GC), the
reaction mixture was poured into 20 mL of water and extracted with 3 × 20
mL of ethylacetate. The organic phase collected was evaporated under
pressure, yielding a thick liquid (2.02 g; 95% yield). MS(EI):
M+(measured) = 213.1; M+(calc) = 213.1; 1H NMR (ppm): major (cis): 3.19
(2H, t, 5.4 Hz, NCH2), 3.39 (2H, t, 5.4 Hz, OCH2), 4.45 (2H, s, PhCH2),
7.28 (2H, d, 6.2 Hz, CH2,6), 7.36 (2H, d, 6.2 Hz, CH3,5), 8.11 (1H, s,
CHO); 13C NMR (ppm): 44.58 (PhCH2), 49.18 (NCH2), 58.70 (OCH2), 128.70
(2C, CH3,5), 128.88 (1C, CH1), 129.92 (2C, C2,6), 136.82 (1C, CH4),
163.74 (1C, CHO). minor (trans): 3.17 (2H, t, 5.4 Hz, NCH2), 3.39 (2H, t,
5.4 Hz, OCH2), 4.50 (2H, s, PhCH2), 7.24 (2H, d, 6.2 Hz, CH2,6), 7.34
(2H, d, 6.2 Hz, CH3,5), 8.28 (1H, s, CHO); 13C NMR (ppm): 50.20 (PhCH2),
49.18 (NCH2), 58.70 (OCH2), 128.70 (2C, CH3,5), 129.92 (1C, CH1), 129.98
(2C, C2,6), 136.84 (1C, CH4), 163.74 (1C, CHO).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amidicity Change as a Significant Driving Force and Thermodynamic
Selection Rule of Transamidation Reactions. A Synergy between Experiment
and Theory
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mucsi, Zoltan; Chass, Gregory A.; Csizmadia, Imre G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Physical Chemistry B (2008), 112(26), 7885-7893

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-(1,1-dimethylethyl)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile
C13H18N2S
42159-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.1444 3.3321 0.0 0
M  V30 2 N 0.0000 4.3625 0.0 0
M  V30 3 N 0.7942 0.0000 0.0 0
M  V30 4 C 8.4152 2.6217 0.0 0
M  V30 5 C 8.4152 1.0817 0.0 0
M  V30 6 C 9.9552 2.6217 0.0 0
M  V30 7 C 8.4152 4.1617 0.0 0
M  V30 8 C 3.7952 2.6217 0.0 0
M  V30 9 C 4.5652 1.2881 0.0 0
M  V30 10 C 2.2889 2.3015 0.0 0
M  V30 11 C 4.5652 3.9555 0.0 0
M  V30 12 C 6.1052 1.2881 0.0 0
M  V30 13 S 3.5348 0.1437 0.0 0
M  V30 14 C 2.1278 0.7700 0.0 0
M  V30 15 C 6.1052 3.9555 0.0 0
M  V30 16 C 6.8752 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 3 14
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(1,1-Dimethylethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-amine
C14H19N3S
405278-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.7288 0.0000 0.0 0
M  V30 2 C 8.9401 2.1166 0.0 0
M  V30 3 C 9.7102 3.4503 0.0 0
M  V30 4 C 10.4802 2.1166 0.0 0
M  V30 5 C 9.7102 0.7829 0.0 0
M  V30 6 C 4.3201 2.1166 0.0 0
M  V30 7 C 2.8138 2.4368 0.0 0
M  V30 8 C 5.0901 3.4503 0.0 0
M  V30 9 C 5.0901 0.7829 0.0 0
M  V30 10 C 2.6527 3.9683 0.0 0
M  V30 11 C 1.5679 1.5316 0.0 0
M  V30 12 S 4.0597 4.5948 0.0 0
M  V30 13 C 6.6301 3.4503 0.0 0
M  V30 14 C 6.6301 0.7829 0.0 0
M  V30 15 N 1.2459 4.5948 0.0 0
M  V30 16 N 0.1609 2.1580 0.0 0
M  V30 17 C 7.4001 2.1166 0.0 0
M  V30 18 C 0.0000 3.6896 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 12
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 42159-76-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 405278-79-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21085528
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Amino-7-t-butyltetrahydrobenzo[b]thieno[2,3-d]pyrimidine (5) A mixture
of 1 (5 mmol, 1.17 g) and formamide (504 mmol, 20 mL) was refluxed for
4h. The solid that precipitated on cooling was recrystallized from
ethanol to give 5 as pale yellow crystals. yield: 2.34 g (95%).
4-Amino-7-t-butyltetrahydrobenzo[b]thieno[2,3-d]pyrimidine (5). Yield
2.34 g (95%). m.p.: 155-157°C, IR, ν cm-1: 3419-3221 (NH2), 1H NMR
(CDCl3): δ 0.92 (s, 9H, tert-butyl group), 1.87-3.09 (several m, 7H,
cyclohexane), 7.92 (bs, 2H, NH2 , D2O exchangeable), 8.35 (s, 1H,
pyrimidine); Anal. calcd. for C14H19N3S (261): C, 64.37; H, 7.28; N,
16.09; found: C, 64.20; H, 7.10; N,15.90.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Utility of the enaminonitrile moiety in the synthesis of some
biologically active thienopyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Azab, Mohammad Emad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Phosphorus, Sulfur and Silicon and the Related Elements (2008), 183(7),
1766-1782

$RFMT $RIREG SCHEME156 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1-[4-(phenylmethoxy)phenyl]ethanone
C15H13BrO2
4254-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5503 2.6673 0.0 0
M  V30 2 C 12.3203 4.0010 0.0 0
M  V30 3 O 12.3203 1.3337 0.0 0
M  V30 4 Br 13.8603 4.0010 0.0 0
M  V30 5 O 5.3901 2.6673 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 C 10.0102 2.6673 0.0 0
M  V30 8 C 9.2402 4.0010 0.0 0
M  V30 9 C 9.2402 1.3337 0.0 0
M  V30 10 C 7.7002 4.0010 0.0 0
M  V30 11 C 7.7002 1.3337 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 13 C 3.0801 1.3337 0.0 0
M  V30 14 C 2.3101 2.6673 0.0 0
M  V30 15 C 2.3101 0.0000 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.7700 0.0000 0.0 0
M  V30 18 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 13
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[4-(Phenylmethoxy)phenyl]-1H-imidazole
C16H14N2O
146698-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.5299 2.6673 0.0 0
M  V30 2 C 9.3000 1.3337 0.0 0
M  V30 3 C 3.9098 2.6673 0.0 0
M  V30 4 C 4.6799 4.0010 0.0 0
M  V30 5 C 4.6799 1.3337 0.0 0
M  V30 6 C 6.2199 4.0010 0.0 0
M  V30 7 C 6.2199 1.3337 0.0 0
M  V30 8 C 6.9899 2.6673 0.0 0
M  V30 9 C 2.3698 2.6673 0.0 0
M  V30 10 C 1.4646 3.9132 0.0 0
M  V30 11 N 1.4646 1.4215 0.0 0
M  V30 12 N 0.0000 3.4374 0.0 0
M  V30 13 C 0.0000 1.8973 0.0 0
M  V30 14 C 10.8400 1.3337 0.0 0
M  V30 15 C 11.6100 0.0000 0.0 0
M  V30 16 C 11.6100 2.6673 0.0 0
M  V30 17 C 13.1500 0.0000 0.0 0
M  V30 18 C 13.1500 2.6673 0.0 0
M  V30 19 C 13.9201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 3 9
M  V30 7 1 4 6
M  V30 8 2 5 7
M  V30 9 2 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4254-67-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 146698-61-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36040013
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted imidazolecarboxamides as acid ceramidase
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Jennifer Y.; Dergado, William F.; Jo, Hyunil; Beresis, Richard;
Adler, Marc
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023023156 A1 2023-02-23

$RFMT $RIREG SCHEME157 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-fluorobenzoic acid
C7H6FNO2
434-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6675 0.0 0
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0012 0.0 0
M  V30 4 F 2.3101 5.3350 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6675 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 3.0801 1.3338 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-4(3H)-quinazolinone
C8H5FN2O
436-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3338 0.0 0
M  V30 2 F 2.3100 0.0000 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 0.7700 2.6674 0.0 0
M  V30 6 C 3.0800 1.3338 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 N 2.3100 5.3349 0.0 0
M  V30 9 N 0.0000 4.0011 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 6
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 434-76-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 436-72-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21172833
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal (thermal condition (stage 2)), key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Potency of Pyruvate Dehydrogenase Complex E1
Inhibitors against Cyanobacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yuan; Feng, Jiangtao; He, Hongwu; Hou, Leifeng; Jiang, Wen; Xie,
Dan; Feng, Lingling; Cai, Meng; Peng, Hao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biochemistry (2017), 56(49), 6491-6502

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-(ethoxycarbonyl)-4-phenylthiophene
C13H13NO2S
4815-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6421 3.4209 0.0 0
M  V30 2 O 7.1485 3.1007 0.0 0
M  V30 3 O 5.1662 4.8856 0.0 0
M  V30 4 C 8.1789 4.2451 0.0 0
M  V30 5 C 9.6852 3.9249 0.0 0
M  V30 6 N 6.3386 0.1437 0.0 0
M  V30 7 C 3.0801 2.4374 0.0 0
M  V30 8 C 4.6116 2.2765 0.0 0
M  V30 9 C 2.4536 1.0306 0.0 0
M  V30 10 C 4.9318 0.7700 0.0 0
M  V30 11 S 3.5981 0.0000 0.0 0
M  V30 12 C 2.3100 3.7711 0.0 0
M  V30 13 C 3.0801 5.1049 0.0 0
M  V30 14 C 0.7700 3.7711 0.0 0
M  V30 15 C 2.3100 6.4386 0.0 0
M  V30 16 C 0.0000 5.1049 0.0 0
M  V30 17 C 0.7700 6.4386 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Phenylthieno[2,3-d]pyrimidin-4(1H)-one
C12H8N2OS
35978-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5674 5.0873 0.0 0
M  V30 2 C 4.4197 1.8517 0.0 0
M  V30 3 C 3.0127 2.4782 0.0 0
M  V30 4 C 4.2588 0.3202 0.0 0
M  V30 5 C 1.9823 1.3337 0.0 0
M  V30 6 C 2.5369 3.9428 0.0 0
M  V30 7 S 2.7523 0.0000 0.0 0
M  V30 8 N 0.4760 1.6540 0.0 0
M  V30 9 N 1.0306 4.2631 0.0 0
M  V30 10 C 0.0000 3.1185 0.0 0
M  V30 11 C 5.7533 2.6217 0.0 0
M  V30 12 C 5.7533 4.1617 0.0 0
M  V30 13 C 7.0870 1.8517 0.0 0
M  V30 14 C 7.0870 4.9318 0.0 0
M  V30 15 C 8.4208 2.6217 0.0 0
M  V30 16 C 8.4208 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-36-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35978-39-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19726114
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of 6-Substituted
Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor
Receptor Kinase and Microtubule Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Romagnoli, Romeo; Prencipe, Filippo; Oliva, Paola; Baraldi, Stefania;
Baraldi, Pier Giovanni; Schiaffino Ortega, Santiago; Chayah, Mariem;
Kimatrai Salvador, Maria; Lopez-Cara, Luisa Carlota; Brancale, Andrea;
Ferla, Salvatore; Hamel, Ernest; Ronca, Roberto; Bortolozzi, Roberta;
Mariotto, Elena; Mattiuzzo, Elena; Viola, Giampietro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(3), 1274-1290

$RFMT $RIREG SCHEME159 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Amino-4,6-dimethylthieno[2,3-b]pyridin-2-yl)ethanone
C11H12N2OS
52505-42-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.6840 4.8720 0.0 0
M  V30 2 C 4.3349 6.8291 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 C 8.9550 4.1618 0.0 0
M  V30 7 C 5.1049 2.8281 0.0 0
M  V30 8 C 4.3349 4.1618 0.0 0
M  V30 9 S 4.0743 1.6836 0.0 0
M  V30 10 N 6.6449 2.8281 0.0 0
M  V30 11 C 2.8284 3.8416 0.0 0
M  V30 12 C 5.1049 5.4954 0.0 0
M  V30 13 C 2.6675 2.3100 0.0 0
M  V30 14 C 7.4149 4.1618 0.0 0
M  V30 15 C 6.6449 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,7,9-Trimethylpyrido[3′,2′:4,5]thieno[3,2-d]pyrimidine
C12H11N3S
2226211-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3200 6.6772 0.0 0
M  V30 2 C 1.0849 0.0000 0.0 0
M  V30 3 C 8.9401 4.0097 0.0 0
M  V30 4 C 4.3200 4.0097 0.0 0
M  V30 5 C 2.8138 3.6896 0.0 0
M  V30 6 C 5.0901 2.6761 0.0 0
M  V30 7 C 5.0901 5.3434 0.0 0
M  V30 8 C 2.6527 2.1580 0.0 0
M  V30 9 N 1.5679 4.5948 0.0 0
M  V30 10 S 4.0596 1.5317 0.0 0
M  V30 11 N 6.6301 2.6761 0.0 0
M  V30 12 C 6.6301 5.3434 0.0 0
M  V30 13 C 1.2459 1.5315 0.0 0
M  V30 14 C 0.1609 3.9685 0.0 0
M  V30 15 C 7.4001 4.0097 0.0 0
M  V30 16 N 0.0000 2.4368 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 13
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 8 10
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52505-42-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2226211-49-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32657294
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3473-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of structurally distinct tricyclic M4 positive allosteric
modulator (PAM) chemotypes - Part 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Long, Madeline F.; Capstick, Rory A.; Spearing, Paul K.; Engers, Julie
L.; Gregro, Alison R.; Bollinger, Sean R.; Chang, Sichen; Luscombe,
Vincent B.; Rodriguez, Alice L.; Cho, Hyekyung P.; Niswender, Colleen M.;
Bridges, Thomas M.; Conn, P. Jeffrey; Lindsley, Craig W.; Engers, Darren
W.; Temple, Kayla J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 53128416

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodoanisole
C7H7IO
529-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 I 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxybenzonitrile
C8H7NO
6609-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 3.0800 1.3338 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 C 0.7700 2.6674 0.0 0
M  V30 9 C 0.7700 5.3349 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 529-28-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6609-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34483952
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-89-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-Catalyzed Cyanation of Aryl Iodides with Formamide as the Cyano
Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peng, Sha; Yang, Luo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Asian Journal of Organic Chemistry (2022), 11(11), e202200437

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodoanisole
C7H7IO
529-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 I 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxybenzonitrile
C8H7NO
6609-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 3.0800 1.3338 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 C 0.7700 2.6674 0.0 0
M  V30 9 C 0.7700 5.3349 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 529-28-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6609-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29362484
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyanides-free cyanation of aryl halides using formamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sawant, Dinesh N.; Wagh, Yogesh S.; Tambade, Pawan J.; Bhatte, Kushal D.;
Bhanage, Bhalchandra M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2011), 353(5), 781-787

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-(phenylmethyl)-2-pyrazinamine
C11H10ClN3
53265-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 Cl 3.0800 0.0000 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 N 2.3100 4.0011 0.0 0
M  V30 7 N 0.7700 1.3338 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 C 0.0000 2.6674 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 7.7000 2.6674 0.0 0
M  V30 12 C 7.7000 5.3349 0.0 0
M  V30 13 C 9.2400 2.6674 0.0 0
M  V30 14 C 9.2400 5.3349 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 10
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Phenylmethyl)-1H-imidazo[4,5-b]pyrazine
C12H10N4
1365094-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 1.3338 0.0 0
M  V30 2 C 2.9292 2.8284 0.0 0
M  V30 3 N 4.4608 2.6674 0.0 0
M  V30 4 C 2.6091 4.3348 0.0 0
M  V30 5 N 1.7849 1.7980 0.0 0
M  V30 6 C 5.0872 4.0742 0.0 0
M  V30 7 N 3.9427 5.1048 0.0 0
M  V30 8 N 1.1444 4.8107 0.0 0
M  V30 9 C 0.3202 2.2738 0.0 0
M  V30 10 C 0.0000 3.7801 0.0 0
M  V30 11 C 6.7708 1.3338 0.0 0
M  V30 12 C 7.5408 0.0000 0.0 0
M  V30 13 C 7.5408 2.6674 0.0 0
M  V30 14 C 9.0808 0.0000 0.0 0
M  V30 15 C 9.0808 2.6674 0.0 0
M  V30 16 C 9.8508 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 2 6 7
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 53265-33-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365094-36-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6925840
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved synthesis of imidazo[4,5-b]pyridines and
imidazo[4,5-b]pyrazines by palladium catalyzed amidation using xantphos
in a 1,4-Dioxane:tert-amyl alcohol aolvent aystem
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Ahmed, Ijaz; Wilson, Robert J.; Williams, Theresa M.;
Kaminsky, Lauren; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(16), 3465-3470

$RFMT $RIREG SCHEME162 STEP1
$RXN



  3  1
$MOL
2-Naphthalenecarboxaldehyde
C11H8O
66-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 2.6675 0.7700 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Toluenesulfinic acid
C7H8O2S
536-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.7700 1.3337 0.0 0 VAL=4
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[(4-Methylphenyl)sulfonyl]-2-naphthalenylmethyl]formamide
C19H17NO3S
1006877-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.8501 0.0 0
M  V30 2 S 8.0022 4.6201 0.0 0 VAL=6
M  V30 3 N 6.6685 2.3101 0.0 0
M  V30 4 O 8.7722 3.2864 0.0 0
M  V30 5 O 7.2322 5.9538 0.0 0
M  V30 6 C 5.3348 1.5400 0.0 0
M  V30 7 O 5.3348 0.0000 0.0 0
M  V30 8 C 13.3370 7.7002 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 4.0010 3.8501 0.0 0
M  V30 11 C 5.3348 6.1601 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 4.0010 6.9302 0.0 0
M  V30 14 C 2.6673 6.1601 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 16 C 1.3337 6.9302 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 18 C 0.0000 6.1601 0.0 0
M  V30 19 C 9.3360 5.3901 0.0 0
M  V30 20 C 10.6697 4.6201 0.0 0
M  V30 21 C 9.3360 6.9302 0.0 0
M  V30 22 C 12.0033 5.3901 0.0 0
M  V30 23 C 10.6697 7.7002 0.0 0
M  V30 24 C 12.0033 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 19
M  V30 7 1 3 6
M  V30 8 2 6 7
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 13 14
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 66-99-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1006877-07-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2926569
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalytic Asymmetric Synthesis of β-Aryl-β-isocyano Esters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morana, Fabio; Basso, Andrea; Bella, Marco; Riva, Renata; Banfi, Luca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2012), 354(11-12), 2199-2210,
S2199/1-S2199/39

$RFMT $RIREG SCHEME163 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluorobenzeneacetaldehyde
C8H7FO
75321-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 F 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Toluenesulfinic acid
C7H8O2S
536-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.7700 1.3337 0.0 0 VAL=4
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-α-[(4-methylphenyl)sulfonyl]benzenepropanenitrile
C16H14FNO2S
908139-62-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0011 0.0 0 VAL=6
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 O 6.9300 2.4611 0.0 0
M  V30 4 O 6.9300 5.5411 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 4.6200 5.3347 0.0 0
M  V30 7 N 3.8500 6.6685 0.0 0
M  V30 8 C 13.0900 4.0011 0.0 0
M  V30 9 F 3.0800 0.0000 0.0 0
M  V30 10 C 8.4700 4.0011 0.0 0
M  V30 11 C 9.2400 2.6674 0.0 0
M  V30 12 C 9.2400 5.3347 0.0 0
M  V30 13 C 10.7800 2.6674 0.0 0
M  V30 14 C 10.7800 5.3347 0.0 0
M  V30 15 C 11.5500 4.0011 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 2.3100 1.3338 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 0.7700 1.3338 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 16
M  V30 8 3 6 7
M  V30 9 1 8 15
M  V30 10 1 9 17
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75321-85-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 908139-62-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28534061
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of pyrroloimidazoles as agents stimulating neurite outgrowth
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beck, Barbara; Leppert, Christian A.; Mueller, Bernhard K.; Doemling,
Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM QSAR & Combinatorial Science (2006), 25(5-6), 527-535

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chlorobenzonitrile
C7H5ClN2
5922-60-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 3.0801 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6687 3.0801 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-4-quinazolinamine
C8H6ClN3
19808-35-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 0.0000 0.0 0
M  V30 2 Cl 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 10
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5922-60-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19808-35-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21090928
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 4 -synthesis of 4-amino-6-chloro-quinazoline A solution of
2-amino-5-chlorobenzonitrile (1.07 g, 7.0 mmol) in formamide (20 ml) was
heated at 180 °C for 6 hours. After cooling to room temperature, water
(30 ml) was added to the reaction mixture. The precipitate was collected
by filtration, washed with water and dried over P2O5, yielding the title
compound as a grey solid (1.2 g, yield: 95 %) which was characterized by
its mass spectrum as follows. MS (m/z): 180 ([M+H]+, 100).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4,6-Di- AND 2,4,6-trisubstituted quinazoline derivatives useful for
treating viral infection and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Ling-Jie; Herdewijn, Piet Andre Maurits Maria; De Jonghe, Steven
Cesar Alfons; Watkins, William John; Chong, Lee Shun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008009078 A2 2008-01-24

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chlorobenzonitrile
C7H5ClN2
5922-60-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 3.0801 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6687 3.0801 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-4-quinazolinamine
C8H6ClN3
19808-35-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 0.0000 0.0 0
M  V30 2 Cl 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 10
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5922-60-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19808-35-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21087802
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM synthesis of 4-amino-6-chloro-quinazoline. A solution of
2-amino-5-chlorobenzonitrile (1.07 g,7.0 mmol) in formamide(20 ml) was
heated at 180 °C for 6 hours. After cooling to room temperature, water
(30 ml) was added to the reaction mixture. The precipitate was collected
by filtration, washed with water and dried over P2O5, yielding the title
compound as a grey solid (1.2 g,yield: 95%) which was characterized by
its mass spectrum as follows:. MS (m/z):180 ([M+H]+, 100)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4,6-Di- AND 2,4,6-trisubstituted quinazoline derivatives useful for
treating viral infection and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Ling-Jie; Herdewijn, Piet Andre Maurits Maria; De Jonghe, Steven
Cesar Alfons; Watkins, William John; Chong, Lee Shun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008009077 A2 2008-01-24

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Chlorophenyl)-2,4-dihydro-5-phenyl-3H-pyrazol-3-one
C15H11ClN2O
60798-13-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0157 0.0000 0.0 0
M  V30 2 Cl 12.3670 5.6420 0.0 0
M  V30 3 N 7.0322 2.5620 0.0 0
M  V30 4 N 5.6252 3.1885 0.0 0
M  V30 5 C 6.8711 1.0304 0.0 0
M  V30 6 C 4.5948 2.0439 0.0 0
M  V30 7 C 5.3648 0.7103 0.0 0
M  V30 8 C 8.3659 3.3320 0.0 0
M  V30 9 C 8.3659 4.8720 0.0 0
M  V30 10 C 9.6995 2.5620 0.0 0
M  V30 11 C 9.6995 5.6420 0.0 0
M  V30 12 C 11.0332 3.3320 0.0 0
M  V30 13 C 11.0332 4.8720 0.0 0
M  V30 14 C 3.0633 2.2048 0.0 0
M  V30 15 C 2.1580 0.9590 0.0 0
M  V30 16 C 2.4368 3.6118 0.0 0
M  V30 17 C 0.6265 1.1201 0.0 0
M  V30 18 C 0.9052 3.7727 0.0 0
M  V30 19 C 0.0000 2.5269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Chlorophenyl)-4-[[1-(4-chlorophenyl)-5-hydroxy-3-phenyl-1H-pyrazol-4-yl]...
C31H20Cl2N4O2
1311144-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8393 9.8150 0.0 0
M  V30 2 O 7.8085 7.1044 0.0 0
M  V30 3 O 8.3291 7.5732 0.0 0
M  V30 4 Cl 7.2669 0.0000 0.0 0
M  V30 5 Cl 15.4513 7.3692 0.0 0
M  V30 6 C 3.8987 7.8744 0.0 0
M  V30 7 C 5.3634 8.3503 0.0 0
M  V30 8 N 3.8987 6.3344 0.0 0
M  V30 9 C 6.2685 7.1044 0.0 0
M  V30 10 N 5.3634 5.8586 0.0 0
M  V30 11 C 2.6528 8.7797 0.0 0
M  V30 12 C 1.2459 8.1533 0.0 0
M  V30 13 C 2.8138 10.3112 0.0 0
M  V30 14 C 0.0000 9.0586 0.0 0
M  V30 15 C 1.5679 11.2164 0.0 0
M  V30 16 C 0.1611 10.5901 0.0 0
M  V30 17 C 7.3456 10.1352 0.0 0
M  V30 18 C 7.9721 11.5420 0.0 0
M  V30 19 C 8.4901 9.1048 0.0 0
M  V30 20 N 9.5036 11.3811 0.0 0
M  V30 21 N 9.8238 9.8748 0.0 0
M  V30 22 C 5.8393 4.3938 0.0 0
M  V30 23 C 4.8087 3.2494 0.0 0
M  V30 24 C 7.3456 4.0737 0.0 0
M  V30 25 C 5.2847 1.7847 0.0 0
M  V30 26 C 7.8215 2.6091 0.0 0
M  V30 27 C 6.7910 1.4646 0.0 0
M  V30 28 C 7.2021 12.8758 0.0 0
M  V30 29 C 7.9721 14.2095 0.0 0
M  V30 30 C 5.6620 12.8758 0.0 0
M  V30 31 C 7.2021 15.5431 0.0 0
M  V30 32 C 4.8920 14.2095 0.0 0
M  V30 33 C 5.6620 15.5431 0.0 0
M  V30 34 C 11.2306 9.2483 0.0 0
M  V30 35 C 12.4766 10.1535 0.0 0
M  V30 36 C 11.3917 7.7167 0.0 0
M  V30 37 C 13.8835 9.5272 0.0 0
M  V30 38 C 12.7985 7.0904 0.0 0
M  V30 39 C 14.0444 7.9956 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 1 17 CFG=2
M  V30 3 1 2 9
M  V30 4 2 3 19
M  V30 5 1 4 27
M  V30 6 1 5 39
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 11
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 1 10 22
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 1 18 28
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 1 21 34
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 60798-13-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1311144-36-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-329-CAS-14440103
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Vilsmeier-type methylenation reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Vilsmeier-type methylenation for synthesis of dipyrazolylmethane
derivatives using formamide or N-methylformamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(21), 3863-3867

$RFMT $RIREG SCHEME166 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroquinoline
C9H6ClN
611-35-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.0010 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-quinolinecarboxamide
C10H7ClN2O
4203-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 C 6.6685 4.6200 0.0 0
M  V30 3 N 8.0021 3.8500 0.0 0
M  V30 4 O 6.6685 6.1600 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 N 4.0011 4.6200 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 1.3336 1.5400 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-35-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4203-20-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-095-CAS-21362579
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7727-54-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, photochemical, sealed vial used, CFl lamp 23 W used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct α-heteroarylation of amides (α to nitrogen) and ethers through a
benzaldehyde-mediated photoredox reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yongqiang; Teuscher, Kevin B.; Ji, Haitao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2016), 7(3), 2111-2118

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Bis(4-chlorophenyl)-1H-pyrazol-5-amine
C15H11Cl2N3
618092-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.3514 0.0000 0.0 0
M  V30 2 Cl 0.0000 5.6421 0.0 0
M  V30 3 Cl 13.8985 2.6878 0.0 0
M  V30 4 N 5.3348 2.5620 0.0 0
M  V30 5 N 6.7417 3.1885 0.0 0
M  V30 6 C 5.4958 1.0304 0.0 0
M  V30 7 C 7.7721 2.0439 0.0 0
M  V30 8 C 7.0021 0.7103 0.0 0
M  V30 9 C 4.0010 3.3320 0.0 0
M  V30 10 C 4.0010 4.8721 0.0 0
M  V30 11 C 2.6673 2.5620 0.0 0
M  V30 12 C 2.6673 5.6421 0.0 0
M  V30 13 C 1.3337 3.3320 0.0 0
M  V30 14 C 1.3337 4.8721 0.0 0
M  V30 15 C 9.3038 2.2049 0.0 0
M  V30 16 C 10.2090 0.9590 0.0 0
M  V30 17 C 9.9301 3.6118 0.0 0
M  V30 18 C 11.7406 1.1201 0.0 0
M  V30 19 C 11.4617 3.7728 0.0 0
M  V30 20 C 12.3669 2.5269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 14
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 7 15
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Bis(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidine
C17H10Cl2N4
1410783-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 7.5409 0.0 0
M  V30 2 Cl 13.8985 4.5867 0.0 0
M  V30 3 C 5.3348 4.4608 0.0 0
M  V30 4 C 5.4957 2.9293 0.0 0
M  V30 5 N 6.7416 5.0873 0.0 0
M  V30 6 C 7.0021 2.6091 0.0 0
M  V30 7 C 4.4653 1.7849 0.0 0
M  V30 8 N 7.7721 3.9428 0.0 0
M  V30 9 N 7.4781 1.1444 0.0 0
M  V30 10 N 4.9412 0.3202 0.0 0
M  V30 11 C 6.4475 0.0000 0.0 0
M  V30 12 C 4.0010 5.2309 0.0 0
M  V30 13 C 2.6673 4.4608 0.0 0
M  V30 14 C 4.0010 6.7709 0.0 0
M  V30 15 C 1.3337 5.2309 0.0 0
M  V30 16 C 2.6673 7.5409 0.0 0
M  V30 17 C 1.3337 6.7709 0.0 0
M  V30 18 C 9.3038 4.1037 0.0 0
M  V30 19 C 10.2090 2.8578 0.0 0
M  V30 20 C 9.9301 5.5107 0.0 0
M  V30 21 C 11.7406 3.0188 0.0 0
M  V30 22 C 11.4617 5.6716 0.0 0
M  V30 23 C 12.3669 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 23
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 8 18
M  V30 13 1 9 11
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 618092-72-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1410783-56-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-7994201
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloroquinoline
C9H6ClN
635-27-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.0010 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 N 4.6201 1.3337 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-quinolinecarboxamide
C10H7ClN2O
908109-06-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.8500 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 N 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 N 5.3347 3.8500 0.0 0
M  V30 8 C 4.0011 6.1600 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 2.6674 6.9300 0.0 0
M  V30 13 C 1.3336 6.1600 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 635-27-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 908109-06-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-095-CAS-21371179
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7727-54-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, photochemical, sealed vial used, CFl lamp 23 W used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct α-heteroarylation of amides (α to nitrogen) and ethers through a
benzaldehyde-mediated photoredox reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yongqiang; Teuscher, Kevin B.; Ji, Haitao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2016), 7(3), 2111-2118

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene]acetate
C10H11ClN2O3
70736-27-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 N 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 Cl 9.3360 0.0000 0.0 0
M  V30 6 O 12.0033 1.5400 0.0 0
M  V30 7 O 10.6697 3.8501 0.0 0
M  V30 8 C 13.3370 2.3101 0.0 0
M  V30 9 O 1.3337 4.6201 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 4.0010 1.5400 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-(4-methoxyphenyl)-1H-1,2,4-triazole-3-carboxylate
C11H11N3O3
57226-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.5456 1.5317 0.0 0
M  V30 2 O 11.9526 2.1580 0.0 0
M  V30 3 O 10.3847 0.0000 0.0 0
M  V30 4 C 13.1984 1.2528 0.0 0
M  V30 5 O 0.7700 3.2067 0.0 0
M  V30 6 C 0.0000 4.5405 0.0 0
M  V30 7 N 6.9300 3.2067 0.0 0
M  V30 8 N 7.8352 1.9609 0.0 0
M  V30 9 C 7.8352 4.4528 0.0 0
M  V30 10 C 9.2998 2.4367 0.0 0
M  V30 11 N 9.2998 3.9767 0.0 0
M  V30 12 C 5.3900 3.2067 0.0 0
M  V30 13 C 4.6200 4.5405 0.0 0
M  V30 14 C 4.6200 1.8731 0.0 0
M  V30 15 C 3.0800 4.5405 0.0 0
M  V30 16 C 3.0800 1.8731 0.0 0
M  V30 17 C 2.3100 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 70736-27-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 57226-99-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28691620
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile One-Pot Synthesis of Methyl
1-Aryl-1H-1,2,4-triazole-3-carboxylates from Nitrilimines with Vilsmeier
Reagent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsai, Shuo-En; Chiang, Kun-Heng; Tseng, Ching-Chun; Chen, Nai-Wei; Chern,
Ching-Yuh; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(8), 1754-1762

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromophenyl)-3-phenyl-1H-pyrazol-5-amine
C15H12BrN3
72411-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0157 0.0000 0.0 0
M  V30 2 Br 12.3670 5.6420 0.0 0
M  V30 3 N 7.0322 2.5620 0.0 0
M  V30 4 N 5.6252 3.1885 0.0 0
M  V30 5 C 6.8711 1.0304 0.0 0
M  V30 6 C 4.5948 2.0439 0.0 0
M  V30 7 C 5.3648 0.7103 0.0 0
M  V30 8 C 8.3659 3.3320 0.0 0
M  V30 9 C 8.3659 4.8720 0.0 0
M  V30 10 C 9.6995 2.5620 0.0 0
M  V30 11 C 9.6995 5.6420 0.0 0
M  V30 12 C 11.0332 3.3320 0.0 0
M  V30 13 C 11.0332 4.8720 0.0 0
M  V30 14 C 3.0633 2.2048 0.0 0
M  V30 15 C 2.1580 0.9590 0.0 0
M  V30 16 C 2.4368 3.6118 0.0 0
M  V30 17 C 0.6265 1.1201 0.0 0
M  V30 18 C 0.9052 3.7727 0.0 0
M  V30 19 C 0.0000 2.5269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromophenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C17H11BrN4
1400634-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 12.3669 7.5408 0.0 0
M  V30 2 N 7.0321 4.4608 0.0 0
M  V30 3 C 6.8711 2.9292 0.0 0
M  V30 4 N 5.6252 5.0873 0.0 0
M  V30 5 C 5.3648 2.6091 0.0 0
M  V30 6 N 7.9016 1.7849 0.0 0
M  V30 7 C 4.5948 3.9427 0.0 0
M  V30 8 C 4.8889 1.1444 0.0 0
M  V30 9 C 7.4258 0.3202 0.0 0
M  V30 10 N 5.9193 0.0000 0.0 0
M  V30 11 C 8.3658 5.2308 0.0 0
M  V30 12 C 9.6994 4.4608 0.0 0
M  V30 13 C 8.3658 6.7708 0.0 0
M  V30 14 C 11.0331 5.2308 0.0 0
M  V30 15 C 9.6994 7.5408 0.0 0
M  V30 16 C 11.0331 6.7708 0.0 0
M  V30 17 C 3.0632 4.1037 0.0 0
M  V30 18 C 2.1580 2.8578 0.0 0
M  V30 19 C 2.4368 5.5106 0.0 0
M  V30 20 C 0.6265 3.0187 0.0 0
M  V30 21 C 0.9052 5.6715 0.0 0
M  V30 22 C 0.0000 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72411-50-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-64-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-14705065
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromophenyl)-3-phenyl-1H-pyrazol-5-amine
C15H12BrN3
72411-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0157 0.0000 0.0 0
M  V30 2 Br 12.3670 5.6420 0.0 0
M  V30 3 N 7.0322 2.5620 0.0 0
M  V30 4 N 5.6252 3.1885 0.0 0
M  V30 5 C 6.8711 1.0304 0.0 0
M  V30 6 C 4.5948 2.0439 0.0 0
M  V30 7 C 5.3648 0.7103 0.0 0
M  V30 8 C 8.3659 3.3320 0.0 0
M  V30 9 C 8.3659 4.8720 0.0 0
M  V30 10 C 9.6995 2.5620 0.0 0
M  V30 11 C 9.6995 5.6420 0.0 0
M  V30 12 C 11.0332 3.3320 0.0 0
M  V30 13 C 11.0332 4.8720 0.0 0
M  V30 14 C 3.0633 2.2048 0.0 0
M  V30 15 C 2.1580 0.9590 0.0 0
M  V30 16 C 2.4368 3.6118 0.0 0
M  V30 17 C 0.6265 1.1201 0.0 0
M  V30 18 C 0.9052 3.7727 0.0 0
M  V30 19 C 0.0000 2.5269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromophenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C17H11BrN4
1400634-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 12.3669 7.5408 0.0 0
M  V30 2 N 7.0321 4.4608 0.0 0
M  V30 3 C 6.8711 2.9292 0.0 0
M  V30 4 N 5.6252 5.0873 0.0 0
M  V30 5 C 5.3648 2.6091 0.0 0
M  V30 6 N 7.9016 1.7849 0.0 0
M  V30 7 C 4.5948 3.9427 0.0 0
M  V30 8 C 4.8889 1.1444 0.0 0
M  V30 9 C 7.4258 0.3202 0.0 0
M  V30 10 N 5.9193 0.0000 0.0 0
M  V30 11 C 8.3658 5.2308 0.0 0
M  V30 12 C 9.6994 4.4608 0.0 0
M  V30 13 C 8.3658 6.7708 0.0 0
M  V30 14 C 11.0331 5.2308 0.0 0
M  V30 15 C 9.6994 7.5408 0.0 0
M  V30 16 C 11.0331 6.7708 0.0 0
M  V30 17 C 3.0632 4.1037 0.0 0
M  V30 18 C 2.1580 2.8578 0.0 0
M  V30 19 C 2.4368 5.5106 0.0 0
M  V30 20 C 0.6265 3.0187 0.0 0
M  V30 21 C 0.9052 5.6715 0.0 0
M  V30 22 C 0.0000 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72411-50-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-64-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29519913
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
Pyrazolo[3,4-d]-pyrimidines (17-32, 65, 66, and 73-76). The reliable
procedure involved the treatment of 5-aminopyrazoles (1-16; 1.0 equiv),
5- amino-4-formylpyrazoles (37-41; 1.0 equiv), 5-aminoquinoline (61; 1.0
equiv), 8-aminoquinoline (62; 1.0 equiv), 5-aminopyrimidine (68; 1.0
equiv), or 2-aminopyrazines (69-71; 1.0 equiv) with PBr3 (~ 3 equiv) in
formamide solution (2 mL) at 50-60 °C over 0.5-1 h. When the reaction was
complete, the reaction mixture was added to saturated sodium bicarbonate
(15 mL) and extracted with dichloromethane (15 mL). The organic extracts
were dried over MgSO4, filtered, and concentrated under reduced pressure.
The residue solution was purified by column chromatography on silica gel
to give the corresponding aromatic or heterocyclic fused pyrimidine
products (17-32, 65, 66, and 73-76) in 82-96% yields.
1-(4-Bromophenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine (24). The
standard procedure involved the treatment of
5-amino-1-(4-bromophenyl)-3-phenyl-1H-pyrazole (8; 102 mg, 0.29 mmol, 1.0
equiv) with PBr3 (80 μL, 0.87 mmol, 3.0 equiv) in formamide solution (2
mL) at 50-60 °C over 0.5-1.0 h. The reaction mixture was then worked up,
and the residue was purified by chromatography on silica gel to give pure
24: 95% yield (96 mg), yellow solid. Mp 176-177 °C (hexane-EtOAc). 1H NMR
(CDCl3, 500 MHz): δ 7.45-7.57 (3H, m), 7.60-7.66 (2H, m), 7.98-8.06 (2H,
m), 8.21-8.29 (2H, m), 9.10 (1H, s), 9.47 (1H, s). 13C NMR (125 MHz,
CDCl3): δ 114.3, 120.0, 122.4 (2 × C), 127.3 (2 × C), 129.2 (2 × C),
130.0, 131.2, 132.2 (2 × C), 137.6, 145.2, 152.8, 153.4, 155.6. IR (KBr):
2374, 2347, 1585, 1495, 1398, 1389, 1215, 1072 cm-1. EIMS m/z (rel int):
350 (100, M+). Anal. Calcd for C17H11BrN4: C, 58.14; H, 3.16; N, 15.95.
Found: C, 58.16; H, 3.18; N, 15.91.
$DTYPE RXN:VAR(1):NOTES
$DATUM sequential three-component heterocyclization, one-pot multi-component
process
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-N-phenyl-N-(phenylmethyl)-2-propenamide
C17H17NO
74480-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 C 5.3900 1.3338 0.0 0
M  V30 5 O 3.0800 2.6674 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 6.9300 1.3338 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 7.7000 2.6674 0.0 0
M  V30 10 C 7.7000 5.3347 0.0 0
M  V30 11 C 9.2400 2.6674 0.0 0
M  V30 12 C 9.2400 5.3347 0.0 0
M  V30 13 C 10.0100 4.0011 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 0.7700 6.6685 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-3-methyl-2-oxo-1-(phenylmethyl)-1H-indole-3-acetamide
C18H18N2O2
2080376-95-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1105 2.6673 0.0 0
M  V30 2 C 3.3405 1.3337 0.0 0
M  V30 3 N 4.1105 0.0000 0.0 0
M  V30 4 O 1.8005 1.3337 0.0 0
M  V30 5 C 2.0946 3.0959 0.0 0
M  V30 6 C 5.7309 7.1895 0.0 0
M  V30 7 O 6.0811 3.8575 0.0 0
M  V30 8 C 2.3101 5.1456 0.0 0
M  V30 9 C 3.0801 6.4792 0.0 0
M  V30 10 C 3.3405 4.0010 0.0 0
M  V30 11 C 0.7700 5.1456 0.0 0
M  V30 12 N 4.5864 6.1591 0.0 0
M  V30 13 C 2.3101 7.8129 0.0 0
M  V30 14 C 4.7473 4.6275 0.0 0
M  V30 15 C 0.0000 6.4792 0.0 0
M  V30 16 C 0.7700 7.8129 0.0 0
M  V30 17 C 7.1955 6.7136 0.0 0
M  V30 18 C 8.3401 7.7441 0.0 0
M  V30 19 C 7.5157 5.2073 0.0 0
M  V30 20 C 9.8046 7.2682 0.0 0
M  V30 21 C 8.9804 4.7313 0.0 0
M  V30 22 C 10.1248 5.7619 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 6 17
M  V30 8 2 7 14
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74480-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2080376-95-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29627239
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7720-78-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Iron-Catalyzed Synthesis of Oxindoles: Application to the Preparation of
Pyrroloindolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Correia, Valquirio G.; Abreu, Juliana C.; Barata, Caio A. E.; Andrade,
Leandro H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(5), 1060-1063

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-chlorobenzoic acid
C7H6ClNO2
89-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-4(3H)-quinazolinone
C8H5ClN2O
31374-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 Cl 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 N 2.3101 0.0000 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31374-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21129501
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal (thermal condition (stage 2)), key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Potency of Pyruvate Dehydrogenase Complex E1
Inhibitors against Cyanobacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yuan; Feng, Jiangtao; He, Hongwu; Hou, Leifeng; Jiang, Wen; Xie,
Dan; Feng, Lingling; Cai, Meng; Peng, Hao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biochemistry (2017), 56(49), 6491-6502

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-chlorobenzoic acid
C7H6ClNO2
89-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-4(3H)-quinazolinone
C8H5ClN2O
31374-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 Cl 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 N 2.3101 0.0000 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31374-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12376188
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1318-93-0
$DTYPE RXN:VAR(1):NOTES
$DATUM solid state (catalyst), microwave, solvent-free
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave enhanced synthesis of quinazolines in solvent-free condition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Balalaie, Saeed; Sharifi, Ali; Ahangarian, Behzad; Kowsari, Elahe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocyclic Communications (2001), 7(4), 337-340

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-chlorobenzoic acid
C7H6ClNO2
89-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-4(3H)-quinazolinone
C8H5ClN2O
31374-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 Cl 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 N 2.3101 0.0000 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31374-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21444752
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and pharmacological evaluation of
6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2
receptor ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Yu-Tong; Wang, Gui-Fei; Yang, Yi-Qiu; Jin, Fujun; Wang, Yifei; Xie,
Xiao-Yang; Mach, Robert H.; Huang, Yun-Sheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 147227-237

$RFMT $RIREG SCHEME173 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxyaniline
C7H9NO
90-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 N 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-Bis(2-methoxyphenyl)methanimidamide
C15H16N2O2
68012-05-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9301 5.3348 0.0 0
M  V30 2 C 5.3901 5.3348 0.0 0
M  V30 3 N 4.6201 4.0011 0.0 0
M  V30 4 O 10.0101 5.3348 0.0 0
M  V30 5 C 11.5501 5.3348 0.0 0
M  V30 6 O 3.0800 1.3337 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 C 7.7001 6.6684 0.0 0
M  V30 9 C 9.2401 6.6684 0.0 0
M  V30 10 C 6.9301 8.0022 0.0 0
M  V30 11 C 10.0101 8.0022 0.0 0
M  V30 12 C 7.7001 9.3359 0.0 0
M  V30 13 C 9.2401 9.3359 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 2.3100 2.6675 0.0 0
M  V30 16 C 2.3100 5.3348 0.0 0
M  V30 17 C 0.7700 2.6675 0.0 0
M  V30 18 C 0.7700 5.3348 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 4 9
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-04-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68012-05-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29706519
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
N,N′-Diarylformamidines (50-56 and 73). The reliable procedure involved
the treatment of arylamines (43-49; 1.0 equiv) or 3-aminopyridine (68;
1.0 equiv) with PBr3 (~3.0 equiv) in formamide solution (2 mL) at 50-60
°C over 0.5-1.0 h. When the reaction was complete, the crude solid was
triturated in cold n-pentane and filtered through a glass frit with
suction. Then the solid was washed with n-pentane and dried in vacuo to
give the crude formamidines (50-56 and 73). The crude products were
recrystallized from the mixture of acetone and diisopropyl ether to give
the corresponding N,N′-diarylformamidine products (50-56 and 73) in
88-97% yields as white to light yellow solids.
N,N'-Bis(2-methoxyphenyl)formamidine (52)..20,33 The standard procedure
involved the treatment of 2-anisidine (45; 51 mg, 0.41 mmol, 1.0 equiv)
with PBr3 (0.12 mL, 1.2 mmol, 3.0 equiv) in formamide solution (2 mL) at
50-60 °C over 0.5-1.0 h. The reaction mixture was then worked up, and the
residue was purified by chromatography on silica gel to give pure 52: 95%
yield (100 mg), yellow solid. Mp 82-84 °C (CH2Cl2-methanol). 1H NMR
(CDCl3, 200 MHz): δ 3.67 (6H, s), 7.04-6.86 (8H, m), 7.95 (1H, s), 8.22
(1H, s). 13C NMR (50 MHz, CDCl3): δ 55.6, 56.2, 110.9, 117.1 (2 × C),
121.0 (2 × C), 123.3 (2 × C), 134.5 (2 × C), 147.2, 150.1, 159.6, 162.7.
IR (KBr): 3315, 3126, 3037, 2987, 2889, 2813, 1664, 1591, 1459, 1300,
1236, 1021 cm-1. EIMS m/z (rel int): 256 (31, M+). Anal. Calcd for
C15H16N2O2: C, 70.29; H, 6.29; N, 10.93. Found: C, 70.33; H, 6.31; N,
10.96.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenecarboxylic acid, 3-amino-5-(4-nitrophenyl)-, methyl ester
C12H10N2O4S
91076-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6375 2.9016 0.0 0
M  V30 2 O 11.2640 4.3086 0.0 0
M  V30 3 O 11.5427 1.6557 0.0 0
M  V30 4 C 12.7955 4.4695 0.0 0
M  V30 5 N 8.9622 0.0000 0.0 0
M  V30 6 N 1.3337 6.3388 0.0 0 VAL=5
M  V30 7 O 1.3337 7.8788 0.0 0
M  V30 8 O 0.0000 5.5688 0.0 0
M  V30 9 C 6.6685 3.2587 0.0 0
M  V30 10 S 8.0755 3.8850 0.0 0
M  V30 11 C 6.8296 1.7271 0.0 0
M  V30 12 C 9.1059 2.7406 0.0 0
M  V30 13 C 8.3359 1.4070 0.0 0
M  V30 14 C 5.3348 4.0287 0.0 0
M  V30 15 C 5.3348 5.5688 0.0 0
M  V30 16 C 4.0012 3.2587 0.0 0
M  V30 17 C 4.0012 6.3388 0.0 0
M  V30 18 C 2.6675 4.0287 0.0 0
M  V30 19 C 2.6675 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 19
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Nitrophenyl)thieno[3,2-d]pyrimidin-4(3H)-one
C12H7N3O3S
722463-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 N 11.1973 3.0801 0.0 0 VAL=5
M  V30 3 O 11.9673 1.7464 0.0 0
M  V30 4 O 11.9673 4.4137 0.0 0
M  V30 5 C 5.0371 3.0801 0.0 0
M  V30 6 S 4.1321 1.8342 0.0 0
M  V30 7 C 4.1321 4.3260 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 2.6673 3.8501 0.0 0
M  V30 10 C 1.3337 1.5400 0.0 0
M  V30 11 N 1.3337 4.6201 0.0 0
M  V30 12 N 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 14 C 6.5772 3.0801 0.0 0
M  V30 15 C 7.3472 4.4137 0.0 0
M  V30 16 C 7.3472 1.7464 0.0 0
M  V30 17 C 8.8872 4.4137 0.0 0
M  V30 18 C 8.8872 1.7464 0.0 0
M  V30 19 C 9.6572 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 19
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91076-99-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 722463-45-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19726107
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of 6-Substituted
Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor
Receptor Kinase and Microtubule Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Romagnoli, Romeo; Prencipe, Filippo; Oliva, Paola; Baraldi, Stefania;
Baraldi, Pier Giovanni; Schiaffino Ortega, Santiago; Chayah, Mariem;
Kimatrai Salvador, Maria; Lopez-Cara, Luisa Carlota; Brancale, Andrea;
Ferla, Salvatore; Hamel, Ernest; Ronca, Roberto; Bortolozzi, Roberta;
Mariotto, Elena; Mattiuzzo, Elena; Viola, Giampietro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(3), 1274-1290

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Hydroxycyclohexanecarbonitrile
C7H11NO
931-97-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1840 1.7145 0.0 0
M  V30 2 N 5.7006 1.9819 0.0 0
M  V30 3 O 3.1940 0.0000 0.0 0
M  V30 4 C 2.6673 1.4470 0.0 0
M  V30 5 C 2.6673 2.9870 0.0 0
M  V30 6 C 1.3337 0.6770 0.0 0
M  V30 7 C 1.3337 3.7571 0.0 0
M  V30 8 C 0.0000 1.4470 0.0 0
M  V30 9 C 0.0000 2.9870 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 4
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Cyanocyclohexyl)formamide
C8H12N2O
1125-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7572 2.5065 0.0 0
M  V30 2 C 4.9369 3.4963 0.0 0
M  V30 3 O 6.3840 2.9696 0.0 0
M  V30 4 C 2.0425 1.5166 0.0 0
M  V30 5 N 1.7752 0.0000 0.0 0
M  V30 6 C 2.3100 3.0332 0.0 0
M  V30 7 C 3.0800 4.3669 0.0 0
M  V30 8 C 0.7700 3.0332 0.0 0
M  V30 9 C 2.3100 5.7006 0.0 0
M  V30 10 C 0.0000 4.3669 0.0 0
M  V30 11 C 0.7700 5.7006 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 3 4 5
M  V30 5 1 4 6
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 931-97-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1125-02-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-22530563
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of substituted amino alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schaub, Thomas; Ernst, Martin; Calleja, Pilar; Hashmi, A. Stephen K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020094454 A1 2020-05-14

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Hydroxycyclohexanecarbonitrile
C7H11NO
931-97-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1840 1.7145 0.0 0
M  V30 2 N 5.7006 1.9819 0.0 0
M  V30 3 O 3.1940 0.0000 0.0 0
M  V30 4 C 2.6673 1.4470 0.0 0
M  V30 5 C 2.6673 2.9870 0.0 0
M  V30 6 C 1.3337 0.6770 0.0 0
M  V30 7 C 1.3337 3.7571 0.0 0
M  V30 8 C 0.0000 1.4470 0.0 0
M  V30 9 C 0.0000 2.9870 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 4
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Cyanocyclohexyl)formamide
C8H12N2O
1125-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7572 2.5065 0.0 0
M  V30 2 C 4.9369 3.4963 0.0 0
M  V30 3 O 6.3840 2.9696 0.0 0
M  V30 4 C 2.0425 1.5166 0.0 0
M  V30 5 N 1.7752 0.0000 0.0 0
M  V30 6 C 2.3100 3.0332 0.0 0
M  V30 7 C 3.0800 4.3669 0.0 0
M  V30 8 C 0.7700 3.0332 0.0 0
M  V30 9 C 2.3100 5.7006 0.0 0
M  V30 10 C 0.0000 4.3669 0.0 0
M  V30 11 C 0.7700 5.7006 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 3 4 5
M  V30 5 1 4 6
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 931-97-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1125-02-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-20235088
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ruthenium-Catalyzed Deaminative Hydrogenation of Amino Nitriles: Direct
Access to 1,2-Amino Alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Calleja, Pilar; Ernst, Martin; Hashmi, A. Stephen K.; Schaub, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2019), 25(40), 9498-9503

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanone, 2-bromo-1-(5-ethyl-3-phenyl-4-isoxazolyl)-
C13H12BrNO2
943327-53-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 2.6092 0.0 0
M  V30 2 C 6.0798 1.4647 0.0 0
M  V30 3 O 3.5429 2.2889 0.0 0
M  V30 4 Br 5.6039 0.0000 0.0 0
M  V30 5 C 8.2358 3.6444 0.0 0
M  V30 6 C 9.6426 4.2709 0.0 0
M  V30 7 C 4.6200 5.3196 0.0 0
M  V30 8 C 5.5252 4.0738 0.0 0
M  V30 9 N 5.5252 6.5655 0.0 0
M  V30 10 C 6.9898 4.5496 0.0 0
M  V30 11 O 6.9898 6.0896 0.0 0
M  V30 12 C 3.0800 5.3196 0.0 0
M  V30 13 C 2.3100 6.6534 0.0 0
M  V30 14 C 2.3100 3.9860 0.0 0
M  V30 15 C 0.7700 6.6533 0.0 0
M  V30 16 C 0.7700 3.9860 0.0 0
M  V30 17 C 0.0000 5.3196 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Ethyl-4-(1H-imidazol-5-yl)-3-phenylisoxazole
C14H13N3O
943327-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2358 3.5272 0.0 0
M  V30 2 C 9.6426 4.1535 0.0 0
M  V30 3 C 5.5252 3.9564 0.0 0
M  V30 4 C 4.6200 5.2023 0.0 0
M  V30 5 C 6.9898 4.4323 0.0 0
M  V30 6 N 5.5252 6.4483 0.0 0
M  V30 7 O 6.9898 5.9723 0.0 0
M  V30 8 C 5.0494 2.4919 0.0 0
M  V30 9 C 3.5847 2.0160 0.0 0
M  V30 10 N 5.9546 1.2460 0.0 0
M  V30 11 N 3.5847 0.4760 0.0 0
M  V30 12 C 5.0494 0.0000 0.0 0
M  V30 13 C 3.0800 5.2023 0.0 0
M  V30 14 C 2.3100 3.8686 0.0 0
M  V30 15 C 2.3100 6.5361 0.0 0
M  V30 16 C 0.7700 3.8686 0.0 0
M  V30 17 C 0.7700 6.5361 0.0 0
M  V30 18 C 0.0000 5.2023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 1 4 13
M  V30 8 1 5 7
M  V30 9 1 6 7
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 943327-53-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 943327-54-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26481152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) 5-Ethyl-4-(1H-imidazol-4-yl)-3-phenyl-isoxazole A mixture of
2-bromo-1-(5-ethyl-3-phenyl-isoxazol-4-yl)-ethanone (0.47 g, 2 mmol) and
formamide (5 mL) was heated at 160 °C overnight. After cooling to room
temperature, water (20 mL) was then added and the resulting mixture
extracted with ethyl acetate. The combined organic extracts were then
evaporated to leave the title compound (0.45 g, 95%) as a brown solid.
MS: m/e = 240.1 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylisoxazolyl imidazoles as GABAA α5 receptor ligands for
the treatment of cognitive disorder and Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buettelmann, Bernd; Han, Bo; Knust, Henner; Thomas, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007074078 A2 2007-07-05

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1-(5-bromo-2-chloro-3-pyridinyl)-2-(2,3-dichlorophenyl)ethanone
C13H6Br2Cl3NO
951259-12-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.8500 0.0 0
M  V30 2 C 4.0011 4.6200 0.0 0
M  V30 3 Br 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 6.1600 0.0 0
M  V30 5 Cl 8.0021 2.3100 0.0 0
M  V30 6 Cl 10.6694 3.8500 0.0 0
M  V30 7 Cl 1.3336 6.1600 0.0 0
M  V30 8 Br 1.3336 0.0000 0.0 0
M  V30 9 C 6.6684 4.6200 0.0 0
M  V30 10 C 8.0021 3.8500 0.0 0
M  V30 11 C 6.6684 6.1600 0.0 0
M  V30 12 C 9.3358 4.6200 0.0 0
M  V30 13 C 8.0021 6.9300 0.0 0
M  V30 14 C 9.3358 6.1600 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 1.3336 4.6200 0.0 0
M  V30 17 C 2.6673 2.3100 0.0 0
M  V30 18 N 0.0000 3.8500 0.0 0
M  V30 19 C 1.3336 1.5400 0.0 0
M  V30 20 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 5 10
M  V30 7 1 6 12
M  V30 8 1 7 16
M  V30 9 1 8 19
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloro-3-[5-(2,3-dichlorophenyl)-4-thiazolyl]pyridine
C14H6BrCl3N2S
951259-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 7.0035 7.2400 0.0 0
M  V30 2 Cl 0.0000 4.1220 0.0 0
M  V30 3 Cl 9.6709 5.7000 0.0 0
M  V30 4 Br 4.5778 0.0000 0.0 0
M  V30 5 C 4.3362 5.7000 0.0 0
M  V30 6 C 2.9292 5.0737 0.0 0
M  V30 7 S 4.1752 7.2317 0.0 0
M  V30 8 N 1.8988 6.2181 0.0 0
M  V30 9 C 2.6688 7.5519 0.0 0
M  V30 10 C 5.6698 4.9300 0.0 0
M  V30 11 C 7.0035 5.7000 0.0 0
M  V30 12 C 5.6698 3.3900 0.0 0
M  V30 13 C 8.3373 4.9300 0.0 0
M  V30 14 C 7.0035 2.6200 0.0 0
M  V30 15 C 8.3373 3.3900 0.0 0
M  V30 16 C 2.6091 3.5673 0.0 0
M  V30 17 C 1.1445 3.0914 0.0 0
M  V30 18 C 3.7536 2.5368 0.0 0
M  V30 19 N 0.8244 1.5851 0.0 0
M  V30 20 C 3.4334 1.0306 0.0 0
M  V30 21 C 1.9687 0.5547 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 17
M  V30 3 1 3 13
M  V30 4 1 4 20
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 6 16
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951259-12-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951259-13-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10543465
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1314-80-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Formamide (528 μL, 13.3 mmol) and P2S5 (6.5 .g, 14.63 mmol) were stirred
in acetonitrile for 30 minutes, until the suspension became an
unstirrable paste. The supernatant was decanted and added to an
acetonitrile solution of
2-bromo-1-(5-bromo-2-chloropyridin-3-yl)-2-(2,3-dichlorophenyl)ethanone
(0.609 g,1.33 mmol). The reaction mixture was stirred at room temperature
overnight. The solids were removed by filtration, rinsed with methylene
chloride, and the filtrate was concentrated and taken up in ethyl ether.
The organics were filtered through silica, which was washed with diethyl
ether. The filtrate was concentrated and the product obtained by
crystallization from hexanes/ether to provide
5-bromo-2-chloro-3-(5-(2,3-dichlorophenyl)thiazol-4-yl)pyridine as a
white solid [532 mg, 95 % yield].
5-bromo-2-chloro-3-(5-(2,3-dichlorophenyl)thiazol-4-yl)pyridine, yield
532 mg, 95 % LC-MS, M+H = 419.0; 1H-NMR (300 MHz, CDCl3) 8.51 (1H, s),
8.36 (1H, d), 7.78 (1H, d), 7.42 (1H, dd), 7.01-7.11 (2H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrazolyl (or triazolyl) substituted pyridinamines or
pyrimidinamines as c-Met protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lauffer, David J.; Davies, Robert J.; Stamos, Dean; Aronov, Alexander;
Deininger, David D.; Grey, Ronald, Jr.; Xu, Jinwang; Li, Pan; Ledford,
Brian; Farmer, Luc; Bethiel, Randy Scott; Jacobs, Dylan; Mcginty, Kira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007111904 A2 2007-10-04

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-2-[2-(3-methylphenyl)hydrazinylidene]acetate
C10H11ClN2O2
96722-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 Cl 8.0022 0.0000 0.0 0
M  V30 6 O 10.6697 1.5400 0.0 0
M  V30 7 O 9.3360 3.8501 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-(3-methylphenyl)-1H-1,2,4-triazole-3-carboxylate
C11H11N3O2
2106294-10-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3037 3.4372 0.0 0
M  V30 2 O 10.2090 4.6831 0.0 0
M  V30 3 O 9.9301 2.0302 0.0 0
M  V30 4 C 11.7405 4.5220 0.0 0
M  V30 5 C 0.0000 3.0800 0.0 0
M  V30 6 N 5.3348 3.0800 0.0 0
M  V30 7 N 6.7416 2.4536 0.0 0
M  V30 8 C 5.4957 4.6116 0.0 0
M  V30 9 C 7.7722 3.5981 0.0 0
M  V30 10 N 7.0022 4.9318 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 2.6673 3.0800 0.0 0
M  V30 13 C 4.0011 0.7700 0.0 0
M  V30 14 C 1.3337 2.3100 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96722-49-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2106294-10-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24960819
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile One-Pot Synthesis of Methyl
1-Aryl-1H-1,2,4-triazole-3-carboxylates from Nitrilimines with Vilsmeier
Reagent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsai, Shuo-En; Chiang, Kun-Heng; Tseng, Ching-Chun; Chen, Nai-Wei; Chern,
Ching-Yuh; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(8), 1754-1762

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Bromoacetophenone
C8H7BrO
99-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Acetylbenzonitrile
C9H7NO
1443-80-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-90-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1443-80-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28647474
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Cyanation of Aryl Halides Using Formamide and
Cyanuric Chloride as a New "CN" Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niknam, Esmaeil; Panahi, Farhad; Khalafi-Nezhad, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2020), 2020(18), 2699-2707

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Diamino-6-hydroxy-2-mercaptopyrimidine
C4H6N4OS
1004-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 2.6674 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 S 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thioxanthine
C5H4N4OS
2487-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7036 0.0000 0.0 0
M  V30 2 S 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1004-76-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2487-40-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-12675847
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Alkyloxyalkylthiohypoxanthines as new potent inhibitors of xanthine
oxidase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Biagi, Giuliana; Giorgi, Irene; Pacchini, Federica; Livi, Oreste;
Scartoni, Valerio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Farmaco (2001), 56(11), 809-813

$RFMT $RIREG SCHEME181 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Azido-3-chlorobenzaldehyde
C7H4ClN3O
1224569-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 4.0010 0.0 0
M  V30 2 N 6.1601 4.0010 0.0 0 CHG=1 VAL=4
M  V30 3 N 7.7001 4.0010 0.0 0 CHG=-1
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 4.0010 0.0 0
M  V30 6 Cl 6.1601 1.3337 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Toluenesulfonic acid
C7H8O3S
104-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide, N-[(2-azido-3-chlorophenyl)[(4-methylphenyl)sulfonyl]methyl]-
C15H13ClN4O3S
2983187-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 S 7.7000 4.0011 0.0 0 VAL=6
M  V30 3 N 5.3900 2.6674 0.0 0
M  V30 4 O 7.7000 2.4611 0.0 0
M  V30 5 O 7.7000 5.5411 0.0 0
M  V30 6 C 6.1600 1.3336 0.0 0
M  V30 7 O 5.3900 0.0000 0.0 0
M  V30 8 N 3.0800 4.0011 0.0 0
M  V30 9 N 1.5400 4.0011 0.0 0 CHG=1 VAL=4
M  V30 10 N 0.0000 4.0011 0.0 0 CHG=-1
M  V30 11 Cl 1.5400 6.6685 0.0 0
M  V30 12 C 13.8600 4.0011 0.0 0
M  V30 13 C 5.3900 5.3347 0.0 0
M  V30 14 C 3.8500 5.3347 0.0 0
M  V30 15 C 6.1600 6.6685 0.0 0
M  V30 16 C 3.0800 6.6685 0.0 0
M  V30 17 C 5.3900 8.0021 0.0 0
M  V30 18 C 3.8500 8.0021 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 10.0100 5.3347 0.0 0
M  V30 21 C 10.0100 2.6674 0.0 0
M  V30 22 C 11.5500 5.3347 0.0 0
M  V30 23 C 11.5500 2.6674 0.0 0
M  V30 24 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 19
M  V30 7 1 3 6
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 14
M  V30 11 2 9 10
M  V30 12 1 11 16
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1224569-37-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2983187-77-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37740653
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,2,3-Benzotriazine Synthesis by Heterocyclization of p-Tosylmethyl
Isocyanide Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maqueda-Zelaya, Francisco; Acena, Jose Luis; Merino, Estibaliz; Vaquero,
Juan J.; Sucunza, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2023), 88(19), 14131-14139

$RFMT $RIREG SCHEME182 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Chlorophenyl)-2,4-dihydro-5-phenyl-3H-pyrazol-3-one
C15H11ClN2O
108124-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0176 7.1820 0.0 0
M  V30 2 Cl 1.3338 0.0000 0.0 0
M  V30 3 N 4.0011 4.6200 0.0 0
M  V30 4 N 5.4080 3.9935 0.0 0
M  V30 5 C 4.1620 6.1516 0.0 0
M  V30 6 C 6.4385 5.1381 0.0 0
M  V30 7 C 5.6685 6.4717 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 1.3338 4.6200 0.0 0
M  V30 11 C 1.3338 1.5400 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 7.9700 4.9772 0.0 0
M  V30 15 C 8.5965 3.5702 0.0 0
M  V30 16 C 8.8752 6.2230 0.0 0
M  V30 17 C 10.1280 3.4093 0.0 0
M  V30 18 C 10.4068 6.0619 0.0 0
M  V30 19 C 11.0332 4.6551 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Chlorophenyl)-4-[[1-(3-chlorophenyl)-5-hydroxy-3-phenyl-1H-pyrazol-4-yl]...
C31H20Cl2N4O2
1311144-34-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8391 9.1746 0.0 0
M  V30 2 O 7.8085 6.4640 0.0 0
M  V30 3 O 8.3290 6.9327 0.0 0
M  V30 4 Cl 4.2541 0.0000 0.0 0
M  V30 5 Cl 15.1290 9.7920 0.0 0
M  V30 6 C 5.3632 7.7099 0.0 0
M  V30 7 C 3.8985 7.2340 0.0 0
M  V30 8 C 6.2684 6.4640 0.0 0
M  V30 9 N 3.8985 5.6940 0.0 0
M  V30 10 N 5.3632 5.2182 0.0 0
M  V30 11 C 2.6527 8.1392 0.0 0
M  V30 12 C 1.2459 7.5129 0.0 0
M  V30 13 C 2.8136 9.6708 0.0 0
M  V30 14 C 0.0000 8.4180 0.0 0
M  V30 15 C 1.5677 10.5760 0.0 0
M  V30 16 C 0.1609 9.9497 0.0 0
M  V30 17 C 7.3455 9.4948 0.0 0
M  V30 18 C 7.9719 10.9016 0.0 0
M  V30 19 C 8.4899 8.4643 0.0 0
M  V30 20 N 9.5034 10.7406 0.0 0
M  V30 21 N 9.8236 9.2343 0.0 0
M  V30 22 C 5.8391 3.7535 0.0 0
M  V30 23 C 4.8087 2.6091 0.0 0
M  V30 24 C 7.3455 3.4333 0.0 0
M  V30 25 C 5.2845 1.1444 0.0 0
M  V30 26 C 7.8214 1.9687 0.0 0
M  V30 27 C 6.7908 0.8242 0.0 0
M  V30 28 C 7.2018 12.2354 0.0 0
M  V30 29 C 7.9719 13.5690 0.0 0
M  V30 30 C 5.6618 12.2354 0.0 0
M  V30 31 C 7.2018 14.9027 0.0 0
M  V30 32 C 4.8918 13.5690 0.0 0
M  V30 33 C 5.6618 14.9027 0.0 0
M  V30 34 C 11.2305 8.6079 0.0 0
M  V30 35 C 12.4764 9.5131 0.0 0
M  V30 36 C 11.3914 7.0763 0.0 0
M  V30 37 C 13.8832 8.8868 0.0 0
M  V30 38 C 12.7982 6.4500 0.0 0
M  V30 39 C 14.0443 7.3552 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 1 17 CFG=2
M  V30 3 1 2 8
M  V30 4 2 3 19
M  V30 5 1 4 25
M  V30 6 1 5 37
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 1 10 22
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 1 18 28
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 1 21 34
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108124-77-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1311144-34-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-329-CAS-10173096
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Vilsmeier-type methylenation reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Vilsmeier-type methylenation for synthesis of dipyrazolylmethane
derivatives using formamide or N-methylformamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(21), 3863-3867

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyanuric chloride
C3Cl3N3
108-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6200 0.0 0
M  V30 2 Cl 5.3349 4.6200 0.0 0
M  V30 3 Cl 2.6674 0.0000 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide, compd. with 2,4,6-trichloro-1,3,5-triazine (1:1)
C3Cl3N3.CH3NO
2415121-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 6.9300 0.0 0
M  V30 2 Cl 5.3349 6.9300 0.0 0
M  V30 3 Cl 2.6674 2.3100 0.0 0
M  V30 4 N 2.6674 6.9300 0.0 0
M  V30 5 C 1.3338 6.1600 0.0 0
M  V30 6 C 4.0011 6.1600 0.0 0
M  V30 7 N 1.3338 4.6200 0.0 0
M  V30 8 N 4.0011 4.6200 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 N 1.3338 0.7700 0.0 0
M  V30 12 O 4.0011 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2415121-39-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28268110
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Cyanation of Aryl Halides Using Formamide and
Cyanuric Chloride as a New "CN" Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niknam, Esmaeil; Panahi, Farhad; Khalafi-Nezhad, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2020), 2020(18), 2699-2707

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyridine
C5H5N
110-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 C 0.7700 0.0000 0.0 0
M  V30 3 C 0.7700 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 N 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxamide
C6H6N2O
1452-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 N 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1452-77-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-095-CAS-21124812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-53-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7727-21-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7761-88-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, Schlenk flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acid-Free Silver-Catalyzed Cross-Dehydrogenative Carbamoylation of
Pyridines with Formamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Wei; Jin, Fengli; Zhao, Qian; Du, Hongyan; Yao, Lifang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(12), 1854-1859

$RFMT $RIREG SCHEME185 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Piperidine
C5H11N
110-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 C 0.7700 0.0000 0.0 0
M  V30 3 C 0.7700 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 N 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Piperidinylmethyl)formamide
C7H14N2O
28919-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 N 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 N 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 28919-15-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-12816937
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):NOTES
$DATUM solid state, microwave, alumina support
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solvent-free preparation of monoacylaminals assisted by microwave
irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharifi, Ali; Mohsenzadeh, Farshid; Naimi-Jamal, M. Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research, Synopses (2000), (8), 394-396

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Chlorophenyl)-1-(2-pyridinyl)-1H-pyrazol-5-amine
C14H11ClN4
1154197-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.7385 0.0000 0.0 0
M  V30 2 Cl 12.3671 6.3388 0.0 0
M  V30 3 C 7.0323 3.2587 0.0 0
M  V30 4 N 5.6253 3.8850 0.0 0
M  V30 5 C 6.8712 1.7271 0.0 0
M  V30 6 N 4.5948 2.7406 0.0 0
M  V30 7 C 5.3649 1.4070 0.0 0
M  V30 8 C 8.3659 4.0287 0.0 0
M  V30 9 C 8.3659 5.5688 0.0 0
M  V30 10 C 9.6996 3.2587 0.0 0
M  V30 11 C 9.6996 6.3388 0.0 0
M  V30 12 C 11.0333 4.0287 0.0 0
M  V30 13 C 11.0333 5.5688 0.0 0
M  V30 14 C 3.0633 2.9016 0.0 0
M  V30 15 C 2.1580 1.6557 0.0 0
M  V30 16 N 2.4368 4.3086 0.0 0
M  V30 17 C 0.6265 1.8166 0.0 0
M  V30 18 C 0.9052 4.4695 0.0 0
M  V30 19 C 0.0000 3.2236 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 13
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Chlorophenyl)-1-(2-pyridinyl)-1H-pyrazolo[3,4-d]pyrimidine
C16H10ClN5
1410783-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 12.3669 7.5408 0.0 0
M  V30 2 C 7.0321 4.4608 0.0 0
M  V30 3 C 6.8711 2.9292 0.0 0
M  V30 4 N 5.6252 5.0873 0.0 0
M  V30 5 C 5.3648 2.6091 0.0 0
M  V30 6 C 7.9016 1.7849 0.0 0
M  V30 7 N 4.5948 3.9427 0.0 0
M  V30 8 N 4.8889 1.1444 0.0 0
M  V30 9 N 7.4258 0.3202 0.0 0
M  V30 10 C 5.9193 0.0000 0.0 0
M  V30 11 C 8.3658 5.2308 0.0 0
M  V30 12 C 9.6994 4.4608 0.0 0
M  V30 13 C 8.3658 6.7708 0.0 0
M  V30 14 C 11.0331 5.2308 0.0 0
M  V30 15 C 9.6994 7.5408 0.0 0
M  V30 16 C 11.0331 6.7708 0.0 0
M  V30 17 C 3.0632 4.1037 0.0 0
M  V30 18 C 2.4368 5.5106 0.0 0
M  V30 19 N 2.1580 2.8578 0.0 0
M  V30 20 C 0.9052 5.6715 0.0 0
M  V30 21 C 0.6265 3.0187 0.0 0
M  V30 22 C 0.0000 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1154197-37-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1410783-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-10398603
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[[4-(dimethylamino)phenyl]methyl]-3-pyridinamine
C14H16ClN3
1154721-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 N 4.6200 2.6674 0.0 0
M  V30 3 N 11.5500 4.0011 0.0 0
M  V30 4 C 12.3200 2.6674 0.0 0
M  V30 5 C 12.3200 5.3349 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 C 7.7000 2.6674 0.0 0
M  V30 9 C 7.7000 5.3349 0.0 0
M  V30 10 C 9.2400 2.6674 0.0 0
M  V30 11 C 9.2400 5.3349 0.0 0
M  V30 12 C 10.0100 4.0011 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 C 2.3100 1.3338 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 N 0.7700 1.3338 0.0 0
M  V30 17 C 0.7700 4.0011 0.0 0
M  V30 18 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 12
M  V30 7 1 6 14
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1H-Imidazo[4,5-b]pyridin-1-ylmethyl)-N,N-dimethylbenzenamine
C15H16N4
1670258-65-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 4.6201 0.0 0
M  V30 2 N 11.0882 1.5400 0.0 0
M  V30 3 C 11.0882 0.0000 0.0 0
M  V30 4 C 12.4219 2.3101 0.0 0
M  V30 5 C 3.0128 4.4766 0.0 0
M  V30 6 N 4.4196 3.8501 0.0 0
M  V30 7 C 1.9823 3.3320 0.0 0
M  V30 8 C 2.5369 5.9411 0.0 0
M  V30 9 C 4.2587 2.3185 0.0 0
M  V30 10 N 2.7523 1.9983 0.0 0
M  V30 11 N 0.4759 3.6523 0.0 0
M  V30 12 C 1.0304 6.2615 0.0 0
M  V30 13 C 0.0000 5.1169 0.0 0
M  V30 14 C 7.0871 3.8501 0.0 0
M  V30 15 C 8.4208 4.6201 0.0 0
M  V30 16 C 7.0871 2.3101 0.0 0
M  V30 17 C 9.7544 3.8501 0.0 0
M  V30 18 C 8.4208 1.5400 0.0 0
M  V30 19 C 9.7544 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 19
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 10
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1154721-49-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1670258-65-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12163660
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved synthesis of imidazo[4,5-b]pyridines and
imidazo[4,5-b]pyrazines by palladium catalyzed amidation using xantphos
in a 1,4-Dioxane:tert-amyl alcohol aolvent aystem
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Ahmed, Ijaz; Wilson, Robert J.; Williams, Theresa M.;
Kaminsky, Lauren; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(16), 3465-3470

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[(4-chlorophenyl)methyl]-3-pyridinamine
C12H10Cl2N2
1154721-55-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 Cl 3.0800 0.0000 0.0 0
M  V30 4 Cl 11.5500 4.0011 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 0.7700 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 C 7.7000 5.3349 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 C 9.2400 5.3349 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 1 3 6
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Chlorophenyl)methyl]-1H-imidazo[4,5-b]pyridine
C13H10ClN3
1207712-78-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 3.7710 0.0 0
M  V30 2 Cl 11.3908 3.7710 0.0 0
M  V30 3 C 2.9292 2.2764 0.0 0
M  V30 4 N 4.4608 2.4374 0.0 0
M  V30 5 C 2.6091 0.7700 0.0 0
M  V30 6 C 1.7849 3.3068 0.0 0
M  V30 7 C 5.0872 1.0306 0.0 0
M  V30 8 N 3.9427 0.0000 0.0 0
M  V30 9 N 1.1444 0.2941 0.0 0
M  V30 10 C 0.3202 2.8310 0.0 0
M  V30 11 C 0.0000 1.3247 0.0 0
M  V30 12 C 6.7708 3.7710 0.0 0
M  V30 13 C 7.5408 2.4374 0.0 0
M  V30 14 C 7.5408 5.1048 0.0 0
M  V30 15 C 9.0808 2.4374 0.0 0
M  V30 16 C 9.0808 5.1048 0.0 0
M  V30 17 C 9.8508 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 12
M  V30 3 1 2 17
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1154721-55-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1207712-78-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-203530
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved synthesis of imidazo[4,5-b]pyridines and
imidazo[4,5-b]pyrazines by palladium catalyzed amidation using xantphos
in a 1,4-Dioxane:tert-amyl alcohol aolvent aystem
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Ahmed, Ijaz; Wilson, Robert J.; Williams, Theresa M.;
Kaminsky, Lauren; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(16), 3465-3470

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[(3-fluorophenyl)methyl]-3-pyridinamine
C12H10ClFN2
1154722-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 Cl 1.3337 4.6201 0.0 0
M  V30 4 F 10.6697 2.3101 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 2.6673 0.7700 0.0 0
M  V30 8 N 0.0000 2.3101 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 11 C 6.6685 3.0801 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 8.0023 5.3901 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 1 3 6
M  V30 5 1 4 14
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(3-Fluorophenyl)methyl]-1H-imidazo[4,5-b]pyridine
C13H10FN3
1365094-41-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 1.6414 0.0 0
M  V30 2 F 11.0882 1.6414 0.0 0
M  V30 3 C 3.0127 1.7849 0.0 0
M  V30 4 N 4.4197 2.4114 0.0 0
M  V30 5 C 1.9823 2.9294 0.0 0
M  V30 6 C 2.5369 0.3203 0.0 0
M  V30 7 C 4.2586 3.9429 0.0 0
M  V30 8 N 2.7523 4.2631 0.0 0
M  V30 9 N 0.4759 2.6091 0.0 0
M  V30 10 C 1.0304 0.0000 0.0 0
M  V30 11 C 0.0000 1.1445 0.0 0
M  V30 12 C 7.0870 2.4114 0.0 0
M  V30 13 C 8.4207 1.6414 0.0 0
M  V30 14 C 7.0870 3.9514 0.0 0
M  V30 15 C 9.7545 2.4114 0.0 0
M  V30 16 C 8.4207 4.7214 0.0 0
M  V30 17 C 9.7545 3.9514 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 12
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1154722-24-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365094-41-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-917454
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved synthesis of imidazo[4,5-b]pyridines and
imidazo[4,5-b]pyrazines by palladium catalyzed amidation using xantphos
in a 1,4-Dioxane:tert-amyl alcohol aolvent aystem
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Ahmed, Ijaz; Wilson, Robert J.; Williams, Theresa M.;
Kaminsky, Lauren; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(16), 3465-3470

$RFMT $RIREG SCHEME190 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-2-mercapto-1-methylethyl]carbamate
C11H15NO2S
1258407-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 N 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0 CFG=1
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0
M  V30 9 S 12.0033 3.0801 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C13H18N2O3S
2602313-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 C 6.6687 3.0801 0.0 0
M  V30 4 N 8.0023 2.3101 0.0 0
M  V30 5 O 6.6687 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0 CFG=1
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0
M  V30 9 S 12.0035 3.0801 0.0 0
M  V30 10 C 13.3372 2.3101 0.0 0
M  V30 11 N 14.6708 3.0801 0.0 0
M  V30 12 C 16.0045 2.3101 0.0 0
M  V30 13 O 17.3383 3.0801 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 15 C 1.3338 3.0801 0.0 0
M  V30 16 C 2.6675 0.7700 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 1.3338 0.0000 0.0 0
M  V30 19 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 12 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1258407-23-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2602313-18-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23168682
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM paraformaldehyde used, Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Nβ-Protected Amino Sulfenyl Methyl Formamides and Sulfonyl
Methyl Formamides: A Simple Protocol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasulu, Chinthaginjala; Sagar, Nagamangala R.; Vishwanatha,
Thimmalapura M.; Durgamma, Suram; Sureshbabu, Vommina V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2021), 6(7), 4680-4686

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-2-dodecanol
C13H28O
1653-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.3337 0.0 0
M  V30 2 C 5.3348 2.1037 0.0 0
M  V30 3 C 2.6673 2.1037 0.0 0
M  V30 4 C 6.6685 1.3337 0.0 0
M  V30 5 C 1.3337 1.3337 0.0 0
M  V30 6 C 8.0022 2.1037 0.0 0
M  V30 7 C 0.5637 2.6673 0.0 0
M  V30 8 C 0.0000 0.5637 0.0 0
M  V30 9 O 2.1037 0.0000 0.0 0
M  V30 10 C 9.3358 1.3337 0.0 0
M  V30 11 C 10.6697 2.1037 0.0 0
M  V30 12 C 12.0033 1.3337 0.0 0
M  V30 13 C 13.3370 2.1037 0.0 0
M  V30 14 C 14.6707 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1,1-Dimethylundecyl)formamide
C14H29NO
1443999-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4137 1.8973 0.0 0
M  V30 2 C 5.7474 2.6673 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 7.0811 1.8973 0.0 0
M  V30 5 N 2.3101 1.3337 0.0 0
M  V30 6 C 3.8501 4.0010 0.0 0
M  V30 7 C 1.7462 3.4374 0.0 0
M  V30 8 C 8.4149 2.6673 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 9.7486 1.8973 0.0 0
M  V30 11 O 0.0000 0.0000 0.0 0
M  V30 12 C 11.0822 2.6673 0.0 0
M  V30 13 C 12.4159 1.8973 0.0 0
M  V30 14 C 13.7497 2.6673 0.0 0
M  V30 15 C 15.0834 1.8973 0.0 0
M  V30 16 C 16.4171 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1653-37-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1443999-07-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-546293
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7550-35-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of Amides from Alcohols; General
Procedure. LiBr (87 mg, 1.0 mmol) and amide (7.5 mmol) were successively
added to a mixture of alcohol (0.5 mmol) and TFA (1.15 mL, 15.0 mmol) in
a screw-cap tube. After the reaction mixture was stirred at 90 °C for 8
h, sat. NaHCO3 (30 mL) was added, and the resultant mixture was extracted
with EtOAc (100 mL). The combined extracts were washed with sat. NaHCO3
and brine, dried (MgSO4), and concentrated under reduced pressure. The
residue was purified by performing silica gel column chromatography to
give the pure amide. N-(2-Methyl-2-dodecyl)formamide (1b). Yield: 94%.
colorless oil; Reactant: Formamide: (15.0 equiv), TFA (30.0 equiv), Metal
halide: LiBr (2.0 equiv), Reactions were carried out for 8 h. IR (neat):
3282 (br), 3055, 2954, 2924, 2854, 2754, 1686, 1670, 1541, 1468, 1385,
1365, 1265 cm-1. 1H NMR (600 MHz, CDCl3): δ (major) = 8.18 (d, J = 12.4
Hz, 1 H), 6.03 (br s, 1 H), 1.49-1.45 (m, 2 H), 1.34-1.20 (m, 22 H), 0.86
(t, J = 6.9 Hz, 3 H); δ (minor) = 8.01 (s, 1 H), 5.28 (br s, 1 H),
1.67-1.63 (m, 2 H), 1.34-1.20 (m, 22 H), 0.86 (t, J = 6.9 Hz, 3 H). 13C
NMR (150 MHz, CDCl3): δ (major) = 163.2, 52.9, 43.9, 32.0, 30.0, 29.8,
29.7, 29.7, 29.4, 28.8, 23.9, 22.8, 14.2; δ (minor) = 160.5, 54.1, 40.8,
32.0, 30.1, 29.8, 29.7, 29.7, 29.4, 27.1, 24.2, 22.8, 14.2. HRMS (ESI):
m/z [M + Na]+ calcd for C14H29NNaO: 250.2147; found: 250.2148.
$DTYPE RXN:VAR(1):NOTES
$DATUM TFA also used as solvent, optimized on reagents, optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of N-substituted amides from alcohols and amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Okada, Iku; Chiba, Kazuhiro; Kitano, Yoshikazu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2013), 45(8), 1069-1075

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-6-bromo-1-naphthalenecarboxylate
C13H12BrNO2
1824676-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 4.6200 5.3349 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 N 2.3100 1.3338 0.0 0
M  V30 7 Br 10.7800 2.6674 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 6.9300 1.3338 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 3.8500 1.3338 0.0 0
M  V30 13 C 6.1600 0.0000 0.0 0
M  V30 14 C 8.4700 1.3338 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 4.6200 0.0000 0.0 0
M  V30 17 C 9.2400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 17
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromobenzo[f]quinazolin-1(2H)-one
C12H7BrN2O
1824676-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 9.2400 2.6674 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 5.3900 4.0011 0.0 0
M  V30 8 C 5.3900 1.3338 0.0 0
M  V30 9 C 3.0800 5.3349 0.0 0
M  V30 10 N 0.7700 4.0011 0.0 0
M  V30 11 N 0.7700 1.3338 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 C 0.0000 2.6674 0.0 0
M  V30 16 C 7.7000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 16
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 7 12
M  V30 12 1 7 13
M  V30 13 2 8 14
M  V30 14 1 9 12
M  V30 15 1 10 15
M  V30 16 2 11 15
M  V30 17 2 13 16
M  V30 18 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1824676-64-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1824676-71-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15091138
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted benzoquinazolinones. Part 2: Synthesis of amino-, and
sulfanyl-derivatives of benzo[f]- and benzo[h]quinazolinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nowak, Monika; Malinowski, Zbigniew; Fornal, Emilia; Jozwiak, Andrzej;
Parfieniuk, Ewa; Gajek, Gabriela; Kontek, Renata
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2015), 71(50), 9463-9473

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methoxyphenyl)-1-phenyl-1H-pyrazol-5-amine
C16H15N3O
19652-13-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.7384 0.0000 0.0 0
M  V30 2 O 12.3671 6.3388 0.0 0
M  V30 3 C 13.7008 5.5688 0.0 0
M  V30 4 N 4.5948 2.7406 0.0 0
M  V30 5 N 5.6253 3.8850 0.0 0
M  V30 6 C 5.3649 1.4070 0.0 0
M  V30 7 C 7.0323 3.2587 0.0 0
M  V30 8 C 6.8712 1.7271 0.0 0
M  V30 9 C 3.0633 2.9016 0.0 0
M  V30 10 C 2.1580 1.6557 0.0 0
M  V30 11 C 2.4368 4.3086 0.0 0
M  V30 12 C 0.6265 1.8166 0.0 0
M  V30 13 C 0.9052 4.4695 0.0 0
M  V30 14 C 0.0000 3.2236 0.0 0
M  V30 15 C 8.3659 4.0287 0.0 0
M  V30 16 C 8.3659 5.5688 0.0 0
M  V30 17 C 9.6996 3.2587 0.0 0
M  V30 18 C 9.6996 6.3388 0.0 0
M  V30 19 C 11.0333 4.0287 0.0 0
M  V30 20 C 11.0333 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 7 15
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methoxyphenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C18H14N4O
1400634-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.4285 3.7827 0.0 0
M  V30 2 C 13.1985 5.1164 0.0 0
M  V30 3 C 6.2684 3.7827 0.0 0
M  V30 4 C 5.3632 2.5369 0.0 0
M  V30 5 N 5.3632 5.0286 0.0 0
M  V30 6 C 3.8987 3.0127 0.0 0
M  V30 7 C 5.6834 1.0304 0.0 0
M  V30 8 N 3.8987 4.5527 0.0 0
M  V30 9 N 2.7542 1.9823 0.0 0
M  V30 10 N 4.5390 0.0000 0.0 0
M  V30 11 C 3.0743 0.4759 0.0 0
M  V30 12 C 7.8085 3.7827 0.0 0
M  V30 13 C 8.5785 2.4491 0.0 0
M  V30 14 C 8.5785 5.1164 0.0 0
M  V30 15 C 10.1185 2.4491 0.0 0
M  V30 16 C 10.1185 5.1164 0.0 0
M  V30 17 C 10.8885 3.7827 0.0 0
M  V30 18 C 2.6528 5.4579 0.0 0
M  V30 19 C 2.8137 6.9895 0.0 0
M  V30 20 C 1.2459 4.8316 0.0 0
M  V30 21 C 1.5679 7.8947 0.0 0
M  V30 22 C 0.0000 5.7367 0.0 0
M  V30 23 C 0.1609 7.2684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 8 18
M  V30 13 1 9 11
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19652-13-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-70-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27399417
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective synthesis of pyrazolo[3,4-d]pyrimidine,
N-(1H-pyrazol-5-yl)formamide, or N-(1H-pyrazol-5-yl)formamidine
derivatives from N-1-substituted-5-aminopyrazoles with new Vilsmeier-type
reagents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chang, Chun-Hsi; Tsai, Henry J.; Huang, Yu-Ying; Lin, Hui-Yi; Wang,
Li-Ya; Wu, Tian-Shung; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2013), 69(4), 1378-1386

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methoxyphenyl)-1-phenyl-1H-pyrazol-5-amine
C16H15N3O
19652-13-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.7384 0.0000 0.0 0
M  V30 2 O 12.3671 6.3388 0.0 0
M  V30 3 C 13.7008 5.5688 0.0 0
M  V30 4 N 4.5948 2.7406 0.0 0
M  V30 5 N 5.6253 3.8850 0.0 0
M  V30 6 C 5.3649 1.4070 0.0 0
M  V30 7 C 7.0323 3.2587 0.0 0
M  V30 8 C 6.8712 1.7271 0.0 0
M  V30 9 C 3.0633 2.9016 0.0 0
M  V30 10 C 2.1580 1.6557 0.0 0
M  V30 11 C 2.4368 4.3086 0.0 0
M  V30 12 C 0.6265 1.8166 0.0 0
M  V30 13 C 0.9052 4.4695 0.0 0
M  V30 14 C 0.0000 3.2236 0.0 0
M  V30 15 C 8.3659 4.0287 0.0 0
M  V30 16 C 8.3659 5.5688 0.0 0
M  V30 17 C 9.6996 3.2587 0.0 0
M  V30 18 C 9.6996 6.3388 0.0 0
M  V30 19 C 11.0333 4.0287 0.0 0
M  V30 20 C 11.0333 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 7 15
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methoxyphenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C18H14N4O
1400634-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.4285 3.7827 0.0 0
M  V30 2 C 13.1985 5.1164 0.0 0
M  V30 3 C 6.2684 3.7827 0.0 0
M  V30 4 C 5.3632 2.5369 0.0 0
M  V30 5 N 5.3632 5.0286 0.0 0
M  V30 6 C 3.8987 3.0127 0.0 0
M  V30 7 C 5.6834 1.0304 0.0 0
M  V30 8 N 3.8987 4.5527 0.0 0
M  V30 9 N 2.7542 1.9823 0.0 0
M  V30 10 N 4.5390 0.0000 0.0 0
M  V30 11 C 3.0743 0.4759 0.0 0
M  V30 12 C 7.8085 3.7827 0.0 0
M  V30 13 C 8.5785 2.4491 0.0 0
M  V30 14 C 8.5785 5.1164 0.0 0
M  V30 15 C 10.1185 2.4491 0.0 0
M  V30 16 C 10.1185 5.1164 0.0 0
M  V30 17 C 10.8885 3.7827 0.0 0
M  V30 18 C 2.6528 5.4579 0.0 0
M  V30 19 C 2.8137 6.9895 0.0 0
M  V30 20 C 1.2459 4.8316 0.0 0
M  V30 21 C 1.5679 7.8947 0.0 0
M  V30 22 C 0.0000 5.7367 0.0 0
M  V30 23 C 0.1609 7.2684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 8 18
M  V30 13 1 9 11
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19652-13-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-70-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-3710535
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methoxyphenyl)-1-phenyl-1H-pyrazol-5-amine
C16H15N3O
19652-13-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.7384 0.0000 0.0 0
M  V30 2 O 12.3671 6.3388 0.0 0
M  V30 3 C 13.7008 5.5688 0.0 0
M  V30 4 N 4.5948 2.7406 0.0 0
M  V30 5 N 5.6253 3.8850 0.0 0
M  V30 6 C 5.3649 1.4070 0.0 0
M  V30 7 C 7.0323 3.2587 0.0 0
M  V30 8 C 6.8712 1.7271 0.0 0
M  V30 9 C 3.0633 2.9016 0.0 0
M  V30 10 C 2.1580 1.6557 0.0 0
M  V30 11 C 2.4368 4.3086 0.0 0
M  V30 12 C 0.6265 1.8166 0.0 0
M  V30 13 C 0.9052 4.4695 0.0 0
M  V30 14 C 0.0000 3.2236 0.0 0
M  V30 15 C 8.3659 4.0287 0.0 0
M  V30 16 C 8.3659 5.5688 0.0 0
M  V30 17 C 9.6996 3.2587 0.0 0
M  V30 18 C 9.6996 6.3388 0.0 0
M  V30 19 C 11.0333 4.0287 0.0 0
M  V30 20 C 11.0333 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 7 15
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methoxyphenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C18H14N4O
1400634-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.4285 3.7827 0.0 0
M  V30 2 C 13.1985 5.1164 0.0 0
M  V30 3 C 6.2684 3.7827 0.0 0
M  V30 4 C 5.3632 2.5369 0.0 0
M  V30 5 N 5.3632 5.0286 0.0 0
M  V30 6 C 3.8987 3.0127 0.0 0
M  V30 7 C 5.6834 1.0304 0.0 0
M  V30 8 N 3.8987 4.5527 0.0 0
M  V30 9 N 2.7542 1.9823 0.0 0
M  V30 10 N 4.5390 0.0000 0.0 0
M  V30 11 C 3.0743 0.4759 0.0 0
M  V30 12 C 7.8085 3.7827 0.0 0
M  V30 13 C 8.5785 2.4491 0.0 0
M  V30 14 C 8.5785 5.1164 0.0 0
M  V30 15 C 10.1185 2.4491 0.0 0
M  V30 16 C 10.1185 5.1164 0.0 0
M  V30 17 C 10.8885 3.7827 0.0 0
M  V30 18 C 2.6528 5.4579 0.0 0
M  V30 19 C 2.8137 6.9895 0.0 0
M  V30 20 C 1.2459 4.8316 0.0 0
M  V30 21 C 1.5679 7.8947 0.0 0
M  V30 22 C 0.0000 5.7367 0.0 0
M  V30 23 C 0.1609 7.2684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 8 18
M  V30 13 1 9 11
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19652-13-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-70-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26983995
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
Pyrazolo[3,4-d]-pyrimidines (17-32, 65, 66, and 73-76). The reliable
procedure involved the treatment of 5-aminopyrazoles (1-16; 1.0 equiv),
5- amino-4-formylpyrazoles (37-41; 1.0 equiv), 5-aminoquinoline (61; 1.0
equiv), 8-aminoquinoline (62; 1.0 equiv), 5-aminopyrimidine (68; 1.0
equiv), or 2-aminopyrazines (69-71; 1.0 equiv) with PBr3 (~ 3 equiv) in
formamide solution (2 mL) at 50-60 °C over 0.5-1 h. When the reaction was
complete, the reaction mixture was added to saturated sodium bicarbonate
(15 mL) and extracted with dichloromethane (15 mL). The organic extracts
were dried over MgSO4, filtered, and concentrated under reduced pressure.
The residue solution was purified by column chromatography on silica gel
to give the corresponding aromatic or heterocyclic fused pyrimidine
products (17-32, 65, 66, and 73-76) in 82-96% yields.
3-(4-Methoxylphenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine (32). The
standard procedure involved the treatment of
5-amino-3-(4-methoxylphenyl)-1-phenyl-1H-pyrazole (16; 101 mg, 0.33 mmol,
1.0 equiv) with PBr3 (90 μL, 1.0 mmol, 3 equiv) in formamide solution (2
mL) at 50-60 °C over 0.5-1 h. The reaction mixture was then worked up,
and the residue was purified by chromatography on silica gel to give pure
32: 94% yield (94 mg), yellow solid. Mp 175-176 °C (hexane-EtOAc). 1H NMR
(CDCl3, 500 MHz): δ 3.87 (3H, s), 7.08-7.84 (2H, m), 7.32-7.36 (1H, m),
7.50-7.56 (2H, m), 7.95- 8.01 (2H, m), 8.28-8.32 (2H, m), 9.10 (1H, s),
9.45 (1H, s). 13C NMR (125 MHz, CDCl3): δ 55.4 (CH3), 114.2, 114.6 (2 ×
C), 121.3 (2 × C), 124.1, 126.7, 128.7 (2 × C), 129.2 (2 × C), 138.6,
144.8, 152.8, 153.2, 155.5, 160.8. IR (KBr): 3047, 2924, 1612, 1582,
1503, 1431, 1356, 1254, 1219, 1092 cm-1. EIMS m/z (rel int): 302 (100,
M+). Anal. Calcd for C18H14N4O: C, 71.51; H, 4.67; N, 18.53. Found: C,
71.48; H, 4.68; N, 18.50.
$DTYPE RXN:VAR(1):NOTES
$DATUM sequential three-component heterocyclization, one-pot multi-component
process
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminobenzoyl chloride
C7H6ClNO
21563-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Anthranilamide
C7H8N2O
88-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 N 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21563-73-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 88-68-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-4974379
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure for Amination All the
experiments were carried out in a parallel synthesizer from REDLEYS
Discovery Technologies, UK. A solution of acid chloride 1a (1.0 gm 7.11
mmol) in formamide (10 ml) was heated to 100-120 °C and maintained at
same temperature for 5 to 6 hours, the reaction mixture was cooled to
room temperature. The reaction mass quenched in excess water and
extracted with dichloromethane. The combined organic solvent was washed
with saturated NaHCO3 aqueous solution and dried over anhydrous Na2SO4.
The solvent was evaporated under reduced pressure to give the residue
which was purified by column chromatography using silica gel and EtOAc=
hexane as eluent. An amount of 0.77 g (6.4 mmol, 90%) of 2a was obtained
as crystals. Compound 2m. Yield 94% Mp in °C (Lit): 109-110; Mp in °C
(Obs.): 108-111
$DTYPE RXN:VAR(1):NOTES
$DATUM excess water used in stage 2, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide as an ammonia synthon in amination of acid chlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasan, S.; Manisankar, P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2010), 40(23), 3538-3543

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-8-Quinolinylbenzamide
C16H12N2O
33757-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 6.6685 0.7700 0.0 0
M  V30 4 C 2.6673 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 1.3337 2.3101 0.0 0
M  V30 7 N 2.6673 4.6201 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 0.7700 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 8.0023 3.0801 0.0 0
M  V30 15 C 8.0023 4.6201 0.0 0
M  V30 16 C 9.3360 2.3101 0.0 0
M  V30 17 C 9.3360 5.3901 0.0 0
M  V30 18 C 10.6697 3.0801 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 2 14
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 12
M  V30 14 2 10 13
M  V30 15 1 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(8-Quinolinyl)-4(3H)-quinazolinone
C17H11N3O
1593583-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 0.7700 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 C 2.6673 3.0800 0.0 0
M  V30 4 C 4.0011 0.7700 0.0 0
M  V30 5 C 1.3337 2.3100 0.0 0
M  V30 6 N 2.6673 4.6201 0.0 0
M  V30 7 C 2.6673 0.0000 0.0 0
M  V30 8 C 1.3337 0.7700 0.0 0
M  V30 9 C 0.0000 3.0800 0.0 0
M  V30 10 C 1.3337 5.3901 0.0 0
M  V30 11 C 0.0000 4.6201 0.0 0
M  V30 12 N 5.3348 3.0800 0.0 0
M  V30 13 C 6.6684 2.3100 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 8.0022 3.0800 0.0 0
M  V30 16 N 6.6684 5.3901 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 9.3359 2.3100 0.0 0
M  V30 19 C 9.3359 5.3901 0.0 0
M  V30 20 C 10.6695 3.0800 0.0 0
M  V30 21 C 10.6695 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 2 6 10
M  V30 11 2 7 8
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 17
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 33757-48-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1593583-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26577733
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-89-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM aerobic, optimization study, optimized on catalyst, optimized on solvent,
optimized on temperature, optimized on stoichiometry of catalyst,
alternative preparation shown, alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-Catalyzed Tandem C-H/N-H Activation, Cyclization[4+2] and
Dehydration of Arylamides with Formamide: Synthesis of
4(3H)-Quinazolinones Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Jian; Wang, Guodong; Hao, Liqiang; Han, Junfen; Li, Hongshuang;
Duan, Guiyun; You, Guirong; Li, Furong; Xia, Chengcai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2019), 11(12), 2799-2802

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4(3H)-Pyrimidinone, 2,5,6-triamino-, sulfate (1:1)
C4H7N5O.H2O4S
35011-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.0800 8.4149 0.0 0 VAL=6
M  V30 2 O 1.5400 8.4149 0.0 0
M  V30 3 O 4.6200 8.4149 0.0 0
M  V30 4 O 3.0800 6.8749 0.0 0
M  V30 5 O 3.0800 9.9549 0.0 0
M  V30 6 N 0.0000 2.6674 0.0 0
M  V30 7 N 1.5400 0.0000 0.0 0
M  V30 8 O 1.5400 5.3349 0.0 0
M  V30 9 N 6.1600 2.6674 0.0 0
M  V30 10 C 1.5400 2.6674 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 N 3.8500 1.3338 0.0 0
M  V30 14 N 3.8500 4.0011 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 6 10
M  V30 6 1 7 11
M  V30 7 2 8 12
M  V30 8 1 9 15
M  V30 9 2 10 11
M  V30 10 1 10 12
M  V30 11 1 11 13
M  V30 12 1 12 14
M  V30 13 1 13 15
M  V30 14 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanine
C5H5N5O
73-40-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7036 0.0000 0.0 0
M  V30 2 N 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35011-47-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 73-40-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26268649
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of an anti-viral purine derivative from a pyrimidine compound
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hemmati, Salar; Sariri, Reyhaneh; Khalili, Gholamhosein
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Chemical Sciences (2004), 2(1), 9-12

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Formamide-d3
CD3NO
43380-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 O 4.0010 2.3101 0.0 0
M  V30 4 H 2.6673 0.0000 0.0 0 MASS=2
M  V30 5 H 1.3337 3.8501 0.0 0 MASS=2
M  V30 6 H 0.0000 1.5400 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-6-chloro-2-pyridinecarbonitrile
C6H4ClN3
95095-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 3.0801 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6687 3.0801 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 N 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C7H3ClDN3
2561455-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 2.6673 0.0 0
M  V30 2 C 3.8501 1.3337 0.0 0
M  V30 3 C 4.6201 2.6673 0.0 0
M  V30 4 N 2.3101 1.3337 0.0 0
M  V30 5 C 4.6201 0.0000 0.0 0
M  V30 6 C 3.8501 4.0010 0.0 0
M  V30 7 N 6.1601 2.6673 0.0 0
M  V30 8 C 1.5400 2.6673 0.0 0
M  V30 9 N 6.1601 0.0000 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 H 8.4702 1.3337 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 43380-64-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 95095-84-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2561455-14-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29322766
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 5614-37-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenylethynes as NF-κB inhibitors and therapeutic uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barbay, J. Kent; Chai, Wenying; Eccles, Wendy; Hack, Michael D.;
Herrmann, Aaron T.; Jones, William M.; Krawczuk, Paul J.; Kreutter, Kevin
D.; Lebsack, Alec D.; Pippel, Daniel J.; Rovira, Alexander R.; Wolin,
Ronald L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020239999 A1 2020-12-03

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Formamide-d3
CD3NO
43380-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 O 4.0010 2.3101 0.0 0
M  V30 4 H 2.6673 0.0000 0.0 0 MASS=2
M  V30 5 H 1.3337 3.8501 0.0 0 MASS=2
M  V30 6 H 0.0000 1.5400 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-6-chloro-2-pyridinecarbonitrile
C6H4ClN3
95095-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 3.0801 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6687 3.0801 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 N 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C7H4ClDN4
3012615-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 0.0000 0.0 0
M  V30 2 Cl 0.0000 4.0011 0.0 0
M  V30 3 C 3.8500 2.6674 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 4.6200 1.3338 0.0 0
M  V30 6 N 2.3100 2.6674 0.0 0
M  V30 7 C 3.8500 5.3349 0.0 0
M  V30 8 N 6.1600 4.0011 0.0 0
M  V30 9 N 6.1600 1.3338 0.0 0
M  V30 10 C 1.5400 4.0011 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 H 8.4700 2.6674 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 10
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 43380-64-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 95095-84-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3012615-63-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38963278
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 5614-37-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolidinone derivatives as inhibitors of NF-κb inducing
kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chai, Wenying; Wolin, Ronald L.; Murphy, Stephen K.; Rovira, Alexander
R.; Lebsack, Alec D.; Adler, Marc; Eccles, Wendy; Greenman, Kevin; Hack,
Michael D.; Jones, William M.; Krawczuk, Paul J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023217906 A1 2023-11-16

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-8-quinolinylbenzamide
C16H11ClN2O
444112-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 O 6.6684 0.7700 0.0 0
M  V30 4 Cl 9.3359 0.7700 0.0 0
M  V30 5 C 2.6673 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 1.3337 2.3100 0.0 0
M  V30 8 N 2.6673 4.6201 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 8.0022 3.0800 0.0 0
M  V30 16 C 9.3359 2.3100 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 10.6695 3.0800 0.0 0
M  V30 19 C 9.3359 5.3901 0.0 0
M  V30 20 C 10.6695 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 2 15
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-3-(8-quinolinyl)-4(3H)-quinazolinone
C17H10ClN3O
2374908-85-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 0.7700 0.0 0
M  V30 2 Cl 9.3358 0.7700 0.0 0
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 2.6673 3.0800 0.0 0
M  V30 5 C 4.0011 0.7700 0.0 0
M  V30 6 C 1.3336 2.3100 0.0 0
M  V30 7 N 2.6673 4.6200 0.0 0
M  V30 8 C 2.6673 0.0000 0.0 0
M  V30 9 C 1.3336 0.7700 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 C 1.3336 5.3900 0.0 0
M  V30 12 C 0.0000 4.6200 0.0 0
M  V30 13 N 5.3347 3.0800 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 5.3347 4.6200 0.0 0
M  V30 16 C 8.0021 3.0800 0.0 0
M  V30 17 N 6.6684 5.3900 0.0 0
M  V30 18 C 8.0021 4.6200 0.0 0
M  V30 19 C 9.3358 2.3100 0.0 0
M  V30 20 C 9.3358 5.3900 0.0 0
M  V30 21 C 10.6694 3.0800 0.0 0
M  V30 22 C 10.6694 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 19
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 2 8 9
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 18
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 444112-59-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2374908-85-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28924658
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-89-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM aerobic, alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-Catalyzed Tandem C-H/N-H Activation, Cyclization[4+2] and
Dehydration of Arylamides with Formamide: Synthesis of
4(3H)-Quinazolinones Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Jian; Wang, Guodong; Hao, Liqiang; Han, Junfen; Li, Hongshuang;
Duan, Guiyun; You, Guirong; Li, Furong; Xia, Chengcai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2019), 11(12), 2799-2802

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Iodo-4-(trifluoromethyl)benzene
C7H4F3I
455-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 I 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzonitrile
C8H4F3N
455-18-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 9.2400 1.5400 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 0.2064 0.0 0
M  V30 9 C 3.8500 2.8736 0.0 0
M  V30 10 C 5.3900 0.2064 0.0 0
M  V30 11 C 5.3900 2.8736 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 455-13-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 455-18-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34483942
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-89-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-Catalyzed Cyanation of Aryl Iodides with Formamide as the Cyano
Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peng, Sha; Yang, Luo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Asian Journal of Organic Chemistry (2022), 11(11), e202200437

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxyaniline
C7H9NO
536-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 N 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Methoxyphenyl)formamide
C8H9NO2
27153-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 536-90-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 27153-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-18264286
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1313-13-9
$DTYPE RXN:VAR(1):NOTES
$DATUM scalable, no solvent, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM MnO2 catalyzed formylation of amines and transamidation of amides under
solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yedage, Subhash L.; D'Silva, Denvert S.; Bhanage, Bhalchandra M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2015), 5(98), 80441-80449

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Benzamide
C7H7NO
55-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzylformamide
C8H9NO
6343-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 N 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 55-21-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6343-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-20456744
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 77-92-9
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, iron oxide support used,
catalyst prepared and used, recyclable catalyst used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Citric acid stabilized on the surface of magnetic nanoparticles as an
efficient and recyclable catalyst for transamidation of carboxamides,
phthalimide, urea and thiourea with amines under neat conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arefi, Marzban; Kazemi Miraki, Maryam; Mostafalu, Ramin; Satari,
Mohammad; Heydari, Akbar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2019), 16(2), 393-400

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Methoxyphenyl)boronic acid
C7H9BO3
5720-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5720-07-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-8173452
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6046-93-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (25) General Procedure for the Synthesis of
Formanilides 2 To an open flask containing a solution of arylboronic acid
1 (1.0 mmol) in formamide (2 mL) were added Cu(OAc)2·H2O (19.9 mg, 10
mol%) and K2CO3 (138.2 mg, 1 mmol), and the mixture was stirred
vigorously at r.t. under air (without bubbling air) for 8-16 h (Table 2).
After completion of the reaction (indicated by TLC), the reaction mixture
was treated with EtOAc (5 mL) and H2O (5 mL). The organic layer was
separated, and the aqueous layer was extracted with EtOAc (3 × 5 mL). The
combined organic phase was washed with H2O (2 × 5 mL), dried over anhyd
Na2SO4, and concentrated to yield a residue, which was purified by flash
chromatography (prepacked silica cartridges). The clean product 2 as a
mixture of rotamers.27 All the products are known compounds and were
characterized by comparison of their melting points and spectral data
with those reported in the literature.14-17 N-Phenylformamide (2a, Table
2)
$DTYPE RXN:VAR(1):NOTES
$DATUM aerobic, no solvent, Chan-Lam coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed formamidation of arylboronic acids: direct access to
formanilides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srivastava, Vishnu P.; Yadav, Deepak K.; Yadav, Arvind K.; Watal, Geeta;
Yadav, Lal Dhar S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2013), 24(11), 1423-1427

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Methoxyphenyl)boronic acid
C7H9BO3
5720-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5720-07-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-18157319
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 86-93-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 15158-11-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, nanopolystyrene anchored Cu(II) complex of
1-phenyl-1H-tetrazole-5-thiol used as catalyst, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization, antibacterial and catalytic activity of a
nanopolymer supported copper(II) complex as a highly active and
recyclable catalyst for the formamidation of arylboronic acids under
aerobic conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nasrollahzadeh, Mahmoud; Zahraei, Ali; Ehsani, Ali; Khalaj, Mehdi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(39), 20351-20357

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Methoxyphenyl)boronic acid
C7H9BO3
5720-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5720-07-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-386522
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1034343-98-0
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM oxide reduced
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, catalyst prepared and
used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and characterization of copper nanoparticles supported on
reduced graphene oxide as a highly active and recyclable catalyst for the
synthesis of formamides and primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fakhri, Parisa; Jaleh, Babak; Nasrollahzadeh, Mahmoud
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2014), 383-38417-22

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-iodobenzoate
C8H7IO2
619-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 I 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-cyanobenzoate
C9H7NO2
1129-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 8.4701 1.3337 0.0 0
M  V30 6 N 10.0101 1.3337 0.0 0
M  V30 7 C 3.8500 1.3337 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 4.6201 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.1601 2.6673 0.0 0
M  V30 12 C 6.9301 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-44-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1129-35-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34483938
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-89-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-Catalyzed Cyanation of Aryl Iodides with Formamide as the Cyano
Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peng, Sha; Yang, Luo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Asian Journal of Organic Chemistry (2022), 11(11), e202200437

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-2-[2-(4-chlorophenyl)hydrazinylidene]acetate
C9H8Cl2N2O2
62465-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 Cl 8.0022 0.0000 0.0 0
M  V30 6 O 10.6697 1.5400 0.0 0
M  V30 7 O 9.3360 3.8501 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 Cl 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-(4-chlorophenyl)-1H-1,2,4-triazole-3-carboxylate
C10H8ClN3O2
57227-00-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7756 1.5317 0.0 0
M  V30 2 O 11.1826 2.1580 0.0 0
M  V30 3 O 9.6147 0.0000 0.0 0
M  V30 4 C 12.4284 1.2528 0.0 0
M  V30 5 Cl 0.0000 3.2067 0.0 0
M  V30 6 N 6.1600 3.2067 0.0 0
M  V30 7 N 7.0652 1.9609 0.0 0
M  V30 8 C 7.0652 4.4528 0.0 0
M  V30 9 C 8.5298 2.4367 0.0 0
M  V30 10 N 8.5298 3.9767 0.0 0
M  V30 11 C 4.6200 3.2067 0.0 0
M  V30 12 C 3.8500 4.5405 0.0 0
M  V30 13 C 3.8500 1.8731 0.0 0
M  V30 14 C 2.3100 4.5405 0.0 0
M  V30 15 C 2.3100 1.8731 0.0 0
M  V30 16 C 1.5400 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62465-90-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 57227-00-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25619738
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile One-Pot Synthesis of Methyl
1-Aryl-1H-1,2,4-triazole-3-carboxylates from Nitrilimines with Vilsmeier
Reagent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsai, Shuo-En; Chiang, Kun-Heng; Tseng, Ching-Chun; Chen, Nai-Wei; Chern,
Ching-Yuh; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(8), 1754-1762

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodo-N,N-dimethylaniline
C8H10IN
698-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 C 0.0000 2.6673 0.0 0
M  V30 4 I 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethylamino)benzonitrile
C9H10N2
1197-19-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 698-70-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1197-19-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25598896
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 366-18-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3264-82-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7446-70-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, sealed vessel used, aerobic, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ni-Mediated Generation of "CN" Unit from Formamide and Its Catalysis in
the Cyanation Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Luo; Liu, Yu-Ting; Park, Yoonsu; Park, Sung-Woo; Chang, Sukbok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2019), 9(4), 3360-3365

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-N-phenylacetamide
C8H8INO
7212-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 3.0800 0.0 0
M  V30 4 O 5.3347 0.7700 0.0 0
M  V30 5 I 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 3.0800 0.0 0
M  V30 8 C 2.6674 0.7700 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 0.0000 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formanilide
C7H7NO
103-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7212-28-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 103-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30746739
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Effective Synthesis of N-Arylformamide from α-Halo-N-arylacetamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chiang, Kun-Heng; Lu, Shi-Han; Yen, Wan-Ping; Uramaru, Naoto; Tseng,
Wei-Siou; Chang, Te-Wei; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heteroatom Chemistry (2016), 27(4), 235-242

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-2-[2-(3-chlorophenyl)hydrazinylidene]acetate
C9H8Cl2N2O2
75998-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 Cl 8.0022 0.0000 0.0 0
M  V30 6 O 10.6697 1.5400 0.0 0
M  V30 7 O 9.3360 3.8501 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 Cl 0.0000 1.5400 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-1,2,4-Triazole, 1-(3-chlorophenyl)-
C8H6ClN3
1644538-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 7.7721 3.0800 0.0 0
M  V30 2 C 3.7710 2.3100 0.0 0
M  V30 3 C 5.1046 3.0800 0.0 0
M  V30 4 C 3.7710 0.7700 0.0 0
M  V30 5 C 6.4384 2.3100 0.0 0
M  V30 6 C 5.1046 0.0000 0.0 0
M  V30 7 C 6.4384 0.7700 0.0 0
M  V30 8 N 2.4374 3.0800 0.0 0
M  V30 9 C 2.2764 4.6115 0.0 0
M  V30 10 N 1.0304 2.4535 0.0 0
M  V30 11 N 0.7700 4.9317 0.0 0
M  V30 12 C 0.0000 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75998-56-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1644538-68-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-530-CAS-19828161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile One-Pot Synthesis of Methyl
1-Aryl-1H-1,2,4-triazole-3-carboxylates from Nitrilimines with Vilsmeier
Reagent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsai, Shuo-En; Chiang, Kun-Heng; Tseng, Ching-Chun; Chen, Nai-Wei; Chern,
Ching-Yuh; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(8), 1754-1762

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dimethoxybenzaldehyde
C9H10O3
93-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 O 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2,5-Dimethoxyphenyl)methyl]formamide
C10H13NO3
1483609-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 5.3347 0.0 0
M  V30 3 C 8.4700 5.3347 0.0 0
M  V30 4 O 9.2400 6.6685 0.0 0
M  V30 5 O 4.6200 1.3338 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 O 1.5400 6.6685 0.0 0
M  V30 8 C 0.0000 6.6685 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 3.8500 5.3347 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 1 7 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 93-02-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1483609-80-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8913192
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):NOTES
$DATUM Leuckart-Wallach reaction, formamide/formic acid also used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient Isocyanide-less Isocyanide-Based Multicomponent Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neochoritis, Constantinos G.; Stotani, Silvia; Mishra, Bhupendra;
Doemling, Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(8), 2002-2005

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzothiazole
C7H5NS
95-16-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 N 4.1321 2.7859 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 S 4.1321 0.2941 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 C 5.0371 1.5400 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 7
M  V30 9 1 6 9
M  V30 10 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Benzothiazolecarboxamide
C8H6N2OS
29198-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 N 7.4149 2.3100 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 2.3100 2.8281 0.0 0
M  V30 5 C 3.0800 4.1618 0.0 0
M  V30 6 N 3.3406 1.6836 0.0 0
M  V30 7 C 0.7700 2.8281 0.0 0
M  V30 8 S 4.5865 3.8416 0.0 0
M  V30 9 C 2.3100 5.4954 0.0 0
M  V30 10 C 4.7474 2.3100 0.0 0
M  V30 11 C 0.0000 4.1618 0.0 0
M  V30 12 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 95-16-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 29198-43-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-095-CAS-21333413
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7727-54-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, photochemical, sealed vial used, CFl lamp 23 W used,
optimization study, optimized on regent and Photosensitizer
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct α-heteroarylation of amides (α to nitrogen) and ethers through a
benzaldehyde-mediated photoredox reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yongqiang; Teuscher, Kevin B.; Ji, Haitao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2016), 7(3), 2111-2118

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-4-(trifluoromethyl)benzene
C7H4ClF3
98-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 Cl 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(Trifluoromethyl)phenyl]formamide
C8H6F3NO
74702-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 O 10.0100 2.8736 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 5.3900 2.8736 0.0 0
M  V30 13 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 2 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-56-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 74702-40-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-8887152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12131-44-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 894086-00-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vial used, Buchwald-Hartwig amination
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM BippyPhos: A Single Ligand With Unprecedented Scope in the
Buchwald-Hartwig Amination of (Hetero)aryl Chlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crawford, Sarah M.; Lavery, Christopher B.; Stradiotto, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2013), 19(49), 16760-16771

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-amino-3-(4-fluorophenyl)-5-isothiazolecarboxylate
C12H11FN2O2S
100361-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.5894 0.4963 0.0 0
M  V30 2 C 9.7758 1.5317 0.0 0
M  V30 3 O 11.1826 2.1580 0.0 0
M  V30 4 O 9.6147 0.0000 0.0 0
M  V30 5 C 12.4284 1.2528 0.0 0
M  V30 6 C 13.8354 1.8791 0.0 0
M  V30 7 F 0.0000 3.2067 0.0 0
M  V30 8 C 6.1600 3.2067 0.0 0
M  V30 9 C 7.0652 1.9609 0.0 0
M  V30 10 N 7.0652 4.4528 0.0 0
M  V30 11 C 8.5299 2.4367 0.0 0
M  V30 12 S 8.5299 3.9767 0.0 0
M  V30 13 C 4.6200 3.2067 0.0 0
M  V30 14 C 3.8500 4.5405 0.0 0
M  V30 15 C 3.8500 1.8731 0.0 0
M  V30 16 C 2.3100 4.5405 0.0 0
M  V30 17 C 2.3100 1.8731 0.0 0
M  V30 18 C 1.5400 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Fluorophenyl)isothiazolo[4,5-d]pyrimidin-7(6H)-one
C11H6FN3OS
498549-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.4581 0.0 0
M  V30 2 F 11.1388 3.7827 0.0 0
M  V30 3 C 4.9788 3.7827 0.0 0
M  V30 4 C 4.0736 2.5368 0.0 0
M  V30 5 N 4.0736 5.0287 0.0 0
M  V30 6 C 2.6091 3.0127 0.0 0
M  V30 7 N 4.3938 1.0306 0.0 0
M  V30 8 S 2.6091 4.5527 0.0 0
M  V30 9 C 1.4645 1.9823 0.0 0
M  V30 10 C 3.2494 0.0000 0.0 0
M  V30 11 N 1.7847 0.4760 0.0 0
M  V30 12 C 6.5188 3.7827 0.0 0
M  V30 13 C 7.2888 5.1165 0.0 0
M  V30 14 C 7.2888 2.4491 0.0 0
M  V30 15 C 8.8288 5.1165 0.0 0
M  V30 16 C 8.8288 2.4491 0.0 0
M  V30 17 C 9.5988 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100361-54-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 498549-36-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16149460
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused pyrimidinones as ubiquitin-specific protease 7
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ioannidis, Stephanos; Talbot, Adam Charles; Follows, Bruce; Buckmelter,
Alexandre Joseph; Wang, Minghua; Campbell, Ann-Marie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016126935 A1 2016-08-11

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-3-(4-chlorophenyl)-1H-pyrazol-5-amine
C15H11Cl2N3
1020237-41-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0175 0.0000 0.0 0
M  V30 2 Cl 4.0011 5.6420 0.0 0
M  V30 3 Cl 12.5648 2.6878 0.0 0
M  V30 4 N 4.0011 2.5620 0.0 0
M  V30 5 N 5.4080 3.1885 0.0 0
M  V30 6 C 4.1621 1.0304 0.0 0
M  V30 7 C 6.4384 2.0439 0.0 0
M  V30 8 C 5.6684 0.7103 0.0 0
M  V30 9 C 2.6673 3.3320 0.0 0
M  V30 10 C 2.6673 4.8720 0.0 0
M  V30 11 C 1.3337 2.5620 0.0 0
M  V30 12 C 1.3337 5.6420 0.0 0
M  V30 13 C 0.0000 3.3320 0.0 0
M  V30 14 C 0.0000 4.8720 0.0 0
M  V30 15 C 7.9701 2.2049 0.0 0
M  V30 16 C 8.8752 0.9590 0.0 0
M  V30 17 C 8.5964 3.6118 0.0 0
M  V30 18 C 10.4069 1.1201 0.0 0
M  V30 19 C 10.1280 3.7728 0.0 0
M  V30 20 C 11.0332 2.5269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 10
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 7 15
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazolo[3,4-d]pyrimidine, 1-(2-chlorophenyl)-3-(4-chlorophenyl)-
C17H10Cl2N4
1410783-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 7.5409 0.0 0
M  V30 2 Cl 12.5648 4.5867 0.0 0
M  V30 3 N 4.0011 4.4608 0.0 0
M  V30 4 C 4.1621 2.9293 0.0 0
M  V30 5 N 5.4080 5.0873 0.0 0
M  V30 6 C 5.6684 2.6091 0.0 0
M  V30 7 N 3.1316 1.7849 0.0 0
M  V30 8 C 6.4384 3.9428 0.0 0
M  V30 9 C 6.1443 1.1444 0.0 0
M  V30 10 C 3.6075 0.3202 0.0 0
M  V30 11 N 5.1138 0.0000 0.0 0
M  V30 12 C 2.6673 5.2309 0.0 0
M  V30 13 C 2.6673 6.7709 0.0 0
M  V30 14 C 1.3337 4.4608 0.0 0
M  V30 15 C 1.3337 7.5409 0.0 0
M  V30 16 C 0.0000 5.2309 0.0 0
M  V30 17 C 0.0000 6.7709 0.0 0
M  V30 18 C 7.9701 4.1037 0.0 0
M  V30 19 C 8.8752 2.8578 0.0 0
M  V30 20 C 8.5964 5.5107 0.0 0
M  V30 21 C 10.4069 3.0188 0.0 0
M  V30 22 C 10.1280 5.6716 0.0 0
M  V30 23 C 11.0332 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 23
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 8 18
M  V30 13 1 9 11
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1020237-41-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1410783-55-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-5857750
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-fluoro-5-methylbenzonitrile
C8H7FN2
1037206-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 7.7000 2.6674 0.0 0
M  V30 3 N 4.6200 0.0000 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 F 0.0000 2.6674 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-6-methyl-4-quinazolinamine
C9H8FN3
1126424-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.3338 0.0 0
M  V30 2 C 5.3900 0.0000 0.0 0
M  V30 3 F 6.9300 2.6674 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1037206-84-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1126424-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21300961
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A - Synthesis of Compound 32A A solution of 5C (0.20 g, 1.33 mmol)
in formamide (15 mL) was heated to 150 °C and stirred for 18 hours. After
cooled to room temperature, ethyl acetate (60 mL) and water (30 mL) were
added and the layers were separated. The organic solution was washed with
water (3x20 mL), dried (MgSO4), filtered, and concentrated in vacuo to
provide the crude product 32A (0.22 g, 93 %). Compound 32A, yield (0.22
g, 93 %). MS found for C9H8FN3: 178.2 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tricyclic indole derivatives as HCV NS5B polymerase inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of HCV
infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Venkatraman, Srikanth; Anilkumar, Gopinadhan N.; Chen, Kevin X.;
Velazquez, Francisco; Zeng, Qingbei; Liu, Duan; Jiang, Yueheng;
Kozlowski, Joseph A.; Njoroge, F. George; Rosenblum, Stuart B.; Gavalas,
Stephen J.; Pinto, Patrick A.; Selyutin, Oleg B.; Vibulbhan, Bancha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009152200 A1 2009-12-17

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-fluoro-5-methylbenzonitrile
C8H7FN2
1037206-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 7.7000 2.6674 0.0 0
M  V30 3 N 4.6200 0.0000 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 F 0.0000 2.6674 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-6-methyl-4-quinazolinamine
C9H8FN3
1126424-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.3338 0.0 0
M  V30 2 C 5.3900 0.0000 0.0 0
M  V30 3 F 6.9300 2.6674 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1037206-84-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1126424-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21364241
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 14. Preparation of Intermediate Compound 14D. Step A-Synthesis of
Compound 14B. A solution of 14A (0.20 g, 1.33 mmol) in formamide (15 mL)
was heated to 150°C and stirred for 18 h. After cooled to room
temperature, ethyl acetate (60 mL) and water (30 mL) were added and the
layers were separated. The organic solution was washed with water (3×20
mL), dried (MgSO4), filtered, and concentrated in vacuo to provide the
crude product 14B (0.22 g, 93 %). MS found for C9H8FN3: 178.2 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2,3-substituted azaindole derivatives for treating viral
infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anilkumar, Gopinadhan N.; Rosenblum, Stuart B.; Venkatraman, Srikanth;
Njoroge, F. George; Kozlowski, Joseph A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009032125 A1 2009-03-12

$RFMT $RIREG SCHEME215 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Azidobenzaldehyde
C7H5N3O
16714-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 4.0010 0.0 0
M  V30 2 N 6.1601 4.0010 0.0 0 CHG=1 VAL=4
M  V30 3 N 7.7002 4.0010 0.0 0 CHG=-1
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 1.5400 1.3337 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Toluenesulfonic acid
C7H8O3S
104-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide, N-[(2-azidophenyl)[(4-methylphenyl)sulfonyl]methyl]-
C15H14N4O3S
2983187-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 S 7.7000 4.0011 0.0 0 VAL=6
M  V30 3 N 5.3900 2.6674 0.0 0
M  V30 4 O 7.7000 5.5411 0.0 0
M  V30 5 O 7.7000 2.4611 0.0 0
M  V30 6 C 6.1600 1.3336 0.0 0
M  V30 7 O 5.3900 0.0000 0.0 0
M  V30 8 N 3.0800 4.0011 0.0 0
M  V30 9 N 1.5400 4.0011 0.0 0 CHG=1 VAL=4
M  V30 10 N 0.0000 4.0011 0.0 0 CHG=-1
M  V30 11 C 13.8600 4.0011 0.0 0
M  V30 12 C 5.3900 5.3347 0.0 0
M  V30 13 C 3.8500 5.3347 0.0 0
M  V30 14 C 6.1600 6.6685 0.0 0
M  V30 15 C 3.0800 6.6685 0.0 0
M  V30 16 C 5.3900 8.0021 0.0 0
M  V30 17 C 3.8500 8.0021 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 20 C 10.0100 2.6674 0.0 0
M  V30 21 C 11.5500 5.3347 0.0 0
M  V30 22 C 11.5500 2.6674 0.0 0
M  V30 23 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 18
M  V30 7 1 3 6
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 13
M  V30 11 2 9 10
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16714-25-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2983187-76-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37740663
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,2,3-Benzotriazine Synthesis by Heterocyclization of p-Tosylmethyl
Isocyanide Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maqueda-Zelaya, Francisco; Acena, Jose Luis; Merino, Estibaliz; Vaquero,
Juan J.; Sucunza, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2023), 88(19), 14131-14139

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-iodobenzene
C6H3BrFI
105931-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.5400 0.0000 0.0 0
M  V30 2 I 0.0000 2.6673 0.0 0
M  V30 3 Br 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluorobenzonitrile
C7H3BrFN
105942-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 7.7001 2.6673 0.0 0
M  V30 3 F 4.6201 0.0000 0.0 0
M  V30 4 Br 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8500 1.3337 0.0 0
M  V30 7 C 3.8500 4.0010 0.0 0
M  V30 8 C 2.3100 1.3337 0.0 0
M  V30 9 C 2.3100 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105931-73-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 105942-08-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34483954
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-89-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-Catalyzed Cyanation of Aryl Iodides with Formamide as the Cyano
Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peng, Sha; Yang, Luo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Asian Journal of Organic Chemistry (2022), 11(11), e202200437

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-5-ethyl-4-methyl-3-thiophenecarboxylate
C10H15NO2S
108354-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 1.5400 0.0 0
M  V30 2 O 7.5415 2.3101 0.0 0
M  V30 3 O 6.2079 0.0000 0.0 0
M  V30 4 C 8.8752 1.5400 0.0 0
M  V30 5 C 10.2089 2.3101 0.0 0
M  V30 6 C 3.1471 0.1773 0.0 0
M  V30 7 N 5.8577 4.8721 0.0 0
M  V30 8 C 0.9051 2.6672 0.0 0
M  V30 9 C 0.0000 3.9131 0.0 0
M  V30 10 C 4.8741 2.3101 0.0 0
M  V30 11 C 3.4672 1.6836 0.0 0
M  V30 12 C 4.7131 3.8416 0.0 0
M  V30 13 C 2.4368 2.8281 0.0 0
M  V30 14 S 3.2068 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Ethyl-5-methylthieno[2,3-d]pyrimidin-4(1H)-one
C9H10N2OS
502648-95-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0204 0.0000 0.0 0
M  V30 2 O 0.0000 1.3172 0.0 0
M  V30 3 C 6.0810 1.3627 0.0 0
M  V30 4 C 7.4148 2.1327 0.0 0
M  V30 5 C 2.3100 2.6508 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 C 3.3406 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 S 4.5864 3.6643 0.0 0
M  V30 10 N 2.3100 5.3182 0.0 0
M  V30 11 C 4.7474 2.1327 0.0 0
M  V30 12 N 0.0000 3.9844 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108354-77-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 502648-95-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16148457
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Computer-aided identification, synthesis and evaluation of substituted
thienopyrimidines as novel inhibitors of HCV replication
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bassetto, Marcella; Leyssen, Pieter; Neyts, Johan; Yerukhimovich, Mark
M.; Frick, David N.; Brancale, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 12331-47

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chlorobenzene
C6H5Cl
108-90-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formanilide
C7H7NO
103-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-90-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 103-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-6846147
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-99-8
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligand free open air copper(II) mediated aryl formamidation and amination
of aryl halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Komati, Rajesh; Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2014), 55(9), 1523-1527

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chlorobenzene
C6H5Cl
108-90-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formanilide
C7H7NO
103-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-90-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 103-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-10490616
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12168-54-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, green chemistry-solvent, Buchwald-Hartwig type
amination, nickel ferrite nanoparticles used as catalyst, catalyst
prepared and used, recyclable and reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM C-N Bond Formation Using Highly Effective and Reusable Nickel Ferrite
Nanoparticles in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moghaddam, Firouz Matloubi; Tavakoli, Ghazal; Moafi, Atiyeh; Saberi,
Vahid; Rezvani, Hamid Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2014), 6(12), 3474-3481

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-2,5-dimethylbenzonitrile
C9H8FN
1126424-97-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 7.7000 2.6674 0.0 0
M  V30 3 C 4.6200 0.0000 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 F 0.0000 2.6674 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-6-methyl-4-quinazolinamine
C9H8FN3
1126424-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.3338 0.0 0
M  V30 2 C 5.3900 0.0000 0.0 0
M  V30 3 F 6.9300 2.6674 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1126424-97-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1126424-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26840612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A — Synthesis of Compound 33B A solution of 33A (0.20 g, 1.33 mmol)
in formamide (15 mL) was heated to 150 °C and allowed to stir for 18
hours. After cooled to room temperature, ethyl acetate (60 mL) and water
(30 mL) were added and the layers were separated. The organic solution
was washed with water (3x20 mL), dried (MgSO4), filtered, and
concentrated in vacuo to provide the crude product 33B (0.22 g, 93 %). MS
found for C9H8FN3: 178.2 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted indole derivatives for inhibition of hepatitis
C virus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anilkumar, Gopinadhan N.; Bennett, Frank; Chan, Tin-Yau; Chen, Kevin X.;
Sannigrahi, Mousumi; Velazquez, Francisco; Venkatraman, Srikanth; Zeng,
Qingbei; Duca, Jose S.; Lesburg, Charles A.; Kozlowski, Joseph A.;
Njoroge, F. George; Rosenblum, Stuart B.; Shih, Neng-Yang; Gavalas,
Stephen J.; Jiang, Yueheng; Pinto, Patrick A.; Pu, Haiyan; Selyutin, Oleg
B.; Vibulbhan, Bancha; Wang, Li; Wu, Wanli; Yang, Weiying; Huang, Yuhua;
Huang, Hsueh-Cheng; Palermo, Robert; Feld, Boris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009032116 A1 2009-03-12

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-chloro-1H-indole-3-carboxylate
C11H11ClN2O2
1126602-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 3.3320 0.0 0
M  V30 2 O 7.1957 2.8561 0.0 0
M  V30 3 O 5.4108 4.8385 0.0 0
M  V30 4 C 8.3401 3.8866 0.0 0
M  V30 5 C 9.8048 3.4107 0.0 0
M  V30 6 Cl 3.0801 5.2891 0.0 0
M  V30 7 N 6.0811 0.0000 0.0 0
M  V30 8 C 3.0801 2.6218 0.0 0
M  V30 9 C 4.5865 2.3016 0.0 0
M  V30 10 C 2.3101 1.2881 0.0 0
M  V30 11 C 2.3101 3.9554 0.0 0
M  V30 12 C 4.7475 0.7700 0.0 0
M  V30 13 N 3.3406 0.1435 0.0 0
M  V30 14 C 0.7700 1.2881 0.0 0
M  V30 15 C 0.7700 3.9554 0.0 0
M  V30 16 C 0.0000 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-3,9-dihydro-4H-pyrimido[4,5-b]indol-4-one
C10H6ClN3O
1450819-39-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.3200 0.0000 0.0 0
M  V30 2 O 1.7288 0.5507 0.0 0
M  V30 3 C 4.3200 2.6673 0.0 0
M  V30 4 C 2.8137 2.9876 0.0 0
M  V30 5 C 5.0900 4.0011 0.0 0
M  V30 6 C 5.0900 1.3336 0.0 0
M  V30 7 C 2.6527 4.5192 0.0 0
M  V30 8 C 1.5679 2.0824 0.0 0
M  V30 9 N 4.0596 5.1455 0.0 0
M  V30 10 C 6.6300 4.0011 0.0 0
M  V30 11 C 6.6300 1.3336 0.0 0
M  V30 12 N 1.2459 5.1455 0.0 0
M  V30 13 N 0.1609 2.7087 0.0 0
M  V30 14 C 7.4000 2.6673 0.0 0
M  V30 15 C 0.0000 4.2403 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1126602-44-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1450819-39-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3783565
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological activity of benzo-fused 7-deazaadenosine
analogues. 5- and 6-substituted 4-amino- or 4-alkylpyrimido[4,5-b]indole
ribonucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tichy, Michal; Pohl, Radek; Tloust'ova, Eva; Weber, Jan; Bahador, Gina;
Lee, Yu-Jen; Hocek, Michal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2013), 21(17), 5362-5372

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-3-(4-fluorophenyl)-1-(4-nitrophenyl)-1H-pyrazole-4-carbonitrile
C16H10FN5O2
1133775-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.9622 1.4070 0.0 0
M  V30 2 N 9.5885 0.0000 0.0 0
M  V30 3 N 5.6850 2.1035 0.0 0
M  V30 4 F 15.2320 4.7915 0.0 0
M  V30 5 N 1.3337 7.7457 0.0 0 VAL=5
M  V30 6 O 1.3337 9.2857 0.0 0
M  V30 7 O 0.0000 6.9757 0.0 0
M  V30 8 C 9.1058 4.1476 0.0 0
M  V30 9 C 8.3358 2.8138 0.0 0
M  V30 10 N 8.0753 5.2920 0.0 0
M  V30 11 C 6.8294 3.1339 0.0 0
M  V30 12 N 6.6684 4.6657 0.0 0
M  V30 13 C 10.6374 4.3085 0.0 0
M  V30 14 C 11.2637 5.7153 0.0 0
M  V30 15 C 11.5426 3.0626 0.0 0
M  V30 16 C 12.7953 5.8764 0.0 0
M  V30 17 C 13.0742 3.2236 0.0 0
M  V30 18 C 13.7005 4.6304 0.0 0
M  V30 19 C 5.3348 5.4357 0.0 0
M  V30 20 C 5.3348 6.9757 0.0 0
M  V30 21 C 4.0010 4.6657 0.0 0
M  V30 22 C 4.0010 7.7457 0.0 0
M  V30 23 C 2.6673 5.4357 0.0 0
M  V30 24 C 2.6673 6.9757 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 11
M  V30 4 1 4 18
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 24
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 1 12 19
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Fluorophenyl)-1-(4-nitrophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C17H11FN6O2
1133775-47-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.3180 8.2567 0.0 0
M  V30 2 F 15.2321 4.4943 0.0 0
M  V30 3 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 C 9.1059 5.1381 0.0 0
M  V30 7 C 8.3358 6.4718 0.0 0
M  V30 8 N 8.0753 3.9936 0.0 0
M  V30 9 C 6.8294 6.1516 0.0 0
M  V30 10 C 8.8117 7.9365 0.0 0
M  V30 11 N 6.6685 4.6201 0.0 0
M  V30 12 N 5.7990 7.2960 0.0 0
M  V30 13 N 7.7811 9.0809 0.0 0
M  V30 14 C 6.2748 8.7607 0.0 0
M  V30 15 C 10.6374 4.9772 0.0 0
M  V30 16 C 11.2637 3.5702 0.0 0
M  V30 17 C 11.5426 6.2231 0.0 0
M  V30 18 C 12.7953 3.4093 0.0 0
M  V30 19 C 13.0742 6.0620 0.0 0
M  V30 20 C 13.7005 4.6552 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 5.3348 2.3100 0.0 0
M  V30 23 C 4.0010 4.6201 0.0 0
M  V30 24 C 4.0010 1.5400 0.0 0
M  V30 25 C 2.6673 3.8501 0.0 0
M  V30 26 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 20
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 26
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 21
M  V30 16 1 12 14
M  V30 17 2 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1133775-46-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1133775-47-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21321772
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antimicrobial activity of some new pyrazole, fused
pyrazolo[3,4-d]-pyrimidine and
pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abunada, Nada M.; Hassaneen, Hamdi M.; Kandile, Nadia G.; Miqdad, Omar A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2008), 13(7), 1501-1517

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-2-[2-(4-fluorophenyl)hydrazinylidene]acetate
C9H8ClFN2O2
118010-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 Cl 8.0022 0.0000 0.0 0
M  V30 6 O 10.6697 1.5400 0.0 0
M  V30 7 O 9.3360 3.8501 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 F 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Fluorophenyl)-1H-1,2,4-triazole
C8H6FN3
81329-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 8.5298 1.3336 0.0 0
M  V30 2 C 3.9098 1.3336 0.0 0
M  V30 3 C 4.6798 2.6673 0.0 0
M  V30 4 C 4.6798 0.0000 0.0 0
M  V30 5 C 6.2198 2.6673 0.0 0
M  V30 6 C 6.2198 0.0000 0.0 0
M  V30 7 C 6.9898 1.3336 0.0 0
M  V30 8 N 2.3698 1.3336 0.0 0
M  V30 9 C 1.4645 2.5795 0.0 0
M  V30 10 N 1.4645 0.0878 0.0 0
M  V30 11 N 0.0000 2.1037 0.0 0
M  V30 12 C 0.0000 0.5636 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118010-84-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 81329-35-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-530-CAS-19828163
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile One-Pot Synthesis of Methyl
1-Aryl-1H-1,2,4-triazole-3-carboxylates from Nitrilimines with Vilsmeier
Reagent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsai, Shuo-En; Chiang, Kun-Heng; Tseng, Ching-Chun; Chen, Nai-Wei; Chern,
Ching-Yuh; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(8), 1754-1762

$RFMT $RIREG SCHEME223 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Fluoren-9-ylmethyl N-[(1S)-1-(mercaptomethyl)-2-methylpropyl]carbamate
C20H23NO2S
1231959-18-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 7.0871 4.4608 0.0 0
M  V30 3 C 8.4207 5.2309 0.0 0
M  V30 4 N 9.7544 4.4608 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0882 5.2309 0.0 0 CFG=2
M  V30 7 C 12.4219 4.4608 0.0 0
M  V30 8 C 11.0882 6.7709 0.0 0
M  V30 9 C 12.4219 2.9208 0.0 0
M  V30 10 C 13.7555 5.2309 0.0 0
M  V30 11 S 12.4219 7.5409 0.0 0
M  V30 12 C 4.4196 4.4608 0.0 0
M  V30 13 C 4.2586 2.9293 0.0 0
M  V30 14 C 3.0128 5.0873 0.0 0
M  V30 15 C 2.7523 2.6091 0.0 0
M  V30 16 C 5.2891 1.7849 0.0 0
M  V30 17 C 1.9823 3.9428 0.0 0
M  V30 18 C 2.5369 6.5519 0.0 0
M  V30 19 C 2.2763 1.1444 0.0 0
M  V30 20 C 4.8132 0.3202 0.0 0
M  V30 21 C 0.4759 4.2630 0.0 0
M  V30 22 C 1.0304 6.8721 0.0 0
M  V30 23 C 3.3069 0.0000 0.0 0
M  V30 24 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 17
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 2 20 23
M  V30 25 1 21 24
M  V30 26 2 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C22H26N2O3S
2602313-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 5.7533 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4208 6.7709 0.0 0
M  V30 6 C 8.4208 9.8510 0.0 0 CFG=1
M  V30 7 C 9.7544 9.0810 0.0 0
M  V30 8 C 8.4208 11.3910 0.0 0
M  V30 9 S 11.0881 9.8510 0.0 0
M  V30 10 C 9.7544 12.1610 0.0 0
M  V30 11 C 7.0871 12.1610 0.0 0
M  V30 12 C 12.4219 9.0810 0.0 0
M  V30 13 N 13.7556 9.8510 0.0 0
M  V30 14 C 15.0893 9.0810 0.0 0
M  V30 15 O 16.4229 9.8510 0.0 0
M  V30 16 C 4.4196 4.4609 0.0 0
M  V30 17 C 3.0128 5.0873 0.0 0
M  V30 18 C 4.2587 2.9293 0.0 0
M  V30 19 C 1.9822 3.9428 0.0 0
M  V30 20 C 2.5367 6.5519 0.0 0
M  V30 21 C 2.7522 2.6091 0.0 0
M  V30 22 C 5.2891 1.7849 0.0 0
M  V30 23 C 0.4759 4.2630 0.0 0
M  V30 24 C 1.0304 6.8721 0.0 0
M  V30 25 C 2.2763 1.1444 0.0 0
M  V30 26 C 4.8132 0.3202 0.0 0
M  V30 27 C 0.0000 5.7277 0.0 0
M  V30 28 C 3.3068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 1 19 21
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 2 24 27
M  V30 29 1 25 28
M  V30 30 2 26 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1231959-18-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2602313-29-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23168714
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM paraformaldehyde used, Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Nβ-Protected Amino Sulfenyl Methyl Formamides and Sulfonyl
Methyl Formamides: A Simple Protocol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasulu, Chinthaginjala; Sagar, Nagamangala R.; Vishwanatha,
Thimmalapura M.; Durgamma, Suram; Sureshbabu, Vommina V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2021), 6(7), 4680-4686

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-2-[2-[4-(trifluoromethyl)phenyl]hydrazinylidene]acetate
C10H8ClF3N2O2
1315307-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.4137 0.0 0
M  V30 2 N 8.0022 3.6437 0.0 0
M  V30 3 C 9.3360 4.4137 0.0 0
M  V30 4 C 10.6697 3.6437 0.0 0
M  V30 5 Cl 9.3360 5.9538 0.0 0
M  V30 6 O 12.0033 4.4137 0.0 0
M  V30 7 O 10.6697 2.1037 0.0 0
M  V30 8 C 13.3370 3.6437 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 F 2.1037 0.0000 0.0 0
M  V30 11 F 0.0000 0.5637 0.0 0
M  V30 12 F 0.5637 2.6673 0.0 0
M  V30 13 C 5.3348 3.6437 0.0 0
M  V30 14 C 5.3348 2.1037 0.0 0
M  V30 15 C 4.0010 4.4137 0.0 0
M  V30 16 C 4.0010 1.3337 0.0 0
M  V30 17 C 2.6673 3.6437 0.0 0
M  V30 18 C 2.6673 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[4-(trifluoromethyl)phenyl]-1H-1,2,4-triazole-3-carboxylate
C11H8F3N3O2
1538957-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.3156 1.5317 0.0 0
M  V30 2 O 12.7226 2.1580 0.0 0
M  V30 3 O 11.1547 0.0000 0.0 0
M  V30 4 C 13.9684 1.2528 0.0 0
M  V30 5 C 1.5400 3.2069 0.0 0
M  V30 6 F 1.5400 4.7469 0.0 0
M  V30 7 F 0.0000 3.2069 0.0 0
M  V30 8 F 1.5400 1.6669 0.0 0
M  V30 9 N 7.7000 3.2069 0.0 0
M  V30 10 N 8.6052 1.9609 0.0 0
M  V30 11 C 8.6052 4.4528 0.0 0
M  V30 12 C 10.0698 2.4369 0.0 0
M  V30 13 N 10.0698 3.9769 0.0 0
M  V30 14 C 6.1600 3.2069 0.0 0
M  V30 15 C 5.3900 4.5405 0.0 0
M  V30 16 C 5.3900 1.8731 0.0 0
M  V30 17 C 3.8500 4.5405 0.0 0
M  V30 18 C 3.8500 1.8731 0.0 0
M  V30 19 C 3.0800 3.2069 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 19
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1315307-30-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1538957-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30916007
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile One-Pot Synthesis of Methyl
1-Aryl-1H-1,2,4-triazole-3-carboxylates from Nitrilimines with Vilsmeier
Reagent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsai, Shuo-En; Chiang, Kun-Heng; Tseng, Ching-Chun; Chen, Nai-Wei; Chern,
Ching-Yuh; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(8), 1754-1762

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Dibutyl 5-ethyl-4,5,13,15-tetrahydro-5-hydroxy-3,15-dioxo-1H,3H-oxepino[3′,4′...
C29H35N2O8P
1352921-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.8912 13.3456 0.0 0
M  V30 2 C 3.3507 6.8467 0.0 0
M  V30 3 C 1.8354 6.5718 0.0 0
M  V30 4 O 5.1679 7.4675 0.0 0
M  V30 5 O 0.0000 9.6294 0.0 0
M  V30 6 O 16.0565 8.0022 0.0 0
M  V30 7 P 16.8266 6.6685 0.0 0 VAL=5
M  V30 8 O 17.5966 5.3348 0.0 0
M  V30 9 O 18.1602 7.4385 0.0 0
M  V30 10 O 15.4929 5.8985 0.0 0
M  V30 11 C 16.8266 4.0010 0.0 0
M  V30 12 C 19.4941 6.6685 0.0 0
M  V30 13 C 17.5966 2.6673 0.0 0
M  V30 14 C 20.8277 7.4385 0.0 0
M  V30 15 C 16.8266 1.3337 0.0 0
M  V30 16 C 22.1614 6.6685 0.0 0
M  V30 17 C 17.5966 0.0000 0.0 0
M  V30 18 C 23.4951 7.4385 0.0 0
M  V30 19 C 7.6201 9.6562 0.0 0
M  V30 20 C 9.1264 9.3358 0.0 0
M  V30 21 N 7.4590 11.1877 0.0 0
M  V30 22 C 6.3740 8.7509 0.0 0
M  V30 23 C 9.8964 10.6697 0.0 0
M  V30 24 N 9.8964 8.0022 0.0 0
M  V30 25 C 6.0522 11.8141 0.0 0
M  V30 26 C 8.8660 11.8141 0.0 0
M  V30 27 C 4.9672 9.3773 0.0 0
M  V30 28 C 11.4364 10.6697 0.0 0
M  V30 29 C 11.4364 8.0022 0.0 0
M  V30 30 C 4.8063 10.9088 0.0 0
M  V30 31 C 3.8701 8.2965 0.0 0
M  V30 32 C 12.2065 9.3358 0.0 0
M  V30 33 C 12.2065 6.6685 0.0 0
M  V30 34 C 3.5084 11.7380 0.0 0
M  V30 35 C 2.3412 8.4803 0.0 0
M  V30 36 C 13.7465 9.3358 0.0 0
M  V30 37 C 13.7465 6.6685 0.0 0
M  V30 38 O 2.0510 11.2402 0.0 0
M  V30 39 C 1.5316 9.7905 0.0 0
M  V30 40 C 14.5165 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 25
M  V30 2 1 2 3
M  V30 3 1 2 31
M  V30 4 1 4 31
M  V30 5 2 5 39
M  V30 6 1 6 7
M  V30 7 1 6 40
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 1 21 25
M  V30 25 1 21 26
M  V30 26 1 22 27
M  V30 27 1 23 26
M  V30 28 2 23 28
M  V30 29 1 24 29
M  V30 30 1 25 30
M  V30 31 2 27 30
M  V30 32 1 27 31
M  V30 33 1 28 32
M  V30 34 1 29 32
M  V30 35 2 29 33
M  V30 36 1 30 34
M  V30 37 1 31 35
M  V30 38 2 32 36
M  V30 39 1 33 37
M  V30 40 1 34 38
M  V30 41 1 35 39
M  V30 42 1 36 40
M  V30 43 2 37 40
M  V30 44 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibutyl 5-ethyl-4,5,13,15-tetrahydro-5-hydroxy-12-methyl-3,15-dioxo-1H,3H-oxe...
C30H37N2O8P
1042921-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.8912 13.3456 0.0 0
M  V30 2 C 12.2065 12.0033 0.0 0
M  V30 3 C 3.3507 6.8467 0.0 0
M  V30 4 C 1.8354 6.5718 0.0 0
M  V30 5 O 5.1679 7.4675 0.0 0
M  V30 6 O 0.0000 9.6294 0.0 0
M  V30 7 O 16.0565 8.0022 0.0 0
M  V30 8 P 16.8266 6.6685 0.0 0 VAL=5
M  V30 9 O 17.5966 5.3348 0.0 0
M  V30 10 O 18.1602 7.4385 0.0 0
M  V30 11 O 15.4929 5.8985 0.0 0
M  V30 12 C 16.8266 4.0010 0.0 0
M  V30 13 C 19.4941 6.6685 0.0 0
M  V30 14 C 17.5966 2.6673 0.0 0
M  V30 15 C 20.8277 7.4385 0.0 0
M  V30 16 C 16.8266 1.3337 0.0 0
M  V30 17 C 22.1614 6.6685 0.0 0
M  V30 18 C 17.5966 0.0000 0.0 0
M  V30 19 C 23.4951 7.4385 0.0 0
M  V30 20 C 7.6201 9.6562 0.0 0
M  V30 21 C 9.1264 9.3358 0.0 0
M  V30 22 N 7.4590 11.1877 0.0 0
M  V30 23 C 6.3740 8.7509 0.0 0
M  V30 24 C 9.8964 10.6697 0.0 0
M  V30 25 N 9.8964 8.0022 0.0 0
M  V30 26 C 8.8660 11.8141 0.0 0
M  V30 27 C 6.0522 11.8141 0.0 0
M  V30 28 C 4.9672 9.3773 0.0 0
M  V30 29 C 11.4364 10.6697 0.0 0
M  V30 30 C 11.4364 8.0022 0.0 0
M  V30 31 C 4.8063 10.9088 0.0 0
M  V30 32 C 3.8701 8.2965 0.0 0
M  V30 33 C 12.2065 9.3358 0.0 0
M  V30 34 C 12.2065 6.6685 0.0 0
M  V30 35 C 3.5084 11.7380 0.0 0
M  V30 36 C 2.3412 8.4803 0.0 0
M  V30 37 C 13.7465 9.3358 0.0 0
M  V30 38 C 13.7465 6.6685 0.0 0
M  V30 39 O 2.0510 11.2402 0.0 0
M  V30 40 C 1.5316 9.7905 0.0 0
M  V30 41 C 14.5165 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 27
M  V30 2 1 2 29
M  V30 3 1 3 4
M  V30 4 1 3 32
M  V30 5 1 5 32
M  V30 6 2 6 40
M  V30 7 1 7 8
M  V30 8 1 7 41
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 2 20 23
M  V30 23 1 21 24
M  V30 24 2 21 25
M  V30 25 1 22 26
M  V30 26 1 22 27
M  V30 27 1 23 28
M  V30 28 1 24 26
M  V30 29 2 24 29
M  V30 30 1 25 30
M  V30 31 1 27 31
M  V30 32 2 28 31
M  V30 33 1 28 32
M  V30 34 1 29 33
M  V30 35 1 30 33
M  V30 36 2 30 34
M  V30 37 1 31 35
M  V30 38 1 32 36
M  V30 39 2 33 37
M  V30 40 1 34 38
M  V30 41 1 35 39
M  V30 42 1 36 40
M  V30 43 1 37 41
M  V30 44 2 38 41
M  V30 45 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1352921-88-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1042921-52-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29657397
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7720-78-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, Minisci reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antitumor Activities and Structure-Activity Relationship of
Phosphotriester Derivatives of Homocamptothecin Based on a Semisynthetic
Route
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yong-Qiang; Zhang, Huo-Jun; Zhang, Jing; Wang, Juan; Yao,
Jian-Zhong; Zhu, Lin-Jian; Zhuang, Chun-Lin; Wang, Sheng-Zheng; Dong,
Guo-Qiang; Sheng, Chun-Quan; Miao, Zhen-Yuan; Zhang, Wan-Nian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Australian Journal of Chemistry (2011), 64(12), 1547-1553

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Naphthylboronic acid
C10H9BO2
13922-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 5.3900 1.3338 0.0 0
M  V30 2 O 6.9300 1.3338 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 3.0800 5.3349 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-1-Naphthalenylformamide
C11H9NO
6330-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0
M  V30 2 C 6.6685 2.3100 0.0 0
M  V30 3 O 8.0021 3.0800 0.0 0
M  V30 4 C 2.6674 3.0800 0.0 0
M  V30 5 C 1.3336 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 1.3336 0.7700 0.0 0
M  V30 9 C 0.0000 3.0800 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3336 5.3900 0.0 0
M  V30 12 C 2.6674 0.0000 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13922-41-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6330-51-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-4451387
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6046-93-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (25) General Procedure for the Synthesis of
Formanilides 2 To an open flask containing a solution of arylboronic acid
1 (1.0 mmol) in formamide (2 mL) were added Cu(OAc)2·H2O (19.9 mg, 10
mol%) and K2CO3 (138.2 mg, 1 mmol), and the mixture was stirred
vigorously at r.t. under air (without bubbling air) for 8-16 h (Table 2).
After completion of the reaction (indicated by TLC), the reaction mixture
was treated with EtOAc (5 mL) and H2O (5 mL). The organic layer was
separated, and the aqueous layer was extracted with EtOAc (3 × 5 mL). The
combined organic phase was washed with H2O (2 × 5 mL), dried over anhyd
Na2SO4, and concentrated to yield a residue, which was purified by flash
chromatography (prepacked silica cartridges). The clean product 2 as a
mixture of rotamers.27 All the products are known compounds and were
characterized by comparison of their melting points and spectral data
with those reported in the literature.14-17 N-Phenylformamide (2a, Table
2)
$DTYPE RXN:VAR(1):NOTES
$DATUM aerobic, no solvent, Chan-Lam coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed formamidation of arylboronic acids: direct access to
formanilides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srivastava, Vishnu P.; Yadav, Deepak K.; Yadav, Arvind K.; Watal, Geeta;
Yadav, Lal Dhar S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2013), 24(11), 1423-1427

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Naphthylboronic acid
C10H9BO2
13922-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 5.3900 1.3338 0.0 0
M  V30 2 O 6.9300 1.3338 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 3.0800 5.3349 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-1-Naphthalenylformamide
C11H9NO
6330-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0
M  V30 2 C 6.6685 2.3100 0.0 0
M  V30 3 O 8.0021 3.0800 0.0 0
M  V30 4 C 2.6674 3.0800 0.0 0
M  V30 5 C 1.3336 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 1.3336 0.7700 0.0 0
M  V30 9 C 0.0000 3.0800 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3336 5.3900 0.0 0
M  V30 12 C 2.6674 0.0000 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13922-41-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6330-51-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-18241794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 86-93-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 15158-11-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, nanopolystyrene anchored Cu(II) complex of
1-phenyl-1H-tetrazole-5-thiol used as catalyst, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization, antibacterial and catalytic activity of a
nanopolymer supported copper(II) complex as a highly active and
recyclable catalyst for the formamidation of arylboronic acids under
aerobic conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nasrollahzadeh, Mahmoud; Zahraei, Ali; Ehsani, Ali; Khalaj, Mehdi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(39), 20351-20357

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Naphthylboronic acid
C10H9BO2
13922-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 5.3900 1.3338 0.0 0
M  V30 2 O 6.9300 1.3338 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 3.0800 5.3349 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-1-Naphthalenylformamide
C11H9NO
6330-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0
M  V30 2 C 6.6685 2.3100 0.0 0
M  V30 3 O 8.0021 3.0800 0.0 0
M  V30 4 C 2.6674 3.0800 0.0 0
M  V30 5 C 1.3336 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 1.3336 0.7700 0.0 0
M  V30 9 C 0.0000 3.0800 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3336 5.3900 0.0 0
M  V30 12 C 2.6674 0.0000 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13922-41-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6330-51-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-4343646
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1034343-98-0
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM oxide reduced
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, catalyst prepared and
used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and characterization of copper nanoparticles supported on
reduced graphene oxide as a highly active and recyclable catalyst for the
synthesis of formamides and primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fakhri, Parisa; Jaleh, Babak; Nasrollahzadeh, Mahmoud
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2014), 383-38417-22

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobenzoyl chloride
C7H6ClNO
16106-38-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobenzamide
C7H8N2O
2835-68-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16106-38-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2835-68-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-2571116
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure for Amination All the
experiments were carried out in a parallel synthesizer from REDLEYS
Discovery Technologies, UK. A solution of acid chloride 1a (1.0 gm 7.11
mmol) in formamide (10 ml) was heated to 100-120 °C and maintained at
same temperature for 5 to 6 hours, the reaction mixture was cooled to
room temperature. The reaction mass quenched in excess water and
extracted with dichloromethane. The combined organic solvent was washed
with saturated NaHCO3 aqueous solution and dried over anhydrous Na2SO4.
The solvent was evaporated under reduced pressure to give the residue
which was purified by column chromatography using silica gel and EtOAc=
hexane as eluent. An amount of 0.77 g (6.4 mmol, 90%) of 2a was obtained
as crystals. Compound 2h. Yield 93% Mp in °C (Lit): 182-184; Mp in °C
(Obs.): 180-184
$DTYPE RXN:VAR(1):NOTES
$DATUM excess water used in stage 2, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide as an ammonia synthon in amination of acid chlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasan, S.; Manisankar, P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2010), 40(23), 3538-3543

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methylphenylboronic acid
C7H9BO2
16419-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Methylphenyl)formamide
C8H9NO
94-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 C 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16419-60-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 94-69-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-180695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1034343-98-0
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM oxide reduced
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, catalyst prepared and
used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and characterization of copper nanoparticles supported on
reduced graphene oxide as a highly active and recyclable catalyst for the
synthesis of formamides and primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fakhri, Parisa; Jaleh, Babak; Nasrollahzadeh, Mahmoud
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2014), 383-38417-22

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methylphenylboronic acid
C7H9BO2
16419-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Methylphenyl)formamide
C8H9NO
94-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 C 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16419-60-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 94-69-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-18152434
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 86-93-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 15158-11-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, nanopolystyrene anchored Cu(II) complex of
1-phenyl-1H-tetrazole-5-thiol used as catalyst, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization, antibacterial and catalytic activity of a
nanopolymer supported copper(II) complex as a highly active and
recyclable catalyst for the formamidation of arylboronic acids under
aerobic conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nasrollahzadeh, Mahmoud; Zahraei, Ali; Ehsani, Ali; Khalaj, Mehdi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(39), 20351-20357

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Aminobenzo[b]thiophene
C8H7NS
20532-28-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.3710 3.0800 0.0 0
M  V30 2 C 2.3699 0.7700 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 3.7036 0.0000 0.0 0
M  V30 5 S 0.9052 0.2941 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 C 0.9052 2.7859 0.0 0
M  V30 8 C 5.0372 0.7700 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Benzo[b]thien-5-ylformamide
C9H7NOS
1485114-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 O 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 C 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 S 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20532-28-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1485114-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26839998
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent,reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst-Free Transamidation of Aromatic Amines with Formamide
Derivatives and Tertiary Amides with Aliphatic Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yin, Jiawen; Zhang, Jingyu; Cai, Changqun; Deng, Guo-Jun; Gong, Hang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(2), 387-392

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,1′-Biphenyl]-4-carboxylic acid, 3-amino-6-chloro-2,2′-difluoro-, methyl ester
C14H10ClF2NO2
2223020-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 4.6200 0.0000 0.0 0
M  V30 2 Cl 4.6200 5.3349 0.0 0
M  V30 3 F 3.0800 5.3349 0.0 0
M  V30 4 N 7.7000 0.0000 0.0 0
M  V30 5 C 9.2400 2.6674 0.0 0
M  V30 6 O 10.0100 4.0011 0.0 0
M  V30 7 O 10.0100 1.3338 0.0 0
M  V30 8 C 11.5500 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 5.3900 1.3338 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 6.9300 1.3338 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 3.0800 2.6674 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 2.3100 1.3338 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.7700 1.3338 0.0 0
M  V30 20 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 11
M  V30 3 1 3 16
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4(3H)-Quinazolinone, 6-chloro-8-fluoro-7-(2-fluorophenyl)-
C14H7ClF2N2O
2226126-47-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 5.3900 5.3349 0.0 0
M  V30 2 Cl 5.3900 0.0000 0.0 0
M  V30 3 F 6.9300 0.0000 0.0 0
M  V30 4 O 0.0000 1.3338 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 N 2.3100 5.3349 0.0 0
M  V30 12 C 0.7700 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 14 N 0.0000 4.0011 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 7.7000 1.3338 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 9.2400 1.3338 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 7
M  V30 3 1 3 16
M  V30 4 2 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 15
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 10
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2223020-30-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2226126-47-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19326443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Janes, Matthew R.; Zhang, Jingchuan; Li, Lian-Sheng; Hansen, Rasmus;
Peters, Ulf; Guo, Xin; Chen, Yuching; Babbar, Anjali; Firdaus, Sarah J.;
Darjania, Levan; Feng, Jun; Chen, Jeffrey H.; Li, Shuangwei; Li,
Shisheng; Long, Yun O.; Thach, Carol; Liu, Yuan; Zarieh, Ata; Ely, Tess;
Kucharski, Jeff M.; Kessler, Linda V.; Wu, Tao; Yu, Ke; Wang, Yi; Yao,
Yvonne; Deng, Xiaohu; Zarrinkar, Patrick P.; Brehmer, Dirk; Dhanak,
Dashyant; Lorenzi, Matthew V.; Hu-Lowe, Dana; Patricelli, Matthew P.;
Ren, Pingda; Liu, Yi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Cell (Cambridge, MA, United States) (2018), 172(3), 578-589.e17

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-(2-oxo-2-phenylethyl)-1H-benzimidazole-2-carboxylate
C17H14N2O3
2639996-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.7533 0.0 0
M  V30 2 C 3.0800 5.7533 0.0 0
M  V30 3 O 2.3100 4.4196 0.0 0
M  V30 4 C 7.9521 5.4031 0.0 0
M  V30 5 O 9.4584 5.0829 0.0 0
M  V30 6 O 7.4762 6.8676 0.0 0
M  V30 7 C 10.4889 6.2273 0.0 0
M  V30 8 N 5.3900 4.4196 0.0 0
M  V30 9 C 4.7637 3.0127 0.0 0
M  V30 10 C 6.9217 4.2586 0.0 0
M  V30 11 C 5.9081 1.9823 0.0 0
M  V30 12 C 3.2990 2.5368 0.0 0
M  V30 13 N 7.2419 2.7523 0.0 0
M  V30 14 C 5.5879 0.4759 0.0 0
M  V30 15 C 2.9788 1.0306 0.0 0
M  V30 16 C 4.1234 0.0000 0.0 0
M  V30 17 C 2.3100 7.0869 0.0 0
M  V30 18 C 3.0800 8.4206 0.0 0
M  V30 19 C 0.7700 7.0869 0.0 0
M  V30 20 C 2.3100 9.7544 0.0 0
M  V30 21 C 0.0000 8.4206 0.0 0
M  V30 22 C 0.7700 9.7544 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 2 17
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 10
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Phenylpyrazino[1,2-a]benzimidazol-1(2H)-one
C16H11N3O
2639996-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 0.0000 0.0 0
M  V30 2 N 6.6684 3.8500 0.0 0
M  V30 3 C 8.1331 4.3259 0.0 0
M  V30 4 C 6.6684 2.3100 0.0 0
M  V30 5 C 5.3347 4.6200 0.0 0
M  V30 6 C 9.0383 3.0800 0.0 0
M  V30 7 C 8.7594 5.7328 0.0 0
M  V30 8 N 8.1331 1.8341 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 10.5698 3.2409 0.0 0
M  V30 12 C 10.2909 5.8938 0.0 0
M  V30 13 N 4.0011 2.3100 0.0 0
M  V30 14 C 11.1962 4.6479 0.0 0
M  V30 15 C 2.6673 4.6200 0.0 0
M  V30 16 C 2.6673 6.1600 0.0 0
M  V30 17 C 1.3336 3.8500 0.0 0
M  V30 18 C 1.3336 6.9300 0.0 0
M  V30 19 C 0.0000 4.6200 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 1 4 9
M  V30 9 2 5 10
M  V30 10 1 6 8
M  V30 11 2 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 10 15
M  V30 16 1 11 14
M  V30 17 2 12 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2639996-03-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2639996-11-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23591276
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Phenyl-1H-[1,4]oxazino[4,3-a]benzimidazol-1-one and Its
Transformation into
4-Phenyl-2,5-dihydro-1H-[1,2,5]triazepino[5,4-a]benzimidazol-1-one
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kharaneko, A. O.; Pekhtereva, T. M.; Kharaneko, O. I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2021), 57(3), 396-401

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-bromo-2-oxocyclohexanecarboxylate
C9H13BrO3
30132-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 C 9.3358 2.3100 0.0 0
M  V30 6 O 2.6674 4.6200 0.0 0
M  V30 7 Br 0.0000 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 3.0800 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 0.0000 0.0 0
M  V30 13 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 9
M  V30 7 1 7 11
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4,5,6,7-tetrahydro-1H-benzimidazole-7-carboxylate
C10H14N2O2
58729-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 3.0801 0.0 0
M  V30 2 O 6.4792 2.3101 0.0 0
M  V30 3 O 5.1456 4.6201 0.0 0
M  V30 4 C 7.8129 3.0801 0.0 0
M  V30 5 C 9.1466 2.3101 0.0 0
M  V30 6 C 2.4781 3.0801 0.0 0
M  V30 7 C 3.8117 2.3101 0.0 0
M  V30 8 C 1.1444 2.3101 0.0 0
M  V30 9 N 2.1579 4.5864 0.0 0
M  V30 10 C 3.8117 0.7700 0.0 0
M  V30 11 C 1.1444 0.7700 0.0 0
M  V30 12 N 0.0000 3.3405 0.0 0
M  V30 13 C 0.6263 4.7473 0.0 0
M  V30 14 C 2.4781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30132-23-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58729-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27580755
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of α-Substituted Imidazole-4-acetic Acid Analogues as a Novel
Class of ρ1 γ-Aminobutyric Acid Type A Receptor Antagonists with Effect
on Retinal Vascular Tone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Krall, Jacob; Brygger, Benjamin M.; Sigurethardottir, Sara B.; Ng,
Clarissa K. L.; Bundgaard, Christoffer; Kehler, Jan; Nielsen, Birgitte;
Bek, Toke; Jensen, Anders A.; Frolund, Bente
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2016), 11(20), 2299-2310

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,1′-Biphenyl]-4-carboxaldehyde
C13H10O
3218-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 1.3337 0.0 0
M  V30 2 O 10.0102 2.6673 0.0 0
M  V30 3 C 4.6201 1.3337 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 C 5.3901 2.6673 0.0 0
M  V30 6 C 6.9302 0.0000 0.0 0
M  V30 7 C 6.9302 2.6673 0.0 0
M  V30 8 C 7.7002 1.3337 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-([1,1′-Biphenyl]-4-ylmethyl)formamide
C14H13NO
1001643-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 2.6673 0.0 0
M  V30 2 N 10.0102 1.3337 0.0 0
M  V30 3 C 11.5503 1.3337 0.0 0
M  V30 4 O 12.3203 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 5.3901 4.0010 0.0 0
M  V30 7 C 5.3901 1.3337 0.0 0
M  V30 8 C 6.9302 4.0010 0.0 0
M  V30 9 C 6.9302 1.3337 0.0 0
M  V30 10 C 7.7002 2.6673 0.0 0
M  V30 11 C 3.0801 2.6673 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 2.3101 4.0010 0.0 0
M  V30 14 C 0.7700 1.3337 0.0 0
M  V30 15 C 0.7700 4.0010 0.0 0
M  V30 16 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3218-36-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1001643-21-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13176372
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):NOTES
$DATUM Leuckart-Wallach reaction, formamide/formic acid also used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient Isocyanide-less Isocyanide-Based Multicomponent Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neochoritis, Constantinos G.; Stotani, Silvia; Mishra, Bhupendra;
Doemling, Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(8), 2002-2005

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[5-(2-bromoacetyl)-2-furanyl]phosphonate
C10H14BrO5P
347869-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 2 O 2.3100 3.8500 0.0 0
M  V30 3 O 3.8500 2.3100 0.0 0
M  V30 4 O 3.8500 5.3900 0.0 0
M  V30 5 C 1.5400 5.1838 0.0 0
M  V30 6 C 2.5164 1.5400 0.0 0
M  V30 7 C 0.0000 5.1838 0.0 0
M  V30 8 C 2.5164 0.0000 0.0 0
M  V30 9 C 9.0056 5.5252 0.0 0
M  V30 10 C 10.4126 4.8989 0.0 0
M  V30 11 O 8.8447 7.0569 0.0 0
M  V30 12 Br 11.6584 5.8041 0.0 0
M  V30 13 C 5.3900 3.8500 0.0 0
M  V30 14 O 6.2952 5.0960 0.0 0
M  V30 15 C 6.2952 2.6041 0.0 0
M  V30 16 C 7.7598 4.6200 0.0 0
M  V30 17 C 7.7598 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[5-(4-thiazolyl)-2-furanyl]phosphonate
C11H14NO4PS
1000608-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 7.5257 3.8500 0.0 0 VAL=5
M  V30 2 O 9.0657 3.8500 0.0 0
M  V30 3 O 7.5257 2.3100 0.0 0
M  V30 4 O 7.5257 5.3900 0.0 0
M  V30 5 C 9.8357 5.1836 0.0 0
M  V30 6 C 8.8593 1.5400 0.0 0
M  V30 7 C 11.3757 5.1836 0.0 0
M  V30 8 C 8.8593 0.0000 0.0 0
M  V30 9 C 5.9857 3.8500 0.0 0
M  V30 10 O 5.0805 5.0959 0.0 0
M  V30 11 C 5.0805 2.6041 0.0 0
M  V30 12 C 3.6158 4.6200 0.0 0
M  V30 13 C 3.6158 3.0800 0.0 0
M  V30 14 C 2.3699 5.5252 0.0 0
M  V30 15 C 2.3699 7.0652 0.0 0
M  V30 16 N 0.9052 5.0494 0.0 0
M  V30 17 S 0.9052 7.5411 0.0 0
M  V30 18 C 0.0000 6.2952 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 347869-10-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000608-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3142713
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1314-80-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The crude 2-(bromoacetyl)-5-furanphosphonic acid diethyl ester (146 mg,
0.45 mmol) was dissolved in anhydrous benzene (2 mL) and treated with
formamide (61 mg, 1.35 mmol) and P4S10 (60 mg, 0.135 mmol). The resulting
mixture was heated to reflux under nitrogen. After 1 h, the reaction was
cooled, quenched with water (10 mL) and saturated sodium bicarbonate (10
mL), and then extracted with CH2Cl2 (2 × 20 mL). The organic extracts
were combined, dried (MgSO4) and evaporated to give a yellow oil, which
was purified by flash chromatography (SiO2, 2 × 15 cm, 65% EtOAc-hexane)
to give 16 as a yellow oil (120 mg, 93%). 1H NMR(CDCl3) δ 8.83 (s, 1H),
7.69 (s, 1H), 7.20 (m, 1H), 6.91 (m, 1H), 4.18 (m, 4H), 1.38 (t, 6H, J =
7.2 Hz).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Potent and Specific Fructose-1,6-Bisphosphatase Inhibitors
and a Series of Orally-Bioavailable Phosphoramidase-Sensitive Prodrugs
for the Treatment of Type 2 Diabetes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dang, Qun; Rao Kasibhatla, Srinivas; Reddy, K. Raja; Jiang, Tao; Reddy,
M. Rami; Potter, Scott C.; Fujitaki, James M.; van Poelje, Paul D.;
Huang, Jingwei; Lipscomb, William N.; Erion, Mark D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2007), 129(50), 15491-15502

$RFMT $RIREG SCHEME235 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(3-Bromophenyl)methyl]-2(1H)-quinoxalinone
C15H11BrN2O
361189-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6674 0.0 0
M  V30 2 O 5.3900 0.0000 0.0 0
M  V30 3 Br 11.5500 5.3347 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 N 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3347 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 7.7000 6.6685 0.0 0
M  V30 19 C 9.2400 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 14
M  V30 3 2 2 12
M  V30 4 1 3 17
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(3-Bromophenyl)methyl]-3,4-dihydro-3-oxo-1(2H)-quinoxalinecarboxaldehyde
C16H13BrN2O2
2840644-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.7700 0.0 0
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 O 6.6685 5.3901 0.0 0
M  V30 5 Br 12.0033 2.3101 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 N 4.0012 2.3101 0.0 0
M  V30 8 C 2.6673 4.6201 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 N 4.0012 5.3901 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 8.0022 3.0801 0.0 0
M  V30 17 C 9.3360 2.3101 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 9.3360 5.3901 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 10
M  V30 4 1 3 16
M  V30 5 2 4 14
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 361189-04-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2840644-46-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34270930
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):NOTES
$DATUM conformer ratio 1:0.3, Leuckart reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-benzylquinoxalin-2(1H)-ones and
4-formyl-3-benzyl-3,4-dihydroquinoxalin-2(1H)-ones from
3-aryloxirane-2-carboxamides via
5-arylidene-2,2-dimethyl-1,3-oxazolidin-4-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mamedov, Vakhid A.; Mamedova, Vera L.; Syakaev, Victor V.; Voronina,
Julia K.; Mahrous, Essam M.; Khikmatova, Gul'naz Z.; Korshin, Dmitry E.;
Shamsutdinova, Leisan R.; Rizvanov, Il'dar Kh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2022), 124132963

$RFMT $RIREG SCHEME236 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-5-[[[2-(4-methoxyphenyl)ethyl]amino]methyl]phenol
C17H21NO3
363132-68-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6674 0.0 0
M  V30 2 N 7.7000 4.0011 0.0 0
M  V30 3 C 9.2400 4.0011 0.0 0
M  V30 4 C 10.0100 5.3347 0.0 0
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 O 0.7700 2.6674 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 O 16.1700 5.3347 0.0 0
M  V30 9 C 16.9400 6.6685 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 3.0800 1.3338 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 11.5500 5.3347 0.0 0
M  V30 17 C 12.3200 6.6685 0.0 0
M  V30 18 C 12.3200 4.0011 0.0 0
M  V30 19 C 13.8600 6.6685 0.0 0
M  V30 20 C 13.8600 4.0011 0.0 0
M  V30 21 C 14.6300 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 16
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Hydroxy-4-methoxyphenyl)methyl]-N-[2-(4-methoxyphenyl)ethyl]formamide
C18H21NO4
363132-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 4.0012 0.0 0
M  V30 2 N 7.7002 2.6675 0.0 0
M  V30 3 C 9.2402 2.6675 0.0 0
M  V30 4 C 6.9302 1.3338 0.0 0
M  V30 5 C 10.0102 4.0012 0.0 0
M  V30 6 O 7.7002 0.0000 0.0 0
M  V30 7 O 2.3101 6.6687 0.0 0
M  V30 8 O 0.7700 4.0012 0.0 0
M  V30 9 C 0.0000 2.6675 0.0 0
M  V30 10 O 16.1704 4.0012 0.0 0
M  V30 11 C 16.9404 5.3348 0.0 0
M  V30 12 C 5.3901 4.0012 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 3.0801 5.3348 0.0 0
M  V30 16 C 3.0801 2.6675 0.0 0
M  V30 17 C 2.3101 4.0012 0.0 0
M  V30 18 C 11.5503 4.0012 0.0 0
M  V30 19 C 12.3203 5.3348 0.0 0
M  V30 20 C 12.3203 2.6675 0.0 0
M  V30 21 C 13.8603 5.3348 0.0 0
M  V30 22 C 13.8603 2.6675 0.0 0
M  V30 23 C 14.6303 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 1 5 18
M  V30 8 1 7 15
M  V30 9 1 8 9
M  V30 10 1 8 17
M  V30 11 1 10 11
M  V30 12 1 10 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 363132-68-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 363132-69-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-4463808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Seven-membered ring formation through Grewe-cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lukacs, A.; Szabo, L.; Hazai, L.; Szantay, C.; Mak, M.; Gorka, A.;
Szantay, C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2001), 57(27), 5843-5850

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoroaniline
C6H6FN
372-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 3.0800 0.0 0
M  V30 2 N 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-Bis(3-fluorophenyl)methanimidamide
C13H10F2N2
18464-35-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 N 5.3348 3.0801 0.0 0
M  V30 4 F 13.3370 3.0801 0.0 0
M  V30 5 F 0.0000 3.0801 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 C 10.6697 3.0801 0.0 0
M  V30 8 C 9.3360 0.7700 0.0 0
M  V30 9 C 12.0033 2.3101 0.0 0
M  V30 10 C 10.6697 0.0000 0.0 0
M  V30 11 C 12.0033 0.7700 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 4.0010 0.7700 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 2.6673 0.0000 0.0 0
M  V30 17 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 12
M  V30 5 1 4 9
M  V30 6 1 5 15
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 372-19-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18464-35-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26276936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
N,N′-Diarylformamidines (50-56 and 73). The reliable procedure involved
the treatment of arylamines (43-49; 1.0 equiv) or 3-aminopyridine (68;
1.0 equiv) with PBr3 (~3.0 equiv) in formamide solution (2 mL) at 50-60
°C over 0.5-1.0 h. When the reaction was complete, the crude solid was
triturated in cold n-pentane and filtered through a glass frit with
suction. Then the solid was washed with n-pentane and dried in vacuo to
give the crude formamidines (50-56 and 73). The crude products were
recrystallized from the mixture of acetone and diisopropyl ether to give
the corresponding N,N′-diarylformamidine products (50-56 and 73) in
88-97% yields as white to light yellow solids.
N,N'-Bis(3-fluorophenyl)formamidine (55).35 The standard procedure
involved the treatment of 3-fluoroaniline (48; 50 mg, 0.52 mmol, 1.0
equiv) with PBr3 (0.15 mL, 1.6 mmol, 3.0 equiv) in formamide solution (2
mL) at 50-60 °C over 0.5-1.0 h. The reaction mixture was then worked up,
and the residue was purified by chromatography on silica gel to give pure
55: 93% yield (108 mg), yellow oil (CH2Cl2- methanol). 1H NMR (CDCl3, 200
MHz): δ 6.22-6.28 (2H, m), 6.32-6.36 (1H, m), 7.14-7.18 (4H, m),
7.25-7.29 (1H, m), 7.48 (1H, s), 8.01 (1H, s). 13C NMR (50 MHz, CDCl3): δ
103.6, 106.5, 109.1, 111.8, 113.9, 118.6, 130.8 (2 × C), 143.6, 150.8,
163.0, 164.8, 165.2. IR (KBr): 3132, 2968, 2827, 1655, 1574, 1481, 1466,
1280, 1257, 1214, 1169, 1109, 1017 cm-1. EIMS m/z (rel int): 232 (100,
M+). Anal. Calcd for C13H10F2N2: C, 67.24; H, 4.32; N, 12.06. Found: C,
67.20; H, 4.36; N, 12.02.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-amino-8,9-dihydro-8,8-dimethyl-5-(1-piperidinyl)-6H-pyrano[4,3-d]thie...
C20H27N3O3S
374547-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.6090 2.3191 0.0 0
M  V30 2 C 10.5783 5.0297 0.0 0
M  V30 3 O 11.3483 6.3633 0.0 0
M  V30 4 O 11.3483 3.6960 0.0 0
M  V30 5 C 12.8883 6.3633 0.0 0
M  V30 6 C 13.6583 7.6971 0.0 0
M  V30 7 C 4.9910 0.0000 0.0 0
M  V30 8 C 3.0112 0.0000 0.0 0
M  V30 9 C 6.6684 4.2597 0.0 0
M  V30 10 C 5.3347 3.4897 0.0 0
M  V30 11 C 6.6684 5.7997 0.0 0
M  V30 12 C 8.1331 3.7838 0.0 0
M  V30 13 C 4.0011 4.2597 0.0 0
M  V30 14 C 5.3347 1.9496 0.0 0
M  V30 15 N 5.3347 6.5697 0.0 0
M  V30 16 S 8.1331 6.2755 0.0 0
M  V30 17 C 9.0383 5.0297 0.0 0
M  V30 18 C 4.0011 5.7997 0.0 0
M  V30 19 C 2.6674 3.4897 0.0 0
M  V30 20 C 4.0011 1.1796 0.0 0
M  V30 21 O 2.6674 1.9496 0.0 0
M  V30 22 N 2.6674 6.5697 0.0 0
M  V30 23 C 1.3336 5.7997 0.0 0
M  V30 24 C 2.6674 8.1097 0.0 0
M  V30 25 C 0.0000 6.5697 0.0 0
M  V30 26 C 1.3336 8.8797 0.0 0
M  V30 27 C 0.0000 8.1097 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 20
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 2 15 18
M  V30 21 1 16 17
M  V30 22 1 18 22
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dihydro-2,2-dimethyl-5-(1-piperidinyl)-2H-pyrano[4′′,3′′:4′,5′]pyrido[3′,...
C19H22N4O2S
889656-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6429 0.9899 0.0 0
M  V30 2 C 5.3576 0.0000 0.0 0
M  V30 3 O 1.0849 9.5275 0.0 0
M  V30 4 C 4.3201 5.5177 0.0 0
M  V30 5 C 5.0901 4.1841 0.0 0
M  V30 6 C 2.8138 5.8379 0.0 0
M  V30 7 C 5.0901 6.8514 0.0 0
M  V30 8 C 6.6301 4.1841 0.0 0
M  V30 9 C 4.3201 2.8503 0.0 0
M  V30 10 C 2.6527 7.3694 0.0 0
M  V30 11 N 1.5679 4.9327 0.0 0
M  V30 12 N 6.6301 6.8514 0.0 0
M  V30 13 S 4.0596 7.9959 0.0 0
M  V30 14 C 7.4001 5.5177 0.0 0
M  V30 15 C 7.4001 2.8503 0.0 0
M  V30 16 C 5.0901 1.5166 0.0 0
M  V30 17 C 1.2459 7.9959 0.0 0
M  V30 18 C 0.1609 5.5591 0.0 0
M  V30 19 O 6.6301 1.5166 0.0 0
M  V30 20 N 0.0000 7.0907 0.0 0
M  V30 21 N 8.9401 5.5177 0.0 0
M  V30 22 C 9.7101 6.8514 0.0 0
M  V30 23 C 9.7101 4.1841 0.0 0
M  V30 24 C 11.2501 6.8514 0.0 0
M  V30 25 C 11.2501 4.1841 0.0 0
M  V30 26 C 12.0201 5.5177 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 16
M  V30 3 2 3 17
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 8 15
M  V30 15 1 9 16
M  V30 16 1 10 13
M  V30 17 1 10 17
M  V30 18 1 11 18
M  V30 19 2 12 14
M  V30 20 1 14 21
M  V30 21 1 15 19
M  V30 22 1 16 19
M  V30 23 1 17 20
M  V30 24 2 18 20
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 374547-25-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 889656-63-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10644624
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2,2-Dimethyl-5-(piperidin-1-yl)-1,4-dihydro-2H-pyrano[
4″,3″:4′,5′]pyrido[3′,2′:4,5]thieno[3,2-d]-pyrimidin-8(9H)-one (IVa). c.
A mixture of 3.89 g (10 mmol) of compound IIIa and 30 mL of formamide was
heated for 6 h under reflux. The mixture was cooled, and the precipitate
was filtered off and washed with water and ethanol. Yield 3.44 g (93%).
mp 319-320°C (from DMF). IR spectrum, v, cm-1: 3470 (NH), 1650 (C=O),
1580 (C=Carom). 1H NMR spectrum, δ, ppm: 1.34 s (6H, CH3), 1.63-1.78 m
(6H, CH2), 3.15-3.19 m [4H, N(CH2)2], 3.14 s (2H, 1-H), 4.64 s (2H, 4-H),
8.05 s (1H, CH), 12.57 br.s (2H, NH). Found, %: C 61.71; H 5.94; N 15.02;
S 8.71. C19H22N4O2S. Calculated, %: C 61.60; H 5.99; N 15.12; S 8.65.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM synthesis of
(piperidin-1-yl)trihydropyrano(cyclopenta)-[4',5']pyrido[3',2':4,5]thieno[3,2-e][1,2,4]triazolo-[4,3-c(1,5-c)]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Paronikyan, E. G.; Dashyan, Sh. Sh.; Noravyan, A. S.; Minasyan, N. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2014), 50(12), 1829-1834

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(trifluoromethyl)benzoic acid
C8H6F3NO2
402-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6673 0.0 0
M  V30 2 F 6.9300 4.2073 0.0 0
M  V30 3 F 8.4700 2.6673 0.0 0
M  V30 4 F 6.9300 1.1273 0.0 0
M  V30 5 N 2.3100 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 O 0.0000 1.3336 0.0 0
M  V30 9 C 5.3900 2.6673 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.0800 1.3336 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(Trifluoromethyl)-4(3H)-quinazolinone
C9H5F3N2O
16499-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 C 6.9300 2.6673 0.0 0
M  V30 3 F 6.9300 4.2073 0.0 0
M  V30 4 F 8.4700 2.6673 0.0 0
M  V30 5 F 6.9300 1.1273 0.0 0
M  V30 6 C 3.0800 1.3336 0.0 0
M  V30 7 C 2.3100 2.6673 0.0 0
M  V30 8 C 4.6200 1.3336 0.0 0
M  V30 9 N 2.3100 0.0000 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 5.3900 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 N 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 402-13-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16499-58-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38331762
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Visible-light-promoted photoredox-catalyzed N-aminoalkylation of
quinazolinones with simple alkylamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gu, Yi-Jie; Cui, Wenwen; Jiang, De-Lu; Yuan, Hua; Liang, Xiao-Wei; Wang,
Shou-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2023), 132154801

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hydroxy-2-nitrobenzaldehyde
C7H5NO4
42454-06-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-[(5-Hydroxy-2-nitrophenyl)methylene]bis[formamide]
C9H9N3O5
135361-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.8501 0.0 0
M  V30 2 N 4.0012 2.3101 0.0 0
M  V30 3 N 2.6675 4.6201 0.0 0
M  V30 4 C 2.6675 1.5400 0.0 0
M  V30 5 C 1.3337 3.8501 0.0 0
M  V30 6 O 2.6675 0.0000 0.0 0
M  V30 7 O 0.0000 4.6201 0.0 0
M  V30 8 N 4.0012 6.9302 0.0 0 VAL=5
M  V30 9 O 4.0012 8.4702 0.0 0
M  V30 10 O 2.6675 6.1601 0.0 0
M  V30 11 O 9.3360 3.8501 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 15 C 6.6685 6.9302 0.0 0
M  V30 16 C 8.0023 4.6201 0.0 0
M  V30 17 C 8.0023 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 1 11 16
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 42454-06-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 135361-38-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-314-CAS-21377868
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazoles and imidazoles as hemoglobin
modifier compounds and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jin, Bohan; Dong, Qing; Hung, Gene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017218960 A1 2017-12-21

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminopyridine
C5H6N2
504-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-2-Pyridinylformamide
C6H6N2O
34813-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 N 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 504-29-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 34813-97-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-4092945
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 11120-01-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM sulfated
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, no solvent, catalyst prepared
and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfated tungstate: a highly efficient catalyst for transamidation of
carboxamides with amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pathare, Sagar P.; Jain, Ashish Kumar H.; Akamanchi, Krishnacharya G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2013), 3(21), 7697-7703

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-methyl-4-(4-nitrophenyl)-3-thiophenecarbonitrile
C12H9N3O2S
605661-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2420 4.6948 0.0 0
M  V30 2 N 1.9218 6.2012 0.0 0
M  V30 3 C 4.9526 0.0000 0.0 0
M  V30 4 N 0.0000 2.2049 0.0 0
M  V30 5 N 9.3037 5.6420 0.0 0 VAL=5
M  V30 6 O 9.3037 7.1821 0.0 0
M  V30 7 O 10.6376 4.8720 0.0 0
M  V30 8 C 3.9690 2.5620 0.0 0
M  V30 9 C 2.5621 3.1885 0.0 0
M  V30 10 C 3.8080 1.0304 0.0 0
M  V30 11 C 1.5317 2.0439 0.0 0
M  V30 12 S 2.3017 0.7103 0.0 0
M  V30 13 C 5.3028 3.3320 0.0 0
M  V30 14 C 6.6364 2.5620 0.0 0
M  V30 15 C 5.3028 4.8720 0.0 0
M  V30 16 C 7.9701 3.3320 0.0 0
M  V30 17 C 6.6364 5.6420 0.0 0
M  V30 18 C 7.9701 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-5-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine
C13H10N4O2S
605661-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5673 5.7975 0.0 0
M  V30 2 C 5.4031 0.0000 0.0 0
M  V30 3 N 9.7544 5.6420 0.0 0 VAL=5
M  V30 4 O 9.7544 7.1820 0.0 0
M  V30 5 O 11.0881 4.8720 0.0 0
M  V30 6 C 3.0127 3.1884 0.0 0
M  V30 7 C 4.4197 2.5620 0.0 0
M  V30 8 C 1.9823 2.0439 0.0 0
M  V30 9 C 2.5369 4.6530 0.0 0
M  V30 10 C 4.2586 1.0304 0.0 0
M  V30 11 S 2.7523 0.7103 0.0 0
M  V30 12 N 0.4759 2.3641 0.0 0
M  V30 13 N 1.0304 4.9732 0.0 0
M  V30 14 C 0.0000 3.8288 0.0 0
M  V30 15 C 5.7533 3.3320 0.0 0
M  V30 16 C 7.0870 2.5620 0.0 0
M  V30 17 C 5.7533 4.8720 0.0 0
M  V30 18 C 8.4206 3.3320 0.0 0
M  V30 19 C 7.0870 5.6420 0.0 0
M  V30 20 C 8.4206 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 15
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 605661-11-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 605661-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21026519
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6-Methyl-5-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4- amine (5). A
suspension of 4 (4.03 g, 15.5 mmol) in formamide (60 mL) was stirred at
155 °C for 17 h, cooled to room temperature, diluted with water, and
filtered. The filter cake was dried to provide the title compound (4.13
g, 93%). 1H NMR (DMSO-d 6) δ 8.36 (d, J = 9.0 Hz, 2H), 8.30 (s, 1H), 7.68
(d, J = 9.0 Hz, 2H), 2.32 (s, 3H); MS (CI) m/z 287 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor
Tyrosine Kinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Yujia; Guo, Yan; Frey, Robin R.; Ji, Zhiqin; Curtin, Michael L.;
Ahmed, Asma A.; Albert, Daniel H.; Arnold, Lee; Arries, Shannon S.;
Barlozzari, Teresa; Bauch, Joy L.; Bouska, Jennifer J.; Bousquet, Peter
F.; Cunha, George A.; Glaser, Keith B.; Guo, Jun; Li, Junling; Marcotte,
Patrick A.; Marsh, Kennan C.; Moskey, Maria D.; Pease, Lori J.; Stewart,
Kent D.; Stoll, Vincent S.; Tapang, Paul; Wishart, Neil; Davidsen, Steven
K.; Michaelides, Michael R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2005), 48(19), 6066-6083

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-methyl-4-(4-nitrophenyl)-3-thiophenecarbonitrile
C12H9N3O2S
605661-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2420 4.6948 0.0 0
M  V30 2 N 1.9218 6.2012 0.0 0
M  V30 3 C 4.9526 0.0000 0.0 0
M  V30 4 N 0.0000 2.2049 0.0 0
M  V30 5 N 9.3037 5.6420 0.0 0 VAL=5
M  V30 6 O 9.3037 7.1821 0.0 0
M  V30 7 O 10.6376 4.8720 0.0 0
M  V30 8 C 3.9690 2.5620 0.0 0
M  V30 9 C 2.5621 3.1885 0.0 0
M  V30 10 C 3.8080 1.0304 0.0 0
M  V30 11 C 1.5317 2.0439 0.0 0
M  V30 12 S 2.3017 0.7103 0.0 0
M  V30 13 C 5.3028 3.3320 0.0 0
M  V30 14 C 6.6364 2.5620 0.0 0
M  V30 15 C 5.3028 4.8720 0.0 0
M  V30 16 C 7.9701 3.3320 0.0 0
M  V30 17 C 6.6364 5.6420 0.0 0
M  V30 18 C 7.9701 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-5-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine
C13H10N4O2S
605661-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5673 5.7975 0.0 0
M  V30 2 C 5.4031 0.0000 0.0 0
M  V30 3 N 9.7544 5.6420 0.0 0 VAL=5
M  V30 4 O 9.7544 7.1820 0.0 0
M  V30 5 O 11.0881 4.8720 0.0 0
M  V30 6 C 3.0127 3.1884 0.0 0
M  V30 7 C 4.4197 2.5620 0.0 0
M  V30 8 C 1.9823 2.0439 0.0 0
M  V30 9 C 2.5369 4.6530 0.0 0
M  V30 10 C 4.2586 1.0304 0.0 0
M  V30 11 S 2.7523 0.7103 0.0 0
M  V30 12 N 0.4759 2.3641 0.0 0
M  V30 13 N 1.0304 4.9732 0.0 0
M  V30 14 C 0.0000 3.8288 0.0 0
M  V30 15 C 5.7533 3.3320 0.0 0
M  V30 16 C 7.0870 2.5620 0.0 0
M  V30 17 C 5.7533 4.8720 0.0 0
M  V30 18 C 8.4206 3.3320 0.0 0
M  V30 19 C 7.0870 5.6420 0.0 0
M  V30 20 C 8.4206 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 15
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 605661-11-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 605661-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21251023
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienopyrimidine and isothiazolopyrimidine kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Michaelides, Michael R.; Curtin, Michael L.; Dai, Yujia; Davidsen, Steven
K.; Frey, Robin R.; Guo, Yan; Ji, Zhiqin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040014756 A1 2004-01-22

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-methyl-4-(4-nitrophenyl)-3-thiophenecarbonitrile
C12H9N3O2S
605661-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2420 4.6948 0.0 0
M  V30 2 N 1.9218 6.2012 0.0 0
M  V30 3 C 4.9526 0.0000 0.0 0
M  V30 4 N 0.0000 2.2049 0.0 0
M  V30 5 N 9.3037 5.6420 0.0 0 VAL=5
M  V30 6 O 9.3037 7.1821 0.0 0
M  V30 7 O 10.6376 4.8720 0.0 0
M  V30 8 C 3.9690 2.5620 0.0 0
M  V30 9 C 2.5621 3.1885 0.0 0
M  V30 10 C 3.8080 1.0304 0.0 0
M  V30 11 C 1.5317 2.0439 0.0 0
M  V30 12 S 2.3017 0.7103 0.0 0
M  V30 13 C 5.3028 3.3320 0.0 0
M  V30 14 C 6.6364 2.5620 0.0 0
M  V30 15 C 5.3028 4.8720 0.0 0
M  V30 16 C 7.9701 3.3320 0.0 0
M  V30 17 C 6.6364 5.6420 0.0 0
M  V30 18 C 7.9701 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-5-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine
C13H10N4O2S
605661-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5673 5.7975 0.0 0
M  V30 2 C 5.4031 0.0000 0.0 0
M  V30 3 N 9.7544 5.6420 0.0 0 VAL=5
M  V30 4 O 9.7544 7.1820 0.0 0
M  V30 5 O 11.0881 4.8720 0.0 0
M  V30 6 C 3.0127 3.1884 0.0 0
M  V30 7 C 4.4197 2.5620 0.0 0
M  V30 8 C 1.9823 2.0439 0.0 0
M  V30 9 C 2.5369 4.6530 0.0 0
M  V30 10 C 4.2586 1.0304 0.0 0
M  V30 11 S 2.7523 0.7103 0.0 0
M  V30 12 N 0.4759 2.3641 0.0 0
M  V30 13 N 1.0304 4.9732 0.0 0
M  V30 14 C 0.0000 3.8288 0.0 0
M  V30 15 C 5.7533 3.3320 0.0 0
M  V30 16 C 7.0870 2.5620 0.0 0
M  V30 17 C 5.7533 4.8720 0.0 0
M  V30 18 C 8.4206 3.3320 0.0 0
M  V30 19 C 7.0870 5.6420 0.0 0
M  V30 20 C 8.4206 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 15
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 605661-11-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 605661-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21259885
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienopyrimidine and isothiazolopyrimidine kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Michaelides, Michael R.; Curtin, Michael L.; Dai, Yujia; Davidsen, Steven
K.; Frey, Robin R.; Guo, Yan; Ji, Zhiqin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030225273 A1 2003-12-04

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-methyl-4-(4-nitrophenyl)-3-thiophenecarbonitrile
C12H9N3O2S
605661-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2420 4.6948 0.0 0
M  V30 2 N 1.9218 6.2012 0.0 0
M  V30 3 C 4.9526 0.0000 0.0 0
M  V30 4 N 0.0000 2.2049 0.0 0
M  V30 5 N 9.3037 5.6420 0.0 0 VAL=5
M  V30 6 O 9.3037 7.1821 0.0 0
M  V30 7 O 10.6376 4.8720 0.0 0
M  V30 8 C 3.9690 2.5620 0.0 0
M  V30 9 C 2.5621 3.1885 0.0 0
M  V30 10 C 3.8080 1.0304 0.0 0
M  V30 11 C 1.5317 2.0439 0.0 0
M  V30 12 S 2.3017 0.7103 0.0 0
M  V30 13 C 5.3028 3.3320 0.0 0
M  V30 14 C 6.6364 2.5620 0.0 0
M  V30 15 C 5.3028 4.8720 0.0 0
M  V30 16 C 7.9701 3.3320 0.0 0
M  V30 17 C 6.6364 5.6420 0.0 0
M  V30 18 C 7.9701 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-5-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine
C13H10N4O2S
605661-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5673 5.7975 0.0 0
M  V30 2 C 5.4031 0.0000 0.0 0
M  V30 3 N 9.7544 5.6420 0.0 0 VAL=5
M  V30 4 O 9.7544 7.1820 0.0 0
M  V30 5 O 11.0881 4.8720 0.0 0
M  V30 6 C 3.0127 3.1884 0.0 0
M  V30 7 C 4.4197 2.5620 0.0 0
M  V30 8 C 1.9823 2.0439 0.0 0
M  V30 9 C 2.5369 4.6530 0.0 0
M  V30 10 C 4.2586 1.0304 0.0 0
M  V30 11 S 2.7523 0.7103 0.0 0
M  V30 12 N 0.4759 2.3641 0.0 0
M  V30 13 N 1.0304 4.9732 0.0 0
M  V30 14 C 0.0000 3.8288 0.0 0
M  V30 15 C 5.7533 3.3320 0.0 0
M  V30 16 C 7.0870 2.5620 0.0 0
M  V30 17 C 5.7533 4.8720 0.0 0
M  V30 18 C 8.4206 3.3320 0.0 0
M  V30 19 C 7.0870 5.6420 0.0 0
M  V30 20 C 8.4206 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 15
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 605661-11-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 605661-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21261821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienopyrimidine and isothiazolopyrimidine kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Michaelides, Michael R.; Dai, Yujia; Davidsen, Steven K.; Frey, Robin R.;
Guo, Yan; Ji, Zhiqin; Curtin, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003080625 A1 2003-10-02

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-methyl-4-(4-nitrophenyl)-3-thiophenecarbonitrile
C12H9N3O2S
605661-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2420 4.6948 0.0 0
M  V30 2 N 1.9218 6.2012 0.0 0
M  V30 3 C 4.9526 0.0000 0.0 0
M  V30 4 N 0.0000 2.2049 0.0 0
M  V30 5 N 9.3037 5.6420 0.0 0 VAL=5
M  V30 6 O 9.3037 7.1821 0.0 0
M  V30 7 O 10.6376 4.8720 0.0 0
M  V30 8 C 3.9690 2.5620 0.0 0
M  V30 9 C 2.5621 3.1885 0.0 0
M  V30 10 C 3.8080 1.0304 0.0 0
M  V30 11 C 1.5317 2.0439 0.0 0
M  V30 12 S 2.3017 0.7103 0.0 0
M  V30 13 C 5.3028 3.3320 0.0 0
M  V30 14 C 6.6364 2.5620 0.0 0
M  V30 15 C 5.3028 4.8720 0.0 0
M  V30 16 C 7.9701 3.3320 0.0 0
M  V30 17 C 6.6364 5.6420 0.0 0
M  V30 18 C 7.9701 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-5-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine
C13H10N4O2S
605661-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5673 5.7975 0.0 0
M  V30 2 C 5.4031 0.0000 0.0 0
M  V30 3 N 9.7544 5.6420 0.0 0 VAL=5
M  V30 4 O 9.7544 7.1820 0.0 0
M  V30 5 O 11.0881 4.8720 0.0 0
M  V30 6 C 3.0127 3.1884 0.0 0
M  V30 7 C 4.4197 2.5620 0.0 0
M  V30 8 C 1.9823 2.0439 0.0 0
M  V30 9 C 2.5369 4.6530 0.0 0
M  V30 10 C 4.2586 1.0304 0.0 0
M  V30 11 S 2.7523 0.7103 0.0 0
M  V30 12 N 0.4759 2.3641 0.0 0
M  V30 13 N 1.0304 4.9732 0.0 0
M  V30 14 C 0.0000 3.8288 0.0 0
M  V30 15 C 5.7533 3.3320 0.0 0
M  V30 16 C 7.0870 2.5620 0.0 0
M  V30 17 C 5.7533 4.8720 0.0 0
M  V30 18 C 8.4206 3.3320 0.0 0
M  V30 19 C 7.0870 5.6420 0.0 0
M  V30 20 C 8.4206 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 15
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 605661-11-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 605661-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21144367
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienopyrimidine and isothiazolopyrimidine kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Michaelides, Michael R.; Dai, Yujia; Davidsen, Steven K.; Frey, Robin R.;
Guo, Yan; Ji, Zhiqin; Arnold, Lee D.; Wishart, Neil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030181468 A1 2003-09-25

$RFMT $RIREG SCHEME243 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chlorobenzoyl chloride
C7H4Cl2O
609-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chlorobenzamide
C7H6ClNO
609-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 N 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 609-65-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 609-66-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-7428435
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure for Amination All the
experiments were carried out in a parallel synthesizer from REDLEYS
Discovery Technologies, UK. A solution of acid chloride 1a (1.0 gm 7.11
mmol) in formamide (10 ml) was heated to 100-120 °C and maintained at
same temperature for 5 to 6 hours, the reaction mixture was cooled to
room temperature. The reaction mass quenched in excess water and
extracted with dichloromethane. The combined organic solvent was washed
with saturated NaHCO3 aqueous solution and dried over anhydrous Na2SO4.
The solvent was evaporated under reduced pressure to give the residue
which was purified by column chromatography using silica gel and EtOAc=
hexane as eluent. An amount of 0.77 g (6.4 mmol, 90%) of 2a was obtained
as crystals. Compound 2c. Yield 93% Mp in °C (Lit): 142-144; Mp in °C
(Obs.): 140-144
$DTYPE RXN:VAR(1):NOTES
$DATUM excess water used in stage 2, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide as an ammonia synthon in amination of acid chlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasan, S.; Manisankar, P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2010), 40(23), 3538-3543

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodotoluene
C7H7I
624-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 I 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methylphenyl)formamide
C8H9NO
3085-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 C 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 624-31-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3085-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-1642597
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-99-8
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligand free open air copper(II) mediated aryl formamidation and amination
of aryl halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Komati, Rajesh; Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2014), 55(9), 1523-1527

$RFMT $RIREG SCHEME245 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(4-Nitrophenyl)methyl]-2(1H)-quinoxalinone
C15H11N3O3
92498-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 N 10.6694 4.6200 0.0 0 VAL=5
M  V30 4 O 10.6694 6.1600 0.0 0
M  V30 5 O 12.0031 3.8500 0.0 0
M  V30 6 C 2.6673 4.6200 0.0 0
M  V30 7 C 1.3336 3.8500 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 2.6673 6.1600 0.0 0
M  V30 10 N 1.3336 2.3100 0.0 0
M  V30 11 C 0.0000 4.6200 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 1.3336 6.9300 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 C 0.0000 6.1600 0.0 0
M  V30 16 C 6.6684 2.3100 0.0 0
M  V30 17 C 6.6684 3.8500 0.0 0
M  V30 18 C 8.0020 1.5400 0.0 0
M  V30 19 C 8.0020 4.6200 0.0 0
M  V30 20 C 9.3358 2.3100 0.0 0
M  V30 21 C 9.3358 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 16
M  V30 3 2 2 14
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 21
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-2-[(4-nitrophenyl)methyl]-3-oxo-1(2H)-quinoxalinecarboxaldehyde
C16H13N3O4
2840644-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 0.7700 0.0 0
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 O 6.6685 5.3901 0.0 0
M  V30 5 N 12.0033 5.3901 0.0 0 VAL=5
M  V30 6 O 13.3370 4.6201 0.0 0
M  V30 7 O 12.0033 6.9302 0.0 0
M  V30 8 C 2.6673 3.0801 0.0 0
M  V30 9 N 4.0010 2.3101 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 5.3348 3.0801 0.0 0
M  V30 13 N 4.0010 5.3901 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 0.0000 3.0801 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 18 C 8.0022 3.0801 0.0 0
M  V30 19 C 8.0022 4.6201 0.0 0
M  V30 20 C 9.3360 2.3101 0.0 0
M  V30 21 C 9.3360 5.3901 0.0 0
M  V30 22 C 10.6697 3.0801 0.0 0
M  V30 23 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 12
M  V30 4 1 3 18
M  V30 5 2 4 16
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 23
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 2 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 92498-72-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2840644-50-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34270932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):NOTES
$DATUM conformer ratio 1:0.3, Leuckart reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-benzylquinoxalin-2(1H)-ones and
4-formyl-3-benzyl-3,4-dihydroquinoxalin-2(1H)-ones from
3-aryloxirane-2-carboxamides via
5-arylidene-2,2-dimethyl-1,3-oxazolidin-4-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mamedov, Vakhid A.; Mamedova, Vera L.; Syakaev, Victor V.; Voronina,
Julia K.; Mahrous, Essam M.; Khikmatova, Gul'naz Z.; Korshin, Dmitry E.;
Shamsutdinova, Leisan R.; Rizvanov, Il'dar Kh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2022), 124132963

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
2-Bromo-N-(phenylmethyl)benzamide
C14H12BrNO
82082-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 Br 1.3337 0.0000 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 0.0000 3.8501 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 9.3360 1.5400 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 12
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Phenylmethyl)-4(3H)-quinazolinone
C15H12N2O
5388-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.0000 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 2.6673 3.8501 0.0 0
M  V30 5 C 4.0012 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 N 4.0012 4.6201 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 N 5.3348 2.3101 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 C 8.0023 2.3101 0.0 0
M  V30 14 C 9.3360 1.5400 0.0 0
M  V30 15 C 8.0023 3.8501 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 9
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 82082-50-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5388-11-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11486961
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51-35-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for CuI-catalyzed formation
of 3-substituted-4-quinazolines and 2,3-disubstituted-4(3H )-quinazolines
from 2-bromo-N-phenylbenzamide. For 3-substituted-4-quinazoline
(11a-11r). A Schlenk tube was charged with N-substituted 2-bromobenzamide
(0.25 mmol), CuI (5 mg, 0.025 mmol), trans-4-hydroxy-L-proline (3 mg,
0.025 mmol), and Cs2CO3 (163 mg, 0.5 mmol). The tube was evacuated and
backfilled with argon before formamide (20 µL, 0.5 mmol) and 1 mL DMF was
added. The reaction mixture was stirred at 80 o C (or 90 o C for
substrate 7l) for 24 h. After the reaction mixture was cooled to room
temperature, 5 mL of saturated NH4Cl solution was added. The mixture was
extracted with EtOAc and the organic layer was washed with water, brine
and dried over Na2SO4. After concentration in vacuo, the residue was
purified by column chromatography on silica gel. The desired
3-substituted 4-quinazoline. 3-Benzylquinazolin-4(3H)-one (11p).1 55 mg,
93% yield. 1H NMR (400 MHz, CDCl3) δ 8.34 (dd, J 1 = 1.2 Hz, J 2 = 8.0
Hz, 1H), 8.11 (s, 1H), 7.78-7.70 (m, 2H), 7.53-7.49 (m, 1H), 7.36-7.31
(m, 5H), 5.21 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 161.16, 148.10, 146.45,
135.81, 134.42, 129.12 (2C), 128.41, 128.10 (2C), 127.60, 127.49, 126.98,
122.29, 49.71; HRMS-ESI: m/z calcd for C15H13N2O [M + H]+, 237.1028,
found 237.1013.
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst formed in-situ; Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Substituted and 2,3-Disubstituted Quinazolinones via
Cu-Catalyzed Aryl Amidation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Lanting; Jiang, Yongwen; Ma, Dawei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(4), 1150-1153

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Amino-1,2,3,4-tetrahydro-5-(4-methoxyphenyl)-2,4-dioxopyrido[2,3-d]pyrimidi...
C15H11N5O3
821770-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 8.0022 0.7700 0.0 0
M  V30 3 O 5.3348 6.9302 0.0 0
M  V30 4 N 4.0012 0.0000 0.0 0
M  V30 5 O 0.0000 6.9302 0.0 0
M  V30 6 O 10.6697 6.9302 0.0 0
M  V30 7 C 12.0033 6.1601 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 4.0012 6.1601 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 N 2.6673 2.3101 0.0 0
M  V30 15 N 1.3337 4.6201 0.0 0
M  V30 16 N 2.6673 6.9302 0.0 0
M  V30 17 C 1.3337 6.1601 0.0 0
M  V30 18 C 6.6685 4.6201 0.0 0
M  V30 19 C 6.6685 6.1601 0.0 0
M  V30 20 C 8.0022 3.8501 0.0 0
M  V30 21 C 8.0022 6.9302 0.0 0
M  V30 22 C 9.3360 4.6201 0.0 0
M  V30 23 C 9.3360 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 2 3 12
M  V30 4 1 4 13
M  V30 5 2 5 17
M  V30 6 1 6 7
M  V30 7 1 6 23
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H12N6O3
2504958-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 7.7002 0.0 0
M  V30 2 N 8.0022 3.0801 0.0 0
M  V30 3 O 0.0000 7.7002 0.0 0
M  V30 4 O 10.6697 7.7002 0.0 0
M  V30 5 C 12.0033 6.9302 0.0 0
M  V30 6 C 5.3348 4.6201 0.0 0
M  V30 7 C 4.0012 5.3901 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 4.0012 6.9302 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 N 2.6673 3.0801 0.0 0
M  V30 14 N 1.3337 5.3901 0.0 0
M  V30 15 N 2.6673 7.7002 0.0 0
M  V30 16 N 4.0012 0.7700 0.0 0
M  V30 17 N 6.6685 0.7700 0.0 0
M  V30 18 C 1.3337 6.9302 0.0 0
M  V30 19 C 5.3348 0.0000 0.0 0
M  V30 20 C 6.6685 5.3901 0.0 0
M  V30 21 C 6.6685 6.9302 0.0 0
M  V30 22 C 8.0022 4.6201 0.0 0
M  V30 23 C 8.0022 7.7002 0.0 0
M  V30 24 C 9.3360 5.3901 0.0 0
M  V30 25 C 9.3360 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 12
M  V30 3 2 3 18
M  V30 4 1 4 5
M  V30 5 1 4 25
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 20
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 13
M  V30 17 2 11 16
M  V30 18 1 12 17
M  V30 19 1 14 18
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 2 17 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 821770-17-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2504958-42-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25667895
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3D-pharmacophore study molecular docking and synthesis of
pyrido[2,3-d]pyrimidine-4(1H) dione derivatives with in vitro potential
anticancer and antioxidant activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gouda, Mustafa A. S.; Salem, Mounir A. I.; Mahmoud, Naglaa F. H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2020), 57(11), 3988-4006

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminoantipyrine
C11H13N3O
83-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.1864 5.4211 0.0 0
M  V30 2 C 3.1864 0.0000 0.0 0
M  V30 3 N 0.0000 4.3858 0.0 0
M  V30 4 C 0.0000 1.0353 0.0 0
M  V30 5 N 3.6156 2.7106 0.0 0
M  V30 6 C 2.7104 3.9564 0.0 0
M  V30 7 N 2.7104 1.4647 0.0 0
M  V30 8 C 1.2459 3.4806 0.0 0
M  V30 9 C 1.2459 1.9406 0.0 0
M  V30 10 C 5.1556 2.7106 0.0 0
M  V30 11 C 5.9256 4.0442 0.0 0
M  V30 12 C 5.9256 1.3769 0.0 0
M  V30 13 C 7.4656 4.0442 0.0 0
M  V30 14 C 7.4656 1.3769 0.0 0
M  V30 15 C 8.2357 2.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 7
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Formylamino)antipyrine
C12H13N3O2
1672-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.0494 5.4211 0.0 0
M  V30 2 C 5.0494 0.0000 0.0 0
M  V30 3 N 8.2357 4.3858 0.0 0
M  V30 4 C 9.6426 3.7593 0.0 0
M  V30 5 O 10.8885 4.6645 0.0 0
M  V30 6 C 8.2357 1.0353 0.0 0
M  V30 7 N 4.6200 2.7106 0.0 0
M  V30 8 C 5.5252 3.9564 0.0 0
M  V30 9 N 5.5252 1.4647 0.0 0
M  V30 10 C 6.9898 3.4806 0.0 0
M  V30 11 C 6.9898 1.9406 0.0 0
M  V30 12 C 3.0800 2.7106 0.0 0
M  V30 13 C 2.3100 1.3769 0.0 0
M  V30 14 C 2.3100 4.0442 0.0 0
M  V30 15 C 0.7700 1.3769 0.0 0
M  V30 16 C 0.7700 4.0442 0.0 0
M  V30 17 C 0.0000 2.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 83-07-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1672-58-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-18212479
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7782-61-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Transamidation Reaction.
Amide (5.1 mmol) and amine (3.0 mmol) were dissolved or suspended in
toluene (3.0 mL), Fe(NO3)3·9H2O (61 mg, 0.15 mmol) was added, and the
mixture was refluxed until complete conversion (by TLC) of the amine. The
hot reaction mixture was filtered through a pad of Celite, concentrated,
and purified by flash chromatography as indicated below.
N-Benzylacetamide (7). The crude mixture was purified by flash
chromatography with DCM. N-Formyl-4-aminoantipyrine (13d). The crude
mixture was purified by flash chromatography with DCM. The product was
obtained as a beige solid. Yield: 644 mg, 93%. The presence of two
rotamers was observed in the NMR spectra in an 0.85 (M):0.15 (m) ratio.
Mp: 188-190 °C (lit.27 192-194 °C). 1H NMR (300 MHz, CDCl3): δ (ppm) 9.21
(s, 1H), 8.47 (m) (d, J = 11.4 Hz, 1H), 8.23 (M) (d, J = 1.2 Hz, 1H),
7.27-7.50 (m, 5H), 3.10 (s, 3H), 2.25 (s, 3H). 13C{1H} NMR (75 MHz,
CDCl3): δ (ppm) 160.5, 149.8, 134.2, 129.3, 127.4, 127.1, 124.7, 124.2,
107.0, 36.1, 35.7, 12.1. IR (ν, cm-1, KBr): 3180, 3111, 3055, 2934, 2877,
1688, 1644, 1590. HRMS: calcd for C12H14N3O2, 232.1086; found, 232.1085.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transamidation of Carboxamides Catalyzed by Fe(III) and Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Becerra-Figueroa, Liliana; Ojeda-Porras, Andrea; Gamba-Sanchez, Diego
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(10), 4544-4552

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethylethyl)-1-(2-pyridinyl)-1H-pyrazol-5-amine
C12H16N4
862368-62-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0177 5.6420 0.0 0
M  V30 2 C 7.9701 3.4372 0.0 0
M  V30 3 C 8.1310 4.9687 0.0 0
M  V30 4 C 9.5016 3.2761 0.0 0
M  V30 5 C 7.8090 1.9055 0.0 0
M  V30 6 N 4.0011 3.0800 0.0 0
M  V30 7 N 5.4079 2.4536 0.0 0
M  V30 8 C 4.1621 4.6116 0.0 0
M  V30 9 C 6.4385 3.5981 0.0 0
M  V30 10 C 5.6685 4.9318 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 1.3337 3.0800 0.0 0
M  V30 13 N 2.6675 0.7700 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 9
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethylethyl)-1-(2-pyridinyl)-1H-pyrazolo[3,4-d]pyrimidine
C14H15N5
1410783-58-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9700 4.1037 0.0 0
M  V30 2 C 8.8752 2.8578 0.0 0
M  V30 3 C 9.5015 4.2647 0.0 0
M  V30 4 C 8.5963 5.5106 0.0 0
M  V30 5 N 4.0011 4.4608 0.0 0
M  V30 6 C 4.1620 2.9292 0.0 0
M  V30 7 N 5.4079 5.0873 0.0 0
M  V30 8 C 5.6685 2.6091 0.0 0
M  V30 9 N 3.1316 1.7849 0.0 0
M  V30 10 C 6.4385 3.9427 0.0 0
M  V30 11 C 6.1443 1.1444 0.0 0
M  V30 12 C 3.6075 0.3202 0.0 0
M  V30 13 N 5.1137 0.0000 0.0 0
M  V30 14 C 2.6674 5.2308 0.0 0
M  V30 15 C 2.6674 6.7708 0.0 0
M  V30 16 N 1.3336 4.4608 0.0 0
M  V30 17 C 1.3336 7.5408 0.0 0
M  V30 18 C 0.0000 5.2308 0.0 0
M  V30 19 C 0.0000 6.7708 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 862368-62-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1410783-58-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29791695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Bromophenyl)-2,4-dihydro-5-phenyl-3H-pyrazol-3-one
C15H11BrN2O
87277-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0157 0.0000 0.0 0
M  V30 2 Br 12.3670 5.6420 0.0 0
M  V30 3 N 7.0322 2.5620 0.0 0
M  V30 4 N 5.6252 3.1885 0.0 0
M  V30 5 C 6.8711 1.0304 0.0 0
M  V30 6 C 4.5948 2.0439 0.0 0
M  V30 7 C 5.3648 0.7103 0.0 0
M  V30 8 C 8.3659 3.3320 0.0 0
M  V30 9 C 8.3659 4.8720 0.0 0
M  V30 10 C 9.6995 2.5620 0.0 0
M  V30 11 C 9.6995 5.6420 0.0 0
M  V30 12 C 11.0332 3.3320 0.0 0
M  V30 13 C 11.0332 4.8720 0.0 0
M  V30 14 C 3.0633 2.2048 0.0 0
M  V30 15 C 2.1580 0.9590 0.0 0
M  V30 16 C 2.4368 3.6118 0.0 0
M  V30 17 C 0.6265 1.1201 0.0 0
M  V30 18 C 0.9052 3.7727 0.0 0
M  V30 19 C 0.0000 2.5269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Bromophenyl)-4-[[1-(4-bromophenyl)-5-hydroxy-3-phenyl-1H-pyrazol-4-yl]me...
C31H20Br2N4O2
1311144-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8393 9.8150 0.0 0
M  V30 2 O 7.8085 7.1044 0.0 0
M  V30 3 O 8.3291 7.5732 0.0 0
M  V30 4 Br 7.2669 0.0000 0.0 0
M  V30 5 Br 15.4513 7.3692 0.0 0
M  V30 6 C 3.8987 7.8744 0.0 0
M  V30 7 C 5.3634 8.3503 0.0 0
M  V30 8 N 3.8987 6.3344 0.0 0
M  V30 9 C 6.2685 7.1044 0.0 0
M  V30 10 N 5.3634 5.8586 0.0 0
M  V30 11 C 2.6528 8.7797 0.0 0
M  V30 12 C 2.8138 10.3112 0.0 0
M  V30 13 C 1.2459 8.1533 0.0 0
M  V30 14 C 1.5679 11.2164 0.0 0
M  V30 15 C 0.0000 9.0586 0.0 0
M  V30 16 C 0.1611 10.5901 0.0 0
M  V30 17 C 7.3456 10.1352 0.0 0
M  V30 18 C 7.9721 11.5420 0.0 0
M  V30 19 C 8.4901 9.1048 0.0 0
M  V30 20 N 9.5036 11.3811 0.0 0
M  V30 21 N 9.8238 9.8748 0.0 0
M  V30 22 C 5.8393 4.3938 0.0 0
M  V30 23 C 4.8087 3.2494 0.0 0
M  V30 24 C 7.3456 4.0737 0.0 0
M  V30 25 C 5.2847 1.7847 0.0 0
M  V30 26 C 7.8215 2.6091 0.0 0
M  V30 27 C 6.7910 1.4646 0.0 0
M  V30 28 C 7.2021 12.8758 0.0 0
M  V30 29 C 7.9721 14.2095 0.0 0
M  V30 30 C 5.6620 12.8758 0.0 0
M  V30 31 C 7.2021 15.5431 0.0 0
M  V30 32 C 4.8920 14.2095 0.0 0
M  V30 33 C 5.6620 15.5431 0.0 0
M  V30 34 C 11.2306 9.2483 0.0 0
M  V30 35 C 11.3917 7.7167 0.0 0
M  V30 36 C 12.4766 10.1535 0.0 0
M  V30 37 C 12.7985 7.0904 0.0 0
M  V30 38 C 13.8835 9.5272 0.0 0
M  V30 39 C 14.0444 7.9956 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 1 17 CFG=2
M  V30 3 1 2 9
M  V30 4 2 3 19
M  V30 5 1 4 27
M  V30 6 1 5 39
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 11
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 1 10 22
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 1 18 28
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 1 21 34
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87277-69-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1311144-37-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-329-CAS-1051611
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Vilsmeier-type methylenation reaction, n-methylformamide may be used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Vilsmeier-type methylenation for synthesis of dipyrazolylmethane
derivatives using formamide or N-methylformamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(21), 3863-3867

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Bromophenyl)-2,4-dihydro-5-phenyl-3H-pyrazol-3-one
C15H11BrN2O
87277-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0157 0.0000 0.0 0
M  V30 2 Br 12.3670 5.6420 0.0 0
M  V30 3 N 7.0322 2.5620 0.0 0
M  V30 4 N 5.6252 3.1885 0.0 0
M  V30 5 C 6.8711 1.0304 0.0 0
M  V30 6 C 4.5948 2.0439 0.0 0
M  V30 7 C 5.3648 0.7103 0.0 0
M  V30 8 C 8.3659 3.3320 0.0 0
M  V30 9 C 8.3659 4.8720 0.0 0
M  V30 10 C 9.6995 2.5620 0.0 0
M  V30 11 C 9.6995 5.6420 0.0 0
M  V30 12 C 11.0332 3.3320 0.0 0
M  V30 13 C 11.0332 4.8720 0.0 0
M  V30 14 C 3.0633 2.2048 0.0 0
M  V30 15 C 2.1580 0.9590 0.0 0
M  V30 16 C 2.4368 3.6118 0.0 0
M  V30 17 C 0.6265 1.1201 0.0 0
M  V30 18 C 0.9052 3.7727 0.0 0
M  V30 19 C 0.0000 2.5269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromophenyl)-4-[[1-(4-bromophenyl)-1,5-dihydro-5-hydroxy-3-phenyl-4H-pyr...
C31H22Br2N4O2
1315480-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8393 9.8150 0.0 0
M  V30 2 O 7.8085 7.1044 0.0 0
M  V30 3 O 8.3291 7.5732 0.0 0
M  V30 4 Br 7.2669 0.0000 0.0 0
M  V30 5 Br 15.4513 7.3692 0.0 0
M  V30 6 C 3.8987 7.8744 0.0 0
M  V30 7 C 5.3634 8.3503 0.0 0
M  V30 8 N 3.8987 6.3344 0.0 0
M  V30 9 C 6.2685 7.1044 0.0 0
M  V30 10 N 5.3634 5.8586 0.0 0
M  V30 11 C 2.6528 8.7797 0.0 0
M  V30 12 C 2.8138 10.3112 0.0 0
M  V30 13 C 1.2459 8.1533 0.0 0
M  V30 14 C 1.5679 11.2164 0.0 0
M  V30 15 C 0.0000 9.0586 0.0 0
M  V30 16 C 0.1611 10.5901 0.0 0
M  V30 17 C 7.3456 10.1352 0.0 0
M  V30 18 C 7.9721 11.5420 0.0 0
M  V30 19 C 8.4901 9.1048 0.0 0
M  V30 20 N 9.5036 11.3811 0.0 0
M  V30 21 N 9.8238 9.8748 0.0 0
M  V30 22 C 5.8393 4.3938 0.0 0
M  V30 23 C 4.8087 3.2494 0.0 0
M  V30 24 C 7.3456 4.0737 0.0 0
M  V30 25 C 5.2847 1.7847 0.0 0
M  V30 26 C 7.8215 2.6091 0.0 0
M  V30 27 C 6.7910 1.4646 0.0 0
M  V30 28 C 7.2021 12.8758 0.0 0
M  V30 29 C 7.9721 14.2095 0.0 0
M  V30 30 C 5.6620 12.8758 0.0 0
M  V30 31 C 7.2021 15.5431 0.0 0
M  V30 32 C 4.8920 14.2095 0.0 0
M  V30 33 C 5.6620 15.5431 0.0 0
M  V30 34 C 11.2306 9.2483 0.0 0
M  V30 35 C 11.3917 7.7167 0.0 0
M  V30 36 C 12.4766 10.1535 0.0 0
M  V30 37 C 12.7985 7.0904 0.0 0
M  V30 38 C 13.8835 9.5272 0.0 0
M  V30 39 C 14.0444 7.9956 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 1 17 CFG=2
M  V30 3 1 2 9
M  V30 4 1 3 19
M  V30 5 1 4 27
M  V30 6 1 5 39
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 11
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 1 10 22
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 1 18 28
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 1 21 34
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87277-69-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1315480-52-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-513-CAS-14354260
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, Vilsmeier-type reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New investigation of Vilsmeier-type reaction using pyrazolones with
various amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Kaneko, Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki;
Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(29), 3786-3792

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-5,6,7,8-tetrahydrofuro[2,3-b]quinoline-2-carboxylate
C14H16N2O3
900289-57-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3304 6.6519 0.0 0
M  V30 2 C 8.3912 5.2891 0.0 0
M  V30 3 O 9.7249 4.5191 0.0 0
M  V30 4 O 8.3912 6.8291 0.0 0
M  V30 5 C 11.0587 5.2891 0.0 0
M  V30 6 C 12.3923 4.5191 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 5.6505 5.1456 0.0 0
M  V30 10 C 3.0801 4.0010 0.0 0
M  V30 11 N 4.6201 1.3337 0.0 0
M  V30 12 O 6.8966 2.9875 0.0 0
M  V30 13 C 7.0575 4.5191 0.0 0
M  V30 14 C 2.3101 2.6673 0.0 0
M  V30 15 C 3.0801 1.3337 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 2.3101 0.0000 0.0 0
M  V30 18 C 0.0000 1.3337 0.0 0
M  V30 19 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7,8,9,10-Tetrahydropyrimido[4′,5′:4,5]furo[2,3-b]quinolin-4(1H)-one
C13H11N3O2
879566-00-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.8986 0.0 0
M  V30 2 C 4.8066 2.0436 0.0 0
M  V30 3 C 3.3420 1.5677 0.0 0
M  V30 4 C 4.8066 3.5836 0.0 0
M  V30 5 C 6.1402 1.2736 0.0 0
M  V30 6 C 2.4368 2.8136 0.0 0
M  V30 7 N 2.7155 0.1609 0.0 0
M  V30 8 O 3.3420 4.0597 0.0 0
M  V30 9 N 6.1402 4.3536 0.0 0
M  V30 10 C 7.4740 2.0436 0.0 0
M  V30 11 C 0.9052 2.6527 0.0 0
M  V30 12 C 1.1840 0.0000 0.0 0
M  V30 13 C 7.4740 3.5836 0.0 0
M  V30 14 C 8.8077 1.2736 0.0 0
M  V30 15 N 0.2787 1.2459 0.0 0
M  V30 16 C 8.8077 4.3536 0.0 0
M  V30 17 C 10.1414 2.0436 0.0 0
M  V30 18 C 10.1414 3.5836 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 2 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 900289-57-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 879566-00-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3229133
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Oxo-3,4,7,8,9,10-hexahydropyrimido[4',5':4,5]furo[2,3-b]quinoline (4).
A mixture of amino ester 3 (2.9 g, 10 mmol) and formamide (30 ml) was
heated at 200-205°C for 3 h. The crystalline precipitate formed upon
cooling was filtered off, thoroughly washed with water and ethanol, and
recrystallized from ethanol. Yield, %: 93. 1H NMR spectrum, δ, ppm (J,
Hz): 12.85 (1H, br. s, NH); 8.10 (1H, s, N═CH); 7.95 (1H, s, ═CH); 3.05
(4H, m, H-7,10); 1.95 (4H, m, H-8,9). Empirical formula: C13H11N3O2,
Found, %: C 67.22, H 4.38, N 17.95, Calculated, %: C 67.72, H 4.59, N
17.42, mp, °C: 305-306.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of
4-amino-4,8,9,10-tetrahydropyrimido[4',3':4,5]furo[2,3-b]quinolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dabaeva, V. V.; Bagdasaryan, M. R.; Noravyan, A. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2007),
43(10), 1333-1335

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[(4-methoxyphenyl)methyl]-3-pyridinamine
C13H13ClN2O
906371-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 Cl 3.0800 0.0000 0.0 0
M  V30 4 O 11.5500 4.0011 0.0 0
M  V30 5 C 12.3200 5.3349 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 7.7000 2.6674 0.0 0
M  V30 14 C 7.7000 5.3349 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 1 3 7
M  V30 5 1 4 5
M  V30 6 1 4 17
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Methoxyphenyl)methyl]-1H-imidazo[4,5-b]pyridine
C14H13N3O
1365094-28-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 1.6414 0.0 0
M  V30 2 O 11.0882 4.7214 0.0 0
M  V30 3 C 12.4219 3.9514 0.0 0
M  V30 4 C 3.0128 1.7849 0.0 0
M  V30 5 N 4.4196 2.4114 0.0 0
M  V30 6 C 1.9823 2.9295 0.0 0
M  V30 7 C 2.5369 0.3203 0.0 0
M  V30 8 C 4.2587 3.9429 0.0 0
M  V30 9 N 2.7523 4.2631 0.0 0
M  V30 10 N 0.4759 2.6091 0.0 0
M  V30 11 C 1.0304 0.0000 0.0 0
M  V30 12 C 0.0000 1.1446 0.0 0
M  V30 13 C 7.0871 2.4114 0.0 0
M  V30 14 C 8.4208 1.6414 0.0 0
M  V30 15 C 7.0871 3.9514 0.0 0
M  V30 16 C 9.7544 2.4114 0.0 0
M  V30 17 C 8.4208 4.7214 0.0 0
M  V30 18 C 9.7544 3.9514 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 18
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 8 9
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 906371-79-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365094-28-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13655616
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on ligand and solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved synthesis of imidazo[4,5-b]pyridines and
imidazo[4,5-b]pyrazines by palladium catalyzed amidation using xantphos
in a 1,4-Dioxane:tert-amyl alcohol aolvent aystem
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Ahmed, Ijaz; Wilson, Robert J.; Williams, Theresa M.;
Kaminsky, Lauren; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(16), 3465-3470

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminophenol
C6H7NO
95-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 O 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Hydroxyphenyl)formamide
C7H7NO2
2843-27-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 95-55-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2843-27-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29145900
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1034343-98-0
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM oxide
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, catalyst prepared and used, sealed tube used, no
solvent, recyclable catalyst used, reusable catalyst used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Graphene Oxide: A Metal-Free Carbocatalyst for the Synthesis of Diverse
Amides under Solvent-Free Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patel, Khushbu P.; Gayakwad, Eknath M.; Patil, Vilas V.; Shankarling,
Ganapati S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2019), 361(9), 2107-2116

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylboronic acid
C6H7BO2
98-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formanilide
C7H7NO
103-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-80-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 103-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-18148420
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 86-93-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 15158-11-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, optimization study, optimized on base, solvent
and temperature, reusable catalyst, nanopolystyrene anchored Cu(II)
complex of 1-phenyl-1H-tetrazole-5-thiol used as catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization, antibacterial and catalytic activity of a
nanopolymer supported copper(II) complex as a highly active and
recyclable catalyst for the formamidation of arylboronic acids under
aerobic conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nasrollahzadeh, Mahmoud; Zahraei, Ali; Ehsani, Ali; Khalaj, Mehdi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(39), 20351-20357

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Bromoacetophenone
C8H7BrO
99-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Acetylphenyl)formamide
C9H9NO2
41656-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 6.6685 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-90-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41656-75-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-1358657
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12168-54-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, green chemistry-solvent, Buchwald-Hartwig type
amination, nickel ferrite nanoparticles used as catalyst, catalyst
prepared and used, recyclable and reusable catalyst, alternative
preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM C-N Bond Formation Using Highly Effective and Reusable Nickel Ferrite
Nanoparticles in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moghaddam, Firouz Matloubi; Tavakoli, Ghazal; Moafi, Atiyeh; Saberi,
Vahid; Rezvani, Hamid Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2014), 6(12), 3474-3481

$RFMT $RIREG SCHEME257 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-amino-2-(4-morpholinyl)-5-thiazolecarboxylate
C9H13N3O3S
99967-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9700 2.9015 0.0 0
M  V30 2 O 8.5963 4.3085 0.0 0
M  V30 3 O 8.8752 1.6557 0.0 0
M  V30 4 C 10.1280 4.4694 0.0 0
M  V30 5 N 6.2948 0.0000 0.0 0
M  V30 6 C 4.0011 3.2586 0.0 0
M  V30 7 S 5.4080 3.8850 0.0 0
M  V30 8 N 4.1620 1.7271 0.0 0
M  V30 9 C 6.4384 2.7406 0.0 0
M  V30 10 C 5.6684 1.4069 0.0 0
M  V30 11 N 2.6674 4.0286 0.0 0
M  V30 12 C 1.3338 3.2586 0.0 0
M  V30 13 C 2.6674 5.5686 0.0 0
M  V30 14 C 0.0000 4.0286 0.0 0
M  V30 15 C 1.3338 6.3386 0.0 0
M  V30 16 O 0.0000 5.5686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Morpholinyl)thiazolo[4,5-d]pyrimidin-7(6H)-one
C9H10N4O2S
99967-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 C 5.0371 3.0801 0.0 0
M  V30 3 S 4.1321 1.8342 0.0 0
M  V30 4 N 4.1321 4.3260 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 2.6673 3.8501 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 N 1.3337 4.6201 0.0 0
M  V30 9 N 0.0000 2.3101 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 11 N 6.5772 3.0801 0.0 0
M  V30 12 C 7.3472 1.7464 0.0 0
M  V30 13 C 7.3472 4.4137 0.0 0
M  V30 14 C 8.8872 1.7464 0.0 0
M  V30 15 C 8.8872 4.4137 0.0 0
M  V30 16 O 9.6572 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99967-78-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99967-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12257104
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) 2-(4-Morpholinyl)[1,3]thiazolo[4,5-d]pyrimidin-7(4H)-one (3) A sealed
tube was charged with methyl
4-amino-2-(4-morpholinyl)-1,3-thiazole-5-carboxylate (4 g, 16.44 mmol)
and formamide (40 mL, 1004 mmol). The reaction was heated at 150 °C
overnight. The reaction mixture was cooled, filtered, and the solid was
washed with DCM and MeOH. The solid was collected and dried under vacuum
to give product. Yield 3.65g ,93%. LCMS (ES) m/z =239.0 (M+H)+, 1H NMR
(400 MHz, DMSO-d6) δ ppm 12.4 (br s, 1H, NH), 8.10 (s, 1H) 3.72 (m, 4H).
3.58 (m, 4H).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design, Synthesis, and SAR of a Novel Thiazolopyrimidinone
Series of Selective PI3K-beta Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lin, Hong; Schulz, Mark J.; Xie, Ren; Zeng, Jin; Luengo, Juan I.; Squire,
Michael D.; Tedesco, Rosanna; Qu, Junya; Erhard, Karl; Mack, James F.;
Raha, Kaushik; Plant, Ramona; Rominger, Cynthia M.; Ariazi, Jennifer L.;
Sherk, Christian S.; Schaber, Michael D.; McSurdy-Freed, Jeanelle;
Spengler, Michael D.; Davis, Charles B.; Hardwicke, Mary Ann; Rivero,
Ralph A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2012), 3(7), 524-529

$RFMT $RIREG SCHEME257 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-amino-2-(4-morpholinyl)-5-thiazolecarboxylate
C9H13N3O3S
99967-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9700 2.9015 0.0 0
M  V30 2 O 8.5963 4.3085 0.0 0
M  V30 3 O 8.8752 1.6557 0.0 0
M  V30 4 C 10.1280 4.4694 0.0 0
M  V30 5 N 6.2948 0.0000 0.0 0
M  V30 6 C 4.0011 3.2586 0.0 0
M  V30 7 S 5.4080 3.8850 0.0 0
M  V30 8 N 4.1620 1.7271 0.0 0
M  V30 9 C 6.4384 2.7406 0.0 0
M  V30 10 C 5.6684 1.4069 0.0 0
M  V30 11 N 2.6674 4.0286 0.0 0
M  V30 12 C 1.3338 3.2586 0.0 0
M  V30 13 C 2.6674 5.5686 0.0 0
M  V30 14 C 0.0000 4.0286 0.0 0
M  V30 15 C 1.3338 6.3386 0.0 0
M  V30 16 O 0.0000 5.5686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Morpholinyl)thiazolo[4,5-d]pyrimidin-7(6H)-one
C9H10N4O2S
99967-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 C 5.0371 3.0801 0.0 0
M  V30 3 S 4.1321 1.8342 0.0 0
M  V30 4 N 4.1321 4.3260 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 2.6673 3.8501 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 N 1.3337 4.6201 0.0 0
M  V30 9 N 0.0000 2.3101 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 11 N 6.5772 3.0801 0.0 0
M  V30 12 C 7.3472 1.7464 0.0 0
M  V30 13 C 7.3472 4.4137 0.0 0
M  V30 14 C 8.8872 1.7464 0.0 0
M  V30 15 C 8.8872 4.4137 0.0 0
M  V30 16 O 9.6572 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99967-78-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99967-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11741458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) 2-(4-Morpholinyl)[1,3]thiazolo[4,5-d]pyrimidin-7(4H)-one A sealed tube
was charged with methyl
4-amino-2-(4-morpholinyl)-1,3-thiazole-5-carboxylate (4 g, 16.44 mmol)
and formamide (40 mL, 1004 mmol). The reaction was heated at 150 °C
overnight. The reaction mixture was cooled, filtered, and the solid was
washed with DCM and MeOH. The solid was collected and dried under vacuum
to give 3.65g (93%) of product. a)
2-(4-Morpholinyl)[1,3]thiazolo[4,5-d]pyrimidin-7(4H)-one, yield 3.65g,
93% LCMS (ES) m/z=239.0 (M+H)+, 1H NMR (400 MHz, DMSO-d6) δ ppm 12.4 (br
s, 1H, NH), 8.10 (s, 1H) 3.72 (m, 4H). 3.58 (m, 4H).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of morpholinylthiazolopyrimidinones as PI3 kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lin, Hong; Luengo, Juan I.; Rivero, Ralph A.; Schulz, Mark James; Xie,
Ren; Zeng, Jin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010135504 A1 2010-11-25

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Methoxyphenyl)boronic acid
C7H9BO3
10365-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 1.3337 1.5400 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 6.6687 1.5400 0.0 0
M  V30 5 C 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Methoxyphenyl)formamide
C8H9NO2
27153-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10365-98-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 27153-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-10311787
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6046-93-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (25) General Procedure for the Synthesis of
Formanilides 2 To an open flask containing a solution of arylboronic acid
1 (1.0 mmol) in formamide (2 mL) were added Cu(OAc)2·H2O (19.9 mg, 10
mol%) and K2CO3 (138.2 mg, 1 mmol), and the mixture was stirred
vigorously at r.t. under air (without bubbling air) for 8-16 h (Table 2).
After completion of the reaction (indicated by TLC), the reaction mixture
was treated with EtOAc (5 mL) and H2O (5 mL). The organic layer was
separated, and the aqueous layer was extracted with EtOAc (3 × 5 mL). The
combined organic phase was washed with H2O (2 × 5 mL), dried over anhyd
Na2SO4, and concentrated to yield a residue, which was purified by flash
chromatography (prepacked silica cartridges). The clean product 2 as a
mixture of rotamers.27 All the products are known compounds and were
characterized by comparison of their melting points and spectral data
with those reported in the literature.14-17 N-Phenylformamide (2a, Table
2)
$DTYPE RXN:VAR(1):NOTES
$DATUM aerobic, no solvent, Chan-Lam coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed formamidation of arylboronic acids: direct access to
formanilides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srivastava, Vishnu P.; Yadav, Deepak K.; Yadav, Arvind K.; Watal, Geeta;
Yadav, Lal Dhar S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2013), 24(11), 1423-1427

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bromoacetanilide
C8H8BrNO
103-88-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 C 6.1601 0.0000 0.0 0
M  V30 4 O 8.4702 1.3337 0.0 0
M  V30 5 Br 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Cyanophenyl)acetamide
C9H8N2O
35704-19-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 2.3100 0.0000 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 C 8.4701 2.6673 0.0 0
M  V30 6 N 10.0101 2.6673 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 6.1601 4.0010 0.0 0
M  V30 11 C 6.1601 1.3337 0.0 0
M  V30 12 C 6.9301 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103-88-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35704-19-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28728484
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 366-18-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3264-82-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7446-70-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, sealed vessel used, aerobic, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ni-Mediated Generation of "CN" Unit from Formamide and Its Catalysis in
the Cyanation Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Luo; Liu, Yu-Ting; Park, Yoonsu; Park, Sung-Woo; Chang, Sukbok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2019), 9(4), 3360-3365

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[2,3-b]pyridine-2-carboxylic acid, 3-amino-5,6-dimethyl-, ethyl ester
C12H14N2O2S
1042441-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.5603 6.6519 0.0 0
M  V30 2 C 7.6212 5.2891 0.0 0
M  V30 3 O 8.9548 4.5191 0.0 0
M  V30 4 O 7.6212 6.8291 0.0 0
M  V30 5 C 10.2887 5.2891 0.0 0
M  V30 6 C 11.6223 4.5191 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 9 C 4.6201 2.6673 0.0 0
M  V30 10 C 3.8501 4.0010 0.0 0
M  V30 11 S 6.1266 2.9875 0.0 0
M  V30 12 N 3.8501 1.3337 0.0 0
M  V30 13 C 4.8805 5.1456 0.0 0
M  V30 14 C 2.3101 4.0010 0.0 0
M  V30 15 C 6.2875 4.5191 0.0 0
M  V30 16 C 2.3101 1.3337 0.0 0
M  V30 17 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 16
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 1 14 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7,8-Dimethylpyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4(3H)-one
C11H9N3OS
1125436-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.9401 2.6675 0.0 0
M  V30 2 O 0.0000 4.7981 0.0 0
M  V30 3 C 7.4001 0.0000 0.0 0
M  V30 4 C 5.0901 4.0011 0.0 0
M  V30 5 C 4.0597 5.1457 0.0 0
M  V30 6 C 4.3201 2.6675 0.0 0
M  V30 7 C 6.6301 4.0011 0.0 0
M  V30 8 C 2.6527 4.5192 0.0 0
M  V30 9 N 4.2206 6.6772 0.0 0
M  V30 10 S 2.8138 2.9876 0.0 0
M  V30 11 N 5.0901 1.3338 0.0 0
M  V30 12 C 7.4001 2.6675 0.0 0
M  V30 13 C 1.4068 5.4244 0.0 0
M  V30 14 C 2.9747 7.5825 0.0 0
M  V30 15 C 6.6301 1.3338 0.0 0
M  V30 16 N 1.5679 6.9560 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 2 2 13
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 8 10
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1042441-82-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1125436-49-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31629495
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Neurotropic Activity, and Molecular Docking of New Condensed
Thieno[2,3-b]pyridine Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dabaeva, V. V.; Baghdasaryan, M. R.; Paronikyan, R. G.; Nazaryan, I. M.;
Hakobyan, H. G.; Hunanyan, L. S.; Paronikyan, E. G.; Dashyan, Sh. Sh.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Bioorganic Chemistry (2022), 48(1), 125-134

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-Bis(4-methoxyphenyl)methanimidamide
C15H16N2O2
1152-75-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 0.0000 0.0 0
M  V30 2 C 8.0023 0.7700 0.0 0
M  V30 3 N 6.6687 0.0000 0.0 0
M  V30 4 O 14.6708 3.0801 0.0 0
M  V30 5 C 16.0046 2.3101 0.0 0
M  V30 6 O 1.3338 3.0801 0.0 0
M  V30 7 C 0.0000 2.3101 0.0 0
M  V30 8 C 10.6698 0.7700 0.0 0
M  V30 9 C 12.0035 0.0000 0.0 0
M  V30 10 C 10.6698 2.3101 0.0 0
M  V30 11 C 13.3372 0.7700 0.0 0
M  V30 12 C 12.0035 3.0801 0.0 0
M  V30 13 C 13.3372 2.3101 0.0 0
M  V30 14 C 5.3348 0.7700 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 2.6675 0.7700 0.0 0
M  V30 18 C 4.0012 3.0801 0.0 0
M  V30 19 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 4 13
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1152-75-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30506540
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
N,N′-Diarylformamidines (50-56 and 73). The reliable procedure involved
the treatment of arylamines (43-49; 1.0 equiv) or 3-aminopyridine (68;
1.0 equiv) with PBr3 (~3.0 equiv) in formamide solution (2 mL) at 50-60
°C over 0.5-1.0 h. When the reaction was complete, the crude solid was
triturated in cold n-pentane and filtered through a glass frit with
suction. Then the solid was washed with n-pentane and dried in vacuo to
give the crude formamidines (50-56 and 73). The crude products were
recrystallized from the mixture of acetone and diisopropyl ether to give
the corresponding N,N′-diarylformamidine products (50-56 and 73) in
88-97% yields as white to light yellow solids.
N,N'-Bis(4-methoxyphenyl)formamidine (53).34 The standard procedure
involved the treatment of 4-anisidine (46; 49 mg, 0.40 mmol, 1.0 equiv)
with PBr3 (0.11 mL, 1.2 mmol, 3.0 equiv) in formamide solution (2 mL) at
50-60 °C over 0.5-1.0 h. The reaction mixture was then worked up, and the
residue was purified by chromatography on silica gel to give pure 53: 92%
yield (94 mg), yellow solid. Mp 118-119 °C (CH2Cl2-methanol). 1H NMR
(CDCl3, 200 MHz): δ 3.66 (6H, s), 6.54-7.26, (8H, m), 7.89 (1H, s), 8.07
(1H, s). 13C NMR (50 MHz, CDCl3): δ 56.9, 57.8, 114.9, 115.2, 118.3 (2 ×
C), 124.3 (2 × C), 135.2 (2 × C), 139.8 (2 × C), 149.5, 160.1, 163.7. IR
(KBr): 3313, 3136, 3022, 2991, 2886, 2804, 1675, 1577, 1465, 1301, 1247,
1036 cm-1. EIMS m/z (rel int): 256 (51, M+). Anal. Calcd for C15H16N2O2:
C, 70.29; H, 6.29; N, 10.93. Found: C, 70.26; H, 6.32; N, 10.91.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorotoluene
C7H7Cl
106-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 Cl 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methylphenyl)formamide
C8H9NO
3085-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 C 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-43-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3085-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-12108261
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51364-51-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 564483-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure Pd-Catalyzed Amidation of
Aryl Halides and Sulfonates (Tables 2, 3 and 4). An oven-dried Schlenk
tube was evacuated and backfilled with argon. [If 3Å molecular sieves
were used, they were activated by heating under reduced pressure and
backfilling the Schlenk tube with argon (this sequence was repeated three
times) at this time.] The Schlenk tube was charged with Pd2dba3 (0.25-4.0
mol % Pd), ligand (0.60-10 mol %) and K3PO4 or K2CO3 (1.0-2.2 equiv). If
the aryl chloride (1.0 equiv) and/or amide (1.0-1.5 equiv) were a solid,
these were also added at this time. The tube was evacuated and backfilled
with argon (this sequence was repeated three times). If the aryl chloride
and/or amide (1.0-1.5 equiv) were a liquid, these were added to the tube
at this time along with t-BuOH. The mixture was stirred in a pre-heated
oil bath (90-110 °C) until the aryl halide was consumed as judged by TLC,
LC-MS or GC analysis (2-24 h, reaction times were not optimized). The
reaction mixture was allowed to cool to room temperature, diluted with
ethyl acetate (or MeOH in case the product was insoluble in ethyl
acetate), and the resultant solution was filtered through Celite, and
concentrated under reduced pressure. The crude material was purified by
column chromatography on silica gel. The crude material was purified by
column chromatography (eluting with hexanes/ethyl acetate = 2/1).
4-Methylformanilide, white solid, yield 124 mg, 92%. Mp = 53-54 °C
(lit.[6] 55-57 °C). 1H NMR (400 MHz, CDCl3) δ: (equilibrium mixture of
E/Z isomers) 8.72 (br-s, 0.55H), 8.61 (d, J = 11.6 Hz, 0.55H), 8.30 (s,
0.45H), 7.81 (br-s, 0.45H), 7.41 (d, J = 8.0 Hz, 0.90H), 7.14-7.09 (m,
2H), 6.97 (d, J = 8.0 Hz, 1.10H), 2.31 and 2.29 (each s, total 3H). 13C
NMR (100 MHz, CDCl3) δ: (equilibrium mixture of E/Z isomers) 163.3,
159.5, 135.3, 134.6, 134.6, 134.4, 130.4, 129.7, 120.3, 119.3, 21.1,
21.0. Anal. Calcd for C8H9NO: C, 71.09; H, 6.71. Found: C, 70.96; H,
6.73.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pd-Catalyzed Amidations of Aryl Chlorides Using Monodentate Biaryl
Phosphine Ligands: A Kinetic, Computational, and Synthetic Investigation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ikawa, Takashi; Barder, Timothy E.; Biscoe, Mark R.; Buchwald, Stephen L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2007), 129(43), 13001-13007

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-5-heptyl-3-thiophenecarboxylate
C14H23NO2S
1186474-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7844 2.9016 0.0 0
M  V30 2 O 2.1580 4.3085 0.0 0
M  V30 3 O 1.8791 1.6557 0.0 0
M  V30 4 C 0.6265 4.4695 0.0 0
M  V30 5 C 0.0000 5.8764 0.0 0
M  V30 6 N 4.4596 0.0000 0.0 0
M  V30 7 C 8.0870 4.0287 0.0 0
M  V30 8 C 9.4208 3.2587 0.0 0
M  V30 9 C 10.7545 4.0287 0.0 0
M  V30 10 C 12.0881 3.2587 0.0 0
M  V30 11 C 13.4218 4.0287 0.0 0
M  V30 12 C 14.7556 3.2587 0.0 0
M  V30 13 C 16.0893 4.0287 0.0 0
M  V30 14 C 4.3159 2.7406 0.0 0
M  V30 15 C 5.3465 3.8852 0.0 0
M  V30 16 C 5.0859 1.4070 0.0 0
M  V30 17 C 6.7533 3.2587 0.0 0
M  V30 18 S 6.5924 1.7271 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 16
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Heptylthieno[2,3-d]pyrimidin-4(1H)-one
C13H18N2OS
1186474-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 C 6.0811 3.9554 0.0 0
M  V30 3 C 7.4148 3.1854 0.0 0
M  V30 4 C 8.7485 3.9554 0.0 0
M  V30 5 C 10.0823 3.1854 0.0 0
M  V30 6 C 11.4160 3.9554 0.0 0
M  V30 7 C 12.7496 3.1854 0.0 0
M  V30 8 C 14.0833 3.9554 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 S 4.5864 1.6538 0.0 0
M  V30 12 N 2.3101 0.0000 0.0 0
M  V30 13 C 3.3405 3.8119 0.0 0
M  V30 14 C 0.7700 2.6673 0.0 0
M  V30 15 C 4.7473 3.1854 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 17 N 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 1 14 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1186474-59-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1186474-45-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19349292
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thieno[2,3-d]pyrimidin-4(3H)-one compounds with antimycobacterial
properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srnivasula, Reddy Venkata Mohan; Mannem, Lenin Babu; Ratnam, Kannaiah
Goud; Gokuladoss, Velvizhi; Yerramsetti, Venkata Swamy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2014DE00279 A 2016-07-08

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-(4-methyl-1-piperazinyl)-1-naphthaleneacetate
C19H24N2O2
1191399-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 5.3900 0.0 0
M  V30 2 C 2.6673 6.9300 0.0 0
M  V30 3 O 1.3336 7.7000 0.0 0
M  V30 4 O 4.0011 7.7000 0.0 0
M  V30 5 C 1.3336 9.2400 0.0 0
M  V30 6 C 0.0000 10.0100 0.0 0
M  V30 7 C 12.0031 7.7000 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6673 2.3100 0.0 0
M  V30 12 C 5.3347 5.3900 0.0 0
M  V30 13 C 6.6684 3.0800 0.0 0
M  V30 14 C 5.3347 0.7700 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 6.6684 4.6200 0.0 0
M  V30 17 C 4.0011 0.0000 0.0 0
M  V30 18 N 8.0020 5.3900 0.0 0
M  V30 19 C 9.3358 4.6200 0.0 0
M  V30 20 C 8.0020 6.9300 0.0 0
M  V30 21 C 10.6694 5.3900 0.0 0
M  V30 22 C 9.3358 7.7000 0.0 0
M  V30 23 N 10.6694 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methyl-1-piperazinyl)-1-naphthaleneacetamide
C17H21N3O
425638-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 C 3.0800 1.3336 0.0 0
M  V30 3 N 2.3100 0.0000 0.0 0
M  V30 4 O 4.6200 1.3336 0.0 0
M  V30 5 C 11.5500 5.3347 0.0 0
M  V30 6 C 2.3100 5.3347 0.0 0
M  V30 7 C 3.0800 6.6685 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 0.7700 5.3347 0.0 0
M  V30 10 C 4.6200 6.6685 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 C 5.3900 5.3347 0.0 0
M  V30 15 C 0.7700 8.0021 0.0 0
M  V30 16 N 6.9300 5.3347 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 7.7000 6.6685 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 9.2400 6.6685 0.0 0
M  V30 21 N 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 21
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1191399-69-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 425638-82-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10779818
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The piperazine intermediate from the above reaction (355 mg, 1.14 mmol)
and formamide (171 mg, 3.8 mmol) was dissolved in DMF (5 mL). The
solution was heated to 105 °C, and a solution of sodium methoxide (5.4 M
in MeOH, 148 μL) was slowly added over 15 min. After 1 h at 105 °C, an
additional portion of sodium methoxide (63 μL) was added, and heating was
continued for another hour. The reaction mixture was cooled to room
temperature, diluted with water, and extracted sequentially with ethyl
acetate and with CH2Cl2. The combined organic layers were dried over
Na2SO4, filtered, and concentrated. Purification by flash chromatography
(ethyl acetate/AcOH/H2O, 700:110:90 to 650:130:120) afforded 6
(monoacetate, 358 mg, 92%) as a solid.
2-[3-(4-Methylpiperazin-1-yl)naphthalen-1-yl]acetamide (6), yield (358
mg, 92%). ES-MS: 284 [M + H]+, 306 [M + Na]+. HRMS: calcd for C17H22N3O
[M + H]+ 284.175 74, found 284.175 84. 1H NMR (DMSO-d6, 500 MHz,
trifluoroacetate salt): δ 2.88 (s, 3H), 3.01-3.12 (m, 2H), 3.16-3.27 (br,
2H), 3.53-3.63 (br, 2H), 3.81 (s, 2H), 3.91-4.01 (br, 2H), 6.97 (s, 1H),
7.19 (s, 1H), 7.33 (dd, J = 8.4, 7.4 Hz, 1H), 7.34 (s, 1H), 7.42 (dd, J =
8.2, 7.4 Hz, 1H), 7.54 (s, 1H), 7.75 (d, J = 8.2 Hz, 1H), 7.93 (d, J =
8.4 Hz, 1H), 10.08-10.20 (br, 1H). 13C NMR (DMSO-d6, 125.8 MHz,
trifluoroacetate salt): δ 39.01, 42.12, 45.88 (2x), 52.28 (2x), 109.40,
121.14, 123.52, 124.00, 126.04, 127.28, 127.40, 134.01, 134.54, 146.72,
171.99. IR (FTIR microscope, transmission, trifluoroacetate salt) νmax
3371, 3198, 3032, 2841, 2733, 2621, 2489, 1673, 1624, 1602, 1509, 1458,
1407, 1272, 1235, 1060 cm-1.
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition (NaoMe) (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Activity Relationship and Pharmacokinetic Studies of
Sotrastaurin (AEB071), a Promising Novel Medicine for Prevention of Graft
Rejection and Treatment of Psoriasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wagner, Juergen; von Matt, Peter; Faller, Bernard; Cooke, Nigel G.;
Albert, Rainer; Sedrani, Richard; Wiegand, Hansjoerg; Jean, Christian;
Beerli, Christian; Weckbecker, Gisbert; Evenou, Jean-Pierre; Zenke,
Gerhard; Cottens, Sylvain
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2011), 54(17), 6028-6039

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzoyl chloride
C7H4Cl2O
122-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzamide
C7H6ClNO
619-56-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 619-56-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-4758094
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure for Amination All the
experiments were carried out in a parallel synthesizer from REDLEYS
Discovery Technologies, UK. A solution of acid chloride 1a (1.0 gm 7.11
mmol) in formamide (10 ml) was heated to 100-120 °C and maintained at
same temperature for 5 to 6 hours, the reaction mixture was cooled to
room temperature. The reaction mass quenched in excess water and
extracted with dichloromethane. The combined organic solvent was washed
with saturated NaHCO3 aqueous solution and dried over anhydrous Na2SO4.
The solvent was evaporated under reduced pressure to give the residue
which was purified by column chromatography using silica gel and EtOAc=
hexane as eluent. An amount of 0.77 g (6.4 mmol, 90%) of 2a was obtained
as crystals. Compound 2i. Yield 92% Mp in °C (Lit): 172-176; Mp in °C
(Obs.): 170-172
$DTYPE RXN:VAR(1):NOTES
$DATUM excess water used in stage 2, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide as an ammonia synthon in amination of acid chlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasan, S.; Manisankar, P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2010), 40(23), 3538-3543

$RFMT $RIREG SCHEME266 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Toluenesulfinic acid
C7H8O2S
536-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.7700 1.3337 0.0 0 VAL=4
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)[(4-methylphenyl)sulfonyl]methyl]formamide
C16H17NO4S
185243-93-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.8501 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 N 6.6685 2.3101 0.0 0
M  V30 4 O 4.5648 3.2864 0.0 0
M  V30 5 O 6.1048 5.9538 0.0 0
M  V30 6 C 8.0022 1.5400 0.0 0
M  V30 7 O 8.0022 0.0000 0.0 0
M  V30 8 O 12.0033 6.9302 0.0 0
M  V30 9 C 13.3370 6.1601 0.0 0
M  V30 10 C 0.0000 7.7002 0.0 0
M  V30 11 C 8.0022 4.6201 0.0 0
M  V30 12 C 8.0022 6.1601 0.0 0
M  V30 13 C 9.3360 3.8501 0.0 0
M  V30 14 C 9.3360 6.9302 0.0 0
M  V30 15 C 10.6697 4.6201 0.0 0
M  V30 16 C 10.6697 6.1601 0.0 0
M  V30 17 C 4.0010 5.3901 0.0 0
M  V30 18 C 4.0010 6.9302 0.0 0
M  V30 19 C 2.6673 4.6201 0.0 0
M  V30 20 C 2.6673 7.7002 0.0 0
M  V30 21 C 1.3337 5.3901 0.0 0
M  V30 22 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 17
M  V30 7 1 3 6
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 16
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 185243-93-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42032203
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anionic N-Heterocyclic Carbenes from Mesoionic Imidazolium-4-pyrrolides:
The Influence of Substituents, Solvents, and Charge on their 77Se NMR
Chemical Shifts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pruschinski, Lucas; Namyslo, Jan C.; Schmidt, Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(20), 15003-15019

$RFMT $RIREG SCHEME266 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Toluenesulfinic acid
C7H8O2S
536-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.7700 1.3337 0.0 0 VAL=4
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)[(4-methylphenyl)sulfonyl]methyl]formamide
C16H17NO4S
185243-93-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.8501 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 N 6.6685 2.3101 0.0 0
M  V30 4 O 4.5648 3.2864 0.0 0
M  V30 5 O 6.1048 5.9538 0.0 0
M  V30 6 C 8.0022 1.5400 0.0 0
M  V30 7 O 8.0022 0.0000 0.0 0
M  V30 8 O 12.0033 6.9302 0.0 0
M  V30 9 C 13.3370 6.1601 0.0 0
M  V30 10 C 0.0000 7.7002 0.0 0
M  V30 11 C 8.0022 4.6201 0.0 0
M  V30 12 C 8.0022 6.1601 0.0 0
M  V30 13 C 9.3360 3.8501 0.0 0
M  V30 14 C 9.3360 6.9302 0.0 0
M  V30 15 C 10.6697 4.6201 0.0 0
M  V30 16 C 10.6697 6.1601 0.0 0
M  V30 17 C 4.0010 5.3901 0.0 0
M  V30 18 C 4.0010 6.9302 0.0 0
M  V30 19 C 2.6673 4.6201 0.0 0
M  V30 20 C 2.6673 7.7002 0.0 0
M  V30 21 C 1.3337 5.3901 0.0 0
M  V30 22 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 17
M  V30 7 1 3 6
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 16
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 185243-93-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13923370
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalytic Asymmetric Synthesis of β-Aryl-β-isocyano Esters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morana, Fabio; Basso, Andrea; Bella, Marco; Riva, Renata; Banfi, Luca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2012), 354(11-12), 2199-2210,
S2199/1-S2199/39

$RFMT $RIREG SCHEME267 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-3-methyl-2-[[[4-(trifluoromethyl)-2-thiazolyl]carbonyl]amino]benzoi...
C14H11F3N2O4S
1251165-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 O 6.1600 6.6685 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 O 3.8500 0.0000 0.0 0
M  V30 6 O 6.1600 1.3338 0.0 0
M  V30 7 C 4.6200 6.6685 0.0 0
M  V30 8 O 1.5400 6.6685 0.0 0
M  V30 9 C 0.0000 6.6685 0.0 0
M  V30 10 C 12.0856 7.0099 0.0 0
M  V30 11 F 11.1804 8.2559 0.0 0
M  V30 12 F 13.3315 7.9151 0.0 0
M  V30 13 F 12.9908 5.7641 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 3.8500 2.6674 0.0 0
M  V30 16 C 3.8500 5.3349 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 2.3100 5.3349 0.0 0
M  V30 19 C 1.5400 4.0011 0.0 0
M  V30 20 C 8.4700 5.3347 0.0 0
M  V30 21 N 9.3751 6.5807 0.0 0
M  V30 22 S 9.3751 4.0889 0.0 0
M  V30 23 C 10.8398 6.1047 0.0 0
M  V30 24 C 10.8398 4.5647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 15
M  V30 8 1 7 16
M  V30 9 1 8 9
M  V30 10 1 8 18
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 23
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-8-methyl-2-[4-(trifluoromethyl)-2-thiazolyl]-4(3H)-quinazolinone
C14H10F3N3O2S
1251165-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.8354 6.1601 0.0 0
M  V30 2 O 8.1679 0.0000 0.0 0
M  V30 3 O 13.5027 4.6201 0.0 0
M  V30 4 C 14.8364 3.8501 0.0 0
M  V30 5 C 1.5316 4.9772 0.0 0
M  V30 6 F 1.6925 3.4457 0.0 0
M  V30 7 F 0.0000 4.8163 0.0 0
M  V30 8 F 1.3705 6.5088 0.0 0
M  V30 9 C 9.5015 3.8501 0.0 0
M  V30 10 C 9.5015 2.3101 0.0 0
M  V30 11 N 8.1679 4.6201 0.0 0
M  V30 12 C 10.8354 4.6201 0.0 0
M  V30 13 C 8.1679 1.5400 0.0 0
M  V30 14 C 10.8354 1.5400 0.0 0
M  V30 15 C 6.8342 3.8501 0.0 0
M  V30 16 C 12.1690 3.8501 0.0 0
M  V30 17 N 6.8342 2.3101 0.0 0
M  V30 18 C 12.1690 2.3101 0.0 0
M  V30 19 C 5.5005 4.6201 0.0 0
M  V30 20 N 4.0936 3.9938 0.0 0
M  V30 21 S 5.3395 6.1517 0.0 0
M  V30 22 C 3.0631 5.1382 0.0 0
M  V30 23 C 3.8331 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 2 2 13
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 22
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 17
M  V30 19 1 15 19
M  V30 20 2 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1251165-84-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1251165-85-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26505339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [00409] Step C: Preparation of
7-methoxy-8-methyl-2-[(4-trifluoromethyl-thiazole-2-yl)-quinazolin-4-ol
206. Compound 205 (2.5 g, 1 eq.) was refluxed in formamide (20 mL) at 160
°C. for 5 hrs. Water was then added and the reaction mixture was
extracted with EtOAc. Organics were dried over Na2SO4, filtered,
concentrated under reduced pressure, and purified by silica gel
chromatography (DCM) to yield compound 206 as a brown solid in 92% yield.
1H NMR (CDCl3, 400 MHz) δ (ppm) 2.46 (s, 3H), 3.92 (s, 3H), 7.07 (d,
J=9.28 Hz, 1H), 7.92 (s, 1H), 8.15 (d, J=9.28 Hz, 1H), 9.87 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic serine protease inhibitors for the treatment
of viral infection, particularly HCV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Parsy, Christophe Claude; Alexandre, Francois-Rene; Leroy, Frederic;
Convard, Thierry; Surleraux, Dominique
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011017389 A1 2011-02-10

$RFMT $RIREG SCHEME268 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-1-(mercaptomethyl)-3-methylbutyl]carbamate
C14H21NO2S
1258407-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 2.3101 0.0 0
M  V30 2 O 6.6685 3.0801 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 N 4.0012 3.0801 0.0 0
M  V30 5 O 5.3348 0.7700 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0 CFG=2
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 C 2.6673 0.7700 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 S 1.3337 0.0000 0.0 0
M  V30 11 C 2.6673 5.3901 0.0 0
M  V30 12 C 0.0000 5.3901 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 14 C 10.6697 2.3101 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 12.0033 3.0801 0.0 0
M  V30 17 C 10.6697 5.3901 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C16H24N2O3S
2602313-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7001 4.0011 0.0 0 CFG=1
M  V30 2 N 6.9301 5.3348 0.0 0
M  V30 3 C 9.2401 4.0011 0.0 0
M  V30 4 C 6.9301 2.6673 0.0 0
M  V30 5 C 5.3901 5.3348 0.0 0
M  V30 6 S 10.0101 5.3348 0.0 0
M  V30 7 C 7.7001 1.3337 0.0 0
M  V30 8 O 4.6201 6.6684 0.0 0
M  V30 9 O 4.6201 4.0011 0.0 0
M  V30 10 C 11.5501 5.3348 0.0 0
M  V30 11 C 6.9301 0.0000 0.0 0
M  V30 12 C 9.2401 1.3337 0.0 0
M  V30 13 C 3.0800 6.6684 0.0 0
M  V30 14 N 12.3201 6.6684 0.0 0
M  V30 15 C 13.8602 6.6684 0.0 0
M  V30 16 O 14.6302 8.0022 0.0 0
M  V30 17 C 2.3100 8.0022 0.0 0
M  V30 18 C 0.7700 8.0022 0.0 0
M  V30 19 C 3.0800 9.3359 0.0 0
M  V30 20 C 0.0000 9.3359 0.0 0
M  V30 21 C 2.3100 10.6695 0.0 0
M  V30 22 C 0.7700 10.6695 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 10 14
M  V30 14 1 13 17
M  V30 15 1 14 15
M  V30 16 2 15 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1258407-26-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2602313-19-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23169513
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM paraformaldehyde used, Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Nβ-Protected Amino Sulfenyl Methyl Formamides and Sulfonyl
Methyl Formamides: A Simple Protocol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasulu, Chinthaginjala; Sagar, Nagamangala R.; Vishwanatha,
Thimmalapura M.; Durgamma, Suram; Sureshbabu, Vommina V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2021), 6(7), 4680-4686

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-9-ethylcarbazole
C14H14N2
132-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4647 5.6252 0.0 0
M  V30 2 C 0.0000 5.1493 0.0 0
M  V30 3 N 8.7355 4.9149 0.0 0
M  V30 4 C 3.8549 2.4369 0.0 0
M  V30 5 C 4.8855 3.5813 0.0 0
M  V30 6 C 2.4481 3.0632 0.0 0
M  V30 7 C 4.0160 0.9052 0.0 0
M  V30 8 C 4.1155 4.9149 0.0 0
M  V30 9 C 6.4255 3.5813 0.0 0
M  V30 10 N 2.6091 4.5947 0.0 0
M  V30 11 C 1.2023 2.1580 0.0 0
M  V30 12 C 2.7702 0.0000 0.0 0
M  V30 13 C 4.8855 6.2487 0.0 0
M  V30 14 C 7.1955 4.9149 0.0 0
M  V30 15 C 1.3632 0.6265 0.0 0
M  V30 16 C 6.4255 6.2487 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 14
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 8 10
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(9-Ethyl-9H-carbazol-3-yl)formamide
C15H14N2O
80776-22-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5873 0.3202 0.0 0
M  V30 2 C 1.0809 0.0000 0.0 0
M  V30 3 N 8.5290 4.5707 0.0 0
M  V30 4 C 9.8627 3.8006 0.0 0
M  V30 5 O 11.1964 4.5707 0.0 0
M  V30 6 C 4.5279 3.8006 0.0 0
M  V30 7 C 4.5279 2.2606 0.0 0
M  V30 8 C 3.0631 4.2767 0.0 0
M  V30 9 C 5.8615 4.5707 0.0 0
M  V30 10 N 3.0631 1.7847 0.0 0
M  V30 11 C 5.8615 1.4906 0.0 0
M  V30 12 C 2.1579 3.0306 0.0 0
M  V30 13 C 2.4368 5.6835 0.0 0
M  V30 14 C 7.1952 3.8006 0.0 0
M  V30 15 C 7.1952 2.2606 0.0 0
M  V30 16 C 0.6263 3.1917 0.0 0
M  V30 17 C 0.9052 5.8444 0.0 0
M  V30 18 C 0.0000 4.5985 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 1 10 12
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 132-32-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 80776-22-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-9011140
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7782-61-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Transamidation Reaction.
Amide (5.1 mmol) and amine (3.0 mmol) were dissolved or suspended in
toluene (3.0 mL), Fe(NO3)3·9H2O (61 mg, 0.15 mmol) was added, and the
mixture was refluxed until complete conversion (by TLC) of the amine. The
hot reaction mixture was filtered through a pad of Celite, concentrated,
and purified by flash chromatography as indicated below.
N-Benzylacetamide (7). The crude mixture was purified by flash
chromatography with DCM. N-(9-Ethyl-9H-carbazol-3-yl)formamide (13b). The
crude mixture was purified by flash chromatography with DCM/AcOEt (8:2).
The product was obtained as white crystals. Yield: 657 mg, 92%. The
presence of two rotamers was observed in the NMR spectra; however, it is
not possible to differentiate all the signals corresponding to each
isomer. Mp: 149-150 °C (lit.26 148 °C). 1H NMR (300 MHz, DMSO): δ (ppm)
9.99-10.33 (m, 1H), 8.74 (d, J = 11.1 Hz, 1H), 8.26-8.57 (m, 1H),
7.93-8.17 (m, 1H), 7.47-7.78 (m, 3H), 7.12-7.50 (m, 2H), 4.41 (d, J = 7.1
Hz, 2H), 1.29 (t, J = 7.0 Hz, 3H). 13C{1H} NMR (75 MHz, DMSO): δ (ppm)
163.5, 159.6, 140.5, 140.5, 137.2, 136.8, 130.8, 130.6, 126.5, 126.3,
123.0, 122.4, 122.4, 122.3, 121.0, 120.7, 119.0, 118.7, 111.6, 110.7,
110.2, 109.6, 37.4, 14.1. IR (ν, cm-1, KBr): 3240, 3049, 2967, 2872,
1654, 1541, 1474. HRMS: calcd for C15H15N2O, 239.1184; found, 239.1177.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transamidation of Carboxamides Catalyzed by Fe(III) and Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Becerra-Figueroa, Liliana; Ojeda-Porras, Andrea; Gamba-Sanchez, Diego
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(10), 4544-4552

$RFMT $RIREG SCHEME270 STEP1
$RXN



  2  1
$MOL
2-Bromo-5-methoxy-N-(4-methoxy-2-methylphenyl)benzamide
C16H16BrNO3
1383744-08-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6675 0.0 0
M  V30 2 N 6.9302 4.0012 0.0 0
M  V30 3 O 6.9302 1.3338 0.0 0
M  V30 4 Br 4.6201 0.0000 0.0 0
M  V30 5 O 1.5400 5.3348 0.0 0
M  V30 6 C 0.0000 5.3348 0.0 0
M  V30 7 C 8.4702 6.6687 0.0 0
M  V30 8 O 13.0903 4.0012 0.0 0
M  V30 9 C 13.8603 5.3348 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 3.8501 4.0012 0.0 0
M  V30 12 C 3.8501 1.3338 0.0 0
M  V30 13 C 2.3101 4.0012 0.0 0
M  V30 14 C 2.3101 1.3338 0.0 0
M  V30 15 C 1.5400 2.6675 0.0 0
M  V30 16 C 8.4702 4.0012 0.0 0
M  V30 17 C 9.2402 5.3348 0.0 0
M  V30 18 C 9.2402 2.6675 0.0 0
M  V30 19 C 10.7802 5.3348 0.0 0
M  V30 20 C 10.7802 2.6675 0.0 0
M  V30 21 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 16
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 5 13
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methoxy-2-methylphenyl)-4(3H)-quinazolinone
C16H14N2O2
1357830-15-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 C 6.9300 0.0000 0.0 0
M  V30 3 O 11.5500 2.6674 0.0 0
M  V30 4 C 12.3200 4.0011 0.0 0
M  V30 5 N 5.3900 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 N 3.0800 1.3338 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 0.7700 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 7.7000 1.3338 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 9.2400 1.3338 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 15
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 10
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1383744-08-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1357830-15-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-111-CAS-14127628
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51-35-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for CuI-catalyzed formation
of 3-substituted-4-quinazolines and 2,3-disubstituted-4(3H )-quinazolines
from 2-bromo-N-phenylbenzamide. For 3-substituted-4-quinazoline
(11a-11r). A Schlenk tube was charged with N-substituted 2-bromobenzamide
(0.25 mmol), CuI (5 mg, 0.025 mmol), trans-4-hydroxy-L-proline (3 mg,
0.025 mmol), and Cs2CO3 (163 mg, 0.5 mmol). The tube was evacuated and
backfilled with argon before formamide (20 µL, 0.5 mmol) and 1 mL DMF was
added. The reaction mixture was stirred at 80 o C (or 90 o C for
substrate 7l) for 24 h. After the reaction mixture was cooled to room
temperature, 5 mL of saturated NH4Cl solution was added. The mixture was
extracted with EtOAc and the organic layer was washed with water, brine
and dried over Na2SO4. After concentration in vacuo, the residue was
purified by column chromatography on silica gel. The desired
3-substituted 4-quinazoline.
6-Methoxy-3-(4-methoxy-2-methylphenyl)quinazolin-4(3H)-one (11j).3 68 mg,
92% yield. 1H NMR (400 MHz, CDCl3) δ 7.89 (s, 1H), 7.72 (d, J = 10.4 Hz,
2H ), 7.40 (dd, J 1 = 3.2 Hz, J 2 = 9.2 Hz, 1H), 7.16 (d, J = 8.4 Hz,
1H), 6.90-6.86 (m, 2H), 3.93 (s, 3H), 3.85 (s, 3H), 2.15 (s, 3H); 13C NMR
(100 MHz, CDCl3) δ 160.75, 160.29, 159.05, 144.82, 142.67, 137.22,
129.68, 129.18, 128.91, 124.73, 123.36, 116.54, 112.54, 106.69, 55.99,
55.61, 18.11. HRMS-ESI: m/z calcd for C17H17N2O3 [M + H]+: 297.1239,
found 297.1214.
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst formed in-situ; Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Substituted and 2,3-Disubstituted Quinazolinones via
Cu-Catalyzed Aryl Amidation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Lanting; Jiang, Yongwen; Ma, Dawei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(4), 1150-1153

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Phenyl-1-(2-quinolinyl)-1H-pyrazol-5-amine
C18H14N4
1400634-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.8391 0.0000 0.0 0
M  V30 2 C 7.8085 2.7106 0.0 0
M  V30 3 N 8.5785 4.0442 0.0 0
M  V30 4 C 8.5785 1.3769 0.0 0
M  V30 5 C 10.1185 4.0442 0.0 0
M  V30 6 C 10.1185 1.3769 0.0 0
M  V30 7 C 10.8885 2.7106 0.0 0
M  V30 8 C 10.8885 5.3779 0.0 0
M  V30 9 C 12.4285 2.7106 0.0 0
M  V30 10 C 12.4285 5.3779 0.0 0
M  V30 11 C 13.1985 4.0442 0.0 0
M  V30 12 N 6.2684 2.7106 0.0 0
M  V30 13 N 5.3632 3.9564 0.0 0
M  V30 14 C 5.3632 1.4647 0.0 0
M  V30 15 C 3.8987 3.4806 0.0 0
M  V30 16 C 3.8987 1.9406 0.0 0
M  V30 17 C 2.6528 4.3858 0.0 0
M  V30 18 C 1.2459 3.7593 0.0 0
M  V30 19 C 2.8137 5.9173 0.0 0
M  V30 20 C 0.0000 4.6645 0.0 0
M  V30 21 C 1.5679 6.8225 0.0 0
M  V30 22 C 0.1609 6.1961 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 7
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)quinoline
C20H13N5
1400634-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.2684 3.7827 0.0 0
M  V30 2 C 5.3632 2.5368 0.0 0
M  V30 3 N 5.3632 5.0286 0.0 0
M  V30 4 C 3.8987 3.0127 0.0 0
M  V30 5 N 5.6834 1.0304 0.0 0
M  V30 6 C 3.8987 4.5527 0.0 0
M  V30 7 C 2.7541 1.9823 0.0 0
M  V30 8 C 4.5390 0.0000 0.0 0
M  V30 9 N 3.0743 0.4759 0.0 0
M  V30 10 C 7.8084 3.7827 0.0 0
M  V30 11 N 8.5784 5.1163 0.0 0
M  V30 12 C 8.5784 2.4491 0.0 0
M  V30 13 C 10.1184 5.1163 0.0 0
M  V30 14 C 10.1184 2.4491 0.0 0
M  V30 15 C 10.8884 3.7827 0.0 0
M  V30 16 C 10.8884 6.4501 0.0 0
M  V30 17 C 12.4284 3.7827 0.0 0
M  V30 18 C 12.4284 6.4501 0.0 0
M  V30 19 C 13.1984 5.1163 0.0 0
M  V30 20 C 2.6528 5.4579 0.0 0
M  V30 21 C 1.2459 4.8314 0.0 0
M  V30 22 C 2.8137 6.9894 0.0 0
M  V30 23 C 0.0000 5.7367 0.0 0
M  V30 24 C 1.5679 7.8947 0.0 0
M  V30 25 C 0.1609 7.2683 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 6 20
M  V30 11 1 7 9
M  V30 12 2 8 9
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 13 16
M  V30 19 1 14 15
M  V30 20 1 15 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1400634-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-67-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29915590
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective synthesis of pyrazolo[3,4-d]pyrimidine,
N-(1H-pyrazol-5-yl)formamide, or N-(1H-pyrazol-5-yl)formamidine
derivatives from N-1-substituted-5-aminopyrazoles with new Vilsmeier-type
reagents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chang, Chun-Hsi; Tsai, Henry J.; Huang, Yu-Ying; Lin, Hui-Yi; Wang,
Li-Ya; Wu, Tian-Shung; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2013), 69(4), 1378-1386

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Phenyl-1-(2-quinolinyl)-1H-pyrazol-5-amine
C18H14N4
1400634-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.8391 0.0000 0.0 0
M  V30 2 C 7.8085 2.7106 0.0 0
M  V30 3 N 8.5785 4.0442 0.0 0
M  V30 4 C 8.5785 1.3769 0.0 0
M  V30 5 C 10.1185 4.0442 0.0 0
M  V30 6 C 10.1185 1.3769 0.0 0
M  V30 7 C 10.8885 2.7106 0.0 0
M  V30 8 C 10.8885 5.3779 0.0 0
M  V30 9 C 12.4285 2.7106 0.0 0
M  V30 10 C 12.4285 5.3779 0.0 0
M  V30 11 C 13.1985 4.0442 0.0 0
M  V30 12 N 6.2684 2.7106 0.0 0
M  V30 13 N 5.3632 3.9564 0.0 0
M  V30 14 C 5.3632 1.4647 0.0 0
M  V30 15 C 3.8987 3.4806 0.0 0
M  V30 16 C 3.8987 1.9406 0.0 0
M  V30 17 C 2.6528 4.3858 0.0 0
M  V30 18 C 1.2459 3.7593 0.0 0
M  V30 19 C 2.8137 5.9173 0.0 0
M  V30 20 C 0.0000 4.6645 0.0 0
M  V30 21 C 1.5679 6.8225 0.0 0
M  V30 22 C 0.1609 6.1961 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 7
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)quinoline
C20H13N5
1400634-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.2684 3.7827 0.0 0
M  V30 2 C 5.3632 2.5368 0.0 0
M  V30 3 N 5.3632 5.0286 0.0 0
M  V30 4 C 3.8987 3.0127 0.0 0
M  V30 5 N 5.6834 1.0304 0.0 0
M  V30 6 C 3.8987 4.5527 0.0 0
M  V30 7 C 2.7541 1.9823 0.0 0
M  V30 8 C 4.5390 0.0000 0.0 0
M  V30 9 N 3.0743 0.4759 0.0 0
M  V30 10 C 7.8084 3.7827 0.0 0
M  V30 11 N 8.5784 5.1163 0.0 0
M  V30 12 C 8.5784 2.4491 0.0 0
M  V30 13 C 10.1184 5.1163 0.0 0
M  V30 14 C 10.1184 2.4491 0.0 0
M  V30 15 C 10.8884 3.7827 0.0 0
M  V30 16 C 10.8884 6.4501 0.0 0
M  V30 17 C 12.4284 3.7827 0.0 0
M  V30 18 C 12.4284 6.4501 0.0 0
M  V30 19 C 13.1984 5.1163 0.0 0
M  V30 20 C 2.6528 5.4579 0.0 0
M  V30 21 C 1.2459 4.8314 0.0 0
M  V30 22 C 2.8137 6.9894 0.0 0
M  V30 23 C 0.0000 5.7367 0.0 0
M  V30 24 C 1.5679 7.8947 0.0 0
M  V30 25 C 0.1609 7.2683 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 6 20
M  V30 11 1 7 9
M  V30 12 2 8 9
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 13 16
M  V30 19 1 14 15
M  V30 20 1 15 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1400634-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-67-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-3391548
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Phenyl-1-(2-quinolinyl)-1H-pyrazol-5-amine
C18H14N4
1400634-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.8391 0.0000 0.0 0
M  V30 2 C 7.8085 2.7106 0.0 0
M  V30 3 N 8.5785 4.0442 0.0 0
M  V30 4 C 8.5785 1.3769 0.0 0
M  V30 5 C 10.1185 4.0442 0.0 0
M  V30 6 C 10.1185 1.3769 0.0 0
M  V30 7 C 10.8885 2.7106 0.0 0
M  V30 8 C 10.8885 5.3779 0.0 0
M  V30 9 C 12.4285 2.7106 0.0 0
M  V30 10 C 12.4285 5.3779 0.0 0
M  V30 11 C 13.1985 4.0442 0.0 0
M  V30 12 N 6.2684 2.7106 0.0 0
M  V30 13 N 5.3632 3.9564 0.0 0
M  V30 14 C 5.3632 1.4647 0.0 0
M  V30 15 C 3.8987 3.4806 0.0 0
M  V30 16 C 3.8987 1.9406 0.0 0
M  V30 17 C 2.6528 4.3858 0.0 0
M  V30 18 C 1.2459 3.7593 0.0 0
M  V30 19 C 2.8137 5.9173 0.0 0
M  V30 20 C 0.0000 4.6645 0.0 0
M  V30 21 C 1.5679 6.8225 0.0 0
M  V30 22 C 0.1609 6.1961 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 7
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)quinoline
C20H13N5
1400634-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.2684 3.7827 0.0 0
M  V30 2 C 5.3632 2.5368 0.0 0
M  V30 3 N 5.3632 5.0286 0.0 0
M  V30 4 C 3.8987 3.0127 0.0 0
M  V30 5 N 5.6834 1.0304 0.0 0
M  V30 6 C 3.8987 4.5527 0.0 0
M  V30 7 C 2.7541 1.9823 0.0 0
M  V30 8 C 4.5390 0.0000 0.0 0
M  V30 9 N 3.0743 0.4759 0.0 0
M  V30 10 C 7.8084 3.7827 0.0 0
M  V30 11 N 8.5784 5.1163 0.0 0
M  V30 12 C 8.5784 2.4491 0.0 0
M  V30 13 C 10.1184 5.1163 0.0 0
M  V30 14 C 10.1184 2.4491 0.0 0
M  V30 15 C 10.8884 3.7827 0.0 0
M  V30 16 C 10.8884 6.4501 0.0 0
M  V30 17 C 12.4284 3.7827 0.0 0
M  V30 18 C 12.4284 6.4501 0.0 0
M  V30 19 C 13.1984 5.1163 0.0 0
M  V30 20 C 2.6528 5.4579 0.0 0
M  V30 21 C 1.2459 4.8314 0.0 0
M  V30 22 C 2.8137 6.9894 0.0 0
M  V30 23 C 0.0000 5.7367 0.0 0
M  V30 24 C 1.5679 7.8947 0.0 0
M  V30 25 C 0.1609 7.2683 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 6 20
M  V30 11 1 7 9
M  V30 12 2 8 9
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 13 16
M  V30 19 1 14 15
M  V30 20 1 15 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1400634-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-67-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26083552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
Pyrazolo[3,4-d]-pyrimidines (17-32, 65, 66, and 73-76). The reliable
procedure involved the treatment of 5-aminopyrazoles (1-16; 1.0 equiv),
5- amino-4-formylpyrazoles (37-41; 1.0 equiv), 5-aminoquinoline (61; 1.0
equiv), 8-aminoquinoline (62; 1.0 equiv), 5-aminopyrimidine (68; 1.0
equiv), or 2-aminopyrazines (69-71; 1.0 equiv) with PBr3 (~ 3 equiv) in
formamide solution (2 mL) at 50-60 °C over 0.5-1 h. When the reaction was
complete, the reaction mixture was added to saturated sodium bicarbonate
(15 mL) and extracted with dichloromethane (15 mL). The organic extracts
were dried over MgSO4, filtered, and concentrated under reduced pressure.
The residue solution was purified by column chromatography on silica gel
to give the corresponding aromatic or heterocyclic fused pyrimidine
products (17-32, 65, 66, and 73-76) in 82-96% yields.
3-Phenyl-1-(quinolin-2-yl)-1H-pyrazolo[3,4-d]pyrimidine (27). The
standard procedure involved the treatment of
5-amino-3-phenyl-1-(quinolin-2-yl)-1H-pyrazole (11; 101 mg, 0.31 mmol,
1.0 equiv) with PBr3 (90 μL, 0.94 mmol, 3.0 equiv) in formamide solution
(2 mL) at 50-60 °C over 0.5-1 h. The reaction mixture was then worked up,
and the residue was purified by chromatography on silica gel to give pure
27: 93% yield (91 mg), yellow solid. Mp 194-195 °C (hexane-EtOAc). 1H NMR
(CDCl3, 500 MHz): δ 7.59-7.49 (4H, m), 7.79-7.75 (1H, m), 7.87-7.89 (1H,
m), 8.13-8.11 (2H, m), 8.37-8.39 (1H, m), 8.47-8.49 (1H, m), 9.26 (1H,
s), 9.55 (1H, s). 13C NMR (125 MHz, CDCl3): δ 114.9, 115.6, 126.8, 127.2,
127.5, 127.8 (2 × C), 129.2 (2 × C), 129.5, 130.4, 131.2, 139.0, 146.6,
147.0, 149.8, 153.0, 154.4, 156.4. IR (KBr): 3055, 2376, 2347, 1582,
1557, 1502, 1477, 1409, 1368, 1325, 1219, 1090 cm-1. EIMS m/z (rel int):
323 (100, M+). Anal. Calcd for C20H13N5: C, 74.29; H, 4.05; N, 21.66.
Found: C, 74.33; H, 3.98; N, 21.61.
$DTYPE RXN:VAR(1):NOTES
$DATUM sequential three-component heterocyclization, one-pot multi-component
process
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-chlorophenyl)-7-ethoxy-4H-1-benzopyran-3-carbonitrile
C18H15ClN2O2
1403826-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 6.6684 0.0 0
M  V30 2 N 0.0000 6.6684 0.0 0
M  V30 3 N 3.0800 9.3358 0.0 0
M  V30 4 O 10.0100 5.3347 0.0 0
M  V30 5 C 10.7800 4.0011 0.0 0
M  V30 6 C 12.3200 4.0011 0.0 0
M  V30 7 Cl 0.7700 0.0000 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 5.3900 5.3347 0.0 0
M  V30 10 C 3.0800 6.6684 0.0 0
M  V30 11 C 6.1600 6.6684 0.0 0
M  V30 12 C 6.1600 4.0011 0.0 0
M  V30 13 C 3.8500 8.0021 0.0 0
M  V30 14 C 7.7000 6.6684 0.0 0
M  V30 15 O 5.3900 8.0021 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 3.0800 4.0011 0.0 0
M  V30 19 C 3.8500 2.6674 0.0 0
M  V30 20 C 1.5400 4.0011 0.0 0
M  V30 21 C 3.0800 1.3336 0.0 0
M  V30 22 C 0.7700 2.6674 0.0 0
M  V30 23 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Chlorophenyl)-8-ethoxy-5H-[1]benzopyrano[2,3-d]pyrimidin-4-amine
C19H16ClN3O2
1403826-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 O 9.3359 9.2401 0.0 0
M  V30 3 C 10.6695 8.4701 0.0 0
M  V30 4 C 12.0032 9.2401 0.0 0
M  V30 5 Cl 4.0011 0.0000 0.0 0
M  V30 6 C 4.0011 6.1601 0.0 0
M  V30 7 C 5.3348 6.9301 0.0 0
M  V30 8 C 2.6673 6.9301 0.0 0
M  V30 9 C 5.3348 8.4701 0.0 0
M  V30 10 C 6.6684 6.1601 0.0 0
M  V30 11 C 2.6673 8.4701 0.0 0
M  V30 12 C 1.3337 6.1601 0.0 0
M  V30 13 O 4.0011 9.2401 0.0 0
M  V30 14 C 6.6684 9.2401 0.0 0
M  V30 15 C 8.0021 6.9301 0.0 0
M  V30 16 N 1.3337 9.2401 0.0 0
M  V30 17 N 0.0000 6.9301 0.0 0
M  V30 18 C 8.0021 8.4701 0.0 0
M  V30 19 C 0.0000 8.4701 0.0 0
M  V30 20 C 4.0011 4.6201 0.0 0
M  V30 21 C 5.3348 3.8500 0.0 0
M  V30 22 C 2.6673 3.8500 0.0 0
M  V30 23 C 5.3348 2.3100 0.0 0
M  V30 24 C 2.6673 2.3100 0.0 0
M  V30 25 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 5 25
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 20
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 13
M  V30 17 2 11 16
M  V30 18 1 12 17
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 2 17 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1403826-26-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1403826-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-18238314
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel chromenes as cytotoxic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kandeel, Manal M.; Kamal, Aliaa M.; Abdelall, Eman K. A.; Elshemy, Heba
A. H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2013), 37(2), 110-114

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-chlorophenyl)-7-ethoxy-4H-1-benzopyran-3-carbonitrile
C18H15ClN2O2
1403826-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 6.6684 0.0 0
M  V30 2 N 0.0000 6.6684 0.0 0
M  V30 3 N 3.0800 9.3358 0.0 0
M  V30 4 O 10.0100 5.3347 0.0 0
M  V30 5 C 10.7800 4.0011 0.0 0
M  V30 6 C 12.3200 4.0011 0.0 0
M  V30 7 Cl 0.7700 0.0000 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 5.3900 5.3347 0.0 0
M  V30 10 C 3.0800 6.6684 0.0 0
M  V30 11 C 6.1600 6.6684 0.0 0
M  V30 12 C 6.1600 4.0011 0.0 0
M  V30 13 C 3.8500 8.0021 0.0 0
M  V30 14 C 7.7000 6.6684 0.0 0
M  V30 15 O 5.3900 8.0021 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 3.0800 4.0011 0.0 0
M  V30 19 C 3.8500 2.6674 0.0 0
M  V30 20 C 1.5400 4.0011 0.0 0
M  V30 21 C 3.0800 1.3336 0.0 0
M  V30 22 C 0.7700 2.6674 0.0 0
M  V30 23 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Chlorophenyl)-8-ethoxy-5H-[1]benzopyrano[2,3-d]pyrimidin-4-amine
C19H16ClN3O2
1403826-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 O 9.3359 9.2401 0.0 0
M  V30 3 C 10.6695 8.4701 0.0 0
M  V30 4 C 12.0032 9.2401 0.0 0
M  V30 5 Cl 4.0011 0.0000 0.0 0
M  V30 6 C 4.0011 6.1601 0.0 0
M  V30 7 C 5.3348 6.9301 0.0 0
M  V30 8 C 2.6673 6.9301 0.0 0
M  V30 9 C 5.3348 8.4701 0.0 0
M  V30 10 C 6.6684 6.1601 0.0 0
M  V30 11 C 2.6673 8.4701 0.0 0
M  V30 12 C 1.3337 6.1601 0.0 0
M  V30 13 O 4.0011 9.2401 0.0 0
M  V30 14 C 6.6684 9.2401 0.0 0
M  V30 15 C 8.0021 6.9301 0.0 0
M  V30 16 N 1.3337 9.2401 0.0 0
M  V30 17 N 0.0000 6.9301 0.0 0
M  V30 18 C 8.0021 8.4701 0.0 0
M  V30 19 C 0.0000 8.4701 0.0 0
M  V30 20 C 4.0011 4.6201 0.0 0
M  V30 21 C 5.3348 3.8500 0.0 0
M  V30 22 C 2.6673 3.8500 0.0 0
M  V30 23 C 5.3348 2.3100 0.0 0
M  V30 24 C 2.6673 2.3100 0.0 0
M  V30 25 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 5 25
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 20
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 13
M  V30 17 2 11 16
M  V30 18 1 12 17
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 2 17 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1403826-26-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1403826-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-18316318
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of some novel chromene derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kandeel, M. M.; Kamal, Aliaa M.; Abdelall, Eman K. A.; Elshemy, Heba A.
H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry: An Indian Journal (2012), 8(9), 342-348

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-chlorophenyl)-7-ethoxy-4H-1-benzopyran-3-carbonitrile
C18H15ClN2O2
1403826-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 6.6684 0.0 0
M  V30 2 N 0.0000 6.6684 0.0 0
M  V30 3 N 3.0800 9.3358 0.0 0
M  V30 4 O 10.0100 5.3347 0.0 0
M  V30 5 C 10.7800 4.0011 0.0 0
M  V30 6 C 12.3200 4.0011 0.0 0
M  V30 7 Cl 0.7700 0.0000 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 5.3900 5.3347 0.0 0
M  V30 10 C 3.0800 6.6684 0.0 0
M  V30 11 C 6.1600 6.6684 0.0 0
M  V30 12 C 6.1600 4.0011 0.0 0
M  V30 13 C 3.8500 8.0021 0.0 0
M  V30 14 C 7.7000 6.6684 0.0 0
M  V30 15 O 5.3900 8.0021 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 3.0800 4.0011 0.0 0
M  V30 19 C 3.8500 2.6674 0.0 0
M  V30 20 C 1.5400 4.0011 0.0 0
M  V30 21 C 3.0800 1.3336 0.0 0
M  V30 22 C 0.7700 2.6674 0.0 0
M  V30 23 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Chlorophenyl)-8-ethoxy-5H-[1]benzopyrano[2,3-d]pyrimidin-4-amine
C19H16ClN3O2
1403826-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 O 9.3359 9.2401 0.0 0
M  V30 3 C 10.6695 8.4701 0.0 0
M  V30 4 C 12.0032 9.2401 0.0 0
M  V30 5 Cl 4.0011 0.0000 0.0 0
M  V30 6 C 4.0011 6.1601 0.0 0
M  V30 7 C 5.3348 6.9301 0.0 0
M  V30 8 C 2.6673 6.9301 0.0 0
M  V30 9 C 5.3348 8.4701 0.0 0
M  V30 10 C 6.6684 6.1601 0.0 0
M  V30 11 C 2.6673 8.4701 0.0 0
M  V30 12 C 1.3337 6.1601 0.0 0
M  V30 13 O 4.0011 9.2401 0.0 0
M  V30 14 C 6.6684 9.2401 0.0 0
M  V30 15 C 8.0021 6.9301 0.0 0
M  V30 16 N 1.3337 9.2401 0.0 0
M  V30 17 N 0.0000 6.9301 0.0 0
M  V30 18 C 8.0021 8.4701 0.0 0
M  V30 19 C 0.0000 8.4701 0.0 0
M  V30 20 C 4.0011 4.6201 0.0 0
M  V30 21 C 5.3348 3.8500 0.0 0
M  V30 22 C 2.6673 3.8500 0.0 0
M  V30 23 C 5.3348 2.3100 0.0 0
M  V30 24 C 2.6673 2.3100 0.0 0
M  V30 25 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 5 25
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 20
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 13
M  V30 17 2 11 16
M  V30 18 1 12 17
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 2 17 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1403826-26-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1403826-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-18151563
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel chromenes as cytotoxic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kandeel, Manal M.; Kamal, Aliaa M.; Abdelall, Eman K. A.; Elshemy, Heba
A. H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharma Chemica (2012), 4(4), 1653-1661

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-6-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-4-phenylthieno[2,3-b]pyri...
C23H16N6S
1413993-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.6840 4.6245 0.0 0
M  V30 2 C 1.3338 7.9565 0.0 0
M  V30 3 N 0.0000 8.7265 0.0 0
M  V30 4 C 9.3840 8.0453 0.0 0
M  V30 5 C 5.1048 4.0011 0.0 0
M  V30 6 C 4.3348 5.3347 0.0 0
M  V30 7 C 6.6448 4.0011 0.0 0
M  V30 8 C 5.1048 6.6684 0.0 0
M  V30 9 C 2.8284 5.6549 0.0 0
M  V30 10 C 7.4148 5.3347 0.0 0
M  V30 11 N 6.6448 6.6684 0.0 0
M  V30 12 S 4.0742 7.8129 0.0 0
M  V30 13 C 2.6674 7.1864 0.0 0
M  V30 14 C 4.3348 2.6674 0.0 0
M  V30 15 C 5.1048 1.3336 0.0 0
M  V30 16 C 2.7948 2.6674 0.0 0
M  V30 17 C 4.3348 0.0000 0.0 0
M  V30 18 C 2.0248 1.3336 0.0 0
M  V30 19 C 2.7948 0.0000 0.0 0
M  V30 20 C 8.9548 5.3347 0.0 0
M  V30 21 C 9.8599 6.5806 0.0 0
M  V30 22 N 9.8599 4.0889 0.0 0
M  V30 23 N 11.3246 6.1047 0.0 0
M  V30 24 N 11.3246 4.5647 0.0 0
M  V30 25 C 12.5705 7.0100 0.0 0
M  V30 26 C 13.9774 6.3836 0.0 0
M  V30 27 C 12.4095 8.5415 0.0 0
M  V30 28 C 15.2233 7.2887 0.0 0
M  V30 29 C 13.6554 9.4467 0.0 0
M  V30 30 C 15.0622 8.8204 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 3 2 3
M  V30 3 1 2 13
M  V30 4 1 4 21
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 11
M  V30 15 1 10 20
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(5-Methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-9-phenylpyrido[3′,2′:4,5]thieno[3...
C24H17N7S
1413992-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 9.6315 0.0 0
M  V30 2 C 9.4370 7.4735 0.0 0
M  V30 3 C 4.1320 5.3056 0.0 0
M  V30 4 C 4.7583 3.8987 0.0 0
M  V30 5 C 2.6673 5.7815 0.0 0
M  V30 6 C 5.0372 6.5515 0.0 0
M  V30 7 C 6.2900 3.7378 0.0 0
M  V30 8 C 2.6673 7.3215 0.0 0
M  V30 9 N 1.3336 5.0115 0.0 0
M  V30 10 S 4.1320 7.7974 0.0 0
M  V30 11 N 6.5687 6.3904 0.0 0
M  V30 12 C 7.1951 4.9836 0.0 0
M  V30 13 C 1.3336 8.0915 0.0 0
M  V30 14 C 0.0000 5.7815 0.0 0
M  V30 15 N 0.0000 7.3215 0.0 0
M  V30 16 C 3.8531 2.6528 0.0 0
M  V30 17 C 4.4796 1.2459 0.0 0
M  V30 18 C 2.3216 2.8137 0.0 0
M  V30 19 C 3.5744 0.0000 0.0 0
M  V30 20 C 1.4163 1.5679 0.0 0
M  V30 21 C 2.0428 0.1611 0.0 0
M  V30 22 C 8.7268 4.8227 0.0 0
M  V30 23 C 9.7572 5.9671 0.0 0
M  V30 24 N 9.4968 3.4889 0.0 0
M  V30 25 N 11.1640 5.3407 0.0 0
M  V30 26 N 11.0030 3.8092 0.0 0
M  V30 27 C 12.4978 6.1108 0.0 0
M  V30 28 C 12.4978 7.6508 0.0 0
M  V30 29 C 13.8314 5.3407 0.0 0
M  V30 30 C 13.8314 8.4208 0.0 0
M  V30 31 C 15.1651 6.1108 0.0 0
M  V30 32 C 15.1651 7.6508 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 23
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 16
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 2 7 12
M  V30 13 1 8 10
M  V30 14 2 8 13
M  V30 15 1 9 14
M  V30 16 1 11 12
M  V30 17 1 12 22
M  V30 18 1 13 15
M  V30 19 2 14 15
M  V30 20 2 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 1 25 27
M  V30 32 2 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1413993-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1413992-40-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21260666
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 5-arylazothiazoles, pyridines and thieno[2,3-b]pyridines
derivatives containing 1,2,3-triazole moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abdelhamid, Abdou Osman; Abdel-Riheem, Nadia Abdelhamid; El-Idreesy,
Tamer Tawhid; Rashdan, Huda Refat Mahmoud
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Chemistry (2012), 3(3), 322-331

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanolamine
C2H7NO
141-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 N 0.0000 0.7700 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Hydroxyethyl)formamide
C3H7NO2
693-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 0.7700 0.0 0
M  V30 2 N 4.0012 0.0000 0.0 0
M  V30 3 C 1.3338 0.0000 0.0 0
M  V30 4 C 5.3348 0.7700 0.0 0
M  V30 5 O 0.0000 0.7700 0.0 0
M  V30 6 O 6.6687 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-43-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 693-06-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-4418257
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7782-61-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Transamidation Reaction.
Amide (5.1 mmol) and amine (3.0 mmol) were dissolved or suspended in
toluene (3.0 mL), Fe(NO3)3·9H2O (61 mg, 0.15 mmol) was added, and the
mixture was refluxed until complete conversion (by TLC) of the amine. The
hot reaction mixture was filtered through a pad of Celite, concentrated,
and purified by flash chromatography as indicated below.
N-Benzylacetamide (7). The crude mixture was purified by flash
chromatography with DCM. N-(2-Hydroxyethyl)formamide (13k). The crude
mixture was purified by flash chromatography with DCM/MeOH (9:1). The
product was obtained as a pale yellow oil. Yield: 246 mg, 92%. 1H NMR
(300 MHz, DMSO): δ (ppm) 8.00 (s. 1H), 4.71 (t, J = 5.4 Hz, 1H),
3.36-3.43 (m, 2H), 3.09-3.17 (m, 2H). 13C{1H} NMR (75 MHz, DMSO): δ (ppm)
161.6, 60.1, 40.5. IR (ν, cm-1, KBr) 3380, 2888, 1666, 1538, 1389. MS
(EI) [M - OH]:71 (56), 58 (70), 43(52), 30 (100).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transamidation of Carboxamides Catalyzed by Fe(III) and Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Becerra-Figueroa, Liliana; Ojeda-Porras, Andrea; Gamba-Sanchez, Diego
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(10), 4544-4552

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Hydroxymethyl)-N-methyl-N-(4-methylphenyl)-2-propenamide
C12H15NO2
1458672-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 3.8501 1.3337 0.0 0
M  V30 3 C 3.8501 4.0010 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 O 4.6201 0.0000 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 C 1.5400 2.6673 0.0 0
M  V30 8 O 0.0000 0.0000 0.0 0
M  V30 9 C 10.7802 2.6673 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 4.0010 0.0 0
M  V30 12 C 6.9302 1.3337 0.0 0
M  V30 13 C 8.4702 4.0010 0.0 0
M  V30 14 C 8.4702 1.3337 0.0 0
M  V30 15 C 9.2402 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1′,5′-Dimethylspiro[furan-3(2H),3′-[3H]indole]-2′,5(1′H,4H)-dione
C13H13NO3
2457343-70-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.0811 1.3628 0.0 0
M  V30 2 C 3.0203 0.0000 0.0 0
M  V30 3 O 8.3944 4.8389 0.0 0
M  V30 4 C 0.0000 6.6520 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 3.0800 3.9845 0.0 0
M  V30 7 C 4.7474 2.1328 0.0 0
M  V30 8 C 4.4254 5.1959 0.0 0
M  V30 9 C 6.0928 3.3442 0.0 0
M  V30 10 C 2.3100 2.6508 0.0 0
M  V30 11 C 2.3100 5.3183 0.0 0
M  V30 12 N 3.3405 1.5064 0.0 0
M  V30 13 O 5.8324 5.8224 0.0 0
M  V30 14 C 6.8628 4.6778 0.0 0
M  V30 15 C 0.7700 2.6508 0.0 0
M  V30 16 C 0.7700 5.3183 0.0 0
M  V30 17 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 12
M  V30 3 2 3 14
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 12
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1458672-70-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2457343-70-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26948519
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7720-78-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical (Hg lamp (450 W) used (stage 1)), photochemical flow
reactor used (stage 1), Dean-Stark apparatus used (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient approach for the synthesis of new (±)-coixspirolactams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nascimento, Vinicius R.; Suenaga, Melissa L. S.; Andrade, Leandro H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2020), 18(28), 5458-5465

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-bromo-5-chlorobenzoic acid
C7H5BrClNO2
150812-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6675 0.0 0
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 N 2.3100 0.0000 0.0 0
M  V30 5 Cl 5.3901 5.3349 0.0 0
M  V30 6 Br 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-6-chloro-4(3H)-quinazolinone
C8H4BrClN2O
17518-98-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3338 0.0 0
M  V30 2 Cl 5.3900 0.0000 0.0 0
M  V30 3 Br 6.9300 2.6674 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 150812-32-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17518-98-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41548559
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):NOTES
$DATUM 67% overall yield from 3-chlorotoluene
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel synthesis of the efficient anti-coccidial drug halofuginone
hydrobromide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Junren; Yao, Qizheng; Liu, Zuliang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2017), 22(7), 1086/1-1086/11

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-3-(4-phenoxyphenyl)-1-(3-piperidinyl)-1H-pyrazole-4-carbonitrile
C21H21N5O
1609467-44-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8391 1.4645 0.0 0
M  V30 2 N 6.3151 0.0000 0.0 0
M  V30 3 N 2.6528 2.4999 0.0 0
M  V30 4 O 12.4285 4.1751 0.0 0
M  V30 5 C 6.2684 4.1751 0.0 0
M  V30 6 C 5.3632 2.9292 0.0 0
M  V30 7 N 5.3632 5.4210 0.0 0
M  V30 8 C 3.8987 3.4051 0.0 0
M  V30 9 N 3.8987 4.9451 0.0 0
M  V30 10 C 7.8085 4.1751 0.0 0
M  V30 11 C 8.5785 2.8415 0.0 0
M  V30 12 C 8.5785 5.5088 0.0 0
M  V30 13 C 10.1185 2.8415 0.0 0
M  V30 14 C 10.1185 5.5088 0.0 0
M  V30 15 C 10.8885 4.1751 0.0 0
M  V30 16 C 2.6528 5.8503 0.0 0
M  V30 17 C 2.8137 7.3819 0.0 0
M  V30 18 C 1.2459 5.2240 0.0 0
M  V30 19 C 1.5679 8.2871 0.0 0
M  V30 20 N 0.0000 6.1292 0.0 0
M  V30 21 C 0.1609 7.6608 0.0 0
M  V30 22 C 13.1985 5.5088 0.0 0
M  V30 23 C 12.4285 6.8426 0.0 0
M  V30 24 C 14.7385 5.5088 0.0 0
M  V30 25 C 13.1985 8.1762 0.0 0
M  V30 26 C 15.5085 6.8426 0.0 0
M  V30 27 C 14.7385 8.1762 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 15
M  V30 5 1 4 22
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 10
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 8 9
M  V30 12 1 9 16
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidine...
C23H22N6O2
1628179-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.1481 9.7767 0.0 0
M  V30 2 O 12.4284 6.5487 0.0 0
M  V30 3 C 1.7288 0.9051 0.0 0
M  V30 4 O 0.4829 0.0000 0.0 0
M  V30 5 C 6.2684 6.5487 0.0 0
M  V30 6 C 5.3632 7.7946 0.0 0
M  V30 7 N 5.3632 5.3027 0.0 0
M  V30 8 C 3.8987 7.3187 0.0 0
M  V30 9 C 5.6834 9.3008 0.0 0
M  V30 10 N 3.8987 5.7787 0.0 0
M  V30 11 N 2.7541 8.3491 0.0 0
M  V30 12 N 4.5390 10.3312 0.0 0
M  V30 13 C 3.0743 9.8554 0.0 0
M  V30 14 C 7.8084 6.5487 0.0 0
M  V30 15 C 8.5784 7.8823 0.0 0
M  V30 16 C 8.5784 5.2149 0.0 0
M  V30 17 C 10.1184 7.8823 0.0 0
M  V30 18 C 10.1184 5.2149 0.0 0
M  V30 19 C 10.8884 6.5487 0.0 0
M  V30 20 C 2.6528 4.8735 0.0 0
M  V30 21 C 2.8137 3.3418 0.0 0
M  V30 22 C 1.2459 5.4998 0.0 0
M  V30 23 N 1.5679 2.4367 0.0 0
M  V30 24 C 0.0000 4.5946 0.0 0
M  V30 25 C 0.1609 3.0631 0.0 0
M  V30 26 C 13.1984 5.2149 0.0 0
M  V30 27 C 12.4284 3.8813 0.0 0
M  V30 28 C 14.7384 5.2149 0.0 0
M  V30 29 C 13.1984 2.5476 0.0 0
M  V30 30 C 15.5084 3.8813 0.0 0
M  V30 31 C 14.7384 2.5476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 19
M  V30 3 1 2 26
M  V30 4 2 3 4
M  V30 5 1 3 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 14
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 8 10
M  V30 13 2 8 11
M  V30 14 1 9 12
M  V30 15 1 10 20
M  V30 16 1 11 13
M  V30 17 2 12 13
M  V30 18 2 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 18 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1609467-44-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1628179-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27783528
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Processes and intermediates for preparing a medicament
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pye, Philip; Ben Haim, Cyril; Conza, Matteo; Houpis, Ioannis Nicolaos
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014139970 A1 2014-09-18

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Chlorophenyl)boronic acid
C6H6BClO2
1679-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1679-18-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-18160194
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 86-93-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 15158-11-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, nanopolystyrene anchored Cu(II) complex of
1-phenyl-1H-tetrazole-5-thiol used as catalyst, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization, antibacterial and catalytic activity of a
nanopolymer supported copper(II) complex as a highly active and
recyclable catalyst for the formamidation of arylboronic acids under
aerobic conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nasrollahzadeh, Mahmoud; Zahraei, Ali; Ehsani, Ali; Khalaj, Mehdi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(39), 20351-20357

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1-Amino-8,9-dihydro-8,8-dimethyl-5-phenyl-6H-furo[2,3-b]pyrano[4,3-d]pyridin...
C25H21BrN2O3
172985-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.0074 9.3192 0.0 0
M  V30 2 C 1.7145 9.5187 0.0 0
M  V30 3 C 0.0000 8.5288 0.0 0
M  V30 4 C 9.0680 7.9566 0.0 0
M  V30 5 O 9.0680 9.4966 0.0 0
M  V30 6 Br 14.4027 4.8766 0.0 0
M  V30 7 C 3.7570 6.6684 0.0 0
M  V30 8 C 5.2970 6.6684 0.0 0
M  V30 9 C 2.9870 5.3347 0.0 0
M  V30 10 C 2.9870 8.0021 0.0 0
M  V30 11 C 6.0670 5.3347 0.0 0
M  V30 12 C 6.3276 7.8129 0.0 0
M  V30 13 C 3.7570 4.0011 0.0 0
M  V30 14 C 1.4470 5.3347 0.0 0
M  V30 15 C 1.4470 8.0021 0.0 0
M  V30 16 N 5.2970 4.0011 0.0 0
M  V30 17 O 7.5734 5.6549 0.0 0
M  V30 18 C 7.7343 7.1866 0.0 0
M  V30 19 O 0.6770 6.6684 0.0 0
M  V30 20 C 2.9870 2.6674 0.0 0
M  V30 21 C 1.4470 2.6674 0.0 0
M  V30 22 C 3.7570 1.3336 0.0 0
M  V30 23 C 0.6770 1.3336 0.0 0
M  V30 24 C 2.9870 0.0000 0.0 0
M  V30 25 C 1.4470 0.0000 0.0 0
M  V30 26 C 10.4018 7.1866 0.0 0
M  V30 27 C 11.7354 7.9566 0.0 0
M  V30 28 C 10.4018 5.6466 0.0 0
M  V30 29 C 13.0691 7.1866 0.0 0
M  V30 30 C 11.7354 4.8766 0.0 0
M  V30 31 C 13.0691 5.6466 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 15
M  V30 3 1 3 15
M  V30 4 2 4 5
M  V30 5 1 4 18
M  V30 6 1 4 26
M  V30 7 1 6 31
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 11 17
M  V30 18 2 12 18
M  V30 19 2 13 16
M  V30 20 1 13 20
M  V30 21 1 14 19
M  V30 22 1 15 19
M  V30 23 1 17 18
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-(4-Bromophenyl)-1,4-dihydro-2,2-dimethyl-5-phenyl-2H-pyrano[4′′,3′′:4′,5′]p...
C26H20BrN3O2
368841-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.7146 9.5187 0.0 0
M  V30 2 C 0.0000 8.5288 0.0 0
M  V30 3 Br 14.6078 5.5862 0.0 0
M  V30 4 C 5.2971 6.6684 0.0 0
M  V30 5 C 3.7571 6.6684 0.0 0
M  V30 6 C 6.3276 7.8129 0.0 0
M  V30 7 C 6.0671 5.3347 0.0 0
M  V30 8 C 2.9871 5.3347 0.0 0
M  V30 9 C 2.9871 8.0021 0.0 0
M  V30 10 C 7.7345 7.1864 0.0 0
M  V30 11 N 6.1666 9.3444 0.0 0
M  V30 12 O 7.5736 5.6549 0.0 0
M  V30 13 N 5.2971 4.0011 0.0 0
M  V30 14 C 3.7571 4.0011 0.0 0
M  V30 15 C 1.4471 5.3347 0.0 0
M  V30 16 C 1.4471 8.0021 0.0 0
M  V30 17 C 8.9804 8.0916 0.0 0
M  V30 18 C 7.4125 10.2496 0.0 0
M  V30 19 O 0.6771 6.6684 0.0 0
M  V30 20 N 8.8194 9.6233 0.0 0
M  V30 21 C 2.9871 2.6674 0.0 0
M  V30 22 C 1.4471 2.6674 0.0 0
M  V30 23 C 3.7571 1.3336 0.0 0
M  V30 24 C 0.6771 1.3336 0.0 0
M  V30 25 C 2.9871 0.0000 0.0 0
M  V30 26 C 1.4471 0.0000 0.0 0
M  V30 27 C 10.3871 7.4653 0.0 0
M  V30 28 C 10.5482 5.9338 0.0 0
M  V30 29 C 11.6332 8.3705 0.0 0
M  V30 30 C 11.9550 5.3073 0.0 0
M  V30 31 C 13.0400 7.7440 0.0 0
M  V30 32 C 13.2009 6.2125 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 16
M  V30 3 1 3 32
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 8 15
M  V30 15 1 9 16
M  V30 16 1 10 12
M  V30 17 2 10 17
M  V30 18 1 11 18
M  V30 19 2 13 14
M  V30 20 1 14 21
M  V30 21 1 15 19
M  V30 22 1 16 19
M  V30 23 1 17 20
M  V30 24 1 17 27
M  V30 25 2 18 20
M  V30 26 2 21 22
M  V30 27 1 21 23
M  V30 28 1 22 24
M  V30 29 2 23 25
M  V30 30 2 24 26
M  V30 31 1 25 26
M  V30 32 2 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172985-31-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 368841-32-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25888877
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
2,2,5-Trimethyl-1,2-dihydro-8-phenyl-4H-pyrano-[4',3':4,5]pyrido[2,3-b]furo[3,2-d]pyrimidine
(IIa). A mixture of 1.7 g (5 mmole) of compound Ia with 20 ml formamide,
0.2 ml piperidine, and 0.2 ml acetic acid was heated to 200°C for 1 h and
cooled. The precipitated crystals were separated by filtration, washed
with water, dried, and recrystallized from an ethanol - chloroform (1:1)
mixture (Table 1). Compounds IIb - IIe were obtained using analogous
procedures (Table 1). Compound IIe 1H NMR spectra (δ, ppm): compound IIe,
9.19 (s, 1H, 10-CH), 8.54 (d, 2H, J 8.7 Hz, C6H4), 7.77 (d, 2H, J 8.7 Hz,
C6H4), 7.48-7.63 (m, 5H, C6H5), 4.84 (s, 2H, 4-CH2), 3.48 (s, 2H, 1-CH2),
1.42 (s, 6H, 2-CH3). M.p.: 246 - 248°C; R f: 0.71; Empirical formula:
C26H20BrN3O2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and anticonvulsant activity of
pyrano[4',3':4,5]pyrido[2,3-b]furo[3,2-d]pyrimidine and
pyrano[4',3':4,5]pyrido[2,3-b]furo[3,2-d]pyridine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Paronikyan, E. G.; Oganisyan, A. Kh.; Noravyan, A. S.; Paronikyan, R. G.;
Dzhagatspanyan, I. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (Translation of
Khimiko-Farmatsevticheskii Zhurnal) (2002), 36(8), 413-414

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate
C11H15NO2S
184174-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1947 3.3320 0.0 0
M  V30 2 O 7.5286 2.5620 0.0 0
M  V30 3 O 6.1947 4.8720 0.0 0
M  V30 4 C 8.8622 3.3320 0.0 0
M  V30 5 N 5.8445 0.0000 0.0 0
M  V30 6 C 3.4543 3.1885 0.0 0
M  V30 7 C 4.8611 2.5620 0.0 0
M  V30 8 C 2.4237 2.0439 0.0 0
M  V30 9 C 3.2020 4.7075 0.0 0
M  V30 10 C 4.7001 1.0304 0.0 0
M  V30 11 S 3.1937 0.7103 0.0 0
M  V30 12 C 0.8864 2.1360 0.0 0
M  V30 13 C 1.8568 5.4575 0.0 0
M  V30 14 C 0.0000 3.3953 0.0 0
M  V30 15 C 0.4318 4.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5,6,7,8,9-Hexahydro-4H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-4-one
C11H12N2OS
40106-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9874 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7472 4.5191 0.0 0
M  V30 5 C 5.6834 1.9067 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 S 3.3404 5.1454 0.0 0
M  V30 9 C 6.0451 5.3481 0.0 0
M  V30 10 C 7.2123 2.0906 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3336 0.0 0
M  V30 13 C 7.5024 4.8504 0.0 0
M  V30 14 C 8.0219 3.4006 0.0 0
M  V30 15 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 184174-81-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 40106-31-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-455971
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis And Bioevaluation Of Thieno[2,3-d]Pyrimidinone Derivatives As
Potential Tumor Cell Growth Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Huangyong; Chen, Changshui; Xu, Shengzhen; Cao, Xiufang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemistry (2013), 692074, 7 pp.

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dichloro-2-iodobenzene
C6H3Cl2I
19230-28-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 2.6674 0.0000 0.0 0
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 Cl 5.3349 1.5400 0.0 0
M  V30 4 C 2.6674 1.5400 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 1.3338 3.8500 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 6
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichlorobenzonitrile
C7H3Cl2N
1194-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 Cl 3.0800 0.0000 0.0 0
M  V30 4 Cl 3.0800 5.3349 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 0.7700 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19230-28-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1194-65-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34483964
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-89-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed vessel used, scalable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-Catalyzed Cyanation of Aryl Iodides with Formamide as the Cyano
Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peng, Sha; Yang, Luo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Asian Journal of Organic Chemistry (2022), 11(11), e202200437

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-fluorobenzoyl chloride
C7H3Cl2FO
21900-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-fluorobenzamide
C7H5ClFNO
88578-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 N 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21900-54-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 88578-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-5290004
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure for Amination All the
experiments were carried out in a parallel synthesizer from REDLEYS
Discovery Technologies, UK. A solution of acid chloride 1a (1.0 gm 7.11
mmol) in formamide (10 ml) was heated to 100-120 °C and maintained at
same temperature for 5 to 6 hours, the reaction mixture was cooled to
room temperature. The reaction mass quenched in excess water and
extracted with dichloromethane. The combined organic solvent was washed
with saturated NaHCO3 aqueous solution and dried over anhydrous Na2SO4.
The solvent was evaporated under reduced pressure to give the residue
which was purified by column chromatography using silica gel and EtOAc=
hexane as eluent. An amount of 0.77 g (6.4 mmol, 90%) of 2a was obtained
as crystals. Compound 2b. Yield 92% Mp in °C (Lit): 192-195; Mp in °C
(Obs.):195-197
$DTYPE RXN:VAR(1):NOTES
$DATUM excess water used in stage 2, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide as an ammonia synthon in amination of acid chlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasan, S.; Manisankar, P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2010), 40(23), 3538-3543

$RFMT $RIREG SCHEME283 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-1H-pyrrolo[2,3-b]pyridine-3-carboxylate
C10H11N3O2
2291326-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3321 0.0 0
M  V30 2 O 7.1954 2.8561 0.0 0
M  V30 3 O 5.4106 4.8383 0.0 0
M  V30 4 C 8.3398 3.8866 0.0 0
M  V30 5 C 9.8045 3.4108 0.0 0
M  V30 6 N 6.0810 0.0000 0.0 0
M  V30 7 C 3.0800 2.6217 0.0 0
M  V30 8 C 4.5864 2.3015 0.0 0
M  V30 9 C 2.3100 1.2880 0.0 0
M  V30 10 C 2.3100 3.9555 0.0 0
M  V30 11 C 4.7473 0.7700 0.0 0
M  V30 12 N 3.3405 0.1437 0.0 0
M  V30 13 N 0.7700 1.2880 0.0 0
M  V30 14 C 0.7700 3.9555 0.0 0
M  V30 15 C 0.0000 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,9-Dihydro-4H-pyrido[3′,2′:4,5]pyrrolo[2,3-d]pyrimidin-4-one
C9H6N4O
2291326-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.8322 2.0824 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 N 3.3404 5.1455 0.0 0
M  V30 9 N 6.1542 5.1455 0.0 0
M  V30 10 C 7.2391 2.7087 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 7.4001 4.2403 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2291326-30-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2291326-31-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22953706
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Cytotoxic and Antiviral Activity Profiling of All-Four
Isomeric Series of Pyrido-Fused 7-Deazapurine Ribonucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Veselovska, Lucia; Kudlova, Natalie; Gurska, Sona; Liskova, Barbora;
Medvedikova, Martina; Hodek, Ondrej; Tloustova, Eva; Milisavljevic,
Nemanja; Tichy, Michal; Perlikova, Pavla; Mertlikova-Kaiserova, Helena;
Trylcova, Jana; Pohl, Radek; Klepetarova, Blanka; Dzubak, Petr; Hajduch,
Marian; Hocek, Michal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2020), 26(57), 13002-13015

$RFMT $RIREG SCHEME284 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(4-Methoxyphenyl)methyl]-2(1H)-quinoxalinone
C16H14N2O2
23465-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 O 10.6695 4.6201 0.0 0
M  V30 4 C 12.0032 3.8500 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 C 1.3337 3.8500 0.0 0
M  V30 7 N 4.0011 3.8500 0.0 0
M  V30 8 C 2.6673 6.1601 0.0 0
M  V30 9 N 1.3337 2.3100 0.0 0
M  V30 10 C 0.0000 4.6201 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 1.3337 6.9301 0.0 0
M  V30 13 C 2.6673 1.5400 0.0 0
M  V30 14 C 0.0000 6.1601 0.0 0
M  V30 15 C 6.6684 2.3100 0.0 0
M  V30 16 C 6.6684 3.8500 0.0 0
M  V30 17 C 8.0021 1.5400 0.0 0
M  V30 18 C 8.0021 4.6201 0.0 0
M  V30 19 C 9.3359 2.3100 0.0 0
M  V30 20 C 9.3359 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 15
M  V30 3 2 2 13
M  V30 4 1 3 4
M  V30 5 1 3 20
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-2-[(4-methoxyphenyl)methyl]-3-oxo-1(2H)-quinoxalinecarboxaldehyde
C17H16N2O3
2840644-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 0.7700 0.0 0
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 O 6.6685 5.3901 0.0 0
M  V30 5 O 12.0033 5.3901 0.0 0
M  V30 6 C 13.3370 4.6201 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 N 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 N 4.0010 5.3901 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 0.0000 3.0801 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 8.0022 3.0801 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 9.3360 2.3101 0.0 0
M  V30 20 C 9.3360 5.3901 0.0 0
M  V30 21 C 10.6697 3.0801 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 11
M  V30 4 1 3 17
M  V30 5 2 4 15
M  V30 6 1 5 6
M  V30 7 1 5 22
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 23465-75-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2840644-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34270922
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):NOTES
$DATUM conformer ratio 1:0.4, Leuckart reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-benzylquinoxalin-2(1H)-ones and
4-formyl-3-benzyl-3,4-dihydroquinoxalin-2(1H)-ones from
3-aryloxirane-2-carboxamides via
5-arylidene-2,2-dimethyl-1,3-oxazolidin-4-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mamedov, Vakhid A.; Mamedova, Vera L.; Syakaev, Victor V.; Voronina,
Julia K.; Mahrous, Essam M.; Khikmatova, Gul'naz Z.; Korshin, Dmitry E.;
Shamsutdinova, Leisan R.; Rizvanov, Il'dar Kh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2022), 124132963

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-9H-fluoren-9-one
C13H9NO
3096-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3798 0.0000 0.0 0
M  V30 2 N 8.9401 3.9845 0.0 0
M  V30 3 C 4.3200 3.9845 0.0 0
M  V30 4 C 2.8137 3.6643 0.0 0
M  V30 5 C 5.0900 2.6508 0.0 0
M  V30 6 C 5.0900 5.3183 0.0 0
M  V30 7 C 2.6527 2.1328 0.0 0
M  V30 8 C 1.5679 4.5695 0.0 0
M  V30 9 C 4.0596 1.5064 0.0 0
M  V30 10 C 6.6300 2.6508 0.0 0
M  V30 11 C 6.6300 5.3183 0.0 0
M  V30 12 C 1.2459 1.5064 0.0 0
M  V30 13 C 0.1609 3.9432 0.0 0
M  V30 14 C 7.4000 3.9845 0.0 0
M  V30 15 C 0.0000 2.4117 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(9-Oxo-9H-fluoren-2-yl)formamide
C14H9NO2
199523-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3798 0.0000 0.0 0
M  V30 2 N 8.9400 3.9844 0.0 0
M  V30 3 C 9.7100 5.3182 0.0 0
M  V30 4 O 11.2500 5.3182 0.0 0
M  V30 5 C 4.3200 3.9844 0.0 0
M  V30 6 C 2.8137 3.6643 0.0 0
M  V30 7 C 5.0900 2.6508 0.0 0
M  V30 8 C 5.0900 5.3182 0.0 0
M  V30 9 C 2.6527 2.1327 0.0 0
M  V30 10 C 1.5679 4.5695 0.0 0
M  V30 11 C 4.0596 1.5064 0.0 0
M  V30 12 C 6.6300 2.6508 0.0 0
M  V30 13 C 6.6300 5.3182 0.0 0
M  V30 14 C 1.2459 1.5064 0.0 0
M  V30 15 C 0.1609 3.9432 0.0 0
M  V30 16 C 7.4000 3.9844 0.0 0
M  V30 17 C 0.0000 2.4116 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 11
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 12 16
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3096-57-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 199523-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30962363
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods of making oligopotent and unipotent hematopoietic stem cell
precursors from CD34+ cells in culture by treatment with hematopoietic
lineage modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cotari, Jesse
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020223517 A1 2020-11-05

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
2-Bromo-N-hexylbenzamide
C13H18BrNO
346663-87-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 4.0010 4.6201 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 C 12.0033 3.0801 0.0 0
M  V30 9 C 13.3370 2.3101 0.0 0
M  V30 10 Br 1.3337 4.6201 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 12
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hexyl-4(3H)-quinazolinone
C14H18N2O
113290-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 0.0000 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 8.0022 2.3101 0.0 0
M  V30 4 C 9.3360 1.5400 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 C 12.0033 1.5400 0.0 0
M  V30 7 C 13.3370 2.3101 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 2.6673 3.8501 0.0 0
M  V30 10 C 4.0010 1.5400 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 N 4.0010 4.6201 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 N 5.3348 2.3101 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 5.3348 3.8501 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 346663-87-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 113290-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7133613
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51-35-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for CuI-catalyzed formation
of 3-substituted-4-quinazolines and 2,3-disubstituted-4(3H )-quinazolines
from 2-bromo-N-phenylbenzamide. For 3-substituted-4-quinazoline
(11a-11r). A Schlenk tube was charged with N-substituted 2-bromobenzamide
(0.25 mmol), CuI (5 mg, 0.025 mmol), trans-4-hydroxy-L-proline (3 mg,
0.025 mmol), and Cs2CO3 (163 mg, 0.5 mmol). The tube was evacuated and
backfilled with argon before formamide (20 µL, 0.5 mmol) and 1 mL DMF was
added. The reaction mixture was stirred at 80 o C (or 90 o C for
substrate 7l) for 24 h. After the reaction mixture was cooled to room
temperature, 5 mL of saturated NH4Cl solution was added. The mixture was
extracted with EtOAc and the organic layer was washed with water, brine
and dried over Na2SO4. After concentration in vacuo, the residue was
purified by column chromatography on silica gel. The desired
3-substituted 4-quinazoline. 3-Hexylquinazolin-4(3H)-one (11n). 53 mg,
92% yield. 1H NMR (400 MHz, CDCl3) δ 8.32 (dd, J 1= 1.2 Hz, J 2 = 8.0 Hz,
1H), 8.03 (s, 1H), 7.75-7.69 (m, 2H), 7.52 (dd, J 1 = 1.6 Hz, J 2 = 8.4
Hz, 1H), 4.01 (t, J = 7.2 Hz, 2H), 1.83-1.76 (m, 2H), 1.38-1.30 (m, 6H),
0.90 (t, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 161.13, 148.18,
146.71, 134.21, 127.46, 127.29, 126.78, 122.27, 47.19, 31.43, 29.44,
26.43, 22.58, 14.08. HRMS-ESI: m/z calcd for C14H19N2O [M + H]+:
231.1497, found 231.1498.
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst formed in-situ; Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Substituted and 2,3-Disubstituted Quinazolinones via
Cu-Catalyzed Aryl Amidation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Lanting; Jiang, Yongwen; Ma, Dawei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(4), 1150-1153

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propanedioic acid, 2-(2-propen-1-yl)-, 1,3-dimethyl ester
C8H12O4
40637-56-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 O 0.7700 5.3347 0.0 0
M  V30 6 O 3.0800 6.6685 0.0 0
M  V30 7 O 5.3900 5.3347 0.0 0
M  V30 8 O 5.3900 2.6674 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 0.0000 6.6685 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 2 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Hydroxy-5-(2-propen-1-yl)-4(1H)-pyrimidinone
C7H8N2O2
16019-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 O 3.0800 0.0000 0.0 0
M  V30 5 O 3.0800 5.3349 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 N 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 2 4 7
M  V30 5 1 5 8
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40637-56-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16019-30-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19088234
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved synthesis of 4-chloro-7H-pyrrolo[2,3-d]pyrimidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yu-Liu; Xu, Cheng-Tao; Liu, Ting; Zhu, Yong; Luo, Yu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2018),
54(6), 638-642

$RFMT $RIREG SCHEME288 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2,3-Dichlorophenyl)piperazine
C10H12Cl2N2
41202-77-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.3347 4.6200 0.0 0
M  V30 2 Cl 8.0021 3.0800 0.0 0
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 5.3347 3.0800 0.0 0
M  V30 5 C 4.0011 0.7700 0.0 0
M  V30 6 C 6.6685 2.3100 0.0 0
M  V30 7 C 5.3347 0.0000 0.0 0
M  V30 8 C 6.6685 0.7700 0.0 0
M  V30 9 N 2.6674 3.0800 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 0.0000 3.0800 0.0 0
M  V30 13 C 1.3336 5.3900 0.0 0
M  V30 14 N 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 6
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2,3-Dichlorophenyl)-1-piperazinecarboxaldehyde
C11H12Cl2N2O
1418125-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.6673 4.6200 0.0 0
M  V30 2 Cl 0.0000 3.0800 0.0 0
M  V30 3 C 9.3358 5.3900 0.0 0
M  V30 4 O 10.6694 4.6200 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6673 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3336 2.3100 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 C 1.3336 0.7700 0.0 0
M  V30 11 N 5.3347 3.0800 0.0 0
M  V30 12 C 6.6684 2.3100 0.0 0
M  V30 13 C 5.3347 4.6200 0.0 0
M  V30 14 C 8.0021 3.0800 0.0 0
M  V30 15 C 6.6684 5.3900 0.0 0
M  V30 16 N 8.0021 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 16
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 41202-77-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1418125-57-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-10374944
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient procedure for N-formylation of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Joseph, Sony; Das, Prasenjit; Srivastava, Bindu; Nizar, Hashim; Prasad,
Mohan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(8), 929-931

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-nitrobenzoyl chloride
C7H3Cl2NO3
41995-04-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0011 0.0 0
M  V30 2 Cl 0.0000 5.3349 0.0 0
M  V30 3 O 0.0000 2.6674 0.0 0
M  V30 4 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 5 O 0.7700 1.3338 0.0 0
M  V30 6 O 3.0800 0.0000 0.0 0
M  V30 7 Cl 6.9300 4.0011 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-nitrobenzamide
C7H5ClN2O3
41994-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0011 0.0 0
M  V30 2 N 0.0000 5.3349 0.0 0
M  V30 3 O 0.0000 2.6674 0.0 0
M  V30 4 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 5 O 0.7700 1.3338 0.0 0
M  V30 6 O 3.0800 0.0000 0.0 0
M  V30 7 Cl 6.9300 4.0011 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 41995-04-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41994-91-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-2846695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure for Amination All the
experiments were carried out in a parallel synthesizer from REDLEYS
Discovery Technologies, UK. A solution of acid chloride 1a (1.0 gm 7.11
mmol) in formamide (10 ml) was heated to 100-120 °C and maintained at
same temperature for 5 to 6 hours, the reaction mixture was cooled to
room temperature. The reaction mass quenched in excess water and
extracted with dichloromethane. The combined organic solvent was washed
with saturated NaHCO3 aqueous solution and dried over anhydrous Na2SO4.
The solvent was evaporated under reduced pressure to give the residue
which was purified by column chromatography using silica gel and EtOAc=
hexane as eluent. An amount of 0.77 g (6.4 mmol, 90%) of 2a was obtained
as crystals. Compound 2l. Yield 92% Mp in °C (Lit): 142-148; Mp in °C
(Obs.): 145-149
$DTYPE RXN:VAR(1):NOTES
$DATUM excess water used in stage 2, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide as an ammonia synthon in amination of acid chlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasan, S.; Manisankar, P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2010), 40(23), 3538-3543

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-phenyl-3-thiophenecarbonitrile
C11H8N2S
4651-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0492 1.4647 0.0 0
M  V30 2 N 4.5733 0.0000 0.0 0
M  V30 3 N 8.2356 2.5000 0.0 0
M  V30 4 C 4.6200 4.1752 0.0 0
M  V30 5 C 5.5252 2.9292 0.0 0
M  V30 6 C 5.5252 5.4211 0.0 0
M  V30 7 C 6.9898 3.4052 0.0 0
M  V30 8 S 6.9898 4.9452 0.0 0
M  V30 9 C 3.0800 4.1752 0.0 0
M  V30 10 C 2.3100 5.5089 0.0 0
M  V30 11 C 2.3100 2.8415 0.0 0
M  V30 12 C 0.7700 5.5089 0.0 0
M  V30 13 C 0.7700 2.8415 0.0 0
M  V30 14 C 0.0000 4.1752 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Phenylthieno[2,3-d]pyrimidin-4-amine
C12H9N3S
195193-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5674 5.0873 0.0 0
M  V30 2 C 4.4197 1.8517 0.0 0
M  V30 3 C 3.0127 2.4782 0.0 0
M  V30 4 C 4.2588 0.3202 0.0 0
M  V30 5 C 1.9823 1.3337 0.0 0
M  V30 6 C 2.5369 3.9428 0.0 0
M  V30 7 S 2.7523 0.0000 0.0 0
M  V30 8 N 0.4760 1.6540 0.0 0
M  V30 9 N 1.0306 4.2631 0.0 0
M  V30 10 C 0.0000 3.1185 0.0 0
M  V30 11 C 5.7533 2.6217 0.0 0
M  V30 12 C 5.7533 4.1617 0.0 0
M  V30 13 C 7.0870 1.8517 0.0 0
M  V30 14 C 7.0870 4.9318 0.0 0
M  V30 15 C 8.4208 2.6217 0.0 0
M  V30 16 C 8.4208 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4651-73-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195193-10-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37447684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and anticancer evaluation of novel
imidazo[1,2-c]thieno[3,2-e]pyrimidin derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alizadeh-Bami, Farzaneh; Mehrabi, Hossein; Safari, Fatemeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2023), 144133594

$RFMT $RIREG SCHEME291 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl 5-amino-3-methylthiophene-2,4-dicarboxylate
C11H15NO4S
4815-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6445 4.0287 0.0 0
M  V30 2 O 9.9782 3.2587 0.0 0
M  V30 3 O 8.6445 5.5687 0.0 0
M  V30 4 C 11.3120 4.0287 0.0 0
M  V30 5 C 12.6456 3.2587 0.0 0
M  V30 6 C 5.5838 5.3914 0.0 0
M  V30 7 C 3.3420 2.9015 0.0 0
M  V30 8 O 2.4368 1.6557 0.0 0
M  V30 9 O 2.7156 4.3085 0.0 0
M  V30 10 C 0.9052 1.8166 0.0 0
M  V30 11 C 0.0000 0.5707 0.0 0
M  V30 12 N 5.0172 0.0000 0.0 0
M  V30 13 C 7.3109 3.2587 0.0 0
M  V30 14 C 5.9039 3.8850 0.0 0
M  V30 15 S 7.1499 1.7271 0.0 0
M  V30 16 C 4.8735 2.7406 0.0 0
M  V30 17 C 5.6435 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,4-dihydro-5-methyl-4-oxothieno[2,3-d]pyrimidine-6-carboxylate
C10H10N2O3S
17417-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 C 6.0811 3.9554 0.0 0
M  V30 4 O 7.4148 3.1854 0.0 0
M  V30 5 O 6.0811 5.4955 0.0 0
M  V30 6 C 8.7486 3.9554 0.0 0
M  V30 7 C 10.0823 3.1854 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 3.3405 3.8119 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 S 4.5865 1.6538 0.0 0
M  V30 13 N 2.3101 0.0000 0.0 0
M  V30 14 C 4.7475 3.1854 0.0 0
M  V30 15 N 0.0000 1.3337 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-30-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17417-67-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2634456
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 25A To a solution of diethyl 5-amino-3-methyl-2,4-thiophenedicarboxylate
in formamide (16 mL) was added acetic acid (0.5 mL). The mixture was
heated at 150°C for 40 h, cooled to 70 °C and water was added (90 mL).
The suspension was cooled to rt with stirring. The solids were filtered,
washed with water (3x10 ml) and dried in air to give a yellow solid
(1.61g, 92%). 25A, Yield (1.61g, 92%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenylamine substituted bicyclic heterocyclic compounds
useful as kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Das, Jagabandhu; Hynes, John; Leftheris, Katerina; Lin, Shuqun;
Wrobleski, Stephen T.; Wu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005042537 A1 2005-05-12

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Bromophenoxy)-1,1′-biphenyl
C18H13BrO
54590-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 5.3901 0.0 0
M  V30 2 Br 13.3370 2.3101 0.0 0
M  V30 3 C 4.0010 3.0801 0.0 0
M  V30 4 C 4.0010 4.6201 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 5.3348 5.3901 0.0 0
M  V30 7 C 6.6685 3.0801 0.0 0
M  V30 8 C 6.6685 4.6201 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 5.3901 0.0 0
M  V30 17 C 9.3360 3.0801 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 20 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 15
M  V30 3 1 2 20
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 3 9
M  V30 7 1 4 6
M  V30 8 2 5 7
M  V30 9 2 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-([1,1′-Biphenyl]-4-yloxy)benzonitrile
C19H13NO
319489-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 5.3901 0.0 0
M  V30 2 C 13.3370 2.3101 0.0 0
M  V30 3 N 14.6707 1.5400 0.0 0
M  V30 4 C 4.0010 3.0801 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 4.0010 4.6201 0.0 0
M  V30 7 C 6.6685 3.0801 0.0 0
M  V30 8 C 5.3348 5.3901 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 16 C 9.3358 4.6201 0.0 0
M  V30 17 C 10.6697 5.3901 0.0 0
M  V30 18 C 9.3358 3.0801 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 20 C 10.6697 2.3101 0.0 0
M  V30 21 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 3 2 3
M  V30 4 1 2 21
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 4 10
M  V30 8 1 5 7
M  V30 9 2 6 8
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54590-35-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 319489-76-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27149471
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Cyanation of Aryl Halides Using Formamide and
Cyanuric Chloride as a New "CN" Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niknam, Esmaeil; Panahi, Farhad; Khalafi-Nezhad, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2020), 2020(18), 2699-2707

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-2-dodecene
C13H26
55103-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 12.0033 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 13.3370 2.3101 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1,1-Dimethylundecyl)formamide
C14H29NO
1443999-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4137 1.8973 0.0 0
M  V30 2 C 5.7474 2.6673 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 7.0811 1.8973 0.0 0
M  V30 5 N 2.3101 1.3337 0.0 0
M  V30 6 C 3.8501 4.0010 0.0 0
M  V30 7 C 1.7462 3.4374 0.0 0
M  V30 8 C 8.4149 2.6673 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 9.7486 1.8973 0.0 0
M  V30 11 O 0.0000 0.0000 0.0 0
M  V30 12 C 11.0822 2.6673 0.0 0
M  V30 13 C 12.4159 1.8973 0.0 0
M  V30 14 C 13.7497 2.6673 0.0 0
M  V30 15 C 15.0834 1.8973 0.0 0
M  V30 16 C 16.4171 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 55103-82-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1443999-07-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-15322760
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7758-02-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Ritter reaction, optimization study, optimized on metal halide, amount of
reactant and reagent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of N-substituted amides from alkenes and amides by a
Bronsted acid mediated electrophilic addition reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mihara, Karin; Okada, Iku; Chiba, Kazuhiro; Kitano, Yoshikazu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2014), 46(11), 1455-1462, 8 pp.

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Tolylboronic acid
C7H9BO2
5720-05-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methylphenyl)formamide
C8H9NO
3085-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 C 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5720-05-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3085-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-6322679
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6046-93-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (25) General Procedure for the Synthesis of
Formanilides 2 To an open flask containing a solution of arylboronic acid
1 (1.0 mmol) in formamide (2 mL) were added Cu(OAc)2·H2O (19.9 mg, 10
mol%) and K2CO3 (138.2 mg, 1 mmol), and the mixture was stirred
vigorously at r.t. under air (without bubbling air) for 8-16 h (Table 2).
After completion of the reaction (indicated by TLC), the reaction mixture
was treated with EtOAc (5 mL) and H2O (5 mL). The organic layer was
separated, and the aqueous layer was extracted with EtOAc (3 × 5 mL). The
combined organic phase was washed with H2O (2 × 5 mL), dried over anhyd
Na2SO4, and concentrated to yield a residue, which was purified by flash
chromatography (prepacked silica cartridges). The clean product 2 as a
mixture of rotamers.27 All the products are known compounds and were
characterized by comparison of their melting points and spectral data
with those reported in the literature.14-17 N-Phenylformamide (2a, Table
2)
$DTYPE RXN:VAR(1):NOTES
$DATUM aerobic, no solvent, Chan-Lam coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed formamidation of arylboronic acids: direct access to
formanilides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srivastava, Vishnu P.; Yadav, Deepak K.; Yadav, Arvind K.; Watal, Geeta;
Yadav, Lal Dhar S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2013), 24(11), 1423-1427

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Tolylboronic acid
C7H9BO2
5720-05-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methylphenyl)formamide
C8H9NO
3085-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 C 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5720-05-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3085-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-18150323
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 86-93-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 15158-11-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, nanopolystyrene anchored Cu(II) complex of
1-phenyl-1H-tetrazole-5-thiol used as catalyst, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization, antibacterial and catalytic activity of a
nanopolymer supported copper(II) complex as a highly active and
recyclable catalyst for the formamidation of arylboronic acids under
aerobic conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nasrollahzadeh, Mahmoud; Zahraei, Ali; Ehsani, Ali; Khalaj, Mehdi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(39), 20351-20357

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromoaniline
C6H6BrN
591-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.0800 0.0 0
M  V30 2 N 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Bromophenyl)formamide
C7H6BrNO
37831-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 O 8.0022 3.0800 0.0 0
M  V30 4 Br 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-19-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 37831-25-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-18258661
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1313-13-9
$DTYPE RXN:VAR(1):NOTES
$DATUM scalable, no solvent, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM MnO2 catalyzed formylation of amines and transamidation of amides under
solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yedage, Subhash L.; D'Silva, Denvert S.; Bhanage, Bhalchandra M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2015), 5(98), 80441-80449

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-5-(phenylamino)-2,4-thiophenedicarbonitrile
C12H8N4S
59615-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 4.1751 0.0 0
M  V30 2 C 5.0492 1.4647 0.0 0
M  V30 3 N 4.5734 0.0000 0.0 0
M  V30 4 N 8.2357 2.4999 0.0 0
M  V30 5 C 8.2357 5.8503 0.0 0
M  V30 6 N 9.4815 6.7556 0.0 0
M  V30 7 C 4.6200 4.1751 0.0 0
M  V30 8 C 5.5251 2.9292 0.0 0
M  V30 9 S 5.5251 5.4210 0.0 0
M  V30 10 C 6.9898 3.4051 0.0 0
M  V30 11 C 6.9898 4.9451 0.0 0
M  V30 12 C 2.3100 5.5089 0.0 0
M  V30 13 C 0.7700 5.5089 0.0 0
M  V30 14 C 3.0800 6.8426 0.0 0
M  V30 15 C 0.0000 6.8426 0.0 0
M  V30 16 C 2.3100 8.1762 0.0 0
M  V30 17 C 0.7700 8.1762 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 12
M  V30 3 3 2 3
M  V30 4 1 2 8
M  V30 5 1 4 10
M  V30 6 3 5 6
M  V30 7 1 5 11
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-6-(phenylamino)thieno[3,2-d]pyrimidine-7-carbonitrile
C13H9N5S
552890-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0202 1.5064 0.0 0
M  V30 2 N 2.7001 0.0000 0.0 0
M  V30 3 N 6.0810 2.8692 0.0 0
M  V30 4 N 3.0800 8.1583 0.0 0
M  V30 5 C 2.3100 4.1572 0.0 0
M  V30 6 C 3.3404 3.0127 0.0 0
M  V30 7 C 3.0800 5.4909 0.0 0
M  V30 8 N 0.7700 4.1572 0.0 0
M  V30 9 C 4.7474 3.6392 0.0 0
M  V30 10 S 4.5864 5.1707 0.0 0
M  V30 11 C 2.3100 6.8245 0.0 0
M  V30 12 C 0.0000 5.4909 0.0 0
M  V30 13 N 0.7700 6.8245 0.0 0
M  V30 14 C 7.4146 3.6392 0.0 0
M  V30 15 C 7.4146 5.1792 0.0 0
M  V30 16 C 8.7484 2.8692 0.0 0
M  V30 17 C 8.7484 5.9492 0.0 0
M  V30 18 C 10.0821 3.6392 0.0 0
M  V30 19 C 10.0821 5.1792 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 9
M  V30 4 1 3 14
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 10
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 59615-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 552890-93-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28250628
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A simple synthesis of some new thienopyridine and thienopyrimidine
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM El-Saghier, Ahmed M. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2002), 7(10), 756-766

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodobenzophenone
C13H9IO
6136-66-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 I 9.3358 4.6200 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 C 5.3347 3.8500 0.0 0
M  V30 6 C 6.6684 1.5400 0.0 0
M  V30 7 C 6.6684 4.6200 0.0 0
M  V30 8 C 8.0021 2.3100 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 2.6674 3.8500 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyanobenzophenone
C14H9NO
1503-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 O 2.3100 5.3349 0.0 0
M  V30 3 C 9.2400 4.0011 0.0 0
M  V30 4 N 10.7800 4.0011 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 C 5.3900 5.3349 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 6.9300 5.3349 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 15 C 0.0000 1.3338 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 3 3 4
M  V30 5 1 3 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6136-66-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1503-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34483946
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-89-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-Catalyzed Cyanation of Aryl Iodides with Formamide as the Cyano
Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peng, Sha; Yang, Luo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Asian Journal of Organic Chemistry (2022), 11(11), e202200437

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
L-Phenylalanine
C9H11NO2
63-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.0800 0.0 0
M  V30 2 C 2.6674 4.6200 0.0 0 CFG=2
M  V30 3 C 1.3338 5.3900 0.0 0
M  V30 4 N 4.0011 5.3900 0.0 0
M  V30 5 O 0.0000 4.6200 0.0 0
M  V30 6 O 1.3338 6.9300 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 5.3347 3.0800 0.0 0
M  V30 10 C 5.3347 0.0000 0.0 0
M  V30 11 C 6.6685 2.3100 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formyl-L-phenylalanine
C10H11NO3
13200-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.8500 0.0 0 CFG=1
M  V30 2 C 4.0011 4.6200 0.0 0
M  V30 3 N 2.6674 2.3100 0.0 0
M  V30 4 C 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 1.3336 6.1600 0.0 0
M  V30 7 O 0.0000 3.8500 0.0 0
M  V30 8 O 1.3336 0.0000 0.0 0
M  V30 9 C 5.3347 3.8500 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 6.6685 4.6200 0.0 0
M  V30 12 C 6.6685 1.5400 0.0 0
M  V30 13 C 8.0021 3.8500 0.0 0
M  V30 14 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 9
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 63-91-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13200-85-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-12783699
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient procedure for N-formylation of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Joseph, Sony; Das, Prasenjit; Srivastava, Bindu; Nizar, Hashim; Prasad,
Mohan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(8), 929-931

$RFMT $RIREG SCHEME299 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(4-Chlorophenyl)methyl]-2(1H)-quinoxalinone
C15H11ClN2O
93986-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 Cl 10.6694 4.6200 0.0 0
M  V30 4 C 2.6673 4.6200 0.0 0
M  V30 5 C 1.3336 3.8500 0.0 0
M  V30 6 N 4.0011 3.8500 0.0 0
M  V30 7 C 2.6673 6.1600 0.0 0
M  V30 8 N 1.3336 2.3100 0.0 0
M  V30 9 C 0.0000 4.6200 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 6.9300 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 0.0000 6.1600 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 8.0021 1.5400 0.0 0
M  V30 16 C 6.6684 3.8500 0.0 0
M  V30 17 C 9.3358 2.3100 0.0 0
M  V30 18 C 8.0021 4.6200 0.0 0
M  V30 19 C 9.3358 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 14
M  V30 3 2 2 12
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(4-Chlorophenyl)methyl]-3,4-dihydro-3-oxo-1(2H)-quinoxalinecarboxaldehyde
C16H13ClN2O2
2840644-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.7700 0.0 0
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 O 6.6685 5.3901 0.0 0
M  V30 5 Cl 12.0033 5.3901 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 N 4.0012 2.3101 0.0 0
M  V30 8 C 2.6673 4.6201 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 N 4.0012 5.3901 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 8.0022 3.0801 0.0 0
M  V30 17 C 9.3360 2.3101 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 9.3360 5.3901 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 10
M  V30 4 1 3 16
M  V30 5 2 4 14
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 93986-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2840644-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34270924
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):NOTES
$DATUM conformer ratio 1:0.3, Leuckart reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-benzylquinoxalin-2(1H)-ones and
4-formyl-3-benzyl-3,4-dihydroquinoxalin-2(1H)-ones from
3-aryloxirane-2-carboxamides via
5-arylidene-2,2-dimethyl-1,3-oxazolidin-4-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mamedov, Vakhid A.; Mamedova, Vera L.; Syakaev, Victor V.; Voronina,
Julia K.; Mahrous, Essam M.; Khikmatova, Gul'naz Z.; Korshin, Dmitry E.;
Shamsutdinova, Leisan R.; Rizvanov, Il'dar Kh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2022), 124132963

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-2-[2-(3-chlorophenyl)hydrazinylidene]acetate
C9H8Cl2N2O2
75998-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 Cl 8.0022 0.0000 0.0 0
M  V30 6 O 10.6697 1.5400 0.0 0
M  V30 7 O 9.3360 3.8501 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 Cl 0.0000 1.5400 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-(3-chlorophenyl)-1H-1,2,4-triazole-3-carboxylate
C10H8ClN3O2
863609-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3037 3.4372 0.0 0
M  V30 2 O 10.2090 4.6831 0.0 0
M  V30 3 O 9.9301 2.0302 0.0 0
M  V30 4 C 11.7405 4.5220 0.0 0
M  V30 5 Cl 0.0000 3.0800 0.0 0
M  V30 6 N 5.3348 3.0800 0.0 0
M  V30 7 N 6.7416 2.4536 0.0 0
M  V30 8 C 5.4957 4.6116 0.0 0
M  V30 9 C 7.7722 3.5981 0.0 0
M  V30 10 N 7.0022 4.9318 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 2.6673 3.0800 0.0 0
M  V30 13 C 4.0011 0.7700 0.0 0
M  V30 14 C 1.3337 2.3100 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75998-56-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 863609-11-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30690998
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile One-Pot Synthesis of Methyl
1-Aryl-1H-1,2,4-triazole-3-carboxylates from Nitrilimines with Vilsmeier
Reagent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsai, Shuo-En; Chiang, Kun-Heng; Tseng, Ching-Chun; Chen, Nai-Wei; Chern,
Ching-Yuh; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(8), 1754-1762

$RFMT $RIREG SCHEME301 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-2-[2-(4-methylphenyl)hydrazinylidene]acetate
C10H11ClN2O2
82417-84-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 Cl 8.0022 0.0000 0.0 0
M  V30 6 O 10.6697 1.5400 0.0 0
M  V30 7 O 9.3360 3.8501 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 C 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-(4-methylphenyl)-1H-1,2,4-triazole-3-carboxylate
C11H11N3O2
57226-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7756 1.5317 0.0 0
M  V30 2 O 11.1826 2.1580 0.0 0
M  V30 3 O 9.6147 0.0000 0.0 0
M  V30 4 C 12.4284 1.2528 0.0 0
M  V30 5 C 0.0000 3.2067 0.0 0
M  V30 6 N 6.1600 3.2067 0.0 0
M  V30 7 N 7.0652 1.9609 0.0 0
M  V30 8 C 7.0652 4.4528 0.0 0
M  V30 9 C 8.5298 2.4367 0.0 0
M  V30 10 N 8.5298 3.9767 0.0 0
M  V30 11 C 4.6200 3.2067 0.0 0
M  V30 12 C 3.8500 4.5405 0.0 0
M  V30 13 C 3.8500 1.8731 0.0 0
M  V30 14 C 2.3100 4.5405 0.0 0
M  V30 15 C 2.3100 1.8731 0.0 0
M  V30 16 C 1.5400 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82417-84-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 57226-97-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29973588
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile One-Pot Synthesis of Methyl
1-Aryl-1H-1,2,4-triazole-3-carboxylates from Nitrilimines with Vilsmeier
Reagent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsai, Shuo-En; Chiang, Kun-Heng; Tseng, Ching-Chun; Chen, Nai-Wei; Chern,
Ching-Yuh; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(8), 1754-1762

$RFMT $RIREG SCHEME302 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-amino-4-cyano-3-thiopheneacetate
C9H10N2O2S
85032-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3028 2.8691 0.0 0
M  V30 2 C 6.6365 3.6391 0.0 0
M  V30 3 O 7.9701 2.8691 0.0 0
M  V30 4 O 6.6365 5.1791 0.0 0
M  V30 5 C 9.3038 3.6391 0.0 0
M  V30 6 C 10.6376 2.8691 0.0 0
M  V30 7 C 2.2420 1.5063 0.0 0
M  V30 8 N 1.9218 0.0000 0.0 0
M  V30 9 N 0.0000 3.9962 0.0 0
M  V30 10 C 3.9690 3.6391 0.0 0
M  V30 11 C 2.5622 3.0128 0.0 0
M  V30 12 C 3.8080 5.1707 0.0 0
M  V30 13 C 1.5317 4.1572 0.0 0
M  V30 14 S 2.3017 5.4908 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 3 7 8
M  V30 8 1 7 11
M  V30 9 1 9 13
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-aminothieno[2,3-d]pyrimidine-5-acetate
C10H11N3O2S
2362041-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 2.4656 0.0 0
M  V30 2 C 7.0870 3.2356 0.0 0
M  V30 3 O 8.4207 2.4656 0.0 0
M  V30 4 O 7.0870 4.7756 0.0 0
M  V30 5 C 9.7545 3.2356 0.0 0
M  V30 6 C 11.0882 2.4656 0.0 0
M  V30 7 N 3.5673 0.0000 0.0 0
M  V30 8 C 3.0127 2.6091 0.0 0
M  V30 9 C 4.4197 3.2356 0.0 0
M  V30 10 C 1.9823 3.7536 0.0 0
M  V30 11 C 2.5369 1.1445 0.0 0
M  V30 12 C 4.2586 4.7671 0.0 0
M  V30 13 S 2.7523 5.0873 0.0 0
M  V30 14 N 0.4759 3.4333 0.0 0
M  V30 15 N 1.0304 0.8242 0.0 0
M  V30 16 C 0.0000 1.9688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 11
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 85032-43-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2362041-99-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-22158199
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, characterization & in-silico prediction of substituted
2-aminothiophene, 1,3,4-thiadiazole and thieno[2,3-d]pyrimidine
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ranganath, P. L. N.; Nizamuddin, N. D.; Rubina, S. K.; Hemanth, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Journal of Pharmaceutical Research (2019), 8(2), 1368-1377

$RFMT $RIREG SCHEME303 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Chlorophenyl)-2,4-dihydro-5-phenyl-3H-pyrazol-3-one
C15H11ClN2O
87277-68-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0177 0.0000 0.0 0
M  V30 2 Cl 4.0011 5.6420 0.0 0
M  V30 3 N 4.0011 2.5620 0.0 0
M  V30 4 N 5.4081 3.1885 0.0 0
M  V30 5 C 4.1621 1.0304 0.0 0
M  V30 6 C 6.4385 2.0439 0.0 0
M  V30 7 C 5.6685 0.7103 0.0 0
M  V30 8 C 2.6675 3.3320 0.0 0
M  V30 9 C 2.6675 4.8720 0.0 0
M  V30 10 C 1.3338 2.5620 0.0 0
M  V30 11 C 1.3338 5.6420 0.0 0
M  V30 12 C 0.0000 3.3320 0.0 0
M  V30 13 C 0.0000 4.8720 0.0 0
M  V30 14 C 7.9701 2.2048 0.0 0
M  V30 15 C 8.8753 0.9590 0.0 0
M  V30 16 C 8.5966 3.6118 0.0 0
M  V30 17 C 10.4069 1.1201 0.0 0
M  V30 18 C 10.1281 3.7727 0.0 0
M  V30 19 C 11.0333 2.5269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Chlorophenyl)-4-[[1-(2-chlorophenyl)-5-hydroxy-3-phenyl-1H-pyrazol-4-yl]...
C31H20Cl2N4O2
1311144-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8391 8.3504 0.0 0
M  V30 2 O 7.8084 5.6398 0.0 0
M  V30 3 O 8.3290 6.1084 0.0 0
M  V30 4 Cl 3.3024 2.1050 0.0 0
M  V30 5 Cl 12.3154 10.2204 0.0 0
M  V30 6 C 5.3632 6.8857 0.0 0
M  V30 7 C 3.8987 6.4098 0.0 0
M  V30 8 C 6.2684 5.6398 0.0 0
M  V30 9 N 3.8987 4.8698 0.0 0
M  V30 10 N 5.3632 4.3939 0.0 0
M  V30 11 C 2.6528 7.3150 0.0 0
M  V30 12 C 2.8137 8.8466 0.0 0
M  V30 13 C 1.2459 6.6885 0.0 0
M  V30 14 C 1.5679 9.7518 0.0 0
M  V30 15 C 0.0000 7.5938 0.0 0
M  V30 16 C 0.1609 9.1253 0.0 0
M  V30 17 C 7.3455 8.6705 0.0 0
M  V30 18 C 7.9718 10.0773 0.0 0
M  V30 19 C 8.4899 7.6400 0.0 0
M  V30 20 N 9.5035 9.9164 0.0 0
M  V30 21 N 9.8237 8.4100 0.0 0
M  V30 22 C 5.8391 2.9292 0.0 0
M  V30 23 C 4.8087 1.7849 0.0 0
M  V30 24 C 7.3455 2.6091 0.0 0
M  V30 25 C 5.2845 0.3202 0.0 0
M  V30 26 C 7.8214 1.1444 0.0 0
M  V30 27 C 6.7910 0.0000 0.0 0
M  V30 28 C 7.2018 11.4110 0.0 0
M  V30 29 C 7.9718 12.7448 0.0 0
M  V30 30 C 5.6618 11.4110 0.0 0
M  V30 31 C 7.2018 14.0784 0.0 0
M  V30 32 C 4.8918 12.7448 0.0 0
M  V30 33 C 5.6618 14.0784 0.0 0
M  V30 34 C 11.2305 7.7836 0.0 0
M  V30 35 C 12.4763 8.6889 0.0 0
M  V30 36 C 11.3914 6.2521 0.0 0
M  V30 37 C 13.8833 8.0625 0.0 0
M  V30 38 C 12.7984 5.6258 0.0 0
M  V30 39 C 14.0442 6.5308 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 1 17 CFG=2
M  V30 3 1 2 8
M  V30 4 2 3 19
M  V30 5 1 4 23
M  V30 6 1 5 35
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 1 10 22
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 1 18 28
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 1 21 34
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87277-68-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1311144-32-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-329-CAS-5926468
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Vilsmeier-type methylenation reaction, n-methylformamide may be used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Vilsmeier-type methylenation for synthesis of dipyrazolylmethane
derivatives using formamide or N-methylformamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(21), 3863-3867

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-3-(4-chlorophenyl)-1-phenyl-1H-pyrazole-4-carboxaldehyde
C16H12ClN3O
873913-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0157 1.5063 0.0 0
M  V30 2 O 7.6955 0.0000 0.0 0
M  V30 3 N 4.7385 0.8097 0.0 0
M  V30 4 Cl 12.3671 7.1485 0.0 0
M  V30 5 C 7.0323 4.0685 0.0 0
M  V30 6 C 6.8712 2.5369 0.0 0
M  V30 7 N 5.6253 4.6948 0.0 0
M  V30 8 C 5.3649 2.2167 0.0 0
M  V30 9 N 4.5948 3.5504 0.0 0
M  V30 10 C 8.3659 4.8385 0.0 0
M  V30 11 C 8.3659 6.3785 0.0 0
M  V30 12 C 9.6996 4.0685 0.0 0
M  V30 13 C 9.6996 7.1485 0.0 0
M  V30 14 C 11.0333 4.8385 0.0 0
M  V30 15 C 11.0333 6.3785 0.0 0
M  V30 16 C 3.0633 3.7113 0.0 0
M  V30 17 C 2.4368 5.1183 0.0 0
M  V30 18 C 2.1580 2.4654 0.0 0
M  V30 19 C 0.9052 5.2792 0.0 0
M  V30 20 C 0.6265 2.6264 0.0 0
M  V30 21 C 0.0000 4.0333 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 1 9 16
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Chlorophenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C17H11ClN4
667909-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 12.3669 7.5408 0.0 0
M  V30 2 C 7.0321 4.4608 0.0 0
M  V30 3 C 6.8711 2.9292 0.0 0
M  V30 4 N 5.6252 5.0873 0.0 0
M  V30 5 C 5.3648 2.6091 0.0 0
M  V30 6 C 7.9016 1.7849 0.0 0
M  V30 7 N 4.5948 3.9427 0.0 0
M  V30 8 N 4.8889 1.1444 0.0 0
M  V30 9 N 7.4258 0.3202 0.0 0
M  V30 10 C 5.9193 0.0000 0.0 0
M  V30 11 C 8.3658 5.2308 0.0 0
M  V30 12 C 9.6994 4.4608 0.0 0
M  V30 13 C 8.3658 6.7708 0.0 0
M  V30 14 C 11.0331 5.2308 0.0 0
M  V30 15 C 9.6994 7.5408 0.0 0
M  V30 16 C 11.0331 6.7708 0.0 0
M  V30 17 C 3.0632 4.1037 0.0 0
M  V30 18 C 2.1580 2.8578 0.0 0
M  V30 19 C 2.4368 5.5106 0.0 0
M  V30 20 C 0.6265 3.0187 0.0 0
M  V30 21 C 0.9052 5.6715 0.0 0
M  V30 22 C 0.0000 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 873913-39-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 667909-99-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30198648
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
Pyrazolo[3,4-d]-pyrimidines (17-32, 65, 66, and 73-76). The reliable
procedure involved the treatment of 5-aminopyrazoles (1-16; 1.0 equiv),
5- amino-4-formylpyrazoles (37-41; 1.0 equiv), 5-aminoquinoline (61; 1.0
equiv), 8-aminoquinoline (62; 1.0 equiv), 5-aminopyrimidine (68; 1.0
equiv), or 2-aminopyrazines (69-71; 1.0 equiv) with PBr3 (~ 3 equiv) in
formamide solution (2 mL) at 50-60 °C over 0.5-1 h. When the reaction was
complete, the reaction mixture was added to saturated sodium bicarbonate
(15 mL) and extracted with dichloromethane (15 mL). The organic extracts
were dried over MgSO4, filtered, and concentrated under reduced pressure.
The residue solution was purified by column chromatography on silica gel
to give the corresponding aromatic or heterocyclic fused pyrimidine
products (17-32, 65, 66, and 73-76) in 82-96% yields.
3-(4-Chlorophenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine(31), yield 92%.
Mp 196- 197 °C (hexane-EtOAc). 1H NMR (CDCl3, 500 MHz): δ 7.34-7.38 (1H,
m), 7.48-7.58 (m, 4 H, ArH), 7.96-8.02 (2H, m), 8.24-8.30 (2H, m), 9.12
(1H, s), 9.46 (1H, s). 13C NMR (125 MHz, CDCl3): δ 114.0, 121.5 (2 × C),
127.0, 128.5 (2 × C), 129.3 (2 × C), 129.5 (2 × C), 130.0, 135.7, 138.4,
143.8, 152.6, 153.3, 155.7. IR (KBr): 3043, 2926, 2848, 1585, 1368, 1219,
1093 cm-1. EIMS m/z (rel int): 306 (100, M+). Anal. Calcd for C17H11ClN4:
C, 66.56; H, 3.61; N, 18.26. Found: C, 66.53; H, 3.62; N, 18.29.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methylphenyl)-1-(2-pyridinyl)-1H-pyrazol-5-amine
C15H14N4
928264-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.7385 0.0000 0.0 0
M  V30 2 C 12.3671 6.3388 0.0 0
M  V30 3 C 7.0323 3.2587 0.0 0
M  V30 4 N 5.6253 3.8850 0.0 0
M  V30 5 C 6.8712 1.7271 0.0 0
M  V30 6 N 4.5948 2.7406 0.0 0
M  V30 7 C 5.3649 1.4070 0.0 0
M  V30 8 C 8.3659 4.0287 0.0 0
M  V30 9 C 8.3659 5.5688 0.0 0
M  V30 10 C 9.6996 3.2587 0.0 0
M  V30 11 C 9.6996 6.3388 0.0 0
M  V30 12 C 11.0333 4.0287 0.0 0
M  V30 13 C 11.0333 5.5688 0.0 0
M  V30 14 C 3.0633 2.9016 0.0 0
M  V30 15 C 2.1580 1.6557 0.0 0
M  V30 16 N 2.4368 4.3086 0.0 0
M  V30 17 C 0.6265 1.8166 0.0 0
M  V30 18 C 0.9052 4.4695 0.0 0
M  V30 19 C 0.0000 3.2236 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 13
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methylphenyl)-1-(2-pyridinyl)-1H-pyrazolo[3,4-d]pyrimidine
C17H13N5
1410783-59-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.3669 7.5408 0.0 0
M  V30 2 C 7.0321 4.4608 0.0 0
M  V30 3 C 6.8711 2.9292 0.0 0
M  V30 4 N 5.6252 5.0873 0.0 0
M  V30 5 C 5.3648 2.6091 0.0 0
M  V30 6 C 7.9016 1.7849 0.0 0
M  V30 7 N 4.5948 3.9427 0.0 0
M  V30 8 N 4.8889 1.1444 0.0 0
M  V30 9 N 7.4258 0.3202 0.0 0
M  V30 10 C 5.9193 0.0000 0.0 0
M  V30 11 C 8.3658 5.2308 0.0 0
M  V30 12 C 9.6994 4.4608 0.0 0
M  V30 13 C 8.3658 6.7708 0.0 0
M  V30 14 C 11.0331 5.2308 0.0 0
M  V30 15 C 9.6994 7.5408 0.0 0
M  V30 16 C 11.0331 6.7708 0.0 0
M  V30 17 C 3.0632 4.1037 0.0 0
M  V30 18 C 2.1580 2.8578 0.0 0
M  V30 19 N 2.4368 5.5106 0.0 0
M  V30 20 C 0.6265 3.0187 0.0 0
M  V30 21 C 0.9052 5.6715 0.0 0
M  V30 22 C 0.0000 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 928264-19-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1410783-59-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-8267868
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Naphthalenylmethyl)propanediamide
C14H14N2O2
92906-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 2.3100 0.0 0
M  V30 2 C 6.6684 3.0800 0.0 0
M  V30 3 C 6.6684 4.6200 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 N 5.3347 5.3900 0.0 0
M  V30 6 O 8.0021 5.3900 0.0 0
M  V30 7 N 9.3358 3.0800 0.0 0
M  V30 8 O 8.0021 0.7700 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 1.3336 3.0800 0.0 0
M  V30 12 C 2.6674 0.7700 0.0 0
M  V30 13 C 4.0011 4.6200 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 1.3336 0.0000 0.0 0
M  V30 17 C 2.6674 5.3900 0.0 0
M  V30 18 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Hydroxy-5-(1-naphthalenylmethyl)-4(3H)-pyrimidinone
C15H12N2O2
500200-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 O 3.0801 5.3348 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 6.9302 4.0012 0.0 0
M  V30 5 C 5.3901 4.0012 0.0 0
M  V30 6 C 7.7002 5.3348 0.0 0
M  V30 7 C 7.7002 2.6675 0.0 0
M  V30 8 C 4.6201 5.3348 0.0 0
M  V30 9 C 6.9302 6.6687 0.0 0
M  V30 10 C 9.2402 5.3348 0.0 0
M  V30 11 C 9.2402 2.6675 0.0 0
M  V30 12 C 5.3901 6.6687 0.0 0
M  V30 13 C 10.0102 4.0012 0.0 0
M  V30 14 C 3.0801 2.6675 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 2.3101 1.3338 0.0 0
M  V30 17 N 0.7700 4.0012 0.0 0
M  V30 18 N 0.7700 1.3338 0.0 0
M  V30 19 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 14
M  V30 3 2 2 15
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 12
M  V30 14 2 10 13
M  V30 15 1 11 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 92906-42-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 500200-85-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30253692
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Hydroxy-5-(1-naphthylmethyl)-6(1H)-pyrimidinone (4a). A mixture of 3
(7.2 g, 30 mmol), formamide (5mL) and sodium ethoxide [prepared by
dissolving (2.8 g, 120 mmol) of sodium metal in 100 mL ethanol] was
refluxed for 12 h. The residue obtained after removal of ethanol in vacuo
was dissolved in warm water (100mL) and acidified with 4M HCl. The solid
product, which formed, was filtered off, dried and recrystallized from
water. 4a (92%) as white prisms. Mp 334- 336°C. 1H-NMR (DMSO-d6) δ 4.06
(s, 2H, CH2), 7.25 (d, 1H, J =7.1, arom.), 7.37 (t, 2H, J = 7.5 Hz,
arom.), .7.51 (m, 2H, arom.), 7.73 (d, 1H, J = 8.0 Hz, arom.), 7.87 (d,
1H, J =8.3Hz, arom.), 8.03 (s, 1H, C2-H), 8.37 (d, 111..J = 7.3 Hz,
arom.); 11.85 (s. br„ 1H, NH). 13C-NMR (DMSO-d6) δ 25.26 (CH2), 100.64
(C-5) 124.05, 125.34, 125.64, 126.04, 128.28; 131.83, 133.24, and 135.96
(C-arom.), 147.45 (C-2). 164.51 (C-4 and CO). Anal. Calcd for C15H12N2O2
(252.37): C, 71.38; H, 4.79; N, 11.14. Found: C, 71.60; H, 4.90; N,
11.30.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nucleic acid component analogues: Synthesis of 2'-deoxynucleosides from
5-substituted-4-hydroxy-6(1H)-pyrimidinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khattab, Ahmed F.; Abdel Megied, Ahmed E.-S.; Pedersen, Erik B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleosides, Nucleotides & Nucleic Acids (2003), 22(1), 99-107

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethylpyridine
C7H9N
100-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Ethyl-2-pyridinecarboxamide
C8H10N2O
78210-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 C 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 N 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-71-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 78210-61-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-095-CAS-21157341
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-53-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7727-21-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7761-88-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, Schlenk flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acid-Free Silver-Catalyzed Cross-Dehydrogenative Carbamoylation of
Pyridines with Formamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Wei; Jin, Fengli; Zhao, Qian; Du, Hongyan; Yao, Lifang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(12), 1854-1859

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(+)-L-Methionine methyl ester
C6H13NO2S
10332-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0 CFG=1
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 N 4.0012 3.8501 0.0 0
M  V30 5 O 1.3337 2.3101 0.0 0
M  V30 6 O 2.6675 0.0000 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 S 8.0023 1.5400 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Formyl-L-methionine methyl ester
C7H13NO3S
28381-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0 CFG=1
M  V30 2 C 2.3100 4.0011 0.0 0
M  V30 3 C 4.6200 5.3347 0.0 0
M  V30 4 N 4.6200 2.6674 0.0 0
M  V30 5 O 1.5400 5.3347 0.0 0
M  V30 6 O 1.5400 2.6674 0.0 0
M  V30 7 C 6.1600 5.3347 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 0.0000 5.3347 0.0 0
M  V30 10 S 6.9300 6.6685 0.0 0
M  V30 11 O 4.6200 0.0000 0.0 0
M  V30 12 C 8.4700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10332-17-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 28381-57-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28292421
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1809269-30-4
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, ee = 90%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide Synthesis through Borinic Acid-Catalysed Transamidation under
Mild Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohy El Dine, Tharwat; Evans, David; Rouden, Jacques; Blanchet, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2016), 22(17), 5894-5898

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexylamine
C6H13N
108-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexylformamide
C7H13NO
766-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 766-93-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25664923
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3240-34-4
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as mixture of rotamers in 83:17 ratio,reaction in a
Schlenk flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide-Catalyzed Nucleophilic Substitutions: Mechanistic Insight and
Rationalization of Catalytic Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kohlmeyer, Corinna; Schaefer, Andre; Huy, Peter H.; Hilt, Gerhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2020), 10(19), 11567-11577

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanone
C6H10O
108-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexylformamide
C7H13NO
766-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-94-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 766-93-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3510891
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):NOTES
$DATUM Leuckart-Wallach reaction, formamide/formic acid also used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient Isocyanide-less Isocyanide-Based Multicomponent Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neochoritis, Constantinos G.; Stotani, Silvia; Mishra, Bhupendra;
Doemling, Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(8), 2002-2005

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-1-(4-methoxyphenyl)-4,5-diphenyl-1H-pyrrole-3-carbonitrile
C24H19N3O
1186242-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7383 1.4070 0.0 0
M  V30 2 N 4.1120 0.0000 0.0 0
M  V30 3 N 8.0157 2.1035 0.0 0
M  V30 4 O 12.3670 7.7457 0.0 0
M  V30 5 C 13.7007 6.9757 0.0 0
M  V30 6 C 5.6252 5.2920 0.0 0
M  V30 7 C 4.5948 4.1476 0.0 0
M  V30 8 N 7.0322 4.6657 0.0 0
M  V30 9 C 5.3648 2.8138 0.0 0
M  V30 10 C 6.8711 3.1339 0.0 0
M  V30 11 C 5.3051 6.7984 0.0 0
M  V30 12 C 3.8404 7.2743 0.0 0
M  V30 13 C 6.4495 7.8289 0.0 0
M  V30 14 C 3.5202 8.7806 0.0 0
M  V30 15 C 6.1293 9.3352 0.0 0
M  V30 16 C 4.6647 9.8112 0.0 0
M  V30 17 C 3.0633 4.3085 0.0 0
M  V30 18 C 2.1580 3.0626 0.0 0
M  V30 19 C 2.4368 5.7153 0.0 0
M  V30 20 C 0.6265 3.2236 0.0 0
M  V30 21 C 0.9052 5.8764 0.0 0
M  V30 22 C 0.0000 4.6305 0.0 0
M  V30 23 C 8.3659 5.4357 0.0 0
M  V30 24 C 9.6995 4.6657 0.0 0
M  V30 25 C 8.3659 6.9757 0.0 0
M  V30 26 C 11.0332 5.4357 0.0 0
M  V30 27 C 9.6995 7.7457 0.0 0
M  V30 28 C 11.0332 6.9757 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 28
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 7 17
M  V30 11 1 8 10
M  V30 12 1 8 23
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(4-Methoxyphenyl)-5,6-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
C25H20N4O
1186242-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.5598 8.3235 0.0 0
M  V30 2 O 12.7443 3.6217 0.0 0
M  V30 3 C 13.8888 4.6521 0.0 0
M  V30 4 C 5.6398 4.6201 0.0 0
M  V30 5 N 6.8857 5.5251 0.0 0
M  V30 6 C 4.3940 5.5251 0.0 0
M  V30 7 C 6.4099 6.9898 0.0 0
M  V30 8 C 4.8698 6.9898 0.0 0
M  V30 9 N 7.1799 8.3235 0.0 0
M  V30 10 C 4.0998 8.3235 0.0 0
M  V30 11 C 6.4099 9.6571 0.0 0
M  V30 12 N 4.8698 9.6571 0.0 0
M  V30 13 C 5.6398 3.0800 0.0 0
M  V30 14 C 6.9735 2.3100 0.0 0
M  V30 15 C 4.3062 2.3100 0.0 0
M  V30 16 C 6.9735 0.7700 0.0 0
M  V30 17 C 4.3062 0.7700 0.0 0
M  V30 18 C 5.6398 0.0000 0.0 0
M  V30 19 C 8.3504 5.0493 0.0 0
M  V30 20 C 8.6706 3.5430 0.0 0
M  V30 21 C 9.4948 6.0798 0.0 0
M  V30 22 C 10.1352 3.0671 0.0 0
M  V30 23 C 10.9595 5.6038 0.0 0
M  V30 24 C 11.2797 4.0975 0.0 0
M  V30 25 C 2.9293 5.0493 0.0 0
M  V30 26 C 2.6091 3.5430 0.0 0
M  V30 27 C 1.7849 6.0798 0.0 0
M  V30 28 C 1.1445 3.0671 0.0 0
M  V30 29 C 0.3202 5.6038 0.0 0
M  V30 30 C 0.0000 4.0975 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 24
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 1 5 19
M  V30 9 1 6 8
M  V30 10 1 6 25
M  V30 11 1 7 8
M  V30 12 2 7 9
M  V30 13 2 8 10
M  V30 14 1 9 11
M  V30 15 1 10 12
M  V30 16 2 11 12
M  V30 17 2 13 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1186242-40-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1186242-55-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21167415
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of certain pyrrole derivatives as antimicrobial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohamed, Mosaad Sayed; El-Domany, Ramdan Ahmed; Abd El-Hameed, Rania
Helmy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Acta Pharmaceutica (Zagreb, Croatia) (2009), 59(2), 145-158

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Amino-3-cyano-4-phenyl-1H-pyrrol-1-yl)-N-2-thiazolylbenzenesulfonamide
C20H15N5O2S2
1256846-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6527 1.0353 0.0 0
M  V30 2 N 1.4068 0.1301 0.0 0
M  V30 3 N 5.8391 0.0000 0.0 0
M  V30 4 S 12.4285 2.7106 0.0 0 VAL=6
M  V30 5 N 13.9685 2.7106 0.0 0
M  V30 6 O 12.4285 4.2506 0.0 0
M  V30 7 O 12.4285 1.1706 0.0 0
M  V30 8 C 3.8987 3.4806 0.0 0
M  V30 9 C 3.8987 1.9406 0.0 0
M  V30 10 C 5.3632 3.9564 0.0 0
M  V30 11 C 5.3632 1.4647 0.0 0
M  V30 12 N 6.2684 2.7106 0.0 0
M  V30 13 C 2.6527 4.3858 0.0 0
M  V30 14 C 2.8137 5.9173 0.0 0
M  V30 15 C 1.2459 3.7593 0.0 0
M  V30 16 C 1.5677 6.8225 0.0 0
M  V30 17 C 0.0000 4.6645 0.0 0
M  V30 18 C 0.1609 6.1961 0.0 0
M  V30 19 C 7.8085 2.7106 0.0 0
M  V30 20 C 8.5785 4.0442 0.0 0
M  V30 21 C 8.5785 1.3769 0.0 0
M  V30 22 C 10.1185 4.0442 0.0 0
M  V30 23 C 10.1185 1.3769 0.0 0
M  V30 24 C 10.8885 2.7106 0.0 0
M  V30 25 C 14.7385 4.0442 0.0 0
M  V30 26 N 16.2700 4.2051 0.0 0
M  V30 27 S 14.1122 5.4512 0.0 0
M  V30 28 C 16.5902 5.7116 0.0 0
M  V30 29 C 15.2565 6.4816 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 4 7
M  V30 7 1 4 24
M  V30 8 1 5 25
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 13
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 1 12 19
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Amino-5-phenyl-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-N-2-thiazolylbenzenesulf...
C21H16N6O2S2
1256846-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.2896 2.4582 0.0 0
M  V30 2 S 12.4285 3.7827 0.0 0 VAL=6
M  V30 3 N 13.9685 3.7827 0.0 0
M  V30 4 O 12.4285 2.2427 0.0 0
M  V30 5 O 12.4285 5.3227 0.0 0
M  V30 6 C 3.8987 3.0127 0.0 0
M  V30 7 C 3.8987 4.5527 0.0 0
M  V30 8 C 5.3632 2.5369 0.0 0
M  V30 9 C 2.7542 1.9823 0.0 0
M  V30 10 C 5.3632 5.0286 0.0 0
M  V30 11 N 6.2684 3.7827 0.0 0
M  V30 12 N 5.6834 1.0304 0.0 0
M  V30 13 N 3.0743 0.4759 0.0 0
M  V30 14 C 4.5390 0.0000 0.0 0
M  V30 15 C 2.6527 5.4579 0.0 0
M  V30 16 C 2.8137 6.9895 0.0 0
M  V30 17 C 1.2459 4.8315 0.0 0
M  V30 18 C 1.5677 7.8947 0.0 0
M  V30 19 C 0.0000 5.7367 0.0 0
M  V30 20 C 0.1609 7.2684 0.0 0
M  V30 21 C 7.8085 3.7827 0.0 0
M  V30 22 C 8.5785 2.4491 0.0 0
M  V30 23 C 8.5785 5.1164 0.0 0
M  V30 24 C 10.1185 2.4491 0.0 0
M  V30 25 C 10.1185 5.1164 0.0 0
M  V30 26 C 10.8885 3.7827 0.0 0
M  V30 27 C 14.7385 5.1164 0.0 0
M  V30 28 N 14.1122 6.5233 0.0 0
M  V30 29 S 16.2700 5.2775 0.0 0
M  V30 30 C 15.2565 7.5537 0.0 0
M  V30 31 C 16.5902 6.7837 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 2 5
M  V30 5 1 2 26
M  V30 6 1 3 27
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 7 15
M  V30 12 1 8 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 1 10 11
M  V30 16 1 11 21
M  V30 17 1 12 14
M  V30 18 2 13 14
M  V30 19 2 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1256846-72-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1256846-76-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21409234
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):NOTES
$DATUM formamide also used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives
bearing sulfonamide moiety for evaluation as anticancer and
radiosensitizing agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghorab, Mostafa M.; Ragab, Fatma A.; Heiba, Helmy I.; Youssef, Hanan A.;
El-Gazzar, Marwa G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(21), 6316-6320

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-1-(1-methylethyl)-3-(3-nitrophenyl)-1H-pyrazole-4-carboxamide
C13H15N5O3
1351926-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5932 1.1444 0.0 0
M  V30 2 N 3.5628 0.0000 0.0 0
M  V30 3 O 6.0996 0.8242 0.0 0
M  V30 4 N 1.4068 2.1797 0.0 0
M  V30 5 C 1.4068 5.5302 0.0 0
M  V30 6 C 1.5679 7.0617 0.0 0
M  V30 7 C 0.0000 4.9037 0.0 0
M  V30 8 N 9.6426 6.5222 0.0 0 VAL=5
M  V30 9 O 11.1826 6.5222 0.0 0
M  V30 10 O 8.8726 7.8559 0.0 0
M  V30 11 C 5.0226 3.8549 0.0 0
M  V30 12 C 4.1174 2.6091 0.0 0
M  V30 13 N 4.1174 5.1008 0.0 0
M  V30 14 C 2.6528 3.0849 0.0 0
M  V30 15 N 2.6528 4.6249 0.0 0
M  V30 16 C 6.5626 3.8549 0.0 0
M  V30 17 C 7.3326 5.1886 0.0 0
M  V30 18 C 7.3326 2.5211 0.0 0
M  V30 19 C 8.8726 5.1886 0.0 0
M  V30 20 C 8.8726 2.5211 0.0 0
M  V30 21 C 9.6426 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 15
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 19
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 16
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dihydro-1-(1-methylethyl)-3-(3-nitrophenyl)-4H-pyrazolo[3,4-d]pyrimidin-4...
C14H13N5O3
1351926-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9022 7.2292 0.0 0
M  V30 2 C 1.4068 2.3259 0.0 0
M  V30 3 C 1.5679 0.7943 0.0 0
M  V30 4 C 0.0000 2.9522 0.0 0
M  V30 5 N 9.6426 1.3336 0.0 0 VAL=5
M  V30 6 O 11.1826 1.3336 0.0 0
M  V30 7 O 8.8726 0.0000 0.0 0
M  V30 8 C 4.1174 5.2469 0.0 0
M  V30 9 C 5.0226 4.0011 0.0 0
M  V30 10 C 2.6528 4.7711 0.0 0
M  V30 11 C 4.4375 6.7534 0.0 0
M  V30 12 N 4.1174 2.7552 0.0 0
M  V30 13 N 2.6528 3.2311 0.0 0
M  V30 14 N 1.5083 5.8015 0.0 0
M  V30 15 N 3.2931 7.7838 0.0 0
M  V30 16 C 1.8284 7.3079 0.0 0
M  V30 17 C 6.5626 4.0011 0.0 0
M  V30 18 C 7.3326 2.6674 0.0 0
M  V30 19 C 7.3326 5.3347 0.0 0
M  V30 20 C 8.8726 2.6674 0.0 0
M  V30 21 C 8.8726 5.3347 0.0 0
M  V30 22 C 9.6426 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 13
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 20
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 17
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1351926-84-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1351926-85-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-12743860
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 10 - Preparation of
1-isopropyl-3-(3-nitrophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one (28)
Compound 27 (1 g, 3.46 mmol) was added to formamide (1.167 mL, 29.3 mmol)
and heated to 160°C for 40 hours. Afterwards, the reaction mixture was
allowed to cool to room temperature and diluted into ice cold water. The
mixture was filtered and was collected. Yield 943 mg, 91%, solid. 1H NMR
(400 MHz, DMSO) δ 12.37 (s, 1H), 9.32 (s, 1H), 8.81 (d, J = 7.8, 1H),
8.23 (d, J = 8.1, 1H), 8.13 (s, 1H), 7.75 (t, J = 8.0, 1H), 5.06 (hept, J
= 6.6, 1H), 1.52 (d, J = 6.7, 6H); 13C NMR (100 MHz, DMSO) δ 157.77,
152.48, 148.16, 148.06, 143.85,133.58, 129.95,123.05, 122.07, 103.02,
49.07, 21.74; [M+H]+ calculated for C14H13N5O3 300.1, found 300.0.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidine and quinazoline derivatives as
inhibitors of kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garske, Adam L.; Shokat, Kevan M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011153553 A2 2011-12-08

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-1-(1-methylethyl)-3-(3-nitrophenyl)-1H-pyrazole-4-carboxamide
C13H15N5O3
1351926-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5932 1.1444 0.0 0
M  V30 2 N 3.5628 0.0000 0.0 0
M  V30 3 O 6.0996 0.8242 0.0 0
M  V30 4 N 1.4068 2.1797 0.0 0
M  V30 5 C 1.4068 5.5302 0.0 0
M  V30 6 C 1.5679 7.0617 0.0 0
M  V30 7 C 0.0000 4.9037 0.0 0
M  V30 8 N 9.6426 6.5222 0.0 0 VAL=5
M  V30 9 O 11.1826 6.5222 0.0 0
M  V30 10 O 8.8726 7.8559 0.0 0
M  V30 11 C 5.0226 3.8549 0.0 0
M  V30 12 C 4.1174 2.6091 0.0 0
M  V30 13 N 4.1174 5.1008 0.0 0
M  V30 14 C 2.6528 3.0849 0.0 0
M  V30 15 N 2.6528 4.6249 0.0 0
M  V30 16 C 6.5626 3.8549 0.0 0
M  V30 17 C 7.3326 5.1886 0.0 0
M  V30 18 C 7.3326 2.5211 0.0 0
M  V30 19 C 8.8726 5.1886 0.0 0
M  V30 20 C 8.8726 2.5211 0.0 0
M  V30 21 C 9.6426 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 15
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 19
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 16
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dihydro-1-(1-methylethyl)-3-(3-nitrophenyl)-4H-pyrazolo[3,4-d]pyrimidin-4...
C14H13N5O3
1351926-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9022 7.2292 0.0 0
M  V30 2 C 1.4068 2.3259 0.0 0
M  V30 3 C 1.5679 0.7943 0.0 0
M  V30 4 C 0.0000 2.9522 0.0 0
M  V30 5 N 9.6426 1.3336 0.0 0 VAL=5
M  V30 6 O 11.1826 1.3336 0.0 0
M  V30 7 O 8.8726 0.0000 0.0 0
M  V30 8 C 4.1174 5.2469 0.0 0
M  V30 9 C 5.0226 4.0011 0.0 0
M  V30 10 C 2.6528 4.7711 0.0 0
M  V30 11 C 4.4375 6.7534 0.0 0
M  V30 12 N 4.1174 2.7552 0.0 0
M  V30 13 N 2.6528 3.2311 0.0 0
M  V30 14 N 1.5083 5.8015 0.0 0
M  V30 15 N 3.2931 7.7838 0.0 0
M  V30 16 C 1.8284 7.3079 0.0 0
M  V30 17 C 6.5626 4.0011 0.0 0
M  V30 18 C 7.3326 2.6674 0.0 0
M  V30 19 C 7.3326 5.3347 0.0 0
M  V30 20 C 8.8726 2.6674 0.0 0
M  V30 21 C 8.8726 5.3347 0.0 0
M  V30 22 C 9.6426 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 13
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 20
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 17
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1351926-84-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1351926-85-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-15346907
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemical genetic strategy for targeting protein kinases based on covalent
complementarity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garske, Adam L.; Peters, Ulf; Cortesi, Arianna T.; Perez, Jenny L.;
Shokat, Kevan M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Proceedings of the National Academy of Sciences of the United States of
America (2011), 108(37), 15046-15052, S15046/1-S15046/32

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-3-[(3-bromophenyl)methyl]-1-(1-methylethyl)-1H-pyrazole-4-carbonitrile
C14H15BrN4
1351926-96-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 4.1751 0.0 0
M  V30 2 C 4.5932 1.4647 0.0 0
M  V30 3 N 5.0692 0.0000 0.0 0
M  V30 4 N 1.4068 2.4999 0.0 0
M  V30 5 C 1.4068 5.8503 0.0 0
M  V30 6 C 1.5679 7.3819 0.0 0
M  V30 7 C 0.0000 5.2240 0.0 0
M  V30 8 Br 11.1826 6.8426 0.0 0
M  V30 9 C 5.0226 4.1751 0.0 0
M  V30 10 C 4.1174 2.9292 0.0 0
M  V30 11 N 4.1174 5.4210 0.0 0
M  V30 12 C 2.6528 3.4051 0.0 0
M  V30 13 N 2.6528 4.9451 0.0 0
M  V30 14 C 7.3326 5.5089 0.0 0
M  V30 15 C 8.8726 5.5089 0.0 0
M  V30 16 C 6.5626 6.8426 0.0 0
M  V30 17 C 9.6426 6.8426 0.0 0
M  V30 18 C 7.3326 8.1762 0.0 0
M  V30 19 C 8.8726 8.1762 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 14
M  V30 3 3 2 3
M  V30 4 1 2 10
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 13
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(3-Bromophenyl)methyl]-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C15H16BrN5
1351926-97-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.7827 0.0 0
M  V30 2 N 5.9022 0.5546 0.0 0
M  V30 3 C 1.4068 5.4579 0.0 0
M  V30 4 C 0.0000 4.8316 0.0 0
M  V30 5 C 1.5679 6.9894 0.0 0
M  V30 6 Br 11.1826 6.4501 0.0 0
M  V30 7 C 4.1173 2.5368 0.0 0
M  V30 8 C 2.6528 3.0127 0.0 0
M  V30 9 C 5.0226 3.7827 0.0 0
M  V30 10 C 4.4375 1.0304 0.0 0
M  V30 11 N 2.6528 4.5527 0.0 0
M  V30 12 N 1.5083 1.9823 0.0 0
M  V30 13 N 4.1173 5.0286 0.0 0
M  V30 14 N 3.2931 0.0000 0.0 0
M  V30 15 C 1.8284 0.4759 0.0 0
M  V30 16 C 7.3326 5.1163 0.0 0
M  V30 17 C 8.8726 5.1163 0.0 0
M  V30 18 C 6.5626 6.4501 0.0 0
M  V30 19 C 9.6426 6.4501 0.0 0
M  V30 20 C 7.3326 7.7838 0.0 0
M  V30 21 C 8.8726 7.7838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 10
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 11
M  V30 7 1 6 19
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1351926-96-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1351926-97-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21310992
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 22 - Preparation of
3-(3-bromobenzyl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
Compound 34 (6.09 g, 19.1 mmol) was added to formamide (26.6 mL, 668
mmol) and heated to 160°C for 27 hours. Afterwards, the reaction mixture
was allowed to cool to room temperature and diluted into ice cold water
(50 mL). A viscous material was filtered and dissolved in EtOAc. This
solution was washed with brine and concentrated in vacuo. Yield 6.23 g,
91%. 1H NMR (400 MHz, DMSO) δ 8.13 (s, 1H), 7.49 (s, 1H), 7.37 (dt, J =
7.5, 1.7, 1H), 7.22 (m, 2H), 4.95 (hept, J = 6.6, 1H), 4.38 (s, 2H), 1.43
(d, J = 6.7, 6H); 13C NMR (100 MHz, DMSO) δ 157.90, 155.39, 153.22,
142.01, 141.86, 131.16, 130.52, 129.00, 127.40, 121.56, 98.39, 47.76,
32.66, 21.71; [M+H]+ calculated for C15H16BrN5 346.0, 348.0 found 346.0:
348.0.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidine and quinazoline derivatives as
inhibitors of kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garske, Adam L.; Shokat, Kevan M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011153553 A2 2011-12-08

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-3-[(3-bromophenyl)methyl]-1-(1-methylethyl)-1H-pyrazole-4-carbonitrile
C14H15BrN4
1351926-96-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 4.1751 0.0 0
M  V30 2 C 4.5932 1.4647 0.0 0
M  V30 3 N 5.0692 0.0000 0.0 0
M  V30 4 N 1.4068 2.4999 0.0 0
M  V30 5 C 1.4068 5.8503 0.0 0
M  V30 6 C 1.5679 7.3819 0.0 0
M  V30 7 C 0.0000 5.2240 0.0 0
M  V30 8 Br 11.1826 6.8426 0.0 0
M  V30 9 C 5.0226 4.1751 0.0 0
M  V30 10 C 4.1174 2.9292 0.0 0
M  V30 11 N 4.1174 5.4210 0.0 0
M  V30 12 C 2.6528 3.4051 0.0 0
M  V30 13 N 2.6528 4.9451 0.0 0
M  V30 14 C 7.3326 5.5089 0.0 0
M  V30 15 C 8.8726 5.5089 0.0 0
M  V30 16 C 6.5626 6.8426 0.0 0
M  V30 17 C 9.6426 6.8426 0.0 0
M  V30 18 C 7.3326 8.1762 0.0 0
M  V30 19 C 8.8726 8.1762 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 14
M  V30 3 3 2 3
M  V30 4 1 2 10
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 13
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(3-Bromophenyl)methyl]-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C15H16BrN5
1351926-97-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.7827 0.0 0
M  V30 2 N 5.9022 0.5546 0.0 0
M  V30 3 C 1.4068 5.4579 0.0 0
M  V30 4 C 0.0000 4.8316 0.0 0
M  V30 5 C 1.5679 6.9894 0.0 0
M  V30 6 Br 11.1826 6.4501 0.0 0
M  V30 7 C 4.1173 2.5368 0.0 0
M  V30 8 C 2.6528 3.0127 0.0 0
M  V30 9 C 5.0226 3.7827 0.0 0
M  V30 10 C 4.4375 1.0304 0.0 0
M  V30 11 N 2.6528 4.5527 0.0 0
M  V30 12 N 1.5083 1.9823 0.0 0
M  V30 13 N 4.1173 5.0286 0.0 0
M  V30 14 N 3.2931 0.0000 0.0 0
M  V30 15 C 1.8284 0.4759 0.0 0
M  V30 16 C 7.3326 5.1163 0.0 0
M  V30 17 C 8.8726 5.1163 0.0 0
M  V30 18 C 6.5626 6.4501 0.0 0
M  V30 19 C 9.6426 6.4501 0.0 0
M  V30 20 C 7.3326 7.7838 0.0 0
M  V30 21 C 8.8726 7.7838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 10
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 11
M  V30 7 1 6 19
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1351926-96-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1351926-97-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21318019
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemical genetic strategy for targeting protein kinases based on covalent
complementarity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garske, Adam L.; Peters, Ulf; Cortesi, Arianna T.; Perez, Jenny L.;
Shokat, Kevan M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Proceedings of the National Academy of Sciences of the United States of
America (2011), 108(37), 15046-15052, S15046/1-S15046/32

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Hydroxymethyl)-N-methyl-N-phenyl-2-propenamide
C11H13NO2
1353568-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 4.0011 4.6200 0.0 0
M  V30 4 C 6.6684 3.0800 0.0 0
M  V30 5 O 5.3347 0.7700 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 6.6684 4.6200 0.0 0
M  V30 8 O 9.3358 3.0800 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 1.3336 3.0800 0.0 0
M  V30 11 C 2.6674 0.7700 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 1.3336 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1′-Methylspiro[furan-3(2H),3′-[3H]indole]-2′,5(1′H,4H)-dione
C12H11NO3
2457343-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.0811 1.3628 0.0 0
M  V30 2 C 3.0203 0.0000 0.0 0
M  V30 3 O 8.3944 4.8388 0.0 0
M  V30 4 C 4.5864 3.6644 0.0 0
M  V30 5 C 3.0801 3.9845 0.0 0
M  V30 6 C 4.7475 2.1328 0.0 0
M  V30 7 C 6.0928 3.3442 0.0 0
M  V30 8 C 4.4254 5.1959 0.0 0
M  V30 9 C 2.3101 2.6509 0.0 0
M  V30 10 C 2.3101 5.3182 0.0 0
M  V30 11 N 3.3405 1.5063 0.0 0
M  V30 12 C 6.8629 4.6779 0.0 0
M  V30 13 O 5.8324 5.8223 0.0 0
M  V30 14 C 0.7700 2.6509 0.0 0
M  V30 15 C 0.7700 5.3182 0.0 0
M  V30 16 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 11
M  V30 3 2 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 11
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1353568-86-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2457343-69-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25213351
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7720-78-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical (Hg lamp (450 W) used (stage 1)), optimization study,
optimized on stoichiometry of catalyst, alternative reaction conditions
shown, photochemical flow reactor used (stage 1), Dean-Stark apparatus
used (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient approach for the synthesis of new (±)-coixspirolactams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nascimento, Vinicius R.; Suenaga, Melissa L. S.; Andrade, Leandro H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2020), 18(28), 5458-5465

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[(4-methoxyphenyl)methyl]-4-methyl-3-pyridinamine
C14H15ClN2O
1365094-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 C 3.0800 0.0000 0.0 0
M  V30 4 Cl 3.0800 5.3349 0.0 0
M  V30 5 O 11.5500 4.0011 0.0 0
M  V30 6 C 12.3200 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3338 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 7.7000 5.3349 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 9.2400 5.3349 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 8
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Methoxyphenyl)methyl]-7-methyl-1H-imidazo[4,5-b]pyridine
C15H15N3O
1365094-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 2.4656 0.0 0
M  V30 2 C 3.5673 0.0000 0.0 0
M  V30 3 O 11.0882 5.5457 0.0 0
M  V30 4 C 12.4219 4.7756 0.0 0
M  V30 5 C 3.0128 2.6091 0.0 0
M  V30 6 N 4.4196 3.2356 0.0 0
M  V30 7 C 1.9823 3.7537 0.0 0
M  V30 8 C 2.5369 1.1446 0.0 0
M  V30 9 C 4.2587 4.7672 0.0 0
M  V30 10 N 2.7523 5.0873 0.0 0
M  V30 11 N 0.4759 3.4335 0.0 0
M  V30 12 C 1.0304 0.8244 0.0 0
M  V30 13 C 0.0000 1.9688 0.0 0
M  V30 14 C 7.0871 3.2356 0.0 0
M  V30 15 C 8.4208 2.4656 0.0 0
M  V30 16 C 7.0871 4.7756 0.0 0
M  V30 17 C 9.7544 3.2356 0.0 0
M  V30 18 C 8.4208 5.5457 0.0 0
M  V30 19 C 9.7544 4.7756 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 14
M  V30 3 1 2 8
M  V30 4 1 3 4
M  V30 5 1 3 19
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 10
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1365094-29-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365094-33-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12533018
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 29154-12-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 857356-94-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1-(4-Methoxybenzyl)-1H-imidazo[4,5-b]pyridine
(3a) To an oven-dried 25 mL Schlenk-tube equipped with a stirbar was
added Pd2(dba)3 · CHCl3 (20.8 mg, 0.02 mmol),
2-Di-t-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-tri-i-propylbiphenyl
(L1) (48 mg, 0.1 mmol), K3PO4 (639 mg, 3.01 mmol) and
2-Chloro-N-(4-methoxybenzyl)pyridin-3-amine (2a) (500 mg, 2.01 mmol) (if
solid). The tube was evacuated and refilled with Ar(g). Formamide (0.12
mL, 3.01 mmol) was added via syringe as a single portion, followed by the
chloropyridine (if liquid) in 4 mL of tert-butanol. The reaction mixture
was degassed with 3 x vacuum / Ar(g) purge cycles. The reaction vessel
was then equipped with a cold-finger under a positive pressure of argon
gas and immersed in a 110°C pre-heated oil-bath for 4h at which time TLC
showed consumption of the chloro-pyridine. The reaction was cooled to
room temperature, diluted with MeOH (4 mL) filtered through a Celite plug
and concentrated to give a dark brown oil. The crude product was purified
on a silica gel column (4.5 cm x 12 cm), eluting with 4% MeOH in CH2Cl2.
1-(4-Methoxybenzyl)-7-methyl-1H-imidazo[4,5-b]pyridine (10) Following the
general experimental;
2-chloro-N-(4-methoxybenzyl)-4-methylpyridin-3-amine (4) (93 mg, 0.4
mmol), Pd2(dba)3·CHCl3 (4.14 mg, 0.004 mmol), L1 (9.6 mg, 0.02 mmol),
K3PO4 (128 mg, 0.6 mmol), formamide (0.022 mL, 0.6 mmol) were combined
with 2.0 mL tert-butanol in a 25 mL Schlenk flask. After 4 h the reaction
was complete, the reaction cooled to RT, filtered through Celite,
concentrated and purified on a silica gel column (2.5 cm x 12 cm),
eluting with 4% MeOH / CH2Cl2. 10 as 92 mg of a green solid (91%). 1H NMR
(300 MHz, CDCl3) δ = 8.34 (d, J = 4.8 Hz, 1H), 8.01 (s, 1H), 6.93-6.77
(m, 5H), 5.44 (s, 2H), 3.74 (s, 3H), 2.43 (s, 3H); 13C NMR (75.4 MHz,
CDCl3) δ = 159.5, 156.5, 146.2, 145.1, 131.4, 128.3, 127.3, 125.6, 120.8,
114.6, 55.4, 50.3, 17.9; FT-IR (NaCl, thin film) ν = 3053, 2959, 2933,
2837, 1696, 1608, 1586, 1513, 1493, 1357, 1249, 1178, 1031, 821 cm-1.
Anal. Calc C15H15N3O: C, 71.13; H, 5.97; N, 16.59; found C, 71.43; H,
5.81; N, 16.61; MP: 105-108°C.
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Imidazo[4,5-b]pyridines and Imidazo[4,5-b]pyrazines by
Palladium Catalyzed Amidation of 2-Chloro-3-amino-heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Zhao, Jinbo; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(7), 1764-1767

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
2-Bromo-N-(4-methylphenyl)benzamide
C14H12BrNO
136926-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 O 5.3900 1.3338 0.0 0
M  V30 4 Br 3.0800 0.0000 0.0 0
M  V30 5 C 11.5500 4.0011 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 7.7000 2.6674 0.0 0
M  V30 14 C 7.7000 5.3349 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 12
M  V30 5 1 4 7
M  V30 6 1 5 17
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methylphenyl)-4(3H)-quinazolinone
C15H12N2O
24122-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 0.0000 0.0 0
M  V30 2 C 11.5503 2.6673 0.0 0
M  V30 3 N 5.3901 2.6673 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 4.6201 4.0010 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 N 3.0801 4.0010 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 0.7700 2.6673 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 13 C 6.9302 2.6673 0.0 0
M  V30 14 C 7.7002 4.0010 0.0 0
M  V30 15 C 7.7002 1.3337 0.0 0
M  V30 16 C 9.2402 4.0010 0.0 0
M  V30 17 C 9.2402 1.3337 0.0 0
M  V30 18 C 10.0102 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 1 2 18
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 8
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 136926-09-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 24122-33-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9861060
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51-35-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for CuI-catalyzed formation
of 3-substituted-4-quinazolines and 2,3-disubstituted-4(3H )-quinazolines
from 2-bromo-N-phenylbenzamide. For 3-substituted-4-quinazoline
(11a-11r). A Schlenk tube was charged with N-substituted 2-bromobenzamide
(0.25 mmol), CuI (5 mg, 0.025 mmol), trans-4-hydroxy-L-proline (3 mg,
0.025 mmol), and Cs2CO3 (163 mg, 0.5 mmol). The tube was evacuated and
backfilled with argon before formamide (20 µL, 0.5 mmol) and 1 mL DMF was
added. The reaction mixture was stirred at 80 o C (or 90 o C for
substrate 7l) for 24 h. After the reaction mixture was cooled to room
temperature, 5 mL of saturated NH4Cl solution was added. The mixture was
extracted with EtOAc and the organic layer was washed with water, brine
and dried over Na2SO4. After concentration in vacuo, the residue was
purified by column chromatography on silica gel. The desired
3-substituted 4-quinazoline. 3-p-Tolylquinazolin-4(3H)-one (11h).1 54 mg,
91% yield. 1H NMR (400 MHz, CDCl3) δ 8.37 (d, J = 8.0 Hz, 1H), 8.11 (s,
1H), 7.81-7.49 (m, 2H), 7.56 (t, J = 7.2 Hz, 1H), 7.35-7.28 (m, 4H), 2.43
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 161.02, 148.04, 146.42, 139.37,
135.05, 134.63, 130.37 (2C), 127.69 (2C), 127.31, 126.86 (2C), 122.54,
21.34. HRMS-ESI: m/z calcd for C15H13N2O [M + H]+: 237.1028, found
237.1022.
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst formed in-situ; Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Substituted and 2,3-Disubstituted Quinazolinones via
Cu-Catalyzed Aryl Amidation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Lanting; Jiang, Yongwen; Ma, Dawei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(4), 1150-1153

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Chlorophenyl)-1-(2-quinolinyl)-1H-pyrazol-5-amine
C18H13ClN4
1410783-48-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.3594 0.0000 0.0 0
M  V30 2 Cl 14.2835 7.1013 0.0 0
M  V30 3 C 5.3900 2.7106 0.0 0
M  V30 4 N 4.6200 4.0442 0.0 0
M  V30 5 C 4.6200 1.3768 0.0 0
M  V30 6 C 3.0800 4.0442 0.0 0
M  V30 7 C 3.0800 1.3768 0.0 0
M  V30 8 C 2.3100 2.7106 0.0 0
M  V30 9 C 2.3100 5.3778 0.0 0
M  V30 10 C 0.7700 2.7106 0.0 0
M  V30 11 C 0.7700 5.3778 0.0 0
M  V30 12 C 0.0000 4.0442 0.0 0
M  V30 13 N 6.9300 2.7106 0.0 0
M  V30 14 N 7.8352 3.9564 0.0 0
M  V30 15 C 7.8352 1.4645 0.0 0
M  V30 16 C 9.2999 3.4806 0.0 0
M  V30 17 C 9.2999 1.9406 0.0 0
M  V30 18 C 10.5458 4.3858 0.0 0
M  V30 19 C 10.3849 5.9173 0.0 0
M  V30 20 C 11.9527 3.7593 0.0 0
M  V30 21 C 11.6307 6.8225 0.0 0
M  V30 22 C 13.1986 4.6645 0.0 0
M  V30 23 C 13.0375 6.1961 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 23
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 8
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3-(4-Chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]quinoline
C20H12ClN5
1410783-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 8.1734 0.0 0
M  V30 2 N 7.3535 3.7827 0.0 0
M  V30 3 C 6.4483 2.5369 0.0 0
M  V30 4 N 6.4483 5.0286 0.0 0
M  V30 5 C 4.9836 3.0127 0.0 0
M  V30 6 N 6.7685 1.0304 0.0 0
M  V30 7 C 4.9836 4.5527 0.0 0
M  V30 8 C 3.8392 1.9821 0.0 0
M  V30 9 C 5.6240 0.0000 0.0 0
M  V30 10 N 4.1594 0.4759 0.0 0
M  V30 11 C 8.8935 3.7827 0.0 0
M  V30 12 N 9.6635 5.1164 0.0 0
M  V30 13 C 9.6635 2.4491 0.0 0
M  V30 14 C 11.2036 5.1164 0.0 0
M  V30 15 C 11.2036 2.4491 0.0 0
M  V30 16 C 11.9736 3.7827 0.0 0
M  V30 17 C 11.9736 6.4500 0.0 0
M  V30 18 C 13.5136 3.7827 0.0 0
M  V30 19 C 13.5136 6.4500 0.0 0
M  V30 20 C 14.2836 5.1164 0.0 0
M  V30 21 C 3.7378 5.4579 0.0 0
M  V30 22 C 3.8987 6.9895 0.0 0
M  V30 23 C 2.3310 4.8315 0.0 0
M  V30 24 C 2.6528 7.8947 0.0 0
M  V30 25 C 1.0849 5.7367 0.0 0
M  V30 26 C 1.2460 7.2682 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 26
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 21
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 14 17
M  V30 20 1 15 16
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1410783-48-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1410783-65-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25664655
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective synthesis of pyrazolo[3,4-d]pyrimidine,
N-(1H-pyrazol-5-yl)formamide, or N-(1H-pyrazol-5-yl)formamidine
derivatives from N-1-substituted-5-aminopyrazoles with new Vilsmeier-type
reagents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chang, Chun-Hsi; Tsai, Henry J.; Huang, Yu-Ying; Lin, Hui-Yi; Wang,
Li-Ya; Wu, Tian-Shung; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2013), 69(4), 1378-1386

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
12-Bromo-2-methyl-2-dodecene
C13H25Br
1427302-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 6.6687 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3338 1.5400 0.0 0
M  V30 8 C 10.6698 2.3101 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3338 0.0000 0.0 0
M  V30 11 C 12.0035 1.5400 0.0 0
M  V30 12 C 13.3372 2.3101 0.0 0
M  V30 13 C 14.6708 1.5400 0.0 0
M  V30 14 Br 16.0046 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(11-Bromo-1,1-dimethylundecyl)formamide
C14H28BrNO
1353562-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4137 1.8973 0.0 0
M  V30 2 C 5.7474 2.6673 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 7.0811 1.8973 0.0 0
M  V30 5 N 2.3101 1.3337 0.0 0
M  V30 6 C 3.8501 4.0010 0.0 0
M  V30 7 C 1.7462 3.4374 0.0 0
M  V30 8 C 8.4149 2.6673 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 9.7486 1.8973 0.0 0
M  V30 11 O 0.0000 0.0000 0.0 0
M  V30 12 C 11.0822 2.6673 0.0 0
M  V30 13 C 12.4159 1.8973 0.0 0
M  V30 14 C 13.7497 2.6673 0.0 0
M  V30 15 C 15.0834 1.8973 0.0 0
M  V30 16 C 16.4171 2.6673 0.0 0
M  V30 17 Br 17.7507 1.8973 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1427302-62-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1353562-14-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-375800
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7758-02-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Ritter reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of N-substituted amides from alkenes and amides by a
Bronsted acid mediated electrophilic addition reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mihara, Karin; Okada, Iku; Chiba, Kazuhiro; Kitano, Yoshikazu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2014), 46(11), 1455-1462, 8 pp.

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-[4-(trifluoromethyl)phenyl]-3-pyridinamine
C12H8ClF3N2
1565870-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 4.0009 0.0 0
M  V30 2 Cl 0.0000 4.0009 0.0 0
M  V30 3 C 9.2400 4.0009 0.0 0
M  V30 4 F 9.2400 5.5409 0.0 0
M  V30 5 F 10.7800 4.0009 0.0 0
M  V30 6 F 9.2400 2.4609 0.0 0
M  V30 7 C 4.6200 4.0009 0.0 0
M  V30 8 C 5.3900 5.3347 0.0 0
M  V30 9 C 5.3900 2.6673 0.0 0
M  V30 10 C 6.9300 5.3347 0.0 0
M  V30 11 C 6.9300 2.6673 0.0 0
M  V30 12 C 7.7000 4.0009 0.0 0
M  V30 13 C 2.3100 2.6673 0.0 0
M  V30 14 C 0.7700 2.6673 0.0 0
M  V30 15 C 3.0800 1.3336 0.0 0
M  V30 16 C 0.0000 1.3336 0.0 0
M  V30 17 N 2.3100 0.0000 0.0 0
M  V30 18 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[4-(Trifluoromethyl)phenyl]-3H-imidazo[4,5-c]pyridine
C13H8F3N3
1565870-73-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7546 4.9318 0.0 0
M  V30 2 F 8.9846 6.2655 0.0 0
M  V30 3 F 11.0882 5.7018 0.0 0
M  V30 4 F 10.5246 3.5981 0.0 0
M  V30 5 N 4.4197 1.8517 0.0 0
M  V30 6 C 3.0128 2.4781 0.0 0
M  V30 7 C 4.2587 0.3202 0.0 0
M  V30 8 C 1.9823 1.3337 0.0 0
M  V30 9 C 2.5369 3.9428 0.0 0
M  V30 10 N 2.7523 0.0000 0.0 0
M  V30 11 C 0.4759 1.6538 0.0 0
M  V30 12 N 1.0304 4.2630 0.0 0
M  V30 13 C 0.0000 3.1186 0.0 0
M  V30 14 C 5.7534 2.6218 0.0 0
M  V30 15 C 5.7534 4.1618 0.0 0
M  V30 16 C 7.0871 1.8517 0.0 0
M  V30 17 C 7.0871 4.9318 0.0 0
M  V30 18 C 8.4208 2.6218 0.0 0
M  V30 19 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 19
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1565870-63-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1565870-73-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8466067
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1359986-21-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 1359986-22-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Experimental D: Palladium Amidation of
3-Amino-4-chloropyridines. To an oven-dried 25 mL Schlenk tube equipped
with a stirbar were added Pd2(dba)3·CHCl3 (1 mol %), Me3(OMe)t-BuXPhos (5
mol %), K3PO4 (1.5 equiv), and pyridine 3 (1 equiv). The reaction vessel
was evacuated under vacuum and refilled with Ar(g).t-BuOH (0.2 M) and
formamide (1.5 equiv) were then added via syringe, and the reaction
mixture was degassed by three vacuum/Ar(g) purge cycles. The reaction
vessel was then equipped with a coldfinger condenser, placed in a
preheated 110°C oil bath, and stirred for the specified time. Upon
consumption of pyridine 3 (as judged by TLC analysis), the reaction
mixture was allowed to cool to room temperature. The reaction mixture was
diluted with methanol and passed through a Celite plug. The crude mixture
was concentrated in vacuo and applied to a silica gel column eluted with
the indicated solvent mixture(s) to give the desired product.
3-Benzyl-3H-imidazo[4,5-c]pyridine (4a). 37 Following general procedure
D: Pyridine 3a (88 mg, 0.4 mmol), Pd2(dba)3·CHCl3 (4.14 mg, 0.004 mmol),
Me3(OMe)-tert-butyl-XPhos26 (10 mg, 0.02 mmol), K3PO4 (128 mg, 0.6 mmol),
and formamide (0.024 mL, 0.6 mmol) were combined with 2 mL of tert-butyl
alcohol in a 25 mL Schlenk tube. After 4 h, TLC analysis indicated the
reaction was complete. The reaction mixture was cooled to rt, filtered
through Celite, concentrated in vacuo, and purified on a silica gel
column, eluted with 3% MeOH/DCM.
3-(4-(Trifluoromethyl)phenyl)-3H-imidazo[4,5-c]pyridine (4j). Following
general procedure D: Pyridine 3j (108 mg, 0.4 mmol), Pd2(dba)3·CHCl3(4
mg, 0.004 mmol), Me3(OMe)-tert-butyl-XPhos26 (10 mg, 0.02 mmol), K3PO4
(128 mg, 0.6 mmol), and formamide (0.024 mL, 0.6 mmol) were combined with
2 mL of tert-butyl alcohol in a 25 mL Schlenk tube. After 6 h, TLC
analysis indicated the reaction was complete. The reaction mixture was
cooled to rt,filtered through Celite, concentrated in vacuo, and purified
on a silica gel column, eluted with 4% MeOH/DCM. 96 mg of pyridine 4j
(91%) as a pale yellow solid. Mp 166-167°C; R f = 0.30 (5% MeOH/DCM); 1H
NMR (600 MHz, CDCl3 ) δ = 8.97 (s, 1H), 8.52 (d, J = 5.7 Hz, 1H), 8.25
(s, 1H), 7.88 (d, J = 8.4 Hz, 2H), 7.76 (d, J = 5.7 Hz, 1H), 7.69 (d, J =
8.4 Hz, 2H); 13C NMR (150 MHz, CDCl3 ) δ = 149.4, 144.4, 143.1, 138.5,
133.9, 131.0, 130.8 (q, J C-F = 33.3 Hz), 127.8 (q, J C-F = 3.7 Hz),
123.9, 123.5 (q, J C-F = 272.9 Hz), 115.5; 19F NMR (282.3 MHz, CDCl3 ) δ
=-63.0; FT-IR (NaCl, thinfilm) ν = 3056, 1606, 1334, 1106 cm-1 . Anal.
Calcd for C13H8F3N3 : C, 59.32; H, 3.06; N, 15.96. Found: C, 59.04; H,
2.77; N, 15.67.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper- and Palladium-Catalyzed Amidation Reactions for the Synthesis of
Substituted Imidazo[4,5-c]pyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wilson, Robert J.; Rosenberg, Adam J.; Kaminsky, Lauren; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(5), 2203-2212

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(1-methylethyl)-3-pyridinamine
C8H11ClN2
160843-96-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 C 4.6200 5.3349 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 Cl 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Methylethyl)-1H-imidazo[4,5-b]pyridine
C9H11N3
1283181-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 3.1885 0.0 0
M  V30 2 C 7.1956 2.7126 0.0 0
M  V30 3 C 5.4107 4.6949 0.0 0
M  V30 4 C 3.0800 2.4782 0.0 0
M  V30 5 C 2.3100 1.1445 0.0 0
M  V30 6 N 4.5865 2.1580 0.0 0
M  V30 7 C 2.3100 3.8119 0.0 0
M  V30 8 N 3.3406 0.0000 0.0 0
M  V30 9 N 0.7700 1.1445 0.0 0
M  V30 10 C 4.7474 0.6265 0.0 0
M  V30 11 C 0.7700 3.8119 0.0 0
M  V30 12 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 160843-96-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1283181-03-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10366605
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved synthesis of imidazo[4,5-b]pyridines and
imidazo[4,5-b]pyrazines by palladium catalyzed amidation using xantphos
in a 1,4-Dioxane:tert-amyl alcohol aolvent aystem
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Ahmed, Ijaz; Wilson, Robert J.; Williams, Theresa M.;
Kaminsky, Lauren; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(16), 3465-3470

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(1-methylethyl)-3-pyridinamine
C8H11ClN2
160843-96-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 C 4.6200 5.3349 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 Cl 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Methylethyl)-1H-imidazo[4,5-b]pyridine
C9H11N3
1283181-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 3.1885 0.0 0
M  V30 2 C 7.1956 2.7126 0.0 0
M  V30 3 C 5.4107 4.6949 0.0 0
M  V30 4 C 3.0800 2.4782 0.0 0
M  V30 5 C 2.3100 1.1445 0.0 0
M  V30 6 N 4.5865 2.1580 0.0 0
M  V30 7 C 2.3100 3.8119 0.0 0
M  V30 8 N 3.3406 0.0000 0.0 0
M  V30 9 N 0.7700 1.1445 0.0 0
M  V30 10 C 4.7474 0.6265 0.0 0
M  V30 11 C 0.7700 3.8119 0.0 0
M  V30 12 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 160843-96-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1283181-03-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11876117
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 29154-12-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1160861-53-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1-(4-Methoxybenzyl)-1H-imidazo[4,5-b]pyridine
(3a) To an oven-dried 25 mL Schlenk-tube equipped with a stirbar was
added Pd2(dba)3 · CHCl3 (20.8 mg, 0.02 mmol),
2-Di-t-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-tri-i-propylbiphenyl
(L1) (48 mg, 0.1 mmol), K3PO4 (639 mg, 3.01 mmol) and
2-Chloro-N-(4-methoxybenzyl)pyridin-3-amine (2a) (500 mg, 2.01 mmol) (if
solid). The tube was evacuated and refilled with Ar(g). Formamide (0.12
mL, 3.01 mmol) was added via syringe as a single portion, followed by the
chloropyridine (if liquid) in 4 mL of tert-butanol. The reaction mixture
was degassed with 3 x vacuum / Ar(g) purge cycles. The reaction vessel
was then equipped with a cold-finger under a positive pressure of argon
gas and immersed in a 110°C pre-heated oil-bath for 4h at which time TLC
showed consumption of the chloro-pyridine. The reaction was cooled to
room temperature, diluted with MeOH (4 mL) filtered through a Celite plug
and concentrated to give a dark brown oil. The crude product was purified
on a silica gel column (4.5 cm x 12 cm), eluting with 4% MeOH in CH2Cl2.
1-Isopropyl-1H-imidazo[4,5-b]pyridine (3h) Following the general
experimental; 2-chloro-N-isopropylpyridin-3-amine (2h) (68 mg, 0.4 mmol),
Pd2(dba)3·CHCl3 (4.14 mg, 0.004 mmol), t-BuBrettphos (9.7 mg, 0.02 mmol),
K3PO4 (128 mg, 0.6 mmol), formamide (0.022 mL, 0.6 mmol) were combined
with 2.0 mL tert-butanol in a 25 mL Schlenk flask. After 3 h the reaction
was complete, the reaction cooled to RT, filtered through Celite,
concentrated and purified on a silica gel column (2.5 cm x 12 cm),
eluting with 4% MeOH / CH2Cl2. 3h as 59 mg of a white solid (91%). 1H NMR
(300 MHz, CDCl3) δ = 8.53 (dd, J = 4.5 Hz, 1.2 Hz, 1H), 8.19 (s, 1H),
7.75 (dd, J = 8.1 Hz, 1.5 Hz, 1H), 7.20 (dd, J = 8.1 Hz, 4.8 Hz, 1H),
4.63 (sept, J = 6.6 Hz, 1H), 1.61 (d, J = 6.6 Hz, 6H); 13C NMR (75.4 MHz,
CDCl3) δ = 156.4, 144.9, 142.6, 125.5, 118.5, 117.9, 48.6, 22.6; FT-IR
(NaCl, thin film) ν = 2980, 2936, 1607, 1488, 1397, 1306, 1282, 1225, 786
cm-1. HRMS (ESI) Calc (C9H11N3)H+: 162.1026, Found: 162.1033; MP:
134-136°C; Rf (4% MeOH / CH2Cl2): 0.25.
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Imidazo[4,5-b]pyridines and Imidazo[4,5-b]pyrazines by
Palladium Catalyzed Amidation of 2-Chloro-3-amino-heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Zhao, Jinbo; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(7), 1764-1767

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
12-Fluoro-2-methyl-2-dodecene
C13H25F
1629636-98-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 6.6687 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3338 1.5400 0.0 0
M  V30 8 C 10.6698 2.3101 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3338 0.0000 0.0 0
M  V30 11 C 12.0035 1.5400 0.0 0
M  V30 12 C 13.3372 2.3101 0.0 0
M  V30 13 C 14.6708 1.5400 0.0 0
M  V30 14 F 16.0046 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(11-Fluoro-1,1-dimethylundecyl)formamide
C14H28FNO
1353562-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4137 1.8973 0.0 0
M  V30 2 C 5.7474 2.6673 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 7.0811 1.8973 0.0 0
M  V30 5 N 2.3101 1.3337 0.0 0
M  V30 6 C 1.7462 3.4374 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 8.4149 2.6673 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 9.7486 1.8973 0.0 0
M  V30 11 O 0.0000 0.0000 0.0 0
M  V30 12 C 11.0822 2.6673 0.0 0
M  V30 13 C 12.4159 1.8973 0.0 0
M  V30 14 C 13.7497 2.6673 0.0 0
M  V30 15 C 15.0834 1.8973 0.0 0
M  V30 16 C 16.4171 2.6673 0.0 0
M  V30 17 F 17.7507 1.8973 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1629636-98-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1353562-12-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-4939831
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-75-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Ritter reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of N-substituted amides from alkenes and amides by a
Bronsted acid mediated electrophilic addition reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mihara, Karin; Okada, Iku; Chiba, Kazuhiro; Kitano, Yoshikazu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2014), 46(11), 1455-1462, 8 pp.

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,7-dihydrospiro[benzo[b]thiophene-6(5H),2′-[1,3]dioxolane]-3-c...
C13H17NO4S
173032-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.1006 3.3321 0.0 0
M  V30 2 O 9.5652 2.8561 0.0 0
M  V30 3 O 7.7804 4.8384 0.0 0
M  V30 4 C 10.7096 3.8867 0.0 0
M  V30 5 C 12.1743 3.4106 0.0 0
M  V30 6 N 8.4507 0.0000 0.0 0
M  V30 7 C 5.4498 2.6217 0.0 0
M  V30 8 C 4.6798 1.2881 0.0 0
M  V30 9 C 6.9562 2.3015 0.0 0
M  V30 10 C 4.6798 3.9555 0.0 0
M  V30 11 C 3.1398 1.2881 0.0 0
M  V30 12 S 5.7103 0.1437 0.0 0
M  V30 13 C 7.1171 0.7700 0.0 0
M  V30 14 C 3.1398 3.9555 0.0 0
M  V30 15 C 2.3698 2.6217 0.0 0
M  V30 16 O 1.4647 1.3758 0.0 0
M  V30 17 O 1.4647 3.8676 0.0 0
M  V30 18 C 0.0000 1.8517 0.0 0
M  V30 19 C 0.0000 3.3917 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5,6,8-Tetrahydrospiro[[1]benzothieno[2,3-d]pyrimidine-7(4H),2′-[1,3]dioxola...
C12H12N2O3S
835632-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 7.4001 4.2405 0.0 0
M  V30 3 C 6.1542 5.1457 0.0 0
M  V30 4 C 7.2392 2.7089 0.0 0
M  V30 5 O 7.7203 5.7467 0.0 0
M  V30 6 O 8.7339 3.4704 0.0 0
M  V30 7 C 4.7474 4.5192 0.0 0
M  V30 8 C 5.8324 2.0824 0.0 0
M  V30 9 C 9.2520 5.9078 0.0 0
M  V30 10 C 9.8783 4.5009 0.0 0
M  V30 11 C 4.5863 2.9876 0.0 0
M  V30 12 S 3.3405 5.1457 0.0 0
M  V30 13 C 3.0800 2.6675 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 2.3100 1.3338 0.0 0
M  V30 16 N 0.7700 4.0011 0.0 0
M  V30 17 N 0.7700 1.3338 0.0 0
M  V30 18 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 7 12
M  V30 12 1 8 11
M  V30 13 1 9 10
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 173032-58-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 835632-37-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-619485
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted thienopyrimidines as MKNK inhibitors for
treatment of particularly hyperproliferative an angiogenesis disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kettschau, Georg; Puehler, Florian; Klar, Ulrich; Wortmann, Lars; Lienau,
Philip; Kosemund, Dirk; Suelzle, Detlev; Haegebarth, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014118229 A1 2014-08-07

$RFMT $RIREG SCHEME324 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine benzyl ester
C9H11NO2
1738-68-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 O 6.6684 0.0000 0.0 0
M  V30 6 N 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formylglycine benzyl ester
C10H11NO3
51354-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 N 9.3360 3.0801 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 O 12.0033 3.0801 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1738-68-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 51354-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-12850081
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 5470-11-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, 100% conversion
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transamidation of primary amides with amines using hydroxylamine
hydrochloride as an inorganic catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allen, C. Liana; Atkinson, Benjamin N.; Williams, Jonathan M. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2012), 51(6), 1383-1386,
S1383/1-S1383/33

$RFMT $RIREG SCHEME325 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Bromophenoxy)naphthalene
C16H11BrO
1919855-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 0.0000 0.0 0
M  V30 2 Br 12.0033 3.0801 0.0 0
M  V30 3 C 2.6673 0.7700 0.0 0
M  V30 4 C 2.6673 2.3101 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 8.0022 0.7700 0.0 0
M  V30 14 C 8.0022 2.3101 0.0 0
M  V30 15 C 9.3360 0.0000 0.0 0
M  V30 16 C 9.3360 3.0801 0.0 0
M  V30 17 C 10.6697 0.7700 0.0 0
M  V30 18 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 13
M  V30 3 1 2 18
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 2 5 9
M  V30 10 2 6 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Naphthalenyloxy)benzonitrile
C17H11NO
214268-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.8501 0.0 0
M  V30 2 C 12.0033 0.7700 0.0 0
M  V30 3 N 13.3370 0.0000 0.0 0
M  V30 4 C 2.6673 1.5400 0.0 0
M  V30 5 C 2.6673 3.0801 0.0 0
M  V30 6 C 4.0010 0.7700 0.0 0
M  V30 7 C 1.3337 0.7700 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 1.3337 3.8501 0.0 0
M  V30 10 C 5.3348 1.5400 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.3348 3.0801 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 8.0022 3.0801 0.0 0
M  V30 15 C 8.0022 1.5400 0.0 0
M  V30 16 C 9.3360 3.8501 0.0 0
M  V30 17 C 9.3360 0.7700 0.0 0
M  V30 18 C 10.6697 3.0801 0.0 0
M  V30 19 C 10.6697 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 14
M  V30 3 3 2 3
M  V30 4 1 2 19
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 2 6 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1919855-73-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 214268-39-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28749792
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Cyanation of Aryl Halides Using Formamide and
Cyanuric Chloride as a New "CN" Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niknam, Esmaeil; Panahi, Farhad; Khalafi-Nezhad, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2020), 2020(18), 2699-2707

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Chlorophenyl)-1-phenyl-1H-pyrazol-5-amine
C15H12ClN3
19652-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.7385 0.0000 0.0 0
M  V30 2 Cl 12.3671 6.3388 0.0 0
M  V30 3 C 7.0323 3.2587 0.0 0
M  V30 4 N 5.6253 3.8850 0.0 0
M  V30 5 C 6.8712 1.7271 0.0 0
M  V30 6 N 4.5948 2.7406 0.0 0
M  V30 7 C 5.3649 1.4070 0.0 0
M  V30 8 C 8.3659 4.0287 0.0 0
M  V30 9 C 8.3659 5.5688 0.0 0
M  V30 10 C 9.6996 3.2587 0.0 0
M  V30 11 C 9.6996 6.3388 0.0 0
M  V30 12 C 11.0333 4.0287 0.0 0
M  V30 13 C 11.0333 5.5688 0.0 0
M  V30 14 C 3.0633 2.9016 0.0 0
M  V30 15 C 2.1580 1.6557 0.0 0
M  V30 16 C 2.4368 4.3086 0.0 0
M  V30 17 C 0.6265 1.8166 0.0 0
M  V30 18 C 0.9052 4.4695 0.0 0
M  V30 19 C 0.0000 3.2236 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 13
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Chlorophenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C17H11ClN4
667909-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 12.3669 7.5408 0.0 0
M  V30 2 C 7.0321 4.4608 0.0 0
M  V30 3 C 6.8711 2.9292 0.0 0
M  V30 4 N 5.6252 5.0873 0.0 0
M  V30 5 C 5.3648 2.6091 0.0 0
M  V30 6 C 7.9016 1.7849 0.0 0
M  V30 7 N 4.5948 3.9427 0.0 0
M  V30 8 N 4.8889 1.1444 0.0 0
M  V30 9 N 7.4258 0.3202 0.0 0
M  V30 10 C 5.9193 0.0000 0.0 0
M  V30 11 C 8.3658 5.2308 0.0 0
M  V30 12 C 9.6994 4.4608 0.0 0
M  V30 13 C 8.3658 6.7708 0.0 0
M  V30 14 C 11.0331 5.2308 0.0 0
M  V30 15 C 9.6994 7.5408 0.0 0
M  V30 16 C 11.0331 6.7708 0.0 0
M  V30 17 C 3.0632 4.1037 0.0 0
M  V30 18 C 2.1580 2.8578 0.0 0
M  V30 19 C 2.4368 5.5106 0.0 0
M  V30 20 C 0.6265 3.0187 0.0 0
M  V30 21 C 0.9052 5.6715 0.0 0
M  V30 22 C 0.0000 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19652-14-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 667909-99-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26608808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective synthesis of pyrazolo[3,4-d]pyrimidine,
N-(1H-pyrazol-5-yl)formamide, or N-(1H-pyrazol-5-yl)formamidine
derivatives from N-1-substituted-5-aminopyrazoles with new Vilsmeier-type
reagents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chang, Chun-Hsi; Tsai, Henry J.; Huang, Yu-Ying; Lin, Hui-Yi; Wang,
Li-Ya; Wu, Tian-Shung; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2013), 69(4), 1378-1386

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Chlorophenyl)-1-phenyl-1H-pyrazol-5-amine
C15H12ClN3
19652-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.7385 0.0000 0.0 0
M  V30 2 Cl 12.3671 6.3388 0.0 0
M  V30 3 C 7.0323 3.2587 0.0 0
M  V30 4 N 5.6253 3.8850 0.0 0
M  V30 5 C 6.8712 1.7271 0.0 0
M  V30 6 N 4.5948 2.7406 0.0 0
M  V30 7 C 5.3649 1.4070 0.0 0
M  V30 8 C 8.3659 4.0287 0.0 0
M  V30 9 C 8.3659 5.5688 0.0 0
M  V30 10 C 9.6996 3.2587 0.0 0
M  V30 11 C 9.6996 6.3388 0.0 0
M  V30 12 C 11.0333 4.0287 0.0 0
M  V30 13 C 11.0333 5.5688 0.0 0
M  V30 14 C 3.0633 2.9016 0.0 0
M  V30 15 C 2.1580 1.6557 0.0 0
M  V30 16 C 2.4368 4.3086 0.0 0
M  V30 17 C 0.6265 1.8166 0.0 0
M  V30 18 C 0.9052 4.4695 0.0 0
M  V30 19 C 0.0000 3.2236 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 13
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Chlorophenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C17H11ClN4
667909-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 12.3669 7.5408 0.0 0
M  V30 2 C 7.0321 4.4608 0.0 0
M  V30 3 C 6.8711 2.9292 0.0 0
M  V30 4 N 5.6252 5.0873 0.0 0
M  V30 5 C 5.3648 2.6091 0.0 0
M  V30 6 C 7.9016 1.7849 0.0 0
M  V30 7 N 4.5948 3.9427 0.0 0
M  V30 8 N 4.8889 1.1444 0.0 0
M  V30 9 N 7.4258 0.3202 0.0 0
M  V30 10 C 5.9193 0.0000 0.0 0
M  V30 11 C 8.3658 5.2308 0.0 0
M  V30 12 C 9.6994 4.4608 0.0 0
M  V30 13 C 8.3658 6.7708 0.0 0
M  V30 14 C 11.0331 5.2308 0.0 0
M  V30 15 C 9.6994 7.5408 0.0 0
M  V30 16 C 11.0331 6.7708 0.0 0
M  V30 17 C 3.0632 4.1037 0.0 0
M  V30 18 C 2.1580 2.8578 0.0 0
M  V30 19 C 2.4368 5.5106 0.0 0
M  V30 20 C 0.6265 3.0187 0.0 0
M  V30 21 C 0.9052 5.6715 0.0 0
M  V30 22 C 0.0000 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19652-14-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 667909-99-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-1598746
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Chlorophenyl)-1-phenyl-1H-pyrazol-5-amine
C15H12ClN3
19652-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.7385 0.0000 0.0 0
M  V30 2 Cl 12.3671 6.3388 0.0 0
M  V30 3 C 7.0323 3.2587 0.0 0
M  V30 4 N 5.6253 3.8850 0.0 0
M  V30 5 C 6.8712 1.7271 0.0 0
M  V30 6 N 4.5948 2.7406 0.0 0
M  V30 7 C 5.3649 1.4070 0.0 0
M  V30 8 C 8.3659 4.0287 0.0 0
M  V30 9 C 8.3659 5.5688 0.0 0
M  V30 10 C 9.6996 3.2587 0.0 0
M  V30 11 C 9.6996 6.3388 0.0 0
M  V30 12 C 11.0333 4.0287 0.0 0
M  V30 13 C 11.0333 5.5688 0.0 0
M  V30 14 C 3.0633 2.9016 0.0 0
M  V30 15 C 2.1580 1.6557 0.0 0
M  V30 16 C 2.4368 4.3086 0.0 0
M  V30 17 C 0.6265 1.8166 0.0 0
M  V30 18 C 0.9052 4.4695 0.0 0
M  V30 19 C 0.0000 3.2236 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 13
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Chlorophenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C17H11ClN4
667909-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 12.3669 7.5408 0.0 0
M  V30 2 C 7.0321 4.4608 0.0 0
M  V30 3 C 6.8711 2.9292 0.0 0
M  V30 4 N 5.6252 5.0873 0.0 0
M  V30 5 C 5.3648 2.6091 0.0 0
M  V30 6 C 7.9016 1.7849 0.0 0
M  V30 7 N 4.5948 3.9427 0.0 0
M  V30 8 N 4.8889 1.1444 0.0 0
M  V30 9 N 7.4258 0.3202 0.0 0
M  V30 10 C 5.9193 0.0000 0.0 0
M  V30 11 C 8.3658 5.2308 0.0 0
M  V30 12 C 9.6994 4.4608 0.0 0
M  V30 13 C 8.3658 6.7708 0.0 0
M  V30 14 C 11.0331 5.2308 0.0 0
M  V30 15 C 9.6994 7.5408 0.0 0
M  V30 16 C 11.0331 6.7708 0.0 0
M  V30 17 C 3.0632 4.1037 0.0 0
M  V30 18 C 2.1580 2.8578 0.0 0
M  V30 19 C 2.4368 5.5106 0.0 0
M  V30 20 C 0.6265 3.0187 0.0 0
M  V30 21 C 0.9052 5.6715 0.0 0
M  V30 22 C 0.0000 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19652-14-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 667909-99-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26193837
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
Pyrazolo[3,4-d]-pyrimidines (17-32, 65, 66, and 73-76). The reliable
procedure involved the treatment of 5-aminopyrazoles (1-16; 1.0 equiv),
5- amino-4-formylpyrazoles (37-41; 1.0 equiv), 5-aminoquinoline (61; 1.0
equiv), 8-aminoquinoline (62; 1.0 equiv), 5-aminopyrimidine (68; 1.0
equiv), or 2-aminopyrazines (69-71; 1.0 equiv) with PBr3 (~ 3 equiv) in
formamide solution (2 mL) at 50-60 °C over 0.5-1 h. When the reaction was
complete, the reaction mixture was added to saturated sodium bicarbonate
(15 mL) and extracted with dichloromethane (15 mL). The organic extracts
were dried over MgSO4, filtered, and concentrated under reduced pressure.
The residue solution was purified by column chromatography on silica gel
to give the corresponding aromatic or heterocyclic fused pyrimidine
products (17-32, 65, 66, and 73-76) in 82-96% yields.
3-(4-Chlorophenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine(31).25 The
standard procedure involved the treatment of
5-amino-3-(4-chlorophenyl)-1-phenyl-1H-pyrazole (15; 99 mg, 0.32 mmol,
1.0 equiv) with PBr3 (90 μL, 0.97 mmol, 3 equiv) in formamide solution (2
mL) at 50-60 °C over 0.5-1 h. The reaction mixture was then worked up,
and the residue was purified by chromatography on silica gel to give pure
31: 91% yield (89 mg), light yellow solid. Mp 196- 197 °C (hexane-EtOAc).
1H NMR (CDCl3, 500 MHz): δ 7.34-7.38 (1H, m), 7.48-7.58 (m, 4 H, ArH),
7.96-8.02 (2H, m), 8.24-8.30 (2H, m), 9.12 (1H, s), 9.46 (1H, s). 13C NMR
(125 MHz, CDCl3): δ 114.0, 121.5 (2 × C), 127.0, 128.5 (2 × C), 129.3 (2
× C), 129.5 (2 × C), 130.0, 135.7, 138.4, 143.8, 152.6, 153.3, 155.7. IR
(KBr): 3043, 2926, 2848, 1585, 1368, 1219, 1093 cm-1. EIMS m/z (rel int):
306 (100, M+). Anal. Calcd for C17H11ClN4: C, 66.56; H, 3.61; N, 18.26.
Found: C, 66.53; H, 3.62; N, 18.29.
$DTYPE RXN:VAR(1):NOTES
$DATUM sequential three-component heterocyclization, one-pot multi-component
process
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME327 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, (2-mercapto-1-methylethyl)-, 9H-fluoren-9-ylmethyl ester, (R)-
C18H19NO2S
202751-94-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2310 0.0 0
M  V30 2 O 7.0870 4.4610 0.0 0
M  V30 3 C 8.4207 5.2310 0.0 0
M  V30 4 N 9.7543 4.4610 0.0 0
M  V30 5 O 8.4207 6.7710 0.0 0
M  V30 6 C 11.0881 5.2310 0.0 0 CFG=2
M  V30 7 C 12.4218 4.4610 0.0 0
M  V30 8 C 11.0881 6.7710 0.0 0
M  V30 9 S 13.7554 5.2310 0.0 0
M  V30 10 C 4.4195 4.4610 0.0 0
M  V30 11 C 4.2586 2.9293 0.0 0
M  V30 12 C 3.0127 5.0873 0.0 0
M  V30 13 C 2.7523 2.6091 0.0 0
M  V30 14 C 5.2890 1.7849 0.0 0
M  V30 15 C 1.9823 3.9429 0.0 0
M  V30 16 C 2.5369 6.5520 0.0 0
M  V30 17 C 2.2763 1.1445 0.0 0
M  V30 18 C 4.8132 0.3202 0.0 0
M  V30 19 C 0.4759 4.2631 0.0 0
M  V30 20 C 1.0304 6.8722 0.0 0
M  V30 21 C 3.3069 0.0000 0.0 0
M  V30 22 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 2 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C20H22N2O3S
2602313-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2310 0.0 0
M  V30 2 O 7.0870 4.4610 0.0 0
M  V30 3 C 8.4208 5.2310 0.0 0
M  V30 4 N 9.7545 4.4610 0.0 0
M  V30 5 O 8.4208 6.7710 0.0 0
M  V30 6 C 11.0881 5.2310 0.0 0 CFG=2
M  V30 7 C 12.4218 4.4610 0.0 0
M  V30 8 C 11.0881 6.7710 0.0 0
M  V30 9 S 13.7556 5.2310 0.0 0
M  V30 10 C 15.0892 4.4610 0.0 0
M  V30 11 N 16.4229 5.2310 0.0 0
M  V30 12 C 17.7565 4.4610 0.0 0
M  V30 13 O 19.0904 5.2310 0.0 0
M  V30 14 C 4.4197 4.4610 0.0 0
M  V30 15 C 4.2588 2.9293 0.0 0
M  V30 16 C 3.0127 5.0873 0.0 0
M  V30 17 C 2.7523 2.6091 0.0 0
M  V30 18 C 5.2892 1.7849 0.0 0
M  V30 19 C 1.9823 3.9429 0.0 0
M  V30 20 C 2.5369 6.5520 0.0 0
M  V30 21 C 2.2765 1.1445 0.0 0
M  V30 22 C 4.8133 0.3202 0.0 0
M  V30 23 C 0.4760 4.2631 0.0 0
M  V30 24 C 1.0306 6.8722 0.0 0
M  V30 25 C 3.3069 0.0000 0.0 0
M  V30 26 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 202751-94-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2602313-24-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23164317
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM paraformaldehyde used, Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Nβ-Protected Amino Sulfenyl Methyl Formamides and Sulfonyl
Methyl Formamides: A Simple Protocol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasulu, Chinthaginjala; Sagar, Nagamangala R.; Vishwanatha,
Thimmalapura M.; Durgamma, Suram; Sureshbabu, Vommina V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2021), 6(7), 4680-4686

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-bromobenzoic acid
C7H6BrNO2
20776-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-4(3H)-quinazolinone
C8H5BrN2O
77150-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0801 0.0 0
M  V30 2 Br 6.6687 2.3101 0.0 0
M  V30 3 C 2.6675 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 1.3338 2.3101 0.0 0
M  V30 6 C 2.6675 4.6201 0.0 0
M  V30 7 C 5.3348 3.0801 0.0 0
M  V30 8 N 4.0012 0.7700 0.0 0
M  V30 9 N 1.3338 0.7700 0.0 0
M  V30 10 C 4.0012 5.3901 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20776-51-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 77150-35-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31670880
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of quinazoline derivatives as novel small-molecule inhibitors
targeting the programmed cell death-1/programmed cell death-ligand 1
(PD-1/PD-L1) interaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Yu; Kun Huang; Gao, Yali; Yuan, Dandan; Ling, Lin; Liu, Jieqing;
Wu, Sihai; Chen, Roufen; Li, He; Xiong, Yizu; Liu, Han; Ma, Junjie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 229113998

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-4-carboxylic acid, 3-amino-1-ethyl-5-methyl-, ethyl ester
C9H15N3O2
2093459-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 1.5400 0.0 0
M  V30 2 O 7.5415 2.3101 0.0 0
M  V30 3 O 6.2079 0.0000 0.0 0
M  V30 4 C 8.8752 1.5400 0.0 0
M  V30 5 C 10.2089 2.3101 0.0 0
M  V30 6 C 3.1471 0.1773 0.0 0
M  V30 7 N 5.8577 4.8721 0.0 0
M  V30 8 C 0.9051 2.6672 0.0 0
M  V30 9 C 0.0000 3.9131 0.0 0
M  V30 10 C 4.8741 2.3101 0.0 0
M  V30 11 C 3.4672 1.6836 0.0 0
M  V30 12 C 4.7131 3.8416 0.0 0
M  V30 13 N 2.4368 2.8281 0.0 0
M  V30 14 N 3.2068 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethyl-1,2-dihydro-3-methyl-4H-pyrazolo[3,4-d]pyrimidin-4-one
C8H10N4O
2093459-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0204 0.0000 0.0 0
M  V30 2 O 0.0000 1.3172 0.0 0
M  V30 3 C 6.0810 1.3627 0.0 0
M  V30 4 C 7.4148 2.1327 0.0 0
M  V30 5 C 2.3100 2.6508 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 C 3.3406 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 N 4.5864 3.6643 0.0 0
M  V30 10 N 2.3100 5.3182 0.0 0
M  V30 11 N 4.7474 2.1327 0.0 0
M  V30 12 N 0.0000 3.9844 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2093459-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2093459-52-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17357647
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic fused pyrimidinone and triazinone derivatives as
new TRPA1 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aiguade Bosch, Jose; Connolly, Stephen; Eastwood, Paul Robert; Gomez
Castillo, Elena; Moreno Mollo, Immaculada Montserrat; Roberts, Richard
Spurring; Sevilla Gomez, Sara
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017060488 A1 2017-04-13

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-1-(4-chlorophenyl)-1H-pyrrole-2-carboxylate
C13H13ClN2O2
2099711-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9845 0.0 0
M  V30 2 O 1.7849 4.4604 0.0 0
M  V30 3 O 4.3940 5.0150 0.0 0
M  V30 4 C 1.4647 5.9667 0.0 0
M  V30 5 C 0.0000 6.4426 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 Cl 10.3115 4.9318 0.0 0
M  V30 8 N 4.9766 1.8517 0.0 0
M  V30 9 C 3.5696 2.4781 0.0 0
M  V30 10 C 4.8157 0.3202 0.0 0
M  V30 11 C 2.5392 1.3337 0.0 0
M  V30 12 C 3.3092 0.0000 0.0 0
M  V30 13 C 6.3103 2.6218 0.0 0
M  V30 14 C 7.6440 1.8517 0.0 0
M  V30 15 C 6.3103 4.1618 0.0 0
M  V30 16 C 8.9778 2.6218 0.0 0
M  V30 17 C 7.6440 4.9318 0.0 0
M  V30 18 C 8.9778 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Chlorophenyl)-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one
C12H8ClN3O
2099711-75-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 Cl 9.7546 4.9318 0.0 0
M  V30 3 N 4.4197 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 C 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 C 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6540 0.0 0
M  V30 10 N 1.0306 4.2631 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 7.0871 1.8517 0.0 0
M  V30 14 C 5.7534 4.1618 0.0 0
M  V30 15 C 8.4208 2.6218 0.0 0
M  V30 16 C 7.0871 4.9318 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2099711-74-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2099711-75-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18710628
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaromatic NMDA receptor modulators for treating
neuropsychiatric disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anderson, David R.; Volkmann, Robert A.; Mennite, Frank S.; Fanger,
Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017100591 A1 2017-06-15

$RFMT $RIREG SCHEME331 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-3-(2-methoxyethoxy)-1-methyl-1H-pyrazole-4-carbonitrile
C8H12N4O2
2132994-89-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3028 2.8691 0.0 0
M  V30 2 C 6.6365 3.6391 0.0 0
M  V30 3 C 7.9701 2.8691 0.0 0
M  V30 4 O 9.3038 3.6391 0.0 0
M  V30 5 C 10.6376 2.8691 0.0 0
M  V30 6 C 2.2420 1.5063 0.0 0
M  V30 7 N 1.9218 0.0000 0.0 0
M  V30 8 N 0.0000 3.9962 0.0 0
M  V30 9 C 1.6752 6.8978 0.0 0
M  V30 10 C 3.9690 3.6391 0.0 0
M  V30 11 C 2.5622 3.0128 0.0 0
M  V30 12 N 3.8080 5.1707 0.0 0
M  V30 13 C 1.5317 4.1572 0.0 0
M  V30 14 N 2.3017 5.4910 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 3 6 7
M  V30 7 1 6 11
M  V30 8 1 8 13
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2-Methoxyethoxy)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C9H13N5O2
2133002-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7306 4.6948 0.0 0
M  V30 2 C 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 O 9.8044 4.7735 0.0 0
M  V30 5 C 10.9488 5.8040 0.0 0
M  V30 6 N 3.0800 6.6519 0.0 0
M  V30 7 C 3.0202 0.0000 0.0 0
M  V30 8 C 3.0800 3.9844 0.0 0
M  V30 9 C 2.3100 2.6508 0.0 0
M  V30 10 C 4.5863 3.6643 0.0 0
M  V30 11 C 2.3100 5.3182 0.0 0
M  V30 12 N 3.3404 1.5064 0.0 0
M  V30 13 N 0.7700 2.6508 0.0 0
M  V30 14 N 4.7472 2.1327 0.0 0
M  V30 15 N 0.7700 5.3182 0.0 0
M  V30 16 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2132994-89-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2133002-19-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21088757
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine
receptor 4 (CCR4) antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miah, Afjal H.; Champigny, Aurelie C.; Graves, Rebecca H.; Hodgson, Simon
T.; Percy, Jonathan M.; Procopiou, Panayiotis A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(20), 5327-5340

$RFMT $RIREG SCHEME332 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(4-methoxyphenyl)acetamide
C9H10ClNO2
22303-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 Cl 10.6697 2.3101 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Formyloxy)-N-(4-methoxyphenyl)acetamide
C10H11NO4
1802772-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 8.0022 0.7700 0.0 0
M  V30 5 O 10.6697 2.3101 0.0 0
M  V30 6 C 12.0033 3.0801 0.0 0
M  V30 7 O 13.3370 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 4.0010 3.0801 0.0 0
M  V30 13 C 4.0010 0.0000 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22303-36-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1802772-45-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29388882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Vilsmeier-Haack reagent-promoted formyloxylation of
α-chloro-N-arylacetamides by formamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Jiann-Jyh; Lu, Shi-Han; Chung, Yu Hsuan; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2015), 5(45), 35934-35939

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-1-cyclopropyl-3-[(phenylmethoxy)methyl]-1H-pyrazole-4-carbonitrile
C15H16N4O
2244618-96-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5315 2.4999 0.0 0
M  V30 2 C 4.7180 1.4645 0.0 0
M  V30 3 N 5.1938 0.0000 0.0 0
M  V30 4 C 6.6873 4.1751 0.0 0
M  V30 5 O 7.4573 5.5088 0.0 0
M  V30 6 C 8.9973 5.5088 0.0 0
M  V30 7 N 2.7774 4.9451 0.0 0
M  V30 8 C 2.7774 3.4051 0.0 0
M  V30 9 N 4.2421 5.4210 0.0 0
M  V30 10 C 4.2421 2.9292 0.0 0
M  V30 11 C 5.1473 4.1751 0.0 0
M  V30 12 C 1.5315 5.8503 0.0 0
M  V30 13 C 0.9052 7.2571 0.0 0
M  V30 14 C 0.0000 6.0113 0.0 0
M  V30 15 C 9.7673 6.8426 0.0 0
M  V30 16 C 8.9973 8.1762 0.0 0
M  V30 17 C 11.3074 6.8426 0.0 0
M  V30 18 C 9.7673 9.5099 0.0 0
M  V30 19 C 12.0774 8.1762 0.0 0
M  V30 20 C 11.3074 9.5099 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 3 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 12
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Cyclopropyl-3-[(phenylmethoxy)methyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C16H17N5O
2244618-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.5602 0.0 0
M  V30 2 O 7.0870 4.7902 0.0 0
M  V30 3 C 8.4207 5.5602 0.0 0
M  V30 4 N 3.5673 8.0257 0.0 0
M  V30 5 C 1.9823 4.2722 0.0 0
M  V30 6 N 2.7523 2.9384 0.0 0
M  V30 7 C 3.0127 5.4166 0.0 0
M  V30 8 N 0.4759 4.5923 0.0 0
M  V30 9 N 4.2586 3.2587 0.0 0
M  V30 10 C 4.4196 4.7902 0.0 0
M  V30 11 C 2.5369 6.8813 0.0 0
M  V30 12 C 0.0000 6.0569 0.0 0
M  V30 13 N 1.0304 7.2015 0.0 0
M  V30 14 C 2.1258 1.5316 0.0 0
M  V30 15 C 2.2869 0.0000 0.0 0
M  V30 16 C 0.8800 0.6263 0.0 0
M  V30 17 C 9.7543 4.7902 0.0 0
M  V30 18 C 11.0882 5.5602 0.0 0
M  V30 19 C 9.7543 3.2502 0.0 0
M  V30 20 C 12.4218 4.7902 0.0 0
M  V30 21 C 11.0882 2.4802 0.0 0
M  V30 22 C 12.4218 3.2502 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 17
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 14
M  V30 11 1 7 10
M  V30 12 2 7 11
M  V30 13 1 8 12
M  V30 14 2 9 10
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2244618-96-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2244618-97-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28957132
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazolopyrimidinamines as CDPK1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hopper, Allen T.; Sibley, L. David; Janetka, James W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020061279 A1 2020-03-26

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-1-cyclopropyl-3-[(phenylmethoxy)methyl]-1H-pyrazole-4-carbonitrile
C15H16N4O
2244618-96-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5315 2.4999 0.0 0
M  V30 2 C 4.7180 1.4645 0.0 0
M  V30 3 N 5.1938 0.0000 0.0 0
M  V30 4 C 6.6873 4.1751 0.0 0
M  V30 5 O 7.4573 5.5088 0.0 0
M  V30 6 C 8.9973 5.5088 0.0 0
M  V30 7 N 2.7774 4.9451 0.0 0
M  V30 8 C 2.7774 3.4051 0.0 0
M  V30 9 N 4.2421 5.4210 0.0 0
M  V30 10 C 4.2421 2.9292 0.0 0
M  V30 11 C 5.1473 4.1751 0.0 0
M  V30 12 C 1.5315 5.8503 0.0 0
M  V30 13 C 0.9052 7.2571 0.0 0
M  V30 14 C 0.0000 6.0113 0.0 0
M  V30 15 C 9.7673 6.8426 0.0 0
M  V30 16 C 8.9973 8.1762 0.0 0
M  V30 17 C 11.3074 6.8426 0.0 0
M  V30 18 C 9.7673 9.5099 0.0 0
M  V30 19 C 12.0774 8.1762 0.0 0
M  V30 20 C 11.3074 9.5099 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 3 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 12
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Cyclopropyl-3-[(phenylmethoxy)methyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C16H17N5O
2244618-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.5602 0.0 0
M  V30 2 O 7.0870 4.7902 0.0 0
M  V30 3 C 8.4207 5.5602 0.0 0
M  V30 4 N 3.5673 8.0257 0.0 0
M  V30 5 C 1.9823 4.2722 0.0 0
M  V30 6 N 2.7523 2.9384 0.0 0
M  V30 7 C 3.0127 5.4166 0.0 0
M  V30 8 N 0.4759 4.5923 0.0 0
M  V30 9 N 4.2586 3.2587 0.0 0
M  V30 10 C 4.4196 4.7902 0.0 0
M  V30 11 C 2.5369 6.8813 0.0 0
M  V30 12 C 0.0000 6.0569 0.0 0
M  V30 13 N 1.0304 7.2015 0.0 0
M  V30 14 C 2.1258 1.5316 0.0 0
M  V30 15 C 2.2869 0.0000 0.0 0
M  V30 16 C 0.8800 0.6263 0.0 0
M  V30 17 C 9.7543 4.7902 0.0 0
M  V30 18 C 11.0882 5.5602 0.0 0
M  V30 19 C 9.7543 3.2502 0.0 0
M  V30 20 C 12.4218 4.7902 0.0 0
M  V30 21 C 11.0882 2.4802 0.0 0
M  V30 22 C 12.4218 3.2502 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 17
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 14
M  V30 11 1 7 10
M  V30 12 2 7 11
M  V30 13 1 8 12
M  V30 14 2 9 10
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2244618-96-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2244618-97-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26837499
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidines and analogs as calcium dependent
protein kinase 1 (CDPK1) inhibitors, compositions, and methods for
treating parasitic infections including toxoplasmosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hopper, Allen T.; Sibley, L. David; Janetka, James W.; Helander, Jon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019036001 A1 2019-02-21

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-1-cyclopropyl-3-[(phenylmethoxy)methyl]-1H-pyrazole-4-carbonitrile
C15H16N4O
2244618-96-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5315 2.4999 0.0 0
M  V30 2 C 4.7180 1.4645 0.0 0
M  V30 3 N 5.1938 0.0000 0.0 0
M  V30 4 C 6.6873 4.1751 0.0 0
M  V30 5 O 7.4573 5.5088 0.0 0
M  V30 6 C 8.9973 5.5088 0.0 0
M  V30 7 N 2.7774 4.9451 0.0 0
M  V30 8 C 2.7774 3.4051 0.0 0
M  V30 9 N 4.2421 5.4210 0.0 0
M  V30 10 C 4.2421 2.9292 0.0 0
M  V30 11 C 5.1473 4.1751 0.0 0
M  V30 12 C 1.5315 5.8503 0.0 0
M  V30 13 C 0.9052 7.2571 0.0 0
M  V30 14 C 0.0000 6.0113 0.0 0
M  V30 15 C 9.7673 6.8426 0.0 0
M  V30 16 C 8.9973 8.1762 0.0 0
M  V30 17 C 11.3074 6.8426 0.0 0
M  V30 18 C 9.7673 9.5099 0.0 0
M  V30 19 C 12.0774 8.1762 0.0 0
M  V30 20 C 11.3074 9.5099 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 3 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 12
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Cyclopropyl-3-[(phenylmethoxy)methyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C16H17N5O
2244618-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.5602 0.0 0
M  V30 2 O 7.0870 4.7902 0.0 0
M  V30 3 C 8.4207 5.5602 0.0 0
M  V30 4 N 3.5673 8.0257 0.0 0
M  V30 5 C 1.9823 4.2722 0.0 0
M  V30 6 N 2.7523 2.9384 0.0 0
M  V30 7 C 3.0127 5.4166 0.0 0
M  V30 8 N 0.4759 4.5923 0.0 0
M  V30 9 N 4.2586 3.2587 0.0 0
M  V30 10 C 4.4196 4.7902 0.0 0
M  V30 11 C 2.5369 6.8813 0.0 0
M  V30 12 C 0.0000 6.0569 0.0 0
M  V30 13 N 1.0304 7.2015 0.0 0
M  V30 14 C 2.1258 1.5316 0.0 0
M  V30 15 C 2.2869 0.0000 0.0 0
M  V30 16 C 0.8800 0.6263 0.0 0
M  V30 17 C 9.7543 4.7902 0.0 0
M  V30 18 C 11.0882 5.5602 0.0 0
M  V30 19 C 9.7543 3.2502 0.0 0
M  V30 20 C 12.4218 4.7902 0.0 0
M  V30 21 C 11.0882 2.4802 0.0 0
M  V30 22 C 12.4218 3.2502 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 17
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 14
M  V30 11 1 7 10
M  V30 12 2 7 11
M  V30 13 1 8 12
M  V30 14 2 9 10
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2244618-96-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2244618-97-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-22114287
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidines as CDPK1 inhibitors, compositions and
methods related thereto
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hopper, Allen T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018170236 A1 2018-09-20

$RFMT $RIREG SCHEME334 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-4-cyano-2-naphthalenecarboxylate
C14H12N2O2
2399456-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 5.3900 0.0 0
M  V30 2 N 0.0000 6.1600 0.0 0
M  V30 3 N 4.0011 6.9300 0.0 0
M  V30 4 C 6.6684 5.3900 0.0 0
M  V30 5 O 8.0021 4.6200 0.0 0
M  V30 6 O 6.6684 6.9300 0.0 0
M  V30 7 C 9.3358 5.3900 0.0 0
M  V30 8 C 10.6694 4.6200 0.0 0
M  V30 9 C 2.6673 3.0800 0.0 0
M  V30 10 C 2.6673 4.6200 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 13 C 4.0011 5.3900 0.0 0
M  V30 14 C 5.3347 3.0800 0.0 0
M  V30 15 C 4.0011 0.7700 0.0 0
M  V30 16 C 1.3336 0.7700 0.0 0
M  V30 17 C 5.3347 4.6200 0.0 0
M  V30 18 C 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 17
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-4-oxobenzo[g]quinazoline-10-carbonitrile
C13H7N3O
2399457-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 5.3900 0.0 0
M  V30 2 N 0.0000 6.1600 0.0 0
M  V30 3 O 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 5.3900 0.0 0
M  V30 5 C 2.6674 4.6200 0.0 0
M  V30 6 C 5.3347 4.6200 0.0 0
M  V30 7 N 4.0011 6.9300 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 5.3347 3.0800 0.0 0
M  V30 10 C 6.6685 5.3900 0.0 0
M  V30 11 C 5.3347 7.7000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 14 N 6.6685 6.9300 0.0 0
M  V30 15 C 4.0011 0.7700 0.0 0
M  V30 16 C 1.3336 0.7700 0.0 0
M  V30 17 C 2.6674 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 2 3 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 8 13
M  V30 13 1 9 12
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 13 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2399456-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2399457-35-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20932117
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu(I)-Catalyzed Ligand-Free Tandem One-Pot or Sequential Annulation via
Knoevenagel Intermediates: An Entry into Multifunctional Naphthalenes,
Phenanthrenes, Quinolines, and Benzo[b]carbazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sunke, Rajnikanth; Kalyani, Adula; Swamy, K. C. Kumara
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2020), 85(2), 1073-1086

$RFMT $RIREG SCHEME335 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C19H13N3O6S
2413011-89-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7036 0.7700 0.0 0
M  V30 2 C 2.3698 0.0000 0.0 0
M  V30 3 C 6.9778 1.1395 0.0 0
M  V30 4 C 8.9470 3.8500 0.0 0
M  V30 5 N 9.7170 5.1837 0.0 0
M  V30 6 O 9.7170 2.5164 0.0 0
M  V30 7 O 14.3370 2.5164 0.0 0
M  V30 8 O 16.9878 4.4734 0.0 0
M  V30 9 C 5.0372 3.0800 0.0 0
M  V30 10 C 5.0372 4.6200 0.0 0
M  V30 11 C 3.7036 2.3100 0.0 0
M  V30 12 C 6.5018 2.6042 0.0 0
M  V30 13 O 6.5018 5.0959 0.0 0
M  V30 14 C 3.7036 5.3900 0.0 0
M  V30 15 C 2.3698 3.0800 0.0 0
M  V30 16 C 7.4070 3.8500 0.0 0
M  V30 17 C 2.3698 4.6200 0.0 0
M  V30 18 C 0.9052 2.6042 0.0 0
M  V30 19 O 0.9052 5.0959 0.0 0
M  V30 20 C 0.0000 3.8500 0.0 0
M  V30 21 C 11.2570 5.1837 0.0 0
M  V30 22 N 12.0270 6.5175 0.0 0
M  V30 23 C 12.0270 3.8500 0.0 0
M  V30 24 C 13.5670 6.5175 0.0 0
M  V30 25 C 13.5670 3.8500 0.0 0
M  V30 26 N 14.3370 5.1837 0.0 0
M  V30 27 S 14.5976 7.6618 0.0 0
M  V30 28 C 15.8434 5.5038 0.0 0
M  V30 29 C 16.0044 7.0355 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 5 21
M  V30 8 2 7 25
M  V30 9 2 8 28
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 2 15 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 24 27
M  V30 30 1 25 26
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C20H14N4O5S
2413012-00-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7036 0.7700 0.0 0
M  V30 2 C 2.3698 0.0000 0.0 0
M  V30 3 C 6.9778 1.1395 0.0 0
M  V30 4 O 14.3370 7.8510 0.0 0
M  V30 5 O 16.9878 5.8939 0.0 0
M  V30 6 C 5.0372 3.0800 0.0 0
M  V30 7 C 5.0372 4.6200 0.0 0
M  V30 8 C 3.7036 2.3100 0.0 0
M  V30 9 C 6.5018 2.6040 0.0 0
M  V30 10 O 6.5018 5.0959 0.0 0
M  V30 11 C 3.7036 5.3900 0.0 0
M  V30 12 C 2.3698 3.0800 0.0 0
M  V30 13 C 7.4070 3.8500 0.0 0
M  V30 14 C 2.3698 4.6200 0.0 0
M  V30 15 C 0.9052 2.6040 0.0 0
M  V30 16 O 0.9052 5.0959 0.0 0
M  V30 17 C 0.0000 3.8500 0.0 0
M  V30 18 C 8.9470 3.8500 0.0 0
M  V30 19 N 9.7170 5.1837 0.0 0
M  V30 20 N 9.7170 2.5162 0.0 0
M  V30 21 C 11.2570 5.1837 0.0 0
M  V30 22 C 11.2570 2.5162 0.0 0
M  V30 23 N 12.0270 3.8500 0.0 0
M  V30 24 C 12.0270 6.5173 0.0 0
M  V30 25 C 13.5670 3.8500 0.0 0
M  V30 26 C 13.5670 6.5173 0.0 0
M  V30 27 N 14.3370 5.1837 0.0 0
M  V30 28 S 14.5976 2.7055 0.0 0
M  V30 29 C 15.8434 4.8635 0.0 0
M  V30 30 C 16.0044 3.3320 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 9
M  V30 4 2 4 26
M  V30 5 2 5 29
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 16 1 12 15
M  V30 17 1 13 18
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 2 21 24
M  V30 27 1 22 23
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 25 28
M  V30 32 1 26 27
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2413011-89-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2413012-00-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25821871
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel benzodifuranyl; 1,3,5-triazines; 1,3,5-oxadiazepines;
and thiazolopyrimidines derived from visnaginone and khellinone as
anti-inflammatory and analgesic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abu-Hashem, Ameen Ali; Al-Hussain, Sami A.; Zaki, Magdi E. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2020), 25(1), 220pp.

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-methylene-4-(methylphenylamino)-4-oxobutanoate
C13H15NO3
2529933-55-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 4.0012 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 O 5.3348 3.8501 0.0 0
M  V30 6 C 8.0022 2.3101 0.0 0
M  V30 7 C 9.3360 1.5400 0.0 0
M  V30 8 C 8.0022 3.8501 0.0 0
M  V30 9 O 10.6697 2.3101 0.0 0
M  V30 10 O 9.3360 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 1.3337 1.5400 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1′-Methylspiro[pyrrolidine-3,4′(1′H)-quinoline]-2,2′,5(3′H)-trione
C13H12N2O3
2529933-68-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.0492 6.7117 0.0 0
M  V30 2 O 1.5400 6.6685 0.0 0
M  V30 3 O 8.2357 2.3259 0.0 0
M  V30 4 C 0.0000 4.0011 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 3.8500 5.3347 0.0 0
M  V30 8 C 5.5252 2.7552 0.0 0
M  V30 9 C 5.5252 5.2470 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 6.9898 3.2311 0.0 0
M  V30 14 N 6.9898 4.7711 0.0 0
M  V30 15 N 1.5400 4.0011 0.0 0
M  V30 16 C 1.5400 1.3338 0.0 0
M  V30 17 C 3.8500 0.0000 0.0 0
M  V30 18 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 12
M  V30 3 2 3 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 2 10 16
M  V30 16 1 11 17
M  V30 17 1 12 15
M  V30 18 1 13 14
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2529933-55-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2529933-68-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22924794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7720-78-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical (Hg lamp (450W) used (stage 1)), Fenton reaction (stage 1),
continuous flow mode (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biobased Spiroimides from Itaconic Acid and Formamides: Molecular Targets
for a Novel Synthetic Application of Renewable Chemicals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hornink, Milene Macedo; Lopes, Alice Uva; Andrade, Leandro Helgueira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2021), 53(2), 296-308

$RFMT $RIREG SCHEME337 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[4-(trifluoromethyl)phenyl]acetamide
C9H7ClF3NO
2707-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 4.2073 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 1.1273 0.0 0
M  V30 5 N 7.7000 2.6673 0.0 0
M  V30 6 C 8.4700 1.3336 0.0 0
M  V30 7 C 10.0100 1.3336 0.0 0
M  V30 8 O 7.7000 0.0000 0.0 0
M  V30 9 Cl 10.7800 0.0000 0.0 0
M  V30 10 C 3.0800 2.6673 0.0 0
M  V30 11 C 3.8500 1.3336 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 5.3900 1.3336 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Formyloxy)-N-[4-(trifluoromethyl)phenyl]acetamide
C10H8F3NO3
1802772-47-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.3337 0.0 0
M  V30 2 F 2.1037 0.0000 0.0 0
M  V30 3 F 0.0000 0.5637 0.0 0
M  V30 4 F 0.5637 2.6673 0.0 0
M  V30 5 N 6.6685 4.4137 0.0 0
M  V30 6 C 8.0022 3.6437 0.0 0
M  V30 7 C 9.3360 4.4137 0.0 0
M  V30 8 O 8.0022 2.1037 0.0 0
M  V30 9 O 10.6697 3.6437 0.0 0
M  V30 10 C 12.0033 4.4137 0.0 0
M  V30 11 O 13.3370 3.6437 0.0 0
M  V30 12 C 2.6673 2.1037 0.0 0
M  V30 13 C 2.6673 3.6437 0.0 0
M  V30 14 C 4.0010 1.3337 0.0 0
M  V30 15 C 4.0010 4.4137 0.0 0
M  V30 16 C 5.3348 2.1037 0.0 0
M  V30 17 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 2 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2707-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1802772-47-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25262878
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Vilsmeier-Haack reagent-promoted formyloxylation of
α-chloro-N-arylacetamides by formamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Jiann-Jyh; Lu, Shi-Han; Chung, Yu Hsuan; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2015), 5(45), 35934-35939

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-(2,2-difluoroethoxy)-5-(5-fluoro-2-pyridinyl)benzoic acid
C14H11F3N2O3
2776086-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 O 6.6685 0.0000 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 O 2.6673 5.3901 0.0 0
M  V30 5 C 2.6673 6.9302 0.0 0
M  V30 6 C 1.3337 7.7002 0.0 0
M  V30 7 F 1.3337 9.2402 0.0 0
M  V30 8 F 0.0000 6.9302 0.0 0
M  V30 9 N 2.6673 2.3101 0.0 0
M  V30 10 F 12.0033 7.7002 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 6.6685 3.0801 0.0 0
M  V30 13 C 5.3348 5.3901 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 4.0012 4.6201 0.0 0
M  V30 16 C 4.0012 3.0801 0.0 0
M  V30 17 C 8.0022 5.3901 0.0 0
M  V30 18 C 8.0022 6.9302 0.0 0
M  V30 19 N 9.3360 4.6201 0.0 0
M  V30 20 C 9.3360 7.7002 0.0 0
M  V30 21 C 10.6697 5.3901 0.0 0
M  V30 22 C 10.6697 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 16
M  V30 10 1 10 22
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-(2,2-Difluoroethoxy)-6-(5-fluoro-2-pyridinyl)-4(3H)-quinazolinone
C15H10F3N3O2
2776086-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 5.3900 0.0 0
M  V30 2 C 2.6673 6.9300 0.0 0
M  V30 3 C 1.3336 7.7000 0.0 0
M  V30 4 F 1.3336 9.2400 0.0 0
M  V30 5 F 0.0000 6.9300 0.0 0
M  V30 6 O 6.6684 0.0000 0.0 0
M  V30 7 F 12.0031 7.7000 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 N 2.6673 2.3100 0.0 0
M  V30 12 C 6.6684 3.0800 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 14 C 5.3347 5.3900 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 6.6684 4.6200 0.0 0
M  V30 17 N 4.0011 0.0000 0.0 0
M  V30 18 C 8.0020 5.3900 0.0 0
M  V30 19 C 8.0020 6.9300 0.0 0
M  V30 20 N 9.3358 4.6200 0.0 0
M  V30 21 C 9.3358 7.7000 0.0 0
M  V30 22 C 10.6694 5.3900 0.0 0
M  V30 23 C 10.6694 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 6 13
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2776086-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2776086-92-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32751603
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of amino quinazoline P2x3 inhibitors treating respiratory
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fiorelli, Claudio; Bruno, Paolo; Biagetti, Matteo; Pizzirani, Daniela;
Pala, Daniele; Ronchi, Paolo; Guariento, Sara; Baker-Glenn, Charles; Van
de Poeel, Herve; Hirst, Kim Louise
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022112490 A1 2022-06-02

$RFMT $RIREG SCHEME339 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)-N,2-dimethyl-2-propenamide
C12H15NO2
294642-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 2.6673 2.3100 0.0 0
M  V30 3 C 4.0011 0.0000 0.0 0
M  V30 4 C 1.3336 1.5400 0.0 0
M  V30 5 O 2.6673 3.8500 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3336 0.0000 0.0 0
M  V30 8 O 9.3358 4.6200 0.0 0
M  V30 9 C 10.6694 3.8500 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 6.6684 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 6.6684 4.6200 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-5-methoxy-1,3-dimethyl-2-oxo-1H-indole-3-acetamide
C13H16N2O3
2080376-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6664 3.6643 0.0 0
M  V30 2 C 8.4364 4.9979 0.0 0
M  V30 3 N 7.6664 6.3317 0.0 0
M  V30 4 O 9.9764 4.9979 0.0 0
M  V30 5 C 6.2874 5.1958 0.0 0
M  V30 6 O 7.6210 1.3627 0.0 0
M  V30 7 C 4.5602 0.0000 0.0 0
M  V30 8 O 1.5400 6.6519 0.0 0
M  V30 9 C 0.0000 6.6519 0.0 0
M  V30 10 C 4.6200 3.9844 0.0 0
M  V30 11 C 6.1264 3.6643 0.0 0
M  V30 12 C 3.8500 2.6508 0.0 0
M  V30 13 C 3.8500 5.3182 0.0 0
M  V30 14 C 6.2874 2.1327 0.0 0
M  V30 15 N 4.8806 1.5064 0.0 0
M  V30 16 C 2.3100 2.6508 0.0 0
M  V30 17 C 2.3100 5.3182 0.0 0
M  V30 18 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 2 6 14
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 15
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 294642-84-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2080376-88-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30671963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7720-78-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Iron-Catalyzed Synthesis of Oxindoles: Application to the Preparation of
Pyrroloindolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Correia, Valquirio G.; Abreu, Juliana C.; Barata, Caio A. E.; Andrade,
Leandro H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(5), 1060-1063

$RFMT $RIREG SCHEME340 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Pyrido[2,3-b]indole-3-carbonitrile, 2-amino-4-(4-chlorophenyl)-9-methyl-
C19H13ClN4
3052429-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6518 1.5400 0.0 0
M  V30 2 N 7.9856 0.7700 0.0 0
M  V30 3 C 0.0000 4.5603 0.0 0
M  V30 4 N 3.9845 0.0000 0.0 0
M  V30 5 Cl 10.6529 6.9301 0.0 0
M  V30 6 C 3.9845 4.6201 0.0 0
M  V30 7 C 5.3182 3.8501 0.0 0
M  V30 8 C 3.6643 6.1264 0.0 0
M  V30 9 C 2.6508 3.8501 0.0 0
M  V30 10 C 5.3182 2.3100 0.0 0
M  V30 11 C 2.1328 6.2874 0.0 0
M  V30 12 C 4.5696 7.3722 0.0 0
M  V30 13 N 1.5063 4.8805 0.0 0
M  V30 14 N 2.6508 2.3100 0.0 0
M  V30 15 C 3.9845 1.5400 0.0 0
M  V30 16 C 1.5063 7.6943 0.0 0
M  V30 17 C 3.9431 8.7792 0.0 0
M  V30 18 C 2.4115 8.9401 0.0 0
M  V30 19 C 6.6518 4.6201 0.0 0
M  V30 20 C 7.9856 3.8501 0.0 0
M  V30 21 C 6.6518 6.1601 0.0 0
M  V30 22 C 9.3193 4.6201 0.0 0
M  V30 23 C 7.9856 6.9301 0.0 0
M  V30 24 C 9.3193 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 3 13
M  V30 4 1 4 15
M  V30 5 1 5 24
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 19
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 2 10 15
M  V30 16 1 11 13
M  V30 17 2 11 16
M  V30 18 1 12 17
M  V30 19 1 14 15
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10H-Pyrimido[5′,4′:5,6]pyrido[2,3-b]indol-4-amine, 5-(4-chlorophenyl)-10-methyl-
C20H14ClN5
3052429-83-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 5.3303 0.0 0
M  V30 2 N 7.9856 3.0800 0.0 0
M  V30 3 Cl 10.6530 7.7001 0.0 0
M  V30 4 C 3.9845 5.3901 0.0 0
M  V30 5 C 5.3182 4.6201 0.0 0
M  V30 6 C 2.6508 4.6201 0.0 0
M  V30 7 C 3.6643 6.8964 0.0 0
M  V30 8 C 5.3182 3.0800 0.0 0
M  V30 9 N 2.6508 3.0800 0.0 0
M  V30 10 N 1.5063 5.6505 0.0 0
M  V30 11 C 2.1328 7.0575 0.0 0
M  V30 12 C 4.5696 8.1423 0.0 0
M  V30 13 C 3.9845 2.3100 0.0 0
M  V30 14 C 6.6518 2.3100 0.0 0
M  V30 15 C 1.5063 8.4643 0.0 0
M  V30 16 C 3.9431 9.5492 0.0 0
M  V30 17 N 3.9845 0.7700 0.0 0
M  V30 18 N 6.6518 0.7700 0.0 0
M  V30 19 C 2.4115 9.7102 0.0 0
M  V30 20 C 5.3182 0.0000 0.0 0
M  V30 21 C 6.6518 5.3901 0.0 0
M  V30 22 C 7.9856 4.6201 0.0 0
M  V30 23 C 6.6518 6.9301 0.0 0
M  V30 24 C 9.3193 5.3901 0.0 0
M  V30 25 C 7.9856 7.7001 0.0 0
M  V30 26 C 9.3193 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 14
M  V30 3 1 3 26
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 21
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 2 8 14
M  V30 15 1 9 13
M  V30 16 1 10 11
M  V30 17 2 11 15
M  V30 18 1 12 16
M  V30 19 2 13 17
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 2 16 19
M  V30 23 1 17 20
M  V30 24 2 18 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3052429-53-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3052429-83-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41255458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot π-extension approach of iminoindoles-to-α-carbolines as
blue-light emitters using the cooperative basic system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lodhi, Rajni; Goud, S. Banuprakash; Samanta, Sampak
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2024), 48(32), 14163-14169

$RFMT $RIREG SCHEME341 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-5,6,7,8-tetrahydro-6-methylthieno[2,3-b][1,6]naphthyridine-2-ca...
C14H17N3O2S
308245-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.8704 0.1773 0.0 0
M  V30 2 C 9.9312 1.5400 0.0 0
M  V30 3 O 11.2649 2.3101 0.0 0
M  V30 4 O 9.9312 0.0000 0.0 0
M  V30 5 C 12.5987 1.5400 0.0 0
M  V30 6 C 13.9324 2.3101 0.0 0
M  V30 7 C 0.0000 5.4955 0.0 0
M  V30 8 C 6.9302 4.1618 0.0 0
M  V30 9 C 6.1601 2.8281 0.0 0
M  V30 10 S 8.4366 3.8416 0.0 0
M  V30 11 N 6.1601 5.4955 0.0 0
M  V30 12 C 7.1906 1.6836 0.0 0
M  V30 13 C 4.6201 2.8281 0.0 0
M  V30 14 C 8.5975 2.3101 0.0 0
M  V30 15 C 4.6201 5.4955 0.0 0
M  V30 16 C 3.8501 4.1618 0.0 0
M  V30 17 C 3.8501 6.8291 0.0 0
M  V30 18 C 2.3101 4.1618 0.0 0
M  V30 19 C 2.3101 6.8291 0.0 0
M  V30 20 N 1.5400 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 20
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7,8,9,10-Tetrahydro-9-methylpyrimido[4′,5′:4,5]thieno[2,3-b][1,6]naphthyridin...
C13H12N4OS
799829-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.8986 0.0 0
M  V30 2 C 11.4751 1.2736 0.0 0
M  V30 3 C 4.8066 2.0436 0.0 0
M  V30 4 C 3.3420 1.5678 0.0 0
M  V30 5 C 4.8066 3.5837 0.0 0
M  V30 6 C 6.1403 1.2736 0.0 0
M  V30 7 C 2.4368 2.8136 0.0 0
M  V30 8 N 2.7155 0.1609 0.0 0
M  V30 9 S 3.3420 4.0597 0.0 0
M  V30 10 N 6.1403 4.3537 0.0 0
M  V30 11 C 7.4741 2.0436 0.0 0
M  V30 12 C 0.9051 2.6527 0.0 0
M  V30 13 C 1.1840 0.0000 0.0 0
M  V30 14 C 7.4741 3.5837 0.0 0
M  V30 15 C 8.8078 1.2736 0.0 0
M  V30 16 N 0.2787 1.2459 0.0 0
M  V30 17 C 8.8078 4.3537 0.0 0
M  V30 18 N 10.1414 2.0436 0.0 0
M  V30 19 C 10.1414 3.5837 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 18
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 308245-61-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 799829-45-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30043359
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetracyclic compounds as glucose uptake inhibitors and preparation
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nakache, Philippe; Erez, Omri; Botti, Simone; Goutopoulos, Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021095032 A1 2021-05-20

$RFMT $RIREG SCHEME342 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-(4-chlorophenyl)-4-methyl-3-furancarbonitrile
C12H9ClN2O
312307-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4323 0.0000 0.0 0
M  V30 2 C 1.2459 1.0353 0.0 0
M  V30 3 N 0.0000 0.1301 0.0 0
M  V30 4 N 1.2459 4.3856 0.0 0
M  V30 5 Cl 11.0215 2.7104 0.0 0
M  V30 6 C 4.8615 2.7104 0.0 0
M  V30 7 C 3.9564 1.4645 0.0 0
M  V30 8 O 3.9564 3.9564 0.0 0
M  V30 9 C 2.4917 1.9404 0.0 0
M  V30 10 C 2.4917 3.4804 0.0 0
M  V30 11 C 6.4015 2.7104 0.0 0
M  V30 12 C 7.1715 4.0442 0.0 0
M  V30 13 C 7.1715 1.3768 0.0 0
M  V30 14 C 8.7115 4.0442 0.0 0
M  V30 15 C 8.7115 1.3768 0.0 0
M  V30 16 C 9.4815 2.7104 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 3 2 3
M  V30 3 1 2 9
M  V30 4 1 4 10
M  V30 5 1 5 16
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Chlorophenyl)-5-methylfuro[2,3-d]pyrimidin-4-amine
C13H10ClN3O
866181-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6079 0.3695 0.0 0
M  V30 2 N 1.3337 0.0000 0.0 0
M  V30 3 Cl 11.1972 3.0800 0.0 0
M  V30 4 C 2.6673 2.3100 0.0 0
M  V30 5 C 4.1320 1.8342 0.0 0
M  V30 6 C 2.6673 3.8500 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 5.0371 3.0800 0.0 0
M  V30 9 O 4.1320 4.3259 0.0 0
M  V30 10 N 1.3337 4.6201 0.0 0
M  V30 11 N 0.0000 2.3100 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 C 6.5771 3.0800 0.0 0
M  V30 14 C 7.3471 4.4137 0.0 0
M  V30 15 C 7.3471 1.7464 0.0 0
M  V30 16 C 8.8871 4.4137 0.0 0
M  V30 17 C 8.8871 1.7464 0.0 0
M  V30 18 C 9.6571 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 7
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 1 8 13
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 312307-51-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 866181-61-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21320525
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 6: Preparation of 4-amino
furopyrimidine-based compound
4-amino-6-(4-chlorophenyl)furo[2,3,d]Pyrimidine(Vla) 20ml of formamide
was applied dropwisely to the 4.37 g (20 mmol) of 2-
amino-3-cyano-5-(4-chlorophenyl)furan (IVa) obtained in Example 5, which
was heated and refluxed for 12 hours and then cooled at a room
temperature. 100 ml of water was added thereto, and a generated solid was
filtered, which was washed with water and n-hexane sufficiently, and
then, dried. Thereafter, the resultant material was re-crystallized with
acetone and ethylalcohol to obtain a brown-colored solid product of
4-amino-6-(4-chlorophenyl)furo[2,3,d]pyrimidine (VIa). Compounds Vlb to
VIy of table 4 were also obtained, respectively, according to the same
method. [Table 4] VId, yield 91% Table 4 shows analysis results of the
obtained 4-amino furopyrimidine based compound VIa to VIy 1H NMR (400 MHz
DMSO-d6) δ (ppm) : 8.17 (s, 1H), 7.72 (d, J = 8.8 Hz, 2H), 7.57 (d, J =
8.8 Hz, 2H), 7.28-7.13 (br s, 2H), 2.51 (s, 3H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of furo[2,3-d]pyrimidines as inhibitors of DDR2 (discoidin
domain receptor 2) tyrosine kinase.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Beom-Seok; Yang, Kyung-Mi; Kim, Hae-Jong; Park, In-Sung; Park,
Sung-Dae; Lee, Jang-Hyuk; Kwon, Hyuk-Man; Woo, Byoung-Young
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005092896 A1 2005-10-06

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole
C16H12N4O
330792-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2420 3.9845 0.0 0
M  V30 2 N 1.9217 5.4908 0.0 0
M  V30 3 N 0.0000 1.4946 0.0 0
M  V30 4 O 9.3038 4.9318 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 C 2.5622 2.4781 0.0 0
M  V30 7 N 3.8080 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 N 2.3016 0.0000 0.0 0
M  V30 10 C 5.3026 2.6218 0.0 0
M  V30 11 C 6.6365 1.8517 0.0 0
M  V30 12 C 5.3026 4.1618 0.0 0
M  V30 13 C 7.9701 2.6218 0.0 0
M  V30 14 C 6.6365 4.9318 0.0 0
M  V30 15 C 7.9701 4.1618 0.0 0
M  V30 16 C 10.6375 4.1618 0.0 0
M  V30 17 C 10.6375 2.6218 0.0 0
M  V30 18 C 11.9713 4.9318 0.0 0
M  V30 19 C 11.9713 1.8517 0.0 0
M  V30 20 C 13.3050 4.1618 0.0 0
M  V30 21 C 13.3050 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 15
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 10
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C17H13N5O
330786-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5673 5.0873 0.0 0
M  V30 2 O 9.7544 4.9318 0.0 0
M  V30 3 C 4.4196 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 N 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 N 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6540 0.0 0
M  V30 10 N 1.0304 4.2631 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 7.0871 1.8517 0.0 0
M  V30 14 C 5.7534 4.1618 0.0 0
M  V30 15 C 8.4208 2.6218 0.0 0
M  V30 16 C 7.0871 4.9318 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 18 C 11.0882 4.1618 0.0 0
M  V30 19 C 12.4219 4.9318 0.0 0
M  V30 20 C 11.0882 2.6218 0.0 0
M  V30 21 C 13.7556 4.1618 0.0 0
M  V30 22 C 12.4219 1.8517 0.0 0
M  V30 23 C 13.7556 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 17
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 12
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 6 8
M  V30 11 2 6 9
M  V30 12 1 7 10
M  V30 13 1 9 11
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 330792-70-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 330786-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-18786283
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of Ibrutinib and its intermediates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kandagatla, Bhaskar; Sen, Saikat; Oruganti, Srinivas; Dhanukar, Vilas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2014CH05522 A 2016-08-26

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoroaniline
C6H6FN
348-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 4.6201 2.6673 0.0 0
M  V30 2 N 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-Bis(2-fluorophenyl)methanimidamide
C13H10F2N2
18464-34-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0
M  V30 4 F 1.3337 0.0000 0.0 0
M  V30 5 F 9.3360 0.0000 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 0.0000 3.8501 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 9.3360 1.5400 0.0 0
M  V30 14 C 8.0023 3.8501 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 12
M  V30 5 1 4 7
M  V30 6 1 5 13
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 348-54-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18464-34-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25446749
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
N,N′-Diarylformamidines (50-56 and 73). The reliable procedure involved
the treatment of arylamines (43-49; 1.0 equiv) or 3-aminopyridine (68;
1.0 equiv) with PBr3 (~3.0 equiv) in formamide solution (2 mL) at 50-60
°C over 0.5-1.0 h. When the reaction was complete, the crude solid was
triturated in cold n-pentane and filtered through a glass frit with
suction. Then the solid was washed with n-pentane and dried in vacuo to
give the crude formamidines (50-56 and 73). The crude products were
recrystallized from the mixture of acetone and diisopropyl ether to give
the corresponding N,N′-diarylformamidine products (50-56 and 73) in
88-97% yields as white to light yellow solids.
N,N'-Bis(2-fluorohenyl)formamidine (54).35 The standard procedure
involved the treatment of 2-fluoroaniline (47; 51 mg, 0.53 mmol, 1.0
equiv) with PBr3 (0.15 mL, 1.6 mmol, 3.0 equiv) in formamide solution (2
mL) at 50-60 °C over 0.5-1.0 h. The reaction mixture was then worked up,
and the residue was purified by chromatography on silica gel to give pure
54: 91% yield (112 mg), yellow oil (CH2Cl2- methanol). 1H NMR (CDCl3, 200
MHz): δ 6.42-6.46 (1H, m), 6.57-6.61 (1H, m), 6.70-6.76 (2H, m),
7.08-7.12 (2H, m), 7.21- 7.25 (2H, m), 7.61 (1H, s), 7.92 (1H, s). 13C
NMR (50 MHz, CDCl3): δ 114.3, 116.3, 118.4, 125.5, 124.4 (2 × C), 127.9
(2 × C), 128.1, 137.5, 153.9, 156.1, 162.8. IR (KBr): 3127, 2951, 2847,
1637, 1561, 1494, 1456, 1277, 1232, 1207, 1175, 1121, 1038 cm-1. EIMS m/
z (rel int): 232 (100, M+). Anal. Calcd for C13H10F2N2: C, 67.24; H,
4.32; N, 12.06. Found: C, 67.22; H, 4.31; N, 12.01.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME345 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(4-Bromophenyl)methyl]-2(1H)-quinoxalinone
C15H11BrN2O
361189-38-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 Br 10.6694 4.6200 0.0 0
M  V30 4 C 2.6673 4.6200 0.0 0
M  V30 5 C 1.3336 3.8500 0.0 0
M  V30 6 N 4.0011 3.8500 0.0 0
M  V30 7 C 2.6673 6.1600 0.0 0
M  V30 8 N 1.3336 2.3100 0.0 0
M  V30 9 C 0.0000 4.6200 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 6.9300 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 0.0000 6.1600 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 8.0021 1.5400 0.0 0
M  V30 16 C 6.6684 3.8500 0.0 0
M  V30 17 C 9.3358 2.3100 0.0 0
M  V30 18 C 8.0021 4.6200 0.0 0
M  V30 19 C 9.3358 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 14
M  V30 3 2 2 12
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(4-Bromophenyl)methyl]-3,4-dihydro-3-oxo-1(2H)-quinoxalinecarboxaldehyde
C16H13BrN2O2
2840644-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.7700 0.0 0
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 O 6.6685 5.3901 0.0 0
M  V30 5 Br 12.0033 5.3901 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 N 4.0012 2.3101 0.0 0
M  V30 8 C 2.6673 4.6201 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 N 4.0012 5.3901 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 8.0022 3.0801 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 9.3360 2.3101 0.0 0
M  V30 19 C 9.3360 5.3901 0.0 0
M  V30 20 C 10.6697 3.0801 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 10
M  V30 4 1 3 16
M  V30 5 2 4 14
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 361189-38-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2840644-45-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34270934
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):NOTES
$DATUM conformer ratio 1:0.3, Leuckart reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-benzylquinoxalin-2(1H)-ones and
4-formyl-3-benzyl-3,4-dihydroquinoxalin-2(1H)-ones from
3-aryloxirane-2-carboxamides via
5-arylidene-2,2-dimethyl-1,3-oxazolidin-4-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mamedov, Vakhid A.; Mamedova, Vera L.; Syakaev, Victor V.; Voronina,
Julia K.; Mahrous, Essam M.; Khikmatova, Gul'naz Z.; Korshin, Dmitry E.;
Shamsutdinova, Leisan R.; Rizvanov, Il'dar Kh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2022), 124132963

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobenzylamine
C7H10N2
4403-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Aminophenyl)methyl]formamide
C8H10N2O
146039-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 O 9.3360 2.3101 0.0 0
M  V30 5 N 0.0000 0.0000 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6675 0.0000 0.0 0
M  V30 11 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4403-71-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 146039-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-12582332
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM R-XIX. a. N-(4-Amino-benzyl)-fromamide (62). A total of 0.5 mL of
4-amino-benzylamine (4 mmol) was dissolved in 3 mL formamide, heated to
80 °C and reacted for 4 h, when the reaction was completed (GC). The
reaction mixture was poured into 20 mL of water and extracted with 3 × 20
mL of ethylacetate. The organic phase collected was evaporated under
pressure, yielding a thick liquid (0.5 g; 91.0%). MS(EI): M+(measured) =
150.1; M+(calc) = 150.2; minor (trans) 1H NMR (ppm): 4.24 (2H, d, 6 Hz,
CH2), 5.00 (2H, bs, NH2), 7.20-7.35 (2H, dd, 2.6 Hz, 8.4 Hz, CH3,5),
7.50-7.70 (2H, dd, 1.0 Hz, 8.4 Hz, CH2,6), 7.96 (1H, dd, 1.4 Hz, 13.1 Hz,
CHO), 8.20 (1H, bs, NH); 13C NMR (ppm): 40.83 (CH2), 114.13 (2C, CH3,5),
126.10 (1C, C1), 128.65 (2C, CH2,6), 147.88 (1C, C4), 165.05 (1C, CHO);
major (cis) 1H NMR (ppm): 4.08 (2H, d, 6 Hz, CH2), 5.00 (2H, bs, NH2),
6.49 (2H, dd, 2.6 Hz, 8.4 Hz, CH3,5), 6.9 (2H, dd, 1.0 Hz, 8.4 Hz,
CH2,6), 8.05 (1H, dd, 0.9 Hz, 0.3 Hz, CHO), 8.10 (1H, bs, NH); 13C NMR
(ppm): 40.83 (CH2), 114.13 (2C, CH3,5) 126.10 (1C, C1), 128.45 (2C,
CH2,6), 147.88 (1C, C4), 163.32 (1C, CHO).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amidicity Change as a Significant Driving Force and Thermodynamic
Selection Rule of Transamidation Reactions. A Synergy between Experiment
and Theory
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mucsi, Zoltan; Chass, Gregory A.; Csizmadia, Imre G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Physical Chemistry B (2008), 112(26), 7885-7893

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluorobenzaldehyde
C7H5FO
446-52-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 F 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Fluorophenyl)methyl]formamide
C8H8FNO
86010-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 N 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 F 1.3336 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-52-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 86010-66-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11302802
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):NOTES
$DATUM Leuckart-Wallach reaction, formamide/formic acid also used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient Isocyanide-less Isocyanide-Based Multicomponent Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neochoritis, Constantinos G.; Stotani, Silvia; Mishra, Bhupendra;
Doemling, Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(8), 2002-2005

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-methyl-3-thiophenecarbonitrile
C6H6N2S
4623-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.7106 0.0 0
M  V30 2 N 5.4498 2.7106 0.0 0
M  V30 3 C 1.9406 5.4211 0.0 0
M  V30 4 N 1.9406 0.0000 0.0 0
M  V30 5 C 2.3698 2.7106 0.0 0
M  V30 6 C 1.4645 3.9564 0.0 0
M  V30 7 C 1.4645 1.4647 0.0 0
M  V30 8 C 0.0000 3.4806 0.0 0
M  V30 9 S 0.0000 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 7
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methylthieno[2,3-d]pyrimidin-4-amine
C7H7N3S
13145-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0801 0.0000 0.0 0
M  V30 2 C 5.7308 1.9571 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 4.0012 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 4.5864 2.9877 0.0 0
M  V30 7 N 0.7700 4.0012 0.0 0
M  V30 8 S 3.3405 5.1456 0.0 0
M  V30 9 N 0.7700 1.3337 0.0 0
M  V30 10 C 4.7473 4.5192 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4623-55-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13145-89-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21041734
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, characterization & in-silico prediction of substituted
2-aminothiophene, 1,3,4-thiadiazole and thieno[2,3-d]pyrimidine
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ranganath, P. L. N.; Nizamuddin, N. D.; Rubina, S. K.; Hemanth, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Journal of Pharmaceutical Research (2019), 8(2), 1368-1377

$RFMT $RIREG SCHEME349 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Phenoxybenzenethiol
C12H10OS
55710-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 1.5400 0.0 0
M  V30 2 S 1.3336 0.0000 0.0 0
M  V30 3 C 2.6674 2.3100 0.0 0
M  V30 4 C 1.3336 1.5400 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 C 0.0000 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 1 2 4
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(Isocyanomethyl)thio]-2-phenoxybenzene
C14H11NOS
1803329-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6675 0.0 0
M  V30 2 S 7.7001 2.6675 0.0 0
M  V30 3 C 9.2401 2.6675 0.0 0
M  V30 4 N 10.0101 1.3338 0.0 0 CHG=1 VAL=4
M  V30 5 C 10.7801 0.0000 0.0 0 CHG=-1
M  V30 6 C 5.3901 4.0011 0.0 0
M  V30 7 C 6.9301 4.0011 0.0 0
M  V30 8 C 4.6201 5.3348 0.0 0
M  V30 9 C 7.7001 5.3348 0.0 0
M  V30 10 C 5.3901 6.6686 0.0 0
M  V30 11 C 6.9301 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 C 2.3100 1.3338 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 0.7700 1.3338 0.0 0
M  V30 16 C 0.7700 4.0011 0.0 0
M  V30 17 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 7
M  V30 5 1 3 4
M  V30 6 3 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 55710-19-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1803329-96-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29996841
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-18-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM paraformaldehyde used in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asmic: An Exceptional Building Block for Isocyanide Alkylations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alwedi, Embarek; Lujan-Montelongo, J. Armando; Pitta, Bhaskar R.; Chao,
Allen; Cortes-Mejia, Rodrigo; del Campo, Jorge M.; Fleming, Fraser F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2018), 20(18), 5910-5913

$RFMT $RIREG SCHEME349 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Phenoxybenzenethiol
C12H10OS
55710-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 1.5400 0.0 0
M  V30 2 S 1.3336 0.0000 0.0 0
M  V30 3 C 2.6674 2.3100 0.0 0
M  V30 4 C 1.3336 1.5400 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 C 0.0000 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 1 2 4
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(Isocyanomethyl)thio]-2-phenoxybenzene
C14H11NOS
1803329-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6675 0.0 0
M  V30 2 S 7.7001 2.6675 0.0 0
M  V30 3 C 9.2401 2.6675 0.0 0
M  V30 4 N 10.0101 1.3338 0.0 0 CHG=1 VAL=4
M  V30 5 C 10.7801 0.0000 0.0 0 CHG=-1
M  V30 6 C 5.3901 4.0011 0.0 0
M  V30 7 C 6.9301 4.0011 0.0 0
M  V30 8 C 4.6201 5.3348 0.0 0
M  V30 9 C 7.7001 5.3348 0.0 0
M  V30 10 C 5.3901 6.6686 0.0 0
M  V30 11 C 6.9301 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 C 2.3100 1.3338 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 0.7700 1.3338 0.0 0
M  V30 16 C 0.7700 4.0011 0.0 0
M  V30 17 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 7
M  V30 5 1 3 4
M  V30 6 3 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 55710-19-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1803329-96-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26151066
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-18-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction in stage 1, paraformaldehyde used in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Composition, synthesis, and use of a new class of isonitriles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fleming, Fraser Fergusson; Lujan-Montelongo, Jesus Armando
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015127226 A1 2015-08-27

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydr...
C25H24N4O5
503614-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.1956 6.8668 0.0 0
M  V30 2 C 1.4647 10.2444 0.0 0
M  V30 3 O 1.7849 11.7509 0.0 0
M  V30 4 O 0.0000 9.7686 0.0 0
M  V30 5 O 5.1358 1.0306 0.0 0
M  V30 6 C 3.9913 0.0000 0.0 0
M  V30 7 O 13.3557 12.2016 0.0 0
M  V30 8 C 4.8856 8.2005 0.0 0
M  V30 9 N 3.8550 7.0560 0.0 0
M  V30 10 C 4.1156 9.5342 0.0 0
M  V30 11 C 6.4256 8.2005 0.0 0
M  V30 12 N 2.4482 7.6824 0.0 0
M  V30 13 C 2.6091 9.2140 0.0 0
M  V30 14 C 4.8856 10.8678 0.0 0
M  V30 15 N 7.1956 9.5342 0.0 0
M  V30 16 C 6.4256 10.8678 0.0 0
M  V30 17 C 4.1753 5.5496 0.0 0
M  V30 18 C 3.0308 4.5192 0.0 0
M  V30 19 C 5.6399 5.0738 0.0 0
M  V30 20 C 3.3509 3.0128 0.0 0
M  V30 21 C 5.9601 3.5673 0.0 0
M  V30 22 C 4.8157 2.5369 0.0 0
M  V30 23 C 8.7357 9.5342 0.0 0
M  V30 24 C 9.5057 8.2005 0.0 0
M  V30 25 C 9.5057 10.8678 0.0 0
M  V30 26 C 11.0457 8.2005 0.0 0
M  V30 27 C 11.0457 10.8678 0.0 0
M  V30 28 C 11.8157 9.5342 0.0 0
M  V30 29 N 13.3557 9.5342 0.0 0
M  V30 30 C 14.1258 10.8678 0.0 0
M  V30 31 C 14.1258 8.2005 0.0 0
M  V30 32 C 15.6658 10.8678 0.0 0
M  V30 33 C 15.6658 8.2005 0.0 0
M  V30 34 C 16.4358 9.5342 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 5 6
M  V30 6 1 5 22
M  V30 7 2 7 30
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 17
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 13
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 1 15 23
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 28 29
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Apixaban
C25H25N5O4
503612-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.1956 6.8668 0.0 0
M  V30 2 C 1.4647 10.2444 0.0 0
M  V30 3 N 0.0000 9.7686 0.0 0
M  V30 4 O 1.7849 11.7509 0.0 0
M  V30 5 O 5.1358 1.0306 0.0 0
M  V30 6 C 3.9913 0.0000 0.0 0
M  V30 7 O 13.3557 12.2016 0.0 0
M  V30 8 C 4.8856 8.2005 0.0 0
M  V30 9 N 3.8550 7.0560 0.0 0
M  V30 10 C 4.1156 9.5342 0.0 0
M  V30 11 C 6.4256 8.2005 0.0 0
M  V30 12 N 2.4482 7.6824 0.0 0
M  V30 13 C 2.6091 9.2140 0.0 0
M  V30 14 C 4.8856 10.8678 0.0 0
M  V30 15 N 7.1956 9.5342 0.0 0
M  V30 16 C 6.4256 10.8678 0.0 0
M  V30 17 C 4.1753 5.5496 0.0 0
M  V30 18 C 3.0308 4.5192 0.0 0
M  V30 19 C 5.6399 5.0738 0.0 0
M  V30 20 C 3.3509 3.0128 0.0 0
M  V30 21 C 5.9601 3.5673 0.0 0
M  V30 22 C 4.8157 2.5369 0.0 0
M  V30 23 C 8.7357 9.5342 0.0 0
M  V30 24 C 9.5057 8.2005 0.0 0
M  V30 25 C 9.5057 10.8678 0.0 0
M  V30 26 C 11.0457 8.2005 0.0 0
M  V30 27 C 11.0457 10.8678 0.0 0
M  V30 28 C 11.8157 9.5342 0.0 0
M  V30 29 N 13.3557 9.5342 0.0 0
M  V30 30 C 14.1258 10.8678 0.0 0
M  V30 31 C 14.1258 8.2005 0.0 0
M  V30 32 C 15.6658 10.8678 0.0 0
M  V30 33 C 15.6658 8.2005 0.0 0
M  V30 34 C 16.4358 9.5342 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 5 6
M  V30 6 1 5 22
M  V30 7 2 7 30
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 17
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 13
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 1 15 23
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 28 29
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 503614-92-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 503612-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18205481
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 122-51-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate from stage 3 added in stage 4 (stage 4)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparation of apixaban and intermediates thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goverdhan, Gilla; Metil, Dattatray Shamrao; Kulkarni, Shweta Mahajan;
Veerender, Murki; Dahanukar, Vilas; Sreenivasulu, Kurella; Charagondla,
Kavitha; Reddy, Anumula Raghupathi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2012CH04558 A 2014-05-02

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(4-methoxyphenyl)-3-pyridinamine
C12H11ClN2O
509953-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 1.5400 0.0 0
M  V30 2 Cl 1.3337 0.0000 0.0 0
M  V30 3 O 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 2.6673 3.8501 0.0 0
M  V30 8 N 0.0000 2.3101 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 6.6685 1.5400 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 8.0023 2.3101 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 8.0023 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 6
M  V30 4 1 3 4
M  V30 5 1 3 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Methoxyphenyl)-1H-imidazo[4,5-b]pyridine
C13H11N3O
1260682-80-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.7546 4.9318 0.0 0
M  V30 2 C 11.0882 4.1618 0.0 0
M  V30 3 N 4.4197 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 C 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 N 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6538 0.0 0
M  V30 10 C 1.0304 4.2630 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 5.7534 4.1618 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 7.0871 4.9318 0.0 0
M  V30 16 C 8.4208 2.6218 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 509953-53-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1260682-80-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13963104
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 29154-12-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1160861-53-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1-(4-Methoxybenzyl)-1H-imidazo[4,5-b]pyridine
(3a) To an oven-dried 25 mL Schlenk-tube equipped with a stirbar was
added Pd2(dba)3 · CHCl3 (20.8 mg, 0.02 mmol),
2-Di-t-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-tri-i-propylbiphenyl
(L1) (48 mg, 0.1 mmol), K3PO4 (639 mg, 3.01 mmol) and
2-Chloro-N-(4-methoxybenzyl)pyridin-3-amine (2a) (500 mg, 2.01 mmol) (if
solid). The tube was evacuated and refilled with Ar(g). Formamide (0.12
mL, 3.01 mmol) was added via syringe as a single portion, followed by the
chloropyridine (if liquid) in 4 mL of tert-butanol. The reaction mixture
was degassed with 3 x vacuum / Ar(g) purge cycles. The reaction vessel
was then equipped with a cold-finger under a positive pressure of argon
gas and immersed in a 110°C pre-heated oil-bath for 4h at which time TLC
showed consumption of the chloro-pyridine. The reaction was cooled to
room temperature, diluted with MeOH (4 mL) filtered through a Celite plug
and concentrated to give a dark brown oil. The crude product was purified
on a silica gel column (4.5 cm x 12 cm), eluting with 4% MeOH in CH2Cl2.
1-(4-Methoxyphenyl)-1H-imidazo[4,5-b]pyridine (3p) Following the general
experimental; 2-chloro-N-(4-methoxyphenyl)pyridin-3-amine (2p) (85 mg,
0.36 mmol), Pd2(dba)3·CHCl3 (4.14 mg, 0.004 mmol), t-BuBrettPhos (9.7 mg,
0.02 mmol), K3PO4 (128 mg, 0.6 mmol), formamide (0.022 mL, 0.6 mmol) were
combined with 1.8 mL tert-butanol in a 25 mL Schlenk flask. After 3 h the
reaction was complete, the reaction cooled to RT, filtered through
Celite, concentrated and purified on a silica gel column (2.5 cm x 12
cm), eluting with 4% MeOH / CH2Cl2. 3p as 74 mg of a white solid (91%).
1H NMR (300 MHz, CDCl3) δ = 8.54 (dd, J = 4.8 Hz, 1.8 Hz, 1H), 8.23 (s,
1H), 7.73 (dd, J = 8.1 Hz, 1.5 Hz, 1H), 7.35 (dd, J = 9 Hz, 2.4 Hz, 2H),
7.20 (dd, J = 8.1 Hz, 4.8 Hz, 1H), 7.05 (dd, J = 9 Hz, 2.1 Hz, 2H), 3.85
(s, 3H); 13C NMR (75.4 MHz, CDCl3) δ = 159.7, 156.3, 145.4, 144.5, 129.4,
126.6, 125.5, 118.7, 118.6, 115.4, 55.7; FT-IR (NaCl, thin film) ν =
3401, 3080, 2963, 2839, 1609, 1517, 1489, 1415, 1252, 1030, 975, 836
cm-1. HRMS (ESI) Calc (C13H12O1N3): 226.0975, Found: 226.0971; MP:
125-129°C; Rf (4% MeOH / CH2Cl2): 0.24.
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Imidazo[4,5-b]pyridines and Imidazo[4,5-b]pyrazines by
Palladium Catalyzed Amidation of 2-Chloro-3-amino-heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Zhao, Jinbo; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(7), 1764-1767

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Bromophenyl)boronic acid
C6H6BBrO2
5467-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)formamide
C7H6BrNO
2617-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5467-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-18153911
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 86-93-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 15158-11-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, nanopolystyrene anchored Cu(II) complex of
1-phenyl-1H-tetrazole-5-thiol used as catalyst, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization, antibacterial and catalytic activity of a
nanopolymer supported copper(II) complex as a highly active and
recyclable catalyst for the formamidation of arylboronic acids under
aerobic conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nasrollahzadeh, Mahmoud; Zahraei, Ali; Ehsani, Ali; Khalaj, Mehdi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(39), 20351-20357

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
2-Bromo-N-(4-methoxyphenyl)benzamide
C14H12BrNO2
55204-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 O 5.3900 1.3338 0.0 0
M  V30 4 Br 3.0800 0.0000 0.0 0
M  V30 5 O 11.5500 4.0011 0.0 0
M  V30 6 C 12.3200 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 7.7000 5.3349 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 9.2400 5.3349 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 13
M  V30 5 1 4 8
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methoxyphenyl)-4(3H)-quinazolinone
C15H12N2O2
22378-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 0.0000 0.0 0
M  V30 2 O 11.5503 2.6673 0.0 0
M  V30 3 C 12.3203 4.0010 0.0 0
M  V30 4 N 5.3901 2.6673 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 4.6201 4.0010 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 N 3.0801 4.0010 0.0 0
M  V30 9 C 2.3101 2.6673 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 14 C 6.9302 2.6673 0.0 0
M  V30 15 C 7.7002 1.3337 0.0 0
M  V30 16 C 7.7002 4.0010 0.0 0
M  V30 17 C 9.2402 1.3337 0.0 0
M  V30 18 C 9.2402 4.0010 0.0 0
M  V30 19 C 10.0102 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 3
M  V30 3 1 2 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 9
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 55204-50-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22378-45-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11990044
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51-35-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for CuI-catalyzed formation
of 3-substituted-4-quinazolines and 2,3-disubstituted-4(3H )-quinazolines
from 2-bromo-N-phenylbenzamide. For 3-substituted-4-quinazoline
(11a-11r). A Schlenk tube was charged with N-substituted 2-bromobenzamide
(0.25 mmol), CuI (5 mg, 0.025 mmol), trans-4-hydroxy-L-proline (3 mg,
0.025 mmol), and Cs2CO3 (163 mg, 0.5 mmol). The tube was evacuated and
backfilled with argon before formamide (20 µL, 0.5 mmol) and 1 mL DMF was
added. The reaction mixture was stirred at 80 o C (or 90 o C for
substrate 7l) for 24 h. After the reaction mixture was cooled to room
temperature, 5 mL of saturated NH4Cl solution was added. The mixture was
extracted with EtOAc and the organic layer was washed with water, brine
and dried over Na2SO4. After concentration in vacuo, the residue was
purified by column chromatography on silica gel. The desired
3-substituted 4-quinazoline. 3-(4-Methoxyphenyl)quinazolin-4(3H)-one
(11i). 2 57 mg, 91% yield. 1H NMR (400 MHz, CDCl3) δ 8.37 (dd, J 1 = 0.4
Hz, J 2 = 8.0 Hz, 1H), 8.11 (s, 1H), 7.80-7.77 (m, 2H), 7.56 (t, J = 6.4
Hz, 1H), 7.34 (d, J = 9.2 Hz, 2H), 7.05 (d, J = 8.8 Hz, 2H), 3.87 (s,
3H); 13C NMR (100 MHz, CDCl3) δ 160.03, 148.00, 147.45, 146.59, 134.65,
130.27, 128.27 (2C), 127.72, 127.65, 127.29, 122.48, 114.96 (2C), 55.74.
HRMS-ESI: m/z calcd for C15H13N2O2 [M + H]+: 253.0977, found 253.0979.
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst formed in-situ; Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Substituted and 2,3-Disubstituted Quinazolinones via
Cu-Catalyzed Aryl Amidation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Lanting; Jiang, Yongwen; Ma, Dawei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(4), 1150-1153

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
B-(2,4-Dimethylphenyl)boronic acid
C8H11BO2
55499-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,4-Dimethylphenyl)formamide
C9H11NO
60397-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 O 8.4702 4.0010 0.0 0
M  V30 4 C 4.6201 0.0000 0.0 0
M  V30 5 C 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 55499-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60397-77-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-9265096
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1034343-98-0
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM oxide reduced
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, catalyst prepared and
used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and characterization of copper nanoparticles supported on
reduced graphene oxide as a highly active and recyclable catalyst for the
synthesis of formamides and primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fakhri, Parisa; Jaleh, Babak; Nasrollahzadeh, Mahmoud
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2014), 383-38417-22

$RFMT $RIREG SCHEME355 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Aminoquinoline
C9H8N2
578-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 4.0010 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 N 3.0801 4.0010 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrido[3,2-h]quinazoline
C11H7N3
231-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 2.6673 0.0 0
M  V30 2 C 4.6201 2.6673 0.0 0
M  V30 3 C 2.3101 1.3337 0.0 0
M  V30 4 N 2.3101 4.0010 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 N 5.3901 4.0010 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 6.9302 4.0010 0.0 0
M  V30 13 C 0.0000 2.6673 0.0 0
M  V30 14 N 7.7002 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 2 5 10
M  V30 10 1 5 11
M  V30 11 2 6 12
M  V30 12 1 7 10
M  V30 13 2 8 13
M  V30 14 1 9 13
M  V30 15 2 11 14
M  V30 16 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 578-66-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 231-19-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29481275
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
Pyrazolo[3,4-d]-pyrimidines (17-32, 65, 66, and 73-76). The reliable
procedure involved the treatment of 5-aminopyrazoles (1-16; 1.0 equiv),
5- amino-4-formylpyrazoles (37-41; 1.0 equiv), 5-aminoquinoline (61; 1.0
equiv), 8-aminoquinoline (62; 1.0 equiv), 5-aminopyrimidine (68; 1.0
equiv), or 2-aminopyrazines (69-71; 1.0 equiv) with PBr3 (~ 3 equiv) in
formamide solution (2 mL) at 50-60 °C over 0.5-1 h. When the reaction was
complete, the reaction mixture was added to saturated sodium bicarbonate
(15 mL) and extracted with dichloromethane (15 mL). The organic extracts
were dried over MgSO4, filtered, and concentrated under reduced pressure.
The residue solution was purified by column chromatography on silica gel
to give the corresponding aromatic or heterocyclic fused pyrimidine
products (17-32, 65, 66, and 73-76) in 82-96% yields.
Pyrido[3,2-h]quinazoline (67).27 The standard procedure involved the
treatment of 8-aminoquinoline (63; 97 mg, 0.81 mmol, 1.0 equiv) with PBr3
(0.23 mL, 2.4 mmol, 3.0 equiv) in formamide solution (2 mL) at 50-60 °C
over 0.5-1.0 h. The reaction mixture was then worked up, and the residue
was purified by chromatography on silica gel to give pure 67: 91% yield
(133 mg), light yellow solid. Mp 171- 172 °C (CH2Cl2-methanol). 1H NMR
(CDCl3, 200 MHz): δ 7.13- 7.19 (1H, m), 7.46-7.51 (1H, m), 7.72-7.76 (1H,
m), 7.82-7.86 (1H, m), 8.69-8.73 (1H, m), 9.12 (1H, s), 9.17 (1H, s). 13C
NMR (50 MHz, CDCl3): δ 119.3, 124.8, 126.6 (2 × C), 127.1, 133.8, 148.4,
152.3, 154.7. IR (KBr): 3047, 2924, 1612, 1582, 1503, 1431, 1356, 1254,
1219, 1092 cm-1. EIMS m/z (rel int): 181 (100, M+). Anal. Calcd for
C11H7N3: C, 72.92; H, 3.89; N, 23.19. Found: C, 72.88; H, 3.86; N, 23.22.
$DTYPE RXN:VAR(1):NOTES
$DATUM sequential three-component heterocyclization, one-pot multi-component
process
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Phenyl-1-(2-pyridinyl)-1H-pyrazol-5-amine
C14H12N4
58589-70-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.2948 0.0000 0.0 0
M  V30 2 N 6.4385 2.7406 0.0 0
M  V30 3 N 5.4080 3.8850 0.0 0
M  V30 4 C 5.6685 1.4070 0.0 0
M  V30 5 C 4.0011 3.2587 0.0 0
M  V30 6 C 4.1620 1.7271 0.0 0
M  V30 7 C 7.9700 2.9015 0.0 0
M  V30 8 C 8.5965 4.3085 0.0 0
M  V30 9 N 8.8752 1.6557 0.0 0
M  V30 10 C 10.1280 4.4694 0.0 0
M  V30 11 C 10.4068 1.8166 0.0 0
M  V30 12 C 11.0332 3.2235 0.0 0
M  V30 13 C 2.6674 4.0287 0.0 0
M  V30 14 C 1.3338 3.2587 0.0 0
M  V30 15 C 2.6674 5.5687 0.0 0
M  V30 16 C 0.0000 4.0287 0.0 0
M  V30 17 C 1.3338 6.3387 0.0 0
M  V30 18 C 0.0000 5.5687 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 7
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 1 5 6
M  V30 8 1 5 13
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Phenyl-1-(2-pyridinyl)-1H-pyrazolo[3,4-d]pyrimidine
C16H11N5
1400634-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4384 3.9427 0.0 0
M  V30 2 C 5.6684 2.6091 0.0 0
M  V30 3 N 5.4080 5.0872 0.0 0
M  V30 4 C 4.1620 2.9292 0.0 0
M  V30 5 C 6.1443 1.1444 0.0 0
M  V30 6 N 4.0011 4.4608 0.0 0
M  V30 7 N 3.1316 1.7849 0.0 0
M  V30 8 N 5.1139 0.0000 0.0 0
M  V30 9 C 3.6075 0.3202 0.0 0
M  V30 10 C 7.9700 4.1036 0.0 0
M  V30 11 C 8.5965 5.5106 0.0 0
M  V30 12 C 8.8752 2.8578 0.0 0
M  V30 13 C 10.1280 5.6715 0.0 0
M  V30 14 C 10.4067 3.0187 0.0 0
M  V30 15 C 11.0332 4.4257 0.0 0
M  V30 16 C 2.6674 5.2308 0.0 0
M  V30 17 C 1.3338 4.4608 0.0 0
M  V30 18 N 2.6674 6.7708 0.0 0
M  V30 19 C 0.0000 5.2308 0.0 0
M  V30 20 C 1.3338 7.5408 0.0 0
M  V30 21 C 0.0000 6.7708 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 6 16
M  V30 11 1 7 9
M  V30 12 2 8 9
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58589-70-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-66-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-14378145
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME357 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-2-[2-[3-(trifluoromethyl)phenyl]hydrazinylidene]acetate
C10H8ClF3N2O2
69241-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 N 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 Cl 9.3360 4.6201 0.0 0
M  V30 6 O 12.0033 3.0801 0.0 0
M  V30 7 O 10.6697 0.7700 0.0 0
M  V30 8 C 13.3370 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 F 2.1037 4.4137 0.0 0
M  V30 11 F 0.0000 3.8501 0.0 0
M  V30 12 F 0.5637 1.7464 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0010 3.0801 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 4.0010 0.0000 0.0 0
M  V30 18 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 16
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazole-3-carboxylate
C11H8F3N3O2
2104285-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6374 3.4372 0.0 0
M  V30 2 O 11.5427 4.6831 0.0 0
M  V30 3 O 11.2638 2.0302 0.0 0
M  V30 4 C 13.0742 4.5220 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 F 2.1037 4.4137 0.0 0
M  V30 7 F 0.0000 3.8501 0.0 0
M  V30 8 F 0.5637 1.7464 0.0 0
M  V30 9 N 6.6685 3.0801 0.0 0
M  V30 10 N 8.0754 2.4536 0.0 0
M  V30 11 C 6.8294 4.6116 0.0 0
M  V30 12 C 9.1059 3.5981 0.0 0
M  V30 13 N 8.3359 4.9318 0.0 0
M  V30 14 C 5.3348 2.3100 0.0 0
M  V30 15 C 4.0011 3.0801 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 2.6673 2.3100 0.0 0
M  V30 18 C 4.0011 0.0000 0.0 0
M  V30 19 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 69241-71-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2104285-94-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26563703
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile One-Pot Synthesis of Methyl
1-Aryl-1H-1,2,4-triazole-3-carboxylates from Nitrilimines with Vilsmeier
Reagent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsai, Shuo-En; Chiang, Kun-Heng; Tseng, Ching-Chun; Chen, Nai-Wei; Chern,
Ching-Yuh; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(8), 1754-1762

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzamide
C7H6BrNO
698-67-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyanobenzamide
C8H6N2O
3034-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 698-67-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3034-34-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30407141
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 366-18-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3264-82-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7446-70-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, sealed vessel used, aerobic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ni-Mediated Generation of "CN" Unit from Formamide and Its Catalysis in
the Cyanation Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Luo; Liu, Yu-Ting; Park, Yoonsu; Park, Sung-Woo; Chang, Sukbok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2019), 9(4), 3360-3365

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Iodophenyl)-2,2-dimethylpropanamide
C11H14INO
70298-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 2.8736 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 1.5400 1.5400 0.0 0
M  V30 4 O 3.8500 0.2062 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 I 10.0100 2.8736 0.0 0
M  V30 9 C 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 4.2073 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 12 C 7.7000 4.2073 0.0 0
M  V30 13 C 7.7000 1.5400 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Cyanophenyl)-2,2-dimethylpropanamide
C12H14N2O
149934-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 2.8736 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 1.5400 1.5400 0.0 0
M  V30 4 O 3.8500 0.2062 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 N 11.5500 2.8736 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 3 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 70298-87-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 149934-51-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28245674
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 366-18-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3264-82-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7446-70-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, sealed vessel used, aerobic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ni-Mediated Generation of "CN" Unit from Formamide and Its Catalysis in
the Cyanation Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Luo; Liu, Yu-Ting; Park, Yoonsu; Park, Sung-Woo; Chang, Sukbok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2019), 9(4), 3360-3365

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Benzylidene-2,6-di-tert-butylcyclohexa-2,5-dienone
C21H26O
7078-98-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6685 0.0 0
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 C 9.2400 2.4611 0.0 0
M  V30 4 C 10.7800 4.0011 0.0 0
M  V30 5 C 9.2400 5.5411 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 C 5.3900 0.0000 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 3.0800 1.3336 0.0 0
M  V30 10 O 7.7000 1.3336 0.0 0
M  V30 11 C 5.3900 5.3347 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 5.3900 2.6674 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 3.0800 6.6685 0.0 0
M  V30 18 C 2.3100 8.0021 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 20 C 0.7700 8.0021 0.0 0
M  V30 21 C 0.7700 5.3347 0.0 0
M  V30 22 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 14
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 15
M  V30 11 2 10 16
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetamide, α-[3,5-bis(1,1-dimethylethyl)-4-oxo-2,5-cyclohexadien-1-yli...
C22H27NO2
3055300-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 1.3336 0.0 0
M  V30 3 N 4.6200 0.0000 0.0 0
M  V30 4 O 6.9300 1.3336 0.0 0
M  V30 5 C 4.6200 8.0021 0.0 0
M  V30 6 C 3.0800 8.0021 0.0 0
M  V30 7 C 3.8500 9.3358 0.0 0
M  V30 8 C 5.3900 9.3358 0.0 0
M  V30 9 C 9.2400 5.3347 0.0 0
M  V30 10 C 9.2400 6.8747 0.0 0
M  V30 11 C 10.7800 5.3347 0.0 0
M  V30 12 C 9.2400 3.7947 0.0 0
M  V30 13 O 7.7000 8.0021 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 5.3900 6.6684 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 C 6.9300 6.6684 0.0 0
M  V30 20 C 3.0800 2.6674 0.0 0
M  V30 21 C 2.3100 4.0011 0.0 0
M  V30 22 C 2.3100 1.3336 0.0 0
M  V30 23 C 0.7700 4.0011 0.0 0
M  V30 24 C 0.7700 1.3336 0.0 0
M  V30 25 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 14
M  V30 3 1 1 20
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 17
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 18
M  V30 14 2 13 19
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7078-98-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3055300-41-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42777149
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 110-05-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7758-94-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Iron-Catalyzed Cross-Dehydrogenative Coupling of para-Quinone Methides
with Formamides: In Situ Activation of C(sp2)-H Bonds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Minjing; Li, Zikang; Shang, Wenli; Xiong, Biquan; Xu, Weifeng; Zhu,
Longzhi; Liu, Yu; Tang, Ke-Wen; Wong, Wai-Yeung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(22), 16663-16678

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Chlorophenyl)-3-phenyl-1H-pyrazol-5-amine
C15H12ClN3
72411-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0157 0.0000 0.0 0
M  V30 2 Cl 12.3670 5.6420 0.0 0
M  V30 3 N 7.0322 2.5620 0.0 0
M  V30 4 N 5.6252 3.1885 0.0 0
M  V30 5 C 6.8711 1.0304 0.0 0
M  V30 6 C 4.5948 2.0439 0.0 0
M  V30 7 C 5.3648 0.7103 0.0 0
M  V30 8 C 8.3659 3.3320 0.0 0
M  V30 9 C 8.3659 4.8720 0.0 0
M  V30 10 C 9.6995 2.5620 0.0 0
M  V30 11 C 9.6995 5.6420 0.0 0
M  V30 12 C 11.0332 3.3320 0.0 0
M  V30 13 C 11.0332 4.8720 0.0 0
M  V30 14 C 3.0633 2.2048 0.0 0
M  V30 15 C 2.1580 0.9590 0.0 0
M  V30 16 C 2.4368 3.6118 0.0 0
M  V30 17 C 0.6265 1.1201 0.0 0
M  V30 18 C 0.9052 3.7727 0.0 0
M  V30 19 C 0.0000 2.5269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Chlorophenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C17H11ClN4
1400634-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 12.3669 7.5408 0.0 0
M  V30 2 N 7.0321 4.4608 0.0 0
M  V30 3 C 6.8711 2.9292 0.0 0
M  V30 4 N 5.6252 5.0873 0.0 0
M  V30 5 C 5.3648 2.6091 0.0 0
M  V30 6 N 7.9016 1.7849 0.0 0
M  V30 7 C 4.5948 3.9427 0.0 0
M  V30 8 C 4.8889 1.1444 0.0 0
M  V30 9 C 7.4258 0.3202 0.0 0
M  V30 10 N 5.9193 0.0000 0.0 0
M  V30 11 C 8.3658 5.2308 0.0 0
M  V30 12 C 9.6994 4.4608 0.0 0
M  V30 13 C 8.3658 6.7708 0.0 0
M  V30 14 C 11.0331 5.2308 0.0 0
M  V30 15 C 9.6994 7.5408 0.0 0
M  V30 16 C 11.0331 6.7708 0.0 0
M  V30 17 C 3.0632 4.1037 0.0 0
M  V30 18 C 2.1580 2.8578 0.0 0
M  V30 19 C 2.4368 5.5106 0.0 0
M  V30 20 C 0.6265 3.0187 0.0 0
M  V30 21 C 0.9052 5.6715 0.0 0
M  V30 22 C 0.0000 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72411-49-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-63-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-12666796
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Chlorophenyl)-3-phenyl-1H-pyrazol-5-amine
C15H12ClN3
72411-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0157 0.0000 0.0 0
M  V30 2 Cl 12.3670 5.6420 0.0 0
M  V30 3 N 7.0322 2.5620 0.0 0
M  V30 4 N 5.6252 3.1885 0.0 0
M  V30 5 C 6.8711 1.0304 0.0 0
M  V30 6 C 4.5948 2.0439 0.0 0
M  V30 7 C 5.3648 0.7103 0.0 0
M  V30 8 C 8.3659 3.3320 0.0 0
M  V30 9 C 8.3659 4.8720 0.0 0
M  V30 10 C 9.6995 2.5620 0.0 0
M  V30 11 C 9.6995 5.6420 0.0 0
M  V30 12 C 11.0332 3.3320 0.0 0
M  V30 13 C 11.0332 4.8720 0.0 0
M  V30 14 C 3.0633 2.2048 0.0 0
M  V30 15 C 2.1580 0.9590 0.0 0
M  V30 16 C 2.4368 3.6118 0.0 0
M  V30 17 C 0.6265 1.1201 0.0 0
M  V30 18 C 0.9052 3.7727 0.0 0
M  V30 19 C 0.0000 2.5269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Chlorophenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C17H11ClN4
1400634-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 12.3669 7.5408 0.0 0
M  V30 2 N 7.0321 4.4608 0.0 0
M  V30 3 C 6.8711 2.9292 0.0 0
M  V30 4 N 5.6252 5.0873 0.0 0
M  V30 5 C 5.3648 2.6091 0.0 0
M  V30 6 N 7.9016 1.7849 0.0 0
M  V30 7 C 4.5948 3.9427 0.0 0
M  V30 8 C 4.8889 1.1444 0.0 0
M  V30 9 C 7.4258 0.3202 0.0 0
M  V30 10 N 5.9193 0.0000 0.0 0
M  V30 11 C 8.3658 5.2308 0.0 0
M  V30 12 C 9.6994 4.4608 0.0 0
M  V30 13 C 8.3658 6.7708 0.0 0
M  V30 14 C 11.0331 5.2308 0.0 0
M  V30 15 C 9.6994 7.5408 0.0 0
M  V30 16 C 11.0331 6.7708 0.0 0
M  V30 17 C 3.0632 4.1037 0.0 0
M  V30 18 C 2.1580 2.8578 0.0 0
M  V30 19 C 2.4368 5.5106 0.0 0
M  V30 20 C 0.6265 3.0187 0.0 0
M  V30 21 C 0.9052 5.6715 0.0 0
M  V30 22 C 0.0000 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72411-49-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-63-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28706240
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
Pyrazolo[3,4-d]-pyrimidines (17-32, 65, 66, and 73-76). The reliable
procedure involved the treatment of 5-aminopyrazoles (1-16; 1.0 equiv),
5- amino-4-formylpyrazoles (37-41; 1.0 equiv), 5-aminoquinoline (61; 1.0
equiv), 8-aminoquinoline (62; 1.0 equiv), 5-aminopyrimidine (68; 1.0
equiv), or 2-aminopyrazines (69-71; 1.0 equiv) with PBr3 (~ 3 equiv) in
formamide solution (2 mL) at 50-60 °C over 0.5-1 h. When the reaction was
complete, the reaction mixture was added to saturated sodium bicarbonate
(15 mL) and extracted with dichloromethane (15 mL). The organic extracts
were dried over MgSO4, filtered, and concentrated under reduced pressure.
The residue solution was purified by column chromatography on silica gel
to give the corresponding aromatic or heterocyclic fused pyrimidine
products (17-32, 65, 66, and 73-76) in 82-96% yields.
1-(4-Chlorophenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine (23). The
standard procedure involved the treatment of
5-amino-1-(4-chlorophenyl)-3-phenyl-1H-pyrazole (7; 106 mg, 0.35 mmol,
1.0 equiv) with PBr3 (0.10 mL, 1.0 mmol, 3.0 equiv) in formamide solution
(2 mL) at 50-60 °C over 0.5-1.0 h. The reaction mixture was then worked
up, and the residue was purified by chromatography on silica gel to give
pure 23: 91% yield (97 mg), yellow solid. M,p 144-145 °C (hexane-EtOAc).
1H NMR (CDCl3, 500 MHz): δ 7.46-7.52 (3H, m), 7.52-7.58 (2H, m),
8.00-8.06 (2H, m), 8.29- 8.35 (2H, m), 9.12 (1H, s), 9.49 (1H, s). 13C
NMR (125 MHz, CDCl3): δ 114.3, 122.2 (2 × C), 127.4 (2 × C), 129.2 (2 ×
C), 129.3 (2 × C), 129.8, 131.3, 132.1, 137.2, 145.2, 152.9, 153.4,
155.7. IR (KBr): 3051, 2922, 2851, 2384, 2349, 1589, 1554, 1406, 1367,
1215 cm-1. EIMS m/z (rel int): 306 (100, M+). Anal. Calcd for C17H11ClN4:
C, 66.56; H, 3.61; N, 18.26. Found: C, 66.53; H, 3.58; N, 18.23.
$DTYPE RXN:VAR(1):NOTES
$DATUM sequential three-component heterocyclization, one-pot multi-component
process
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetone cyanohydrin
C4H7NO
75-86-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 N 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Cyano-1-methylethyl)formamide
C5H8N2O
58004-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 1.3337 0.0 0
M  V30 2 N 2.3101 2.6673 0.0 0
M  V30 3 C 4.4137 2.1037 0.0 0
M  V30 4 C 3.8501 0.0000 0.0 0
M  V30 5 C 1.7462 0.5637 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 N 5.7474 2.8737 0.0 0
M  V30 8 O 0.0000 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 3 3 7
M  V30 7 2 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-86-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58004-55-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-22530566
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used, product obtained as mixture of isomers in ratio 9:1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of substituted amino alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schaub, Thomas; Ernst, Martin; Calleja, Pilar; Hashmi, A. Stephen K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020094454 A1 2020-05-14

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetone cyanohydrin
C4H7NO
75-86-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 N 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Cyano-1-methylethyl)formamide
C5H8N2O
58004-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 1.3337 0.0 0
M  V30 2 N 2.3101 2.6673 0.0 0
M  V30 3 C 4.4137 2.1037 0.0 0
M  V30 4 C 3.8501 0.0000 0.0 0
M  V30 5 C 1.7462 0.5637 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 N 5.7474 2.8737 0.0 0
M  V30 8 O 0.0000 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 3 3 7
M  V30 7 2 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-86-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58004-55-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-20235084
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ruthenium-Catalyzed Deaminative Hydrogenation of Amino Nitriles: Direct
Access to 1,2-Amino Alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Calleja, Pilar; Ernst, Martin; Hashmi, A. Stephen K.; Schaub, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2019), 25(40), 9498-9503

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-aminonaphtho[2,1-b]furan-2-carboxylate
C15H13NO3
847200-28-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3304 5.3182 0.0 0
M  V30 2 C 8.3912 3.9554 0.0 0
M  V30 3 O 9.7249 3.1854 0.0 0
M  V30 4 O 8.3912 5.4955 0.0 0
M  V30 5 C 11.0587 3.9554 0.0 0
M  V30 6 C 12.3923 3.1854 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 C 5.6505 3.8119 0.0 0
M  V30 11 C 2.3101 1.3337 0.0 0
M  V30 12 C 2.3101 4.0010 0.0 0
M  V30 13 O 6.8966 1.6538 0.0 0
M  V30 14 C 4.6201 0.0000 0.0 0
M  V30 15 C 7.0575 3.1854 0.0 0
M  V30 16 C 3.0801 0.0000 0.0 0
M  V30 17 C 0.7700 1.3337 0.0 0
M  V30 18 C 0.7700 4.0010 0.0 0
M  V30 19 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14
M  V30 14 2 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 1 12 18
M  V30 18 1 13 15
M  V30 19 2 14 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Naphtho[1′,2′:4,5]furo[3,2-d]pyrimidin-8(9H)-one
C14H8N2O2
877843-14-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.7101 2.7844 0.0 0
M  V30 2 C 4.6201 3.5813 0.0 0
M  V30 3 C 5.6505 2.4369 0.0 0
M  V30 4 C 3.0800 3.5813 0.0 0
M  V30 5 C 5.3901 4.9150 0.0 0
M  V30 6 C 7.0575 3.0633 0.0 0
M  V30 7 N 5.4896 0.9052 0.0 0
M  V30 8 C 2.3100 4.9150 0.0 0
M  V30 9 C 2.3100 2.2477 0.0 0
M  V30 10 O 6.8964 4.5948 0.0 0
M  V30 11 C 4.6201 6.2488 0.0 0
M  V30 12 C 8.3033 2.1580 0.0 0
M  V30 13 C 6.7354 0.0000 0.0 0
M  V30 14 C 3.0800 6.2488 0.0 0
M  V30 15 C 0.7700 4.9150 0.0 0
M  V30 16 C 0.7700 2.2477 0.0 0
M  V30 17 N 8.1423 0.6265 0.0 0
M  V30 18 C 0.0000 3.5813 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 6 10
M  V30 12 1 6 12
M  V30 13 1 7 13
M  V30 14 1 8 14
M  V30 15 2 8 15
M  V30 16 1 9 16
M  V30 17 2 11 14
M  V30 18 1 12 17
M  V30 19 2 13 17
M  V30 20 1 15 18
M  V30 21 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 847200-28-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 877843-14-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7419827
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological study of some new naphtho[2,1-b]furan and
related heterocyclic systems
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Badr, Mahmoud Z. A.; El-Dean, Adel M. Kamal; Moustafa, Osama S.; Zaki,
Remon M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2006), (11), 748-752

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Propen-2-ol, 1,1-diphenyl-, 2-(4-methylbenzenesulfonate)
C22H20O3S
849943-94-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0011 0.0 0
M  V30 2 C 5.3901 5.3348 0.0 0
M  V30 3 O 6.9301 5.3348 0.0 0
M  V30 4 C 4.6201 6.6686 0.0 0
M  V30 5 S 7.7001 6.6686 0.0 0 VAL=6
M  V30 6 O 8.4701 8.0022 0.0 0
M  V30 7 O 6.3664 7.4386 0.0 0
M  V30 8 C 13.0350 3.5885 0.0 0
M  V30 9 C 5.3901 2.6675 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 6.9301 2.6675 0.0 0
M  V30 12 C 5.3901 0.0000 0.0 0
M  V30 13 C 7.7001 1.3337 0.0 0
M  V30 14 C 6.9301 0.0000 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 2.3100 2.6675 0.0 0
M  V30 17 C 2.3100 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.7700 5.3348 0.0 0
M  V30 20 C 0.0000 4.0011 0.0 0
M  V30 21 C 9.0339 5.8986 0.0 0
M  V30 22 C 9.0339 4.3586 0.0 0
M  V30 23 C 10.3675 6.6686 0.0 0
M  V30 24 C 10.3675 3.5885 0.0 0
M  V30 25 C 11.7012 5.8986 0.0 0
M  V30 26 C 11.7012 4.3586 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 1 15
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 2 5 6
M  V30 8 2 5 7
M  V30 9 1 5 21
M  V30 10 1 8 26
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Methyl-2,2-diphenylethenyl)formamide
C16H15NO
849944-12-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 C 5.3348 5.3901 0.0 0
M  V30 3 N 6.6685 4.6201 0.0 0
M  V30 4 C 5.3348 6.9302 0.0 0
M  V30 5 C 8.0023 5.3901 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 5.3901 0.0 0
M  V30 8 C 2.6675 6.9302 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 1.3337 7.7002 0.0 0
M  V30 11 C 0.0000 5.3901 0.0 0
M  V30 12 C 0.0000 6.9302 0.0 0
M  V30 13 C 4.0012 3.0801 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 2.6675 0.7700 0.0 0
M  V30 18 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 2 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 849943-94-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 849944-12-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-5140526
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51364-51-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 97239-80-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-(2,2-Diphenyl-1-methylethenyl)formamide (Table 2, entry 9). A Schlenk
tube was charged with Pd2dba3 (18.3 mg, 0.0200 mmol, 4.0 mol% Pd), dipf
(33.5 mg, 0.0800 mmol, 8.0 mol%), 2,2-diphenyl-1-methylethenyl tosylate
(364 mg, 1.00 mmol), K3PO4 (425 mg, 2.00 mmol), evacuated and backfilled
with N2. Formamide (80 μL, 2.01 mmol) and tert-amyl alcohol (4.0 mL) were
added. The Schlenk tube was sealed and the reaction mixture was stirred
at 100 °C for 20 h. The resulting brown suspension was filtered eluting
with MeOH (30 mL). The filtrate was concentrated and the residue was
purified by flash chromatography on silica gel (hexane:EtOAc = 2:1).
Fractions containing the product were repurified by flash chromatography
on silica gel (CH2Cl2:hexane:EtOAc = 8:4:1) to provide 216 mg of the
desired enamide (91% yield) as a white solid.
N-(2,2-Diphenyl-1-methylethenyl)formamide (Table 2, entry 9), yield 216
mg (91%) Mp: 115-116 °C; NMR spectra displayed two sets of signals (6:1
ratio) due to amide rotamers. 1H NMR (400 MHz, CDCl3) δ 8.58 (d, J = 11.5
Hz, 0.86H), 8.08 (d, J = 1.7 Hz, 0.14H), 7.46 (br d, J = 11.5 Hz, 0.86H),
7.40-7.13 (m, 10H), 6.83 (br s, 0.14H), 2.36 (s, 0.42H), 2.18 (s, 2.58H)
ppm; 13C NMR (100 MHz, CDCl3; mj = major, mn = minor sets of signals) δ
160.7 (mj), 159.1 (mn), 140.4 (mj), 138.9 (mj), 130.1 (mj), 129.9 (mn),
129.7 (mj), 129.6 (mn), 129.3 (mj), 129.0 (mn), 128.3 (mj), 128.2 (mn),
127.70 (mj), 127.68 (mj), 127.4 (mn), 126.9 (mj), 123.9 (mj), 18.1 (mn),
16.2 (mj) ppm; IR (neat) cm-1; Anal. Calcd. for C16H15NO: C, 80.98; H,
6.37; N, 5.90. Found: C, 80.94; H, 6.28; N, 5.82.
$DTYPE RXN:VAR(1):NOTES
$DATUM in-situ generated catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of Enamides via Palladium-Catalyzed Amidation of Enol
Tosylates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Klapars, Artis; Campos, Kevin R.; Chen, Cheng-yi; Volante, Ralph P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2005), 7(6), 1185-1188

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-amino-4-methylthiophene-2-carboxylate
C7H9NO2S
85006-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.5400 0.0 0
M  V30 2 O 6.6363 2.3101 0.0 0
M  V30 3 O 5.3026 0.0000 0.0 0
M  V30 4 C 7.9700 1.5400 0.0 0
M  V30 5 N 2.2418 0.1773 0.0 0
M  V30 6 C 0.0000 2.6672 0.0 0
M  V30 7 C 3.9690 2.3101 0.0 0
M  V30 8 C 2.5620 1.6836 0.0 0
M  V30 9 S 3.8079 3.8416 0.0 0
M  V30 10 C 1.5316 2.8281 0.0 0
M  V30 11 C 2.3016 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methylthieno[3,2-d]pyrimidin-4(3H)-one
C7H6N2OS
175137-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0801 0.0 0
M  V30 2 C 6.6520 3.0203 0.0 0
M  V30 3 C 2.6675 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 S 2.9877 4.5864 0.0 0
M  V30 7 C 5.1456 3.3405 0.0 0
M  V30 8 N 4.0012 0.7700 0.0 0
M  V30 9 N 1.3337 0.7700 0.0 0
M  V30 10 C 4.5192 4.7473 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 7
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 85006-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 175137-13-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10980134
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM <Step 1 > Preparation of 7-methy3H-thieno[3,2-d]pyrimidin-4-one
3-amino-4-methylhiophene-2-carboxylic acid methyl ester (10.2 g, 59.6
mmol) was dissolved in formamide (25 mL), followed by refluxing for 24
hours at 200°C. The reaction solution was slowly cooled to room
temperature. The resulting solid was filtered, washed with diethyl ether,
and dried to obtain the title compound. Yield (9 g, 91%). 1 Spectrum (300
MHz, DMSO-d6): δ 8.17 (s, 1H), 7.81 (s, 1H), 2.31 (s, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thieno[3,2-d]pyrimidine derivatives having inhibitory
activity for protein kinases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bae, In Hwan; Son, Jung Beom; Han, Sang Mi; Kwak, Eun Joo; Kim, Ho Seok;
Song, Ji Young; Byun, Eun Young; Jun, Seung Ah; Ahn, Young Gil; Suh, Kwee
Hyun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013100632 A1 2013-07-04

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-3-phenyl-1H-pyrazol-5-amine
C15H12ClN3
890764-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0177 0.0000 0.0 0
M  V30 2 Cl 4.0011 5.6420 0.0 0
M  V30 3 N 4.0011 2.5620 0.0 0
M  V30 4 N 5.4081 3.1885 0.0 0
M  V30 5 C 4.1621 1.0304 0.0 0
M  V30 6 C 6.4385 2.0439 0.0 0
M  V30 7 C 5.6685 0.7103 0.0 0
M  V30 8 C 2.6675 3.3320 0.0 0
M  V30 9 C 2.6675 4.8720 0.0 0
M  V30 10 C 1.3338 2.5620 0.0 0
M  V30 11 C 1.3338 5.6420 0.0 0
M  V30 12 C 0.0000 3.3320 0.0 0
M  V30 13 C 0.0000 4.8720 0.0 0
M  V30 14 C 7.9701 2.2048 0.0 0
M  V30 15 C 8.8753 0.9590 0.0 0
M  V30 16 C 8.5966 3.6118 0.0 0
M  V30 17 C 10.4069 1.1201 0.0 0
M  V30 18 C 10.1281 3.7727 0.0 0
M  V30 19 C 11.0333 2.5269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C17H11ClN4
1400634-59-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 7.5408 0.0 0
M  V30 2 N 4.0011 4.4608 0.0 0
M  V30 3 C 4.1620 2.9292 0.0 0
M  V30 4 N 5.4080 5.0873 0.0 0
M  V30 5 C 5.6685 2.6091 0.0 0
M  V30 6 N 3.1316 1.7849 0.0 0
M  V30 7 C 6.4385 3.9427 0.0 0
M  V30 8 C 6.1443 1.1444 0.0 0
M  V30 9 C 3.6075 0.3202 0.0 0
M  V30 10 N 5.1139 0.0000 0.0 0
M  V30 11 C 2.6674 5.2308 0.0 0
M  V30 12 C 2.6674 6.7708 0.0 0
M  V30 13 C 1.3338 4.4608 0.0 0
M  V30 14 C 1.3338 7.5408 0.0 0
M  V30 15 C 0.0000 5.2308 0.0 0
M  V30 16 C 0.0000 6.7708 0.0 0
M  V30 17 C 7.9700 4.1037 0.0 0
M  V30 18 C 8.8752 2.8578 0.0 0
M  V30 19 C 8.5965 5.5106 0.0 0
M  V30 20 C 10.4068 3.0187 0.0 0
M  V30 21 C 10.1280 5.6715 0.0 0
M  V30 22 C 11.0332 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 890764-10-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-59-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-4070203
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot synthesis pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis and antiproliferative evaluation of
pyrazolo[3,4-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yu-Ying; Wang, Li-Ya; Chang, Chun-Hsi; Kuo, Yueh-Hsiung; Kaneko,
Kimiyoshi; Takayama, Hiroyuki; Kimura, Masayuki; Juang, Shin-Hun; Wong,
Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(47), 9658-9664

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-3-phenyl-1H-pyrazol-5-amine
C15H12ClN3
890764-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0177 0.0000 0.0 0
M  V30 2 Cl 4.0011 5.6420 0.0 0
M  V30 3 N 4.0011 2.5620 0.0 0
M  V30 4 N 5.4081 3.1885 0.0 0
M  V30 5 C 4.1621 1.0304 0.0 0
M  V30 6 C 6.4385 2.0439 0.0 0
M  V30 7 C 5.6685 0.7103 0.0 0
M  V30 8 C 2.6675 3.3320 0.0 0
M  V30 9 C 2.6675 4.8720 0.0 0
M  V30 10 C 1.3338 2.5620 0.0 0
M  V30 11 C 1.3338 5.6420 0.0 0
M  V30 12 C 0.0000 3.3320 0.0 0
M  V30 13 C 0.0000 4.8720 0.0 0
M  V30 14 C 7.9701 2.2048 0.0 0
M  V30 15 C 8.8753 0.9590 0.0 0
M  V30 16 C 8.5966 3.6118 0.0 0
M  V30 17 C 10.4069 1.1201 0.0 0
M  V30 18 C 10.1281 3.7727 0.0 0
M  V30 19 C 11.0333 2.5269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 6 14
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine
C17H11ClN4
1400634-59-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 7.5408 0.0 0
M  V30 2 N 4.0011 4.4608 0.0 0
M  V30 3 C 4.1620 2.9292 0.0 0
M  V30 4 N 5.4080 5.0873 0.0 0
M  V30 5 C 5.6685 2.6091 0.0 0
M  V30 6 N 3.1316 1.7849 0.0 0
M  V30 7 C 6.4385 3.9427 0.0 0
M  V30 8 C 6.1443 1.1444 0.0 0
M  V30 9 C 3.6075 0.3202 0.0 0
M  V30 10 N 5.1139 0.0000 0.0 0
M  V30 11 C 2.6674 5.2308 0.0 0
M  V30 12 C 2.6674 6.7708 0.0 0
M  V30 13 C 1.3338 4.4608 0.0 0
M  V30 14 C 1.3338 7.5408 0.0 0
M  V30 15 C 0.0000 5.2308 0.0 0
M  V30 16 C 0.0000 6.7708 0.0 0
M  V30 17 C 7.9700 4.1037 0.0 0
M  V30 18 C 8.8752 2.8578 0.0 0
M  V30 19 C 8.5965 5.5106 0.0 0
M  V30 20 C 10.4068 3.0187 0.0 0
M  V30 21 C 10.1280 5.6715 0.0 0
M  V30 22 C 11.0332 4.4257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 17
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 890764-10-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400634-59-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28603100
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Standard Procedure for Synthesis of
Pyrazolo[3,4-d]-pyrimidines (17-32, 65, 66, and 73-76). The reliable
procedure involved the treatment of 5-aminopyrazoles (1-16; 1.0 equiv),
5- amino-4-formylpyrazoles (37-41; 1.0 equiv), 5-aminoquinoline (61; 1.0
equiv), 8-aminoquinoline (62; 1.0 equiv), 5-aminopyrimidine (68; 1.0
equiv), or 2-aminopyrazines (69-71; 1.0 equiv) with PBr3 (~ 3 equiv) in
formamide solution (2 mL) at 50-60 °C over 0.5-1 h. When the reaction was
complete, the reaction mixture was added to saturated sodium bicarbonate
(15 mL) and extracted with dichloromethane (15 mL). The organic extracts
were dried over MgSO4, filtered, and concentrated under reduced pressure.
The residue solution was purified by column chromatography on silica gel
to give the corresponding aromatic or heterocyclic fused pyrimidine
products (17-32, 65, 66, and 73-76) in 82-96% yields.
1-(2-Chlorophenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine (19). The
standard procedure involved the treatment of
5-amino-1-(2-chlorophenyl)-3-phenyl-1H-pyrazole (3; 99 mg, 0.32 mmol, 1.0
equiv) with PBr3 (0.09 mL, 0.97 mmol, 3.0 equiv) in formamide solution (2
mL) at 50-60 °C over 0.5-1.0 h. The reaction mixture was then worked up,
and the residue was purified by chromatography on silica gel to give pure
19: 91% yield (89 mg), yellow solid. Mp 142-143 °C (hexane-EtOAc). 1H NMR
(CDCl3, 500 MHz): δ 7.43-7.49 (3H, m), 7.50-7.56 (2H, m), 7.57-7.65 (2H,
m), 8.02-8.08 (2H, m), 9.07 (1H, s), 9.52 (1H, s). 13C NMR (125 MHz,
CDCl3): δ 122.9, 127.3 (2 × C), 127.6, 129.2 (2 × C), 129.6 (2 × C),
130.7 (2 × C), 131.4, 132.1, 134.7, 145.6, 152.8, 154.5, 155.9. IR (KBr):
3061, 2924, 2370, 2349, 1581, 1557, 1516, 1497, 1304, 1223, 1088 cm-1.
EIMS m/z (rel int): 306 (89, M+). Anal. Calcd for C17H11ClN4: C, 66.56;
H, 3.61; N, 18.26. Found: C, 66.59; H, 3.58; N, 18.22.
$DTYPE RXN:VAR(1):NOTES
$DATUM sequential three-component heterocyclization, one-pot multi-component
process
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of Electrophilic Heteroaromatic Substitution: Synthesis of
Heteroaromatic-Fused Pyrimidine Derivatives via Sequential
Three-Component Heterocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying; Chang, Chun-Hsi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(19), 8492-8500

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichlorobenzoyl chloride
C7H3Cl3O
89-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichlorobenzamide
C7H5Cl2NO
2447-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 N 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-75-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2447-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-11702109
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure for Amination All the
experiments were carried out in a parallel synthesizer from REDLEYS
Discovery Technologies, UK. A solution of acid chloride 1a (1.0 gm 7.11
mmol) in formamide (10 ml) was heated to 100-120 °C and maintained at
same temperature for 5 to 6 hours, the reaction mixture was cooled to
room temperature. The reaction mass quenched in excess water and
extracted with dichloromethane. The combined organic solvent was washed
with saturated NaHCO3 aqueous solution and dried over anhydrous Na2SO4.
The solvent was evaporated under reduced pressure to give the residue
which was purified by column chromatography using silica gel and EtOAc=
hexane as eluent. An amount of 0.77 g (6.4 mmol, 90%) of 2a was obtained
as crystals. Compound 2e. Yield 91% Mp in °C (Lit): 191-194; Mp in °C
(Obs.): 190-192
$DTYPE RXN:VAR(1):NOTES
$DATUM excess water used in stage 2, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide as an ammonia synthon in amination of acid chlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasan, S.; Manisankar, P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2010), 40(23), 3538-3543

